Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5783646980634424,-2.376907847253897,0.0,0.0,0.0,48/91,17.48%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPL41;RPS18;RPS7;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPS5;RPL10A;RPL11;RPL36A;SRP14;RPL34;RPS29;RPL32;RPLP2;RPLP0;RPL4;RPL30;RPS4X;SSR2;RPS21;RPL26;RPL29;RPS8;ARL6IP1;SRP68;RPS23;RPL31;RPL23A;RPL19;RPL36
prerank,cytoplasmic translation (GO:0002181),-0.5783711265931993,-2.373448807192688,0.0,0.0,0.0,59/91,27.95%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPL41;RPS18;RPS7;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPS5;RPL10A;RPL11;DRG2;RPL36A;FTSJ1;RPL34;RPL22L1;RPS29;RPL32;RPLP0;RPL4;RPL30;RPS4X;RPS21;RPL26;RPL29;RPS8;RPS23;RPL31;RPL23A;RPL19;RPL36;GSPT2;RPL17;RPL23;UBA52;RPS11;RPL15;RPL38;GSPT1;RPL13A;RPS12;RPL18A;RPS25;RPL24
prerank,establishment of endothelial barrier (GO:0061028),-0.7347744845833165,-2.3610615654534146,0.0,0.0,0.0,21/29,20.24%,TJP1;RAPGEF2;PECAM1;AFDN;RAPGEF6;EZR;F11R;RDX;RAP1A;TJP2;RAPGEF1;PPP1R16B;ROBO4;ICAM1;RAPGEF3;RAP2C;RAB1A;SOX18;RAP2B;MSN;RAB1B
prerank,protein targeting to ER (GO:0045047),-0.5635022342251008,-2.3410636834870786,0.0,0.0,0.0,58/99,23.84%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPL41;RPS18;RPS7;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;SPCS2;RPS5;RPL10A;RPL11;RPL36A;SRP14;RPL34;RPS29;RPL32;RPLP2;RPLP0;RPL4;RPL30;RPS4X;RPS21;RPL26;RPL29;RPS8;SRP68;RPS23;RPL31;RPL23A;SGTB;RPL19;RPL36;CHMP4B;CHMP4A;EDEM1;RPL17;RPL23;UBA52;ZFAND2B;RPS11;RPL15;RPL38
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5736838335953937,-2.3073545665530166,0.0,0.0,0.0,52/87,23.84%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPL41;RPS18;RPS7;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPS5;RPL10A;RPL11;RPL36A;SRP14;RPL34;RPS29;RPL32;RPLP2;RPLP0;RPL4;RPL30;RPS4X;RPS21;RPL26;RPL29;RPS8;SRP68;RPS23;RPL31;RPL23A;RPL19;RPL36;RPL17;RPL23;UBA52;ZFAND2B;RPS11;RPL15;RPL38
prerank,collagen fibril organization (GO:0030199),0.672186896310912,2.2406366880862563,0.0,0.002633185350749062,0.003,26/88,6.89%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;COL23A1;LOXL4;LUM;PLOD1;COL7A1;COL10A1;ADAMTS14;COL22A1;DPT;COLGALT1;LOXL3;LOXL2;COLGALT2;COL1A2;NF1;COL12A1;COL26A1;COL16A1;COL4A2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5221691989767716,-2.2176301850949325,0.0,0.0010213739522405539,0.004,60/110,23.84%,RPS14;RPS9;RPS16;SMG6;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;PPP2R1A;RPL41;RPS18;RPS7;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPS5;RPL10A;RPL11;HELZ2;RPL36A;PYM1;RPL34;RPS29;RPL32;RPLP2;RPLP0;RPL4;RPL30;RPS4X;RPS21;RPL26;RPL29;SMG5;RPS8;RPS23;RPL31;PABPC1;EIF3E;RPL23A;RPL19;RPL36;GSPT2;RBM8A;RPL17;RPL23;UBA52;NCBP2;RPS11;RPL15;MAGOH;RPL38
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.666295366512019,-2.207293902849174,0.0,0.0008754633876347606,0.004,18/34,14.71%,FLT1;FOXC1;GAS1;NRP1;KDR;NOTCH1;VEGFD;ANXA1;VEGFC;SEMA6A;GAB1;MAPK14;ITGB1BP1;NR4A1;HSPB1;FLT4;RAMP2;ERN1
prerank,regulation of cell junction assembly (GO:1901888),-0.6844454530634917,-2.159985853344308,0.0,0.0026045035782134127,0.016,12/27,6.20%,TJP1;RAPGEF2;ROCK2;PRKCH;MEF2C;PDLIM5;OCLN;F11R;CLDN5;RAP1A;RUNX1;RAPGEF1
prerank,dopamine metabolic process (GO:0042417),-0.7193424339309242,-2.090701075792951,0.0,0.008170991617924431,0.054,6/18,8.19%,SNCAIP;MOXD1;TGFB2;MAOB;MAOA;GCH1
prerank,extracellular structure organization (GO:0043062),0.570165412830935,2.080427610412358,0.0,0.04695847208835827,0.091,49/204,6.89%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;COL18A1;DCN;LAMC1;LAMB1;COL4A1;ITGA11;COL23A1;NID1;ITGA8;LUM;ITGAD;TGFBI;COL7A1;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;ADAMTS6;COL22A1;ITGA3;ITGB5;ITGAE;VCAN;MMP28;MMP24;MMP25;TNR;ST7;SPP1;RECK;APLP1;COL1A2;ADAM19;NF1;MMP11;COLQ;ADAMTS12;TEX14;COL16A1;COL4A2
prerank,external encapsulating structure organization (GO:0045229),0.5695203614758358,2.0757084398143184,0.0,0.03627944261032041,0.101,48/205,6.89%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;COL18A1;DCN;LAMC1;LAMB1;COL4A1;ITGA11;COL23A1;NID1;ITGA8;LUM;ITGAD;TGFBI;COL7A1;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;ADAMTS6;COL22A1;ITGA3;ITGB5;ITGAE;VCAN;MMP28;MMP24;MMP25;TNR;ST7;SPP1;RECK;APLP1;COL1A2;ADAM19;NF1;MMP11;COLQ;ADAMTS12;COL16A1;COL4A2
prerank,extracellular matrix organization (GO:0030198),0.5545730183385076,2.067636323726125,0.0,0.030720495758739058,0.111,61/276,6.89%,LAMA1;COL15A1;SCUBE1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;FLRT2;COL18A1;DCN;LAMC1;LAMB1;COL4A1;ITGA11;GPM6B;COL23A1;LOXL4;NID1;ITGA8;LUM;ITGAD;TGFBI;PLOD1;COL7A1;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;ADAMTS6;COL22A1;ITGA3;ITGB5;DPT;ITGAE;VCAN;MMP28;MMP24;MMP25;TNR;COLGALT1;ST7;SPP1;LOXL3;LOXL2;COLGALT2;RECK;APLP1;KLKB1;COL1A2;ADAM19;NF1;COL12A1;COL26A1;MMP11;COLQ;ADAMTS12;COL16A1;COL4A2
prerank,muscle cell development (GO:0055001),-0.6326930687411868,-2.0323518842644837,0.0,0.01924268526021204,0.135,11/30,17.70%,NEBL;MYOF;IGF1;CXADR;ANK2;DMD;MYH11;HEY2;RAMP2;DYSF;SDC1
prerank,vascular process in circulatory system (GO:0003018),-0.791723358559246,-2.029696535013983,0.00234192037470726,0.017159082397641304,0.142,10/13,18.06%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,regulation of tube diameter (GO:0035296),-0.791723358559246,-2.029696535013983,0.00234192037470726,0.017159082397641304,0.142,10/13,18.06%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.8031589300094519,-2.0243269270090645,0.0,0.017064801725126793,0.149,6/12,8.04%,MBNL1;CYP26B1;TGFB2;SKI;MEGF8;LRP6
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.7642997265347633,-2.0046881786173567,0.0,0.022849594417267253,0.207,9/14,13.22%,FOXC1;NRP1;KDR;VEGFD;VEGFC;GAB1;PIK3CD;MYO1C;FLT4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.7074668654901529,-1.9694971037232936,0.0,0.035053554040895815,0.307,10/17,12.08%,DOCK5;IGF1;DOCK4;ADAMTS1;IGFBP5;NRP1;S100A11;VTN;CCN4;MDK
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.731495846507719,1.9650427271307747,0.0,0.19274916767483133,0.533,5/25,6.68%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,epithelial cell morphogenesis (GO:0003382),0.8098852055084909,1.9647866001503265,0.0,0.160916882545776,0.533,4/17,5.83%,COL15A1;COL18A1;COL22A1;SIPA1L3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.5756987424509505,-1.9491194733594466,0.0,0.04657465222216926,0.402,21/36,22.14%,CAV1;NPR3;EGFR;NOS3;ZDHHC21;NOSTRIN;SCARB1;CALM1;APOE;GCH1;PIK3CB;TERT;DDAH1;DHFR;NOS1AP;WASL;AKT1;NOSIP;NUS1;LYPLA1;DDAH2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7866066940986389,-1.9444233064224234,0.002325581395348837,0.04679094317676138,0.425,10/11,20.24%,TJP1;RAPGEF2;AFDN;RAPGEF6;F11R;TJP2;RAP2C;RAB1A;RAP2B;RAB1B
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.5400061117883191,-1.931784199954991,0.0,0.0542009110655654,0.498,17/44,11.11%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6585258214640488,-1.9242037478542227,0.0024875621890547263,0.05689590479217906,0.546,9/20,16.33%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,icosanoid secretion (GO:0032309),-0.7619829473950501,-1.9149311493018164,0.0,0.06060833032595448,0.583,4/12,6.23%,ABCC4;ANXA1;ACE;BDKRB2
prerank,positive regulation of wound healing (GO:0090303),-0.5679310175226774,-1.9131195938418055,0.0,0.059006232326582864,0.59,11/36,5.28%,OCLN;PLPP3;MYLK;ITGB1;THBS1;FOXC2;ST3GAL4;ACTG1;KANK1;VTN;ANXA1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7731798746562771,-1.9054645763562563,0.0,0.06289806502252283,0.633,6/12,2.54%,DOCK5;MEF2C;DOCK4;ADAMTS1;IGFBP5;TPM1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5616497520851288,-1.9054422834041924,0.0,0.06016336654328271,0.633,17/35,17.93%,PLXNA2;SEMA3D;SEMA3C;PLXNA4;SEMA7A;NRP2;NRP1;RAC1;SEMA6A;SEMA4B;PLXNB1;SEMA5B;FLNA;MET;SEMA6C;SEMA3G;SEMA6B
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.5992474954317089,-1.8891816171184528,0.0,0.07032159661176214,0.703,13/27,19.62%,HMBOX1;BMPR2;DACH1;SMG6;PDGFA;ACVRL1;NIBAN2;SMG5;ATM;CDKN1A;PARP4;HGF;RGCC
prerank,carbohydrate biosynthetic process (GO:0016051),-0.6340180152831095,-1.8741703370892357,0.005,0.08113794676598962,0.764,9/21,16.33%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,negative regulation of hemostasis (GO:1900047),-0.7313067508258091,-1.8730446242761742,0.0,0.07919576491219064,0.77,7/12,15.14%,THBD;VTN;CD34;APOE;SERPINE1;EDN1;SERPINE2
prerank,cell junction organization (GO:0034330),-0.4873531542604833,-1.865212838912881,0.0,0.0841158192667443,0.804,17/71,9.53%,SDK1;TJP1;APBB2;LIMS2;OCLN;CXADR;SLC8A3;ACTB;APP;ACTG1;TGFB2;DVL1;TJP2;CDC42;MAPT;SMAD3;PPFIBP1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.417650772085686,-1.8582621266442136,0.0,0.08807161679605692,0.83,63/168,17.48%,DDX5;CSDE1;RPS14;RPS9;RPS16;SMG6;TUT7;RPLP1;RPL13;SAMD4A;CNOT10;RPL27A;RPS2;RPL37A;RPL5;RPL8;PPP2R1A;RPL41;RPS18;RPS7;RPS20;PARN;RPS19;NBAS;PAN3;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;CNOT8;RPS5;RPL10A;RPL11;RC3H1;ERI1;HELZ2;RPL36A;PYM1;RPL34;RPS29;RPL32;RPLP2;RPLP0;RPL4;RPL30;RPS4X;RPS21;RPL26;RPL29;POLR2G;SMG5;RPS8;ATM;RPS23;RPL31;PABPC1;EIF3E;RPL23A;RPL19;RPL36
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6741752972616601,1.8566461504487581,0.00625,0.638484752667344,0.951,5/32,6.68%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.5073856221277949,-1.8553226694389038,0.0,0.08795086322534867,0.837,17/51,11.11%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A
prerank,negative regulation of vascular permeability (GO:0043116),-0.7371301781984771,-1.8552700077508892,0.002242152466367713,0.08510087770068296,0.837,7/12,13.97%,PTPRJ;SLIT2;CLDN5;PDE3A;CEACAM1;DDAH1;RAMP2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6444681695382708,-1.8541758374286712,0.0022935779816513763,0.08350226272769226,0.839,11/19,19.57%,TJP1;ROCK2;PRKCH;OCLN;F11R;CLDN5;RUNX1;MYO1C;EPHA2;SNAI1;NPHP4
prerank,genitalia development (GO:0048806),0.7969465406169098,1.8387971016056457,0.0017452006980802793,0.6902237100650979,0.974,4/12,4.32%,CHD7;WNT5A;DNAJC19;TBX3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.8006698736053414,1.8374766384369605,0.0017543859649122807,0.6234797758273611,0.977,5/12,8.12%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7250685429009934,-1.8373113857515606,0.0047169811320754715,0.09996697557554422,0.895,5/12,10.09%,CAV1;CAMK2D;CALM1;SRI;GJD3
prerank,regulation of cellular component biogenesis (GO:0044087),-0.5277144906681878,-1.8362359329596265,0.0,0.09808904028608374,0.899,15/39,12.62%,SNCAIP;TJP1;RAPGEF2;ROCK2;EZR;TIE1;RDX;RAP1A;HSPA8;NOTCH1;RAPGEF1;APOE;PARP10;NCLN;VPS11
prerank,lipid catabolic process (GO:0016042),0.737355653875083,1.8324219675041526,0.0049261083743842365,0.5937832965939135,0.98,5/18,5.18%,HSD11B1;CEL;ACADL;LIPC;LIPH
prerank,anterograde trans-synaptic signaling (GO:0098916),0.4909677895543072,1.82993233175105,0.0,0.5562404569718701,0.984,64/224,15.41%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;CEL;SLC18A3;CHRNB4;NRXN2;GRIN2B;NOVA1;NRXN1;GABRA1;GRIK2;ASIC2;KCNQ3;GRIA4;GRIA1;GABRD;PCDHB16;SCN2B;SLC12A6;PDYN;HTR2B;DLG2;GRIK4;CAMKK2;KCNIP2;GRIN2A;GRIK1;PCDHB4;PTCHD1;PCDHB11;GPR176;LPAR3;PRKACB;HTR5A;HTR1A;GABRG3;NPY;PRKACA;CACNB4;HTR2C;MBP;CAMK4;PLP1;GLRA3;GABRG2;GRM5;KCND2;GLRA1;DLG4;SYT5;CBLN1;HTR4;GLRA2;ATXN3;GABRB1;SYN2;PRKAR1A;GLRB;APBA2
prerank,regulation of tissue remodeling (GO:0034103),-0.6413681412974739,-1.8280441820763298,0.004739336492890996,0.10500925845447295,0.916,7/18,13.22%,LEPR;IL18;CST3;RUNX1;MDK;CEACAM1;FLT4
prerank,myelin maintenance (GO:0043217),0.8191934288937731,1.8198733529351885,0.0033277870216306157,0.5724252376378377,0.991,7/10,15.08%,EPB41L3;PTEN;ABCD2;PRX;DEGS1;MYRF;CLU
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.6499308397942064,1.8197936346033208,0.003125,0.5287976324888886,0.991,9/32,14.99%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;TRPC3;P2RX4;AKAP6;F2R
prerank,atrial septum morphogenesis (GO:0060413),-0.7617280260657049,-1.814955268735765,0.004395604395604396,0.1188178909697897,0.939,6/10,12.55%,NOTCH2;BMPR2;TGFB2;SOX4;ACVR1;HEY2
prerank,muscle contraction (GO:0006936),-0.42134961980732094,-1.8123322216313547,0.0,0.11956884400896084,0.948,29/126,13.32%,SORBS1;MYOF;TMOD3;ROCK2;SNTB1;SORBS3;ACTN2;VIM;VCL;CALD1;MYLK;EDNRA;TPM1;SNTA1;MYL6;CRYAB;BDKRB2;CALM1;ITGA1;MYL9;DMD;MYH11;GJC1;LMOD1;KCNJ12;ACTA2;DTNA;NOS1;TMOD1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7430866471621007,1.8120027261670757,0.003367003367003367,0.5347874057592737,0.995,7/16,12.66%,APOD;PPARA;ABCD2;ADCY7;APPL2;PYCARD;PDCD4
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.6556579188776436,-1.8107588418261429,0.007058823529411765,0.1185897972655519,0.951,5/17,3.66%,ROCK2;VCL;F11R;CLDN5;ZDHHC21
prerank,organophosphate ester transport (GO:0015748),-0.5997607782058566,-1.8092774057669312,0.0,0.11746875581242414,0.955,11/24,17.43%,PITPNC1;OSBPL8;EPG5;PLTP;PITPNA;SCARB1;ABCA3;TNFAIP8L3;PRELID2;PRELID1;PCTP
prerank,translation (GO:0006412),-0.386563695915286,-1.7946518043056245,0.0,0.13497849614994398,0.971,101/208,29.35%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPL41;RPS18;RPS7;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;EEF1G;RPL35A;RPS15A;RPS5;ABCF1;RPL10A;RPL11;DRG2;RPL36A;FTSJ1;EEF1A1;RPL34;RPL22L1;KARS1;RPS29;RPL32;RPLP2;RPLP0;RPL4;EEF2K;RPL30;RPS4X;RPS21;RPL26;RPL29;IARS2;GARS1;RPS8;EEF1D;EEFSEC;MRPS7;RPS23;APEH;RPL31;NOA1;RPL23A;GTPBP1;RPL19;SRBD1;RPL36;MRPS17;AGO2;MRPL16;GSPT2;MRPL2;EEF1E1;MRPS18A;MRPS18B;RARS1;RPL17;RPL23;GATC;UBA52;RPS11;MRPL24;PTCD3;QARS1;RPL15;MRPL57;RPL38;MRPL55;LARS2;MRPS34;HARS2;GSPT1;TRMT112;MRPL36;MRPL35;RPL13A;MRPS12;RPS12;RPL18A;RPS25;RPL24;MRPL34;FASTKD2;FARSB;EIF4EBP2;MRPL18;GTPBP2
prerank,platelet degranulation (GO:0002576),-0.4233325392697799,-1.7938166800340052,0.0,0.13289096492601848,0.971,39/118,19.41%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;ANXA5;LHFPL2;PCDH7;APP;ECM1;SPARC;SRGN;TGFB2;VEGFD;VEGFC;CD109;PDGFA;CALM1;ENDOD1;SERPINE1;TAGLN2;CD63;ITGB3;LGALS3BP;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;ALDOA;EGF;LAMP2;HGF;TIMP3
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7249588412883099,-1.7921097445389278,0.0,0.13242985195392157,0.973,6/11,18.57%,NOS3;CALM1;GCH1;DHFR;AKT1;PRKG2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.7082158952221755,1.7868154411955584,0.008064516129032258,0.648290233354419,0.999,5/19,8.12%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,positive regulation of angiogenesis (GO:0045766),-0.41725664106368354,-1.7865024041332886,0.0,0.13782711932663247,0.978,40/108,14.81%,FLT1;ANXA3;TJP1;TEK;ITGB8;BMPER;ITGB1;NOS3;THBS1;KLF4;FOXC2;TIE1;ECM1;KDR;VEGFD;CYP1B1;CD34;RUNX1;VEGFC;GAB1;HIPK1;FGF1;HK2;HYAL1;GATA2;PIK3CD;SERPINE1;ETS1;CTSH;HSPB1;MDK;HIPK2;PKM;SMAD1;RAPGEF3;RRAS;RAMP2;CDH5;GATA6;PIK3R6
prerank,lymphocyte chemotaxis (GO:0048247),0.6186883807073822,1.7797917016703186,0.0030816640986132513,0.6552242881113917,0.999,7/34,10.64%,CYP7B1;XCL1;CXCL10;MSMP;CCL15;GPR183;CCL25
prerank,myotube cell development (GO:0014904),-0.7579124199822459,-1.7763936950862607,0.0023094688221709007,0.14978567774020776,0.986,4/10,5.84%,IGF1;SKI;CAV2;SIX1
prerank,chemical synaptic transmission (GO:0007268),0.4678266354421256,1.7712171235094236,0.0,0.6711008468438492,0.999,79/284,15.41%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;PTEN;CEL;SLC18A3;CHRNB4;NRXN2;GRID2;PTPRN2;GRIN2B;NOVA1;NRXN1;GRID1;GABRA1;GRIK5;GRIK2;ASIC2;KCNQ3;GRIA4;GRIA1;GABRD;PCDHB16;SCN2B;SLC12A6;VAMP2;PDYN;HTR2B;CHAT;DLG2;GRIK4;CAMKK2;KCNIP2;GRIN2A;FCHSD2;NAPB;GRIK1;PCDHB4;PTCHD1;PCDHB11;GPR176;LPAR3;PRKACB;SNPH;HTR5A;HTR1A;GABRG3;NPY;PRKACA;CACNB4;HTR2C;MBP;CAMK4;PLP1;GLRA3;ERC2;GABRG2;GRM5;KCND2;GLRA1;DLG4;SHISA6;RIMS1;SYT5;DNAJC5;CBLN1;HTR4;GLRA2;UNC13A;ATXN3;GABRB1;SYN2;PRKAR1A;GLRB;APBA2
prerank,organic anion transport (GO:0015711),-0.45597689184931967,-1.770824502835815,0.0,0.1544595972320147,0.991,29/76,26.00%,ABCG2;ABCC4;SLC4A10;LRRC8C;SLC16A2;SLC26A7;SLCO2A1;SLCO1C1;SLC22A6;SLC39A8;SLC4A3;LRRC8D;ABCC6;CA4;SLC4A8;CYB5R1;SLC35A2;SLC26A6;SLC52A3;SLCO5A1;SLC35C2;SLC35B2;CFTR;SLC17A9;SLC4A7;CYB5R4;SLC25A4;SLCO4A1;SLC52A2
prerank,neuron cell-cell adhesion (GO:0007158),0.7339280920007331,1.7645861204230417,0.010380622837370242,0.67682616052587,1.0,7/14,8.82%,ASTN2;CEL;NRXN2;NRXN1;CNTN4;ASTN1;NRXN3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7676113436361572,1.764227996708705,0.009009009009009009,0.6441602900148231,1.0,2/12,1.86%,APOD;CBLB
prerank,glycosaminoglycan catabolic process (GO:0006027),0.568543532345195,1.763713234362377,0.0013869625520110957,0.615024325089956,1.0,11/55,5.55%,CEMIP;DCN;LUM;HSPG2;BGN;GPC4;VCAN;GPC5;CEMIP2;HMMR;SLC9A1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5771015903741923,-1.7618625244546842,0.00267379679144385,0.16633415270221502,0.996,11/24,25.67%,PECAM1;ITGB1;EZR;F11R;NT5E;ICAM1;VCAM1;MSN;GFUS;CERCAM;ITGB2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6728025281546993,1.7612763985375277,0.011570247933884297,0.6001990735993099,1.0,9/21,13.14%,EPHA7;GRIN2B;NGFR;SOX2;DELE1;BIRC2;PYCARD;FYN;PSMB9
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7404754867246197,-1.760008398037484,0.01,0.16583560379335324,0.997,5/10,6.69%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF
prerank,steroid catabolic process (GO:0006706),0.8079565953548982,1.7581291171106472,0.012704174228675136,0.589195170603972,1.0,2/10,3.88%,HSD11B1;SPP1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5881246860987147,-1.7562118355351546,0.010126582278481013,0.16502849633326752,0.997,5/21,2.79%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5881246860987147,-1.7562118355351546,0.010126582278481013,0.16502849633326752,0.997,5/21,2.79%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,cellular response to sterol (GO:0036315),0.7646446374647689,1.7552356065716253,0.003472222222222222,0.5801403435085106,1.0,3/13,2.31%,RORA;GRAMD1B;GPLD1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.436846315920426,-1.7533203637658623,0.0,0.1669133481624788,0.998,33/92,13.96%,ANXA3;DOCK5;ROCK2;FOXP1;TEK;DOCK1;THBS1;NRP2;BMPR2;FOXC2;NRP1;SPARC;KDR;TGFB2;RAC1;SCARB1;PPM1F;AAMP;FGF1;ITGB1BP1;ATOH8;HYAL1;PIK3CB;ENPP2;PIK3CD;ETS1;MAPRE2;CTSH;ITGB3;PLCG2;FLT4;PTK2B;RRAS
prerank,positive regulation of leukocyte migration (GO:0002687),0.6477330110961944,1.7531412689256487,0.00782472613458529,0.5685120316304745,1.0,3/27,1.04%,PTN;XCL1;EDN3
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.5376607861688917,-1.7520984577337921,0.0029411764705882353,0.1654135543132622,0.998,6/31,6.03%,RANBP3L;CRIM1;SMAD6;NOTCH1;SKI;CDK6
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.7966475115768863,1.746746256045402,0.005474452554744526,0.5816881985494728,1.0,2/10,0.48%,APOD;LRP1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.7490373522201309,1.7460590795698412,0.010273972602739725,0.5632991123410108,1.0,7/13,15.42%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81;BRSK2
prerank,peptide biosynthetic process (GO:0043043),-0.3948290027905396,-1.745367670004075,0.0,0.17351341023945413,1.0,78/153,29.13%,RPS14;RPS9;GGTA1;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPL41;RPS18;RPS7;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;DMD;RPS5;ABCF1;RPL10A;RPL11;RPL36A;EEF1A1;RPL34;RPS29;RPL32;RPLP2;RPLP0;RPL4;RPL30;RPS4X;RPS21;RPL26;RPL29;RPS8;FURIN;MRPS7;RPS23;RPL31;PCSK5;RPL23A;RPL19;SRBD1;RPL36;MRPS17;AGO2;GSPT2;MRPS18A;MRPS18B;RPL17;RPL23;RPS11;MRPL24;RPL15;RPL38;MRPL55;HARS2;GSPT1;MRPL36;MRPL35;RPL13A;MRPS12;RPS12;RPL18A;RPS25;RPL24;MRPL34;GGT1;FARSB;EIF4EBP2;MRPL18
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.6038507810816427,1.7440168168600316,0.0113314447592068,0.5522212290515348,1.0,17/37,17.68%,DYNLL1;TRAF3IP1;WDR35;DYNC2LI1;IFT81;KIFAP3;TTC21B;IFT74;TNPO1;IFT88;SSX2IP;TRIP11;KIF3C;DYNLL2;CLUAP1;IFT43;PCM1
prerank,muscle cell differentiation (GO:0042692),0.5983864543589787,1.7401056955971284,0.012861736334405145,0.5530316185466065,1.0,4/32,2.01%,TBX18;RORA;TMEM204;GLMN
prerank,regulation of stress fiber assembly (GO:0051492),-0.44704182051853986,-1.7393512410359075,0.004545454545454545,0.18000537399833333,1.0,27/74,11.16%,PHLDB2;TJP1;ROCK2;PPM1E;ARHGEF18;SORBS3;WASF2;CCN2;TPM1;F11R;NRP1;LIMCH1;S100A10;ACTG1;RAC1;CGNL1;CDC42;TMEFF2;PPM1F;ARHGEF15;RHPN2;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A;ARHGAP28
prerank,regulation of steroid metabolic process (GO:0019218),0.6636445182191173,1.7390663297745375,0.004885993485342019,0.5398029969035577,1.0,4/23,7.81%,RORA;NR1H4;ACADL;DGKQ
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5057408182593414,-1.73534940000157,0.006042296072507553,0.18333855154784404,1.0,16/38,18.05%,ROCK2;CAV1;KLF4;SIRPA;INSR;CD34;RAC1;KLF2;SMAD3;CX3CR1;ASS1;DDAH1;EDN1;PTGS2;NOS1AP;AKT1
prerank,inner ear morphogenesis (GO:0042472),0.661698787997524,1.7347273568972075,0.014950166112956811,0.5446012457649226,1.0,4/22,7.28%,TBX18;CHD7;ZIC1;MYO6
prerank,regulation of glucose metabolic process (GO:0010906),0.6040289161757753,1.7318586541162575,0.0015337423312883436,0.5413602570572266,1.0,7/34,7.81%,RORA;OGT;GPLD1;PDK1;IRS1;IRS2;DGKQ
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.376660056553125,-1.7308358599762008,0.0,0.18838675119103554,1.0,49/182,12.78%,IGF1;PICALM;SLC24A3;ROCK2;FOXP1;MEF2C;ITGB8;OCLN;ROBO1;NOTCH2;APP;KLF4;NFKB1;KDM4A;CLDN5;KDR;RIN3;WWP2;NOTCH1;WNT4;TGFB2;PRKAA2;CD34;SMO;RUNX1;ADAM10;DICER1;APOE;XDH;ACVRL1;MAPT;CELF1;ATOH8;CITED2;GATA2;SFRP1;TNRC6A;SLC7A5;PARP10;PARP9;OPTN;VHL;TARDBP;MAP2K2;TNRC6C;HEY2;PTRH2;TERT;TLE5
prerank,camera-type eye development (GO:0043010),0.6463745557999206,1.7280766245484276,0.009508716323296355,0.5428750464794316,1.0,2/25,1.19%,LAMA1;TENM3
prerank,arachidonate transport (GO:1903963),-0.7211102082841848,-1.7264474917479853,0.00909090909090909,0.18927518440663527,1.0,3/10,6.23%,ANXA1;ACE;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),-0.7211102082841848,-1.7264474917479853,0.00909090909090909,0.18927518440663527,1.0,3/10,6.23%,ANXA1;ACE;BDKRB2
prerank,blood circulation (GO:0008015),-0.47190453886011857,-1.7253029417705614,0.0031746031746031746,0.18756726285040742,1.0,19/49,14.52%,MYOF;ROCK2;NOS3;TBC1D8;GUCY1A1;GCLC;COL4A3;ACE;BDKRB2;CYB5R3;ELN;ACVRL1;ITGB1BP1;NPR1;GPX1;ADCY6;SCPEP1;AGTR1;F5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6380832265658676,1.7234849673641366,0.006172839506172839,0.5498303795018648,1.0,8/26,10.32%,PPARA;SLC30A10;ABCD2;TLR6;ADGRB1;TLR4;CYBA;SLC25A33
prerank,hyaluronan catabolic process (GO:0030214),0.6917943111634746,1.7162070466089834,0.006472491909385114,0.5709107258021129,1.0,4/18,5.55%,CEMIP;CEMIP2;HMMR;SLC9A1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.6007444595079942,1.7153689908730867,0.0074962518740629685,0.558586385738901,1.0,6/34,6.74%,RORA;ENPP1;WNT5A;LRP3;RUNX1T1;ZFP36L2
prerank,hyaluronan metabolic process (GO:0030212),0.6513751707467704,1.7109446005708768,0.0015748031496062992,0.5643062494730281,1.0,4/23,5.55%,CEMIP;CEMIP2;HMMR;SLC9A1
prerank,embryonic digit morphogenesis (GO:0042733),0.6909964154225272,1.7075777033318706,0.01437699680511182,0.5655892354284606,1.0,8/18,11.68%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3;MSX1
prerank,cochlea morphogenesis (GO:0090103),0.7671571013626618,1.7042743915342746,0.026119402985074626,0.5680981903655542,1.0,1/10,0.03%,TBX18
prerank,response to ketone (GO:1901654),-0.5561433874356648,-1.7019499161968847,0.0027397260273972603,0.23056988674958656,1.0,9/24,18.27%,CAV1;SLIT2;THBS1;TGFB2;WBP2;ABHD2;ABCB4;CATSPER2;TGFBR3
prerank,triglyceride homeostasis (GO:0070328),0.6218848524067501,1.700934894052245,0.016793893129770993,0.5691956470580729,1.0,3/26,5.18%,RORA;NR1H4;LIPC
prerank,actomyosin structure organization (GO:0031032),-0.428973953459344,-1.6997092766497222,0.0,0.2309413063130489,1.0,23/75,16.89%,SORBS1;TJP1;TMOD3;FAM171A1;ROCK2;EPB41L5;ACTN2;PGM5;ITGB1;TPM1;F11R;PHACTR1;CDC42BPB;FRMD5;ZYX;LMOD1;CSRP2;TMOD1;MYH10;CDC42BPG;EPB41L1;CUL3;FHDC1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5892280946300529,-1.6979569827434986,0.010443864229765013,0.23046281858355863,1.0,6/20,10.58%,PICALM;BCL2L1;RHOQ;DAB2;PKDCC;TMEM59
prerank,basement membrane organization (GO:0071711),0.7220208563997886,1.6970158806183806,0.020761245674740483,0.5743635546321392,1.0,4/14,0.92%,FLRT2;LAMB1;COL4A1;NID1
prerank,regulation of small molecule metabolic process (GO:0062012),0.6153782412777109,1.6934882279646915,0.0047694753577106515,0.5787441688792695,1.0,6/28,7.81%,RORA;PPARA;NR1H4;PDK1;ACADL;DGKQ
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.6135839717941048,-1.6926408226896745,0.002398081534772182,0.23803705991201002,1.0,10/15,28.27%,LEMD3;MAGI2;SKI;ACVR1;ACVR2B;CSNK2B;SMAD7;FSTL3;ACVR2A;FKBP1A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7288866267029567,1.6922604229372546,0.013888888888888888,0.5707951705159454,1.0,6/13,13.40%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6463989685820094,-1.6920154385115904,0.009828009828009828,0.2354431697648709,1.0,7/13,22.86%,ACTN2;CAV1;CAB39;NOS1;PTK2B;STK39;CASQ2
prerank,positive regulation of vasculature development (GO:1904018),-0.4058814006377716,-1.6883548766971932,0.0,0.23907932379207938,1.0,33/94,14.81%,FLT1;ANXA3;TEK;ITGB8;ITGB1;NOS3;THBS1;TIE1;ECM1;KDR;VEGFD;CYP1B1;CD34;RUNX1;VEGFC;GAB1;HIPK1;FGF1;HK2;HYAL1;GATA2;PIK3CD;SERPINE1;ETS1;CTSH;HSPB1;HIPK2;RAPGEF3;RRAS;RAMP2;CDH5;GATA6;PIK3R6
prerank,diol metabolic process (GO:0034311),-0.5849185086240836,-1.6882874525373213,0.009900990099009901,0.2354777646890597,1.0,9/19,26.03%,PLPP3;NOS3;DEGS2;CALM1;GCH1;AKT1;PRKG2;SPHK2;ASAH2
prerank,phospholipid transport (GO:0015914),-0.46146726208159433,-1.6880859309169711,0.0,0.23223215253774765,1.0,18/52,18.29%,PITPNC1;ATP10A;OSBPL8;ATP8A1;PLTP;PITPNA;ATP11B;SCARB1;ABCA3;APOE;TNFAIP8L3;ATP8B1;MFSD2A;ABCB4;PRELID2;PRELID1;PCTP;ATP8A2
prerank,oogenesis (GO:0048477),0.701131690896025,1.6871217683456248,0.01652892561983471,0.5829137524134959,1.0,2/15,2.72%,PTN;NANOS3
prerank,actin filament bundle organization (GO:0061572),-0.5017471747199513,-1.683839498775464,0.0029850746268656717,0.23805441261403018,1.0,16/33,23.45%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;SHROOM1;LIMA1;BAIAP2;RFLNA;RFLNB;DMTN;ADD2;CORO1B
prerank,cardiac conduction system development (GO:0003161),0.6377181413631097,1.682303655339378,0.00946372239747634,0.5944216445577315,1.0,5/24,6.21%,TBX18;MSC;SMAD5;GJA1;CACNA1G
prerank,triglyceride catabolic process (GO:0019433),0.6624703252731096,1.6813069592462424,0.013157894736842105,0.5861860692300855,1.0,5/19,12.34%,LIPC;LIPH;FABP5;FABP4;FABP3
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6260426535988171,-1.6801953970582304,0.01485148514851485,0.24207477331341942,1.0,7/16,16.97%,ROCK2;GSN;RUFY3;KANK1;PTK2B;CDH5;BCAS3
prerank,negative regulation of coagulation (GO:0050819),-0.6289233754671395,-1.679123930535826,0.004866180048661801,0.24069578396859456,1.0,9/14,24.32%,THBD;VTN;CD34;APOE;SERPINE1;EDN1;SERPINE2;TFPI;PROCR
prerank,positive regulation of cell migration (GO:0030335),-0.3544944910439231,-1.6751817237073336,0.0,0.24568040232068003,1.0,70/253,12.61%,FLT1;PDGFD;FN1;DOCK5;IGF1;TJP1;RAPGEF2;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PECAM1;PODXL;EGFR;IGF1R;MYLK;DOCK1;ITGB1;FER;THBS1;SEMA7A;ITGA6;BMPR2;NRP1;RDX;KDR;INSR;NOTCH1;SOD2;RUFY3;ACTG1;TGFB2;S100A11;VTN;APC;NEDD9;DAB2;SMO;ADAM10;SEMA6A;GAB1;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;FGF1;ACVR1;RHOC;PDGFC;SMURF2;HYAL1;ENPP2;PIK3CD;FAM107A;ELP5;SPAG9;CCN4;SEMA5B;EPHB2;MYO1C;CTSH;CD151;RET;MDK;TRIP6;PLCG2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6917640047222873,1.6724513907554084,0.01620745542949757,0.6174438026441225,1.0,5/15,6.34%,PPARA;GPLD1;PPARD;IRS1;IRS2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5233276580153821,-1.6701645096280686,0.014749262536873156,0.25328906731048895,1.0,17/30,32.57%,CAV1;INPP5F;PPP2R1A;MVP;SFRP1;PTPN2;PRKCZ;PRKCD;DMTN;SOCS3;HYAL2;PTPN6;NTF3;SOCS1;SAMSN1;PPP2CA;SH3BP5L
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7482853969638514,1.6690385727663415,0.02857142857142857,0.6214504178501882,1.0,5/11,14.88%,PPARA;SLC30A10;ABCD2;FYN;ABCB7
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.7167116374655453,1.6688383990425488,0.012195121951219513,0.6098201268203505,1.0,2/13,3.16%,ENPP1;TPST1
prerank,inositol phosphate metabolic process (GO:0043647),-0.4635427755338728,-1.6656852757848757,0.01238390092879257,0.26009647332521285,1.0,17/46,15.59%,PLCE1;PLCB1;INPP4B;ITPKB;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;ITPK1;PLCH1;INPP5B
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.4976041218095735,-1.6640136610198943,0.006349206349206349,0.260075854038853,1.0,12/38,11.02%,BCL2L1;NOS3;THBS1;TNFSF10;FAS;GSK3B;MADD;CASP8;GPX1;SERPINE1;SFRP1;ICAM1
prerank,apical junction assembly (GO:0043297),-0.4500977638454409,-1.6636203638239864,0.0032679738562091504,0.2574030256734236,1.0,20/53,20.05%,OCLN;VCL;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RHOC;RAB13;ARL2;RAMP2;CDH5;CTNNA1;PAK2;PKN2;DLG1;CLDN11;PDCD6IP
prerank,actin crosslink formation (GO:0051764),-0.659773789216637,-1.6628636239098544,0.011961722488038277,0.2557299538799052,1.0,6/12,18.97%,BAIAP2L1;DPYSL3;FLNA;BAIAP2;GAS2L3;GAS2
prerank,ribosomal small subunit assembly (GO:0000028),-0.6007462566366986,-1.6623303605532322,0.012224938875305624,0.2535295279209593,1.0,7/16,14.42%,RPS14;PRKDC;RPS19;RPS27;RPS15;RPS5;MRPS7
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.6091922942337441,-1.6620195850351809,0.00954653937947494,0.2507903104940977,1.0,12/17,32.15%,ATP5F1B;ATP5F1C;ATP5MG;VPS9D1;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.6485781307972648,1.6614819790805389,0.021311475409836064,0.6335945513016671,1.0,5/18,9.03%,PTN;IL34;TENM4;NF1;TNFRSF21
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6641863537470367,1.6608982250570623,0.02003338898163606,0.6240122644205127,1.0,7/17,13.71%,KCNS2;ANK3;VAMP2;KCNG1;KCNAB1;KCNE4;AKAP6
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.40949759529573937,-1.6599899780331406,0.0,0.2520857030903946,1.0,37/84,18.18%,ANXA3;ROCK2;FOXP1;TEK;PLPP3;NOS3;THBS1;NRP2;BMPR2;FOXC2;NRP1;ATP5F1B;SPARC;KDR;RAC1;MAPK14;SCARB1;AAMP;FGF1;ITGB1BP1;ATOH8;PIK3CB;GATA2;PIK3CD;ETS1;HSPB1;ITGB3;FLT4;TMSB4X;PTK2B;RRAS;EDN1;MET;SIRT1;BCAS3;AKT1;EGF
prerank,polyol metabolic process (GO:0019751),-0.4663665505790505,-1.6592845403960903,0.009433962264150943,0.25025233174435485,1.0,17/46,15.59%,PLCE1;PLCB1;INPP4B;ITPKB;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;ITPK1;PLCH1;INPP5B
prerank,central nervous system development (GO:0007417),0.446187045411191,1.6587258226714092,0.0,0.6229634649742731,1.0,70/250,17.38%,APOD;CHST8;ROBO2;CHD7;ADGRL3;COL4A1;EPHA7;ZFHX3;MEIS1;HSPG2;MARCKS;PTEN;SH3GL3;CNTNAP2;ADGRA2;ZIC4;GRIN2B;MEIS2;AFF2;VCAN;ASIC2;POU3F3;LOXL3;TBX3;ZIC1;SOX6;NF1;ZBTB16;ADORA2A;GRIN2A;CNTN4;GRIK1;SZT2;IER3IP1;HAPLN2;NPAS2;RPS6KA6;C1QA;DSCAML1;DHX30;RELN;MBP;ABCB6;CNTN6;AMIGO3;AHI1;SOX10;ALDH5A1;SMARCA1;PLXNB2;SOX9;ANKLE2;MYRF;ATN1;ADAM22;EML1;BAG6;ARNT2;BPTF;CHD8;HAPLN3;PBX2;TBC1D23;HAPLN1;NRCAM;NDUFS4;SMG9;CDK5;ZIC5;NHEJ1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5244680588788099,-1.6527633640105055,0.00872093023255814,0.26067531866651833,1.0,15/30,26.75%,BCL2L1;NOS3;TNFSF10;FAS;GSK3B;CASP8;GPX1;SERPINE1;ICAM1;TRADD;RFFL;TNFAIP3;CFLAR;BRCA1;PARK7
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.56630015051571,-1.647052276433498,0.013054830287206266,0.27048535690210473,1.0,5/20,10.58%,PICALM;BCL2L1;RHOQ;DAB2;TMEM59
prerank,positive regulation of signaling (GO:0023056),0.5654656157669957,1.646455419802646,0.012618296529968454,0.674230484937952,1.0,9/37,11.20%,ECE1;HCRT;EDN3;GRIK2;SCRIB;RIMS2;RAB29;DLG4;RIMS1
prerank,acylglycerol homeostasis (GO:0055090),0.6396613399151552,1.6463988759373898,0.025196850393700787,0.6618238124024198,1.0,2/20,5.18%,RORA;LIPC
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6194702578558463,1.646137722435144,0.019261637239165328,0.6508193916295829,1.0,3/22,8.42%,APOD;CIDEA;BSCL2
prerank,cAMP biosynthetic process (GO:0006171),0.7722980108467064,1.6448094429488156,0.014010507880910683,0.6456410893045744,1.0,6/10,7.99%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,tight junction assembly (GO:0120192),-0.4517330826415987,-1.6420029549561144,0.006514657980456026,0.2783281848520407,1.0,24/49,26.92%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;ACTG1;APC;LSR;RAB13;ARL2;CLDN12;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP;PATJ;CLDN10;MARVELD2;CLDN1;ECT2
prerank,histone H3-K9 demethylation (GO:0033169),-0.6724607130801725,-1.6393993525668407,0.006802721088435374,0.2808230314345687,1.0,7/11,26.06%,KDM4C;KDM4A;PHF8;HR;KDM4B;KDM3B;KDM1A
prerank,cranial nerve development (GO:0021545),0.7370862011305233,1.636329041736553,0.0176678445229682,0.6784840920430083,1.0,3/11,7.32%,CHD7;SALL1;TMEM126A
prerank,catecholamine biosynthetic process (GO:0042423),-0.6710881541163778,-1.636225020423024,0.018018018018018018,0.28476398016877363,1.0,3/11,8.19%,MOXD1;TGFB2;GCH1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6977414165196361,-1.6356832239782815,0.0255863539445629,0.2826725368108036,1.0,6/10,17.30%,ATP5F1C;ATP5MG;VPS9D1;ATP5MC2;ATP5F1D;ATP5MC1
prerank,response to laminar fluid shear stress (GO:0034616),-0.6951982055270128,-1.631831570225027,0.017429193899782137,0.2889070377471775,1.0,6/10,14.84%,SMAD6;KLF4;SREBF2;KLF2;ASS1;MAP2K5
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.5346487639005205,-1.6296488215419531,0.021164021164021163,0.29087780044506567,1.0,6/24,10.58%,PICALM;BCL2L1;RHOQ;DAB2;ITGB1BP1;TMEM59
prerank,glycogen metabolic process (GO:0005977),-0.5118055890493655,-1.623853432575279,0.019337016574585635,0.30138279945216784,1.0,11/27,13.27%,PRKAG2;PYGB;PGM2L1;GBE1;CALM1;GSK3B;GYG1;UGP2;GAA;PGM2;PPP1R3C
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5576685411127065,1.6207729427673074,0.017857142857142856,0.7519053069691577,1.0,8/40,4.84%,PDGFRA;NTRK3;NTRK2;TXK;C5AR1;FGFR1;ARHGAP6;HTR2B
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.5849157718839583,1.6207154603650777,0.022151898734177215,0.7392894870965124,1.0,7/30,4.74%,VAMP5;GGA2;RAB34;SEC16A;SPTBN1;ANK3;VAMP2
prerank,integrated stress response signaling (GO:0140467),0.6915713028539484,1.620581494041617,0.02023608768971332,0.7275773782434146,1.0,10/14,23.80%,OMA1;HERPUD1;EIF2AK1;EIF2S1;HSPA5;IMPACT;EIF2AK3;CCL2;DDIT3;ATF4
prerank,DNA damage checkpoint signaling (GO:0000077),-0.5151125197443918,-1.6205422991150913,0.014204545454545454,0.30563222738136436,1.0,15/28,27.44%,ATR;CDC5L;ATM;NBN;DONSON;CLOCK;HUS1;PRPF19;E2F1;ATRIP;CHEK2;HINFP;CHEK1;BRIP1;RHNO1
prerank,cellular response to fluid shear stress (GO:0071498),-0.6534282394477605,-1.6204397630510556,0.01809954751131222,0.30247358409453745,1.0,7/12,14.84%,MEF2C;KLF4;SREBF2;KLF2;HDAC3;ASS1;MAP2K5
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6019352118362108,-1.6169959719853078,0.014598540145985401,0.30747441458249636,1.0,11/16,32.15%,ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.6145777379413508,1.6162850636901795,0.024469820554649267,0.7392667872227991,1.0,3/24,4.82%,CEMIP;ANK3;MTCL1
prerank,phosphate ion homeostasis (GO:0055062),0.7374142642453706,1.6143099041273263,0.023985239852398525,0.7379250138131961,1.0,1/10,0.11%,ENPP1
prerank,anion transport (GO:0006820),-0.4887477466043513,-1.6123722777567062,0.022408963585434174,0.3165271549662232,1.0,7/33,7.34%,ABCG2;SLC13A4;SLC13A3;LRRC8C;SLC26A7;SLC22A6;LRRC8D
prerank,regulation of protein targeting to membrane (GO:0090313),0.5868510030147998,1.6098475893722304,0.025236593059936908,0.749296958303475,1.0,3/28,4.82%,CEMIP;ANK3;MTCL1
prerank,actin filament depolymerization (GO:0030042),-0.6707216534780498,-1.6098137414866371,0.03917050691244239,0.31916159704991676,1.0,6/11,20.75%,MICAL2;GSN;CFL1;DSTN;MICAL3;TWF2
prerank,sensory perception of sound (GO:0007605),0.48226833674301506,1.6089623750612723,0.015915119363395226,0.7422796249587753,1.0,6/88,1.83%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,negative regulation of chemokine production (GO:0032682),0.667499098894822,1.6083014368596678,0.03814262023217247,0.7339867020142659,1.0,1/14,0.04%,APOD
prerank,regulation of GTPase activity (GO:0043087),-0.35709143883302324,-1.6080562761311268,0.0,0.3205532727786709,1.0,57/177,15.63%,PKP4;PLXNA2;EPHA4;PICALM;RAPGEF2;FGD5;LRCH1;PLXNA4;CHN2;SIPA1L1;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;ITGA6;F11R;RASGRF1;RDX;S100A10;RAP1A;NDEL1;RASIP1;SH3BP4;CAV2;WNK1;SRGAP2;RAPGEF1;EFNA5;GSK3B;RALBP1;ITGB1BP1;RSU1;NGEF;PLXNB1;CPEB2;SGSM2;SFRP1;MAPRE2;ARL2;GMIP;ARHGAP27;ARHGAP12;TGM2;TBC1D7;ALS2;PRKG1;EVI5L;TBC1D10B;RAPGEF3;PLXNA1;CX3CL1;ARHGAP44;ARHGAP15;EZH2;RAP1GDS1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5735187496625812,1.6042017698680184,0.028875379939209727,0.7454345175251306,1.0,7/32,3.72%,APOD;DLC1;CASK;PTEN;CDKN2A;MAP4K4;ARHGAP6
prerank,cilium movement (GO:0003341),0.5310755885224664,1.6037069854842108,0.012747875354107648,0.7370924144710442,1.0,13/47,15.73%,CFAP251;CCDC63;ODAD4;DNAAF4;ADCY10;RSPH9;DNAI4;DNAH9;SPA17;CABYR;GAS8;ZBBX;CCDC39
prerank,regulation of phospholipase activity (GO:0010517),0.7354312584419065,1.6036083793825346,0.04424778761061947,0.726470947464868,1.0,3/10,3.91%,LRP1;FGFR1;PDPK1
prerank,muscle filament sliding (GO:0030049),-0.45968647329674756,-1.6017616234456777,0.023323615160349854,0.33033168850316397,1.0,20/38,39.94%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNI3;TNNC1;TCAP;MYBPC2;MYL3;ACTA1;MYH6
prerank,actin-myosin filament sliding (GO:0033275),-0.45968647329674756,-1.6017616234456777,0.023323615160349854,0.33033168850316397,1.0,20/38,39.94%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNI3;TNNC1;TCAP;MYBPC2;MYL3;ACTA1;MYH6
prerank,response to sterol (GO:0036314),0.7246331584034301,1.6011459238003092,0.01916376306620209,0.7297279442119974,1.0,1/11,0.04%,RORA
prerank,sulfate transport (GO:0008272),-0.5936526575550656,-1.600120615712377,0.027906976744186046,0.3312698742348207,1.0,4/14,4.07%,SLC13A4;SLC26A7;SLC26A2;SLC26A11
prerank,protein autoprocessing (GO:0016540),0.6539114185580645,1.599476711510371,0.03,0.7276241645548133,1.0,6/17,13.25%,CASP4;FXN;OMA1;HTRA2;SPRTN;MYRF
prerank,negative regulation of viral life cycle (GO:1903901),-0.6161738284714624,-1.5976132231536517,0.017766497461928935,0.33479164006473056,1.0,9/15,20.67%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;PPIA;SNX3;IFITM2
prerank,macrophage activation involved in immune response (GO:0002281),-0.6298267150471724,-1.5964352545186833,0.02830188679245283,0.33441450745665524,1.0,6/13,15.39%,LBP;NMI;IFI35;CX3CR1;PLCG2;DYSF
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5621826168423252,-1.5962353835008758,0.020202020202020204,0.33169273852641123,1.0,8/18,16.97%,ROCK2;TEK;RUFY3;KANK1;PTK2B;CDH5;LLGL2;BCAS3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.41028084908890405,-1.5960400254425358,0.0,0.3287312492765268,1.0,15/75,9.70%,PLCE1;PLCB1;ROCK2;RGS3;RGS6;RGS5;NMT2;MGRN1;RGS12;MGLL;YWHAB;CALM1;FRMPD1;RGS4;GIT1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6394207591251231,1.5951113008171982,0.027777777777777776,0.7411037474793931,1.0,3/18,1.04%,PTN;XCL1;EDN3
prerank,Rap protein signal transduction (GO:0032486),-0.6637113376758595,-1.5941340762821525,0.018691588785046728,0.33037907940295935,1.0,7/10,23.70%,RAPGEF2;RAP1A;RAPGEF1;RAPGEF3;RAP2C;RAP2B;RAP1B
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.6203988069476526,-1.5921978010552489,0.030162412993039442,0.3323430678949323,1.0,6/13,20.22%,GOPC;YWHAB;NFKBIA;FLNA;SUFU;GET4
prerank,positive regulation of cell motility (GO:2000147),-0.3455650752223398,-1.591071542262095,0.0,0.331960417230929,1.0,58/205,12.43%,FLT1;PDGFD;IGF1;TJP1;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;CAVIN1;PECAM1;PODXL;SPOCK2;EGFR;IGF1R;MYLK;ITGB1;FER;NTN1;THBS1;SEMA7A;ITGA6;RDX;KDR;INSR;NOTCH1;SOD2;RUFY3;ACTG1;APC;NEDD9;DAB2;SMO;ADAM10;SEMA6A;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;FGF1;ACVR1;RHOC;PDGFC;PIK3CD;FAM107A;ELP5;SPAG9;SEMA5B;EPHB2;MYO1C;CTSH;CD151;RET;MDK;TRIP6
prerank,regulation of T cell chemotaxis (GO:0010819),0.7044414591177169,1.5889296066315284,0.0347985347985348,0.7653544838726498,1.0,3/11,1.65%,XCL1;CXCL10;WNT5A
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.541332945582746,1.5888242159382504,0.01355421686746988,0.7552487594210956,1.0,7/38,12.13%,RORA;CCDC22;NR1H4;CARD19;TLE1;PYCARD;TRIM59
prerank,retina homeostasis (GO:0001895),-0.5147966976011892,-1.5879409141577088,0.03626943005181347,0.337135899827833,1.0,7/23,12.29%,ACTB;POTEF;ACTG1;WHRN;B2M;HSPB1;PRDX1
prerank,lamellipodium assembly (GO:0030032),-0.5106579852617387,-1.5877025992942662,0.013333333333333334,0.33442701407647857,1.0,9/26,11.11%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SRGAP2;SPATA13;CCDC88A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6561643189028701,-1.5862695509612832,0.03803131991051454,0.33162389485588356,1.0,6/10,21.58%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6561643189028701,-1.5862695509612832,0.03803131991051454,0.33162389485588356,1.0,6/10,21.58%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7027200208874208,1.585659052540629,0.02564102564102564,0.7620967446873415,1.0,4/12,3.48%,DCN;BGN;DSE;VCAN
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5694689937182738,-1.584133041769866,0.03598971722365039,0.33390984218637576,1.0,11/18,33.26%,ITGB1;JAM2;SLC39A8;CX3CR1;VCAM1;GCNT1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,presynapse organization (GO:0099172),0.7139455380680134,1.583824645018203,0.04576271186440678,0.761820850035634,1.0,3/10,4.25%,WNT5A;C5AR1;LRRTM3
prerank,modified amino acid transport (GO:0072337),0.6505998861399465,1.5837570214137202,0.03225806451612903,0.7520494392199354,1.0,3/15,1.47%,SLC6A13;SLC16A12;SLC6A8
prerank,regulation of histone deacetylation (GO:0031063),-0.6171188055302832,-1.5829772724267626,0.030878859857482184,0.33380374839867616,1.0,6/13,22.41%,CAMK2D;SAP30BP;AKAP8;ZBTB7B;SPHK2;APLNR
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5647408038119716,1.5829076279101435,0.03167420814479638,0.747189441392158,1.0,13/33,11.60%,CEL;GRID2;GRID1;GRIK5;GRIK2;ABR;GRIK4;FABP5;GRIK1;RELN;LRRC4C;PSMC5;NRG3
prerank,ethanol metabolic process (GO:0006067),0.7040933514840035,1.5826809565700306,0.037300177619893425,0.7387623783406752,1.0,2/12,1.55%,ADH1A;ALDH1A1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5467520052000164,1.5820528035166266,0.020558002936857563,0.732655691523803,1.0,9/37,12.66%,APOD;PPARA;ABCD2;TLR6;ADCY7;APPL2;TLR4;PYCARD;PDCD4
prerank,stress fiber assembly (GO:0043149),-0.5915724930277129,-1.5813721930908762,0.0375,0.3316760084043433,1.0,4/15,4.19%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5915724930277129,-1.5813721930908762,0.0375,0.3316760084043433,1.0,4/15,4.19%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,brain development (GO:0007420),0.44893128592689735,1.5808613984944997,0.0036101083032490976,0.7298812035728189,1.0,36/136,16.67%,APOD;ROBO2;ADGRL3;COL4A1;EPHA7;ZFHX3;MEIS1;HSPG2;CTNNA2;PTEN;CNTNAP2;GRIN2B;MEIS2;AFF2;ZIC1;SOX6;NF1;GRIN2A;CNTN4;IER3IP1;DSCAML1;RELN;ABCB6;AMIGO3;SMARCA1;PLXNB2;EML1;BAG6;ARNT2;BPTF;CHD8;PBX2;CENPF;TBC1D23;NDUFS4;SMG9
prerank,epidermis development (GO:0008544),0.5093270869026763,1.579859668964504,0.019971469329529243,0.7259472579902602,1.0,11/56,9.63%,EMP1;EDA2R;PLOD1;COL7A1;HDAC1;SVEP1;ATP2A2;FABP5;FLOT2;GLI1;EVPL
prerank,T cell differentiation in thymus (GO:0033077),0.6733011358065089,1.5795966232047747,0.03616636528028933,0.7183286292228613,1.0,4/14,9.18%,MR1;RABL3;ZFP36L2;GLI3
prerank,regulation of receptor recycling (GO:0001919),0.6568566795256712,1.5791873799346172,0.039383561643835614,0.7116879170756245,1.0,4/16,8.90%,ECE1;TBC1D16;SCRIB;RAB29
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5961464259501037,-1.5789266761195897,0.046153846153846156,0.3348319158932596,1.0,4/15,5.80%,PRKCH;IL18;NFKB1;MAPK9
prerank,negative regulation of nervous system development (GO:0051961),0.6289544093489151,1.577866355708135,0.038128249566724434,0.7102197917923976,1.0,4/17,9.04%,ROBO2;REST;SORL1;APPL2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4738994346331801,1.5769827187127323,0.013297872340425532,0.7065505041545637,1.0,6/85,1.83%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,regulation of stem cell population maintenance (GO:2000036),0.6279612077967142,1.5753193859302466,0.03691275167785235,0.706674664621616,1.0,8/18,17.47%,PTN;LOXL2;REST;NCOA3;KAT2A;CNOT1;MYC;CNOT3
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.666950884146006,1.5749772298318072,0.04180602006688963,0.7004068910097099,1.0,6/14,15.09%,ENPP1;ENPP3;ITPA;AK4;AK8;AK3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6458454133778899,1.5735734167552609,0.01926444833625219,0.6998118845007995,1.0,2/16,3.91%,RORA;PDK1
prerank,phagosome-lysosome fusion (GO:0090385),0.7299390766145212,1.572847696318725,0.030357142857142857,0.6954501840188574,1.0,4/10,10.53%,RAB34;RAB20;ARL8B;SYT7
prerank,receptor clustering (GO:0043113),0.5694307102445265,1.5716969677488646,0.029275808936825885,0.6934646484017642,1.0,6/27,5.23%,PTN;NRXN2;NRXN1;SCRIB;DLG3;DLG2
prerank,positive regulation of neuron projection development (GO:0010976),0.474630469052739,1.5716510163572295,0.011450381679389313,0.6859350313317945,1.0,22/85,14.38%,ROR1;PTN;NTRK3;ROR2;TENM3;WNT5A;NTRK2;CAPRIN1;PRKCI;PRKD1;RELN;P3H1;STMN2;BMP7;EPHA3;DHX36;PLXNB2;RETREG3;ARHGAP35;LRRC7;LYN;CUX2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.532555934260052,-1.57079268445357,0.021739130434782608,0.3523902831965666,1.0,10/22,25.39%,PDGFD;ACE;PDGFA;CALM1;PDGFC;NBN;RAP2C;NEK10;TAOK2;GREM1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6334100557628941,-1.5691485165482846,0.02843601895734597,0.3537609318370862,1.0,5/11,22.86%,ACTN2;CAV1;CAB39;STK39;CASQ2
prerank,neurotransmitter uptake (GO:0001504),0.6908278228596553,1.5677827745883623,0.03963963963963964,0.6979195077271085,1.0,2/12,1.53%,SLC1A3;ATP1A2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5872169893347957,1.5671907751520482,0.021739130434782608,0.6932432867444894,1.0,2/24,0.61%,RORA;SULF1
prerank,actin filament bundle assembly (GO:0051017),-0.47874224168257085,-1.5670091326164894,0.006269592476489028,0.35607760428894164,1.0,11/33,15.35%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;SHROOM1;LIMA1;BAIAP2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6684682742931743,1.5667715564510156,0.043327556325823226,0.68778990120372,1.0,6/13,12.34%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA;ENTPD7
prerank,regulation of T cell migration (GO:2000404),0.6270536880555623,1.5664490503178181,0.039538714991762765,0.6819296430870736,1.0,3/18,1.15%,APOD;CXCL10;TMEM102
prerank,protein oxidation (GO:0018158),0.6883621279076675,1.564509010972818,0.047957371225577264,0.6843325352957247,1.0,3/11,4.28%,LOXL4;LOXL3;LOXL2
prerank,supramolecular fiber organization (GO:0097435),0.4141164045015734,1.5642281524646129,0.0010695187165775401,0.6784475200242478,1.0,64/333,11.84%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;RND3;COL23A1;LOXL4;LUM;GGA2;TGFBI;PLOD1;COL7A1;COL10A1;ERMN;ADAMTS14;HSPG2;MYO7A;MARCKS;COL22A1;NCKAP5L;DPT;COLGALT1;TNXB;TCHH;LOXL3;ELMO1;LOXL2;COLGALT2;MYO1B;MFAP4;RAC3;PPP1R9A;COL1A2;SORL1;NF1;COL12A1;COL26A1;CLIP3;ACTN1;CAPN3;COL16A1;COL4A2;CALCA;RHOBTB3;MYO6;CALB1;P3H1;CLRN1;STMN2;ADAMTS2;WDR73;STMN4;ZBED3;IAPP;TGFBR1;KATNA1;SLK;TUBGCP4;MYO1G;LTBP3;LTBP2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6167251767531663,1.5632312421682653,0.03636363636363636,0.6762400028093802,1.0,4/19,7.18%,ENPP1;TPST1;SLC35B3;PAPSS2
prerank,sprouting angiogenesis (GO:0002040),-0.42979187130832397,-1.5631557716099076,0.016181229773462782,0.3632674950205085,1.0,23/51,18.05%,TEK;RSPO3;SLIT2;BMPER;ROBO1;THBS1;NRP1;EFNB2;KDR;OTULIN;VEGFD;EPHB4;VEGFC;ACVRL1;ITGB1BP1;CCBE1;NR4A1;FLT4;PTK2B;RAMP2;ESM1;NAXE;AKT1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.6920024797857663,1.5629578744875579,0.05123674911660778,0.67066514370558,1.0,5/11,7.06%,LIG3;TIPIN;FBXO5;MSH3;GMNN
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5248139932554987,1.5628123057537793,0.025222551928783383,0.6645379622223743,1.0,9/46,2.36%,LAMC3;LAMC1;LAMB1;PIK3R1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5097349435314019,-1.561880900657501,0.019943019943019943,0.3634729438040052,1.0,5/24,7.33%,LPGAT1;PLA2G4A;CDS2;PGS1;ABCA3
prerank,endothelial cell development (GO:0001885),0.5844923677381498,1.5616407792748737,0.03245749613601236,0.6632993898536886,1.0,3/25,2.53%,COL15A1;COL18A1;COL22A1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.615024898986502,1.5615362700487974,0.03503184713375796,0.6572361112424094,1.0,4/20,3.02%,SULF1;SPRY4;SPRY1;FGFBP3
prerank,cellular glucan metabolic process (GO:0006073),-0.6229141640549386,-1.5612304713708636,0.05057471264367816,0.3624077142470356,1.0,5/11,13.27%,PRKAG2;GBE1;GSK3B;UGP2;PPP1R3C
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6796367614431867,1.5601530089831037,0.03442340791738382,0.6579865511754126,1.0,1/12,0.09%,IL33
prerank,macrophage differentiation (GO:0030225),-0.6041279067355019,-1.5600965673286027,0.056372549019607844,0.36252423903492115,1.0,6/13,24.55%,IL31RA;CDC42;CASP8;SIRT1;CSF1R;PARP1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5155457723613982,-1.5569234532382328,0.034210526315789476,0.368287019698899,1.0,14/22,36.33%,AEBP1;HSPA8;APOE;MAPT;GPX1;ARL2;CAMSAP2;PARK7;CAMSAP3;EFEMP2;MAP1S;PIK3CA;AKAP13;PRUNE1
prerank,regulation of keratinocyte migration (GO:0051547),0.6782511346158813,1.5568766141035828,0.05319148936170213,0.6668435380329009,1.0,4/12,9.21%,PTEN;MAP4K4;IQSEC1;MTOR
prerank,renal system development (GO:0072001),0.5102785353106891,1.5563259080926246,0.02679830747531735,0.6630478868939056,1.0,7/52,3.07%,TBX18;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.45484359948540565,-1.5560098997894456,0.014492753623188406,0.3676338468358876,1.0,8/34,6.27%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;NEDD9;RAC1;CDC42
prerank,regulation of neuroblast proliferation (GO:1902692),0.6429917223797009,1.5556929097540548,0.04830917874396135,0.6594332050133032,1.0,4/15,5.73%,PTN;LRRK2;NF1;DISC1
prerank,fatty acid metabolic process (GO:0006631),0.45042816147434317,1.555149342920779,0.0075,0.6553402145104812,1.0,25/115,15.53%,LPIN3;GGT5;PPARA;ACOX2;ACSF2;CEL;ABCD2;PEX2;PPARD;CRAT;ACADSB;LIPC;LIPH;ECHDC3;PER2;HSD17B8;FA2H;ACOT7;SGPL1;ACSL6;ACLY;NDUFAB1;NUDT19;LPIN2;ACOT2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5707695909620072,1.5545827642522176,0.030944625407166124,0.6520702078392326,1.0,5/25,3.72%,APOD;ROBO2;DLC1;PTEN;ARHGAP6
prerank,smooth muscle cell differentiation (GO:0051145),0.6885841474333259,1.554563126067036,0.036585365853658534,0.6461381732282513,1.0,2/12,0.72%,TBX18;TMEM204
prerank,regulation of cell migration (GO:0030334),-0.3236140903997,-1.5544452371503925,0.0,0.36907096606683176,1.0,106/382,12.43%,FLT1;PDGFD;PLXNA2;CLIC4;EPHA4;IGF1;TJP1;SYNE2;LMO4;ROCK2;DPYSL3;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PLXNA4;VCL;PTPRJ;PECAM1;SLIT2;ROBO1;PODXL;EGFR;AFDN;IGF1R;MYLK;ITGB1;FER;PTPRK;THBS1;SEMA7A;IGFBP5;ARID2;CDH1;TPM1;ITGA6;CLDN5;RDX;DACH1;LIMCH1;MAGI2;MCTP1;KDR;INSR;PHACTR1;NOTCH1;SOD2;RUFY3;ACTG1;KANK1;AMOT;CYP1B1;MINK1;APC;NEDD9;DAB2;ANXA1;SMO;ACE;RAC1;ADAM10;SEMA6A;SRGAP3;SRGAP2;SEMA4B;PDGFA;TMEFF2;PPM1F;CCN1;SH3RF2;PRR5L;FGF1;ACVR1;RHOC;ACVRL1;PDGFC;FRMD5;PLXNB1;CITED2;ENPP2;IFITM1;PIK3CD;SERPINE1;FAM107A;SFRP1;SPATA13;ELP5;SPAG9;CAMK2B;ROBO4;SEMA5B;EPHB2;LMNA;RNF41;MYO1C;CTSH;CD151;DAG1;ARPIN;RET;MDK;CEACAM1;DLG5;AMOTL2;TRIP6
prerank,nitric oxide metabolic process (GO:0046209),-0.6032117360909859,-1.5540548538373948,0.03015075376884422,0.36730600247355183,1.0,8/14,25.34%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,response to estrogen (GO:0043627),-0.4773789139278627,-1.5540326775102713,0.02185792349726776,0.3643636258204213,1.0,11/31,16.97%,CAV1;NCOA4;TRIM24;TRIM25;WBP2;CITED2;SFRP1;ARID5A;SFR1;ESR1;BCAS3
prerank,regulation of nervous system development (GO:0051960),0.5354313470132178,1.5539991423426553,0.028694404591104734,0.642980378858138,1.0,8/37,10.11%,PTN;GBX1;NPHP3;TENM4;DOCK7;PER2;LGI4;WNT3
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4709690844439754,-1.5539814680868835,0.01775147928994083,0.3616252102328052,1.0,19/36,26.82%,SGMS1;DEPTOR;TPD52L1;TMBIM6;FAS;CRADD;MADD;NR4A2;CX3CR1;CYLD;PPIA;CX3CL1;ING5;TRAF1;QARS1;TRIM39;RB1;ASAH2;BDNF
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5702278779189944,-1.5516495583761845,0.03350515463917526,0.3648542304822733,1.0,5/16,12.55%,NOTCH2;BMPR2;NOTCH1;TGFB2;HEY2
prerank,cAMP metabolic process (GO:0046058),0.6843969013702853,1.5515790696969969,0.02564102564102564,0.6476838027887919,1.0,6/13,7.99%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,positive regulation of leukocyte activation (GO:0002696),0.6053873672264478,1.5503225876324478,0.0372168284789644,0.6471151842759767,1.0,5/18,9.69%,IL33;WNT5A;TSLP;TLR6;TLR4
prerank,bile acid biosynthetic process (GO:0006699),0.5760450260477702,1.5492749951693081,0.03503184713375796,0.6460081393837699,1.0,4/24,3.59%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5836327949758731,-1.5479853959805623,0.03713527851458886,0.3719216633522501,1.0,6/16,6.43%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;MAPK14
prerank,positive regulation of T cell migration (GO:2000406),0.608685144281645,1.547782691524528,0.03747870528109029,0.6471499631199353,1.0,4/20,1.65%,XCL1;CXCL10;TMEM102;WNT5A
prerank,negative regulation of cell motility (GO:2000146),-0.3713355212390049,-1.5477688352787728,0.0,0.3696096989670505,1.0,33/108,12.23%,CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;CDH1;TPM1;CLDN5;DACH1;LIMCH1;MAGI2;MCTP1;KANK1;CYP1B1;SRGAP3;SRGAP2;TMEFF2;ACVRL1;FRMD5;CITED2;IFITM1;SERPINE1;SFRP1;RNF41;DAG1;ARPIN;DLG5
prerank,neural tube development (GO:0021915),-0.5748602513257646,-1.5468363311065214,0.0477326968973747,0.36911029461017003,1.0,5/15,19.50%,ALDH1A2;DVL1;SOX4;SOX11;ARL13B
prerank,glucose metabolic process (GO:0006006),0.49126248210828,1.5454066501922619,0.014884979702300407,0.6523678209618948,1.0,10/58,8.16%,APOD;MDH1;PFKFB1;GDPGP1;PPARD;IRS2;OMA1;CRTC2;ALDOB;PER2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.6138144814425434,-1.5452597468997822,0.03931203931203931,0.3702590570989942,1.0,8/13,25.34%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.37487966946561235,-1.5452422859224955,0.014354066985645933,0.3674981447638783,1.0,30/103,15.34%,PLCE1;IGF1;RAPGEF2;RAPGEF5;ARHGEF18;TIAM2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;PLD2;RAC1;RASGRP3;MAPK14;NUCB1;RALBP1;ARHGAP18;RRAGC;RGL2;CCDC88A;RALB;CCDC88C;BCR;RAB38;RRAS;GRB2;CDKN1A;GRAP
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.42527671261568334,-1.5445244709648502,0.024390243902439025,0.3668682384270593,1.0,18/51,17.39%,CRIM1;SMAD6;BMPER;LEMD3;NBL1;FSTL1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SMURF2;HIPK2;SMAD1;CHRDL1;RBPMS2;GREM2;ACVR2B
prerank,positive regulation of chemotaxis (GO:0050921),0.5171588594017584,1.5436713023077777,0.022865853658536585,0.6544572297700864,1.0,9/43,11.26%,PTN;NTRK3;XCL1;EDN3;SEMA5A;DSCAM;PRKD1;LGMN;P2RX4
prerank,negative regulation of developmental process (GO:0051093),-0.406954533626096,-1.5429320215013425,0.007352941176470588,0.3685977324064753,1.0,25/69,20.59%,NFIB;ROCK2;FOXC1;NOS3;CST3;KLF7;NOTCH1;KANK1;TFRC;CDK6;TBX1;ARHGEF15;MAPT;RC3H1;TBX2;SFRP1;ARPIN;HEY2;RAPGEF3;ADCK1;FGFR3;WNT11;VASH1;HOPX;MIF
prerank,ganglioside biosynthetic process (GO:0001574),-0.570827253310418,-1.542792287830799,0.03255813953488372,0.3662403082537076,1.0,7/15,16.33%,ST8SIA4;B4GALT5;ST3GAL1;ST6GALNAC3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,dermatan sulfate metabolic process (GO:0030205),0.6690515286328452,1.5426365082081162,0.04377104377104377,0.6530299669857673,1.0,4/13,3.48%,DCN;BGN;DSE;VCAN
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6277572583576302,1.541603207187919,0.04452054794520548,0.6517996467649045,1.0,3/17,4.37%,PTN;IL34;TENM4
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6298867675547832,-1.5406985053259872,0.0603448275862069,0.36961026639702393,1.0,5/10,22.41%,MGRN1;PDE3A;PDE11A;CDC34;APLNR
prerank,sodium-independent organic anion transport (GO:0043252),-0.648836716514561,-1.5399786985671766,0.041379310344827586,0.3690194049034762,1.0,3/10,1.88%,SLC16A2;SLCO2A1;SLCO1C1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6663940417942111,1.5397831892087084,0.05226480836236934,0.6542201072572923,1.0,4/12,14.16%,IL34;PTK2;IL12A;LYN
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.640613245867215,-1.538944345517837,0.03325942350332594,0.36934969592628847,1.0,6/11,10.22%,MLLT3;RSPO3;WNT5B;CSNK1D;DAB2;SFRP1
prerank,regulation of actin filament depolymerization (GO:0030834),0.6750810536429752,1.5381596088660283,0.06181818181818182,0.6558844284164113,1.0,3/12,5.28%,PLEKHH2;SEMA5A;MTPN
prerank,endoderm development (GO:0007492),0.6623809837413591,1.5356769559770431,0.060240963855421686,0.6613610728593873,1.0,2/13,4.00%,LAMC1;DUSP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5100835172613082,1.5337470231041181,0.018571428571428572,0.6646435475547735,1.0,5/51,1.04%,PTN;IL34;XCL1;CXCL10;EDN3
prerank,protein hydroxylation (GO:0018126),0.6294918966480979,1.5332399567596402,0.05067567567567568,0.6615842221279549,1.0,8/15,16.57%,PLOD1;HIF1AN;VIPAS39;P3H1;P3H3;ASPH;VPS33B;PLOD2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6173675510689396,1.5323880028435075,0.04865771812080537,0.659901938510893,1.0,6/16,9.29%,SEC16B;SEC16A;RYR2;GBF1;LRRK2;TAPT1
prerank,lipoprotein transport (GO:0042953),0.6929725884391765,1.531635245612155,0.04964539007092199,0.6579990425670196,1.0,7/10,24.45%,LRP1;UNC119;PRKCB;MIA3;UNC119B;VMP1;ZDHHC17
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6184966076204099,1.5312787490841688,0.03577235772357724,0.654020044677649,1.0,4/17,2.64%,CASK;SULF1;TMEM204;ITGA3
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5215479083764678,-1.530763414740282,0.04580152671755725,0.3892678169804456,1.0,11/20,10.47%,IGF1;SLIT2;IGFBP5;NRP1;IGFBP3;S100A11;VTN;ACE;PDGFA;SERPINE1;CCN4
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.6436686256659447,1.5293875907941161,0.044142614601018676,0.6573559143477122,1.0,5/14,8.12%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,phagolysosome assembly (GO:0001845),0.6794094155887261,1.5285274064437255,0.04634581105169341,0.6560640046996226,1.0,4/12,10.53%,RAB34;RAB20;ARL8B;SYT7
prerank,regulation of organelle organization (GO:0033043),-0.38821907990494736,-1.5282649949155664,0.0,0.3930188184109292,1.0,23/80,19.33%,CLIC4;TJP1;EZR;DIAPH1;MTM1;ARMH3;F11R;STX18;RDX;VPS35;SQSTM1;MAVS;MAPT;PLXNB1;CLEC16A;VPS11;SURF4;ARL6IP1;PAK2;LMAN1;MSN;MARK2;CAMSAP2
prerank,nucleotide catabolic process (GO:0009166),-0.5579734564534697,-1.5278746458072294,0.046753246753246755,0.3913671528082434,1.0,9/16,20.08%,SAMHD1;DERA;NUDT3;XDH;VCP;GPX1;NT5E;GDA;NT5C1A
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5871714299674053,1.5276153732345363,0.05472636815920398,0.6551077148015929,1.0,8/22,16.57%,DYNLL1;CDKN2A;CDKN2D;BMP7;TP53;ANKLE2;CDKN2C;PRKRIP1
prerank,response to purine-containing compound (GO:0014074),0.6062893893717589,1.5263744097792313,0.05546492659053834,0.6553773802829467,1.0,10/17,24.34%,P2RY1;RYR2;DGKQ;TRPC3;P2RX4;TRPM2;NDUFS4;ABCC9;STAT1;P2RY6
prerank,regulation of vasculogenesis (GO:2001212),-0.5758551937538609,-1.5257613347151984,0.045351473922902494,0.3942677306534026,1.0,8/14,13.96%,RAPGEF2;KDR;RAP1A;CD34;XDH;CEACAM1;HEY2;RRAS
prerank,cristae formation (GO:0042407),-0.4886491389349746,-1.525514078762873,0.03553299492385787,0.3920867590519386,1.0,16/27,32.15%,APOOL;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;CHCHD3;LETM1;UQCC3;APOO;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5056636736672465,-1.5239312335059407,0.03116883116883117,0.3934246754328328,1.0,14/26,24.06%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;TIFA;ALPK1;UBA52;TNFAIP3;IKBKG;NOD2
prerank,intestinal lipid absorption (GO:0098856),0.6782279001078051,1.5235578040932822,0.04225352112676056,0.662489178976535,1.0,3/11,10.59%,NPC1L1;CEL;SOAT2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5713534949872351,1.5228534377597673,0.03431372549019608,0.660138897411072,1.0,9/24,16.64%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6511577620450193,1.5222838026997962,0.06303236797274275,0.6576646391814039,1.0,6/14,15.26%,AUTS2;KMT2E;KMT2A;WDR5;SNW1;PAXIP1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5652056804563506,1.5210064761879991,0.033846153846153845,0.6582633403771058,1.0,2/26,0.61%,RORA;SULF1
prerank,leukocyte tethering or rolling (GO:0050901),-0.5560669910328129,-1.520108517387558,0.05925925925925926,0.40130633728491566,1.0,10/17,33.26%,ITGB1;JAM2;CX3CR1;VCAM1;GCNT1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,apical protein localization (GO:0045176),-0.6311518063810624,-1.5196871726597416,0.05274725274725275,0.3999249583643365,1.0,6/10,12.17%,ACTB;SHROOM3;GOPC;MAL;ATP8B1;SHROOM2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5123823067145269,1.519514847373205,0.03249630723781388,0.6598683886429365,1.0,13/41,16.64%,XCL1;ITPR1;GRIN2B;RYR2;HTR2B;GRIN2A;TRPV3;HTR2C;TRPM2;RYR3;CACNA2D1;F2R;CHERP
prerank,cellular response to alcohol (GO:0097306),0.5105709167925186,1.5188592220062243,0.04101838755304102,0.6579127378460452,1.0,14/42,14.26%,PTGFR;GRAMD1B;ADCY5;GPLD1;JUP;ADCY8;ADCY3;ADCY2;ADCY7;GLRA1;SPIDR;GLRA2;MAP4K1;GNG2
prerank,regulation of protein import into nucleus (GO:0042306),0.5313601777464037,1.516925974465927,0.05089820359281437,0.6614587416624299,1.0,6/36,4.50%,APOD;PIK3R1;JUP;PIK3R2;MDFIC;ZIC1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4343847129437991,-1.5167464605829974,0.011461318051575931,0.40500135576898594,1.0,18/39,24.81%,RPS14;RPS16;RPS7;DDX52;RPS19;RPS24;RPS27;RPS15;LSM6;RIOK1;RPS5;RIOK3;MRPS7;NPM1;NOL11;TSR3;PWP2;LTV1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.621924703544416,-1.5163402493171678,0.047619047619047616,0.40336350254280423,1.0,8/12,20.67%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;SNX3;IFITM2
prerank,pore complex assembly (GO:0046931),-0.5218824056780276,-1.5160413257009637,0.03950617283950617,0.40166496836409205,1.0,9/19,14.95%,ANO6;AFDN;ADAM10;BAD;NUP98;NUP153;TMEM170A;NUP205;P2RX7
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.4496825618430625,-1.514601729843663,0.024930747922437674,0.40285182231164207,1.0,11/32,14.08%,HMBOX1;PARN;TNKS2;NEK7;CCT3;MAP2K7;ATR;CCT4;CCT7;ATM;MAP3K4
prerank,melanocyte differentiation (GO:0030318),0.6645771228653896,1.512708391274996,0.07368421052631578,0.6756907372670311,1.0,2/11,1.42%,ENPP1;SLC24A5
prerank,neutrophil chemotaxis (GO:0030593),0.48560656911284883,1.5120238477178598,0.03409090909090909,0.6734530543317945,1.0,7/53,5.36%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,regulation of fat cell differentiation (GO:0045598),0.46344104268580344,1.5108167474754843,0.02557200538358008,0.6740070454874183,1.0,20/74,19.28%,RORA;ENPP1;WNT5A;LRP3;PTPRQ;PPARD;RUNX1T1;ZBTB16;ZFP36L2;WDFY2;ZFPM2;CARM1;FTO;ASXL1;FERMT2;FRZB;TAF8;BMP2;ALOX5;CMKLR1
prerank,bicellular tight junction assembly (GO:0070830),-0.4231411304524969,-1.5104505447795218,0.01935483870967742,0.4120549363003112,1.0,21/46,26.92%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RAB13;ARL2;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP;PATJ;CLDN10;MARVELD2;CLDN1;ECT2
prerank,positive regulation of immune system process (GO:0002684),-0.5473806812719713,-1.5101916595654359,0.0498812351543943,0.4101215498134448,1.0,4/16,9.73%,TGFB2;ANXA1;PIK3CB;PIK3CD
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.48863833484037017,-1.5095448567614498,0.05714285714285714,0.4093989339722953,1.0,11/24,17.93%,SEMA3D;SEMA3C;SEMA7A;NRP1;SEMA6A;MEGF8;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,response to progesterone (GO:0032570),-0.5216031167337172,-1.5093961986113968,0.0678391959798995,0.4071476950794209,1.0,6/18,15.86%,CAV1;THBS1;TGFB2;WBP2;ABHD2;CATSPER2
prerank,negative regulation of cell migration (GO:0030336),-0.34697374518895857,-1.5085384371746424,0.0,0.40685967126615086,1.0,38/137,12.23%,PHLDB2;CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;CDH1;TPM1;CLDN5;DACH1;LIMCH1;MAGI2;MCTP1;IGFBP3;PTPRG;KANK1;CYP1B1;RAC1;SRGAP3;SRGAP2;TMEFF2;ARHGDIB;ACVRL1;ITGB1BP1;CITED2;IFITM1;SERPINE1;SFRP1;RNF41;DAG1;ARPIN;DLG5
prerank,presynapse assembly (GO:0099054),0.6194226318252389,1.5080075835302418,0.056572379367720464,0.6820890481779622,1.0,4/16,4.25%,WNT5A;PTEN;CEL;LRRTM3
prerank,bile acid metabolic process (GO:0008206),0.5571503863434579,1.5075764956237923,0.043478260869565216,0.6790630193187049,1.0,4/27,3.59%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6039129399902949,1.5074907199179648,0.06745362563237774,0.6746455753697332,1.0,7/18,6.27%,GRID2;GRID1;GRIK5;GRIK2;GRIK4;NAPB;GRIK1
prerank,dendrite morphogenesis (GO:0048813),0.5314737945098943,1.507427875137377,0.0549618320610687,0.6702899138536144,1.0,7/35,2.38%,PTN;DOCK10;CTNNA2;PTEN;FARP1;EPHB1;ABITRAM
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6808566137925014,1.5056495807495565,0.06806282722513089,0.6732299120144303,1.0,4/10,12.56%,ENPP1;APPL2;PRKCB;GSK3A
prerank,interstrand cross-link repair (GO:0036297),0.4811882194884733,1.5056474543490777,0.03872752420470263,0.6685990537032998,1.0,13/53,11.90%,FANCI;ERCC6L2;ERCC1;FAN1;USP1;FANCA;NEIL3;RPA1;ERCC4;RNF168;FAAP100;FAAP20;POLN
prerank,regulation of protein kinase A signaling (GO:0010738),0.5844123345585173,1.503936640669981,0.05601317957166392,0.671305956634802,1.0,7/20,14.82%,AKAP5;ADGRV1;AKAP7;LRRK2;IAPP;AKAP6;PRKAR1A
prerank,positive regulation of vascular permeability (GO:0043117),-0.5971928146198033,-1.5038519893129834,0.055944055944055944,0.4172819987124099,1.0,5/12,13.18%,TJP1;OCLN;TJP2;PDE3A;TRPV4
prerank,axonogenesis (GO:0007409),0.40819009693452873,1.5035806215339536,0.0011261261261261261,0.668130478895165,1.0,68/237,17.06%,LAMA1;ROBO2;LAMA2;PIK3R1;EPHA7;ISL2;AUTS2;WNT5A;CTNNA2;PTEN;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;ANK3;EPHA6;NEFH;UNC5A;RAB8A;ADGRB1;DSCAM;CNTN4;LLGL1;IRS2;DAB1;DOCK7;PALLD;DSCAML1;PTPRO;PTK2;UNC5C;RELN;EPHB6;DCC;PRKCA;NRXN3;NEXN;OPHN1;CNTN6;LYPLA2;EPHA3;PTPRA;PPP3CB;DOK5;USP33;UNC5D;FYN;SH3KBP1;GFRA1;ARHGAP35;KIF5C;GFRA2;EPHA5;GDNF;EVL;BRSK2;FGFR2;NRCAM;NTNG2;NTNG1;ULK2;TUBB3;EFNA1;CYFIP1;SLITRK1;CDK5
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4822449613546345,1.5028139930204343,0.03586206896551724,0.6669372184441155,1.0,14/57,17.80%,ADCY5;AKAP5;GPR37L1;ADCY8;ADCY3;ADCY2;ADCY7;HTR5A;HTR1A;LPAR1;HTR4;GPR37;GRM7;ADRA2A
prerank,negative regulation of GTPase activity (GO:0034260),-0.5061483299423251,-1.5027898119256893,0.02570694087403599,0.4175690985667766,1.0,8/22,10.89%,LRCH1;F11R;RDX;SH3BP4;WNK1;CPEB2;ARL2;GMIP
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5241341786887124,-1.5026536784556892,0.04738154613466334,0.41524511001498576,1.0,5/19,6.01%,SLCO1C1;APP;KLF4;NFKB1;KLF2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.47353592994086025,1.5023350957287847,0.025780189959294438,0.6642224774251928,1.0,18/59,15.20%,RUNX2;TCF7L2;PTEN;AGO4;THRA;CDKN2A;CDK8;MED12;TWIST1;MED6;TP53;AGO3;MED10;MED8;SOX9;MED1;MED25;TNRC6B
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6560485046487426,1.5022553650303458,0.0659536541889483,0.6600752006797714,1.0,5/12,12.23%,MYCBP2;PTEN;EPHB1;EPHB6;ARHGAP35
prerank,regulation of phospholipase C activity (GO:1900274),0.6125774132104487,1.501146588722188,0.0711864406779661,0.6602843054355132,1.0,3/15,2.95%,PDGFRA;NTRK3;FGFR1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6405486661886687,1.5009484255979735,0.070446735395189,0.6566332732552134,1.0,3/12,8.35%,CDC14B;PTEN;GOLGA2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4462772864951382,-1.500128585698886,0.033707865168539325,0.42034321784854867,1.0,15/35,27.47%,PICALM;HIP1R;VTN;RAC1;B2M;RAB21;PIK3CB;SERPINE1;HIP1;HFE;HNRNPK;CCL19;BICD1;FLOT1;ARF1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6104890957108714,1.4993613846775207,0.06643952299829642,0.6593576433297242,1.0,5/15,11.27%,PDGFRA;EIF4A3;MTHFD1L;TWIST1;TGFBR1
prerank,protein localization to cell-cell junction (GO:0150105),-0.5557405052772707,-1.497741146512398,0.055288461538461536,0.4244367636552237,1.0,8/15,7.82%,TJP1;ARHGEF18;ACTB;F11R;ACTG1;CGNL1;TJP2;LSR
prerank,peptide catabolic process (GO:0043171),0.5780240642025662,1.4959785900624927,0.05374592833876222,0.669473126589471,1.0,4/23,4.68%,ECE1;GGT5;GGT7;CPQ
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.582853839989972,1.4959637043999243,0.057755775577557754,0.6652275610621404,1.0,7/21,8.11%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7;AMPD2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.5551686973126191,-1.4952235788235957,0.061381074168797956,0.4290153614642417,1.0,9/15,29.07%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;ORMDL2;SPHK2;SAMD8;NSMAF
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6176883632023086,1.49476839568982,0.06451612903225806,0.6661902672750879,1.0,3/15,4.17%,PPARA;PPARD;NR1H2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.31187371775688066,-1.4933947499384868,0.0,0.4314511956017396,1.0,138/306,29.35%,MEF2A;RPS14;RPS9;RPS16;PTMA;ST3GAL4;RPLP1;RPL13;DRG1;TOP1;RPL27A;B4GALT5;RPS2;RPL37A;RPL5;ALAS1;RPL8;RPL41;RPS18;RPS7;RPS20;RPS19;RPS24;RPS27;RPS15;EXT1;RPL21;APOE;TBRG1;RPL10;EEF1G;RPL35A;LARGE1;RPS15A;RPS5;ABCF1;RPL10A;RPL11;PTMS;RPL36A;EEF1A1;RRAGC;ORC6;RBBP8;NR4A2;RPL34;RECQL5;RPS29;POLR2B;RPL32;RPLP2;ATR;RPLP0;POLR2H;RPL4;EEF2K;RPL30;RPS4X;RPS21;RPL26;RPL29;POLR2G;TERT;FUT9;RPS8;EEF1D;EEFSEC;ATM;POLR2C;POLE2;NBN;MRPS7;ING4;KAT5;RPS23;RPL31;GCNT1;ST3GAL2;RPL23A;ING5;DONSON;GTPBP1;RPL19;SRBD1;HUS1;RPL36;MRPS17;AGO2;HOXD3;CREBL2;ORC1;GSPT2;MCM6;MRPS18A;MRPS18B;GAL3ST2;TYMS;RPL17;RPL23;TOP1MT;E2F1;MCM9;RPS11;MRPL24;POLD2;RPL15;RPL38;MRPL55;MCM8;RPA2;RMI2;CDC45;HARS2;ATRIP;GSPT1;BRCA1;PCLAF;MRPL36;MRPL35;RPL13A;NT5M;CHEK1;MRPS12;RPS12;POLR2I;RPL18A;BRIP1;RHNO1;RPS25;RPL24;MRPL34;POLR2K;ALAS2;POLD1;FARSB;EIF4EBP2;MRPL18;GTPBP2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4958570235779246,1.4932664760249346,0.06386066763425254,0.6682644257560247,1.0,6/48,8.81%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;PRKACA
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4915274642337451,-1.4928136255489608,0.03888888888888889,0.43033889187735336,1.0,14/28,24.06%,IRAK2;OTULIN;UBB;AAMP;CASP8;LACC1;TAB2;CYLD;UBE2N;UBC;UBA52;TNFAIP3;IKBKG;NOD2
prerank,regulation of feeding behavior (GO:0060259),-0.5981659958931951,-1.4922493254247446,0.06813186813186813,0.42931542922582405,1.0,1/11,0.96%,LEPR
prerank,cGMP-mediated signaling (GO:0019934),0.6311744200772866,1.489442140276104,0.059233449477351915,0.6802895461337117,1.0,4/13,9.26%,PDE9A;HTR2B;KCNC2;HTR2C
prerank,positive regulation of hydrolase activity (GO:0051345),-0.34016536431747135,-1.4882117891942193,0.0,0.43804985002410607,1.0,45/137,18.56%,PKP4;CD200;PICALM;RAPGEF2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;ITGA6;F11R;RASGRF1;S100A10;RAP1A;NDEL1;CAV2;SRGAP2;RAPGEF1;CALM1;GSK3B;MTMR9;RALBP1;RHOC;RSU1;PLXNB1;SGSM2;SFRP1;MAPRE2;ARHGAP27;CTSH;TGM2;TBC1D7;ALS2;EVI5L;RAPGEF3;CX3CL1;EZH2;RAP1GDS1;RGS10;BCAS3;ERBB2;HMGB2;WNT11;AGRN
prerank,inflammatory response (GO:0006954),0.41190802648088815,1.4876275904274923,0.009142857142857144,0.6833971632425191,1.0,22/195,6.66%,SCUBE1;GGT5;XCL1;IL1RN;IL2RA;CXCL10;PTGFR;CXCL1;HSPG2;CD40;C5AR1;TPST1;MMP25;NFATC3;LOXL3;FOS;TLR6;CCL15;ADORA2A;ADORA1;PRDX5;ADCY8
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.45293758451143495,-1.4862637171962712,0.049132947976878616,0.44077300056763635,1.0,13/31,14.13%,PPP1R13B;HIP1R;YWHAB;GSK3B;YWHAG;BAD;CASP8;BAX;PPP3CC;PPP3R1;BID;BOK;ZNF205
prerank,circulatory system development (GO:0072359),-0.3494155625902301,-1.4861033709304023,0.0,0.4385607470977187,1.0,40/118,15.68%,HEG1;PLCE1;FN1;TEK;MEF2C;CACNA1C;MICAL2;PDLIM5;CXADR;FOXC1;OSR1;MEF2A;FOXC2;NXN;RBP4;NOTCH1;TGFB2;TCF25;GLI2;SOX4;TBX1;SOX17;ACVR1;SH3PXD2B;ACVRL1;POU6F1;CRIP1;FOXL1;CITED2;CASP8;ZDHHC16;HEY2;TAB2;FLT4;RAMP2;CDH5;STRA6;CDKN1A;CACYBP;MKKS
prerank,"phagocytosis, engulfment (GO:0006911)",-0.431713326227153,-1.485526129294229,0.04477611940298507,0.4374758697855445,1.0,8/36,6.27%,RHOBTB1;GULP1;DOCK1;THBS1;GSN;RHOBTB2;RAC1;CDC42
prerank,Notch signaling involved in heart development (GO:0061314),-0.6083781324750118,-1.4840316083415082,0.043478260869565216,0.4389427515036084,1.0,7/11,18.13%,RBPJ;NOTCH2;NOTCH1;HEYL;GALNT11;HEY2;SNAI1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.625851809271716,1.483735171977889,0.07445008460236886,0.6955449387947367,1.0,3/14,1.54%,SULF1;SPRY4;SPRY1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3787500141059939,-1.4827106776459953,0.008064516129032258,0.44033425479931937,1.0,17/72,8.57%,HEG1;ARHGEF18;ROBO1;ARHGEF28;NET1;KANK2;F11R;NRP1;GPR4;KANK1;RASIP1;RAC1;PRAG1;ARHGDIB;APOE;RALBP1;EPS8L2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4576912840992605,-1.4825950636659582,0.0326975476839237,0.43812616732027926,1.0,19/30,14.01%,TJP1;OCLN;VCL;PECAM1;ACTB;ITGB1;ESAM;F11R;CLDN5;JAM2;ACTG1;TJP2;LSR;DMD;SLC1A1;GJB6;CLDN12;MFSD2A;CDH5
prerank,positive regulation of macrophage activation (GO:0043032),0.5820092288421403,1.4817624303634278,0.07082630691399663,0.6999748097503641,1.0,4/17,9.69%,IL33;WNT5A;TLR6;TLR4
prerank,regulation of kinase activity (GO:0043549),0.4391856528590643,1.4811739774562767,0.028683181225554105,0.6981246206365584,1.0,19/89,10.44%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;NPRL2;EPHA6;ANKRD54;CAMKK2;IRS2;AXL;EPHB6;FGR;EPHA3
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3690448202749482,-1.4808168509093846,0.016260162601626018,0.44053112879023815,1.0,18/82,10.56%,RANBP3L;CRIM1;SMOC1;IGF1;SMAD6;DDX5;MEF2C;BMPR2;NOTCH1;WNT4;SKI;IL6ST;CDK6;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,neuron migration (GO:0001764),0.48715358377282003,1.4805231026236525,0.052259887005649715,0.6965609902484573,1.0,12/48,8.69%,SH3RF1;ADGRL3;AUTS2;NTRK2;ASTN2;DNAAF4;FGFR1;LRP12;CDKL5;DISC1;ASTN1;RELN
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5976853355466851,1.4804379672663546,0.05950413223140496,0.6927204193458386,1.0,3/18,7.52%,APOD;MDFIC;POLR1A
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3648097121653637,-1.4804124512810322,0.011278195488721804,0.43907441033864797,1.0,29/85,15.43%,PLCE1;IGF1;ARHGEF18;DENND4A;ARHGEF28;KANK2;NOTCH2;RASGRF1;RDX;SHOC2;SQSTM1;NOTCH1;TGFB2;DENND3;KANK1;GABARAP;ARHGAP17;RAPGEF1;NGF;ARHGDIB;EPS8L2;MADD;EPHB2;MAPKAP1;DENND1A;BCR;GRB2;ARHGAP44;DENND4C
prerank,fatty acid transmembrane transport (GO:1902001),-0.5112548111048081,-1.480253617462835,0.05913978494623656,0.43702525052886115,1.0,5/19,5.12%,PRKAG2;ABCD3;SLC2A1;ABCD4;PRKAA2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6169465197015067,-1.4779984709562437,0.05542725173210162,0.4411983275764627,1.0,2/10,4.72%,NFKB1;SREBF2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.674144640607444,1.4774181076121866,0.0740072202166065,0.7013050317495001,1.0,1/10,0.09%,IL33
prerank,hexose metabolic process (GO:0019318),0.49861900443426177,1.4773809600838854,0.047895500725689405,0.6972600783492531,1.0,6/39,7.08%,APOD;GDPGP1;PPARD;IRS2;OMA1;ALDOB
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.5568567798606834,-1.4760308628192442,0.06473214285714286,0.44439922297760664,1.0,8/15,21.58%,RBPJ;EGFR;FER;CEACAM1;RHBDF2;ERBB2;EGF;MVB12B
prerank,muscle cell migration (GO:0014812),-0.6218156498262603,-1.4747341521288901,0.060810810810810814,0.44565563232023353,1.0,5/10,11.88%,CCN3;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.49140423607976175,-1.4726683715140558,0.041025641025641026,0.4491691036341408,1.0,12/24,24.06%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;UBA52;TNFAIP3;IKBKG;NOD2
prerank,bicarbonate transport (GO:0015701),-0.4798547607843942,-1.4726630501766365,0.052770448548812667,0.4466594530377995,1.0,11/25,24.09%,SLC4A10;SLC26A7;SLC39A8;SLC4A3;CA4;SLC4A8;CYB5R1;SLC26A6;CFTR;SLC4A7;CYB5R4
prerank,microvillus organization (GO:0032528),-0.5823755690621295,-1.4718812497869684,0.06601466992665037,0.446410030325867,1.0,6/13,4.97%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.5570318635700485,-1.4714008695048353,0.07058823529411765,0.4453530889752896,1.0,7/14,16.97%,NCOA4;TRIM24;WBP2;SFRP1;ARID5A;SFR1;BCAS3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5215661829242852,-1.471258053653291,0.060453400503778336,0.44328532399242027,1.0,7/17,12.55%,RBPJ;NOTCH2;NOTCH1;ACVR1;HEYL;GALNT11;HEY2
prerank,diacylglycerol metabolic process (GO:0046339),-0.4854853482161823,-1.4709366462466136,0.0670391061452514,0.44171841939799394,1.0,6/23,12.34%,PLCE1;DGKH;PGS1;DGKG;LIPE;DGKZ
prerank,regulation of lamellipodium organization (GO:1902743),-0.5564553466245287,-1.4707625572805667,0.04092071611253197,0.43989404054530873,1.0,9/14,21.80%,FER;RAC1;CAPZB;CDC42;CD44;PDPN;EPHA2;TWF2;DMTN
prerank,smooth muscle contraction (GO:0006939),-0.5536344548484007,-1.4697288543951215,0.07529411764705882,0.44053412824845023,1.0,6/14,12.11%,ROCK2;MYLK;EDNRA;BDKRB2;MYH11;ACTA2
prerank,blood vessel endothelial cell migration (GO:0043534),-0.48595661113802646,-1.4695112732961109,0.056265984654731455,0.43873587398417,1.0,11/22,18.05%,SLIT2;ROBO1;ID1;NRP1;EFNB2;KDR;EPHB4;NR4A1;CDH5;SOX18;AKT1
prerank,positive regulation of embryonic development (GO:0040019),-0.5090462139186439,-1.4694882095837738,0.037037037037037035,0.436449563565812,1.0,6/19,10.04%,PLCB1;OSR1;WNT4;B4GALT5;CFL1;NIBAN2
prerank,sensory perception (GO:0007600),0.4855704680032791,1.468782075826658,0.05202312138728324,0.7306905393264224,1.0,10/45,11.26%,TRPA1;ADGRV1;MYO7A;NIPSNAP1;C5AR1;PDYN;ADORA2A;PTGES;CLRN1;P2RX4
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5793124245468685,1.4683570345749466,0.06482982171799027,0.7282063638348314,1.0,4/18,4.98%,PPARA;PAG1;TNFAIP8L2;PTPN22
prerank,axonemal dynein complex assembly (GO:0070286),0.5399862567856201,1.4670358597434134,0.06485671191553545,0.730109067164203,1.0,7/27,9.82%,CCDC63;ODAD4;DNAAF4;DNAAF3;TTC12;DNAI4;CCDC65
prerank,nervous system development (GO:0007399),0.37994151724751096,1.466971119385187,0.0,0.7260931158062576,1.0,102/429,16.06%,CHST8;ROBO2;CHD7;PTN;ADGRL3;RBFOX1;GPM6B;NRG1;MERTK;CXCL1;TEAD1;ADGRV1;MARCKS;UNC119;PTEN;SEMA5A;ERBB4;SH3GL3;FARP1;EPHB1;ADGRA2;NRXN2;BTBD2;ZIC4;NRXN1;WDPCP;VCAN;ASIC2;PCDHA5;POU3F3;PCDHB16;TBX3;DPYSL2;DCHS1;ZIC1;SOX6;APLP1;PRX;ADGRB2;NF1;ZBTB16;ADGRB1;DSCAM;ADORA2A;CNTN4;ADORA1;GRIK1;SZT2;PCDHB4;LIMK1;HAPLN2;NPAS2;PCDHB11;RPS6KA6;UTP11;DSCAML1;NAV2;NAV3;DHX30;RELN;AXL;RAB29;MBP;TENM1;LSAMP;OPHN1;LPAR1;CNTN6;AHI1;SOX10;ALDH5A1;PRPS1;DLG4;RBFOX3;FGF12;TGFBR1;FKTN;NDUFV2;GFRA1;MYT1L;CBLN1;DPF2;ANKLE2;ATN1;GFRA2;ADAM22;SDCBP2;ARNT2;SCN2A;ATXN3;HAPLN3;GDNF;EVL;GLRB;FGF5;APBA2;NRSN2;TRIM3;KIRREL3;JAG1;HAPLN1;NRCAM
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4591254624391252,1.4666571931732566,0.03480589022757698,0.7232277113460873,1.0,19/60,15.26%,RUNX2;TCF7L2;PTEN;AGO4;CDKN2A;CDK8;MED12;SRF;MED6;TP53;DHX36;AGO3;MED10;MED8;SOX9;MED1;MED25;TNRC6B;PAXIP1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5219608540658671,1.4664114718230836,0.054858934169279,0.7201251627060167,1.0,3/32,1.25%,CXCL10;HRG;CXCL1
prerank,microvillus assembly (GO:0030033),-0.5670656341135691,-1.4656499726381798,0.085,0.44481217952571617,1.0,6/14,4.97%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5574880112605025,-1.4656415444983049,0.06443914081145585,0.4424787543352254,1.0,2/14,0.41%,IGF1;CD200
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5089984788716205,-1.4652870338881436,0.04218362282878412,0.44108439434632224,1.0,8/19,12.55%,SMAD6;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;HEYL;HEY2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.49982067075408376,-1.4640053635998418,0.0702247191011236,0.4423882374991892,1.0,8/22,15.64%,SLIT2;KANK3;HIP1R;GSN;KANK1;SSH1;TMSB4X;PRKCD
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5002339041787759,-1.4635746715486357,0.0521978021978022,0.4411757942858031,1.0,9/20,17.93%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6669009227136564,1.4623250580124598,0.07478260869565218,0.7342274589961489,1.0,7/10,23.80%,HERPUD1;EIF2S1;HSPA5;EIF2AK3;CCL2;DDIT3;ATF4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5235591674652932,-1.4623247572511362,0.06451612903225806,0.4422613049073614,1.0,5/17,4.25%,PBX1;RBPJ;NOTCH3;MAML2;NOTCH1
prerank,carboxylic acid metabolic process (GO:0019752),-0.44134015573198015,-1.4622174504046965,0.044444444444444446,0.4403063726713777,1.0,8/33,6.29%,DDO;CSGALNACT1;ST6GAL1;SLC2A1;PLA2G4A;PON3;ST3GAL1;CYB5R3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.37653684385724273,-1.4607977872070217,0.0196078431372549,0.44214962503642374,1.0,17/73,8.84%,CRIM1;SMAD6;RBPJ;BMPER;LEMD3;NBL1;XIAP;FSTL1;BMPR2;FOXD1;SKIL;NOTCH1;SKI;UBE2D3;CCN1;ACVRL1;SMURF2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.543746518138267,1.4597918700123986,0.05245901639344262,0.7411458323246267,1.0,9/26,16.64%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5588500246826451,1.4585148160621695,0.07763975155279502,0.7424228479503399,1.0,9/23,22.26%,XCL1;NR1H4;PDCD1LG2;AXL;TLR4;LGALS9;INHBA;DDIT3;HMGB1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6171115038850049,-1.458029286347252,0.061465721040189124,0.4475880646953975,1.0,7/10,22.04%,TUT7;UBB;NEDD8;UBC;ISG15;CHFR;UBA52
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.6014956619356061,-1.4558707613732491,0.04794520547945205,0.45130137632571904,1.0,5/11,16.20%,MEF2C;EFNB2;TGFB2;GPER1;MYOCD
prerank,positive regulation of cell projection organization (GO:0031346),0.422840894650272,1.455571456596303,0.01699029126213592,0.7513355534137324,1.0,25/115,12.23%,ROR1;ROBO2;PTN;NTRK3;ROR2;PLXNC1;TENM3;WNT5A;NTRK2;GRIP1;NGFR;CDKL5;CARMIL2;CAPRIN1;PRKCI;CDKL3;PRKD1;RELN;P3H1;STMN2;EPHA3;DLG4;PLXNB2;RETREG3;ARHGAP35
prerank,regulated exocytosis (GO:0045055),-0.3265642275859296,-1.4554443968118944,0.0,0.44999351401617127,1.0,47/173,19.52%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;ANXA5;LHFPL2;PCDH7;APP;ECM1;SPARC;SRGN;SYT9;TGFB2;VEGFD;VEGFC;CD109;ARHGAP17;PDGFA;CALM1;STX1A;ENDOD1;RAB31;SERPINE1;TAGLN2;CD63;ITGB3;LGALS3BP;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;SYNGR2;ALDOA;CPLX2;CPLX1;EGF;LAMP2;HGF;TIMP3;RAB11FIP1
prerank,organelle fission (GO:0048285),0.5353280944417954,1.4554363827622738,0.06584992343032159,0.747680830996591,1.0,8/24,15.21%,SEC16B;MTFR2;OPA1;DNM1;WASHC5;PEX11A;MTFP1;PEX19
prerank,positive regulation of chemokine production (GO:0032722),0.4825968152796487,1.4543194617738633,0.06990014265335236,0.7483424007772067,1.0,8/44,11.00%,IL33;WNT5A;TSLP;TWIST1;MBP;TLR4;EIF2AK2;PYCARD
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6475511807188661,1.4529211383722682,0.09107468123861566,0.7504480179416921,1.0,5/12,12.47%,BOD1;CENPE;RMDN1;CENPC;CDT1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4795685763477665,-1.4518340274194406,0.04336043360433604,0.45795931960400404,1.0,8/24,22.41%,RAPGEF2;MGRN1;PDE3A;PDE11A;PRKAR2A;PRKAR2B;CDC34;APLNR
prerank,cellular response to interleukin-12 (GO:0071349),-0.40688235821991425,-1.4517564591808005,0.04659498207885305,0.45585510573547156,1.0,20/48,23.70%,PLCB1;SIRPA;SOD2;CDC42;PITPNA;TALDO1;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,regulation of nervous system process (GO:0031644),-0.5166663267318562,-1.4515588306477856,0.08048780487804878,0.4542131675529923,1.0,4/18,2.50%,ROCK2;SLC8A3;NOS3;APP
prerank,cellular response to glucagon stimulus (GO:0071377),0.5970050450076916,1.4511964664601609,0.08013355592654424,0.7540613878786744,1.0,7/17,8.81%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;ADCY7;PRKACA
prerank,regulation of multicellular organismal development (GO:2000026),0.5381289205724593,1.4510182277588735,0.08267090620031796,0.7507196887000213,1.0,6/25,14.10%,PTN;GBX1;CCSAP;KAT2A;DHX36;BAG6
prerank,regulation of telomere capping (GO:1904353),-0.481851561751193,-1.4490319389371848,0.04891304347826087,0.45919143566253684,1.0,8/23,14.35%,SMG6;TNKS2;NEK7;MAP2K7;RTEL1;ATM;MAP3K4;NBN
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5944705919749722,1.4488122333866555,0.08754208754208755,0.756481357020416,1.0,6/16,15.26%,AUTS2;KMT2A;BCOR;WDR5;SNW1;PAXIP1
prerank,positive regulation of neuron migration (GO:2001224),-0.5755061026985658,-1.4487922792458205,0.09133489461358314,0.4576281161933885,1.0,3/11,12.08%,RAPGEF2;SEMA6A;MDK
prerank,lipoprotein localization (GO:0044872),0.6475380037416298,1.4483896608365379,0.08453237410071943,0.7543860195031246,1.0,7/11,24.45%,LRP1;UNC119;PRKCB;MIA3;UNC119B;VMP1;ZDHHC17
prerank,neurotransmitter transport (GO:0006836),0.4484105003920156,1.4481274319553168,0.048846675712347354,0.7512926210438832,1.0,16/73,13.35%,SLC1A3;CASK;ATP1A2;SLC18A3;NRXN2;PTPRN2;NRXN1;VAMP2;CHAT;PPFIA2;SNPH;SLC29A1;RIMS1;DNAJC5;PPFIA4;UNC13A
prerank,modulation by symbiont of host process (GO:0044003),-0.6030814994216579,-1.4477253495568587,0.08653846153846154,0.4581994240524275,1.0,7/10,22.04%,UBB;B2M;PGK1;ENO1;UBC;MRC1;UBA52
prerank,outer dynein arm assembly (GO:0036158),0.5990689768298223,1.44750033476643,0.0728476821192053,0.7498789986341288,1.0,3/14,2.42%,CCDC63;ODAD4;DNAAF4
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5747068080178463,1.4474169516147117,0.06408094435075885,0.7462296276977637,1.0,6/18,11.34%,ODAD4;DNAAF4;ADCY10;NPHP3;SPA17;CABYR
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.45765538366913944,-1.447147913729483,0.047058823529411764,0.45762960334241626,1.0,11/29,15.64%,TJP1;SLIT2;SHANK3;KANK3;HIP1R;KANK1;SHANK1;SSH1;ARPIN;LIMA1;PRKCD
prerank,cardiolipin metabolic process (GO:0032048),-0.5540111442108142,-1.4461148001188928,0.06744186046511629,0.4582610967297599,1.0,6/13,17.39%,PLA2G4A;PGS1;LCLAT1;PLA2G6;HADHA;PLSCR3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.5205344187049703,-1.4458975742836164,0.08188585607940446,0.4566136541633086,1.0,5/16,4.60%,IGF1;IGFBP6;IGFBP5;IGFBP3;IGFBP2
prerank,carboxylic acid catabolic process (GO:0046395),-0.5720032644425902,-1.4457042830519475,0.0671462829736211,0.4549229188321522,1.0,4/12,15.46%,ACOT8;PON3;RENBP;NPL
prerank,positive regulation of cell communication (GO:0010647),0.5228914793839747,1.4455925327283174,0.07178631051752922,0.7505047623137633,1.0,10/28,18.69%,HCRT;EDN3;GRIK2;ANK3;RIMS2;DLG4;RIMS1;NMU;SYT1;CLSTN1
prerank,aorta development (GO:0035904),0.6025636004001851,1.4455911201486646,0.10068259385665529,0.7465220532424163,1.0,2/14,0.48%,ROBO2;LRP1
prerank,limb morphogenesis (GO:0035108),-0.48661473273640965,-1.4454688407814513,0.046798029556650245,0.45340753920635574,1.0,6/20,8.04%,MBNL1;CYP26B1;TGFB2;SKI;MEGF8;LRP6
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.644109763032201,1.4445879329112126,0.09773123909249563,0.7470258602823476,1.0,2/11,0.64%,XCL1;TARM1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5297260682626987,-1.4444675066428547,0.08461538461538462,0.4539005391583859,1.0,5/16,10.78%,CAV1;INPP5F;PPP2R1A;PTPN2;VHL
prerank,negative regulation of gene expression (GO:0010629),-0.2986619982186311,-1.4444402548493245,0.0,0.4517799629776261,1.0,84/302,17.98%,DAPK1;IGF1;PICALM;SLC24A3;ROCK2;FOXP1;MEF2C;ITGB8;OCLN;ROBO1;PPHLN1;NOTCH2;IGFBP5;APP;KLF4;NFKB1;KDM4A;CLDN5;SRGN;KDR;TMBIM6;WWP2;NOTCH1;WNT4;TGFB2;SAMD4A;CNOT10;PRKAA2;CD34;SMO;RUNX1;LGR4;ADAM10;ATP2B1;DICER1;LSM6;APOE;XDH;ACVRL1;MAPT;CELF1;CNOT8;RPS6KA5;BTG2;ATOH8;CITED2;PTBP3;GATA2;CPEB3;PPM1D;SFRP1;TNRC6A;SLC7A5;PARP10;PARP9;VHL;TARDBP;GAPDH;PAIP2;MAP2K2;RBM4;TNRC6C;HEY2;PTRH2;TERT;TLE5;YBX1;LSM2;TOB1;DHFR;ERN1;JARID2;EZH2;SIRT1;GPER1;PRKAA1;ESR1;TRIM27;HAVCR2;TWSG1;RBBP7;AGO2;DNMT3B;PPP1R11
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.45954361169589464,-1.4444066529587933,0.04986149584487535,0.44973757466316194,1.0,5/26,5.12%,PRKAG2;ADIPOR2;ERLIN1;LPGAT1;PRKAA2
prerank,regulation of plasminogen activation (GO:0010755),-0.5785598719464926,-1.4443793640770746,0.08470588235294117,0.44767976599102244,1.0,6/12,15.14%,THBS1;RUNX1;SERPINE1;ENO1;CTSZ;SERPINE2
prerank,activation of protein kinase A activity (GO:0034199),0.607053799467142,1.4431794279038117,0.08429752066115702,0.7492197658862884,1.0,7/16,8.81%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;ADCY7;PRKACA
prerank,regulation of hippo signaling (GO:0035330),-0.5051962380211482,-1.4428572600658136,0.0731070496083551,0.44992241873627564,1.0,8/17,18.46%,MAPK14;MOB3B;SCHIP1;AJUBA;DLG5;MARK3;VGLL4;SOX11
prerank,positive regulation of glucose import (GO:0046326),-0.4847550262568121,-1.4421183526618828,0.05897435897435897,0.449721451277567,1.0,6/21,4.59%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,sulfur compound catabolic process (GO:0044273),0.4892444644513777,1.4410137411853772,0.06140350877192982,0.7548234900301696,1.0,9/38,10.43%,DCN;GGT5;LUM;BGN;GGT7;VCAN;ADO;GNS;TXN2
prerank,granulocyte chemotaxis (GO:0071621),0.4623589148530646,1.4408827948213336,0.04950495049504951,0.7513766969348378,1.0,7/55,5.36%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,response to organonitrogen compound (GO:0010243),0.49292472937068776,1.4408040146997168,0.07165109034267912,0.7478382830601468,1.0,16/38,19.43%,NR1H4;SEL1L;KYNU;MTOR;DNAJB12;RCN3;GLRA3;GLRA1;TRPM2;MEAK7;GLRA2;GLRB;BRSK2;UBXN6;KAT7;RHBDD1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5068746242284718,-1.4404164098852592,0.08247422680412371,0.452509515800655,1.0,3/18,3.71%,PRKAG2;OCLN;SLC2A1
prerank,heart trabecula morphogenesis (GO:0061384),-0.5065103125127622,-1.4403025163569072,0.06613756613756613,0.45065288492747113,1.0,7/18,4.47%,TEK;RBPJ;ADGRG6;S1PR1;RBP4;NOTCH1;TGFB2
prerank,protein localization to cell junction (GO:1902414),-0.4742843473997178,-1.438899401997835,0.05194805194805195,0.4524055898243165,1.0,6/22,7.55%,HEG1;TJP1;ARHGEF18;CGNL1;TJP2;SHANK1
prerank,oligosaccharide metabolic process (GO:0009311),-0.41169251524986195,-1.4381893598904965,0.032679738562091505,0.4523543419231403,1.0,14/46,13.03%,B4GALT1;ST3GAL6;FUT8;ST8SIA4;B3GALT1;ST3GAL4;ST6GALNAC3;MANBA;MAN2C1;ST3GAL3;MPDU1;ST8SIA2;NAGA;FUT9
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.5466679229713557,-1.4356617771997395,0.07398568019093078,0.4577546208310104,1.0,8/14,29.12%,THBS1;KLF4;NOTCH1;ITGB1BP1;MAP2K5;CARD10;DLL4;HDAC5
prerank,cellular sodium ion homeostasis (GO:0006883),0.5862185186445914,1.4356409029303987,0.1,0.766994409941125,1.0,3/15,5.55%,ATP1A2;ATP1A3;SLC9A1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6343698000625764,1.4348711267053287,0.11090909090909092,0.7662884452687552,1.0,2/10,5.31%,DCN;LRRK2
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5968107856906308,-1.4348428882191226,0.09047619047619047,0.458186497931563,1.0,4/10,15.46%,ST6GAL1;ST3GAL1;RENBP;NPL
prerank,negative regulation of biosynthetic process (GO:0009890),0.589680114907872,1.4348381770551784,0.10309278350515463,0.7624952437097641,1.0,3/16,2.37%,PPARA;SLC30A10;ABCD2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5268888164056933,-1.433154861061293,0.082010582010582,0.46087165686050097,1.0,10/16,19.83%,NPR3;SCARB1;APOE;GCH1;PIK3CB;TERT;DHFR;NOS1AP;AKT1;NUS1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6394626291537866,1.4331131414067018,0.10018214936247723,0.766452977940114,1.0,5/11,11.72%,DLC1;FAP;CIDEA;TP53;PTGIS
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4593310014484141,-1.4330120381923876,0.07267441860465117,0.4590937891814231,1.0,8/26,10.61%,ROCK2;SHANK3;RDX;ACTG1;RAC1;CDC42;SHANK1;FHOD1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5912261402151854,-1.4329842359469924,0.08144796380090498,0.4571230115612509,1.0,7/11,24.46%,FOXO1;CAV1;FAS;ATP6V0A2;CCDC115;TMEM199;ATP6V1G1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6013014756235722,1.432462232215986,0.08614864864864864,0.7654235383374368,1.0,3/14,7.60%,GHR;PIK3R1;PTK2
prerank,regulation of secretion (GO:0051046),0.6111465061260233,1.4321119900311683,0.09358752166377816,0.7631253430997496,1.0,5/13,15.68%,NRG1;GPLD1;MYO6;POFUT2;SGK1
prerank,epithelium development (GO:0060429),-0.33723241518345487,-1.4319678112424383,0.004975124378109453,0.4579275398408797,1.0,25/107,14.38%,ALDH1A2;VCL;OSR1;KANK2;KDR;WNT4;CD34;SMO;DVL1;SIX1;TOLLIP;ERRFI1;TBX1;PGK1;SOX17;BDH2;PTER;TBX2;TAGLN2;TAGLN;DAG1;PCNA;ALDOC;MFSD2A;GATA6
prerank,cholesterol homeostasis (GO:0042632),0.4508243488023065,1.4314345205161834,0.046831955922865015,0.762280827188346,1.0,5/64,5.18%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.41842341999539684,-1.4304808447307873,0.03642384105960265,0.4599832494671832,1.0,14/41,22.34%,MEF2C;RBPJ;TPM1;CPE;NOTCH1;TGFB2;SOX4;HEYL;HEY2;TGFBR3;SOX11;PKP2;TGFBR2;SMAD7
prerank,negative regulation of viral transcription (GO:0032897),-0.5536392469284377,-1.4297102710226488,0.0748792270531401,0.46013348483814054,1.0,6/13,18.95%,TRIM11;IFITM3;TRIM14;TRIM27;UBP1;HEXIM1
prerank,motile cilium assembly (GO:0044458),0.6300713079379852,1.429574641696462,0.07944732297063903,0.7666630502315253,1.0,4/12,15.73%,RSPH9;DNAAF3;E2F4;CCDC39
prerank,sterol homeostasis (GO:0055092),0.4491050775402813,1.429523971748054,0.04281767955801105,0.7631240548272342,1.0,5/65,5.18%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4448743510507029,1.4295089451717031,0.058981233243967826,0.7594167084556863,1.0,16/68,17.68%,IL33;WNT5A;IL16;TSLP;TLR6;TLR8;TWIST1;MBP;TLR4;CYBA;PYCARD;TIRAP;F2R;DHX9;LGALS9;MYD88
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.3684455231959747,-1.4294056853629533,0.028,0.45889476779670624,1.0,22/67,13.78%,FN1;DOCK5;LIMS2;DOCK1;VIT;NRP1;S100A10;NEDD9;RAC1;CDK6;CDC42;PPM1F;GSK3B;RSU1;ECM2;SFRP1;NPNT;ARL2;MDK;PLEKHA2;FLNA;PTK2B
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4515709817850183,-1.4291053777215859,0.06301369863013699,0.4576937949561329,1.0,11/28,21.10%,OCLN;DRG1;RAC1;MAPT;GIT1;ARL2;SLAIN2;MET;CDK5RAP2;NUMA1;FES
prerank,heart morphogenesis (GO:0003007),0.4736216253028638,1.4278846945724868,0.04456824512534819,0.7626943921816693,1.0,11/50,12.33%,CHD7;FLRT2;DLC1;RYR2;TBX3;HTR2B;PTK2;MDM4;TGFBR1;SOX9;OLFM1
prerank,central nervous system myelination (GO:0022010),0.6318516168519527,1.4276053053182758,0.11333333333333333,0.760185625153567,1.0,7/11,17.66%,PTEN;TENM4;PLP1;SOX10;MYRF;CLU;ABCA2
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5758247006321597,1.4274657075534387,0.08263069139966273,0.7534387095070842,1.0,5/16,6.91%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5758247006321597,1.4274657075534387,0.08263069139966273,0.7534387095070842,1.0,5/16,6.91%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.46962675922043573,-1.426991813089644,0.0659025787965616,0.46166281047203567,1.0,12/26,21.40%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;TRPV4;MET;CDK5RAP2;NUMA1;FES;KATNB1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.44658343371401377,1.4267364759988,0.03776223776223776,0.7530614713760021,1.0,15/69,8.37%,PDGFRA;PLCL1;PIK3R1;OGT;PTEN;FGFR1;GAB2;PIK3R2;HTR2B;IRS1;NF1;IRS2;PI4KA;RPS6KB1;PLEKHA1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.4432555237418905,-1.4252096841217625,0.05714285714285714,0.4646434383532729,1.0,12/27,23.75%,NFKB1;MAP3K5;CUL1;UBB;MAP2K7;MAP3K8;CCDC88C;UBC;UBA52;IKBKB;TAOK2;IKBKG
prerank,ERBB2 signaling pathway (GO:0038128),0.519161016792714,1.4249516192370728,0.07934131736526946,0.7572486713943618,1.0,7/31,8.81%,PIK3R1;NRG1;ERBB4;PTPRR;NRG2;NRG4;PRKCA
prerank,amide transport (GO:0042886),-0.44919593454954787,-1.4249150777732293,0.05670103092783505,0.4634597057364163,1.0,13/26,31.03%,ABCG2;SLC25A32;CERT1;PLTP;SLC38A5;TAP2;PDPN;ABCB9;GLTP;DISP1;AQP11;SLC5A6;ABCA13
prerank,cellular response to ionizing radiation (GO:0071479),-0.39639928004435054,-1.4242831642627725,0.056962025316455694,0.46312088676860524,1.0,22/47,28.10%,NET1;CRYAB;MAPK14;TLK2;INO80;ATR;RPL26;EEF1D;ATM;GRB2;CDKN1A;SIRT1;TMEM109;CLOCK;HUS1;RAD51;LIG4;KDM1A;RHOB;ECT2;RHNO1;GADD45A
prerank,regulation of synapse assembly (GO:0051963),0.47133575782600534,1.4229374961138002,0.07324364723467862,0.7622737217675583,1.0,16/46,18.69%,ROBO2;SRPX2;EPHB1;GRID2;GPC4;NRXN1;SETD5;SYNDIG1;LRFN5;IL1RAP;CUX2;LHFPL4;IL1RAPL1;SLITRK1;GPC6;CLSTN1
prerank,cellular response to purine-containing compound (GO:0071415),0.6483428519514647,1.4228497350347336,0.08880994671403197,0.7591019942507758,1.0,4/10,13.85%,P2RY1;RYR2;TRPM2;RYR3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.606178926005105,1.4227983474082777,0.08680555555555555,0.755711774979364,1.0,1/13,0.09%,IL33
prerank,retinol metabolic process (GO:0042572),0.5972419496570216,1.4219658957718917,0.09931506849315068,0.7557324372466733,1.0,3/14,2.43%,ADH1A;RDH10;RDH11
prerank,epithelial structure maintenance (GO:0010669),-0.5830094119290045,-1.4218275218299599,0.09255079006772009,0.46756132400807715,1.0,2/11,4.08%,CXADR;RBP4
prerank,positive regulation of synapse assembly (GO:0051965),0.5165400163880445,1.4213935204143522,0.08538587848932677,0.7546413904740185,1.0,10/27,18.69%,SRPX2;EPHB1;GRID2;NRXN1;SYNDIG1;IL1RAP;VSTM5;CUX2;IL1RAPL1;CLSTN1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6158356808019235,1.4213243252079126,0.10084033613445378,0.7513763779928136,1.0,2/14,1.04%,ECE1;EDN3
prerank,homotypic cell-cell adhesion (GO:0034109),-0.41359963702802494,-1.4208637790967868,0.0471976401179941,0.4681925818919303,1.0,15/39,13.99%,FN1;VCL;ACTB;PLPP3;GNAS;MEGF11;ACTG1;TJP2;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4110727687515544,-1.419245386633015,0.03363914373088685,0.47070648798465825,1.0,19/40,26.13%,MAGI2;INSR;VTN;DAB2;B2M;RAB21;SERPINE1;CD63;HIP1;HFE;WASL;HNRNPK;EGF;TBC1D5;CCL19;BICD1;GREM1;NTF3;ARRB2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5136240558647257,-1.4190845362160844,0.07962529274004684,0.4691534102522171,1.0,8/16,25.67%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;DTX3L;KMT5C
prerank,ameboidal-type cell migration (GO:0001667),-0.3825958561130721,-1.418818718962334,0.037037037037037035,0.4679185579682295,1.0,20/51,18.47%,SEMA3D;SEMA3C;SEMA7A;AMOT;CCN3;GPC3;SEMA6A;SRGAP2;MEGF8;SEMA4B;TBX1;PHACTR4;SEMA5B;AMOTL2;SEMA6C;PKN2;SEMA3G;SEMA6B;AKT1;FAT2
prerank,cellular protein metabolic process (GO:0044267),-0.2904511871608689,-1.418489625510838,0.0,0.46687947484098463,1.0,113/396,18.19%,FN1;ST3GAL6;IGF1;ST8SIA4;IGFBP6;RPS14;RPS9;MSRB3;IGFBP5;PAPPA;APP;CPE;CST3;FSTL1;UBE2G1;RPS16;IGFBP3;RPLP1;RPL13;PRKDC;WWP2;DENND3;IGFBP2;FDX1;RPL27A;GPC3;UBE2D3;RPS2;RPL37A;RPL5;ST3GAL1;RPL8;ADAM10;SERPIND1;RPL41;RPS18;RPS7;RPS20;PRSS23;FBXL2;RPS19;RPS24;LMCD1;RPS27;NUCB1;RPS15;CCN1;ABCA3;RPL21;APOE;RPL10;MSLN;RPL35A;TNC;LAMB2;RPS15A;MANBA;SPCS2;RPS5;ABCF1;RPL10A;RPL11;RPL36A;EEF1A1;SHISA5;RPL34;ST8SIA2;RPS29;SEC11C;CTSH;RPL32;RPLP2;RPLP0;APH1A;RPL4;GALNT11;RPL30;RPS4X;RPS21;RPL26;RPL29;CSNK1G3;APH1B;CLN5;RPS8;GOLM1;MMP15;FURIN;GATA6;MRPS7;F5;USP25;CHRDL1;MMP1;RPS23;RPL31;PARP4;FDXR;UBE2L6;PCSK5;TTF1;RPL23A;YME1L1;NEDD8;RPL19;SRBD1;RPL36;MRPS17;SIAH2;AGO2;QPCT;MFGE8;YES1
prerank,synapse assembly (GO:0007416),0.4393619969785232,1.4183163159394603,0.050870147255689425,0.7609621214629987,1.0,16/67,11.40%,ADGRL3;WNT5A;PTEN;FARP1;NRXN2;GRID2;NRXN1;GABRA1;PCDHB16;LRRTM3;DSCAM;PCDHB4;PCDHB11;RAB29;GABRG2;PLXNB2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4783672245788154,-1.4182075268130778,0.0718232044198895,0.4657772916461953,1.0,8/20,15.78%,ANO6;ENTPD1;IL18;APP;TXNIP;NT5E;P2RX7;PSTPIP1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.505501366550733,1.4179930046474116,0.08116385911179173,0.7586728778780315,1.0,11/31,16.30%,PDGFRA;EIF4A3;HOXC9;DSCAML1;TWIST1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,positive regulation of kinase activity (GO:0033674),0.413618932829918,1.4173797310476575,0.04182509505703422,0.7577614919761109,1.0,22/107,10.44%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;TRAF4;ERBB4;EPHB1;FGFR1;EPHA6;CENPE;MRNIP;PTK2;JTB;RELN;AXL;EPHB6;CACUL1;DAXX;EPHA3
prerank,sodium ion export across plasma membrane (GO:0036376),0.5954147060079392,1.4171422598132417,0.10580204778156997,0.7554115800525631,1.0,3/13,5.55%,ATP1A2;ATP1A3;SLC9A1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.636879137237686,1.4164575024283612,0.09187279151943463,0.7548903536372434,1.0,4/12,11.91%,PPARA;ITGAV;NR1H2;ABCA5
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.43947520227510517,-1.415909889356361,0.06395348837209303,0.47005161343038654,1.0,12/30,23.72%,FLT1;MLLT3;KDR;ACE;SFRP1;FLT4;FLT3;ARMC6;CSF1R;FSTL3;BATF;SP7
prerank,cellular response to interleukin-2 (GO:0071352),0.62897599461707,1.4155667979032158,0.11036789297658862,0.7517625564435836,1.0,2/11,3.13%,IL2RA;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.62897599461707,1.4155667979032158,0.11036789297658862,0.7517625564435836,1.0,2/11,3.13%,IL2RA;JAK1
prerank,endocardial cushion development (GO:0003197),-0.4786542129102014,-1.4155207615863616,0.07651715039577836,0.46904712817192057,1.0,8/21,12.04%,NOS3;BMPR2;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3895108318246717,-1.414919430786398,0.0392156862745098,0.46873973877925046,1.0,9/47,7.05%,RAPGEF2;ROCK2;CAV1;NFKB1;ERLIN1;SIRPA;WNT4;CD34;SIK1
prerank,regulation of hydrolase activity (GO:0051336),-0.36629241511533595,-1.4146943991674652,0.02681992337164751,0.4674664655190458,1.0,23/71,15.41%,PLXNA2;EPHA4;FGD5;CAV1;PLXNA4;CHN2;SIPA1L1;RAPGEF6;RDX;RASIP1;EFNA5;RALBP1;ITGB1BP1;NGEF;PLXNB1;ARHGAP27;ARHGAP12;NOS1;PRKG1;TBC1D10B;PLXNA1;ARHGAP44;ARHGAP15
prerank,negative chemotaxis (GO:0050919),-0.41604526386658014,-1.414264999775102,0.03951367781155015,0.466690874531633,1.0,9/33,6.77%,SEMA3D;SEMA3C;SLIT2;ROBO1;NTN1;SEMA7A;SEMA6A;SEMA4B;PDGFA
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5333315765729775,1.4135519839451658,0.10526315789473684,0.7567003241657068,1.0,4/22,9.17%,APOD;MDFIC;LRRK2;SP100
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.42914343490763995,1.4134409617922272,0.06438896189224705,0.7538002462494781,1.0,22/72,20.10%,ENPP1;ERCC1;ANKLE1;FAN1;FEN1;POLK;ERCC5;PDE12;RPA1;ERCC4;RFC3;EDC3;GTF2H3;EDC4;ERCC2;GTF2H1;FBH1;DXO;CUL4A;REXO4;DDB1;DDX1
prerank,regulation of muscle contraction (GO:0006937),-0.4502317780397149,-1.4124783472982656,0.06470588235294118,0.46971862467758974,1.0,7/26,13.51%,PLCE1;CAV1;TPM1;SRI;MYL9;PPP1R12B;ENO1
prerank,regulation of establishment of protein localization (GO:0070201),0.6085869798794703,1.4123880944203744,0.09731543624161074,0.7549712997054333,1.0,5/13,11.73%,CORO2B;CEP295;CEP135;SCFD1;SPIDR
prerank,respiratory system development (GO:0060541),0.49592958644710106,1.4116052065363034,0.08643815201192251,0.7547144195717731,1.0,5/32,4.09%,CHD7;BASP1;ITGA3;NPHP3;LOXL3
prerank,organelle transport along microtubule (GO:0072384),-0.43127615633424843,-1.411424164954903,0.046012269938650305,0.4708982327905547,1.0,15/31,24.85%,NDEL1;CDC42;UBB;MAPT;TRAK2;BICD2;BORCS5;DYNC1I1;RAB1A;RAB6A;TMEM201;BICDL1;COPG2;BICD1;KIF5B
prerank,regulation of interleukin-1 production (GO:0032652),-0.5215088357329265,-1.4107402543007554,0.09523809523809523,0.4709071485066975,1.0,4/15,12.18%,FOXP1;SIRPA;ANXA1;CEACAM1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.641399862720649,1.410523377758618,0.11486486486486487,0.7562848592124971,1.0,5/10,21.17%,CD40;FGR;BAG6;LYN;BTLA
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5303077916911274,1.4104268458052192,0.09816971713810316,0.7533989852090562,1.0,6/23,8.81%,PDE4B;RYR2;APLP1;LRRK2;SLC9A1;PRKACA
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4186793530741937,-1.4103238119714736,0.043343653250773995,0.47024386236623567,1.0,10/37,13.67%,CAV1;BCL2L1;BECN1;RPS7;NCK1;UBB;BAD;BAX;BID;BOK
prerank,steroid biosynthetic process (GO:0006694),0.4487423106857268,1.4098169263419,0.061813186813186816,0.7527000570307143,1.0,6/56,6.25%,HSD11B1;CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D
prerank,regulation of monooxygenase activity (GO:0032768),-0.4750639750832714,-1.4092890304979127,0.06914893617021277,0.471097045046201,1.0,13/23,22.14%,CAV1;EGFR;NOS3;ZDHHC21;NOSTRIN;CALM1;DDAH1;NOS1AP;WASL;AKT1;NOSIP;LYPLA1;DDAH2
prerank,negative regulation of response to external stimulus (GO:0032102),0.4156882403666122,1.4088056440407706,0.04481434058898848,0.7538847821301097,1.0,14/105,8.22%,RORA;CASK;PPARA;NR1H4;CTNNA2;PTEN;TRAF3IP1;GRID2;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,intermediate filament organization (GO:0045109),-0.5212735046166994,-1.4086349002406784,0.09947643979057591,0.47081580542145296,1.0,3/17,3.29%,VIM;MTM1;KLHL24
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.4467373562503006,-1.4084283698742306,0.07397260273972603,0.46961879095855363,1.0,16/25,34.95%,CSGALNACT1;B3GALT1;NDST1;NDST3;EXT1;B3GALNT1;FUT9;B3GNT2;HAS1;B3GNT9;NDST4;HAS2;B3GNT3;HAS3;B3GNT6;B4GAT1
prerank,lamellipodium organization (GO:0097581),-0.44113367028152284,-1.4080378393019022,0.08192090395480225,0.4687668709090325,1.0,8/29,11.11%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SPATA13;CCDC88A
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.44962541995114436,-1.407719770489075,0.07526881720430108,0.46772790694801536,1.0,5/26,2.79%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,cardiac muscle tissue development (GO:0048738),0.47110803814884017,1.4073583220344428,0.06847360912981455,0.756909699026357,1.0,9/50,11.68%,TBX18;MSC;NRG1;SMAD5;GJA1;CACNA1G;BMP7;NDUFV2;MSX1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.41318814208269833,1.4069792189621366,0.04207920792079208,0.7552474983170003,1.0,25/102,11.12%,ENPP1;LPIN3;PIK3R1;ADCY5;CPEB1;SLC30A10;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;ADCY8;ADCY3;ADCY2;RPS6KB1;PRKACB;ADCY7;PRKACA;GCK;SLC25A33;RAB15
prerank,pyruvate metabolic process (GO:0006090),-0.3814449115069597,-1.406932531896787,0.04912280701754386,0.46827985131583255,1.0,21/52,20.98%,BSG;ME2;DLAT;HK1;LDHA;PGK1;PFKFB2;SLC16A1;TPI1;HK2;GLO1;ME1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;LDHB;GAPDHS;PGM1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3955115988324378,-1.4062480569510039,0.06228373702422145,0.4684525623869229,1.0,19/46,23.70%,PLCB1;SOD2;CDC42;PITPNA;TALDO1;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,diterpenoid metabolic process (GO:0016101),0.45223758238925316,1.4061810952231273,0.07713884992987377,0.755385158924541,1.0,7/55,4.75%,LRP1;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,positive regulation of phospholipase activity (GO:0010518),0.5403891205462565,1.4057772769201797,0.09350237717908082,0.7538337036182892,1.0,4/22,3.91%,PDGFRA;NTRK3;FGFR1;PDPK1
prerank,negative regulation of macrophage activation (GO:0043031),-0.5136631616216789,-1.4053989716680622,0.09162303664921466,0.4688824594344312,1.0,2/16,0.90%,CD200;IL31RA
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4011617272439097,-1.4053797710739921,0.03560830860534125,0.4670723212507489,1.0,11/39,8.29%,TSPAN5;RBPJ;ROBO1;MAML2;NOS3;NOTCH1;TGFB2;CCN3;IL6ST;EPN2;ITGB1BP1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5717636425876654,1.4050156808691365,0.09724473257698542,0.7538790984121154,1.0,5/16,12.83%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,response to growth factor (GO:0070848),-0.4003564304430131,-1.4039722194592021,0.05592105263157895,0.4690434223279947,1.0,21/41,23.87%,KLF4;BMPR2;ACVR1;ACVRL1;SFRP1;TBC1D7;NOS1;CPNE3;GATA6;MAP2K5;PLK5;EPHA2;ACVR2B;ERBB2;AKT1;CIB1;HDAC6;TWF2;TGFBR2;EMD;ACVR2A
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6445386284088036,1.403404183463822,0.13095238095238096,0.7574498990586921,1.0,3/10,15.08%,C5AR1;SORL1;CLU
prerank,morphogenesis of an epithelium (GO:0002009),0.524665168877569,1.4031655164818657,0.09822866344605476,0.7553168111522066,1.0,7/25,12.20%,TBX18;KDF1;TRAF3IP1;PRKX;AHI1;SOX10;SOX9
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5796961141520179,1.4028317060755,0.11221122112211221,0.7534487399767285,1.0,2/15,2.07%,NTRK3;IL16
prerank,mesenchyme morphogenesis (GO:0072132),-0.5035576091506997,-1.4028137348612204,0.08418367346938775,0.470615991550753,1.0,7/17,12.04%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,positive regulation of locomotion (GO:0040017),-0.4357096693685048,-1.4022683097814106,0.06382978723404255,0.4702578524015121,1.0,6/27,10.71%,CAVIN1;SPOCK2;NTN1;THBS1;PPM1F;STX3
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5232270438638216,1.4013888839521607,0.09523809523809523,0.7562934337812515,1.0,4/25,4.86%,ZFYVE28;PPARA;CBLB;CNRIP1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.46550114041325097,-1.4006492592864086,0.06735751295336788,0.4727623046798415,1.0,5/23,15.12%,IGF1;GIT1;CX3CR1;CEACAM1;CX3CL1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.535799694619408,1.3995677552816288,0.10586319218241043,0.7604712437000811,1.0,4/21,8.54%,PPARA;SLC30A10;ABCD2;PINK1
prerank,response to ethanol (GO:0045471),0.5909264719095296,1.3994398784703224,0.11418685121107267,0.7579094117236936,1.0,6/14,18.07%,GRIN2B;GRIN2A;ADCY7;GLRA1;GLRA2;GRIN3A
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5962755974178714,-1.3994386014493205,0.11261261261261261,0.47445704878232736,1.0,2/10,1.28%,CD200;SLIT2
prerank,regulation of urine volume (GO:0035809),-0.5789281745955394,-1.3984353969326726,0.10046728971962617,0.475346660662524,1.0,3/10,10.15%,NPR3;NPR1;ADCY6
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5793577497108587,1.3982579233633672,0.12231404958677686,0.7598480685903274,1.0,8/16,12.76%,PTN;RBM24;SOX6;NUDT21;DHX36;LTBP3;SOX9;HOXB4
prerank,mesenchymal cell differentiation (GO:0048762),-0.37989393950230466,-1.3977558783193578,0.026845637583892617,0.47531958171951083,1.0,15/51,12.55%,RANBP3L;ROCK2;DDX5;MEF2C;LEF1;RBPJ;FOXC1;NOTCH1;WNT4;TGFB2;GSK3B;LRP6;HEYL;DLG5;HEY2
prerank,motor neuron axon guidance (GO:0008045),-0.5230776274058836,-1.397264838924209,0.09156626506024096,0.47484407345515905,1.0,5/15,5.43%,EPHA4;SLIT2;NTN1;TMEFF1;RAC1
prerank,odontogenesis (GO:0042476),0.48591602102173537,1.3966214956857268,0.07090103397341212,0.7635767950511653,1.0,8/35,7.03%,LAMB1;EDA;HDAC1;ANKRD11;TUFT1;COL1A2;BCOR;AMELX
prerank,embryonic eye morphogenesis (GO:0048048),-0.5704017208777514,-1.396420666517855,0.10817307692307693,0.47527064233875077,1.0,6/11,22.87%,MFAP5;LRP6;TBX2;EFEMP1;MFAP2;KDM2B
prerank,protein ADP-ribosylation (GO:0006471),-0.44255603321814097,-1.3962794571790034,0.07754010695187166,0.4739083329501588,1.0,13/28,27.29%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;SIRT1;PARP4;SIRT5;PARP2;PARP1;PARP12;ARF4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5853443234008213,1.396123532004229,0.10161290322580645,0.7625337856499096,1.0,4/15,3.48%,DCN;BGN;DSE;VCAN
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6354971063720087,1.3958155134732668,0.123046875,0.7607827775905014,1.0,7/10,21.60%,GPR37L1;LRRK2;PYCR1;RIPK1;GPR37;STK26;PDE8A
prerank,rRNA processing (GO:0006364),-0.3105008387610327,-1.3956815897982544,0.006944444444444444,0.47380013205704613,1.0,83/172,30.37%,NSA2;RPS14;RPS9;RPS16;RPLP1;RPL13;PRKDC;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPL41;RPS7;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;LSM6;PDCD11;RIOK1;RPL10;RPL35A;DDX27;RPL10A;RPL11;ERI1;RPL36A;RPL34;RIOK3;RPL32;RPLP2;RPLP0;ESF1;UTP3;RPL4;RPL30;RPL26;RPL29;NOLC1;EXOSC2;IMP3;RPL31;EXOSC3;SART1;RPL23A;RPL19;RPL36;WDR12;PES1;LAS1L;RRP15;SENP3;RPL17;RPL23;RRP12;NOL11;UBA52;EXOSC1;TSR3;RPL15;PWP2;RPL38;WDR74;MRM2;NOP2;RSL1D1;RPL13A;RPL18A;EXOSC4;RPS25;NHP2;RPL24;WDR75;RRP36;NOP53;BMS1;WDR46;PIH1D2;RRP9
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4687194531740945,-1.3953414770064498,0.08157894736842106,0.4729363873367956,1.0,6/24,9.92%,ROCK2;PRKCH;FOXC1;RUNX1;ERRFI1;TRIM16
prerank,regulation of cation transmembrane transport (GO:1904062),0.49647267330124517,1.3945907096453416,0.08242612752721618,0.7627246152559966,1.0,10/29,13.34%,DPP6;DPP10;KCNIP1;SLC30A5;KCNIP2;KCNAB1;KCNIP4;FGF12;KCNN2;KCNAB3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6081276190648457,1.39355020932778,0.1128747795414462,0.7639791073651023,1.0,3/13,9.17%,APOD;MDFIC;SP100
prerank,neutrophil migration (GO:1990266),0.4400083396899902,1.393474104854629,0.06566347469220246,0.7612347730723952,1.0,7/58,5.36%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,acylglycerol catabolic process (GO:0046464),0.5040615512015116,1.3932672980548897,0.10975609756097561,0.7590447587177326,1.0,8/30,12.34%,LIPC;LIPH;FABP5;FABP4;ABHD16A;LYPLA2;ABHD12;FABP3
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5415582709146198,1.3929965559253634,0.1136,0.7570899411335692,1.0,7/21,15.36%,LPIN3;CEL;PPARD;FAH;HOGA1;NUDT19;LPIN2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.46555487920732475,-1.3928856109428152,0.10732984293193717,0.477785116538768,1.0,5/21,8.04%,CAV1;APC;DVL1;GSK3B;LRP6
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3655821770410893,-1.3928614328053346,0.03018867924528302,0.4760763440973417,1.0,20/63,15.13%,CXADR;SIPA1L1;FER;EZR;NRP1;PARVB;RICTOR;S1PR1;GSN;PHACTR1;MINK1;NEDD9;ANXA1;GAB1;CDC42BPB;PTPN1;TRPV4;FLNA;CDC42BPG;GRB2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.49939209811945057,-1.3923639476491063,0.07785888077858881,0.4754796151783379,1.0,7/17,9.67%,SLIT2;ROBO1;NRP1;EFNB2;KDR;EPHB4;NR4A1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.5501627444263576,1.391320171854762,0.12231404958677686,0.7611234495581501,1.0,11/18,23.26%,MCM7;LIG3;GINS3;POLA1;RFC3;MCM4;POLE3;MCMDC2;POLE;RFC4;GINS1
prerank,negative regulation of transferase activity (GO:0051348),0.5081929792607764,1.3911705597742308,0.09828393135725429,0.7586708554622476,1.0,10/28,12.56%,FBXO5;NPRL2;IRS2;LIMK1;ERCC4;TERF1;EIF4A2;PIF1;TP53;GSK3A
prerank,sulfur amino acid catabolic process (GO:0000098),0.6281537635663655,1.3910772579039905,0.10669077757685352,0.7560711239061862,1.0,4/10,10.43%,MTRR;BLMH;ADO;TXN2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5651685070729991,-1.390998371507484,0.1180722891566265,0.4774687525043304,1.0,7/11,25.24%,KANK1;CD44;ENPP2;ARPIN;PDPN;CORO1B;SRC
prerank,regulation of viral entry into host cell (GO:0046596),-0.4325207882475052,-1.3904620207076208,0.07563025210084033,0.47724257064764103,1.0,16/30,29.16%,LY6E;GSN;TRIM25;TRIM5;TRIM11;IFITM3;TRIM14;IFITM1;TRIM27;CD74;SNX3;IFITM2;TRIM6;P4HB;CIITA;MID2
prerank,O-glycan processing (GO:0016266),-0.38109714547945694,-1.3904582009359652,0.0436241610738255,0.47551605692705096,1.0,17/54,20.64%,ST6GAL1;GXYLT2;ST3GAL4;B4GALT5;ST3GAL1;ST6GALNAC2;C1GALT1C1;ST3GAL3;GALNT11;GALNT1;GCNT1;ST3GAL2;B3GNT2;GALNT6;GALNT3;GXYLT1;GALNT12
prerank,potassium ion transport (GO:0006813),0.40248658785763997,1.3893170422245888,0.036069651741293535,0.7605240571507951,1.0,25/120,14.08%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNQ3;SLC9A9;KCNMA1;SLC9A1;KCNIP2;KCNG1;KCNH4;KCNAB1;KCNC2;HCN2;TMEM175;HCN1;HCN3;KCND2;KCNK1;KCNN2;KCNJ8;KCNH7;KCNAB3;KCNH8
prerank,response to insulin (GO:0032868),0.4255558834203618,1.3893081886091347,0.04819277108433735,0.7575794726637438,1.0,22/80,13.67%,ENPP1;LPIN3;PIK3R1;CPEB1;OGT;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;ZBED3;GCK;SLC25A33;RAB15;GSK3A;MEAK7;SLC39A14
prerank,sulfur compound transport (GO:0072348),-0.444556952822429,-1.3893005417835103,0.07202216066481995,0.47675959788063427,1.0,6/27,7.34%,ABCG2;SLC13A4;SLC26A7;SLC6A6;SLC26A11;LRRC8D
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5493384073165688,1.3891481369580998,0.11467116357504216,0.7553264749609615,1.0,7/19,5.49%,SCRIB;DLG3;FSCN1;MTCL1;PARD3B;DLG2;PRKCI
prerank,bone morphogenesis (GO:0060349),-0.5330024419516526,-1.3891099502015416,0.08521303258145363,0.4755605616126077,1.0,4/14,8.04%,CYP26B1;BMPR2;SKI;LRP6
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5731297594412197,1.3887640931491334,0.11551724137931034,0.7540302139088569,1.0,4/15,5.21%,LRP1;FAP;FSCN1;CARMIL2
prerank,positive regulation of bone resorption (GO:0045780),0.6105325334604514,1.3882207353089784,0.12867647058823528,0.7534312151399098,1.0,4/11,19.32%,SPP1;PRKCA;ADAM8;ATP6AP1
prerank,striated muscle cell development (GO:0055002),-0.5220074818361198,-1.3878917384006157,0.10047846889952153,0.4770947951126301,1.0,5/14,17.70%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5454654523490413,-1.3873699093879344,0.0812807881773399,0.4769311161245075,1.0,4/12,4.82%,PLCB1;SLIT2;NBL1;CCN3
prerank,regulation of platelet activation (GO:0010543),0.5486186598279313,1.3864334445707245,0.09807073954983923,0.758089656893839,1.0,6/21,9.69%,PDGFRA;HRG;TXK;C1QTNF1;PRKCA;TLR4
prerank,regulation of synapse organization (GO:0050807),0.5112179036192923,1.3863396711477558,0.10015408320493066,0.7554912600377991,1.0,9/26,8.06%,ARHGAP22;WNT5A;CTNNA2;YWHAZ;CDKL5;NEDD4;SETD5;ABHD17C;ABHD17B
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5506980991345007,-1.3860846168271952,0.12555066079295155,0.4788040586482651,1.0,7/11,19.43%,EZR;RDX;DAB2;RAB21;VPS11;MSN;MTMR2
prerank,response to glucagon (GO:0033762),0.5533826045647066,1.3847882071519861,0.11935483870967742,0.7589021779848504,1.0,7/19,8.81%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;ADCY7;PRKACA
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4345124704800194,1.3847586767517068,0.06149732620320856,0.7561128082612746,1.0,22/65,18.78%,RORA;CPEB1;TBL2;EPAS1;EGLN2;HP1BP3;MDM4;TWIST1;PINK1;AK4;MTOR;BMP7;KCND2;TP53;PTGIS;FAM162A;SCN2A;MYC;TSC1;ADAM8;SUV39H2;HIF1A
prerank,limb development (GO:0060173),0.5125379671336094,1.3836740865939896,0.10093167701863354,0.7576531958332101,1.0,8/28,15.26%,CHD7;KDF1;SALL1;KREMEN1;GLI3;KAT2A;LNPK;IQCE
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.560063776060354,-1.3834439430652248,0.12289156626506025,0.4838041229146857,1.0,5/11,9.51%,THBS1;SEMA6A;KLF2;EPN2;PIK3CB
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5529628593307548,-1.3829297765502746,0.1087962962962963,0.4834358498200716,1.0,3/12,7.60%,PICALM;ROCK2;APOE
prerank,carbohydrate catabolic process (GO:0016052),-0.40227599451666224,-1.3820317929423582,0.06382978723404255,0.4840316423334649,1.0,19/38,20.98%,DERA;HK1;LDHA;PGK1;PFKFB2;TPI1;HK2;MANBA;MAN2C1;GAPDH;NAGA;PKM;ALDOC;ENO1;PFKL;ALDOA;MAN2B2;GAPDHS;PGM1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4460400212591876,-1.381092268561918,0.08169014084507042,0.48480881270217085,1.0,6/26,4.59%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,response to axon injury (GO:0048678),0.5540031679852154,1.3804848262781388,0.10714285714285714,0.767809585500805,1.0,1/18,0.04%,APOD
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5001288993765334,-1.3802938345052678,0.11219512195121951,0.48535260158280713,1.0,5/15,28.71%,MOXD1;PAOX;SAT2;DDC;SRM
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.3599109833993465,-1.3794342118593879,0.053231939163498096,0.48581116352682663,1.0,27/70,20.07%,BCL2L1;CASP8AP2;MCL1;FAS;TGFB2;GABARAP;CRADD;NGF;CASP2;HIPK1;GSK3B;IFI27;CASP3;SMAD3;BAD;CASP8;BAX;RNF41;BID;BAG3;BOK;P2RX7;TNFRSF1A;FGFR3;ERBB3;CIB1;TRADD
prerank,phasic smooth muscle contraction (GO:0014821),0.61872895975231,1.3788693510230854,0.13261648745519714,0.771493498123995,1.0,2/10,4.84%,EDN3;HTR2B
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.38997900124379026,1.3780050475669998,0.04470588235294118,0.7721799542416544,1.0,22/138,10.44%,ROR1;PDGFRA;PTN;NTRK3;EPHA7;ROR2;MERTK;PTPRT;NTRK2;ERBB4;EPHB1;CD8B;FGFR1;EPHA6;PTPRU;PTK2;EFS;AXL;EPHB6;FGR;AHI1;EPHA3
prerank,DNA packaging (GO:0006323),0.5661361430766724,1.3773132706040245,0.12,0.7721084600696416,1.0,4/16,10.84%,NAA10;CHAF1B;NOC2L;TP53
prerank,potassium ion transmembrane transport (GO:0071805),0.39238053563239916,1.3772243396947306,0.03902439024390244,0.7695123925886792,1.0,28/135,14.08%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNT2;KCNQ3;SLC12A6;SLC9A9;ATP1A3;SLC9A1;KCNIP2;KCNG1;KCNH4;KCNAB1;KCNC2;HCN2;TMEM175;HCN1;HCN3;KCND2;KCNE4;KCNK1;KCNN2;KCNJ8;KCNH7;KCNAB3;KCNH8
prerank,histone H3-K36 demethylation (GO:0070544),-0.5909892837631042,-1.3758199682114267,0.10609480812641084,0.49362469292647176,1.0,6/10,22.87%,KDM4C;KDM4A;RIOX2;PHF8;KDM4B;KDM2B
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6176791565652319,1.3758140431532595,0.1366120218579235,0.7721922086330483,1.0,1/10,0.11%,ENPP1
prerank,renal water homeostasis (GO:0003091),0.5319101430405992,1.3756181293259258,0.12417218543046357,0.7701156914029637,1.0,7/23,8.81%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;ADCY7;PRKACA
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4205962123928131,1.37516392052749,0.07702523240371846,0.7692075297549787,1.0,18/76,13.98%,FANCI;PRICKLE1;MYCBP2;GNL3;LRRK2;PSMD10;PINK1;COMMD1;TSPYL5;BIRC2;SAE1;NDFIP2;GSK3A;SPRTN;DCUN1D5;PTTG1IP;AXIN1;UBE2D1
prerank,negative regulation of protein processing (GO:0010955),-0.5468468530840779,-1.3751440228841734,0.13425925925925927,0.4937491914122878,1.0,6/12,15.14%,THBS1;GAS1;SERPINE1;TMEM59;CTSZ;SERPINE2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5177455011902604,1.3750441743678372,0.10034013605442177,0.7668603753775237,1.0,1/23,0.02%,CEMIP
prerank,microtubule-based transport (GO:0099111),0.5994797980961207,1.3739439836596472,0.12743362831858407,0.768748657027477,1.0,4/12,11.34%,DNAAF4;ADCY10;SPA17;CABYR
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.49330847762918906,-1.3736201437623283,0.10077519379844961,0.4960187738663697,1.0,7/18,12.36%,SAMHD1;DERA;FUCA1;OGA;MANBA;NGLY1;NAGA
prerank,regulation of nuclear division (GO:0051783),0.5318792503008076,1.3734211393773392,0.11690363349131122,0.7680540380190356,1.0,6/20,11.50%,L3MBTL1;PKMYT1;FBXO5;CDK13;RCC1;MKI67
prerank,vitamin transport (GO:0051180),-0.42845466998489434,-1.3733804154452354,0.07627118644067797,0.4950226216720525,1.0,21/29,47.87%,ABCG2;SLC25A32;PDPN;CUBN;SLC52A3;AFM;SLC52A2;CD320;SLC5A6;TCN2;TTPA;SLC2A2;SLC23A1;SLC27A1;SLC46A1;AMN;SLC2A6;FOLR2;FOLR1;SLC2A10;TCN1
prerank,vacuolar acidification (GO:0007035),-0.45961711183019877,-1.3723050794762888,0.08378378378378379,0.496215054883582,1.0,12/21,27.46%,ATP6V0A4;CLN5;ATP6V0E2;ATP6AP2;TMEM9;ATP6V0A2;ATP6V0D2;ATP6V0A1;CCDC115;TMEM199;CLN6;SLC11A1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5867881450805384,1.3714953544925308,0.11858407079646018,0.7732596142310599,1.0,7/13,23.67%,FGFR1;PDPK1;SIRT6;IGF2;SP1;HMGB1;ADAM17
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.34987050753219473,-1.3712890944782885,0.026119402985074626,0.49728599020992076,1.0,23/65,20.53%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;INTS3;PSMD8;PSMD12;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;PSMB10;PABIR1;CHFR;PSME2;PSMC3
prerank,monocyte differentiation (GO:0030224),-0.5653004102603197,-1.3710740513606632,0.11212814645308924,0.49619950122091955,1.0,7/10,30.43%,PIR;IL31RA;PDE1B;CSF1R;MYH9;PPARG;MT1G
prerank,positive regulation of cytokinesis (GO:0032467),0.4873971434563048,1.3708685411310166,0.1095890410958904,0.7729384858867255,1.0,3/32,0.95%,SVIL;CDC14B;RXFP3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6248561659241215,1.3698581656240023,0.13711151736745886,0.774257891352744,1.0,2/10,0.88%,DCN;HRG
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.52650297831454,-1.3697783060345854,0.10476190476190476,0.4962464795778875,1.0,2/14,2.92%,ABCG2;HMOX2
prerank,heme catabolic process (GO:0042167),-0.52650297831454,-1.3697783060345854,0.10476190476190476,0.4962464795778875,1.0,2/14,2.92%,ABCG2;HMOX2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3655201535612245,-1.3697587061092087,0.049342105263157895,0.4946403631895356,1.0,22/55,24.40%,CAV1;BCL2L1;TPD52L1;BECN1;TNFSF10;FAS;WWOX;CRADD;BAD;BAX;BID;CYLD;BOK;GPER1;PAK2;ING5;AGT;NUPR1;BCL10;TRIM39;HYAL2;BCL2L11
prerank,Wnt signaling pathway (GO:0016055),-0.3316867377403753,-1.3696496266459,0.035398230088495575,0.49329266820636214,1.0,28/92,14.32%,LEF1;WNT5B;PLPP3;CPE;NXN;WNT9A;VPS35;WNT4;APC;DVL1;CUL1;FZD4;UBB;ARL6;FZD7;WLS;GSK3B;LRP6;WNT6;NR4A2;SFRP1;BCL9L;PLCG2;CSNK1G3;CCDC88C;FZD3;VPS29;WNT16
prerank,amino acid import across plasma membrane (GO:0089718),0.5056951692083358,1.369384826658243,0.11021069692058347,0.7733829554572345,1.0,4/24,4.79%,SLC1A3;SLC1A5;SLC6A13;SLC7A8
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4362292312533244,-1.369376987875066,0.08587257617728532,0.4924146646632808,1.0,12/26,19.62%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;MTBP;ANXA1;HYAL1;CCND1;ANKRD17;AKT1;RGCC
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5924578946096787,1.3691413861734802,0.12343470483005367,0.7716554389340289,1.0,4/12,12.27%,DCN;HRG;ADAMTS12;IL12A
prerank,intracellular lipid transport (GO:0032365),-0.45069368675961974,-1.3688836214438023,0.08157894736842106,0.4920426315338926,1.0,5/21,5.12%,PRKAG2;ABCD3;ABCD4;CERT1;PRKAA2
prerank,B cell differentiation (GO:0030183),-0.382727091601013,-1.3688328864400063,0.052795031055900624,0.49051688331143056,1.0,14/46,18.32%,PTPRJ;FNIP1;TPD52;HDAC4;ITGB1;DNAJB9;PTPN2;IRF2BP2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK
prerank,negative regulation of immune effector process (GO:0002698),-0.5303130371402112,-1.3668796264223697,0.11192214111922141,0.4942092621266553,1.0,5/13,16.47%,FER;CD55;RPS19;RC3H1;HAVCR2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6036387711519041,1.366117723478919,0.13908450704225353,0.7813695401345975,1.0,2/11,1.22%,COLEC12;UNC93B1
prerank,positive regulation of dendrite development (GO:1900006),0.6262916903968759,1.3658825678645026,0.13793103448275862,0.7795103243078682,1.0,2/10,9.54%,PTN;BMP7
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.47492788900053984,-1.3655875349185302,0.09852216748768473,0.49586826052710736,1.0,8/18,18.86%,CTSC;EZR;RDX;VPS35;APOE;VPS11;VGLL4;MSN
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4855831293212559,-1.3654008106288,0.07579462102689487,0.49469286678499325,1.0,7/18,19.48%,EZR;RDX;VPS35;VPS11;VGLL4;MSN;WDR91
prerank,ribosome assembly (GO:0042255),-0.38403783812633674,-1.3653556623584728,0.04823151125401929,0.4931905715357772,1.0,21/47,29.96%,RPS14;RPL5;RPS19;RPS27;RPS15;RPL10;RPS5;RPL11;RPLP0;MRPS7;RPL23A;MRPL20;NPM1;MPV17L2;PWP2;RPF2;NOP2;RPL24;NOP53;EIF2A;MRPS2
prerank,negative regulation of defense response to virus (GO:0050687),0.6063391475581226,1.3648960147005433,0.12277580071174377,0.7806709812279284,1.0,2/10,2.85%,TRAF3IP1;TSPAN6
prerank,cardiac cell development (GO:0055006),-0.554827869884267,-1.3648332073771756,0.11848341232227488,0.4929679798707845,1.0,3/11,9.13%,CXADR;NOTCH1;MYH11
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5501948676353168,-1.3643040937477418,0.09734513274336283,0.49275885921741924,1.0,4/11,4.82%,SLIT2;NBL1;RIN3;CCN3
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5564400735144721,1.3642375367686443,0.1186161449752883,0.780461870997813,1.0,3/16,7.06%,LRP1;HDAC1;SRF
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5823689395500904,1.3639289031092507,0.13020833333333334,0.7789098253613651,1.0,8/12,20.60%,MBTPS2;H6PD;DGKQ;CLCN2;SREBF1;ABCA2;KPNB1;MBTPS1
prerank,chloride transmembrane transport (GO:1902476),0.4367221864777188,1.3639041427663816,0.08600583090379009,0.7762722806476682,1.0,14/48,15.07%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;LRRC8A;GABRB1;GLRB
prerank,neural crest cell migration (GO:0001755),-0.39922465835770815,-1.363427324539337,0.07204610951008646,0.4934453853382202,1.0,10/36,10.66%,FN1;SEMA3D;SEMA3C;SEMA7A;NRP1;SEMA6A;SEMA4B;TBX1;PHACTR4;SEMA5B
prerank,inositol lipid-mediated signaling (GO:0048017),0.442635514346894,1.363294053781041,0.09246088193456614,0.7762188480802513,1.0,12/50,7.69%,PDGFRA;PLCL1;PIK3R1;OGT;FGFR1;GAB2;PIK3R2;IRS1;IRS2;ADAP2;PI4KA;RPS6KB1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.363457921189357,-1.3631334148681253,0.019455252918287938,0.49266702139146146,1.0,36/65,34.37%,FOXP1;PIR;IL31RA;LEF1;RUNX1;CDC42;RXRA;MAPK14;OSTM1;GLO1;CASP8;PIK3CD;CDKN1A;SIRT1;PDE1B;EPHA2;TGFBR2;CSF1R;E2F1;TYROBP;BATF;CCL19;PARP1;MYH9;SPI1;CEBPA;SNX10;SBNO2;PPARG;MT1G;CSF1;EFNA2;BATF2;DEK;TREM2;PML
prerank,base-excision repair (GO:0006284),0.44855711012221594,1.362716213896411,0.08085106382978724,0.775896658584308,1.0,13/48,13.83%,POLG;LIG3;FEN1;POLQ;ERCC5;NEIL3;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,purine ribonucleotide transport (GO:0015868),-0.5061267622637338,-1.3620078284178896,0.1261904761904762,0.4940911368341625,1.0,4/16,7.54%,ABCC4;LRRC8C;LRRC8D;ABCC6
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4358605221105739,-1.3618041437570034,0.0807799442896936,0.49306662806678514,1.0,8/26,9.67%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;SLC35D2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4535612611145051,-1.3615307907155998,0.09090909090909091,0.4922930493302162,1.0,6/21,10.75%,FOXP1;PRKCH;ELF1;RUNX1;SLC39A10;ELF2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4462521513482811,-1.3615264381618197,0.0945945945945946,0.49073482879939323,1.0,8/25,12.15%,ACTN2;ATP1B3;WNK4;WNK1;ANK2;DMD;STAC;TRPC6
prerank,kidney development (GO:0001822),0.42866052961542456,1.3613370015339776,0.09472259810554803,0.7786274224136835,1.0,10/65,5.61%,ROBO2;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3;NF1;ZBTB16;PRKX
prerank,negative regulation of lipid storage (GO:0010888),0.531170149235584,1.361245939827913,0.11129032258064517,0.7763310729485244,1.0,4/19,4.17%,PPARA;ITGAV;PPARD;NR1H2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4267999347060985,1.361023422509655,0.0782122905027933,0.7745983839951776,1.0,9/70,2.36%,LAMC3;LAMC1;LAMB1;PIK3R1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,defense response to fungus (GO:0050832),0.5512526065961851,1.3606805623967277,0.1296928327645051,0.7733632196411326,1.0,2/17,0.88%,CLEC4E;HRG
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4005156295909065,-1.3604227055723117,0.0782608695652174,0.4920137802598893,1.0,12/35,14.08%,HMBOX1;PARN;TNKS2;NEK7;CCT3;MAP2K7;ATR;CCT4;RTEL1;CCT7;ATM;MAP3K4
prerank,long-term synaptic potentiation (GO:0060291),0.528473892721417,1.359707197412706,0.11392405063291139,0.7747216059580561,1.0,5/21,5.87%,GRIN2B;VAMP2;MPP2;GRIN2A;CRHR2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.43959687322619123,-1.359478291701388,0.11139896373056994,0.49137619926324894,1.0,12/24,20.27%,FOXK1;HK1;PGK1;TPI1;HK2;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,canonical glycolysis (GO:0061621),-0.43959687322619123,-1.359478291701388,0.11139896373056994,0.49137619926324894,1.0,12/24,20.27%,FOXK1;HK1;PGK1;TPI1;HK2;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3897458212254131,-1.3593977018246477,0.053125,0.4899996285129339,1.0,6/43,2.45%,IGF1;FOXP1;IL18;ADAMTS1;THBS1;IGFBP5
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5597999473071589,-1.3590563724412326,0.11777777777777777,0.48923876752319523,1.0,7/11,20.41%,ARL6IP5;MAP3K5;PRODH;CYP1B1;STK25;PRKCD;GSKIP
prerank,cell-cell junction organization (GO:0045216),-0.3437510025604178,-1.3584099587940055,0.021551724137931036,0.4894423979136735,1.0,13/79,5.85%,SDK1;PKP4;TJP1;LIMS2;OCLN;CXADR;AFDN;CDH1;CLDN5;CDH8;TGFB2;CTNND1;TJP2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4460407248704728,-1.3577433543183304,0.09322033898305085,0.48980228014637517,1.0,14/26,26.03%,SPTLC2;NOS3;ACER2;ACER3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;SPHK2;DDAH2;ASAH1;NQO1;ASAH2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.43088991868722903,-1.357711483703921,0.10761154855643044,0.4883674018289403,1.0,12/25,20.27%,FOXK1;HK1;PGK1;TPI1;HK2;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,regulation of interferon-gamma production (GO:0032649),0.4234706067459683,1.3563027896138995,0.07793923381770146,0.7855789456144292,1.0,13/71,12.27%,XCL1;NR1H4;TXK;PDE4B;SCRIB;CD276;PTPN22;PDCD1LG2;TLR8;AXL;TLR4;PYCARD;IL12A
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5775000535018122,-1.356037489783963,0.11208791208791209,0.49103841403343623,1.0,6/10,13.96%,RAPGEF2;KDR;RAP1A;CD34;CEACAM1;RRAS
prerank,adenine nucleotide transport (GO:0051503),-0.4989134860131527,-1.355629798492077,0.11407766990291263,0.4904954915538718,1.0,8/17,24.71%,ABCC4;LRRC8C;LRRC8D;ABCC6;SLC25A5;SLC35B2;SLC17A9;SLC25A4
prerank,retinal metabolic process (GO:0042574),0.5980759033947441,1.35546306766373,0.12,0.786131216977202,1.0,2/12,2.43%,RDH10;RDH11
prerank,purine ribonucleotide metabolic process (GO:0009150),0.41974784350995303,1.3549327490504113,0.07482993197278912,0.7855610122721126,1.0,18/68,17.01%,ENPP1;PDE9A;ACSF2;TPST1;LRRK2;AMPD2;AK4;OPA1;ACOT7;ACSL6;ACLY;ENTPD7;MFN1;AK3;SULT6B1;ACOT2;EFL1;ADSS1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.44206259598635556,-1.3547578420052722,0.10164835164835165,0.4911815795660955,1.0,10/24,9.95%,SMAD6;SEMA3C;ROBO1;NRP2;BMPR2;NRP1;TGFB2;TBX1;ACVR1;TBX2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.34352594318779844,-1.3547266233184125,0.025454545454545455,0.48972989576689674,1.0,17/76,10.04%,TSPAN5;RBPJ;EGFR;NOTCH3;MAML2;NOS3;WWP2;NOTCH1;TGFB2;SREBF2;CCN3;IL6ST;EPN2;PRAG1;ITGB1BP1;GATA2;NIBAN2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5504902623461786,-1.3543434820123421,0.1396508728179551,0.4891696125011981,1.0,6/11,17.73%,ADIPOR2;KDR;CD34;GATA2;ITGB3;MCAM
prerank,axon guidance (GO:0007411),0.3709283402602416,1.3542593053673955,0.04074505238649592,0.7857567420978485,1.0,45/201,12.39%,LAMA1;ROBO2;LAMA2;PIK3R1;EPHA7;PLXNC1;CHN1;WNT5A;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;EPHA6;UNC5A;DSCAM;CNTN4;IRS2;DAB1;PALLD;DSCAML1;PTPRO;PTK2;UNC5C;RELN;EPHB6;DCC;PRKCA;NRXN3;NEXN;OPHN1;CNTN6;LYPLA2;EPHA3;PTPRA;DOK5;USP33;UNC5D;FYN;PLXNB2;SH3KBP1;GFRA1;ARHGAP35;KIF5C
prerank,negative regulation of defense response (GO:0031348),0.4128946370286734,1.3540040946972716,0.07989347536617843,0.7842311607528882,1.0,10/77,8.22%,RORA;PPARA;NR1H4;TRAF3IP1;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4729194447019416,-1.353728145700095,0.09319899244332494,0.48923311024493216,1.0,4/19,15.12%,IGF1;GIT1;CX3CR1;CX3CL1
prerank,regulation of protein kinase C signaling (GO:0090036),0.5772631025589507,1.3536566083208343,0.1495798319327731,0.7829661769950457,1.0,3/14,2.03%,WNT5A;ADGRV1;CD40
prerank,iron ion homeostasis (GO:0055072),-0.36622832752753814,-1.3533586169638527,0.04946996466431095,0.4886665285260999,1.0,26/58,26.27%,ABCG2;PICALM;NEO1;HMOX2;TFRC;CUL1;SCARA5;B2M;BDH2;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;FTH1;CCDC115;TMEM199;NUBP1;ATP6V1G1;SLC11A2;SMAD4
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.46062474477540627,-1.3532125513859732,0.10026385224274406,0.4875989424876783,1.0,4/20,10.82%,RAPGEF2;ADRA1B;ZDHHC21;LMBRD2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.34761326296718803,-1.353114716029786,0.04905660377358491,0.4864298104265785,1.0,32/66,24.92%,PLCB1;EGFR;FHL1;ADAMTS1;KANK2;KLF4;RDX;CCND2;APC;ANXA1;CDK6;HYAL1;FAM107A;WEE1;INO80;PSME3;CCND1;PLK5;CDKN1A;ANKRD17;DCUN1D3;DLG1;AKT1;RBL1;PSME2;RGCC;RBL2;E2F1;CDK2AP2;LSM10;PTPN6;RB1
prerank,vascular transport (GO:0010232),0.40743805804128264,1.3524199330847007,0.07529722589167767,0.7851295665216734,1.0,9/81,2.50%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3
prerank,protein trimerization (GO:0070206),0.5713791069426534,1.3523495561294823,0.1353135313531353,0.7801664543692761,1.0,3/14,7.19%,SLC1A5;CLYBL;ASIC1
prerank,protein homotrimerization (GO:0070207),0.5713791069426534,1.3523495561294823,0.1353135313531353,0.7801664543692761,1.0,3/14,7.19%,SLC1A5;CLYBL;ASIC1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5056108863205614,-1.3515555529521677,0.11463414634146342,0.48884814397782445,1.0,4/14,11.55%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4136866787318058,-1.350462751745451,0.11549295774647887,0.4902409827440053,1.0,12/32,15.46%,THBS1;KLF4;FOXC2;KDR;JCAD;NOTCH1;ANXA1;ITGB1BP1;GATA2;FGFBP1;MAP2K5;PTGS2
prerank,negative regulation of lyase activity (GO:0051350),0.5489929381626701,1.3498232085287611,0.1281198003327787,0.7875287732513461,1.0,3/16,5.71%,AKAP5;ADGRV1;MTRR
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4610092440571185,1.349745978232635,0.11179173047473201,0.7852367285070396,1.0,10/35,18.62%,CDH6;PCDHB16;DCHS1;CDH11;PCDHB4;PCDHB11;CDH10;PCDHGB4;CDH9;ATP2C1
prerank,serine family amino acid catabolic process (GO:0009071),0.6117381916244709,1.34955210721839,0.13357400722021662,0.7833668673185679,1.0,3/10,12.14%,THNSL2;GLDC;AMT
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3928516644553041,1.349378955264999,0.06140350877192982,0.7814977563221486,1.0,16/100,8.12%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;PTEN;PIP4K2A;FGFR1;ENTPD5;NEDD4;IRS2;PTPN13;PTK2;TWIST1
prerank,prostanoid biosynthetic process (GO:0046457),-0.4941023339712397,-1.3492095324566113,0.12594458438287154,0.49194291824012265,1.0,8/15,20.59%,PTGDS;PTGS1;PTGES3;PLA2G4A;EDN1;PTGS2;CD74;MIF
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4634144030448448,-1.3487187594992274,0.10101010101010101,0.491746470324854,1.0,8/20,22.98%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC;TTBK1;STOX1
prerank,cellular potassium ion homeostasis (GO:0030007),0.5652341954186901,1.3479418530875285,0.13263525305410123,0.7847121816722465,1.0,3/13,5.24%,ATP1A2;KCNMA1;ATP1A3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5732344432447379,1.347687040649038,0.14505119453924914,0.7831367701959059,1.0,11/14,28.26%,SEC24B;SAR1A;SCAP;SEC23A;SEC24A;MIA3;TBC1D20;SEC24C;SEC23B;SEC24D;SEC13
prerank,Golgi to plasma membrane transport (GO:0006893),0.44837687286752037,1.3470040005166746,0.10441176470588236,0.7834068390601934,1.0,12/47,11.10%,VAMP5;CCDC22;GGA2;STXBP6;RAB34;SPTBN1;ANK3;VAMP2;LLGL1;COMMD1;EXOC1;VAMP4
prerank,glutamate receptor signaling pathway (GO:0007215),0.4665253343972546,1.3469730072436585,0.10401188707280833,0.7809936852877033,1.0,17/37,21.74%,GRIA3;GRID2;GRIN2B;GRIK2;GRIA4;FMR1;GRIK4;GRIN2A;GRIK1;GRM5;GRM7;GRIN3A;GRIA2;GRM1;HOMER3;CDK5R1;HOMER2
prerank,negative regulation of cell differentiation (GO:0045596),0.37308492168527513,1.3467084057944807,0.03908045977011494,0.7796493743895286,1.0,36/181,13.83%,RORA;ENPP1;PPARA;MEIS1;SPRY1;WNT5A;ADGRV1;PTEN;ITGAV;LRP3;NPHP3;MEIS2;SPRED1;NR1H2;TBX3;REST;RUNX1T1;IL17RD;ZBTB16;CNTN4;ZFP36L2;ADAMTS12;SPRED2;TWIST1;SOX2;BMP7;ZFPM2;TGFBR1;IQCB1;ABCA5;SOX9;TWIST2;PDCD4;IGF2;ASXL1;MED1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6133476897881849,1.345877165310646,0.16758747697974216,0.7805207299540281,1.0,3/10,9.21%,MAP4K4;IQSEC1;MTOR
prerank,regulation of cholesterol storage (GO:0010885),0.5546531143386719,1.3456026977649045,0.13109243697478992,0.7790683965629677,1.0,3/15,4.17%,PPARA;PPARD;NR1H2
prerank,cognition (GO:0050890),0.45084469978308656,1.3454415382593137,0.10463378176382661,0.7773112679014731,1.0,17/42,21.40%,CHD7;C5AR1;SOBP;METTL23;NF1;SETD5;PTCHD1;RP9;GRM5;TUSC3;CUX2;LHCGR;CYFIP1;GPR155;MGAT3;BBS4;CTNS
prerank,positive regulation of heart contraction (GO:0045823),0.5294165886267517,1.3453551629589144,0.1305785123966942,0.7752466653991967,1.0,4/19,5.69%,EDN3;ATP1A2;RYR2;ATP2A2
prerank,cellular response to growth factor stimulus (GO:0071363),-0.30080343007777033,-1.3449368280034106,0.019867549668874173,0.5004389869324071,1.0,44/151,14.99%,FLT1;RAPGEF2;SOX5;MEF2C;EGFR;FOXC1;KLF4;GAS1;BMPR2;NRP1;MAGI2;IQGAP1;KDR;RAP1A;NOTCH1;WNT4;WWOX;ANXA1;SEMA6A;RAPGEF1;MAPK14;TBX1;PDE3A;CD44;ACVR1;ACVRL1;ITGB1BP1;MAPT;SMAD3;HYAL1;EEF1A1;NR4A1;SFRP1;RAB35;HSPB1;NOS1;NR3C1;FLT4;RAMP2;CPNE3;ERN1;MAP2K5;PLK5;KIDINS220
prerank,regulation of blood coagulation (GO:0030193),-0.41888130213999325,-1.3446363588461427,0.08031088082901554,0.4996329659673117,1.0,11/27,15.14%,CAV1;THBD;THBS1;ST3GAL4;VTN;CD34;APOE;SERPINE1;EPHB2;EDN1;SERPINE2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6085460529982555,1.344401027023126,0.15427509293680297,0.776547258232333,1.0,2/10,1.65%,XCL1;WNT5A
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3968840043855783,1.3442882465778472,0.07585335018963338,0.7745564706418568,1.0,18/98,11.33%,CEMIP;LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;ANK3;YWHAZ;MTCL1;PRKCI;CLIP3;NECAB2;NKD2;EPHA3;TP53;FYN
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3927508199818642,1.3439263316919599,0.0736196319018405,0.7735113488649933,1.0,38/107,20.22%,HCRT;ATP1A2;PTEN;CEL;CHRNB4;GRID2;GRID1;GRIK5;GRIK2;ABR;FMR1;LRRK2;GRIK4;GRIK1;TMEM108;RIMS2;RELN;OPHN1;GRM5;DLG4;DGKI;RIMS1;LRRC4C;PSMC5;NRG3;UNC13A;DLGAP3;NMU;TPRG1L;CDK5;GRM7;CAMK2A;SYT1;CLSTN1;GRM1;PXK;NPTX2;USP46
prerank,activation of phospholipase C activity (GO:0007202),0.49375683510968627,1.3436436511363195,0.10377358490566038,0.7720698179366118,1.0,7/29,12.61%,NTRK2;TXK;C5AR1;ARHGAP6;HTR2B;LPAR1;CD86
prerank,positive regulation of telomerase activity (GO:0051973),-0.40021316578983956,-1.3432143959985536,0.07736389684813753,0.501925046715699,1.0,8/33,14.08%,HMBOX1;KLF4;PTGES3;PARN;NEK7;MAP2K7;CCT4;MAP3K4
prerank,regulation of anoikis (GO:2000209),-0.47685746761259407,-1.3427906288437492,0.0967741935483871,0.5014867305136852,1.0,8/19,12.78%,CAV1;ITGB1;MCL1;NOTCH1;SIK1;MYBBP1A;PTRH2;TLE5
prerank,regulation of response to stress (GO:0080134),0.6138343298713551,1.3427480878693456,0.16906474820143885,0.773245746671846,1.0,2/10,6.66%,CORO2B;ADCY8
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.41269783730338894,1.3425297575454103,0.08731241473396999,0.7717207966707814,1.0,8/72,2.95%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;FGFR1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.43426426287723163,-1.3424440642921756,0.10776942355889724,0.5009240916087421,1.0,7/25,6.79%,EGFR;THBS1;APP;ITGA6;NRP1;PTGES3;FZD7
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.42735250585331136,-1.341487529894529,0.11202185792349727,0.5018977369064831,1.0,10/25,18.05%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;EDN1;PTGS2;NOS1AP;AKT1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.46841786559168574,1.3412535342765222,0.11432926829268293,0.7743697729305653,1.0,6/36,4.74%,VAMP5;GGA2;RAB34;SPTBN1;ANK3;VAMP2
prerank,positive regulation of dendrite extension (GO:1903861),0.5320183815978092,1.3407122587756004,0.11913357400722022,0.7740692654481497,1.0,7/17,18.66%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4361563538286852,-1.3403156046609834,0.11235955056179775,0.5034676647025579,1.0,10/27,7.74%,PHLDB2;TJP1;ARHGEF18;WASF2;SHANK3;F11R;CGNL1;TMEFF2;SHANK1;RHPN2
prerank,muscle organ development (GO:0007517),0.43689393112864644,1.3402790669097693,0.09793103448275862,0.7733630048617941,1.0,10/54,8.41%,LAMA2;ITGA11;UTRN;CXCL10;VAMP5;SMTN;SGCE;SOX6;CAPN3;CHD2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5891835187133929,1.340164153072373,0.16521739130434782,0.7714230733476873,1.0,3/11,14.72%,IL34;PRKCA;RIPK1
prerank,transport across blood-brain barrier (GO:0150104),0.4017656419811187,1.3398127189322764,0.07339449541284404,0.7703917132443839,1.0,11/83,5.76%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3;SLC7A8;FABP5
prerank,regulation of dendrite extension (GO:1903859),0.5242447824069055,1.33923826208983,0.12277580071174377,0.7703117194179034,1.0,7/18,18.66%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,positive regulation of binding (GO:0051099),-0.33419824632098954,-1.3389512520486966,0.0502283105022831,0.5056214405542089,1.0,28/84,18.18%,IGF1;RAPGEF2;CAV1;FOXC1;HMBOX1;APP;CLDN5;HIP1R;SKI;VTN;NGF;B2M;GSK3B;APOE;RPL11;PARP9;RALB;HIPK2;TERT;CLN5;RAN;AMFR;MARK3;DDX11;MET;HFE;HMGB2;EGF
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5172196891732663,-1.338950835846376,0.12441314553990611,0.504146599057684,1.0,4/13,6.96%,CAV1;CAMK2D;CALM1;SRI
prerank,regulation of acrosome reaction (GO:0060046),-0.5674059360348801,-1.338944116396565,0.13411764705882354,0.5026946504998291,1.0,1/10,0.43%,PLCB1
prerank,mesenchymal to epithelial transition (GO:0060231),0.6194679554234657,1.3381172695237473,0.15752212389380532,0.7723822469256828,1.0,2/10,2.49%,BASP1;SALL1
prerank,acidic amino acid transport (GO:0015800),0.5364312530158122,1.3380840413913215,0.15537190082644628,0.7701505190652738,1.0,4/17,8.53%,SLC1A3;SLC6A13;GJA1;SLC25A22
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5534552828416379,1.3379127545466443,0.13874788494077833,0.7684685993331958,1.0,5/16,10.93%,RBM24;ZC3H12D;DND1;ZFP36L2;DHX36
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.39645534584274705,-1.3377559472710425,0.08358208955223881,0.5042689472389886,1.0,11/32,18.40%,SORBS1;PRKAG2;ADIPOR2;PRKAA2;APOE;CEACAM1;ASXL3;CREB1;GPER1;AKT1;CREBL2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4218110755355219,-1.337752457041952,0.10192837465564739,0.5028108507216081,1.0,10/26,18.05%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;EDN1;PTGS2;NOS1AP;AKT1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.38512959149780174,1.3376871029249215,0.05334987593052109,0.7670282741909237,1.0,25/144,12.56%,CEMIP;SEC16B;PIK3R1;AKAP5;MICALL2;TCF7L2;SEC16A;JUP;ANK3;PIK3R2;YWHAZ;ZIC1;VAMP2;MTCL1;SORL1;PINK1;RAB29;TENM1;TMEM30A;SAE1;SAR1A;TP53;FYN;HTRA2;GSK3A
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4215640716439201,-1.3371240553492056,0.11212121212121212,0.503072131475191,1.0,12/28,15.15%,FOXP1;XIAP;SAMHD1;CD55;ERAP1;TRIM5;CASP8;ELMOD2;IRF1;GATA6;CX3CL1;TRAF3
prerank,peptidyl-amino acid modification (GO:0018193),0.6247748108472644,1.3366311188970887,0.16054158607350097,0.7687124553306091,1.0,4/10,23.47%,METAP1D;ATP7A;FKBP10;FKBP7
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.46903601998816946,-1.336379050059333,0.12686567164179105,0.5035438340243191,1.0,8/17,21.63%,PODXL;FOXC2;TGFB2;RET;SKAP1;CIB1;ADAM9;PIEZO1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3685775749069616,1.3358320440462408,0.048863636363636366,0.7694532433822899,1.0,31/214,9.69%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;XCL1;SPRY1;SLC30A10;NTRK2;PTEN;ERBB4;C5AR1;EPHB1;PTPRR;P2RY1;CNKSR3;SPRED1;YWHAZ;GCNT2;HTR2B;PTPN22;CCL15;RPS6KA6;GLIPR2;SPRED2;NECAB2;GPR183;PRKCA;HTR2C;MAP2K1;TLR4
prerank,gliogenesis (GO:0042063),-0.48217535412432705,-1.3357188813041465,0.13032581453634084,0.5037275453284585,1.0,4/15,6.03%,NFIB;TGFB2;ANXA1;CDK6
prerank,retinoid metabolic process (GO:0001523),0.4121631507397739,1.3353414476990069,0.09261744966442953,0.7690192776561503,1.0,8/71,4.75%,LRP1;ADH1A;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,positive regulation of synaptic transmission (GO:0050806),0.4146396424556533,1.3351898650279561,0.08266666666666667,0.7672371547684056,1.0,17/72,11.20%,AKAP5;CACNG3;GRIN2B;NRXN1;GRIK2;VAMP2;FMR1;MPP2;GRIN2A;CRHR2;ADCY8;RIMS2;RELN;LGMN;CACNG4;DLG4;RIMS1
prerank,positive regulation of viral genome replication (GO:0045070),0.4800042545362334,1.3349575487361454,0.1298904538341158,0.7658796448386159,1.0,11/29,20.03%,PPARA;PPID;TOP2B;PPIH;PDE12;STAU1;CNOT7;ADAR;HACD3;TOP2A;DDB1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3781785710100107,1.3346662109043343,0.06332138590203107,0.7647940563175608,1.0,22/151,11.00%,ROR1;PDGFRA;NTRK3;ROR2;XCL1;SLC30A10;NTRK2;ERBB4;C5AR1;P2RY1;GCNT2;HTR2B;PTPN22;CCL15;GLIPR2;NECAB2;GPR183;PRKCA;HTR2C;MAP2K1;CCL25;PYCARD
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5235167630849764,-1.3345742185193759,0.14772727272727273,0.5053781728269694,1.0,3/12,3.96%,IGF1R;INSR;UVRAG
prerank,negative regulation of T cell activation (GO:0050868),0.4633518325197524,1.3345498259051691,0.11503067484662577,0.7629621997102148,1.0,7/35,12.61%,PAG1;GLMN;TNFAIP8L2;PTPN22;PDCD1LG2;TNFRSF21;CD86
prerank,sodium ion homeostasis (GO:0055078),0.5129190019125742,1.3342110413934312,0.14662273476112025,0.7619617806871695,1.0,3/21,5.55%,ATP1A2;ATP1A3;SLC9A1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.48240986267168184,1.3340698325918758,0.1261682242990654,0.760224172203429,1.0,11/27,18.86%,VAMP2;RIMS2;SYT3;ARL8B;SYT7;PPP3CB;RIMS1;SYT5;VAMP7;SYT1;SYT6
prerank,protein import into nucleus (GO:0006606),0.417445117193546,1.3338239448839833,0.09004092769440655,0.7589046705200032,1.0,26/66,23.87%,PRICKLE1;CBLB;CSE1L;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;KPNA1;PTTG1IP;NUP107;NXT2;EIF4ENIF1;TNPO2;IPO9;NUP54;NUP155;KPNB1;RANBP2;KPNA2;IPO4;NUP35;IPO8;E2F3
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4750643700231973,-1.3334691083412895,0.1386861313868613,0.5067637328591564,1.0,12/16,37.07%,NOS3;GUCY1A1;APOE;NOS1;DDAH1;AGT;DDAH2;NDNF;GUCY1B1;MAFA;CD36;NOS2
prerank,negative regulation of catalytic activity (GO:0043086),-0.4378370023871616,-1.33280273002898,0.11081794195250659,0.507079867427407,1.0,13/24,24.27%,NOTCH1;NES;PARP9;NOS1;SIRT1;IFIT1;NOSIP;HDAC6;APBA3;CCAR2;OXA1L;PLN;MT3
prerank,regulation of myoblast differentiation (GO:0045661),-0.4189635258092528,-1.3327478106607686,0.09144542772861357,0.5057925057150515,1.0,7/32,6.43%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;NOTCH1;MAPK14
prerank,rRNA metabolic process (GO:0016072),-0.29687450950222327,-1.3326409837142026,0.006993006993006993,0.5046686820107577,1.0,57/160,22.16%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPL41;RPS7;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RPL10;RPL35A;MAPT;DDX27;RPL10A;RPL11;DIS3L;RPL36A;RPL34;RPL32;RPLP2;RPLP0;ESF1;UTP3;RPL4;RPL30;RPL26;RPL29;NOLC1;EXOSC2;IMP3;RPL31;EXOSC3;NIFK;RPL23A;RPL19;RPL36;WDR12;PES1;LAS1L;SENP3;RPL17;RPL23;RRP12;NOL11;UBA52;EXOSC1
prerank,telomere maintenance via recombination (GO:0000722),0.6016841201846206,1.332374823174733,0.15384615384615385,0.762277558229015,1.0,3/11,7.75%,TEP1;ERCC1;ERCC4
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4687626958469988,-1.3320470326768283,0.13842482100238662,0.5047526203435302,1.0,9/18,19.43%,EZR;RDX;DAB2;RAB21;MAP2K2;VPS11;MSN;SNX3;MTMR2
prerank,negative regulation of TOR signaling (GO:0032007),-0.39168351259669787,-1.3306899631417002,0.10884353741496598,0.5067522408608849,1.0,12/36,16.09%,FNIP1;RNF152;DEPTOR;SESN1;PRKAA2;SH3BP4;UBR1;UBR2;TBC1D7;ATM;SIRT1;PRKAA1
prerank,neuromuscular junction development (GO:0007528),0.4966047193435068,1.3301807468097693,0.1201923076923077,0.7684974544278249,1.0,7/24,14.99%,PDZRN3;ANK3;NEDD4;LRRK2;CACNB4;UNC13A;F2R
prerank,neuron fate commitment (GO:0048663),0.5674639419976774,1.3298837756393875,0.16062176165803108,0.767431506626766,1.0,3/14,12.25%,ISL2;TGFBR1;MYT1L
prerank,L-glutamate transmembrane transport (GO:0015813),0.5968633803759997,1.3285171704277545,0.1619217081850534,0.7706404762468403,1.0,2/10,8.53%,SLC1A3;SLC25A22
prerank,pulmonary valve development (GO:0003177),-0.4696147828651222,-1.3282046344744576,0.12345679012345678,0.5118667204156739,1.0,8/18,4.47%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;BMPR2;NOTCH1;TGFB2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.36937329629839327,-1.3281516255049415,0.0749063670411985,0.5105771140481031,1.0,27/54,29.36%,NSA2;RPL5;RPL10;RPL35A;RPL10A;RPL11;RPLP0;RPL26;RPL23A;MRPL20;WDR12;PES1;NIP7;NPM1;PAK1IP1;LAS1L;RRP15;GTF3A;WDR74;RPF2;NOP2;RSL1D1;NHP2;RPL24;LTO1;NOP53;NOP16
prerank,transcription preinitiation complex assembly (GO:0070897),0.5722393670036704,1.3274034741624559,0.15221238938053097,0.7725384198032422,1.0,6/12,22.08%,TAF12;TAF1B;BDP1;TAF11;GTF2B;GTF2A2
prerank,visual system development (GO:0150063),-0.3961284514070069,-1.3273553092571821,0.09011627906976744,0.5112256224950898,1.0,12/37,12.56%,SMOC1;PBX1;FOXC1;RBP4;TGFB2;PBX4;ATF6;HIPK1;SH3PXD2B;ZDHHC16;FREM2;HIPK2
prerank,arachidonic acid metabolic process (GO:0019369),-0.4029959121219946,-1.3270594624395613,0.103125,0.5105731740086068,1.0,14/35,25.24%,PTGDS;PTGS1;PTGES3;PLA2G4A;MGLL;CYP1B1;GPX1;PTGS2;CYP2U1;ALOX12;PLA2G4C;FAAH;CYP2S1;CBR1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4203953645608376,1.3270326054961086,0.09628610729023383,0.7716679046528978,1.0,25/62,22.22%,MEIS1;KMT2E;HDAC1;L3MBTL1;AGO4;MEIS2;KMT2A;ZBTB16;WDR5;PRKCB;AGO3;LYN;MAFB;TNRC6B;HOXA9;AGO1;ASH2L;CBFB;CDC73;KMT2C;RBBP5;CREBBP;HSPA9;RBM15;HOXA5
prerank,endodermal cell differentiation (GO:0035987),0.46804882475994725,1.3268167806325206,0.11027190332326284,0.7701219776212378,1.0,7/31,6.89%,LAMB1;COL7A1;ITGAV;ITGB5;COL12A1;RTF1;COL4A2
prerank,keratan sulfate metabolic process (GO:0042339),-0.4058117784553669,-1.3265770133669974,0.09090909090909091,0.5104180143128537,1.0,9/31,9.67%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;HEXB;SLC35D2
prerank,positive regulation of reproductive process (GO:2000243),-0.40550831420033856,-1.3265362277981985,0.09821428571428571,0.5091161539089641,1.0,4/31,8.84%,PLCB1;LHFPL2;PDE3A;SMURF2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.45467975109134867,-1.3240841191327544,0.10776942355889724,0.514017445217583,1.0,5/19,13.03%,TJP1;AFDN;NOTCH1;PPM1F;DENND6A
prerank,DNA replication initiation (GO:0006270),0.4598279406475419,1.323989014662423,0.12577639751552794,0.7788351893133656,1.0,13/37,15.66%,MCM7;CDC7;POLA1;GMNN;RPA1;POLE4;NOC3L;MCM4;POLE3;CDT1;DBF4;MCM10;ORC2
prerank,protein import (GO:0017038),0.39712223374949124,1.323797291384682,0.09554973821989529,0.7773002196612331,1.0,27/84,19.21%,PRICKLE1;ABCD2;CSE1L;PEX2;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;NXT2;EIF4ENIF1;HSPA4;SLC25A17;CLU;PEX19;TNPO2;IPO9;PEX12;NUP155;ALDH3A2;KPNB1;PEX3;PEX14
prerank,response to light stimulus (GO:0009416),0.42811024640384904,1.3237490670701277,0.10504201680672269,0.775282493332116,1.0,13/55,15.84%,GPR88;COPS3;TYR;USP1;ERCC5;CDKN2D;ERCC4;UVSSA;GPR52;SPRTN;REV1;ERCC2;CRY2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5003914531830743,1.3228393339189652,0.1533442088091354,0.7765896264025404,1.0,3/22,2.91%,GHR;ERBB4;TSLP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3471384237765472,-1.322682454503923,0.07364341085271318,0.5163087534111217,1.0,19/61,16.14%,IGF1;ROBO1;NET1;NOTCH2;F11R;RASGRF1;GPR4;SHOC2;NOTCH1;RAC1;RAPGEF1;NGF;PRAG1;PIK3CB;MAPRE2;ALS2;ADGRG1;GRB2;LPAR4
prerank,secondary palate development (GO:0062009),0.5575392459228452,1.321681076874986,0.15104166666666666,0.7788568287131806,1.0,2/14,1.65%,CHD7;WNT5A
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.44999209398865114,-1.320946872958219,0.1278772378516624,0.5195706847268527,1.0,4/20,10.04%,IGF1;FOXC1;LAMTOR5;NIBAN2
prerank,extracellular transport (GO:0006858),0.5695268352843845,1.3207149224005916,0.16845878136200718,0.7803354030320385,1.0,5/12,13.86%,DNAAF4;ADCY10;SPA17;CABYR;TSG101
prerank,ion homeostasis (GO:0050801),-0.41483994193724205,-1.3204845622056347,0.11475409836065574,0.5194097895008913,1.0,6/30,6.36%,SLC4A10;FHL1;CAMK2D;WNK4;WNK1;SLC4A3
prerank,cellular lipid catabolic process (GO:0044242),0.49379835336547334,1.319762175794014,0.138763197586727,0.781736198974499,1.0,7/27,15.36%,LPIN3;CEL;PPARD;ACADL;ABHD12;NUDT19;LPIN2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3929522663294659,-1.319726377545117,0.10541310541310542,0.5199563633327421,1.0,12/31,18.38%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD;CDK9
prerank,neuron projection regeneration (GO:0031102),0.6007433175787522,1.3195709207557063,0.17863720073664824,0.7802536152563249,1.0,1/10,0.18%,PTN
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.561435082805742,-1.3195553535429583,0.17674418604651163,0.5190204969992664,1.0,7/10,36.40%,INPP5F;PPP2R1A;PTPN2;SOCS3;SOCS1;PPP2CA;NF2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5556902231835338,-1.3194711329572393,0.15690866510538642,0.517843254920432,1.0,5/10,21.63%,PODXL;DPP4;WNK1;SKAP1;PIEZO1
prerank,response to hexose (GO:0009746),0.4965055430831115,1.3181003653865198,0.14351851851851852,0.783621660312664,1.0,6/25,10.06%,TCF7L2;GPLD1;VAMP2;EIF2B1;IRS2;ZBED3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5715677462461245,1.3172523237092961,0.16074450084602368,0.7849350968342148,1.0,6/13,12.20%,PPARA;NFATC3;PPARD;REST;SRF;SOX9
prerank,female gamete generation (GO:0007292),0.4733369218236937,1.3170067434509152,0.13978494623655913,0.7836693042570085,1.0,3/29,6.64%,PTN;NANOS3;DIAPH2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.45647137817846434,-1.3168091814344984,0.10704960835509138,0.5236277010566321,1.0,4/20,6.59%,PLCE1;CAV1;ZDHHC21;ATP2B1
prerank,regulation of protein metabolic process (GO:0051246),-0.3804235888161539,-1.3163049793182684,0.08630952380952381,0.5234878282590065,1.0,14/44,18.09%,ROCK2;LTBP4;APP;KLF4;VPS35;ACE;KLF2;APOE;SSH1;FURIN;MAP2K5;TRAF3;NEDD8;TMEM9
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5071457772624952,1.3162706489099592,0.1566068515497553,0.7842784869476161,1.0,4/20,5.55%,ATP1A2;KCNMA1;ATP1A3;SLC9A1
prerank,cGMP metabolic process (GO:0046068),0.5691116907379552,1.3158450589665893,0.18198529411764705,0.7837115425550256,1.0,1/12,0.31%,PDE9A
prerank,synapse organization (GO:0050808),0.3775016145691868,1.3157955001032924,0.07281553398058252,0.781781303147878,1.0,36/125,17.73%,PDZRN3;ADGRL3;PTEN;C5AR1;FARP1;NRXN2;GPC4;NRXN1;PCDHB16;ANK3;REST;NEDD4;LRRK2;DSCAM;PCDHB4;PCDHB11;C1QA;PPFIA2;LRFN5;C1QC;RAB29;CACNB4;GRM5;LRRC4C;CBLN1;PPFIA4;UNC13A;F2R;KIRREL3;NRCAM;NTNG1;CYFIP1;SLITRK1;CDK5;GPC6;SEMA3E
prerank,response to glucose (GO:0009749),0.44020492551965607,1.3150098530841456,0.12553495007132667,0.7825773519813213,1.0,11/46,10.07%,ZBTB20;TCF7L2;TRA2B;GPLD1;VAMP2;EIF2B1;IRS2;ADCY8;PRKACA;ZBED3;GCK
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5238003591849208,1.314650142845916,0.141396933560477,0.7818263406248854,1.0,6/17,18.23%,GPLD1;SORL1;CIDEA;BSCL2;ADRA2A;PDE3B
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5858490648285799,1.314566435651389,0.16262975778546712,0.7800136425863134,1.0,4/11,14.16%,JAK1;ANK3;PRKCA;LYN
prerank,regulation of cholesterol metabolic process (GO:0090181),0.5052433106146074,1.3145210323168672,0.15859766277128548,0.7780569740690051,1.0,10/20,20.60%,NR1H4;MBTPS2;ACADL;DGKQ;SREBF1;LDLRAP1;ABCA2;KPNB1;ARV1;MBTPS1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3984664175382276,-1.3143395884113074,0.11711711711711711,0.5273626265340545,1.0,10/35,9.05%,FLT1;MEF2C;CAV1;THBS1;SPARC;COL4A3;CAV2;APOE;XDH;ATOH8
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5124537558272331,1.3141600096029762,0.1492063492063492,0.7772309408612627,1.0,6/21,15.26%,MED12;SRF;TWIST1;DHX36;MED1;PAXIP1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4641041214394925,-1.3139996337169928,0.1329923273657289,0.5266401783033375,1.0,7/18,12.04%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.36624218604234415,-1.3138495165329196,0.11188811188811189,0.5255864397903341,1.0,11/47,8.29%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;KANK1;NEDD9;RAC1;CDC42;EFNA5;ITGB1BP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3800877331377778,1.312973324776317,0.07453416149068323,0.779743342329443,1.0,27/117,17.39%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;GPR176;PRKACB;ADCY7;PRKACA;FGR;IAPP;FYN;GPR27;HTR4;CD81;LYN;GNG2;PRKAR1A;LHCGR;PTGER4;DPEP1;HTR6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5797750359220329,1.3118437446599827,0.18392857142857144,0.7817221307403112,1.0,4/12,10.01%,TLR6;ADGRB1;TLR4;CYBA
prerank,epiboly involved in wound healing (GO:0090505),-0.4770006642265639,-1.311270541390964,0.11529411764705882,0.5310631133728364,1.0,9/16,16.87%,TMEFF2;CCN1;CD44;RHOC;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,cellular response to cAMP (GO:0071320),-0.40428502674420475,-1.310571092496758,0.08913649025069638,0.5315099311593956,1.0,11/30,23.70%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,plasma membrane tubulation (GO:0097320),-0.5095977002792852,-1.3101106525048052,0.15753424657534246,0.531416521078623,1.0,3/13,3.91%,FNBP1L;PACSIN2;CAVIN2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5996207489864498,1.3093424352436256,0.1746031746031746,0.7889256420297102,1.0,3/10,11.83%,OGT;DGKQ;PDK2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5810814501645019,1.308832914734912,0.1588785046728972,0.7887742301754637,1.0,1/11,1.32%,RTP4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.35159057044397557,-1.3086294772467233,0.05647840531561462,0.5339212016227041,1.0,20/56,27.60%,SMAD6;BMPER;BMPR2;TGFB2;DAB2;SNX25;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;SMAD7;INHBB;ACVR2A;GREM1;SMAD4;TTK;EMILIN1
prerank,peptidyl-arginine modification (GO:0018195),-0.48591930889012064,-1.308453185517966,0.1425339366515837,0.5329756254780598,1.0,13/15,47.62%,ART3;PRMT7;PRMT8;KRTCAP2;PADI2;PARK7;PRMT1;PRMT5;NDUFAF5;ART1;PADI1;PADI4;ART4
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.39315588901521425,-1.3070508321176888,0.1162079510703364,0.5353239172057207,1.0,13/33,13.07%,TJP1;BMPER;THBS1;KLF4;SEMA6A;KLF2;EPN2;PPP1R16B;FGF1;PIK3CB;CEACAM1;PKM;SMAD1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.5702500617661616,1.3053296591336274,0.16095890410958905,0.7999016170976287,1.0,5/12,21.11%,TIPIN;GMNN;CDT1;KAT7;WDR18
prerank,regulation of macrophage differentiation (GO:0045649),0.5396470808334031,1.3050630919306019,0.16387959866220736,0.7986503077493693,1.0,4/15,14.72%,IL34;C1QC;PRKCA;RIPK1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.36361705751812423,-1.3043493329023208,0.06484641638225255,0.5410852151999079,1.0,25/49,30.23%,ACER2;NDRG1;MAPK14;ATR;BID;CDC5L;ATM;NBN;GRB2;DONSON;CLOCK;HUS1;PRPF19;E2F1;BATF;ATRIP;CHEK2;HINFP;CHEK1;BRIP1;RHNO1;GADD45A;SESN2;E2F7;TRIAP1
prerank,endoderm formation (GO:0001706),0.4515255378074829,1.30424708857487,0.13201820940819423,0.7997635735374282,1.0,7/35,6.89%,LAMB1;COL7A1;ITGAV;ITGB5;DUSP1;COL12A1;COL4A2
prerank,regulation of leukocyte activation (GO:0002694),-0.5022778801925861,-1.3031536351500674,0.16494845360824742,0.5427725943868826,1.0,7/14,21.59%,CD200;GPER1;CD74;MFHAS1;MIF;SHPK;MYO18A
prerank,triglyceride metabolic process (GO:0006641),0.4277255980501424,1.3031479989994577,0.10751104565537556,0.8018729984609964,1.0,11/48,15.36%,LPIN3;SEL1L;LIPC;LIPH;FABP5;FABP4;AGMO;GK;FABP3;GPAT3;LPIN2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.35322881233611303,1.3029940439635515,0.046485260770975055,0.8003104603284642,1.0,29/208,11.00%,RORA;ROR1;MAP3K14;EDA2R;CCDC22;NR1H4;WNT5A;TRAF4;CD40;TSPAN6;LURAP1;GJA1;PDPK1;HTR2B;TLR6;CAPN3;CARD19;TNFRSF19;TRIM8;PRKD1;PINK1;TLE1;PRKCB;BIRC2;LPAR1;IRAK1;NDFIP2;DHX36;PYCARD
prerank,blood vessel morphogenesis (GO:0048514),0.4206848049877753,1.3024505422001988,0.1225071225071225,0.8002245612158047,1.0,3/54,2.01%,LAMA1;COL4A1;GLMN
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3275014552406703,-1.3018377741604001,0.06810035842293907,0.5448329511707316,1.0,19/74,13.30%,EYA2;IGF1;BCL2L1;EYA1;EYA4;NOS3;THBS1;ITGA6;MCL1;TNFSF10;FAS;GSK3B;ACVR1;CASP8;GPX1;SERPINE1;ICAM1;TERT;PSME3
prerank,regulation of lipid kinase activity (GO:0043550),0.5768885303037468,1.301654494269328,0.17487266553480477,0.8011076457464588,1.0,2/11,4.13%,PIK3R1;PIK3R2
prerank,presynaptic endocytosis (GO:0140238),0.4863324271226984,1.3012805687104387,0.16560509554140126,0.8002932958609927,1.0,9/24,19.06%,CEL;VAMP2;OPHN1;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5820874148050224,1.3012793280517674,0.18181818181818182,0.7981863358637354,1.0,1/10,0.04%,APOD
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5003665669926246,-1.3012762857938058,0.17737789203084833,0.5449976739519402,1.0,3/13,3.82%,SORBS1;IGF1;INSR
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5552809426005153,-1.300936637775846,0.1571753986332574,0.5444561524162302,1.0,8/10,25.54%,RDX;CEACAM1;PRKG1;SERPINE2;PRKCD;CD9;ALOX12;ADAMTS18
prerank,protein localization to Golgi apparatus (GO:0034067),-0.4084230688713232,-1.3005605711114723,0.14367816091954022,0.5439556460181405,1.0,10/27,17.02%,CSNK1D;GBP5;ARFRP1;OPTN;GAK;VPS13A;BICD2;ARL1;VPS13D;RAB6A
prerank,neuron development (GO:0048666),0.36639425971930223,1.300494544981586,0.0885478158205431,0.7991163184712718,1.0,37/141,17.06%,LAMB1;NCDN;ISL2;GPM6B;ETV1;TENM3;NTRK2;MICALL2;CNTNAP2;LRP12;TENM4;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;DOCK7;TENM2;SRF;NPY;STMN2;TENM1;OPHN1;LGI4;STMN4;PLP1;MYT1L;GPRIN1;ATP7A;STMN1;LYN;EPHA5;GDNF;PBX2;TBC1D23;GPRIN3;CDK5
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.5004946920542082,-1.3000561046482846,0.14454976303317535,0.5439784748703023,1.0,4/13,7.60%,DKK3;NFKB1;ERLIN1;APOE
prerank,mesoderm development (GO:0007498),-0.4611240978902158,-1.2999320518172708,0.14285714285714285,0.5429497248070196,1.0,5/18,7.16%,FOXC2;TIE1;MESD;TBX1;BMX
prerank,fibrinolysis (GO:0042730),0.5675073726694757,1.2996843806480995,0.18592964824120603,0.7999861292992255,1.0,2/13,8.42%,HRG;PLAU
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5130479576891711,-1.2994901696935939,0.1654320987654321,0.5426780930449909,1.0,3/12,3.82%,SORBS1;IGF1;INSR
prerank,negative regulation of hydrolase activity (GO:0051346),-0.36606984236999157,-1.298749795896279,0.07333333333333333,0.5432144544491636,1.0,12/49,12.70%,LRCH1;CST3;F11R;RDX;ECM1;SH3BP4;WNK1;SH3RF2;CPEB2;ARL2;GMIP;NOS1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5037981826788906,1.298576922182502,0.16831683168316833,0.8021656811007051,1.0,7/19,11.77%,PTGFR;RYR2;STIMATE;PRKACA;ADGRL1;GRM5;TRPM2
prerank,positive regulation of secretion (GO:0051047),0.5921858695863251,1.2984097874379836,0.1813285457809695,0.8007404357387526,1.0,2/11,7.83%,GPLD1;TRH
prerank,negative regulation of neurogenesis (GO:0050768),0.4667773670649797,1.2983215940836603,0.1308980213089802,0.7990254658772986,1.0,7/34,9.04%,PTN;PTEN;NGFR;REST;SORL1;NF1;APPL2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.40958580615186124,-1.2983178486929665,0.12352941176470589,0.542987534523749,1.0,9/28,18.62%,PRKAG2;ADIPOR2;SIRPA;PRKAA2;RAC1;CX3CR1;SIRT1;NOS1AP;SIRT5
prerank,negative regulation of centrosome duplication (GO:0010826),0.5691241485279093,1.2980817109811613,0.19672131147540983,0.797903037374252,1.0,4/11,11.37%,MDM1;TRIM37;KAT2A;TMEM67
prerank,Notch signaling pathway (GO:0007219),-0.34935787494866033,-1.2977782807354141,0.07773851590106007,0.5430125474353318,1.0,16/59,14.16%,PBX1;RBPJ;SORBS2;NOTCH3;MAML2;NOTCH2;NOTCH1;ADAM10;MIB1;APH1A;HEYL;GALNT11;MDK;HEY2;APH1B;YBX1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.34917477279879316,-1.2972242787881219,0.0756578947368421,0.5431124724489588,1.0,16/58,10.11%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;ACER3;CERT1;SGMS2;DEGS2;SPNS2;VAPA;VAPB;ELOVL4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.40885969573642206,-1.2967878977594933,0.12362637362637363,0.5429093751265348,1.0,11/28,21.32%,CASP8AP2;GABARAP;CRADD;NGF;CASP8;BAX;BID;BAG3;TNFRSF1A;TRADD;ZDHHC3
prerank,regulation of neuron projection development (GO:0010975),0.360832139027448,1.2967003299273456,0.06976744186046512,0.8011409581956466,1.0,42/163,17.06%,ROR1;PTN;NTRK3;ROR2;CHN1;TENM3;WNT5A;CTNNA2;NTRK2;PTEN;CSMD3;CDKL5;LRRK2;PRKCI;DISC1;PTPRO;PPFIA2;TANC2;PRKD1;RELN;P3H1;DCC;STMN2;RAB29;LPAR1;EPHA3;LRRC4C;PLXNB2;RETREG3;ARHGAP35;GSK3A;LRRC7;LYN;BRSK2;DENND5A;NTNG2;NTNG1;CBFA2T2;NCS1;IL1RAPL1;RTN4RL1;CDK5
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4524011024040049,1.2966016276763388,0.13587786259541984,0.7994382477324549,1.0,10/34,12.56%,GRID2;GRIN2B;GABRA1;MPP2;LRRK2;GRIN2A;GABRG3;GABRG2;GLRA1;GSK3A
prerank,cell projection organization (GO:0030030),-0.39754030545230146,-1.296549556956287,0.12716763005780346,0.5422686882658511,1.0,8/30,6.77%,ITGB1;PACSIN2;PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,negative regulation of cyclase activity (GO:0031280),0.5444300660662164,1.2955665953296103,0.16468590831918506,0.8011896245132236,1.0,2/14,1.69%,AKAP5;ADGRV1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.599238967568576,1.2955076834146884,0.16518650088809947,0.7993736991870379,1.0,1/10,0.32%,GHR
prerank,regulation of phagocytosis (GO:0050764),0.415560068741042,1.2953686656274526,0.13194444444444445,0.7978596624485055,1.0,9/53,11.00%,IL15RA;MERTK;ITGAV;TUB;LYAR;CYBA;FGR;SYT7;PYCARD
prerank,regulation of complement activation (GO:0030449),0.44828281858035857,1.2949784861984528,0.14182344428364688,0.7972737503597926,1.0,10/40,16.85%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU;CFH
prerank,regulation of hemopoiesis (GO:1903706),0.599298697357327,1.2949100061680716,0.2003577817531306,0.7954794727929991,1.0,5/10,21.13%,PTN;PRKCB;MAFB;CBFB;CREBBP
prerank,positive regulation of organelle organization (GO:0010638),-0.38710339023178547,-1.2948942542419342,0.12058823529411765,0.5452461334531516,1.0,14/32,25.45%,SORBS3;STX18;UVRAG;ANXA1;GSK3B;SURF4;SYNJ1;P2RX7;ATL3;LMAN1;ADRB2;SHCBP1L;PFDN2;LIG4
prerank,membrane assembly (GO:0071709),0.45627363555186823,1.2939510457040868,0.14285714285714285,0.7970623022442974,1.0,7/34,6.44%,PTEN;CEL;NRXN2;NRXN1;SPTBN1;ANK3;FLOT2
prerank,extracellular matrix assembly (GO:0085029),0.4892824275741048,1.2938749232700548,0.1610305958132045,0.795324451836652,1.0,8/23,16.29%,LAMB1;GPM6B;TNXB;MFAP4;LTBP3;ATP7A;NTNG2;NTNG1
prerank,electron transport chain (GO:0022900),0.538388363603655,1.2933533589306014,0.17560975609756097,0.7953841890322122,1.0,2/15,4.10%,POR;SDHB
prerank,negative regulation of leukocyte activation (GO:0002695),-0.48408339730235916,-1.2932167059772328,0.14536340852130325,0.5485799497484016,1.0,2/15,0.90%,CD200;IL31RA
prerank,inhibitory synapse assembly (GO:1904862),0.563700940043183,1.292916576494832,0.1746880570409982,0.7950424405613928,1.0,3/11,10.62%,WNT5A;GABRA1;GABRG2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5518232093687068,1.2925464327384755,0.17676767676767677,0.7944415272034505,1.0,2/13,2.76%,XCL1;MR1
prerank,alanine transport (GO:0032328),-0.5546450184589664,-1.2923951208310274,0.1891304347826087,0.5495506409125839,1.0,5/10,31.93%,SLC6A6;SLC6A17;SLC36A4;SLC7A10;SLC36A2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.30460282531041394,-1.2916895409057645,0.04522613065326633,0.5500052540023573,1.0,33/108,17.99%,DAPK1;ROBO1;ARL6IP5;CASP8AP2;TNFSF10;ACER2;HIP1R;MAP3K5;GSN;FAS;UACA;COL4A3;EGLN3;CRADD;NGF;CASP2;PPM1F;XDH;VCP;MAPT;SMAD3;BAD;CASP8;BAX;BID;ATP2A3;HIP1;BOK;SIRT1;GPER1;AIFM1;LAPTM5;SLC22A2
prerank,regulation of focal adhesion assembly (GO:0051893),0.4172488700640583,1.2915076309824893,0.1309192200557103,0.7963070070757715,1.0,15/54,11.33%,APOD;DLC1;GPM6B;HRG;PEAK1;PTEN;MAP4K4;ARHGAP6;SLC9A1;COL16A1;DUSP22;PTK2;EPHA3;PTPRA;SLK
prerank,granulocyte differentiation (GO:0030851),-0.4649835437285764,-1.2912275595610012,0.1325581395348837,0.549852443461832,1.0,6/18,15.18%,LEF1;LBR;RXRA;JAGN1;TAL1;CDKN1A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4845603572656554,1.2911732573114647,0.1480891719745223,0.795507952614268,1.0,4/25,5.69%,TBX18;RYR2;JUP;ATP2A2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3744017419829086,1.2908179814910918,0.0906832298136646,0.7948291924447299,1.0,26/116,17.39%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;GPR176;PRKACB;ADCY7;PRKACA;FGR;IAPP;FYN;GPR27;HTR4;LYN;GNG2;PRKAR1A;LHCGR;PTGER4;DPEP1;HTR6
prerank,mitotic recombination (GO:0006312),0.5363770469685339,1.2908175957165737,0.18556701030927836,0.7928470747578354,1.0,4/15,12.39%,TEP1;ERCC1;MSH3;RAD52
prerank,cell junction assembly (GO:0034329),-0.30924381367539294,-1.2902669490643086,0.06698564593301436,0.5510853800532476,1.0,17/100,7.46%,SDK1;PKP4;FN1;TJP1;LIMS2;SPOCK2;ACTB;SHANK3;CDH1;ITGA6;CLDN5;CDH8;ACTG1;CTNND1;CDC42;DNER;DNM3
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.4433570170470902,-1.2899246619590947,0.15384615384615385,0.5505760863228927,1.0,8/19,10.22%,TEK;PTPRJ;NRP1;KDR;S100A10;RAC1;PPM1F;SFRP1
prerank,ear morphogenesis (GO:0042471),0.5034385562648993,1.2899218426845767,0.18608414239482202,0.7943857321539638,1.0,4/20,8.12%,CHD7;ZIC1;MYO6;TWIST1
prerank,negative regulation of phosphorylation (GO:0042326),0.3918409703414491,1.289625171101962,0.10824742268041238,0.7934512731221148,1.0,24/85,16.57%,DYNLL1;NTRK3;PPARA;PTEN;TRAF3IP1;PFKFB1;CDKN2A;NPRL2;LRRK2;CDKN2D;IRS2;CBFA2T3;PTPN13;BMP7;ZBED3;DNAJC10;ANKLE2;PIP5KL1;CDKN2C;LYN;ATG14;FBLN1;IMPACT;PRKRIP1
prerank,establishment of protein localization to organelle (GO:0072594),0.39726285523266947,1.28958158585289,0.10606060606060606,0.7916871635783053,1.0,21/72,18.45%,PRICKLE1;CSE1L;NUP214;RYR2;FAM53C;NUTF2;CD68;POM121;PINK1;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;NXT2;EIF4ENIF1;PEX19;TNPO2;IPO9;NUP155;KPNB1
prerank,energy reserve metabolic process (GO:0006112),-0.4503235574571058,-1.2895075864968508,0.15625,0.5502004281233743,1.0,6/19,13.27%,PRKAG2;LEPR;GBE1;GSK3B;UGP2;PPP1R3C
prerank,response to reactive oxygen species (GO:0000302),0.4177684015809056,1.2893185114862578,0.11976911976911978,0.7906837947538146,1.0,6/54,6.18%,APOD;PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5
prerank,positive regulation of response to wounding (GO:1903036),-0.4258366921549835,-1.2891657187840577,0.14689265536723164,0.5497232296239741,1.0,8/24,5.81%,OCLN;MYLK;ITGB1;ACTG1;KANK1;VTN;ANXA1;SCARF1
prerank,glycolipid metabolic process (GO:0006664),-0.36532430981791786,-1.289014521420925,0.1292517006802721,0.5488145623790152,1.0,18/47,24.05%,ST3GAL6;ST3GAL4;SMPD3;FUCA1;ST6GALNAC3;HEXB;NAGA;UGCG;B3GALNT1;ESYT3;SMPD1;ST3GAL2;GM2A;ARSA;GLTP;PSAP;ST8SIA6;ASAH1
prerank,engulfment of apoptotic cell (GO:0043652),-0.47635420782632154,-1.2886670429949825,0.14460784313725492,0.5483431423061413,1.0,4/15,5.43%,RHOBTB1;THBS1;RHOBTB2;RAC1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.49565943195471784,-1.288066085705969,0.1662531017369727,0.5485532833348702,1.0,5/13,10.61%,ROCK2;ACTG1;RAC1;CDC42;FHOD1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.4409555947519472,-1.287796580638932,0.15294117647058825,0.5479282278432496,1.0,5/18,16.19%,TMBIM6;NRDE2;PTBP3;TERT;ESR1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.46455745720746694,-1.2877833218632568,0.12864077669902912,0.5466183109518925,1.0,6/17,19.62%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.4843198295557482,-1.2870987548076422,0.1411192214111922,0.5471727511613904,1.0,7/15,27.69%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,eye development (GO:0001654),0.4177415021641916,1.2870765916610514,0.14202898550724638,0.7972909072732338,1.0,3/54,3.27%,LAMA1;MEIS1;MEIS2
prerank,negative regulation of bone mineralization (GO:0030502),0.5476571701474658,1.2868597113752984,0.1825938566552901,0.7961255833479725,1.0,2/13,6.61%,ENPP1;BCOR
prerank,regulation of exocytosis (GO:0017157),0.4249956432102439,1.2867614598867985,0.15616045845272206,0.7945228049793265,1.0,15/46,19.32%,CADPS2;STXBP6;VAMP2;RAB8A;CADPS;RAB3C;RIMS2;RAB15;CLASP2;CLASP1;RAB2B;IL1RAPL1;STXBP5;SYT1;ATP6AP1
prerank,receptor recycling (GO:0001881),0.5905275321182831,1.2863090650343523,0.16483516483516483,0.79422836156811,1.0,4/10,20.19%,PHETA2;SORL1;PHETA1;ARFGEF2
prerank,intraciliary retrograde transport (GO:0035721),0.5789056511895018,1.2861221164771652,0.1797945205479452,0.7929869795797272,1.0,4/12,16.70%,WDR35;DYNC2LI1;TTC21B;IFT43
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5418736844512256,-1.285821806971123,0.1715686274509804,0.549350713408946,1.0,6/10,22.54%,FN1;LAPTM4B;FURIN;GATA6;TSKU;TYROBP
prerank,regulation of mitotic nuclear division (GO:0007088),0.41116572647543587,1.284702676148917,0.13458950201884254,0.7966421448299055,1.0,13/55,12.86%,EDN3;L3MBTL1;PHIP;DUSP1;PKMYT1;FBXO5;CDK13;BMP7;NME6;RCC1;MKI67;NUSAP1;IGF2
prerank,positive regulation of cellular component movement (GO:0051272),-0.41980238986016755,-1.2841132110630777,0.12169312169312169,0.5526751374269836,1.0,10/24,23.96%,CAVIN1;SPOCK2;NTN1;RPS19;ETS1;CCDC25;PDPN;CSF1R;TUBB2B;CCL19
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4571383837999709,-1.2841031795443416,0.15064935064935064,0.5513455924210219,1.0,6/17,20.44%,LPGAT1;PLA2G4A;LCLAT1;PLAAT3;PLA2G4E;PLA2G4C
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5405786608690947,-1.2839488427835526,0.16592920353982302,0.5503934449522224,1.0,3/10,19.62%,NOTCH1;PPM1F;RGCC
prerank,glucan biosynthetic process (GO:0009250),-0.5071382466218778,-1.283351997613526,0.2,0.5493918805118814,1.0,6/12,13.27%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),-0.5071382466218778,-1.283351997613526,0.2,0.5493918805118814,1.0,6/12,13.27%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.47494325830411344,-1.2831765820517773,0.1776765375854214,0.5485809318387401,1.0,7/15,27.48%,SAMHD1;PTPN2;NLRC5;ISG15;USP18;YTHDF2;TTLL12
prerank,leukotriene biosynthetic process (GO:0019370),0.5279317844101339,1.2829835299959318,0.1896838602329451,0.8012765979058517,1.0,2/14,2.25%,GGT5;GGT7
prerank,negative regulation of synaptic transmission (GO:0050805),0.49158696975929084,1.2829649555832991,0.18404907975460122,0.7993874668765543,1.0,4/23,12.29%,PTEN;PNKD;LRRK2;CBLN1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5125732593278582,-1.2828715258280867,0.18577981651376146,0.5480795499919441,1.0,2/12,4.25%,EPHA4;NOTCH1
prerank,response to ATP (GO:0033198),0.5077892215423145,1.2828654436126539,0.17445482866043613,0.7978445606918179,1.0,6/18,13.85%,P2RY1;DGKQ;TRPC3;P2RX4;HSP90B1;RYR3
prerank,positive regulation of histone methylation (GO:0031062),0.4855062162826307,1.282341941186698,0.1674565560821485,0.7978424712270826,1.0,8/24,19.42%,AUTS2;OGT;KMT2A;WDR5;SNW1;PAXIP1;RIF1;CHTOP
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.42549312790157073,1.2821189740366823,0.14685314685314685,0.7966904831410575,1.0,17/46,19.86%,ATP1A2;CACNG3;NRXN1;LRRK2;GRIK1;RELN;OPHN1;CACNG4;GRM5;DGKI;UNC13A;TPRG1L;CDK5;GRM7;SYT1;GRM1;CCL2
prerank,pinocytosis (GO:0006907),0.5875999387310329,1.2815095993219539,0.19322033898305085,0.7969732230979379,1.0,3/10,11.82%,RAB34;PYCARD;MAPKAPK3
prerank,modulation by symbiont of entry into host (GO:0052372),-0.47230027808914765,-1.280380583367688,0.15526315789473685,0.5533393568875742,1.0,5/16,8.61%,CAV1;TRIM25;TRIM5;TRIM14;EXOC2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5424971151169623,1.2801585872103658,0.17857142857142858,0.8003686563844989,1.0,2/14,1.65%,XCL1;WNT5A
prerank,regulation of endothelial cell migration (GO:0010594),-0.3215481702154779,-1.2793095988920413,0.084,0.5548590837903501,1.0,35/85,18.18%,ANXA3;ROCK2;FOXP1;TEK;SLIT2;BMPER;THBS1;NRP2;BMPR2;FOXC2;NRP1;SPARC;KDR;RAC1;SCARB1;AAMP;APOE;FGF1;ACVRL1;ITGB1BP1;ATOH8;PIK3CB;PIK3CD;ETS1;ITGB3;CEACAM1;FLT4;PTK2B;RRAS;EDN1;DNAJA4;EPHA2;BCAS3;AKT1;EGF
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4732195545545274,1.279182025300961,0.1936,0.8021809590091034,1.0,8/28,12.56%,ENPP1;PIP4K2A;IRS1;RPS6KB1;APPL2;PRKCB;TNS2;GSK3A
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5749167972018702,1.27897021797967,0.19389587073608616,0.8010505108018033,1.0,1/10,0.33%,SH3RF1
prerank,amino acid transmembrane transport (GO:0003333),-0.3608333140821138,-1.2776333076440765,0.10714285714285714,0.5583705486334504,1.0,12/45,12.28%,SLC47A1;SLC16A2;SLC6A6;SLC38A11;SLC22A4;SLC7A1;SLC3A2;LRRC8D;SLC38A5;SLC38A10;SLC7A5;SFXN1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.43806967830993204,-1.2771896303522279,0.16576086956521738,0.5582611676971331,1.0,12/20,31.88%,PTGES3;PSMG2;NDUFAF1;MKKS;PSMG3;HOPX;HSPD1;PFDN6;HSPA1A;PTGES3L;BBS12;BBS10
prerank,neuromuscular process controlling balance (GO:0050885),0.546071890441608,1.2763030988886725,0.1934931506849315,0.8091759819060769,1.0,3/12,8.77%,MYO7A;NRXN1;CLRN1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3621864951577001,-1.2761411184275686,0.10989010989010989,0.5598455592225694,1.0,15/45,15.64%,NCAM1;CAMK2D;TRIM25;TRIM5;B2M;IRF2;CD44;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G;VCAM1;PRKCD
prerank,response to chemokine (GO:1990868),-0.4849508296739131,-1.2760607717750332,0.14583333333333334,0.5587306683248178,1.0,3/13,5.90%,LRCH1;FOXC1;WNK1
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.502149528376915,-1.275767881997635,0.178743961352657,0.5581991725457766,1.0,7/13,27.69%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4158697985955139,-1.2755580101554047,0.15025906735751296,0.5561050302331485,1.0,8/23,12.01%,PPP1R13B;YWHAB;YWHAG;BAD;CASP8;PPP3CC;PPP3R1;BID
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4158697985955139,-1.2755580101554047,0.15025906735751296,0.5561050302331485,1.0,8/23,12.01%,PPP1R13B;YWHAB;YWHAG;BAD;CASP8;PPP3CC;PPP3R1;BID
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4009805851657782,-1.2755239430404803,0.16052631578947368,0.554883046941725,1.0,9/27,17.01%,AHNAK;CAMK2D;CALM1;ANK2;DMD;JPH1;NOS1;JPH2;CACNB1
prerank,regulation of immune effector process (GO:0002697),0.43683537008103845,1.2748605491115186,0.15593705293276108,0.8126455096412442,1.0,10/41,16.85%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU;CFH
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5505271043847897,1.274487696014549,0.17667238421955403,0.8121519674760682,1.0,2/13,1.69%,AKAP5;ADGRV1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.35093409859954106,1.2742026492593421,0.09658421672555949,0.811360586770902,1.0,34/159,12.98%,ROBO2;ADGRL3;TENM3;CDH6;PTPRT;GRID2;GPC4;MMP24;PCDHB16;TENM4;DCHS1;CDH11;DSCAM;CDH15;CDH3;CNTN4;PCDHB4;TENM2;PCDHB11;PALLD;DSCAML1;LRFN5;ADGRL1;NEXN;TENM1;CNTN6;AMIGO3;LRRC4C;UNC5D;PLXNB2;CLDN15;CBLN1;CDH10;CADM3
prerank,negative regulation of blood coagulation (GO:0030195),0.4444578944485135,1.2741686529595952,0.16863905325443787,0.8095692219118276,1.0,6/38,9.47%,PDGFRA;HRG;KLKB1;C1QTNF1;PLAU;F8
prerank,muscle tissue morphogenesis (GO:0060415),-0.46778755280410284,-1.274101070643193,0.16708229426433915,0.5574239027086901,1.0,5/16,18.27%,MYLK;NOTCH1;TBX1;HEY2;TGFBR3
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5547824747786732,1.273908462866961,0.1917808219178082,0.8086536936895448,1.0,3/13,3.48%,DCN;BGN;VCAN
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3807301243682239,1.2735716815834126,0.11406844106463879,0.8080261223351284,1.0,11/95,4.75%,CEMIP;DCN;LUM;HSPG2;BGN;DSE;GPC4;VCAN;B4GALT2;GCNT2;GPC5
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5211451107904699,1.2735607484456497,0.1800356506238859,0.8061812769498949,1.0,2/15,4.96%,FAH;KYNU
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5459709224281695,1.2735163562837215,0.19473684210526315,0.8044882513368946,1.0,7/13,22.90%,CBLB;KPNA1;NUP54;KPNB1;RANBP2;KPNA2;NUP35
prerank,protein-containing complex disassembly (GO:0032984),-0.3486417494194458,-1.273131531034007,0.09764309764309764,0.558778690072907,1.0,12/54,9.63%,CAV1;UVRAG;HSPA8;GABARAP;APC;EPG5;DVL1;GABARAPL1;GSK3B;VCP;LRP6;PYM1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4171695135524997,1.2728395540148019,0.14684287812041116,0.8052750285250068,1.0,13/50,16.62%,RORA;RAB34;PTCH2;ZIC1;IFT81;GLI1;GLI3;GAS8;HERC4;TXNDC15;EVC;FGFR2;PDCL
prerank,plasma membrane repair (GO:0001778),-0.4992488696225047,-1.2727640041215182,0.1925754060324826,0.5584198188985218,1.0,4/13,15.39%,MYOF;AHNAK2;SMPD1;DYSF
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5855312755584854,1.2724684306318252,0.18980667838312829,0.8046896315299541,1.0,3/10,6.34%,GPLD1;IRS1;IRS2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4624125346959541,1.2716066286017684,0.17492260061919504,0.8059761812205953,1.0,5/29,7.82%,SPRY1;PTEN;SPRED1;IL17RD;SPRED2
prerank,negative regulation of protein binding (GO:0032091),-0.3244125176933341,-1.2712484375208695,0.09652509652509653,0.5609660639854681,1.0,24/71,19.40%,CAV1;ACTB;TMBIM6;DAB2;DVL1;MITD1;PTPRF;B2M;GSK3B;ITGB1BP1;NES;STYX;BAX;RALB;ATP2A3;TLE5;CTSZ;CDKN1A;DDX11;PRKCD;HFE;IFIT1;AKT1;ADRB2
prerank,cell differentiation in hindbrain (GO:0021533),0.5737009145147164,1.2712233709431027,0.2,0.805635119226292,1.0,8/11,28.09%,GRID2;OPHN1;CBLN1;ATP7A;FAIM2;AGTPBP1;PROX1;KNDC1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4857789130665943,-1.271125093372836,0.171990171990172,0.5600363609126998,1.0,7/14,13.05%,MEF2C;SLIT2;IGFBP5;TPM1;IGFBP3;SERPINE1;PRKG1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5203795944160468,-1.2703177136617463,0.16941176470588235,0.5608998897372173,1.0,5/11,9.73%,RAPGEF2;MEF2C;ANXA1;PIK3CB;PIK3CD
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4326273676633393,-1.2700428154198693,0.14948453608247422,0.5604151792548941,1.0,5/20,10.22%,NBL1;GLI2;ACVR1;ACVRL1;SFRP1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.45513386344042706,-1.2681486184458013,0.14175257731958762,0.5641027206349706,1.0,8/18,22.54%,LBP;NMI;IFI35;KARS1;PLCG2;DYSF;DOCK2;TYROBP
prerank,vasodilation (GO:0042311),-0.49299310591360174,-1.2680961673446116,0.18510158013544017,0.5629522742249755,1.0,6/13,19.40%,NOS3;SOD2;KLF2;NOS1;GPER1;ADRB2
prerank,regulation of cellular component organization (GO:0051128),-0.2923683302088746,-1.2674971170846587,0.037037037037037035,0.5632066324269293,1.0,30/135,14.25%,PLCE1;SNCAIP;TJP1;PICALM;RAPGEF2;ROCK2;MLLT3;LTBP4;NET1;PACSIN2;MARK4;HIP1R;RAP1A;CAMK2D;HSPA8;SOCS2;TFRC;RAPGEF1;APOE;RAB5A;RAB5C;STK38L;FAM107A;PTPN1;NCLN;CEACAM1;SNX17;HIP1;AGTR1;ARHGEF11
prerank,myotube differentiation (GO:0014902),-0.4490864894259992,-1.2673502743788418,0.1865671641791045,0.5622901461292306,1.0,4/17,4.87%,IGF1;MEF2C;JAM2;SKI
prerank,cell-substrate junction assembly (GO:0007044),-0.3831325819396295,-1.267320757111625,0.14613180515759314,0.5610958521996045,1.0,13/33,13.57%,SORBS1;FN1;ACTN2;PTPRK;THSD1;ITGA6;PLEC;LAMA3;ITGB4;CD151;TRIP6;BCR;DST
prerank,nucleoside salvage (GO:0043174),-0.5359727300409318,-1.266109906092376,0.18820861678004536,0.5630128922153355,1.0,7/10,40.23%,UPP2;TK2;DCK;CDA;TK1;UPP1;UCKL1
prerank,negative regulation of anoikis (GO:2000811),-0.47894533956211505,-1.265662990563269,0.18225419664268586,0.5629396337422489,1.0,4/14,4.25%,CAV1;ITGB1;MCL1;NOTCH1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3808164261452522,-1.2647067967991679,0.1286549707602339,0.5642864627650962,1.0,13/33,19.62%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;ANXA1;HYAL1;PLCG2;CCND1;EZH2;ANKRD17;AKT1;RGCC
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4045695133197782,-1.2641110164083489,0.13370473537604458,0.5644790301936738,1.0,11/24,16.20%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.5365865979352606,-1.2640246734102065,0.2088167053364269,0.5634478419288546,1.0,5/10,17.74%,TSN;DROSHA;DICER1;TERT;AGO2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5315070174175588,1.2639362991578231,0.17881944444444445,0.8308872782768002,1.0,5/15,12.05%,GGT5;GGT7;ABHD16A;HOGA1;ABHD12
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3581756151451313,1.2636641212849864,0.10607866507747318,0.8299618626571336,1.0,25/152,11.18%,ADGRL3;CXCL10;PTGFR;ADCY5;AKAP5;CALCRL;GPR3;GPR37L1;ADGRB2;ADGRB1;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;LPAR3;PRKACB;ADCY7;ADGRB3;ADGRL1;LPAR1;GNA11;IAPP;GPR26
prerank,development of primary male sexual characteristics (GO:0046546),-0.3722272108486999,-1.2636046416304398,0.1440677966101695,0.5633384590749229,1.0,6/34,4.50%,KITLG;CSDE1;LHFPL2;WNT4;TGFB2;NCOA4
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.49452825690106983,-1.2635586565062082,0.18439716312056736,0.5622072767443717,1.0,7/13,36.57%,STX3;TYROBP;GPD1L;ABCA7;STX4;RANGRF;RIC3
prerank,inorganic cation transmembrane transport (GO:0098662),0.338798524957502,1.262917261889742,0.07221006564551423,0.8309914234125387,1.0,49/268,14.26%,SLC1A3;KCNK2;KCNS2;TRPA1;MCOLN2;SLC6A13;SLC24A5;SLC6A8;ATP1A2;SLC30A10;NALCN;ITGAV;ASIC2;KCNQ3;SCN2B;SLC30A5;SLC9A9;SLC39A7;ATP1A3;SLC9A1;ATP2A2;CACNA1G;TRPV3;KCNG1;ASIC1;KCNH4;KCNAB1;TRPC3;KCNC2;HCN2;SLC30A3;TMEM175;HCN1;HCN3;KCND2;P2RX4;KCNK1;TRPM2;TRPC7;KCNN2;KCNJ8;KCNH7;ATP6V0E1;SCN1A;KCNAB3;SLC39A14;RYR3;KCNH8;SCN2A
prerank,aortic valve development (GO:0003176),-0.3775265674770508,-1.2622317738713953,0.138328530259366,0.5645716497026431,1.0,8/34,4.25%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;BMPR2;TIE1;NOTCH1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.44847144219920426,-1.261656784166632,0.17737789203084833,0.5648681284635522,1.0,7/18,9.13%,FN1;CD200;ITGB8;TGFB2;CD34;SMAD3;LRRC32
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5241129771686796,1.2611844402993255,0.20408163265306123,0.835609535829239,1.0,4/14,7.82%,ZEB1;SPRY1;SPRED1;SPRED2
prerank,epithelial cell migration (GO:0010631),-0.3706985252273306,-1.2598680053303946,0.13256484149855907,0.5686245841692436,1.0,9/37,5.33%,KANK2;NOS3;FSTL1;DPP4;NRP1;ANLN;KANK1;CYP1B1;GIPC1
prerank,carnitine metabolic process (GO:0009437),0.5440939878588116,1.2592644089144627,0.21305841924398625,0.8410462144464441,1.0,7/12,26.06%,ACADL;CRAT;TMLHE;ALDH9A1;CPT1A;CPT1C;CROT
prerank,regulation of inclusion body assembly (GO:0090083),-0.5052861810712826,-1.2591899110625226,0.19811320754716982,0.5690959478690735,1.0,7/11,32.00%,SNCAIP;DNAJA4;DNAJB1;HSPA1A;DNAJB2;HSPA1B;HSPA2
prerank,carnitine shuttle (GO:0006853),-0.5157030058339231,-1.259089118414453,0.2009685230024213,0.5681167272956158,1.0,2/11,5.12%,PRKAG2;PRKAA2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43143967322887106,1.2590834629122305,0.16946564885496182,0.8398001844154354,1.0,7/37,13.45%,CEMIP;SPRED1;DGKQ;SPRED2;BMP7;S1PR2;AXIN1
prerank,transepithelial transport (GO:0070633),0.5341685775294843,1.2588759171656392,0.19550173010380623,0.8386994567743801,1.0,2/15,2.31%,SLC1A3;GPLD1
prerank,positive regulation of cell division (GO:0051781),0.4341802864970189,1.258826548881418,0.1795252225519288,0.8369588593768651,1.0,4/38,4.84%,SVIL;CDC14B;RXFP3;HTR2B
prerank,fat cell differentiation (GO:0045444),-0.3297241367252643,-1.2585640239848797,0.09965635738831616,0.5682454657474262,1.0,12/57,10.21%,SMAD6;FOXO1;WNT5B;BBS9;OSBPL8;KLF4;OSBPL11;ERAP1;PRDM16;NR4A1;FAM120B;NR4A2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3967712678004317,1.258508448165977,0.14921465968586387,0.8363501069966268,1.0,15/64,11.33%,CASK;GPM6B;UTRN;PEAK1;CDKN2A;MAP4K4;JUP;NF1;SLC9A1;PTK2;PLAU;EPHA3;PTPRA;CCL25;SLK
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.34193340634117514,-1.2584132976199456,0.1166077738515901,0.567323852788493,1.0,9/48,6.27%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;PRKDC;NEDD9;RAC1;CDC42
prerank,tyrosine metabolic process (GO:0006570),0.5639842365249192,1.2576652644125086,0.21482889733840305,0.8375451303862248,1.0,2/11,4.93%,TYR;FAH
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.42140157580865706,-1.2575425622990153,0.15425531914893617,0.568409452589456,1.0,6/21,19.92%,OSBPL8;MBOAT1;PLA2G4A;PLAAT3;PLA1A;PLA2G4E
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5113981470728022,-1.2572679683953611,0.18669527896995708,0.5679413837604235,1.0,4/11,17.01%,CAMK2D;NOS1;NOS1AP;CACNB1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.42384964932094743,1.2571204037707766,0.16714697406340057,0.8377601759092634,1.0,13/41,17.80%,IL34;NTRK2;UNC119;DLG3;DOCK3;RELN;GRM5;DLG4;FYN;CASS4;AREG;EFNA1;ADRA2A
prerank,mRNA methylation (GO:0080009),-0.4638529714113151,-1.256942857979101,0.16262135922330098,0.567556002650555,1.0,4/15,8.56%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.396356731622187,1.256588888854755,0.12482269503546099,0.8378874683022863,1.0,11/59,12.24%,CYP7B1;ACOX2;OSBPL3;OSBPL6;LIPC;LIPH;PER2;HSD17B8;HOGA1;GAMT;ACLY
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4517415628606549,-1.256388773999296,0.1949367088607595,0.5678159748458615,1.0,6/17,17.25%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5008128904295058,1.256008442037519,0.18706293706293706,0.8382306699884513,1.0,6/18,15.04%,POR;EDN3;FXN;PDP1;ATP7A;GDNF
prerank,regulation of chemokine production (GO:0032642),0.4369780735467384,1.2559490248128464,0.1678832116788321,0.83657535660241,1.0,6/36,11.00%,IL33;WNT5A;TSLP;TLR4;EIF2AK2;PYCARD
prerank,cellular response to chemokine (GO:1990869),0.416231057998519,1.2553562543945516,0.17126269956458637,0.8368435455626103,1.0,5/46,5.36%,XCL1;CXCL10;CXCL1;DUSP1;CCL15
prerank,import into nucleus (GO:0051170),0.3879415762825548,1.255253867743583,0.14705882352941177,0.8353374893506573,1.0,21/73,18.47%,PRICKLE1;CSE1L;GEMIN2;NUP214;FAM53C;NUTF2;POM121;SNUPN;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;NXT2;EIF4ENIF1;SNRPF;TNPO2;IPO9;NUP155;KPNB1;GEMIN8
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5554793277584436,1.255227456593247,0.21254355400696864,0.8335982142788003,1.0,3/12,5.60%,MYO7A;NKD1;DSCAM
prerank,regulation of DNA binding (GO:0051101),-0.3487896014113262,-1.255166641165881,0.1144578313253012,0.5698704674821146,1.0,15/44,24.04%,IGF1;LEF1;FOXC1;SKI;SMO;NGF;NFKBIA;SUMO3;HMGB2;CSNK2B;EGF;E2F1;TXN;ILRUN;SUMO1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.47895979290955837,1.2551278923394293,0.1987281399046105,0.8321001941164192,1.0,4/21,8.35%,CDC14B;PTEN;FBXO5;GOLGA2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4976239480403362,1.2550172743496335,0.19516129032258064,0.8306923030772361,1.0,8/19,17.54%,CDKL5;CAPRIN1;CDKL3;RELN;DHX36;CUX2;IL1RAPL1;CUL7
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.35656317187185355,1.2546133514924285,0.10945273631840796,0.8302981748994398,1.0,17/138,7.72%,RORA;PPARA;TEAD1;NR1H4;HDAC1;TAF9B;TAF12;THRA;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;TAF3;NR2C1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4285603101997233,-1.2543009231476,0.15469613259668508,0.5709547149492163,1.0,9/20,25.57%,GLYR1;PRKAA2;SOX4;RPS6KA5;NOS1;PRKAA1;TADA2B;RUVBL2;BRCA1
prerank,positive regulation of coagulation (GO:0050820),-0.5326284329507662,-1.2539642469390122,0.19825708061002179,0.5693922718637207,1.0,6/10,29.23%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.5326284329507662,-1.2539642469390122,0.19825708061002179,0.5693922718637207,1.0,6/10,29.23%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4197566537269757,-1.2538173462935442,0.1654320987654321,0.5685551060429346,1.0,9/20,23.39%,ACTN2;OSR1;GOPC;CAMK2D;CAB39;TCAF2;STK39;CASQ2;PLN
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4870246828916867,1.253604502116777,0.1952,0.8322412366429149,1.0,8/19,23.23%,IL34;PTK2;JAM3;AKIRIN1;CMKLR1;RARRES2;MAPK1;CAMK1D
prerank,GPI anchor metabolic process (GO:0006505),0.4554553831244621,1.2533397915205302,0.18968133535660092,0.8313650973413336,1.0,6/26,12.83%,PIGV;GPLD1;PIGQ;PIGP;PIGA;PIGL
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.38683647436571084,1.2527394616137992,0.1545338441890166,0.8317458736093041,1.0,23/75,17.06%,ISL2;CTNNA2;FARP1;ABITRAM;ANK3;NEFH;RAB8A;ADGRB1;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;OPHN1;SDC2;BRSK2;FGFR2;CDHR1;NRCAM;NTNG2;NTNG1;SLITRK1;CDK5
prerank,negative regulation of kinase activity (GO:0033673),-0.3242273789447125,-1.2527035646709728,0.0958904109589041,0.5702390337122967,1.0,25/62,24.92%,PRKAG2;PPM1E;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;LRP6;ITGB1BP1;MAPT;YWHAG;HSPB1;CEACAM1;PPIA;PRDX3;PAK2;TRIM27;AKT1;GSKIP;DUSP19;CAMK2N1;QARS1;DBNDD2;WWTR1;RB1
prerank,negative regulation of inflammatory response (GO:0050728),0.3450603599576238,1.2526928976896472,0.09573241061130335,0.8301140826126195,1.0,29/182,12.78%,RORA;GGT5;ADORA2B;PPARA;ADCY5;NR1H4;CALCRL;TNFAIP8L2;PPARD;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;GPR176;ENPP3;PRKACB;ADCY7;LRFN5;CD200R1;PRKACA;FGR;IAPP;FYN;PTGIS;GPR27;HTR4;FNDC4
prerank,negative regulation of epithelial cell migration (GO:0010633),0.44821254646746606,1.252616361243159,0.1908284023668639,0.8286082364759979,1.0,7/33,9.17%,DCN;NR2F2;PTEN;PTPRR;MCC;ADGRB1;SP100
prerank,positive regulation of neuron death (GO:1901216),0.4110829155128058,1.252437201543399,0.17902097902097902,0.8274761061448692,1.0,13/46,15.08%,EPHA7;WNT5A;GRIN2B;REST;FOS;TLR6;NF1;C1QA;TLR4;DAXX;FYN;EIF2S1;CLU
prerank,protein localization to cell periphery (GO:1990778),-0.28701731112310136,-1.2523088728586504,0.04242424242424243,0.5701194937084538,1.0,28/133,9.40%,TSPAN5;RAPGEF2;ROCK2;ACTN2;CAV1;BSG;RAPGEF6;LIN7A;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;RAMP1;TTC7B;PACS1;KCNB1;ANK2;LRP6;ITGB1BP1;EHD4;TSPAN17;KCNIP3;TTC7A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3031322537138203,-1.2519934019438723,0.08415841584158416,0.5697342516766457,1.0,26/104,13.07%,CRIM1;SMAD6;CAV1;BMPER;LEMD3;NBL1;BMPR2;MAGI2;SKIL;NOTCH1;CCN3;SKI;UBE2D3;CD109;UBB;ASPN;SNX25;ACVR1;SMAD3;SMURF2;PRDM16;SNX6;BCL9L;SPRED3;HIPK2;SMAD1
prerank,meiosis I (GO:0007127),0.4648463001735974,1.2512073237448638,0.2129783693843594,0.8303501949894705,1.0,7/23,15.22%,SGO1;MEIKIN;ZCWPW1;SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,positive regulation of GTPase activity (GO:0043547),-0.2775724243331905,-1.2510139327363656,0.007936507936507936,0.5712417391084788,1.0,62/188,18.80%,PKP4;TBC1D4;PICALM;RAPGEF2;SIPA1L1;TIAM2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;ITGA6;F11R;SIPA1L2;RASGRF1;S100A10;TBC1D8;RAP1A;RAP1GAP2;NDEL1;CAV2;TBC1D22B;ARHGAP42;SRGAP2;RAPGEF1;ARHGEF15;GSK3B;RANGAP1;RALBP1;RUNDC1;RSU1;NGEF;PLXNB1;SGSM2;SFRP1;MAPRE2;GMIP;GRTP1;APC2;ARHGAP27;TGM2;TBC1D7;ALS2;TBC1D22A;EVI5L;BCR;TBC1D10B;RAPGEF3;TBCK;CX3CL1;EZH2;RAP1GDS1;TBC1D13;RGS10;EPHA2;BCAS3;ERBB2;SYDE2;WNT11;AGRN;TBC1D5
prerank,regulation of synapse maturation (GO:0090128),0.570056490664094,1.2509143103757356,0.19859402460456943,0.8296875733371057,1.0,4/10,8.94%,NRXN1;YWHAZ;RELN;ADGRL1
prerank,homeostasis of number of cells (GO:0048872),-0.5053418966429968,-1.2508881195574488,0.21818181818181817,0.570367583955736,1.0,5/12,11.54%,NOS3;NOTCH1;CCN3;CX3CR1;UBAP2L
prerank,regulation of fibrinolysis (GO:0051917),0.5416878578926504,1.2508617946015355,0.21635434412265758,0.8280854969920589,1.0,3/13,5.22%,HRG;FAP;KLKB1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5221575022689053,-1.2505906245885043,0.19517543859649122,0.5699869002243357,1.0,3/10,6.99%,RARB;RXRA;TBX1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.30533956211758007,-1.2504874533571342,0.1,0.5690093887858715,1.0,20/88,9.73%,TEK;CAV1;THBS1;NRP2;BMPR2;TIE1;NRP1;ECM1;SPARC;KDR;VEGFD;CAV2;VEGFC;PPP1R16B;APOE;XDH;ACVRL1;ATOH8;NR4A1;PIK3CD
prerank,positive regulation of transferase activity (GO:0051347),0.35228405008407593,1.25037412974284,0.11477411477411477,0.8281149917799583,1.0,30/142,15.69%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;SERINC1;EPHA6;SORL1;PARM1;HNRNPA2B1;PINK1;AXL;EPHB6;RFC3;EPHA3;POLG2;GSK3A;IGF2;DCUN1D5;AXIN1;SERINC5;HNRNPD;EPHA5;MYC;FGFR2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4476979888098366,-1.250331411828734,0.1889763779527559,0.5682290114534412,1.0,4/17,5.12%,PRKAG2;CAV1;ADIPOR2;PRKAA2
prerank,insulin receptor signaling pathway (GO:0008286),-0.3282107289745173,-1.25024315086133,0.11522633744855967,0.5672645875078289,1.0,14/69,7.49%,SORBS1;FOXO1;IGF1R;FER;ATP6V0A4;FOXC2;INSR;RHOQ;GRB14;APC;CAV2;GRB10;GAB1;GSK3B
prerank,vasculogenesis (GO:0001570),-0.3780259580189089,-1.2500612428882845,0.1601123595505618,0.566589888582528,1.0,13/32,22.41%,ITGB8;CAV1;KDR;NOTCH1;RASIP1;SOX17;HEY2;RAMP2;SOX18;RASA1;TGFBR3;TGFBR2;APLNR
prerank,excitatory postsynaptic potential (GO:0060079),0.4958626285676007,1.2499992856634998,0.1902439024390244,0.8276544204941712,1.0,5/19,5.84%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A
prerank,activation of adenylate cyclase activity (GO:0007190),0.44490166725815383,1.249982328467877,0.16161616161616163,0.8259424716849557,1.0,7/35,7.99%,ADORA2B;ADCY5;ADCY8;ADCY3;ACR;ADCY2;ADCY7
prerank,positive regulation of lipid localization (GO:1905954),0.567401952820516,1.2499499557615577,0.2309027777777778,0.8243000270312696,1.0,1/11,0.48%,LRP1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.40374180642186297,1.2498075056924618,0.17647058823529413,0.8230442762453734,1.0,13/52,10.44%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3;EPB41L2;GPSM2;NKD2;EPHA3
prerank,membrane lipid catabolic process (GO:0046466),-0.5247057382922342,-1.2497079936185498,0.18454935622317598,0.5662782225812955,1.0,4/10,12.36%,FUCA1;CYP1B1;ENPP2;NAGA
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4879911803854323,-1.2488114464270401,0.19656019656019655,0.567524497244833,1.0,8/13,17.74%,BTG2;CPEB3;TNRC6A;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4147523946171515,1.2479473732934963,0.14831130690161526,0.8283318435773022,1.0,11/48,8.11%,ADCY5;ADCY10;SLC35B3;GMPS;COASY;ADCY8;ADCY3;PAPSS2;ADCY2;ADCY7;AMPD2
prerank,triglyceride biosynthetic process (GO:0019432),0.49568743065695925,1.2477279279153226,0.20481927710843373,0.827383518394321,1.0,5/18,15.36%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.47415894981594237,-1.2475231398713327,0.20187793427230047,0.5695705821365638,1.0,6/14,23.96%,IL18;NFKBIZ;ANXA1;PRKCZ;SOCS5;CCL19
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5380124106440185,1.2470542028937042,0.2376599634369287,0.8280564899949189,1.0,7/12,18.66%,RIMS2;SYT7;RIMS1;SYT5;UNC13A;UNC13C;SYT1
prerank,positive regulation of lipid transport (GO:0032370),0.5391502476376049,1.246002625215294,0.208955223880597,0.8301838940899839,1.0,2/12,3.88%,LRP1;SPP1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.48192091207717136,1.2459984425491966,0.19689922480620156,0.8284343278784612,1.0,8/22,15.26%,MED12;SRF;PSMC4;TP53;DHX36;PSMC5;MED1;PAXIP1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.42272692328105943,1.2459400076760416,0.18061674008810572,0.8268907153172551,1.0,16/39,21.82%,STEAP3;SEL1L;RAB8A;RAB3C;RCN3;RAB15;LTBP2;TMEM167A;MTTP;TVP23B;COPG1;MIA3;SVBP;CANX;SCG2;TANGO6
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4416172607459339,-1.2455622278891982,0.1956521739130435,0.5735160652395316,1.0,7/17,4.47%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;NOTCH1;TGFB2
prerank,filopodium assembly (GO:0046847),-0.45105384246018015,-1.2448184413258458,0.18159806295399517,0.5744027242805512,1.0,5/16,10.26%,FGD5;EZR;SRGAP2;DNM3;SPATA13
prerank,negative regulation of axon extension (GO:0030517),-0.3738885157713156,-1.244589828189309,0.141643059490085,0.5738369463807735,1.0,14/30,27.57%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B;RTN4;MT3;SEMA3F;RNF6;RTN4R
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.46072419967169514,-1.2443300747861572,0.21014492753623187,0.5733349411858477,1.0,7/15,18.23%,EGFR;IGF1R;KDR;BMX;PTK2B;AATK;TEC
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.34911724703902447,-1.2443183966084457,0.11526479750778816,0.5721711346102778,1.0,24/48,29.22%,BCL2L1;MCL1;PRKDC;CASP2;HIPK1;FNIP2;CRIP1;DYRK2;BAX;HIPK2;BOK;ATM;SIRT1;TMEM109;EPHA2;E2F1;IKBKE;BCL2L11;CHEK2;BRCA1;MSH2;DDIT4;SFN;TNFRSF1B
prerank,protein localization to synapse (GO:0035418),0.548215008633728,1.2440201155525035,0.2191780821917808,0.8321773064781851,1.0,5/12,17.17%,NRXN2;NRXN1;DLG4;PCLO;MPP4
prerank,metanephros development (GO:0001656),0.4612719533481344,1.2434742101837695,0.20310077519379846,0.8324524450117551,1.0,4/26,9.54%,ROBO2;BASP1;NF1;BMP7
prerank,superoxide metabolic process (GO:0006801),-0.3822308441258554,-1.2433810032509434,0.16129032258064516,0.5735501009263275,1.0,14/29,26.87%,SH3PXD2A;NOS3;SOD2;SH3PXD2B;PRDX1;NOX4;SOD3;ALOX12;NRROS;CYBB;CYB5R4;MT3;NCF2;NOXO1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.3803930096733158,-1.2432107238554746,0.1694915254237288,0.5728204169460376,1.0,15/33,28.38%,GCLC;PRODH;SLC39A8;GOT2;RIMKLB;OAT;NIT2;DDAH1;DDAH2;CAD;GLUL;PYCR2;FPGS;PYCR3;GGT1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.34356713894441826,1.2429247645611738,0.1111111111111111,0.8327725266843776,1.0,50/173,20.56%,SEC16B;DYNLL1;KDELR3;COL7A1;COPA;SEC16A;KDELR2;DCTN3;SPTBN1;GRIA1;ANK3;GBF1;COPZ2;TMEM115;DCTN2;IER3IP1;TRAPPC2L;CNIH4;COPB1;GOLGA2;RAB29;DCTN4;COG6;F8;SEC24B;SAR1A;SCFD1;VAMP4;RAB2A;MCFD2;VAMP7;BGLAP;TRIP11;COG1;DYNLL2;AREG;ERGIC2;SEC23A;SEC24A;TMED3;TMED9;COPG1;MIA3;TBC1D20;TRAPPC12;COPB2;CNIH3;TRAPPC2;TRAPPC5;ACTR10
prerank,signal peptide processing (GO:0006465),-0.5048664391674159,-1.2429119226200849,0.19457013574660634,0.5724236391862656,1.0,5/11,16.36%,SPCS2;SEC11C;CLN5;FURIN;PCSK5
prerank,regulation of protein binding (GO:0043393),-0.290258721445949,-1.2424686207610707,0.05555555555555555,0.5724564651311093,1.0,35/114,18.05%,RAPGEF2;CAV1;ACTB;HDAC4;APP;CLDN5;HIP1R;TMBIM6;VTN;DAB2;DVL1;MITD1;B2M;PRMT7;GSK3B;ITGB1BP1;NES;RPL11;STYX;BAX;PRMT8;RALB;HIPK2;TERT;TLE5;RAN;AMFR;CTSZ;MARK3;CDKN1A;DDX11;PRKCD;HFE;IFIT1;AKT1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3672969198455701,1.2418655635999456,0.125,0.8349295277667576,1.0,21/95,12.39%,MORF4L1;MCM7;LIG3;FAN1;FEN1;POLQ;CDC7;ERCC5;RPA1;ERCC4;POLL;MMS22L;ZFYVE26;BRCA2;REV3L;MCM4;RECQL;SPIDR;POLN;XRCC1;RAD52
prerank,negative regulation of proteolysis (GO:0045861),-0.36669116429065274,-1.241443512347512,0.1608187134502924,0.5739927866429839,1.0,12/34,22.09%,EPHA4;PTPN3;CST3;GAS1;ECM1;TMEM59;SERPINE2;AKT1;CLN8;TIMP3;HDAC6;CAMK2N1
prerank,regulation of stem cell differentiation (GO:2000736),0.3721802593322707,1.241151769940916,0.1406451612903226,0.8359445362634286,1.0,27/89,18.62%,PDGFRA;PTN;PSMD1;RBM24;KMT2A;PSMD10;ZFP36L2;PSMA5;PSMB5;NUDT21;PSMC4;OCIAD1;PSMA4;EIF2AK2;PSMC5;HOXB4;PSMB9;SMYD5;PUS7;GDNF;JAG1;PSMD14;PSMA7;LDB1;PSMD11;PSMA2;CBFB
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.47928156061298743,-1.2408873539732668,0.18876404494382024,0.5742971371014215,1.0,5/13,18.57%,NOS3;CALM1;GCH1;AKT1;PRKG2
prerank,metal ion export (GO:0070839),0.4383057739224668,1.2401973423812285,0.1951588502269289,0.8376406312390142,1.0,7/31,13.86%,ATP1A2;KCNT2;ATP1A3;SLC9A1;KCNIP2;KCNE4;ATP7A
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5322883874859584,1.2398679952072853,0.21311475409836064,0.8371335094256392,1.0,2/13,1.86%,ZFYVE28;CBLB
prerank,negative regulation of viral process (GO:0048525),-0.3324772361563248,-1.2397535313341008,0.10810810810810811,0.5760800763889844,1.0,18/57,20.67%,MAVS;TRIM5;TRIM11;IFITM3;TRIM14;ZC3HAV1;IFITM1;PARP10;SRPK1;PPIA;RNASEL;TRIM35;TRIM27;ISG15;IFIT1;UBP1;HEXIM1;IFITM2
prerank,regulation of angiogenesis (GO:0045765),-0.2742150457642074,-1.2395829421971298,0.06349206349206349,0.5753165059277083,1.0,52/192,14.81%,FLT1;ANXA3;ROCK2;TEK;ITGB8;BMPER;FOXC1;ITGB1;ADAMTS1;NOS3;THBS1;KLF4;TIE1;CLDN5;ECM1;SPARC;KDR;TGFB2;COL4A3;AMOT;VEGFD;CYP1B1;CD34;RUNX1;VEGFC;SEMA6A;GAB1;PGK1;HIPK1;PPP1R16B;FGF1;HK2;NPR1;HYAL1;STAB1;GATA2;PIK3CD;SERPINE1;NIBAN2;SFRP1;ETS1;CTSH;HSPB1;CEACAM1;HIPK2;GTF2I;RAPGEF3;RRAS;RAMP2;CDH5;GATA6;PIK3R6
prerank,digestive tract morphogenesis (GO:0048546),0.5183295944353218,1.239051782148409,0.22128378378378377,0.8383638803353708,1.0,1/14,0.15%,PDGFRA
prerank,embryonic axis specification (GO:0000578),-0.46541273957231555,-1.2388227731974997,0.20145631067961164,0.5761676988252695,1.0,3/15,9.91%,SMAD6;COBL;CXXC4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.43197595305270675,1.2383749345637416,0.172821270310192,0.8391630288401688,1.0,10/35,15.01%,PDE9A;PDE7B;HTR2B;RIMS2;ADCY2;DGKQ;HTR2C;SOX9;AKAP6;EPHA5
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5037247013039863,1.2381004907464213,0.21322314049586777,0.8384196632779461,1.0,4/17,7.11%,PPARA;PFKFB1;PDE12;CBFA2T3
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4255524616836508,1.2380439572953363,0.19616519174041297,0.8369358391754798,1.0,4/35,2.25%,GGT5;ACSS3;PAM;GGT7
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5183833937329502,-1.2379263503103615,0.22916666666666666,0.5773255816377252,1.0,5/10,28.48%,APC;CDC42;RCC2;ECT2;SPAG5
prerank,midbody abscission (GO:0061952),-0.4436308315438041,-1.2377174046432526,0.20698254364089774,0.5767164099125777,1.0,13/17,39.44%,CHMP2B;MITD1;CHMP7;CHMP4B;CHMP4A;CHMP1A;PDCD6IP;CHMP4C;CHMP2A;CHMP6;VPS4A;KIF20A;CHMP3
prerank,regulation of lymphocyte activation (GO:0051249),0.5392197819049847,1.2376700117455974,0.2112676056338028,0.8366018955446891,1.0,2/12,10.02%,PAG1;KAT2A
prerank,recombinational repair (GO:0000725),0.3723036224953482,1.2375991174432446,0.12911725955204217,0.8351857107968444,1.0,18/77,12.39%,MORF4L1;LIG3;FAN1;FEN1;POLQ;ERCC5;RPA1;ERCC4;POLL;MMS22L;ZFYVE26;BRCA2;REV3L;RECQL;SPIDR;POLN;XRCC1;RAD52
prerank,integrin-mediated signaling pathway (GO:0007229),-0.31071398825071617,-1.2374733843927688,0.10526315789473684,0.5761022410273129,1.0,24/73,13.78%,FN1;ITGB8;PLPP3;DOCK1;ITGB1;ADAMTS1;SEMA7A;ITGA10;ITGBL1;NRP1;FYB1;LAMA3;NEDD9;DAB2;ADAM10;CDC42;ITGB4;LAMA5;ITGB1BP1;ZYX;ITGB3;CEACAM1;DST;PTK2B
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3817651131373767,-1.2374666609546392,0.15598885793871867,0.5749461071585221,1.0,14/30,28.27%,DKK3;LTBP4;XIAP;FSTL1;SMAD3;SMURF2;TWSG1;TGFBR3;SOX11;SMAD7;FSTL3;SMAD4;TRIM33;FKBP1A
prerank,myeloid cell development (GO:0061515),-0.4365481556002184,-1.2374346968956746,0.185378590078329,0.5738864535958387,1.0,9/18,28.68%,FOXP1;APP;ALAS1;ABCB10;NRROS;DMTN;SRC;NCKAP1L;ALAS2
prerank,regulation of cell communication (GO:0010646),0.4324681976285686,1.2372595818424397,0.18344155844155843,0.8347738257018418,1.0,3/35,3.92%,TBX18;MTCH1;RYR2
prerank,positive regulation of response to stimulus (GO:0048584),0.41691710085030903,1.2370558336882564,0.17549167927382753,0.8338384304894559,1.0,6/40,6.50%,ACOX2;WNT5A;CDKN2A;ANKLE1;FMR1;ECHDC3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3817530482266633,-1.2369716870741758,0.17222222222222222,0.573927975184946,1.0,7/29,6.69%,IGF1;NOTCH2;RASGRF1;SHOC2;NOTCH1;RAPGEF1;NGF
prerank,transition metal ion homeostasis (GO:0055076),-0.39578580059008606,-1.2366800963088633,0.17280453257790368,0.5735022978717422,1.0,6/28,8.30%,PICALM;XIAP;NEO1;HMOX2;B2M;BDH2
prerank,nucleotide-excision repair (GO:0006289),0.35895052693836804,1.2366138937500097,0.14687100893997446,0.8337199714291926,1.0,25/101,15.57%,COPS3;ERCC1;ISY1;LIG3;FAN1;POLK;ERCC5;POLA1;RPA1;ERCC4;POLL;UVSSA;XPC;COMMD1;BRCA2;RFC3;TP53;GTF2H3;XRCC1;POLB;COPS4;ERCC2;ATXN3;GTF2H1;MMS19
prerank,activation of protein kinase activity (GO:0032147),0.36543846350066617,1.2359387165879678,0.1334981458590853,0.8345674971705727,1.0,24/106,14.82%,NTRK3;GHR;NRG1;ADCY5;WNT5A;MAP4K4;PDPK1;PRR5;TLR6;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;ADCY7;PINK1;PRKACA;MTOR;IRAK1;CD86;AXIN1;STRADB;TIRAP;PRKAR1A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4173927148176123,1.2356122267738945,0.17251461988304093,0.8341441379369834,1.0,7/39,7.58%,CASK;SPRY4;CORO2B;CDKN2A;MAP4K4;GCNT2;PTPRO
prerank,negative regulation of T cell proliferation (GO:0042130),0.4522631659039435,1.2351803793610638,0.19281045751633988,0.8340008038186506,1.0,7/28,16.66%,GLMN;SCRIB;PDCD1LG2;TNFRSF21;CD86;PRKAR1A;LGALS9
prerank,synaptonemal complex organization (GO:0070193),0.5067465339889875,1.2341981866482075,0.22586206896551725,0.8341796156026835,1.0,4/15,20.37%,STAG3;TEX11;BAG6;TRIP13
prerank,synaptonemal complex assembly (GO:0007130),0.5067465339889875,1.2341981866482075,0.22586206896551725,0.8341796156026835,1.0,4/15,20.37%,STAG3;TEX11;BAG6;TRIP13
prerank,regulation of protein kinase B signaling (GO:0051896),0.336420404512558,1.2339828312407402,0.11361079865016872,0.83326396819219,1.0,33/193,12.87%,PDGFRA;NTRK3;PIK3R1;NRG1;PPARA;NTRK2;TCF7L2;PTEN;SEMA5A;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PLEKHA1;PINK1;AXL;TSPYL5;IAPP;RCN3;P2RX4;TGFBR1;FYN;CD86;IGF2;CASS4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4324333629767233,1.2331644948658904,0.19497784342688332,0.8347286042565075,1.0,10/35,13.83%,POLG;LIG3;FEN1;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,negative regulation of reproductive process (GO:2000242),0.4945526100559074,1.233124893976287,0.20165289256198346,0.8332168448973872,1.0,3/17,4.00%,SULF1;GJA1;DUSP1
prerank,chondrocyte differentiation (GO:0002062),-0.3745789816425603,-1.2330752212262286,0.16954022988505746,0.5816356798980878,1.0,9/32,5.48%,NFIB;SOX5;MEF2C;WNT5B;OSR1;BMPR2;CCN3;RUNX1;SULF2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.47773749771323665,-1.2324998077557145,0.23394495412844038,0.5819961059810428,1.0,4/13,13.29%,NOS3;PRODH;NOS1;DDAH1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5383720845363832,1.2320896769220198,0.23448275862068965,0.8353172460361166,1.0,2/12,1.15%,CXCL10;TMEM102
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4442155063312974,-1.2319833209316249,0.19070904645476772,0.5821684155176847,1.0,7/16,18.83%,SIK3;LAMTOR5;CLEC16A;PIP4P1;GPR137;SEH1L;RRAGB
prerank,vesicle organization (GO:0016050),-0.3515487267511071,-1.2318825507511872,0.14057507987220447,0.5812614649226139,1.0,10/46,7.31%,CAV1;FNBP1L;SRGN;LAPTM4B;SQSTM1;CD34;CHMP2B;CAV2;VPS18;HOOK1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5696559814989772,1.2313002391089645,0.23392857142857143,0.834847904541189,1.0,3/10,7.11%,PPARA;PFKFB1;CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),0.5696559814989772,1.2313002391089645,0.23392857142857143,0.834847904541189,1.0,3/10,7.11%,PPARA;PFKFB1;CBFA2T3
prerank,regulation of transmembrane transport (GO:0034762),-0.3836474587733859,-1.2312931038057677,0.16666666666666666,0.5816131404876019,1.0,8/31,12.02%,OCLN;ACTB;SLC2A1;WWP2;KCNJ13;CTTNBP2NL;KCNJ2;KCNJ12
prerank,chemokine-mediated signaling pathway (GO:0070098),0.41751166520395067,1.2310199322097108,0.17717717717717718,0.834192418336105,1.0,4/42,5.36%,XCL1;CXCL10;CXCL1;CCL15
prerank,peptide cross-linking (GO:0018149),-0.39829518166427735,-1.2308764446079914,0.1618798955613577,0.5815312639040123,1.0,3/25,5.28%,FN1;THBS1;ANXA1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4730303161000486,1.230872812947846,0.21815286624203822,0.8330587162915617,1.0,9/20,22.22%,MEIS1;MEIS2;ZBTB16;MAFB;HOXA9;LDB1;CDC73;HSPA9;HOXA5
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4698954385530593,-1.2304988041545217,0.22769953051643194,0.5813108222604506,1.0,4/13,3.00%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,regulation of humoral immune response (GO:0002920),0.4178580343347197,1.230301521426734,0.17489421720733428,0.8335296750680287,1.0,10/44,16.85%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU;CFH
prerank,zinc ion transmembrane transport (GO:0071577),0.4700982729604067,1.230100532042035,0.2231543624161074,0.832602062148755,1.0,7/22,16.81%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A14;SLC39A13
prerank,negative regulation of secretion (GO:0051048),0.5538543074707016,1.2295496609068954,0.2375,0.8329521327539795,1.0,2/10,6.65%,NRG1;SPX
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3695057772716902,1.2295471795417552,0.16380449141347425,0.8313146555000216,1.0,22/82,19.43%,DYNLL1;ATF5;DCTN3;HAUS3;HAUS1;HMMR;DCTN2;HAUS8;CEP192;PRKACA;CEP135;TP53;SSNA1;CEP250;CEP152;CENPF;CSNK1E;CLASP1;ALMS1;PCM1;ATAD5;TUBA1A
prerank,regulation of response to oxidative stress (GO:1902882),0.5457558330448136,1.2295155610002382,0.23148148148148148,0.829803091890196,1.0,5/11,18.86%,ACOX2;GGT7;PINK1;AIFM2;ALOX5
prerank,skeletal muscle organ development (GO:0060538),0.45331071453037874,1.229408224697386,0.2032520325203252,0.8285722014118848,1.0,3/26,2.16%,SVIL;MSC;BASP1
prerank,embryonic heart tube development (GO:0035050),-0.47329573156047716,-1.2292953354784362,0.20654911838790932,0.5833942104633438,1.0,6/14,17.34%,MEGF8;SOX17;ACVR1;CITED2;TBX2;SOX18
prerank,clathrin-dependent endocytosis (GO:0072583),-0.39995767170868235,-1.229054720285489,0.192090395480226,0.5828772825601038,1.0,7/26,12.87%,PICALM;FNBP1L;INPP5F;AP2A1;GPR107;CLTB;GAK
prerank,negative regulation of nuclear division (GO:0051784),0.5549947160733869,1.228763795157801,0.2370617696160267,0.8292171403038637,1.0,3/11,9.99%,FBXO5;BMP7;NME6
prerank,clathrin coat assembly (GO:0048268),-0.45663574300284543,-1.2284742911259616,0.19759036144578312,0.5831811118324275,1.0,7/15,22.64%,PICALM;HIP1R;CLTB;HIP1;AP2S1;CALY;PIK3C2A
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.42861313975031234,1.2282214549734418,0.21221374045801528,0.8296375363568892,1.0,7/33,8.37%,PIK3R1;PTEN;PIK3R2;HTR2B;IRS1;NF1;PLEKHA1
prerank,regulation of chemotaxis (GO:0050920),0.43913592192239037,1.2278453999077055,0.18952234206471494,0.8293795257533503,1.0,6/30,11.26%,PDGFRA;MYCBP2;ADGRA2;ZSWIM8;GPR183;P2RX4
prerank,substantia nigra development (GO:0021762),0.4301933003823705,1.2277467347515238,0.1824925816023739,0.828128221243683,1.0,9/37,14.28%,DYNLL1;GNB4;BASP1;SEC16A;MBP;PLP1;S100A1;NDRG2;HSPA5
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2728220464188494,-1.2273821710617419,0.050955414012738856,0.5849487191708749,1.0,36/150,12.33%,PRKAG2;SMAD6;PPM1E;CAV1;OCLN;SLIT2;PLPP3;TRIB2;DEPTOR;PARD3;SIRPA;IGFBP3;PRKDC;NIBAN1;DVL1;NCK1;ERRFI1;CEP85;CALM1;PPM1F;PRR5L;MVP;SNX25;XDH;LRP6;ITGB1BP1;DMD;YWHAG;PPEF2;SFRP1;EPHB2;TARDBP;HSPB1;CEACAM1;SPRED3;PRKCZ
prerank,multivesicular body assembly (GO:0036258),-0.37608936479312055,-1.2267659433244833,0.1685082872928177,0.5854402901838671,1.0,12/30,22.74%,VPS37A;CHMP2B;VPS37B;IST1;CHMP7;CHMP4B;CHMP4A;CHMP1A;PDCD6IP;VPS28;VPS36;CHMP4C
prerank,plasma membrane invagination (GO:0099024),-0.38091950276666225,-1.2262901711402696,0.1534090909090909,0.5855013138133142,1.0,5/29,6.27%,GULP1;SNX18;DOCK1;GSN;CDC42
prerank,positive regulation of DNA binding (GO:0043388),-0.37538485109056374,-1.2260112601881152,0.16569767441860464,0.5851247097595685,1.0,11/31,26.75%,IGF1;FOXC1;SKI;NGF;NIBAN2;HMGB2;EGF;TXN;RB1;TRIM6;PARK7
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.49051043852954607,1.2257784914282075,0.22294022617124395,0.8337581901269452,1.0,7/17,15.41%,ATP1A2;GJA1;RYR2;ATP1A3;PRKACA;GJC3;GJA5
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5013318910552096,1.2248959872116247,0.22150882825040127,0.8352713248439325,1.0,7/18,24.49%,C5AR1;GPLD1;BAG6;LYN;CMKLR1;SPG21;BCAR1
prerank,alpha-amino acid catabolic process (GO:1901606),0.44111474923326294,1.2248135810090428,0.2086677367576244,0.8339494003437383,1.0,7/29,10.41%,THNSL2;FAH;KYNU;ACADSB;MTRR;BLMH;HOGA1
prerank,lymphocyte migration (GO:0072676),0.43254060591850785,1.2243575704162277,0.2046875,0.8339100687023386,1.0,8/32,20.53%,XCL1;MSMP;CCL15;CCL25;MYO1G;ADAM8;CCL2;CCL14
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5069802615530468,1.2237575977669248,0.19930675909878684,0.834470189297343,1.0,5/15,11.26%,SEMA5A;FGFR1;PRKD1;LGMN;P2RX4
prerank,macrophage activation (GO:0042116),-0.3673219730159144,-1.2237130039206312,0.18571428571428572,0.5900671203254868,1.0,10/34,15.39%,FOXP1;APP;LBP;NMI;CD93;IFI35;MAPT;PLCG2;CX3CL1;DYSF
prerank,phosphate ion transport (GO:0006817),-0.4539463749652368,-1.223644648905358,0.20227272727272727,0.5890606700383356,1.0,4/16,12.55%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,regulation of gastrulation (GO:0010470),-0.4607217830741539,-1.2234016435086,0.21534653465346534,0.5885001416185756,1.0,2/14,2.01%,PHLDB2;OSR1
prerank,positive regulation of nervous system development (GO:0051962),0.40624116592571297,1.223170291474397,0.19696969696969696,0.83487395172601,1.0,9/42,11.48%,SRPX2;EPHB1;GRID2;NRXN1;SERPINF1;SYNDIG1;IL1RAP;NAP1L1;SNW1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.37405103612623836,-1.2224832755000186,0.19518716577540107,0.5897397303366106,1.0,13/29,23.94%,CAV1;THBS1;TNFSF10;WWOX;SFRP1;RET;BID;CYLD;GPER1;PAK2;AGT;BCL10;HYAL2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.496071115190363,1.2224677673619329,0.2195945945945946,0.8357919716738847,1.0,7/18,14.38%,PTEN;NRXN1;RIMS2;RELN;DLG4;RIMS1;CUX2
prerank,endothelial cell differentiation (GO:0045446),0.531506815900158,1.2218189199184044,0.25133689839572193,0.8365072839351727,1.0,1/12,0.06%,SCUBE1
prerank,receptor catabolic process (GO:0032801),-0.3986648091233243,-1.221436199413642,0.19843342036553524,0.5913600489942177,1.0,5/24,8.81%,BECN1;RNF43;UVRAG;SNX25;AP2A1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4680431243798867,-1.2213093602648601,0.22815533980582525,0.5905679203385323,1.0,5/15,10.22%,RSPO3;WNT5B;CSNK1D;GPC3;SFRP1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.36797589894990546,1.2211772795309719,0.17483443708609273,0.8372013185813447,1.0,10/87,4.65%,PDGFRA;DLC1;LRP1;RND3;GPM6B;HRG;IQGAP3;CORO2B;FSCN1;RAC3
prerank,negative regulation of immune response (GO:0050777),0.34153286616441664,1.2210732509755273,0.13007159904534607,0.8359472308401006,1.0,31/154,17.39%,GGT5;ADORA2B;ADCY5;CALCRL;TRAF3IP1;DHX58;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;GPR176;ENPP3;LYAR;PRKACB;ADCY7;PRKACA;FGR;IAPP;FYN;GPR27;HTR4;LYN;GNG2;COL3A1;PRKAR1A;LHCGR;PTGER4;DPEP1;HTR6
prerank,regulation of stem cell proliferation (GO:0072091),0.48623259380697464,1.2210074288460544,0.21768707482993196,0.8345720695648485,1.0,5/17,16.16%,KDF1;GJA1;EIF2AK2;AGO3;FBLN1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3181221265126299,-1.2208143024305789,0.13584905660377358,0.5906868317713599,1.0,17/68,10.53%,LEF1;WNT5B;CAV1;PLPP3;WNT9A;WNT4;APC;DVL1;FZD4;FZD7;GSK3B;RAB5A;LRP6;WNT6;NR4A2;SFRP1;BCL9L
prerank,ncRNA processing (GO:0034470),-0.266109357899703,-1.2201989391892376,0.05042016806722689,0.5911152454482542,1.0,68/200,22.16%,RPS14;RPS9;DGCR8;RPS16;TUT7;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPL41;RPS7;DDX52;RPS19;RPS24;DROSHA;RPS27;RPP30;DICER1;RPS15;RPL21;PDCD11;RPL10;INTS3;RPL35A;SMAD3;DDX27;RPL10A;RPL11;RPL36A;RPL34;KARS1;RPL32;RPLP2;RPLP0;ESF1;UTP3;RPL4;RPL30;RPL26;RPL29;SMAD1;NOLC1;EXOSC2;INTS9;INTS10;IMP3;RPL31;INTS1;ADAT1;EXOSC3;RPL23A;RPL19;RPL36;AGO2;WDR12;PES1;LAS1L;SENP3;RPL17;RPL23;RRP12;NOL11;UBA52;EXOSC1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.44218993048839694,-1.2201759127772847,0.23002421307506055,0.5900211646788185,1.0,6/17,13.67%,BCL2L1;SOD2;BAD;BAX;BID;BOK
prerank,SNARE complex assembly (GO:0035493),0.5426871458068798,1.2200481865394026,0.2463768115942029,0.8364584625450083,1.0,3/10,11.10%,STXBP6;VAMP2;VAMP4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.46332966235508605,1.219899458702204,0.2106969205834684,0.8338086540318702,1.0,9/21,20.03%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.46332966235508605,1.219899458702204,0.2106969205834684,0.8338086540318702,1.0,9/21,20.03%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,negative regulation of JNK cascade (GO:0046329),-0.3750604580542769,-1.2198747598916404,0.19476744186046513,0.5896572530907038,1.0,8/31,15.98%,MECOM;SIRPA;HIPK3;SH3RF2;HDAC3;CYLD;MAPK8IP1;PER1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.564160747864784,1.2195107479248437,0.2518518518518518,0.8336821379246337,1.0,4/10,16.66%,SCRIB;PDCD1LG2;PRKAR1A;LGALS9
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3969744739224337,-1.2194636025471393,0.1745152354570637,0.5895911525673779,1.0,5/25,15.74%,TMTC2;CAV1;CNNM2;CNNM4;JPH2
prerank,selective autophagy (GO:0061912),-0.3288847632135662,-1.2192691036283294,0.1423611111111111,0.5889641366255542,1.0,25/56,22.31%,VIM;RETREG1;BECN1;SQSTM1;ATG13;WDFY3;UBB;USP30;ATG2B;DYNC1H1;UBE2N;ATM;DYNC1I1;UBC;ATG2A;LGALS8;DYNC1LI1;ARL13B;AMBRA1;KLHL3;HDAC6;MAP1LC3B;CFTR;UBA52;UFM1
prerank,protein localization to phagophore assembly site (GO:0034497),0.5397431567001505,1.2192488785669104,0.22324723247232472,0.8330474175114086,1.0,6/11,20.91%,ATG9B;WDR45B;ATG9A;WIPI2;PACS2;MFN2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.48381927136783853,-1.219200970323413,0.22483940042826553,0.5880161159139266,1.0,4/12,12.55%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,gene expression (GO:0010467),-0.2556944226656058,-1.2189639940265682,0.016129032258064516,0.5874950770035393,1.0,139/348,29.13%,TSPAN5;MEF2A;RPS14;AGFG1;RPS9;RPS16;SMG6;PTMA;RPLP1;RPL13;DRG1;THOC2;THOC1;RPL27A;RPS2;RPL37A;RPL5;WDR33;RPL8;RPL41;RPS18;NUP50;RPS7;RPS20;RPS19;RPS24;DROSHA;RPS27;RPS15;RPL21;RPL10;RPL35A;HNRNPF;RPS15A;RPS5;ABCF1;TSPAN17;RPL10A;RPL11;RPL36A;EEF1A1;ALKBH5;SRSF3;RRAGC;NR4A2;LMF1;RPL34;NUP98;RPS29;SNRNP40;POLR2B;RPL32;RPLP2;RPLP0;POLR2H;RPL4;NUP153;SRSF4;RBM4;THOC3;RPL30;RPS4X;RPS21;RPL26;RPL29;HNRNPH1;POLR2G;SMG5;NOX4;RPS8;NUP43;POLR2C;RNASEL;MRPS7;NUP205;ATXN1;RPS23;RPL31;SRSF7;RAE1;RPL23A;NUFIP1;RPL19;ALYREF;SRBD1;HHEX;RPL36;MRPS17;AGO2;SRSF2;HNRNPK;HOXD3;CREBL2;SEH1L;GSPT2;CLP1;RBM15B;MRPS18A;MRPS18B;RBM8A;RPL17;RPL23;E2F1;DDX39A;DDX20;DDX25;NCBP2;RPS11;MRPL24;RPL15;NXT1;MAGOH;RPL38;MRPL55;HSPD1;BICD1;HARS2;GSPT1;DUSP11;MRPL36;MRPL35;RPL13A;U2AF2;POLDIP3;MRPS12;RPS12;POLR2I;RPL18A;RPS25;RPL24;TSPAN33;MRPL34;FASTKD2;POLR2K;RBMS2;FARSB;NXF1;EIF4EBP2;MRPL18
prerank,zinc ion transport (GO:0006829),0.4704663848869929,1.2188955608673377,0.23588039867109634,0.832750259645966,1.0,7/21,16.81%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A14;SLC39A13
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.33329122604962486,-1.218448991421658,0.13548387096774195,0.5876927356966306,1.0,16/51,14.30%,HMBOX1;SMG6;PARN;TNKS2;NEK7;CCT3;MAP2K7;ATR;CCT4;CCT7;STN1;SMG5;HNRNPC;ATM;MAP3K4;TEN1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.45726380772020875,1.2178527048133136,0.24635332252836303,0.8350228209165012,1.0,7/27,12.56%,ENPP1;PIP4K2A;IRS1;RPS6KB1;PRKCB;TNS2;GSK3A
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.4154479061506872,-1.217467865453156,0.2,0.5891735448456823,1.0,6/21,8.59%,TUT7;SAMD4A;CNOT10;PARN;PAN3;CNOT8
prerank,regulation of glucose import (GO:0046324),-0.37833989445205235,-1.217413091784727,0.18862275449101795,0.5882137167046143,1.0,8/30,5.55%,SORBS1;PRKAG2;IGF1;OCLN;OSBPL8;INSR;RHOQ;GRB10
prerank,T cell mediated immunity (GO:0002456),-0.46039648919978204,-1.2167949896217738,0.2188183807439825,0.5886340578072896,1.0,5/13,19.51%,CD55;CTSH;GNL1;BTN3A3;CD46
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4447088509014904,-1.2167204175030193,0.22276029055690072,0.5877205828244236,1.0,9/15,17.74%,BTG2;TENT4A;CPEB3;TNRC6A;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.47523792554152455,-1.2155039125341478,0.22477064220183487,0.5899116774904469,1.0,7/13,17.25%,SEMA7A;TGFB2;CUEDC2;PLCG2;SIRT1;CD74;LAPTM5
prerank,protein-containing complex subunit organization (GO:0043933),0.3577996258392001,1.215315589327092,0.17786069651741293,0.8425102160481432,1.0,22/109,12.20%,LAMC1;WIPF1;TEAD1;PPID;CD40;EPRS1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;LLGL1;CAPN3;WASF3;MDM4;KIFAP3;IL1RAP;TP53;DLG4;RIMS1;TUBGCP4;SOX9
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5007681334768106,-1.2151676943559424,0.24018475750577367,0.5897470904980023,1.0,4/11,7.85%,MECOM;CD34;RUNX1;ETV6
prerank,axon development (GO:0061564),0.37853233090655425,1.2146575425664767,0.17391304347826086,0.8432858579049269,1.0,23/78,17.19%,ISL2;CTNNA2;SEMA5A;ANK3;NEFH;RAB8A;ADGRB1;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;PLP1;ARHGAP35;BRSK2;FGFR2;NRCAM;NTNG2;NTNG1;RTN4RL1;SLITRK1;CDK5;GRM7
prerank,negative regulation of apoptotic process (GO:0043066),-0.2493445515386325,-1.2137874147041745,0.04081632653061224,0.5923247049675585,1.0,158/444,25.45%,IGF1;TJP1;SMAD6;FOXO1;TEK;PRKCH;ERC1;MEF2C;IL31RA;LEF1;CAV1;BCL2L1;FNIP1;EGFR;IGF1R;ITGB1;RETREG1;OSR1;XIAP;THBS1;NOTCH2;ANXA5;KLF4;NFKB1;FSTL1;MCL1;PTMA;KDR;TMBIM6;PRKDC;SQSTM1;CCND2;FAS;ARHGAP10;NOTCH1;SOD2;GCLC;SOCS2;PRKAA2;DAB2;ANXA1;AVEN;ADAM10;TFRC;IL6ST;CRYAB;SIX1;CD38;HIPK3;BNIP2;UBB;NGF;CAT;CASP2;NRBP2;CARD14;TBX1;CD44;SH3RF2;GSK3B;APOE;RPL10;CASP3;GLO1;LAMTOR5;CFL1;CITED2;SNX6;GPX1;BNIP3L;NFKBIA;RNF144B;NIBAN2;KLHL20;NR4A2;SFRP1;CX3CR1;VHL;HDAC3;RPS6KA1;TNFAIP8;CTSH;HSPB1;FOXQ1;BID;MDK;BAG3;PTRH2;FLT4;FLNA;FZD3;PTK2B;TPT1;ARL6IP1;GATA6;MAP2K5;CX3CL1;PRELID1;PRKCD;SIRT1;PRKAA1;PRDX3;ANXA4;PAK2;TRIM27;YME1L1;PDPN;UBC;CD74;SIAH2;RASA1;HNRNPK;AKT1;ERBB3;WNT11;NUAK2;HGF;ALOX12;NPM1;CIB1;DNAJC3;MIF;PIM2;SON;NAA35;MAEA;ASNS;MYO18A;HIGD1A;UBA52;SIX4;DDAH2;UFM1;NUPR1;VDAC1;KDM2B;SOX8;CFLAR;PPIF;MGMT;QARS1;IKBKB;MTDH;CLCF1;ZFAND6;BIRC3;MT3;TMEM14A;HSPD1;CD27;RB1;SRC;CRLF1;PDK4;GREM1;NTF3;HSPA1A;LIG4
prerank,axoneme assembly (GO:0035082),0.42941066889419915,1.213750771322573,0.21875,0.8448902081738355,1.0,8/30,18.76%,RSPH9;DNAAF3;TTC12;DNAI4;CCDC65;GAS8;CCDC39;SPEF1
prerank,regulation of peptide hormone secretion (GO:0090276),0.3791748698758772,1.2136938894651543,0.20555555555555555,0.8435348454733872,1.0,11/67,10.61%,CHD7;RAPGEF4;CACNA1E;ITPR1;PER2;PRKCA;KCNC2;HTR2C;GCK;SYT7;PPP3CB
prerank,cellular response to fatty acid (GO:0071398),0.5337522384694798,1.213665625742781,0.2571428571428571,0.842087753327773,1.0,2/12,5.14%,NR1H4;IRS1
prerank,multivesicular body organization (GO:0036257),-0.368957047061413,-1.2136087951239225,0.15363128491620112,0.5916917035294942,1.0,12/31,22.74%,VPS37A;CHMP2B;VPS37B;IST1;CHMP7;CHMP4B;CHMP4A;CHMP1A;PDCD6IP;VPS28;VPS36;CHMP4C
prerank,cellular response to lipid (GO:0071396),0.33266154420777233,1.213503509731652,0.12658227848101267,0.8411111258541029,1.0,35/191,14.16%,RORA;CXCL10;CXCL1;ADCY5;ATP1A2;NR1H4;WNT5A;GPLD1;PDE4B;SPP1;NCOA3;PDCD1LG2;IRS1;ATP1A3;CD68;ADCY8;ADCY3;ADCY2;AXL;TLR4;WNT3;PLAA;IRAK1;EPHA3;PYCARD;SNW1;SOX9;HTRA2;NRIP1;CD86;PDCD4;TESC;MED1;MAP4K1;LYN
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.45156980783970585,1.2134053289225322,0.21981424148606812,0.839919112240049,1.0,7/25,12.56%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A;GLRA1;GSK3A
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3068136138377783,-1.2132394936444526,0.128,0.5915637265811768,1.0,22/73,13.67%,ROBO1;CASP8AP2;TNFSF10;ACER2;HIP1R;FAS;COL4A3;EGLN3;CRADD;NGF;CASP2;XDH;VCP;MAPT;SMAD3;BAD;CASP8;BAX;BID;ATP2A3;HIP1;BOK
prerank,skeletal system morphogenesis (GO:0048705),0.40920634487344,1.2130103191771244,0.19648093841642228,0.8397838251643579,1.0,11/42,16.30%,PDGFRA;ANKRD11;FGFR1;HOXC9;DSCAML1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,positive regulation of cell adhesion (GO:0045785),-0.31523480035073537,-1.2129750742260461,0.140625,0.591113206607023,1.0,22/74,14.58%,EPHA4;PTPRJ;AFDN;VIT;TPM1;FOXC2;TGFB2;RAC1;PPM1F;RSU1;ECM2;FRMD5;HYAL1;CITED2;NPNT;STX3;ARL2;RET;MDK;TGM2;ATM;ADGRG1
prerank,oxoacid metabolic process (GO:0043436),0.4505342315818143,1.2129135810873228,0.21651090342679127,0.8385579861637764,1.0,3/27,5.45%,ENPP1;TPST1;GRHPR
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4642139123354363,1.2123944240771631,0.24722662440570523,0.8388629595572423,1.0,5/22,9.54%,IL1RN;GCNT2;FLOT2;MBP;BMP7
prerank,glycolytic process (GO:0006096),-0.37101292074615777,-1.2122233398566864,0.20385674931129477,0.5919220296336661,1.0,14/28,20.98%,HK1;LDHA;PGK1;PFKFB2;TPI1;HK2;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS;PGM1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.43020519266722024,-1.2121713068832451,0.22695035460992907,0.5910091931644101,1.0,7/17,19.71%,CAV1;OSR1;KLF7;CEACAM1;APOLD1;MAFG;MAFF
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5376599441632521,1.212102416890557,0.2623239436619718,0.838370197986088,1.0,5/10,18.42%,TLR6;CD68;TLR4;MYD88;MIA3
prerank,protein import into mitochondrial matrix (GO:0030150),0.48360946848086833,1.2120754645547356,0.24620573355817876,0.8369448463915912,1.0,6/18,21.19%,DNAJC19;TIMM44;DNAJC15;PAM16;GRPEL1;TIMM21
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3501759227932693,1.2118866308291312,0.16709511568123395,0.8360597872836901,1.0,10/101,6.35%,CEMIP;IL34;EDN3;WNT5A;CD40;FGFR1;HTR2B;LRRK2;MTCP1;PSMD10
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.38377652241217197,1.2118865591602015,0.1977715877437326,0.8314660521887247,1.0,20/61,20.22%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;SEC23A;SEC24A;PPP6R3;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,COPII vesicle coating (GO:0048208),0.38377652241217197,1.2118865591602015,0.1977715877437326,0.8314660521887247,1.0,20/61,20.22%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;SEC23A;SEC24A;PPP6R3;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,vesicle coating (GO:0006901),0.38377652241217197,1.2118865591602015,0.1977715877437326,0.8314660521887247,1.0,20/61,20.22%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;SEC23A;SEC24A;PPP6R3;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,platelet aggregation (GO:0070527),-0.3619040663862567,-1.2116560353903973,0.1657142857142857,0.5911477025958517,1.0,12/33,13.99%,FN1;VCL;ACTB;GNAS;ACTG1;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.42155457777500693,-1.2108400308151681,0.19899244332493704,0.5921543396726442,1.0,8/19,14.84%,ELF1;KLF4;IRAK2;MAVS;RUNX1;PARP9;TLE5;MAP2K5
prerank,regulation of dendrite development (GO:0050773),0.4238465611069042,1.21044850426353,0.22857142857142856,0.8351626319685659,1.0,7/37,9.54%,PTN;CSMD3;CDKL5;NEDD4;ADGRB3;DCC;BMP7
prerank,negative regulation of lymphocyte activation (GO:0051250),0.46643819775273,1.210236791245847,0.22419354838709676,0.8344554766358263,1.0,3/21,4.98%,PAG1;TNFAIP8L2;PTPN22
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3113362192456616,-1.209731520981964,0.14074074074074075,0.5939629990262902,1.0,23/67,16.38%,FLT1;ROCK2;WASF2;DOCK1;NRP2;NRP1;KDR;CLEC14A;VEGFD;RAC1;VEGFC;CDC42;MAPK14;NCK1;AAMP;PIK3CB;HSPB1;ITGB3;FLT4;PTK2B;ELMO2;BAIAP2;PAK2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.4978759888095401,-1.2096988979588554,0.21103117505995203,0.5918594460796338,1.0,8/11,41.11%,CALM1;SRI;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.4978759888095401,-1.2096988979588554,0.21103117505995203,0.5918594460796338,1.0,8/11,41.11%,CALM1;SRI;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,regulation of microtubule-based process (GO:0032886),-0.3679116909686268,-1.208926174719205,0.14473684210526316,0.592972473200784,1.0,17/36,20.57%,PHLDB2;DIAPH1;MARK4;APC;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;CYLD;MACF1;BICD2;PRKAA1;ERBB2;MARK2;HDAC6
prerank,dendrite self-avoidance (GO:0070593),0.49507672266050984,1.2088850916535874,0.21530249110320285,0.8379396926151447,1.0,6/16,9.97%,DSCAM;CNTN4;PALLD;DSCAML1;NEXN;CNTN6
prerank,negative regulation of programmed cell death (GO:0043069),-0.2503057051338747,-1.2086075954362476,0.02857142857142857,0.5927160716595965,1.0,117/355,23.22%,MECOM;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;IL31RA;LEF1;BCL2L1;EGFR;IGF1R;OSR1;KANK2;XIAP;THBS1;NOTCH2;ANXA5;NFKB1;FSTL1;MCL1;PTMA;KDR;TMBIM6;PRKDC;SQSTM1;CCND2;FAS;ARHGAP10;GCLC;SOCS2;PRKAA2;DAB2;ANXA1;AVEN;ADAM10;TFRC;IL6ST;CRYAB;CD38;HIPK3;BNIP2;UBB;NGF;CAT;CASP2;CARD14;CD44;SH3RF2;GSK3B;RPL10;CASP3;GLO1;CFL1;CITED2;BNIP3L;NFKBIA;RNF144B;NIBAN2;KLHL20;SFRP1;VHL;HDAC3;RPS6KA1;TNFAIP8;CTSH;HSPB1;BID;BAG3;FLT4;FLNA;PTK2B;TPT1;ARL6IP1;GATA6;CX3CL1;PRELID1;MET;SIRT1;PRKAA1;PRDX3;ANXA4;PAK2;YME1L1;PDPN;UBC;CD74;LAPTM5;SIAH2;RASA1;HNRNPK;AKT1;WNT11;NUAK2;DCPS;HGF;NPM1;CIB1;DNAJC3;MIF;PIM2;SON;NAA35;ASNS;MYO18A;HIGD1A;UBA52;SIX4;DDAH2;UFM1;NUPR1;VDAC1;SOX8;CFLAR;PPIF;MGMT;IKBKB
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.50188117087438,-1.2084038523505751,0.2560706401766004,0.592179498944549,1.0,5/11,16.20%,MEF2C;EFNB2;FZD7;FRS2;MYOCD
prerank,negative regulation of binding (GO:0051100),-0.302756554088265,-1.2081731718266124,0.13025210084033614,0.5916920320335796,1.0,30/81,24.04%,LEF1;CAV1;ACTB;TMBIM6;DAB2;SMO;DVL1;MITD1;GSK3B;ITGB1BP1;NES;STYX;NFKBIA;BAX;ARHGAP28;SUMO3;RALB;TLE5;CTSZ;CDKN1A;DDX11;PRKCD;IFIT1;AKT1;E2F1;TTBK1;BAG2;ILRUN;PLN;SUMO1
prerank,regulation of protein ubiquitination (GO:0031396),0.353288540641509,1.2081294259405926,0.16709183673469388,0.8391323364873442,1.0,24/108,16.39%,FANCI;PRICKLE1;OGT;MYCBP2;PRMT3;LRRK2;ADGRB1;PSMD10;PER2;PINK1;COMMD1;TSPYL5;DAXX;BIRC2;NDFIP2;TGFBR1;GSK3A;SPRTN;PTTG1IP;AXIN1;UBE2D1;PAXIP1;USP4;NDFIP1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.48276152098397446,1.2079507531718865,0.2222222222222222,0.8382497856715785,1.0,4/18,9.72%,CORO2B;CCT5;CEP295;CEP135
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3885802612589105,-1.2077739880087868,0.19060773480662985,0.5915850213773381,1.0,11/25,25.48%,RBPJ;AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;AGT;RTN4;DOK1;CNOT9
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.43507766258283376,-1.2077258256935686,0.22646310432569974,0.5905748208109987,1.0,6/17,18.44%,COX15;COX6C;COX5B;AFG1L;COX4I1;COX6B1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.29706517478910116,-1.2076665686137678,0.1482889733840304,0.5896531358245407,1.0,22/80,12.49%,EPHA4;PICALM;ROCK2;VIM;LARP4;THBS1;ELAVL1;PRKDC;NIBAN1;SMPD3;SAMD4A;RPL5;LARP4B;SIRT3;SOX4;CASP3;PYM1;CPEB3;PLA2G6;RPS4X;EIF3D;RPL26
prerank,tRNA 5'-leader removal (GO:0001682),0.5116471883206648,1.2075687218626854,0.24464285714285713,0.8381098233177648,1.0,4/13,9.96%,RPP40;POP5;PRORP;POP7
prerank,COPII-coated vesicle budding (GO:0090114),0.37312104792895917,1.2074030261897317,0.18438761776581428,0.8371672376888721,1.0,23/68,20.22%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;SAR1A;PPP6C;SCFD1;MCFD2;SCAP;AREG;TRAPPC10;SEC23A;SEC24A;PPP6R3;MIA3;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.372882061559854,-1.2073937335976221,0.17717717717717718,0.5892986008414883,1.0,15/29,39.94%,TPM1;S1PR1;NOTCH1;TGFBR3;PKP2;SMAD7;FKBP1A;TTN;TNNI3;TNNC1;TBX20;NOG;TCAP;MYL3;MYH6
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2960135173201199,-1.207248859394492,0.12322274881516587,0.5886183647782016,1.0,28/94,14.82%,PLCB1;NFKB1;IRAK2;PSMC6;SQSTM1;PELI1;PSMD9;IL1R1;PSMF1;PSMB7;CUL1;TOLLIP;UBB;RPS6KA5;PSMD8;PSMD12;NFKBIA;MAP3K8;PSMA3;TAB2;PSME3;PSMA6;UBE2N;IRAK4;PSMD4;PSMD7;PSMB6;PSMC1
prerank,sphingosine metabolic process (GO:0006670),-0.4341320431962872,-1.2069766250446516,0.2037914691943128,0.5882603277929471,1.0,4/17,4.50%,SPTLC2;PLPP3;ACER2;ACER3
prerank,response to ionizing radiation (GO:0010212),-0.3133653984490568,-1.2066658473413792,0.125,0.5880121874846587,1.0,31/70,28.10%,EYA1;NET1;ANXA1;MAPK14;INTS3;RNF8;INO80;BRCC3;EEF1D;ATM;KAT5;GRB2;CDKN1A;SMPD1;SIRT1;PRKAA1;DCUN1D3;CLOCK;HUS1;EYA3;FANCD2;RFWD3;RAD51;LIG4;BRCA1;BRSK1;RHOB;ECT2;MSH2;RHNO1;GADD45A
prerank,embryonic skeletal system development (GO:0048706),0.4228850666509029,1.2065701317838589,0.20474777448071216,0.8385491238124589,1.0,8/35,13.75%,PDGFRA;SULF1;WNT5A;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4030769637623954,-1.2065296783357835,0.18699186991869918,0.5872981345336071,1.0,8/24,7.74%,PHLDB2;TJP1;ARHGEF18;WASF2;F11R;CGNL1;TMEFF2;RHPN2
prerank,regulation of aerobic respiration (GO:1903715),0.4956514921626052,1.2058438962599074,0.25418060200668896,0.8395812647569437,1.0,7/15,20.12%,CBFA2T3;PINK1;AK4;SLC25A33;ATP7A;COX7A2L;UQCC2
prerank,positive regulation of cellular component organization (GO:0051130),-0.2863589310506514,-1.205812416018409,0.08256880733944955,0.588172268795443,1.0,30/107,15.38%,TRABD2B;ATP10A;FNIP1;IGF1R;SHANK3;INSR;TGFB2;GPC3;DAB2;RUNX1;TFRC;GSK3B;APOE;FNIP2;VCP;RHOC;HYAL1;GPX1;BAX;CAMK2B;CD151;AJUBA;BID;SURF4;RAPGEF3;CDH5;ABCB4;TAL1;MMP1;SMPD1
prerank,neuron projection morphogenesis (GO:0048812),0.3476562887362311,1.20538988698567,0.1695906432748538,0.8396703972305877,1.0,35/137,17.06%,EPB41L3;ISL2;DOCK10;CTNNA2;PTEN;FARP1;EPHB1;ABITRAM;CNTNAP2;MAP4K4;ANK3;LRRK2;NEFH;RAB8A;ADGRB1;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;BMP7;DLG4;ATP7A;CTTN;SDC2;BRSK2;SGK1;FGFR2;TNIK;NRCAM;IMPACT;NTNG2;NTNG1;SLITRK1;CDK5
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3469077194225122,1.20538524874412,0.15950920245398773,0.8381881230079186,1.0,31/124,17.06%,LAMB1;NCDN;GPM6B;MICALL2;CNTNAP2;WDPCP;LRP12;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;DOCK7;FAM161A;PLEKHA1;KIFAP3;NPY;STMN2;OPHN1;STMN4;PLP1;GPRIN1;STMN1;FAM161B;LYN;CTTN;GDNF;TBC1D23;CYFIP1;GPRIN3;CDK5
prerank,aortic valve morphogenesis (GO:0003180),-0.3738720931509074,-1.2048938340438407,0.19373219373219372,0.5895370452332478,1.0,8/30,7.38%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;TIE1;NOTCH1;ELN
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3374316393034271,1.2046857382134342,0.1668639053254438,0.8391115444188096,1.0,39/150,18.47%,PDGFRA;PIK3R1;NRG1;TCF7L2;SEMA5A;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PINK1;AXL;TSPYL5;IAPP;P2RX4;TGFBR1;FYN;CD86;IGF2;CASS4;MYDGF;FERMT2;FGF5;AREG;FGFR2;HAX1;MAZ;PIK3CG;ADAM8;RHOG;PDGFRB;SPRY2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4825359129110705,1.2044511285060515,0.23627287853577372,0.8383829770719473,1.0,4/16,11.48%,TRA2B;PRDX6;CELF4;SNW1
prerank,cell part morphogenesis (GO:0032990),-0.46790492216000035,-1.2042151533227863,0.2511111111111111,0.5901773751867888,1.0,2/13,2.53%,PACSIN2;MTM1
prerank,amino sugar metabolic process (GO:0006040),-0.5098001538002247,-1.203829798220693,0.25389755011135856,0.590079581504653,1.0,3/10,5.16%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4784410698622124,1.2038006147700309,0.23731587561374795,0.8392400577062384,1.0,11/19,26.52%,PRDX5;MTOR;TENM1;DHX36;ZC3H8;CHD8;AR;MAF1;RPTOR;POLR3F;ELL
prerank,cytoplasmic translational initiation (GO:0002183),-0.4256029654028848,-1.2034163406556695,0.21024258760107817,0.590087381251879,1.0,6/17,16.65%,EIF5;EIF2S2;MCTS1;RBM4;EIF3D;EIF4H
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3905831478515132,-1.2030441789260866,0.21246458923512748,0.5900995304598031,1.0,8/24,13.78%,EPHA4;CTSC;UBB;APOE;TMF1;GPX1;PSME3;PTK2B
prerank,positive regulation of cell differentiation (GO:0045597),-0.25899609078984515,-1.2026626570830352,0.05102040816326531,0.589967442385315,1.0,50/237,12.18%,RANBP3L;IGF1;PLCB1;RAPGEF2;KITLG;CDON;PRKCH;SOX5;MEF2C;LEF1;BOC;IL18;FOXC1;CCN2;NBL1;MEF2A;SLC6A6;NFKB1;BMPR2;KDR;IGFBP3;RAP1A;CDS1;WNT4;TGFB2;CD34;DAB2;IL6ST;MAPK9;CDC42;MAPK14;BNIP2;NGF;CCN1;PKDCC;ACVR1;ACVRL1;SMAD3;IFITM1;SFRP1;SPAG9;CCN4;BCL9L;NPNT;VHL;RPS6KA1;HEYL;MDK;RBM4;CEACAM1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5199942763982213,1.2025324430080107,0.2626970227670753,0.8422532009075101,1.0,6/13,18.86%,MBTPS2;NR1H2;USP19;CLU;EIF2AK3;ALOX5
prerank,xenobiotic transport (GO:0042908),-0.4320278338327957,-1.2024252965357989,0.2119700748129676,0.5895261408850032,1.0,6/17,10.42%,ABCG2;SLC47A1;SLC22A4;ABCA3;SLC22A18;SLC7A5
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5336761438038281,1.2023845994501507,0.23827392120075047,0.841271483676416,1.0,6/11,27.66%,REST;PINK1;NONO;HIF1A;ATF4;NR4A3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3353988116240972,-1.20209787982469,0.14714714714714713,0.5893476465820685,1.0,20/47,24.48%,APOOL;MICOS10;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;TIMM9;ATP5MC2;GHITM;ATP5F1D;ATP5MC1;TIMM13;CHCHD3;TIMM8B;ROMO1;LETM1;NDUFA13;UQCC3;APOO;TIMM10B
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5316712232654551,1.2020057515288685,0.25226860254083483,0.8411772184271227,1.0,1/11,0.63%,XCL1
prerank,blood vessel diameter maintenance (GO:0097746),-0.362851426966488,-1.2013238955090155,0.1863905325443787,0.5903302398982857,1.0,15/34,15.85%,ROCK2;EDNRA;NOS3;GCLC;ACE;KLF2;BDKRB2;ITGB1BP1;NPR1;ADCY6;SCPEP1;NOS1;AGTR1;EDN1;GPER1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.49465474033507106,-1.2002635036254092,0.2517321016166282,0.591984004139005,1.0,5/11,21.21%,VCPIP1;STX18;VAPB;ARL6IP1;RTN4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5099623497736507,1.1999896582986433,0.23985890652557318,0.8468912352821385,1.0,4/14,15.36%,LPIN3;CHKA;SELENOI;LPIN2
prerank,cytoskeleton organization (GO:0007010),-0.28252823550789136,-1.1998424562647712,0.11413043478260869,0.5920424791471891,1.0,25/114,9.17%,PLCE1;RHOBTB1;MICAL2;FGD5;MARK1;SYNE3;LARP4;DIAPH1;PACSIN2;TPM1;LRCH3;BRWD3;ARHGAP10;RHOBTB2;NEDD9;PLD2;RAC1;SEMA6A;ARAP3;CAPZB;APOE;CDC42BPB;RHOC;MAST3;CFL1
prerank,skeletal system development (GO:0001501),0.3408372930697939,1.1996039728525305,0.16881594372801875,0.8468836743563996,1.0,35/148,17.00%,COL13A1;CHD7;SULF1;TRPS1;COL10A1;WNT5A;ANKRD11;FGFR1;VCAN;GJA1;TBX3;SOX6;CDH11;COL1A2;ZBTB16;CREB3L2;HAPLN2;PAPSS2;ALX4;P3H1;BMP7;TGFBR1;SOX9;IGF2;BGLAP;TRIP11;ATP7A;FBN1;EVC;HAPLN3;FGFR2;HAPLN1;PTGER4;STC1;FRZB
prerank,visual perception (GO:0007601),0.3565801418607568,1.1976361541551421,0.17866666666666667,0.8523456600134913,1.0,7/84,3.85%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,negative regulation of transposition (GO:0010529),-0.42947642851276224,-1.197405201687491,0.22142857142857142,0.5973794678760599,1.0,4/16,11.74%,TUT7;MYBL1;TEX15;UBR2
prerank,regulation of cellular response to heat (GO:1900034),-0.3015704936627707,-1.1971219334220526,0.15510204081632653,0.5971131944156066,1.0,22/77,16.03%,PTGES3;CAMK2D;HSPA8;CD34;HSPH1;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;NUP98;CAMK2G;ATR;NUP153;BAG3;ATM;NUP43;HIKESHI;NUP205;SIRT1;RAE1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5018253265106967,-1.1961842707952253,0.24541284403669725,0.5984612328272005,1.0,6/10,18.46%,NOTCH1;LRP6;PHACTR4;ARHGAP12;LIN7C;SOX11
prerank,T cell differentiation (GO:0030217),0.4121224471181149,1.1957552765532007,0.23052959501557632,0.8574865151254105,1.0,7/40,11.94%,CHD7;MR1;RABL3;PTPN22;ZFP36L2;GLI3;LMBR1L
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4686664368342797,-1.1953237116324702,0.255,0.5997378831899407,1.0,4/12,3.44%,PODXL;PROM1;MAGI2;IQGAP1
prerank,T-helper cell differentiation (GO:0042093),-0.458873995270017,-1.1953134403702117,0.24498886414253898,0.5987240445654851,1.0,2/14,0.95%,FOXP1;LEF1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.39151382744321944,-1.1953094785304657,0.2144638403990025,0.5976816096929674,1.0,10/25,25.12%,EPHA4;PSMF1;RPL5;RPS7;RPL11;HIPK2;HFE;RPL23;TRIM39;ALAD
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3246804341308556,-1.1947546167177006,0.14695340501792115,0.5981294204503165,1.0,8/55,6.46%,IGF1;IL18;IGFBP2;ANXA1;SLC7A1;TFRC;IL6ST;NCK1
prerank,actin filament organization (GO:0007015),-0.26710321664099246,-1.19464223354464,0.075,0.5974098098922951,1.0,43/151,18.27%,NEBL;TMOD3;RHOBTB1;BAIAP2L1;DPYSL3;SHROOM4;SHROOM3;TPM1;MYO1D;HIP1R;GSN;RUFY3;RHOBTB2;NEDD9;COBL;RAC1;ARHGAP17;CGNL1;CDC42;VILL;INPPL1;RHOC;FHOD1;MYO1C;MYO1E;CD2AP;ARHGAP12;LMOD1;SHROOM2;TRPV4;TMOD1;DSTN;FLNA;HIP1;SHROOM1;ELMO2;BAIAP2;WASL;ALDOA;TPM2;GAS2L3;DLG1;RFLNA
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.39026820791659106,-1.1940141039144803,0.21354166666666666,0.59809313923873,1.0,11/24,29.24%,CAMK2D;CALM1;SRI;DMD;JPH1;NOS1;JPH2;GSTO1;CASQ2;FKBP1A;JPH3
prerank,RNA catabolic process (GO:0006401),0.39332750859285515,1.193930281373732,0.21099554234769688,0.8623481135149424,1.0,13/46,17.83%,RNASEH2C;AGO4;FEN1;ZC3H12D;ZFP36L2;AGO3;MTREX;RNASEH2B;DIS3L2;HNRNPD;RNASEH1;PPP1R8;DXO
prerank,protein localization to plasma membrane (GO:0072659),-0.2770679181400582,-1.193900295607448,0.09467455621301775,0.5973314052062835,1.0,27/129,9.40%,TSPAN5;RAPGEF2;ROCK2;ACTN2;BSG;AFDN;RAPGEF6;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;RAMP1;TTC7B;PACS1;KCNB1;ANK2;LRP6;ITGB1BP1;EHD4;TSPAN17;KCNIP3;TTC7A
prerank,mammary gland development (GO:0030879),0.46476615589106934,1.1937611310458758,0.24390243902439024,0.8614619361760792,1.0,5/21,12.23%,NRG1;ERBB4;TBX3;WNT3;ARHGAP35
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2909744269814173,-1.1935870988986808,0.10416666666666667,0.5971522111648576,1.0,29/94,17.12%,DDX5;BCL2L1;PPP1R13B;ARL6IP5;MCL1;MAP3K5;PRKDC;PRODH;CYP1B1;CUL1;JMY;CASP2;PPM1F;FNIP2;CRIP1;BAD;BAX;MYBBP1A;HIPK2;ATP2A3;BOK;ATM;HINT1;ERN1;CDKN1A;PRKCD;CUL3;EPHA2;AIFM1
prerank,negative regulation of neuron differentiation (GO:0045665),0.45891806097117993,1.1934325426063734,0.24375,0.8611671002805025,1.0,8/22,18.77%,REST;CNTN4;SOX2;BMP7;SOX9;MED1;CALR;HEY1
prerank,neurotrophin signaling pathway (GO:0038179),-0.415548426214151,-1.193275758786883,0.2231638418079096,0.5969375886795859,1.0,9/21,15.13%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF;CASP3;FRS2;KIDINS220;GRB2
prerank,protein-containing complex assembly (GO:0065003),0.3207656715856906,1.193047395552243,0.1258426966292135,0.860977825166726,1.0,65/259,16.79%,SEC16B;LAMC1;WIPF1;TEAD1;COL7A1;HDAC1;PPID;TCF7L2;CD40;PYGO1;SEC16A;EPRS1;RSPH9;GRIA1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;LRRK2;SLC9A1;BCL9;TLE2;LLGL1;NOL3;ADCY8;CAPN3;COL16A1;WASF3;TRAPPC2L;MDM4;GOLGA2;KIFAP3;TLE1;OPA1;F8;IL1RAP;DNAJB12;SEC24B;GSDMD;PPP6C;TP53;SCFD1;DLG4;RIMS1;TUBGCP4;MCFD2;WDCP;SOX9;CAND1;AXIN1;RIPK1;FERMT2;DHX9;TFAP4;AREG;MYC;TRAPPC10;DET1;FERMT3;SEC23A;PDZD11;SEC24A;PPP6R3;DNAJB14
prerank,regulation of cellular pH (GO:0030641),-0.3667445155883025,-1.1929884561181343,0.1792717086834734,0.5966940718291551,1.0,9/29,18.43%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;LACC1;SLC4A8;SLC9A5;SLC26A6;SLC9B1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5005566462287262,1.1928528570447416,0.25125628140703515,0.8601140361230856,1.0,3/14,6.34%,GPLD1;IRS1;IRS2
prerank,response to hydrogen peroxide (GO:0042542),-0.33894307598062684,-1.1928237319373542,0.17771084337349397,0.5960625681943212,1.0,21/45,26.92%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;CAT;GPX1;ANKZF1;STK25;PRKCD;SIRT1;PRDX3;APTX;HDAC6;ADAM9;TNFAIP3;PPIF;OSER1;RHOB;PARK7;ECT2
prerank,regulation of cell motility (GO:2000145),-0.27943154613148724,-1.1928003399005807,0.1073170731707317,0.5950893817061507,1.0,37/121,18.41%,PLXNA2;LMO4;ROCK2;PLXNA4;CAVIN1;SPOCK2;EGFR;NTN1;DIAPH1;AMOT;INPP5F;MINK1;RAC1;CDK6;PRAG1;FGF1;FRMD5;ARHGAP18;PLXNB1;ENPP2;SPATA13;ROBO4;LMNA;CEACAM1;AMOTL2;MACF1;FLNA;TMSB4X;PLXNA1;SERPINE2;CCDC25;PKN2;ERBB2;AKT1;SPINT2;EGF;ERBB3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34875535113011974,-1.1919114698083502,0.1826086956521739,0.59647185848011,1.0,10/36,18.05%,MECOM;FOXO1;EZR;SIRPA;SH3RF2;HDAC3;CYLD;PPIA;PER1;DLG1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.357824849500083,-1.19172425956172,0.21428571428571427,0.595949101262751,1.0,6/37,4.26%,IGF1;MEF2C;ADAMTS1;IGFBP5;TPM1;SOD2
prerank,protein localization to chromatin (GO:0071168),-0.4205871886943398,-1.1914525616853766,0.21674876847290642,0.5956464005242866,1.0,8/18,28.16%,PPHLN1;ESR1;CHMP7;RUVBL2;MCM9;MCM8;MSH2;SGF29
prerank,regulation of macrophage migration (GO:1905521),-0.5008068888034172,-1.1913369816632107,0.25635103926096997,0.594927804575022,1.0,4/10,13.78%,CD200;MTUS1;CX3CR1;PTK2B
prerank,positive regulation of interferon-gamma production (GO:0032729),0.39337501135194564,1.1910498497250093,0.23380281690140844,0.8650144081256518,1.0,9/48,12.27%,TXK;PDE4B;SCRIB;CD276;PTPN22;TLR8;TLR4;PYCARD;IL12A
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4079599724514536,1.1905737128060274,0.24107142857142858,0.8652062929690345,1.0,10/40,15.14%,CCDC22;PTEN;GLMN;PDCL3;PTK2;COMMD1;AXIN1;CLU;ARAF;CSNK2A2
prerank,mitotic cytokinetic process (GO:1902410),-0.4052672465091057,-1.1905300870658893,0.22588832487309646,0.5960773244455131,1.0,10/20,26.89%,CHMP2B;MITD1;KLHDC8B;CHMP7;CHMP4B;CHMP4A;CHMP1A;PDCD6IP;CHMP4C;CHMP2A
prerank,intracellular protein transmembrane transport (GO:0065002),0.40008559820665757,1.1903134110539344,0.22287390029325513,0.864722804343379,1.0,17/42,22.76%,DNAJC19;PEX2;PEX7;SEC63;SEC61B;TIMM44;RTN2;DNAJC15;HSPA5;PAM16;PEX12;PEX6;PEX14;GRPEL1;TIMM21;CHCHD4;C2CD5
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.522631787494831,1.1902669283563965,0.2580071174377224,0.8633769805544589,1.0,4/11,14.53%,TLR6;CYBA;LYN;TIRAP
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4367134381290826,-1.190022285539388,0.23095238095238096,0.5962958612129466,1.0,6/16,13.83%,THBS1;JCAD;PPP1R16B;GATA2;FGFBP1;AGTR1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5472135235140467,1.189966122628824,0.25618374558303886,0.8630489363070365,1.0,2/10,4.17%,ABCD2;NR1H2
prerank,regulation of developmental growth (GO:0048638),-0.3756699471753756,-1.1899549004955394,0.19047619047619047,0.5954401697898707,1.0,7/29,7.60%,IGF1;PLCB1;APP;INSR;SIX1;GSK3B;APOE
prerank,cytosolic transport (GO:0016482),-0.28019437784726214,-1.1891218424694059,0.12053571428571429,0.5966620389428674,1.0,31/108,19.48%,ERC1;VTI1A;EEA1;BECN1;MYO1D;VPS35;DOP1B;HOOK1;SNX32;RAB5A;AP2A1;ARFRP1;SNX6;KLHL20;SPAG9;MON2;GAK;CLN5;VPS13A;VPS29;VPS51;TBC1D10B;ARL1;TRIM27;RAB6A;LAPTM5;TMEM87B;TBC1D5;PLEKHJ1;VPS54;WDR91
prerank,ribosome biogenesis (GO:0042254),-0.26213364353497154,-1.1890111902011529,0.06766917293233082,0.5959478113687346,1.0,85/187,30.37%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPL41;RPS7;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RIOK1;RPL10;RPL35A;DDX27;RPL10A;RPL11;RPL36A;RPL34;RPL32;RPLP2;RPLP0;ESF1;UTP3;RPL4;RPL30;RPL26;RPL29;NOLC1;EXOSC2;RAN;IMP3;RPL31;EXOSC3;RPL23A;RPL19;RPL36;WDR12;PES1;NIP7;NPM1;PAK1IP1;LAS1L;SENP3;RPL17;RPL23;RRP12;NOL11;UBA52;EXOSC1;GTF3A;GLUL;RPL15;PWP2;RPL38;WDR74;LTV1;MRM2;LSG1;RPF2;MRPL36;RPL13A;RPL18A;EXOSC4;RPS25;RPL24;WDR75;LTO1;RRP36;NOP53;NOP16;EIF2A;BMS1;WDR46;PIH1D2;RRP9
prerank,secretion (GO:0046903),-0.45430910643023675,-1.1889443642676796,0.2437357630979499,0.5951157171754348,1.0,4/14,9.15%,TPD52;SLC22A6;SLC22A4;NPR1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.39440868475107355,-1.1882719336044782,0.2440944881889764,0.5959137312593983,1.0,6/22,17.25%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,regulation of neuron differentiation (GO:0045664),0.36099301383551896,1.1881490227599574,0.19920844327176782,0.8678410974130512,1.0,26/76,25.12%,ZEB1;ZFHX3;TCF4;FGFR1;REST;LRRK2;CNTN4;BEND6;SOX2;BMP7;MED1;NRCAM;IMPACT;BRINP1;CALR;BMP2;RHOA;HEY1;CDK5R1;MMD2;DTX1;ZC4H2;TRIM32;NREP;CPNE1;VWC2
prerank,tRNA 5'-end processing (GO:0099116),0.48748234883050695,1.188080611036601,0.2579505300353357,0.866612072485126,1.0,8/15,24.04%,RPP40;POP5;PRORP;POP7;RPP21;POP4;TRMT10C;SSB
prerank,transport along microtubule (GO:0010970),-0.46242625917221825,-1.1873760431716065,0.24824355971896955,0.5972402372467396,1.0,10/13,30.07%,APP;CDC42;BAG3;BORCS5;DYNC1I1;SPG11;COPG2;DYNC1I2;CAMSAP3;APBA1
prerank,regulation of fibroblast migration (GO:0010762),-0.4040357754203635,-1.1872705596678863,0.23057644110275688,0.596533972651526,1.0,9/20,23.94%,ITGB1;THBS1;RAC1;PRR5L;ITGB1BP1;HAS1;RFFL;DMTN;HYAL2
prerank,protein catabolic process (GO:0030163),-0.3188018106699576,-1.1872361477877134,0.1524163568773234,0.5956055514449465,1.0,25/59,25.46%,DDI2;UBE2G1;HSPA8;DENND3;TRIM24;OGA;APOE;VCP;MANBA;NGLY1;RNF41;CEACAM1;CLPX;CLN5;USE1;SIAH2;STT3B;CLN8;LAMP2;PRPF19;RNF5;PSMA8;CLN6;TPP1;CHEK2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.34972435201826213,1.187189514352117,0.20347394540942929,0.8682474696620764,1.0,20/110,11.18%,ADGRL3;CXCL10;PTGFR;ADCY5;CALCRL;GPR3;ADGRB2;ADGRB1;ADORA2A;ADCY8;ADCY3;CALCA;ADCY2;LPAR3;ADCY7;ADGRB3;ADGRL1;LPAR1;IAPP;GPR26
prerank,positive regulation of histone modification (GO:0031058),-0.35962080789198597,-1.1867369383688047,0.19658119658119658,0.5959799269628511,1.0,13/33,26.06%,GLYR1;RPS6KA5;SAP30BP;AKAP8;NOS1;UBE2N;CDK9;ZBTB7B;TADA2B;RUVBL2;APLNR;BRCA1;KDM1A
prerank,phospholipid biosynthetic process (GO:0008654),-0.35549326711741,-1.186736147191741,0.18991097922848665,0.594987794666813,1.0,14/36,29.63%,SGMS1;MBOAT1;SGMS2;AGPAT4;CPNE3;FDPS;NUS1;DOLPP1;PIP5K1A;SPHK2;FITM2;AGPAT5;SAMD8;MVD
prerank,regulation of actin filament-based process (GO:0032970),0.3651996665107123,1.1867251123425528,0.2125340599455041,0.8683257275743791,1.0,9/70,4.65%,DLC1;LRP1;RND3;GPM6B;HRG;IQGAP3;CORO2B;FSCN1;RAC3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.43665893178124465,1.186502784460234,0.2593220338983051,0.8676044105821167,1.0,13/26,23.80%,GPR37L1;REST;LRRK2;NOL3;PYCR1;PINK1;FYN;HTRA2;GPR37;PDE8A;BAG5;MAPK7;ATF4
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3608711081715093,-1.1863760642063554,0.207492795389049,0.5949520351633204,1.0,6/34,8.31%,PICALM;ROCK2;ACTN2;GOPC;GSK3B;MAPT
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3702416860812947,-1.1863069994258018,0.23255813953488372,0.5941204395297797,1.0,6/30,6.85%,ROBO1;NET1;F11R;GPR4;RAC1;PRAG1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4416293371257509,1.1858853685599826,0.24509803921568626,0.8683083011704209,1.0,14/25,28.56%,HTATSF1;SETD5;ZNF326;EAF2;THOC5;CCNK;LDB1;KAT7;DDX39B;CCNT2;EAF1;ELL;WDR43;HMGN1
prerank,mitotic spindle assembly (GO:0090307),0.3987090821000864,1.1855620974698156,0.24778761061946902,0.867956206442284,1.0,20/42,24.66%,CCDC61;LSM14A;AAAS;GOLGA2;CEP192;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;RHOA;KPNB1;SMC3;KIF11;KIFC1;TPX2;KIF23;TOGARAM1;STAG1
prerank,positive regulation of growth (GO:0045927),-0.31391684507189643,-1.1849537570301811,0.18118466898954705,0.5966335514534151,1.0,21/64,19.90%,PLCB1;EGFR;INSR;TGFB2;ADAM10;CDC42;PPM1F;HYAL1;SFRP1;INO80;RPS6KA1;EXOSC2;MFSD2A;CDKN2AIP;ZPR1;PABIR1;ERBB2;AKT1;SDCBP;LGI1;CIB1
prerank,sensory perception of taste (GO:0050909),0.5445888151725746,1.1844726411507365,0.2833935018050541,0.8704680605560835,1.0,2/10,7.19%,ASIC2;ASIC1
prerank,mitochondrion distribution (GO:0048311),-0.46843453439702376,-1.1843614719596065,0.23623853211009174,0.5971173054272141,1.0,5/12,17.78%,MEF2A;MTM1;MAPT;TRAK2;MSTO1
prerank,regulation of secretion by cell (GO:1903530),0.3838840731224364,1.1843236309370773,0.20612813370473537,0.8695008694011863,1.0,14/54,13.12%,HCRT;CHRNB4;DNAJC1;VAMP2;FMR1;RAB8A;LLGL1;RAB3C;RIMS2;HTR1A;P3H1;RAB15;RIMS1;ARFIP1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3941842005115712,1.1837773040939954,0.24273255813953487,0.8700696340279175,1.0,10/46,9.81%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.49254338179649954,1.1836534932138245,0.27533783783783783,0.8690034114882768,1.0,6/14,21.30%,IL34;PTK2;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,regulation of cholesterol transport (GO:0032374),0.4627313447764972,1.1834160702045495,0.2520193861066236,0.8683506147022827,1.0,3/20,4.17%,LRP1;OSBPL6;NR1H2
prerank,negative regulation of hippo signaling (GO:0035331),-0.4601132587964054,-1.183150178337914,0.2541966426858513,0.5993442711361237,1.0,5/12,16.53%,MAPK14;AJUBA;DLG5;MARK3;VGLL4
prerank,positive regulation of RNA splicing (GO:0033120),0.4165464940645315,1.1831334936623965,0.22993827160493827,0.8679157437109637,1.0,8/29,17.98%,PIK3R1;TRA2B;PRDX6;CELF4;SNW1;RBM20;HNRNPLL;HABP4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5259124918042428,1.182110702515676,0.2638146167557932,0.8698957263129413,1.0,2/10,10.11%,WNT5A;WNT3
prerank,tryptophan metabolic process (GO:0006568),0.5157574105753777,1.1818918971823402,0.27964601769911507,0.8692195252902567,1.0,3/11,17.64%,KYNU;ATP7A;KMO
prerank,positive regulation of blood coagulation (GO:0030194),-0.4294291119379029,-1.1813294829944083,0.24154589371980675,0.6031655275213531,1.0,4/17,3.50%,ANO6;THBD;THBS1;ST3GAL4
prerank,postsynaptic membrane organization (GO:0001941),0.4747458972189217,1.181282283827411,0.2916666666666667,0.8700020716488385,1.0,3/17,3.11%,CEL;NRXN2;NRXN1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5279177089051371,1.1808024472207441,0.26631393298059963,0.8672781799762447,1.0,4/10,18.44%,ERCC1;TERF1;SMARCAL1;WRN
prerank,t-circle formation (GO:0090656),0.5279177089051371,1.1808024472207441,0.26631393298059963,0.8672781799762447,1.0,4/10,18.44%,ERCC1;TERF1;SMARCAL1;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5279177089051371,1.1808024472207441,0.26631393298059963,0.8672781799762447,1.0,4/10,18.44%,ERCC1;TERF1;SMARCAL1;WRN
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.42697942375131115,-1.1807403691826943,0.23857868020304568,0.6037009992464379,1.0,2/17,3.07%,RAPGEF2;ADRA1B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4905084413969899,-1.180491283856916,0.2762557077625571,0.6032967250024072,1.0,4/10,10.39%,SHANK3;APP;RAB5A;CAMK2B
prerank,protein heterooligomerization (GO:0051291),0.4635453629411572,1.180447404266716,0.2600671140939597,0.867073679598164,1.0,4/17,10.14%,GRIN2B;KCNC2;HSD17B8;NUDT21
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.41430269369391837,1.1804369373798504,0.2298325722983257,0.86565895017209,1.0,7/34,10.03%,PDGFRA;PIK3R1;PIK3R2;IRS1;PTK2;PRKD1;FGR
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.41733898560836524,1.1801910167323262,0.2630769230769231,0.8650607333007583,1.0,2/33,1.96%,APOD;PTEN
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3330381109200018,1.180020326225422,0.18321513002364065,0.8642436154923513,1.0,44/161,18.61%,TBX18;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;KREMEN1;PSMA5;PTPRU;PTPRO;PSMB5;NKD2;SOX2;TLE1;GLI1;GLI3;PSMC4;PSMA4;SHISA6;PSMC5;JADE1;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CHD8;AMER2;DVL3;PSMD14;PSMA7;FRZB;HECW1;BMP2;PSMD11;LZTS2;PSMA2
prerank,extracellular matrix disassembly (GO:0022617),0.382481071638636,1.1799635102647752,0.2347949080622348,0.862986701536176,1.0,4/53,6.70%,SCUBE1;LAMC1;KLKB1;MMP11
prerank,inorganic anion transport (GO:0015698),-0.32112403200393924,-1.1797155039310505,0.22570532915360503,0.604311573393876,1.0,8/53,4.07%,CLIC4;SLC13A4;SLC4A10;ANO6;XPR1;SLC26A7;ANO1;SLC26A11
prerank,negative regulation of blood pressure (GO:0045776),-0.46245321342172085,-1.1795680061659615,0.24766355140186916,0.6036875335178642,1.0,4/13,12.70%,NOS3;BMPR2;SCPEP1;NOS1
prerank,catecholamine metabolic process (GO:0006584),-0.44165319108522855,-1.1793814018060373,0.23980815347721823,0.603182466843872,1.0,1/14,0.20%,SNCAIP
prerank,neuron projection development (GO:0031175),0.3304870930543703,1.1789863506185032,0.1724537037037037,0.8650684566724148,1.0,40/168,17.19%,LAMB1;NCDN;EPB41L3;GPM6B;DOCK10;ADGRV1;MICALL2;PTEN;EPHB1;CNTNAP2;MAP4K4;LRP12;PPP1R9A;NEDD4;LRRK2;NEFH;UNC5A;CNTN4;TMEM108;DOCK7;NPY;STMN2;BMP7;OPHN1;STMN4;PLP1;DLG4;IFT88;GPRIN1;ATP7A;STMN1;LYN;CTTN;GDNF;SGK1;TNIK;TBC1D23;GPRIN3;CDK5;GRM7
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.45320108583112423,-1.1788635658951894,0.2800982800982801,0.603677288363183,1.0,4/13,25.67%,MAPT;PRKCD;TYROBP;ITGB2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2921644498952681,-1.1788096310551066,0.15481171548117154,0.6028122275987298,1.0,30/87,22.34%,SMAD6;ARHGEF18;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;TGFB2;SKI;UBB;ACVR1;ACVRL1;SMAD3;LRRC32;ZYX;PRKCZ;SMAD1;CDH5;FURIN;SIRT1;UBC;TWSG1;TGFBR3;USP9X;ADAM9;TGFBR2;NRROS;UBA52;SMAD7
prerank,positive regulation of signal transduction (GO:0009967),-0.2497153324494126,-1.1787103232657772,0.04310344827586207,0.6020904164799673,1.0,53/238,13.78%,SORBS1;TSPAN5;IGF1;VWF;TEK;LIMS2;RSPO3;RBPJ;ROBO1;MAML2;NOS3;TPD52L1;SHANK3;NRP1;SMARCA4;VPS35;FAS;JCAD;NOTCH1;RSPO2;TGFB2;KANK1;CCN3;SKI;VTN;SMO;CAV2;SULF2;GRB10;CRADD;IL6ST;KLF2;EPN2;WLS;SHANK1;FGF1;ITGB1BP1;CCBE1;CITED2;TRIM16;BAX;SFRP1;MYO1C;CD63;ITGB3;DLG5;PRKCZ;TERT;TTC23;GKAP1;MACF1;FLNA;PTK2B
prerank,cellular component disassembly (GO:0022411),0.3828885789700903,1.1784015818674431,0.23863636363636365,0.8656425807265974,1.0,4/53,6.70%,SCUBE1;LAMC1;KLKB1;MMP11
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.262133415299014,-1.1782232579487166,0.09883720930232558,0.6023502815988068,1.0,47/153,20.39%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;PRKDC;CAMK2D;TOP1;TLK1;VRK3;MAPK9;WNK1;HIPK3;MAPK14;HIPK1;GSK3B;TLK2;STK38L;RPS6KA5;DYRK2;MAST3;CAB39;RPS6KA1;ATR;MAP2K2;PRKCZ;HIPK2;CSNK1G3;ATM;ERN1;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;STK32B;MAP3K10;AKT1;SBK1;MARK2;VRK2;CSNK1A1;ULK3;MKNK1;PKN3
prerank,negative regulation of cellular senescence (GO:2000773),0.5013650475953224,1.176992061820372,0.2826855123674912,0.8692214596076978,1.0,4/13,8.12%,SLC30A10;FBXO5;ZKSCAN3;TWIST1
prerank,nuclear migration (GO:0007097),-0.4463112853428345,-1.1767967951096245,0.26269315673289184,0.605042601513102,1.0,3/13,3.81%,SYNE2;SYNE3;CLMN
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33707393574222266,1.1766528140802337,0.17789072426937738,0.8689134451856921,1.0,28/125,15.99%,DYNLL1;BUB1B;CENPU;EFHC1;DCTN2;SGO1;CENPE;SUN2;GPSM2;NSL1;PTPA;RCC1;TBCE;SPDL1;RMDN1;INCENP;NUSAP1;CEP126;CENPC;NUP107;EML1;BUB1;STMN1;CLASP2;DYNLL2;KIF2A;CENPF;CLASP1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.46022326628328847,-1.1763792363727756,0.27014218009478674,0.6051790379819585,1.0,3/12,4.24%,DPYSL3;CTPS1;CTPS2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.37640140155072177,-1.1759762560244578,0.22631578947368422,0.6052891227327781,1.0,11/26,17.31%,FOXP1;KANK2;SMARCA4;DAB2;VPS18;SFRP1;HEYL;VPS11;SIRT1;PER1;CLOCK
prerank,positive regulation of ATPase activity (GO:0032781),0.40463289435088645,1.1757594380948952,0.25,0.870621167237517,1.0,11/41,19.42%,DYNLL1;RYR2;DNAJC24;MSH3;ALDOB;DNAJC10;DYNLL2;DHX9;MSH6;SSBP1;CHTOP
prerank,regulation of lymphocyte migration (GO:2000401),-0.4897277395211604,-1.1757521203071075,0.2693208430913349,0.6048536751378213,1.0,6/10,31.40%,JAM2;WASL;AKT1;MSN;SLC8B1;STK10
prerank,chromatin disassembly (GO:0031498),-0.44333167356455666,-1.1756697328039998,0.26558891454965355,0.6031024779193165,1.0,11/14,43.06%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;HMGA1;SMARCB1
prerank,nucleosome disassembly (GO:0006337),-0.44333167356455666,-1.1756697328039998,0.26558891454965355,0.6031024779193165,1.0,11/14,43.06%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;HMGA1;SMARCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5144155887698737,1.1756500077118308,0.25546218487394956,0.8681355134866787,1.0,2/13,3.13%,IL15RA;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.5144155887698737,1.1756500077118308,0.25546218487394956,0.8681355134866787,1.0,2/13,3.13%,IL15RA;JAK1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.39652710700200733,1.1752173717276873,0.2272069464544139,0.8683400707342087,1.0,9/43,7.06%,PPARA;TEAD1;GNL3;NFATC3;NGFR;PPARD;REST;FOS;SRF
prerank,keratinocyte differentiation (GO:0030216),-0.35519612418617175,-1.1747677264334855,0.2152230971128609,0.6044626352532594,1.0,13/29,24.99%,CLIC4;ANXA1;TXNIP;CASP3;UGCG;BCR;WNT16;EPHA2;ADAM9;PIP5K1A;ASAH1;DSP;EXPH5
prerank,cGMP biosynthetic process (GO:0006182),-0.4936618334788696,-1.1744012804506667,0.2673913043478261,0.6044800756299956,1.0,4/10,27.72%,GUCY1A1;NPR1;GUCY2C;GUCY1B1
prerank,regulation of interleukin-6 production (GO:0032675),0.3470358036075082,1.1739486163032182,0.20848938826466917,0.8714030498114944,1.0,13/96,11.00%,IL33;WNT5A;IL16;TSLP;PTPN22;TLR6;TLR8;TWIST1;CD200R1;MBP;TLR4;CYBA;PYCARD
prerank,peroxisome organization (GO:0007031),0.4454994450684525,1.1738534846688282,0.2573913043478261,0.8703029537532215,1.0,10/25,19.21%,SEC16B;ABCD2;PEX2;PEX7;PEX11A;PEX19;PEX12;PEX3;PEX6;PEX14
prerank,sensory perception of pain (GO:0019233),0.45409682439695215,1.1738037499758325,0.2435064935064935,0.8690329149655961,1.0,4/21,11.26%,TRPA1;NIPSNAP1;PTGES;P2RX4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2944128184027069,-1.1737795113025558,0.1446280991735537,0.6052435068988136,1.0,13/80,6.27%,PLCE1;DPYSL3;OCLN;FNBP1L;WASF2;NRP1;MARK4;ANLN;RHOQ;NDEL1;APC;RAC1;CDC42
prerank,cellular response to copper ion (GO:0071280),-0.42987895023982625,-1.1733788640122285,0.2347417840375587,0.6052970752075628,1.0,12/16,37.09%,MT2A;MT3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;HSF1;AQP1
prerank,embryonic limb morphogenesis (GO:0030326),0.4145985140339533,1.1732321286224225,0.2403560830860534,0.8695597050479346,1.0,7/34,9.18%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.49138041975004754,1.1730363265620376,0.2768959435626102,0.8688239380076591,1.0,2/14,4.94%,ACOX2;CRAT
prerank,negative regulation of cell aging (GO:0090344),0.47794841025708407,1.1730222327037512,0.26936619718309857,0.8674568865806677,1.0,6/16,15.45%,SLC30A10;FBXO5;ZKSCAN3;TWIST1;FOXM1;MAP3K3
prerank,protein targeting to mitochondrion (GO:0006626),0.3825016098319921,1.1728564433505704,0.2445414847161572,0.8666756262422413,1.0,20/52,25.62%,TIMM10;DNAJC19;IMMP2L;PMPCA;PITRM1;TIMM44;AGK;DNAJC15;HSPA4;PAM16;IMMP1L;GRPEL1;MFN2;TIMM21;GDAP1;CHCHD4;FIS1;TOMM34;SAMM50;TOMM40L
prerank,ceramide transport (GO:0035627),-0.4600410992884118,-1.1728188487936175,0.25663716814159293,0.6057616442395936,1.0,5/12,20.86%,CERT1;PLTP;ABCB4;GLTP;PSAP
prerank,peptidyl-glutamic acid modification (GO:0018200),0.444111548935606,1.1727592063145782,0.2601880877742947,0.865645102670399,1.0,6/24,14.86%,NAA10;TTLL6;GGCX;AGBL4;TPGS1;VKORC1L1
prerank,regulation of embryonic development (GO:0045995),-0.35149505584919344,-1.1725014270028642,0.20766773162939298,0.6056374342457782,1.0,9/34,11.59%,PHLDB2;PLCB1;INSR;B4GALT5;TRIP12;SOX17;CFL1;NIBAN2;DAG1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3424332990877085,-1.172076937351703,0.20689655172413793,0.6057548293965042,1.0,17/36,27.44%,ATR;CDC5L;ATM;NBN;DONSON;CLOCK;HUS1;SETMAR;PRPF19;E2F1;CDC45;ATRIP;CHEK2;HINFP;CHEK1;BRIP1;RHNO1
prerank,ERBB signaling pathway (GO:0038127),0.3695727356150227,1.17174135253988,0.24230254350736277,0.8679527141282172,1.0,13/64,12.90%,PIK3R1;NRG1;SLC30A10;ERBB4;PTPRR;NRG2;PDPK1;NRG4;PTK2;PRKCA;SOX9;CUL5;GAREM1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.31317736425178844,-1.1717243515374505,0.19865319865319866,0.6057034696236316,1.0,18/55,16.43%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;PSMD8;PSMD12;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;PSMB10
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4503033137073382,-1.1717108406225765,0.2599009900990099,0.6047667571220634,1.0,12/14,54.03%,IL18;PAEP;IL17D;CD84;RASGRP1;ISL1;CARD9;IL23A;IL12B;IL23R;IL17F;IL1B
prerank,organic cation transport (GO:0015695),-0.40984294990745684,-1.1713151158024062,0.24129353233830847,0.60481276610749,1.0,4/20,7.84%,SLC47A1;SLC22A4;SLC22A18;RALBP1
prerank,synaptic membrane adhesion (GO:0099560),0.49950940560190366,1.1711679848375045,0.2799325463743676,0.8685711476136413,1.0,6/14,17.65%,GPC4;LRFN5;LRRC4C;NTNG1;SLITRK1;GPC6
prerank,regulation of cholesterol esterification (GO:0010872),-0.485058061073225,-1.1709720591626116,0.2709251101321586,0.6046871548904884,1.0,4/10,20.51%,APOE;STARD4;AGTR1;AGT
prerank,positive regulation of hormone secretion (GO:0046887),0.46502046147872195,1.1705568704294242,0.2625,0.8692343039569482,1.0,3/17,12.01%,EDN3;SPP1;VAMP7
prerank,positive regulation of vasoconstriction (GO:0045907),-0.4562937893979668,-1.170368314102041,0.25586854460093894,0.6052350765106363,1.0,2/13,3.07%,CAV1;ADRA1B
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.42780438470257753,-1.1697370670493157,0.2290249433106576,0.6059288831723122,1.0,5/15,8.50%,RAI2;RICTOR;TGFB2;STOX2;CELF1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4046776064723083,-1.1695267574418198,0.24866310160427807,0.6055422336405414,1.0,7/19,13.77%,CSGALNACT1;NDST1;NDST3;EXT1;UGDH;GLCE;HS3ST3B1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.4349210965202439,-1.16913573741576,0.26785714285714285,0.6056040804099153,1.0,10/16,29.54%,PYGB;PGM2L1;CALM1;GAA;PGM2;PHKG1;AOAH;PHKG2;PHKA2;PYGL
prerank,regulation of receptor binding (GO:1900120),-0.49025964454554183,-1.1688100841641613,0.27155172413793105,0.6055168756860309,1.0,5/10,16.82%,PTPRF;B2M;ATP2A3;GREM2;HFE
prerank,heart development (GO:0007507),0.3283029136914377,1.1687215827333235,0.20163170163170163,0.8743306093569332,1.0,22/150,11.44%,SCUBE1;CHD7;ECE1;FLRT2;DLC1;NTRK3;PTEN;ERBB4;DNAAF4;SALL1;HTR2B;NF1;BCOR;ADAP2;SRF;PTK2;BMP7;KAT2A;ZFPM2;FGF12;TGFBR1;NDUFV2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5310433630750797,1.1679752468510927,0.29636048526863085,0.8755228400121627,1.0,4/12,14.28%,KDELR3;KDELR2;TAPT1;HSPA5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4412483453987916,1.167960489989681,0.27009646302250806,0.8741597726180942,1.0,2/23,2.23%,GHR;ERBB4
prerank,histone H3-K4 methylation (GO:0051568),0.43894117490023354,1.1678187761857792,0.2671875,0.8732483779515379,1.0,13/26,23.71%,OGT;CXXC1;KMT2A;WDR5;DYDC2;PAXIP1;ASH2L;SETD4;KMT2C;RBBP5;MEN1;KDM6A;TET2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.46990550451108287,1.167481228111965,0.27101200686106347,0.8730561261633183,1.0,7/16,19.00%,MCM7;RPA1;MCM4;RECQL;MCMDC2;WRN;SSBP1
prerank,dendritic spine morphogenesis (GO:0060997),0.4921577543949925,1.1668342272553238,0.2722689075630252,0.8739343077794387,1.0,3/15,2.36%,DOCK10;PTEN;EPHB1
prerank,protein localization to lysosome (GO:0061462),0.4190887082050844,1.1663154904630564,0.2617960426179604,0.8743113288030214,1.0,8/28,13.40%,NEDD4;SORL1;SZT2;SNX16;AP3M1;RNF128;HGS;CD81
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.4933946013553263,-1.1650663516268331,0.3047404063205418,0.6140480899315207,1.0,1/10,0.26%,EPHA4
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2898081097098804,-1.1649880860614976,0.1592920353982301,0.6132984430278251,1.0,30/88,23.94%,PRKAG2;PTPRB;PPM1E;CAV1;SLC8A3;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;MVP;LRP6;ITGB1BP1;YWHAG;PTPN1;HSPB1;CEACAM1;PPIA;CDKN1A;PAK2;TRIM27;AKT1;NPM1;GSKIP;DUSP19;CAMK2N1;QARS1;DBNDD2;WWTR1;HYAL2
prerank,negative regulation of type I interferon production (GO:0032480),-0.3389727120463669,-1.1643783600879132,0.22916666666666666,0.6138556864559197,1.0,17/40,24.33%,NPLOC4;SIRPA;MAVS;TRIM25;PCBP2;RNF125;CYLD;NLRX1;NLRC5;UBE2L6;TBK1;HAVCR2;ISG15;TNFAIP3;ILRUN;IKBKE;REL
prerank,regulation of bone mineralization (GO:0030500),0.37879231918800543,1.1642737303364028,0.24890829694323144,0.8799227713753115,1.0,4/55,1.69%,ENPP1;PTN;GPM6B;ADGRV1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4333966068466841,1.1642040582895736,0.27129337539432175,0.878754094782173,1.0,10/26,14.38%,PTEN;NRXN1;LRRK2;TMEM108;RIMS2;RELN;DLG4;RIMS1;CBLN1;CUX2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3328213282529479,1.1641746279149259,0.2014475271411339,0.8774720978134241,1.0,22/142,11.77%,PDGFRA;PTGFR;ADCY5;ATP1A2;WNT5A;C5AR1;P2RY1;ACKR2;CCR9;RYR2;ADCY8;CALCA;C1QTNF1;CALB1;LPAR3;TRPC3;PRKACA;CCKBR;LPAR1;IAPP;DLG4;TRPC7
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42645077472641335,-1.1640749346791368,0.26666666666666666,0.6136888571346301,1.0,6/15,13.07%,TJP1;BMPER;KLF4;FGF1;PKM;SMAD1
prerank,positive regulation of biosynthetic process (GO:0009891),0.39789774168775005,1.1636296053480244,0.26876876876876876,0.8779510121388157,1.0,11/40,12.06%,ZBTB20;PPARA;MTPN;TLR6;LARP6;ADGRB1;AMELX;MTOR;TLR4;CYBA;CREB3L1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.30522007652497624,-1.1635245880486524,0.2012987012987013,0.6141938755732521,1.0,17/60,19.62%,HMBOX1;KLF4;PTGES3;PARN;TNKS2;NEK7;CCT3;MAP2K7;ATR;CCT4;CCT7;PCNA;ATM;MAP3K4;HNRNPA1;HGF;RGCC
prerank,organophosphate biosynthetic process (GO:0090407),-0.34395410326837467,-1.163460201618415,0.2096317280453258,0.6133950640401469,1.0,7/37,7.96%,MBOAT1;TPK1;ITPKB;AGPAT4;NFS1;IP6K2;TPI1
prerank,heme biosynthetic process (GO:0006783),-0.38961106514598104,-1.1634573919043694,0.2545454545454545,0.6124496019939939,1.0,7/22,12.42%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,synaptic vesicle exocytosis (GO:0016079),0.3975135937510723,1.163303215122965,0.2571428571428571,0.8777048404654242,1.0,14/40,18.66%,VAMP2;SNAP23;RIMS2;SNPH;SNAP29;SYT7;RIMS1;SYT5;DNAJC5;UNC13A;PCLO;CDK5;UNC13C;SYT1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5080602973898426,1.163080002988579,0.29238754325259514,0.877076740341919,1.0,2/14,6.35%,CCDC22;PSMD10
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.32539362950455175,1.162970374029769,0.19244823386114496,0.8760768255791069,1.0,28/166,14.03%,RORA;PPARA;TEAD1;NR1H4;HDAC1;TAF9B;TAF12;THRA;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;POLR1A;TAF3;NR2C1;TAF1D;TBPL1;TAF1B;SNW1;GTF2H3;ESR2;MED1;NRBF2;HDAC10;ERCC2
prerank,mitotic spindle organization (GO:0007052),0.3241173328316457,1.1629287268758812,0.19437652811735942,0.8748492244829628,1.0,34/153,15.99%,DYNLL1;BUB1B;CENPU;CCDC61;LSM14A;EFHC1;AAAS;DCTN2;SGO1;CENPE;SUN2;GPSM2;GOLGA2;CEP192;NSL1;PTPA;RCC1;TBCE;SPDL1;RMDN1;INCENP;CEP126;CENPC;NUP107;MAP9;EML1;BUB1;STMN1;CLASP2;DYNLL2;KIFC2;KIF2A;CENPF;CLASP1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3065051276656638,1.162599809242184,0.14731182795698924,0.8746688213594301,1.0,48/308,12.33%,IL33;PTN;GHR;LRP1;HCRT;OGT;WNT5A;PLA2R1;GLMN;TXK;GPR3;THRA;LURAP1;GJA1;FBXO5;LOXL2;ACADL;REST;GCNT2;SOX6;NCOA3;HTR2B;SORL1;ZBTB16;FABP5;SIRT6;EPAS1;FABP4;OMA1;HMCES;GLIPR2;TWIST1;PER2;BSCL2;G0S2;APPL2;MTOR;TAPT1;KAT2A;FGR;ZBED3;KSR2;EIF2AK2;TGFBR1;SMTNL2;VAMP7;SOX9;OLFM1
prerank,microtubule depolymerization (GO:0007019),0.47507848396775343,1.1624795723987515,0.2778702163061564,0.873700820328055,1.0,6/17,15.88%,NCKAP5L;STMN2;CCSAP;STMN4;STMN1;KIF2A
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4556181708446093,-1.1624002904487454,0.2745995423340961,0.6142943861914824,1.0,5/13,18.08%,ANO6;AZIN1;P2RX7;ACSL5;SLC26A6
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.42904289909432103,1.1621489698613883,0.2543720190779014,0.873478758740563,1.0,7/25,12.23%,TRA2B;GEMIN2;BCAS2;MPHOSPH10;SLU7;DBR1;SRSF10
prerank,regulation of platelet aggregation (GO:0090330),-0.4105541652320778,-1.1617904985221146,0.25380710659898476,0.6149554371208891,1.0,10/17,25.54%,F11R;CEACAM1;PRKG1;SERPINE2;PRKCD;CD9;PDPN;ALOX12;DMTN;ADAMTS18
prerank,positive regulation of protein modification process (GO:0031401),-0.2516068543370427,-1.161634697206612,0.10948905109489052,0.6144515913365666,1.0,50/203,15.85%,TRABD2B;ROCK2;TEK;LEPR;PECAM1;KRAS;FNIP1;EGFR;APP;LIMCH1;CSNK1D;KDR;NIBAN1;INSR;CCND2;FAS;VEGFD;DAB2;MAVS;ACE;RAC1;VEGFC;TFRC;PPP1R7;RAMP1;EFNA5;CALM1;CARD14;TBX1;CCN1;PPP1R16B;FGF1;RALBP1;HDAC3;CAMTA1;ITGB3;RALB;FLT4;TMEM119;UBE2N;RAPGEF3;PPIA;CDH5;CCND1;KAT5;SMPD1;PRKCD;SIRT1;NOS1AP;GPER1
prerank,fluid transport (GO:0042044),-0.4655120813164032,-1.161542115059489,0.2853828306264501,0.6137535841120452,1.0,8/12,53.40%,PDPN;SLC26A6;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7
prerank,positive regulation of autophagy (GO:0010508),-0.28931140596366856,-1.161511861060903,0.19313304721030042,0.6128869818838196,1.0,23/81,16.44%,DAPK1;FOXO1;RNF152;KDR;SESN1;PRKAA2;ATF6;SH3BP4;TRIM5;TRIM14;GSK3B;BAD;PIK3CB;BNIP3L;TMEM59;OPTN;PAFAH1B2;KAT5;TICAM1;SIRT1;PRKAA1;TBK1;TRIM27
prerank,myelin assembly (GO:0032288),0.5399050982958578,1.1614569601345461,0.3128390596745027,0.8745046182109767,1.0,2/10,4.37%,EPB41L3;TENM4
prerank,regulation of cellular component size (GO:0032535),-0.3601535749834527,-1.1614496016063547,0.20958083832335328,0.6121026214664894,1.0,7/30,8.32%,PICALM;EZR;RDX;RIN3;RAP1GAP2;RAC1;LAMTOR5
prerank,regulation of protein autophosphorylation (GO:0031952),0.40680785864345625,1.1614302211466776,0.25925925925925924,0.8732287204914542,1.0,2/36,0.58%,ENPP1;EPHA7
prerank,monocarboxylic acid metabolic process (GO:0032787),0.33421516915770005,1.1611395675220855,0.2020460358056266,0.8728865660061882,1.0,21/117,11.81%,GGT5;ADH1A;PPARA;SLC6A8;ACSF2;PPARD;MCCC1;KYNU;ACADSB;GRHPR;MTHFD1L;ABAT;ECHDC3;PER2;PDHX;FA2H;CKM;HOGA1;GAMT;ACOT7;SGPL1
prerank,regulation of cation channel activity (GO:2001257),0.3494327297126284,1.161110941613822,0.23872679045092837,0.8716363038722534,1.0,20/89,11.17%,KCNS2;GRIA3;CACNG3;GRIN2B;GRIA4;DLG3;GRIA1;ANK3;VAMP2;DLG2;GRIN2A;KCNG1;KCNAB1;RELN;PRKACA;CACNB4;CACNG4;DLG4;FGF12;SHISA6
prerank,axon extension (GO:0048675),-0.3831540546448629,-1.1607767981918076,0.24528301886792453,0.6127506054477816,1.0,4/23,3.00%,ALCAM;SLIT2;NRP2;NRP1
prerank,sodium ion transmembrane transport (GO:0035725),0.3553640087119924,1.160680894046179,0.2453083109919571,0.8716676192712913,1.0,16/84,14.26%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;SLC9A9;ATP1A3;SLC9A1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4720008812750179,1.160008681905567,0.28865979381443296,0.8725533960173922,1.0,5/16,20.71%,VAMP2;ARL8B;VAMP7;PLEKHM2;ULBP1
prerank,calcium-mediated signaling (GO:0019722),0.3460979720780626,1.159484505516089,0.23803191489361702,0.8730322628360258,1.0,20/93,11.77%,PTGFR;ACKR2;CCR9;PDPK1;RYR2;PPP1R9A;HTR2B;LRRK2;SLC9A1;STIMATE;ATP2A2;CAMKK2;PRKACA;ADGRL1;KSR2;RCAN3;PPP3CB;GRM5;P2RX4;TRPM2
prerank,negative regulation of metabolic process (GO:0009892),0.3742858229452096,1.159339936661135,0.24895104895104894,0.8721400646213947,1.0,10/54,9.81%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4275016814350538,-1.1590234361746874,0.27403846153846156,0.6162841379030467,1.0,4/16,4.50%,DDX5;RBFOX2;PPARGC1B;NCOA4
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3748016908442285,1.1587386446565127,0.24316546762589927,0.8728989088541868,1.0,21/52,22.04%,RBFOX1;TRA2B;NOVA1;RBM24;REST;FMR1;KHDRBS3;DDX17;WTAP;CELF4;SMU1;RBFOX3;ZBTB7A;HNRNPL;RBM5;SRSF6;KHDRBS1;FXR1;SRSF12;RBM15;RBM25
prerank,positive regulation of mRNA processing (GO:0050685),0.43646679970247515,1.1584171766575964,0.29790660225442833,0.8725961769503107,1.0,5/21,11.48%,TRA2B;PRDX6;CELF4;DHX36;SNW1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.48724120157894857,-1.158222876688866,0.30275229357798167,0.6173008176753214,1.0,4/10,24.27%,HDAC6;AOC3;OXA1L;MT3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.28846838944022224,-1.1580041868794675,0.19583333333333333,0.6169173980211452,1.0,24/86,19.93%,RBPJ;THBS1;BMPR2;FOXD1;NOTCH1;TGFB2;DAB2;GIPC1;CCN1;ACVR1;ACVRL1;CITED2;SH2B1;HIPK2;CDH5;GDF11;HFE;TGFB1I1;ACVR2B;TWSG1;CSNK2B;SOX11;SDCBP;NUMA1
prerank,embryonic digestive tract development (GO:0048566),0.4590682804915844,1.157651112357963,0.2733333333333333,0.8738983624667795,1.0,2/18,2.49%,PDGFRA;SALL1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5267838848143706,1.1575961943771989,0.3162878787878788,0.8727389015978833,1.0,6/10,22.26%,CDC7;WIZ;CDT1;DBF4;SSBP1;ATRX
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.28828941972330885,-1.1575828709802396,0.16299559471365638,0.6169637555949467,1.0,32/87,20.69%,FBXL7;FHL1;KANK2;KLF4;PSMC6;PSMD9;APC;PSMF1;PSMB7;AVEN;CUL1;CDK6;PSMD8;PSMD12;FAM107A;WEE1;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;CDKN1A;PSMB10;DCUN1D3;DLG1;RBL1;PSME2;RGCC;PSMC3;RBL2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43534281191916235,1.1574528994090227,0.2797527047913447,0.871920072118081,1.0,6/23,12.56%,PPARA;PFKFB1;CBFA2T3;GCK;ERFE;GSK3A
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.33018450615733663,-1.1573564923729738,0.2084592145015106,0.6165257179302162,1.0,11/44,15.80%,ANO6;ACTN2;ATP1B3;WNK4;WNK1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4697976656505872,-1.1571686453627108,0.28725701943844495,0.6160477900559906,1.0,5/11,21.90%,RNF185;VCP;TOR1A;RNF5;UGGT1
prerank,maturation of LSU-rRNA (GO:0000470),-0.37739353493133077,-1.1571126792077986,0.23579545454545456,0.6152775400491641,1.0,11/26,27.91%,NSA2;RPL10A;NIFK;WDR12;PES1;LAS1L;RRP15;RPF2;NOP2;RSL1D1;NHP2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.371487173641232,1.1570944583181808,0.2601398601398601,0.8717916673269862,1.0,12/53,20.79%,CALCRL;HTR2B;LPAR3;HTR5A;HTR1A;NPY;HTR2C;HTR4;LHCGR;HTR6;CCL2;CHRM2
prerank,regulation of TORC1 signaling (GO:1903432),-0.3473226711140148,-1.1564476407951232,0.19940476190476192,0.6160454360278618,1.0,11/33,18.83%,RNF152;SESN1;SIK3;LAMTOR5;RRAGC;CLEC16A;PIP4P1;ATM;GPR137;SEH1L;RRAGB
prerank,positive regulation of TOR signaling (GO:0032008),-0.3389410068261346,-1.1562172091185867,0.24172185430463577,0.6157066046890112,1.0,12/40,18.83%,FNIP1;RICTOR;SIK3;LAMTOR5;RRAGC;CLEC16A;PIP4P1;HDAC3;LAMTOR3;GPR137;SEH1L;RRAGB
prerank,positive regulation of lipid storage (GO:0010884),-0.3950631644237554,-1.1561756178159723,0.26869806094182824,0.6148770535851271,1.0,4/21,6.47%,NFKB1;OSBPL11;SREBF2;SCARB1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.26427395588877256,-1.155376667242989,0.14201183431952663,0.61595637814659,1.0,47/152,18.18%,RSPO3;WNT5B;CAV1;EGFR;XIAP;NFKB1;RNF146;SMARCA4;CSNK1D;PSMC6;PSMD9;RSPO2;KANK1;SKI;GPC3;TBL1X;PSMF1;PSMB7;LGR4;SULF2;WNK1;SOX4;WLS;TNKS2;VCP;SMURF2;PSMD8;PSMD12;GID8;SFRP1;PSMA3;CSNK1G3;TERT;DKK2;PSME3;MACF1;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;PSMB10;FAM53B;HHEX;ATP6AP2;TMEM9;EGF
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4791146598560754,-1.155305134485522,0.30269058295964124,0.6151939589135305,1.0,4/10,23.13%,KLF4;TLE5;MAP2K5;SIGIRR
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.2926361949271711,-1.1541468101160217,0.17408906882591094,0.6173932041763821,1.0,20/73,14.82%,KITLG;FOXC1;PSMC6;LMO2;PRKDC;PSMD9;PSMF1;PSMB7;RUNX1;PSMD8;GATA2;PSMD12;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;TAL1;PSMB6;PSMC1
prerank,magnesium ion transport (GO:0015693),-0.46594100773661723,-1.1538533321104896,0.2857142857142857,0.6171993078684612,1.0,4/12,12.53%,SLC41A1;NIPAL2;MRS2;CNNM4
prerank,regulation of protein phosphorylation (GO:0001932),-0.2498995455907431,-1.1533793753679795,0.08791208791208792,0.6175051294385824,1.0,42/256,8.04%,PLCE1;FN1;ROCK2;TEK;LEPR;OCLN;PECAM1;SLIT2;BMPER;KRAS;FNIP1;EGFR;PLPP3;FER;APP;LIMCH1;CSNK1D;SIRPA;KDR;IGFBP3;PRKDC;NIBAN1;INSR;CCND2;FAS;VEGFD;DAB2;MAVS;RAC1;VEGFC;TFRC;PDGFA;EFNA5;CARD14;TBX1;CCN1;PRR5L;FGF1;XDH;FNIP2;RALBP1;LRP6
prerank,endothelial cell proliferation (GO:0001935),-0.4165294706236706,-1.1529437859341651,0.2535885167464115,0.6177325038847076,1.0,6/17,8.29%,TEK;BMPER;BMPR2;CD34;ACVRL1;ITGB1BP1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3311206943022327,-1.1528601978353077,0.23163841807909605,0.6170026355543703,1.0,19/38,29.56%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;RHNO1;BMI1;YAF2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5120570334002778,1.152460483533928,0.2898032200357782,0.8865164879338105,1.0,7/11,23.80%,MBTPS2;TP53;CREB3L1;HSPA5;ATF6B;DDIT3;ATF4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3509541403622903,1.152266052578901,0.25,0.8858400569061232,1.0,16/80,13.98%,FANCI;PRICKLE1;MYCBP2;LRRK2;PSMD10;PINK1;COMMD1;TSPYL5;BIRC2;NDFIP2;GSK3A;SPRTN;DCUN1D5;PTTG1IP;AXIN1;UBE2D1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.48838745334395234,1.152022428504463,0.28942807625649913,0.8852822750955766,1.0,4/13,16.65%,PRICKLE1;TBX3;SOX9;SRA1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5054843385816418,1.1517713576960686,0.3111888111888112,0.8821357675743453,1.0,4/11,21.65%,COASY;ACOT7;PANK2;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5054843385816418,1.1517713576960686,0.3111888111888112,0.8821357675743453,1.0,4/11,21.65%,COASY;ACOT7;PANK2;SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.5054843385816418,1.1517713576960686,0.3111888111888112,0.8821357675743453,1.0,4/11,21.65%,COASY;ACOT7;PANK2;SLC25A16
prerank,acylglycerol metabolic process (GO:0006639),-0.3348547463325965,-1.1507606757969964,0.18154761904761904,0.6213247790657722,1.0,10/37,14.23%,CAV1;DGKH;MGLL;PGS1;APOE;DGKG;ABHD2;LMF1;DGKZ;PLAAT3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.45323291440729674,1.1507283211651302,0.3003246753246753,0.8845185255749876,1.0,3/20,2.73%,NR2F2;PTEN;CDKN2A
prerank,cellular response to virus (GO:0098586),0.4111566565917721,1.1504341554693387,0.2800658978583196,0.8841903934917527,1.0,9/30,20.06%,CXCL10;GBF1;FMR1;IL12A;MAPK11;LGALS9;RRP1B;HIF1A;GSDME
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.40364081981448185,-1.1503135085584795,0.2725060827250608,0.6215692924334709,1.0,8/20,13.67%,BCL2L1;MCL1;FAS;CASP2;GSK3B;CASP3;BAX;BOK
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.44251406244275826,1.1498461037878642,0.3010033444816054,0.8849746895129439,1.0,7/20,21.43%,EPAS1;PINK1;DAXX;TGFBR1;DCUN1D5;HIF1A;ZMIZ1
prerank,regulation of microtubule polymerization (GO:0031113),-0.3350179405368746,-1.1495479741119519,0.2551928783382789,0.6226442397138979,1.0,13/40,21.10%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;CDH5;MET;CDK5RAP2;EML2;CAMSAP2;NUMA1;FES
prerank,neuropeptide signaling pathway (GO:0007218),0.3673437765011849,1.149387152163589,0.269774011299435,0.8852222889216076,1.0,11/58,16.10%,RXFP3;SORCS3;PDYN;SORL1;NPY;GLRA3;GLRA1;GLRA2;NMU;GLRB;GPR37
prerank,protein localization to cilium (GO:0061512),0.4120296407531808,1.149334078992231,0.26574500768049153,0.884068482750812,1.0,7/32,10.88%,ODAD4;WDR35;TUB;ZNF423;RAB29;TTC21B;TCTN2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5189784419578616,1.149303961305021,0.29225352112676056,0.8828322296870579,1.0,2/11,8.71%,MERTK;AXL
prerank,epithelial tube morphogenesis (GO:0060562),-0.3495599275791477,-1.1491968487521345,0.2628398791540785,0.62262589716404,1.0,9/32,8.16%,MEF2C;SLIT2;PODXL;RASIP1;MEGF8;GLI2;SOX17;ACVR1;ACVRL1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3384157201020842,-1.149183139128163,0.2268370607028754,0.6217441672687353,1.0,11/37,16.09%,PHLDB2;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;MAPRE2;CYLD;BICD2;PRKAA1
prerank,homologous chromosome segregation (GO:0045143),0.44610376652182626,1.1491274412881454,0.2979397781299525,0.8821514097035019,1.0,4/20,12.44%,SGO1;MEIKIN;ZCWPW1;CENPC
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.41373696359406936,-1.1487350281292472,0.2753623188405797,0.6219884246112013,1.0,3/18,4.60%,IGF1;IL18;IGFBP2
prerank,cellular response to amyloid-beta (GO:1904646),0.39843141081369476,1.148726440183462,0.27835051546391754,0.882142132802069,1.0,11/35,11.33%,LRP1;GJA1;NGFR;CASP4;ATP1A3;TLR6;GRIN2A;LGMN;TLR4;GRM5;FYN
prerank,regulation of intracellular protein transport (GO:0033157),-0.3500533945377987,-1.1487089804681776,0.24293785310734464,0.6211248585883445,1.0,10/32,17.04%,PTPN14;RUFY3;NDEL1;PRR5L;IFI27;CEP290;PTPN1;OAZ1;BCAS3;OAZ2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.391352913715681,1.148461620683305,0.26785714285714285,0.8816775703084568,1.0,11/43,12.86%,ENPP1;OGT;PIP4K2A;IRS1;SORL1;RPS6KB1;PRKCB;TNS2;ERFE;GSK3A;IGF2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5184636201777452,1.1481437801975607,0.328719723183391,0.8814220051503638,1.0,3/10,10.93%,CPEB1;NUDT21;DHX36
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3198080872655545,-1.1478906556156343,0.21221864951768488,0.6224183053361361,1.0,12/46,10.14%,MAP3K1;PIEZO2;CASP8AP2;F11R;NFKB1;FAS;CRADD;CASP2;MAP2K4;BAD;CASP8;IRF1
prerank,dendritic spine organization (GO:0097061),0.428444430845391,1.1476239314369372,0.28100470957613816,0.8818455083616208,1.0,7/26,11.33%,DOCK10;PTEN;EPHB1;ITGA3;LGMN;DLG4;FYN
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5073767581403922,1.1472743225281112,0.3067375886524823,0.881748970568816,1.0,4/11,18.00%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,steroid metabolic process (GO:0008202),0.35238786067051997,1.1470552758103714,0.24764468371467024,0.8811281763930537,1.0,2/72,0.26%,HSD11B1;CYP7B1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.45455218771181616,-1.1468204636772903,0.31567328918322296,0.6242170855475141,1.0,5/12,15.51%,CYP26B1;DHRS3;KLF2;TRIM16;EZH2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3487635634564324,1.1461307024041307,0.2506775067750677,0.8829987393817669,1.0,15/72,14.82%,COPS3;ERCC1;ISY1;LIG3;POLK;ERCC5;RPA1;ERCC4;UVSSA;RFC3;GTF2H3;XRCC1;COPS4;ERCC2;GTF2H1
prerank,water transport (GO:0006833),-0.4479932868064987,-1.1460405422097035,0.28054298642533937,0.6253150938642662,1.0,8/12,55.14%,PDPN;CFTR;AQP11;AQP1;AQP9;AQP6;AQP7;SLC5A1
prerank,endocrine system development (GO:0035270),-0.3849490861590402,-1.1460117479035423,0.24937655860349128,0.6244716605795868,1.0,9/21,18.52%,DKK3;WNT4;SIX1;GLI2;TBX1;MDK;STRA6;HOXD3;WNT11
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.4571127539970218,-1.1459475318272327,0.3056179775280899,0.6236796000905085,1.0,7/12,36.09%,GCLC;BDH2;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,regulation of inflammatory response (GO:0050727),0.310630474737041,1.1457428721927878,0.21371428571428572,0.8829765621126958,1.0,26/190,12.78%,RORA;IL33;XCL1;PPARA;NR1H4;WNT5A;IL16;TSLP;TNFAIP8L2;PPARD;VAMP2;CASP4;ADAMTS12;BCL6;PTGES;ENPP3;PLA2G7;LRFN5;CD200R1;TLR4;BIRC2;PTGIS;CASP12;PDCD4;AREL1;FNDC4
prerank,positive regulation of translational initiation (GO:0045948),0.4572275541728649,1.1452065634329578,0.30201342281879195,0.8835118212401307,1.0,8/18,24.50%,BOLL;RPS6KB1;MTOR;HABP4;KHDRBS1;YTHDF1;EIF2B5;POLR2D
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.40403407018651893,1.1448376504978879,0.2987987987987988,0.8835240586982248,1.0,16/34,23.01%,PTPRT;PTPRQ;DUSP1;PTPN22;DUSP22;PTPN13;PTPRO;TNS2;UBASH3B;DUSP8;PTPN18;PTPN11;DUSP6;PTPRZ1;DUSP10;DUSP7
prerank,cellular response to hypoxia (GO:0071456),0.3282861778425194,1.144408303472194,0.23587223587223588,0.8836661014375451,1.0,35/126,18.78%,RORA;CPEB1;HIF1AN;PSMD1;TBL2;EPAS1;PSMD10;EGLN2;HP1BP3;PSMA5;PSMB5;MDM4;TWIST1;PINK1;AK4;MTOR;BMP7;PSMC4;PSMA4;KCND2;TP53;PSMC5;PTGIS;FAM162A;PSMB9;SCN2A;MYC;PSMD14;PSMA7;ADAM8;SUV39H2;ARNT;PSMD11;PSMA2;HIF1A
prerank,positive regulation of MAPK cascade (GO:0043410),0.3089569760765116,1.1441564601814038,0.21541950113378686,0.8832541203456461,1.0,34/245,11.00%,ROR1;PDGFRA;IL34;NTRK3;ROR2;XCL1;EDN3;SLC30A10;NTRK2;CD40;ERBB4;C5AR1;FGFR1;P2RY1;GPR37L1;GCNT2;HTR2B;PTPN22;LRRK2;CCL15;GLIPR2;NECAB2;GPR183;SOX2;PRKCA;HTR2C;TENM1;MAP2K1;LPAR1;IRAK1;IAPP;EIF2AK2;CCL25;PYCARD
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3135586462326383,1.1440846740249495,0.2140391254315305,0.8822038296781728,1.0,27/199,10.00%,TBX18;PLCL1;HOXC10;NR1H4;SPRY1;ALDH1A1;PTEN;PTPRR;NOVA1;MCC;GJA1;SPRED1;NR1H2;LOXL2;ZNF423;IL17RD;TRPV3;SPX;DOCK7;SRF;RPS6KA6;PTPRO;SPRED2;CIDEA;TLR4;NRDC;BRCA2
prerank,atrioventricular valve development (GO:0003171),-0.4351055386509328,-1.1440834997701939,0.2725,0.6274273072491098,1.0,7/14,22.41%,BMPR2;NOTCH1;TGFB2;ACVR1;HEYL;TGFBR2;APLNR
prerank,cellular defense response (GO:0006968),0.3915908837002479,1.1437748252007842,0.275177304964539,0.8819412882752597,1.0,5/40,5.75%,ADORA2B;CLEC5A;C5AR1;CCR9;ADORA2A
prerank,regulation of macrophage activation (GO:0043030),0.4090231541672884,1.1436984746877001,0.2641509433962264,0.8809115066589752,1.0,5/30,9.69%,IL33;WNT5A;TLR6;LRFN5;TLR4
prerank,nucleoside catabolic process (GO:0009164),-0.4645687925648884,-1.1436553679656336,0.2887323943661972,0.6275375714940458,1.0,4/11,10.38%,UPP2;DERA;UPB1;NT5E
prerank,regulation of cell aging (GO:0090342),-0.46444574538862027,-1.1434184360170994,0.3010989010989011,0.6272095222493299,1.0,6/11,26.46%,NEK6;LMNA;VASH1;MIF;PNPT1;RSL1D1
prerank,negative regulation of wound healing (GO:0061045),-0.36048462567886447,-1.1428786530072976,0.24802110817941952,0.627793124050561,1.0,9/28,15.14%,PHLDB2;THBD;VTN;CD34;CD109;APOE;SERPINE1;EDN1;SERPINE2
prerank,epithelial cell differentiation (GO:0030855),0.3438874240815981,1.1428032123283314,0.24621212121212122,0.8825875343281621,1.0,9/88,9.20%,SCUBE1;HDAC1;BASP1;ERBB4;SCRIB;CASP6;E2F4;GLI1;EDF1
prerank,establishment of protein localization to membrane (GO:0090150),-0.29510118656963513,-1.1426831230519066,0.21140939597315436,0.6273021224749773,1.0,14/66,12.53%,SYNE3;EGFR;AFDN;VPS37A;PARD3;NACA;ZDHHC21;VPS37B;ARL6;FRMPD1;MYO1C;RAB3IP;BID;ZDHHC14
prerank,regulation of keratinocyte proliferation (GO:0010837),0.42827307603036163,1.1426302442070433,0.2864321608040201,0.8818828599819541,1.0,7/22,17.55%,CASK;CDH3;PRKD1;MED1;AREG;FGFR2;SRSF6
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3938442203546413,-1.142251277811802,0.2917771883289125,0.6274603759495574,1.0,7/21,16.20%,MEF2C;CXADR;SIK1;ACVR1;MYH11;CBY1;MYOCD
prerank,regulation of cytoskeleton organization (GO:0051493),-0.2745178810375072,-1.1419286911585063,0.17061611374407584,0.6274371863978793,1.0,25/108,8.91%,PHLDB2;CLIC4;TJP1;RHOBTB1;ROCK2;SORBS3;EZR;DIAPH1;F11R;RICTOR;HIP1R;IQGAP1;RHOQ;RHOBTB2;PRKAA2;RAC1;ARHGAP17;PDGFA;EFNA5;GSK3B;RHOC;MAPT;TRIM36;ARHGAP18;PLXNB1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.4443791097423405,-1.1419102710082685,0.2907488986784141,0.626582054822483,1.0,5/12,24.58%,TNKS2;PARP10;PARP2;PARP1;PARP12
prerank,gland development (GO:0048732),-0.3086737391507062,-1.1415938742851441,0.20863309352517986,0.6264387203520404,1.0,20/59,18.86%,DKK3;CAV1;EZR;ARID5B;WNT4;ANXA1;COBL;SIX1;GLI2;TBX1;LSR;CITED2;MDK;STRA6;MET;TGFBR3;HOXD3;WNT11;EPHB3;MSN
prerank,sarcomere organization (GO:0045214),-0.3639228314196706,-1.141493654896438,0.2452316076294278,0.6257837781374773,1.0,16/27,43.23%,ACTN2;TPM1;CSRP2;TNNT3;SIX4;MYOM2;KRT19;TTN;CASQ1;MYPN;MYLK3;TCAP;OBSCN;MYH6;CSRP1;SYNPO2L
prerank,sensory perception of light stimulus (GO:0050953),0.3367649383831171,1.1413721103899848,0.2402088772845953,0.8848299545192038,1.0,7/87,3.85%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3679602729818657,1.1411436365488292,0.27155172413793105,0.8843255291425728,1.0,9/52,6.00%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2946783836710333,-1.1411042754246623,0.2084942084942085,0.6258148228438756,1.0,24/72,22.53%,SLIT2;SHANK3;KANK3;HIP1R;ATXN7;HSPA8;KANK1;APC;CRYAB;SHANK1;APOE;SSH1;APC2;ARPIN;CDH5;LIMA1;PRKCD;EML2;CAMSAP2;CHADL;CIB1;TWF2;KATNB1;PFDN4
prerank,cellular response to estradiol stimulus (GO:0071392),-0.40741257632983174,-1.1410669126211679,0.28329297820823246,0.624984799218091,1.0,8/18,21.43%,EGFR;LCOR;SFRP1;KAT5;GPER1;ESR1;CCDC62;RUVBL2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3334378612927883,-1.1409543813915262,0.24157303370786518,0.62431527238267,1.0,18/36,29.56%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;BMI1;YAF2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.378416288376461,-1.140554999365592,0.2578125,0.6235027474565722,1.0,9/23,26.27%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.378416288376461,-1.140554999365592,0.2578125,0.6235027474565722,1.0,9/23,26.27%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,stem cell differentiation (GO:0048863),-0.336887506465685,-1.1404929953346208,0.22364217252396165,0.6227639758665695,1.0,7/39,10.22%,MLLT3;MEF2C;OSR1;TGFB2;ACE;LRP6;SFRP1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4695958439304674,1.1402070429556057,0.2922824302134647,0.8862046162327555,1.0,5/15,11.68%,EDA;HDAC1;ANKRD11;AMELX;MSX1
prerank,positive regulation of cytokine production (GO:0001819),0.301906134377706,1.1390955920623524,0.1891025641025641,0.888762750767112,1.0,34/292,11.00%,RORA;IL33;SULF1;XCL1;NR1H4;WNT5A;PLA2R1;GLMN;CD40;TXK;IL16;PDE4B;TSLP;LURAP1;SCRIB;SPTBN1;HTR2B;CD276;PTPN22;TLR6;SORL1;DHX58;TLR8;TWIST1;MBP;TLR4;DDX41;CYBA;KAT2A;FGR;IRAK1;EIF2AK2;DHX36;PYCARD
prerank,cellular response to cadmium ion (GO:0071276),-0.3684028610032089,-1.1388951292450495,0.2584856396866841,0.6259956801670586,1.0,16/24,32.57%,EGFR;MAPK9;MT2A;AKT1;SUMO1;MT3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;JUN;HSF1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3963187344785041,1.138866090430711,0.2914798206278027,0.8882266957747261,1.0,5/35,4.80%,DLC1;SPRY4;SPRY1;ITGA3;ARHGAP24
prerank,"wound healing, spreading of cells (GO:0044319)",-0.3684238796402973,-1.1388003818930483,0.2712765957446808,0.6253718401273969,1.0,10/24,16.87%,TMEFF2;CCN1;CD44;RHOC;ACVRL1;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.31017119489353634,-1.1385987069019692,0.22857142857142856,0.6249628724698395,1.0,23/55,28.10%,THBS1;CYP1B1;RAC1;MAPK14;XDH;RNF41;AGTR1;GRB2;CDKN1A;ACE2;SIRT5;MPV17;PID1;ROMO1;AGT;TGFBR2;SPHK2;MT3;CBR1;BRCA1;NOXO1;ARF4;GADD45A
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4051170315693222,1.1384457335184661,0.28180354267310787,0.8883555984918092,1.0,10/32,23.49%,LPIN3;CHAT;CHKA;STARD10;CSNK2A2;LPIN2;SLC44A1;PCYT1A;ABHD3;SLC44A5
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.37756566742511277,-1.1383584972940348,0.2493573264781491,0.6247010307533988,1.0,6/21,15.97%,SNTA1;ANK2;KCNQ1;FLNA;NOS1AP;SCN4B
prerank,regulation of neuron projection arborization (GO:0150011),0.4768544309319366,1.1379791085507551,0.30236486486486486,0.8885733011886938,1.0,8/15,20.39%,WNT5A;GRIP1;DLG4;NTNG2;NTNG1;DVL3;DVL2;MAP3K13
prerank,neutrophil activation (GO:0042119),0.5028098218989012,1.1379571060120257,0.31494661921708184,0.8873580217980788,1.0,2/12,12.87%,KMT2E;PREX1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5026197298105856,1.1379542641275515,0.32342657342657344,0.8860814781640751,1.0,5/13,15.16%,WNT5A;TSLP;AXL;TRIM44;DHX9
prerank,chromatin assembly (GO:0031497),0.3897953405020912,1.137890047830164,0.28315946348733234,0.8850217141065309,1.0,10/38,12.20%,NAP1L3;ASF1A;CHAF1B;NOC2L;SPTY2D1;DAXX;TP53;NAP1L1;POLE3;SOX9
prerank,mRNA splice site selection (GO:0006376),0.40422676937790863,1.1377273596089217,0.2852807283763278,0.8842309868493726,1.0,13/30,23.13%,ISY1;NOL3;CELF4;SLU7;LUC7L2;SRSF10;SRSF9;SF3A3;SRSF6;PRPF39;LUC7L3;SRSF12;CELF6
prerank,sterol metabolic process (GO:0016125),-0.3032793986168467,-1.1376533681199528,0.21323529411764705,0.6256568083236572,1.0,20/60,21.54%,PRKAG2;CYP26B1;LBR;CYP39A1;FDX1;CYP1B1;RXRA;LIPA;APOE;PIP4P1;SOAT1;PMVK;FDXR;CYP51A1;INSIG1;CLN8;OSBPL1A;INSIG2;EBP;TSKU
prerank,sphingolipid metabolic process (GO:0006665),-0.2716931413559095,-1.1375815450512485,0.18584070796460178,0.6249791597339145,1.0,36/108,22.19%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;SMPD3;ACER3;CERT1;SGMS2;PPP2R1A;DEGS2;SPNS2;VAPA;ST6GALNAC3;VAPB;HEXB;ENPP2;ELOVL4;UGCG;ELOVL7;B3GALNT1;ESYT3;KDSR;SMPD1;SPTSSA;GM2A;CLN8;ARSA;ORMDL2;GLTP;PSAP;CERS2;SPHK2;CERKL
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3494911574071824,-1.137483515539846,0.24629080118694363,0.6242981945026737,1.0,11/32,16.06%,DDX5;PPP1R13B;JMY;HIPK1;DYRK2;MYBBP1A;HIPK2;BOK;HINT1;SIRT1;TMEM109
prerank,regulation of phospholipid metabolic process (GO:1903725),0.5122763650185502,1.1374669389777785,0.31607142857142856,0.8838864615238453,1.0,3/10,6.29%,DNAJC19;MTMR4;MTMR1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.392808869947071,1.1356735334189443,0.2916053019145803,0.8886451189172532,1.0,10/37,17.22%,ENTPD2;RNASEH2C;ENTPD5;MTREX;NUDT9;RNASEH2B;ENTPD7;HNRNPD;RNASEH1;PPP1R8
prerank,positive regulation of phosphorylation (GO:0042327),0.3037903684745434,1.1352050916819463,0.2022346368715084,0.8889976764442724,1.0,23/240,6.00%,ROR1;PDGFRA;IL34;NTRK3;EPHA7;ROR2;ZBTB20;MERTK;NTRK2;GLMN;CD40;ERBB4;EPHB1;PFKFB1;FGFR1;P2RY1;ENTPD5;FMR1;EPHA6;LRRK2;DSCAM;CAMKK2;CLIP3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3862086510049926,-1.1351507307683217,0.26735218508997427,0.6292963211372995,1.0,14/20,38.04%,SLC8A3;MICU1;MCUB;SMDT1;YME1L1;MCUR1;LETM1;MCU;SLC8B1;MICU2;PMPCB;SLC25A23;STOML2;SPG7
prerank,regulation of oxidative phosphorylation (GO:0002082),0.46291315458174986,1.1351068256658081,0.31810490693739424,0.8880634823747938,1.0,6/16,14.84%,PDE12;PINK1;AK4;SLC25A33;ATP7A;COX7A2L
prerank,endochondral bone morphogenesis (GO:0060350),0.5205500983698753,1.1345020023185672,0.34210526315789475,0.8888245474488323,1.0,1/11,0.07%,COL13A1
prerank,protein heterotetramerization (GO:0051290),0.47764578372239586,1.1333187169132932,0.31951640759930916,0.8914619496207615,1.0,3/13,10.14%,GRIN2B;HSD17B8;NUDT21
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2940034090612653,-1.1332390458906512,0.22580645161290322,0.6335102492693684,1.0,34/73,29.12%,ACTB;PPHLN1;HDAC4;DDX21;SF3B1;PRMT7;WBP2;GPX1;PPM1D;SMARCA5;MYO1C;MYBBP1A;POLR2H;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;POLR1H;TAF1C;CTCF;POLR1G;HDAC6;POLR1C;SPHK2;MTF2;PHF2;PHF1;CGGBP1;SPI1;ZFP57;POLR2K;BMI1;HDAC5
prerank,monocyte chemotaxis (GO:0002548),0.4031323285582249,1.1328174950353136,0.28134556574923547,0.8919087803123641,1.0,6/32,10.64%,XCL1;MSMP;CCL15;CALCA;PTPRO;CCL25
prerank,response to retinoic acid (GO:0032526),-0.2946800690789213,-1.1327204926434387,0.19572953736654805,0.6339585307452883,1.0,16/59,15.06%,WNT5B;ACER2;WNT9A;RBP4;FZD4;RXRA;FZD7;TBX1;WNT6;TRIM16;CTSH;RET;PTK2B;ATM;GATA6;CREB1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.4152786813927636,-1.13242028713272,0.3176178660049628,0.6337979372579267,1.0,7/16,10.83%,PDGFD;PTPRJ;FER;NRP1;PDGFA;PDGFC;PTPN1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4460097913197449,-1.132292596217602,0.30260047281323876,0.6332275112651752,1.0,4/11,17.49%,FOXO1;NOTCH1;LMNA;GLRX3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.5040362357645236,1.1322057765353213,0.3293718166383701,0.8927324731018157,1.0,3/11,5.14%,GHR;PIK3R1;IRS1
prerank,cartilage development (GO:0051216),-0.3075304741597207,-1.132153505414361,0.24468085106382978,0.6327021023695238,1.0,10/49,7.29%,NFIB;SOX5;MEF2C;ITGB8;WNT5B;OSR1;CCN3;RUNX1;SULF2;CD44
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.233729624353764,-1.1320459678771264,0.0958904109589041,0.632081098690564,1.0,106/341,23.23%,FBXL7;WWP1;NPLOC4;VPS37A;RNF146;UBE2G1;ASB2;PSMC6;RNF185;RNF43;SQSTM1;PELI1;WWP2;PSMD9;ARIH1;CDC23;UBE2D3;TBL1X;PSMF1;PSMB7;TRIM25;TRIP12;ANAPC10;PTTG1;TOLLIP;VPS37B;IFI27;UBE2H;VCP;RNF8;PCBP2;MIB1;UBA6;SMURF2;PSMD8;RC3H1;KCTD21;FBXL19;UBE2A;RNF125;PSMD12;RNF144B;GID8;KLHL20;RNF11;SPSB4;RNF114;RCHY1;KCTD6;PSMA3;FBXL4;PSME3;UBE3D;PSMA6;AMFR;PSMD4;PSMD7;ELOC;KAT5;PSMB6;PSMC1;UCHL1;SIAH3;SIRT1;HECTD3;UBE2L6;PSMB10;FBXL14;ANAPC16;NEDD8;CUL3;ANAPC15;CLOCK;TGFB1I1;SIAH2;BUB3;PPP1R11;ANAPC11;RAD23B;ANKIB1;USP9X;CHFR;PSME2;WDR91;KLHL25;KLHL3;KCTD2;PSMC3;CDC34;FZR1;RNF166;KBTBD7;RNF5;VPS28;MAEA;MVB12B;RFFL;ANAPC2;TNFAIP1;ZFAND2B;TNFAIP3;FBXO22;ADRM1;RLIM;PSMA8;FBXO10
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.4400598441638628,-1.1318938622383499,0.3142857142857143,0.6315207080972103,1.0,3/13,6.39%,DDO;ACOT8;GOT2
prerank,sensory organ development (GO:0007423),0.3757456761246955,1.1315392895989407,0.28487518355359764,0.8938238894805481,1.0,6/51,5.83%,CHD7;ECE1;MEIS1;MYO7A;MEIS2;SIPA1L3
prerank,positive regulation of telomere capping (GO:1904355),-0.40419729025926565,-1.131442537297864,0.3071253071253071,0.6317588292832166,1.0,5/17,14.08%,TNKS2;NEK7;MAP2K7;RTEL1;MAP3K4
prerank,negative regulation by host of viral transcription (GO:0043922),0.4949300593401921,1.1303251922757531,0.30236486486486486,0.8967300850780656,1.0,2/12,4.38%,HDAC1;REST
prerank,histone deacetylation (GO:0016575),0.3798484343169187,1.1300017740929955,0.2944693572496263,0.8965858974230205,1.0,8/43,8.16%,MIER2;HDAC1;MORF4L1;REST;SIRT6;BRMS1L;BRMS1;PER2
prerank,regulation of protein kinase activity (GO:0045859),-0.2718331212941232,-1.1299119650717526,0.19369369369369369,0.6348100930159983,1.0,30/106,18.42%,PRKAG2;PLCE1;RAPGEF2;PPM1E;TRIB2;DEPTOR;IQGAP1;RAP1A;UVRAG;DVL1;CEP85;PPM1F;CCN1;LRP6;ITGB1BP1;YWHAG;HSPB1;CEACAM1;TAB2;ALS2;PTK2B;PPIA;RAP2C;CDKN1A;SIRT1;PAK2;TRIM27;RAP2B;AKT1;LCP2
prerank,autonomic nervous system development (GO:0048483),-0.4100868681108088,-1.1295305035733099,0.2810126582278481,0.6349136301190336,1.0,4/17,10.03%,FN1;NRP1;SOX4;PHACTR4
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.44813783633862925,1.1287783343686688,0.30267558528428096,0.8994824207620459,1.0,7/18,18.20%,COLGALT1;FSCN1;CARMIL2;IER3IP1;CLASP2;CLASP1;BMP2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.28731820355278687,-1.1283410737186481,0.20357142857142857,0.6370911835995039,1.0,28/71,23.19%,CTSC;DDI2;UBB;VCP;NGLY1;CASP8;CTSO;RNF41;CTSH;CLPX;PSMA6;CTSZ;YME1L1;NEDD8;UBC;ISG15;CTSS;CHMP4B;USP9X;CHFR;CLPP;PDCD6IP;HDAC6;PRPF19;UBA52;TNFAIP3;CHMP4C;PSMA8
prerank,positive regulation of macrophage migration (GO:1905523),0.4409224508512781,1.1282203075336905,0.288961038961039,0.9001279311110875,1.0,7/19,21.30%,IL34;PTK2;P2RX4;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,regulation of actin filament polymerization (GO:0030833),-0.2914123568420411,-1.1280262140344413,0.2217741935483871,0.6369780746872755,1.0,17/69,15.64%,BAIAP2L1;SLIT2;FER;ESAM;KANK3;HIP1R;KANK1;NCK1;ARHGAP18;SSH1;ARHGAP28;COTL1;LMOD1;PTK2B;PLEKHG2;BAIAP2;PRKCD
prerank,activation of protein kinase B activity (GO:0032148),0.40566823981850697,1.1276265909225036,0.2961832061068702,0.9009888749227822,1.0,7/29,9.21%,NTRK3;NRG1;WNT5A;PDPK1;PRR5;PINK1;MTOR
prerank,nuclear membrane organization (GO:0071763),-0.39718705389076325,-1.127025119458098,0.2608695652173913,0.6386694238232127,1.0,12/19,37.87%,TARDBP;TOR1A;GPER1;CHMP7;CHMP4B;TOR1AIP1;EMD;CHMP2A;UBXN2A;NSFL1C;VPS4A;PLK1
prerank,carbohydrate transport (GO:0008643),-0.4660895359554929,-1.1268959914160177,0.3211845102505695,0.6381138761008162,1.0,9/11,46.57%,SLC26A6;AQP11;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC50A1;SLC2A5;AQP9
prerank,B cell receptor signaling pathway (GO:0050853),-0.34274758370400904,-1.126101971116236,0.2753623188405797,0.639162124912779,1.0,9/32,18.32%,MEF2C;CD38;BMX;PIK3CD;BAX;PLCG2;SH2B2;TEC;BLNK
prerank,cyclooxygenase pathway (GO:0019371),-0.4797818958609954,-1.1257457295113438,0.3154034229828851,0.6392501787546868,1.0,3/10,3.04%,PTGDS;PTGS1;PTGES3
prerank,regulation of myelination (GO:0031641),0.4236151323019633,1.1255851859009762,0.3228346456692913,0.906730680991412,1.0,5/25,13.25%,PTN;TENM4;TNFRSF21;LGI4;MYRF
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.31305267816779314,-1.125102939603361,0.25846153846153846,0.6401129797017433,1.0,18/47,25.39%,FOXO1;EGFR;IGF1R;ARL6IP5;FAS;TGFB2;MAPK8IP3;MAP2K2;PPIA;STK25;MAPK8IP1;PER1;TGFBR3;QARS1;TAOK2;NOD2;MID1;GREM1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.40654266739415057,1.1249656092558662,0.2839313572542902,0.9076256887172895,1.0,8/29,11.29%,AGO4;SPOUT1;ZC3H7B;LIN28B;HNRNPA2B1;MRPL44;SRRT;AGO3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4118073011584661,-1.1249646502643669,0.3002481389578164,0.6395551056059471,1.0,5/16,26.82%,CLDN5;CLDN12;CLDN11;CLDN10;CLDN1
prerank,mitochondrial protein processing (GO:0034982),0.5007517174536747,1.1248873960030064,0.33515482695810567,0.9066118974491714,1.0,4/11,17.78%,OMA1;IMMP2L;PMPCA;IMMP1L
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4534832577703626,1.1244517873865845,0.3230240549828179,0.9068675533997488,1.0,8/17,24.75%,CTNNA2;FCHSD2;WASF3;ARFIP1;CYFIP1;GMFB;ABI2;ARFIP2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4040040447323858,-1.1242102715779911,0.30843373493975906,0.6406908573412955,1.0,4/16,4.25%,IGF1;MEF2C;RBPJ;NOTCH1
prerank,eye morphogenesis (GO:0048592),0.4571281996675127,1.1240036591948768,0.32901134521880065,0.9071249567449879,1.0,3/19,5.46%,TENM3;NKD1;NF1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.26806604190166267,-1.123820433876569,0.18357487922705315,0.6408086010283002,1.0,27/112,14.24%,SMAD6;SOX5;ARHGEF18;MEF2C;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;WNT4;TGFB2;WWOX;SKI;UBB;PDE3A;ACVR1;ACVRL1;SMAD3;LRRC32;ZYX;SFRP1;PRKCZ;NR3C1;SMAD1;CDH5;FURIN
prerank,negative regulation of protein transport (GO:0051224),-0.3655086341450785,-1.123702711603218,0.29873417721518986,0.6402469887811644,1.0,7/25,18.88%,WWP2;PPM1F;PKDCC;APOE;RHBDF2;CYP51A1;SNX3
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3935291353243556,-1.1234277399965322,0.29658792650918636,0.6400530990138557,1.0,4/18,4.12%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,response to amyloid-beta (GO:1904645),0.372188725336021,1.123364827118379,0.2813411078717201,0.9080205455867056,1.0,11/44,11.33%,LRP1;GJA1;NGFR;CASP4;ATP1A3;TLR6;GRIN2A;LGMN;TLR4;GRM5;FYN
prerank,central nervous system neuron differentiation (GO:0021953),0.40029836862039203,1.123362108187947,0.29256965944272445,0.9067574133087856,1.0,16/33,28.28%,NTRK2;GRID2;MDGA2;NPY;OPHN1;CBLN1;ATP7A;SPOCK1;TOX;ZC4H2;FAIM2;CTNNB1;AGTPBP1;PROX1;KNDC1;GBA2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4489995903018112,1.1233559333904917,0.32040472175379425,0.9055113177826257,1.0,5/17,15.47%,ATP1A2;ATP1A3;BMP7;MED1;AR
prerank,purine nucleotide catabolic process (GO:0006195),-0.4271491216715594,-1.1230049297429396,0.3225806451612903,0.6402914305295859,1.0,6/13,20.08%,XDH;GPX1;NT5E;HINT1;GDA;NT5C1A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3965249989824483,-1.1228623983682702,0.2956730769230769,0.639729474433836,1.0,6/17,19.51%,IL18;CD55;BACH2;GNL1;BTN3A3;CD46
prerank,glucan catabolic process (GO:0009251),-0.4239021024403792,-1.1228485376445965,0.33002481389578164,0.6388770041228056,1.0,5/15,11.51%,PYGB;PGM2L1;CALM1;GAA;PGM2
prerank,cell differentiation in spinal cord (GO:0021515),0.5056207355024526,1.122844882591182,0.31746031746031744,0.9060315151370683,1.0,2/10,4.62%,MDGA2;SOX6
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2830606478855516,-1.1227616475962465,0.1946564885496183,0.6382224432956457,1.0,29/74,23.19%,RBPJ;PSMC6;PSMD9;NOTCH1;EGLN3;HIF3A;PSMF1;PSMB7;UBB;PSMD8;CITED2;PSMD12;VHL;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;ELOC;PSMB6;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;STOX1;PSMA8
prerank,positive regulation of cell cycle process (GO:0090068),0.33512872040999775,1.1223115328687063,0.2532808398950131,0.9065502614528653,1.0,14/91,13.52%,SVIL;CDC14B;RXFP3;EDN3;PHIP;FEN1;CDC7;CEP295;GPSM2;WIZ;NUSAP1;USP19;IGF2;DBF4
prerank,protein import into peroxisome membrane (GO:0045046),0.4353114721388195,1.1222720541889832,0.3093645484949833,0.9054343521946161,1.0,10/22,22.95%,ABCD2;PEX2;SLC25A17;PEX19;PEX12;ALDH3A2;PEX3;PEX14;GDAP1;FIS1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.46793639392816455,-1.1221719141329338,0.30839002267573695,0.6387835443711407,1.0,5/10,19.38%,ABCA3;APOE;ABCB4;PRELID1;DBI
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4550122209486886,1.122131531053948,0.3311367380560132,0.9033642163334381,1.0,4/17,6.34%,TSLP;JAK1;IRS1;IRS2
prerank,cellular response to interleukin-7 (GO:0098761),0.4550122209486886,1.122131531053948,0.3311367380560132,0.9033642163334381,1.0,4/17,6.34%,TSLP;JAK1;IRS1;IRS2
prerank,regulation of wound healing (GO:0061041),-0.32496960346204573,-1.1219366004851998,0.27522935779816515,0.6384890188849942,1.0,9/42,5.48%,CAV1;OCLN;MYLK;ITGB1;ACTG1;KANK1;VTN;ANXA1;CD109
prerank,response to cadmium ion (GO:0046686),-0.35300916223926954,-1.120787925955422,0.2853333333333333,0.6405979076478335,1.0,16/26,32.57%,EGFR;MAPK9;MT2A;AKT1;SUMO1;MT3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;JUN;HSF1
prerank,focal adhesion assembly (GO:0048041),-0.38354551834515993,-1.12014822824429,0.3032581453634085,0.6414183708762236,1.0,4/21,2.41%,SORBS1;ACTN2;PTPRK;THSD1
prerank,cell-cell junction assembly (GO:0007043),-0.28652019513195076,-1.1196429071367386,0.2808988764044944,0.6418498098067751,1.0,21/63,16.48%,PKP4;TJP1;VCL;ACTB;CLDN5;CDH8;ACTG1;GJB2;CTNND1;RHOC;GJC1;GJD3;GJB6;CLDN12;TRPV4;RAMP2;CDH5;CTNNA1;PAK2;PKN2;CD9
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.46846773333153346,-1.119349820240589,0.31264367816091954,0.6417249346030376,1.0,4/11,20.69%,NRP1;RAC1;HGF;MST1R
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.35756685843707836,-1.1191326122869487,0.28450704225352114,0.6413950116541458,1.0,3/26,0.63%,EPHA4;PICALM;ROCK2
prerank,cellular response to osmotic stress (GO:0071470),-0.38311860261906305,-1.1181485190428588,0.27540106951871657,0.6431354151482124,1.0,5/21,13.18%,MYLK;YBX3;LRRC8D;CAB39;TRPV4
prerank,glutamate metabolic process (GO:0006536),-0.39094012872772504,-1.1180223714150246,0.2924281984334204,0.6425779937432704,1.0,4/19,9.20%,GCLC;PRODH;GOT2;OAT
prerank,positive regulation of transport (GO:0051050),0.3381096106536669,1.117934921470696,0.2720105124835742,0.9162462424354018,1.0,14/85,11.00%,IL15RA;LRP1;MERTK;GPLD1;KMT2A;TUB;FMR1;CDH3;CLIP3;LYAR;KCTD7;CYBA;PLAA;PYCARD
prerank,regulation of gene expression (GO:0010468),-0.21953079922469282,-1.1178868949485326,0.0,0.6420686496892173,1.0,225/903,18.92%,BNC2;PRDM6;FN1;IGF1;APBB2;PICALM;SLC24A3;ROCK2;FOXP1;ERC1;MEF2C;ITGB8;DENND4A;LEF1;RBPJ;OCLN;ROBO1;LARP4;MBNL1;KRAS;AFDN;HDAC4;FOXC1;EZR;OSR1;FOXN3;NOS3;NOTCH2;PPARGC1B;CDH1;APP;AHNAK;GTF2IRD1;KLF4;NFKB1;ZNF462;GPBP1L1;KDM4A;FOXD1;KAT6B;ESRRG;CLDN5;RDX;SMARCA2;PRRX2;SIRPA;KDR;GSN;VPS35;INSR;AHNAK2;YBX3;WWP2;NOTCH1;WNT4;ACTG1;TGFB2;TDRD7;NFKBIZ;TAPBP;PRKAA2;CD34;RPL5;ASCC2;SMO;DVL1;RUNX1;NFYC;ADAM10;TFRC;SLC39A8;MAPK9;PPP2R1A;SIX1;RPS7;TRIM5;CDK6;MEGF8;PRDM2;MOG;TRIM11;AFF4;MAPK14;NOVA2;PRDM11;SOX4;NGF;CRABP2;FZD7;TRIM14;DICER1;PPM1F;IRF2;PLAG1;GSK3B;APOE;FGF1;XDH;SOX17;ANK2;HNRNPF;ACVRL1;PCBP2;MAPT;LAMTOR5;WNT6;CELF1;CRIP1;SMAD3;VSX1;GZF1;RPS6KA5;ACTR8;ATOH8;RPL11;RC3H1;CITED2;CASP8;MYBL1;PTBP3;PIK3CB;GATA2;GPX1;PIK3CD;RFX3;HMG20B;SFRP1;MYCBP;NFYA;TNRC6A;SLC7A5;PARP10;CASZ1;CCN4;PARP9;ETS1;VHL;EPHB2;UBAP2;GCFC2;TARDBP;MBNL2;CTSH;MZF1;MYBBP1A;AJUBA;FASTK;ACTA2;MAP2K2;TNRC6C;HEY2;PLCG2;PTRH2;HNRNPH1;TERT;TLE5;FUS;NR3C1;SMAD1;HNRNPDL;TMEM119;ACTR5;MSL3;ATM;RAMP2;CDH5;PTHLH;ZNF205;YBX1;HINT1;WNT16;TOB1;TICAM1;CIAO3;ZNF219;CAVIN4;P2RX7;NFYB;TRAF3;POGZ;ATXN1;MATR3;EZH2;SRRM4;SIRT1;CHD3;NOS1AP;GPER1;ZPR1;PER1;PRKAA1;MED23;ESR1;TRIM27;HAVCR2;TRRAP;HFE;DNAJA4;FAM50A;BTN3A3;CD74;NFKB2;CLOCK;SOX18;ACVR2B;AGO2;DNMT3B;OGG1;HNRNPK;SLC22A2;AKT1;ACE2;PQBP1;EGF;BHLHE40;HOXD3;CREBL2;APBB1;SOX11;EFEMP1;WNT11;IFNGR1;RBL1;MSN;AFF3
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.3336845158142095,-1.1178737638884941,0.2676470588235294,0.6412268710698901,1.0,7/35,7.73%,NR3C2;DDX5;RBFOX2;PPARGC1B;NCOA4;WBP2;TMF1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.3823942193217714,-1.117635677599908,0.3178294573643411,0.640961219679533,1.0,3/21,2.45%,IGF1;ADAMTS1;IGFBP5
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41309267115863463,1.1172376598994547,0.31280388978930307,0.9173818388788345,1.0,8/26,17.80%,ADCY5;NR1H4;GPLD1;ADCY8;PPP3CB;EPHA5;BRSK2;ADRA2A
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4573074620255736,1.1172160093927492,0.32669983416252074,0.9161797548205841,1.0,3/16,4.80%,AUTS2;OGT;ARHGAP24
prerank,positive regulation of cell death (GO:0010942),0.3572813380151154,1.1169085647217916,0.292749658002736,0.9159811654302513,1.0,13/59,15.08%,LRP1;SLC6A13;ACOX2;WNT5A;GRIN2B;FOS;LRRK2;C1QA;DAXX;FYN;EIF2S1;RIPK1;CLU
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4544523671314481,-1.1168581037653482,0.3301204819277108,0.6422316597584369,1.0,9/12,50.98%,IL18;PAEP;IL17D;RASGRP1;ISL1;CARD9;IL23A;IL12B;IL23R
prerank,embryonic organ morphogenesis (GO:0048562),0.38372928380859456,1.1168171258180901,0.2986627043090639,0.915059149233755,1.0,10/42,16.30%,PDGFRA;RYR2;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4;FBN1;FGFR2;HOXA9
prerank,receptor metabolic process (GO:0043112),-0.2978518214187487,-1.1166015198699286,0.24752475247524752,0.6420431095894003,1.0,11/53,8.55%,PICALM;CAV1;ITGB1;BECN1;UVRAG;ACKR3;TFRC;RAMP1;SNX25;DNM3;RAB31
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.46645010538834664,1.1165265633079204,0.35714285714285715,0.9147961558759344,1.0,6/15,17.80%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4731417631722141,-1.1161622306181742,0.34505494505494505,0.6422779329762484,1.0,2/10,8.55%,ANO6;RAB31
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.29571884866520304,-1.116073147269472,0.24187725631768953,0.6416163944330107,1.0,24/59,22.82%,ROCK2;PRKDC;CAMK2D;WNK1;HIPK3;HIPK1;GSK3B;ACVR1;CDC42BPB;DYRK2;HIPK2;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;CSNK2B;AKT1;SBK1;MARK2;TGFBR2;TTBK1;CAD;STK39
prerank,protein phosphorylation (GO:0006468),-0.22293824547112412,-1.11551140419805,0.06451612903225806,0.6421740460751674,1.0,120/478,19.14%,FLT1;PRKAG2;EPHA4;DAPK1;MAP3K1;ROCK2;TEK;PRKCH;ERC1;MARK1;ERG;DCLK1;EGFR;IGF1R;TRIB2;FER;APP;BMPR2;RICTOR;CSNK1D;MARK4;KDR;MAP3K5;IGFBP3;NEK6;PRKDC;INSR;CAMK2D;GTF2H5;TOP1;TGFB2;EPHB4;WNK4;MINK1;SIK3;PRKAA2;TLK1;VRK3;ADAM10;SNRK;CDK17;MAPK9;WNK1;CDK6;HIPK3;MAPK14;PRAG1;NRBP2;SIK1;BMX;HIPK1;PKDCC;GSK3B;FNIP2;ACVR1;CDC42BPB;ACVRL1;TLK2;NEK7;STK38L;RPS6KA5;CDK19;DYRK2;MAST3;LIPE;PIK3CD;CAB39;CAMK2B;EPHB2;CDKL2;RPS6KA1;ATR;RET;FASTK;EEF2K;SRPK1;PRKCZ;HIPK2;CSNK1G3;PRKAG3;PRKG1;FLT4;BCR;PTK2B;ATM;RNASEL;TBCK;ERN1;CDC42BPG;MARK3;STK17B;CREB1;STK25;FLT3;PRKCD;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;STK32B;MAP3K10;ACVR2B;ERBB2;CSNK2B;AATK;AKT1;FGFR3;TEC;TGFBR3;CDK9;EFEMP1;WNT11;PRKG2;NUAK2;EPHB3;MAP4K3;SBK1;MARK2;VRK2
prerank,in utero embryonic development (GO:0001701),0.41118755174949856,1.1153221216202287,0.3055555555555556,0.9177103695873333,1.0,7/25,18.20%,CHD7;PTPRR;TGFBR1;IGF2;ARNT2;FGFR2;BMP2
prerank,regulation of transferase activity (GO:0051338),-0.4138033728765399,-1.115002246894023,0.3234567901234568,0.6426331358661793,1.0,6/17,20.02%,HMBOX1;SMG6;ATM;NLRC5;PARP4;JMJD8
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2788040787194386,-1.1149271545036266,0.20987654320987653,0.6419704956007626,1.0,14/79,6.18%,CRIM1;SMAD6;SLIT2;BMPER;LEMD3;NBL1;THBS1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SULF2;EPN2
prerank,regulation of protein localization to centrosome (GO:1904779),-0.4645025785770735,-1.1147025340037193,0.3568075117370892,0.6416771600192723,1.0,3/10,7.49%,MARK4;APC;GSK3B
prerank,positive regulation of cellular process (GO:0048522),0.2849556345913568,1.1146287520457903,0.17520491803278687,0.9188104821367861,1.0,97/565,15.69%,PDGFRA;PTN;COLEC12;IL34;NTRK3;IL15RA;LRP1;ZFHX3;NRG1;MERTK;EDN3;TMEM102;HOXC10;PTGFR;MEIS1;ACOX2;HDAC1;WNT5A;TAF9B;NTRK2;PTEN;PHIP;ERBB4;ITGAV;FLT3LG;TSLP;FGFR1;GAB2;ANKLE1;MEIS2;TIPIN;RYR2;POU3F3;FBXO5;TBX3;TENM4;GCNT2;HTR2B;TUB;FMR1;CDC7;IRS1;MTPN;CDH3;IRS2;PSMD10;ECHDC3;FXN;SRF;LYAR;PTK2;CDK13;TRPC3;HTR1A;PRKCA;GLI1;CCKBR;LGMN;CACUL1;TSPYL5;TLR4;CYBA;SLC25A33;POFUT2;DHX36;PYCARD;NAP1L1;RTKN2;P2RX4;TGFBR1;SOX9;EXOSC9;ACLY;IL12A;CD86;IGF2;GAREM1;FAM98B;S1PR2;MYRF;CD81;AKAP6;DHPS;LYN;FOXM1;DOT1L;CLEC11A;F2R;GDNF;FGF5;CIAO1;N6AMT1;CNOT7;AREG;AR;MYC;FGFR2
prerank,cellular response to interleukin-4 (GO:0071353),0.5163775028683735,1.1144445383837576,0.3351063829787234,0.9181352634052147,1.0,1/10,0.63%,XCL1
prerank,cation transport (GO:0006812),-0.25193543915439404,-1.1143036918447307,0.18404907975460122,0.6418843719480536,1.0,25/167,12.15%,TRPM3;TRPM6;SLC47A1;ANO6;PIEZO2;SLC8A3;KCNK5;SLC6A6;ANO1;SLC9B2;SLC22A4;KCNJ13;KCNQ4;SLC7A1;SLC3A2;SLC41A1;SLC22A18;SLC38A5;KCNJ2;KCNK9;SLC1A1;SLC6A17;SCN7A;KCNJ12;TRPC6
prerank,"transcription, DNA-templated (GO:0006351)",-0.24126032993141014,-1.1142824981584414,0.18110236220472442,0.6410764748723962,1.0,62/207,24.56%,PIR;MLLT3;DDX5;SOX5;GLIS3;KLF13;TSC22D1;MEF2A;NFKB1;PTMA;ELOA;DDX21;GTF2H5;DRG1;TRIM24;HIPK3;AFF4;SNAPC3;CRCP;UBTF;RRAGC;NR4A2;NFYA;RBMX;SMARCA5;MAF;POLR2B;RPAP1;POLR2H;POLR3G;POLR2G;POLR2C;ELOC;GTF2E2;TTF1;GMEB2;CEBPD;BTF3;PMF1;MLLT1;HOXD3;CDK9;CREBL2;NELFCD;GTF3C6;TAF1C;ZBTB7B;GTF2H4;LEO1;E2F1;POLR1C;POLRMT;NCBP2;POLR3K;GTF3A;TWNK;TAF2;CTDP1;HSF2BP;GTF2F2;PARP1;NCOA6
prerank,histone lysine demethylation (GO:0070076),-0.3703732636906325,-1.114269854819209,0.32432432432432434,0.6402560244040283,1.0,10/25,26.06%,KDM4C;KDM4A;RIOX2;PHF8;HR;KDM4B;KDM3B;KDM2B;PHF2;KDM1A
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2611601061174605,-1.1130859431440918,0.25136612021857924,0.6423802950861323,1.0,39/129,18.18%,CAV1;EGFR;XIAP;NFKB1;RNF146;CSNK1D;PSMC6;PSMD9;KANK1;GPC3;TBL1X;PSMF1;PSMB7;LGR4;WNK1;SOX4;WLS;TNKS2;VCP;SMURF2;PSMD8;PSMD12;GID8;SFRP1;PSMA3;CSNK1G3;DKK2;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;PSMB10;FAM53B;HHEX;ATP6AP2;TMEM9;EGF
prerank,regulation of viral release from host cell (GO:1902186),-0.37562584920331754,-1.1126449598786943,0.296,0.6426962997432658,1.0,5/21,6.62%,CHMP2B;TRIM25;TRIM5;TRIM11;VPS37B
prerank,primary neural tube formation (GO:0014020),0.39905143276198796,1.1125124103628574,0.30660377358490565,0.9235663156043022,1.0,4/30,6.37%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,inorganic anion transmembrane transport (GO:0098661),0.33950322335072847,1.1125028175463822,0.2971830985915493,0.9223269014502676,1.0,16/63,15.37%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;LRRC8A;SLC25A30;GABRB1;GLRB;SLC25A14
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40211468992514804,-1.1124662536581291,0.30848329048843187,0.6423294639853914,1.0,6/17,15.85%,MEF2C;TPM1;SOD2;PRKG1;CDKN1A;GPER1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3692227183994493,1.1122756284175601,0.3031161473087819,0.9218115223056702,1.0,9/44,14.16%,SPRY4;SPRY1;DUSP1;PTPN22;SORL1;NF1;BMP7;PDCD4;LYN
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4631360622949168,-1.1120739209185215,0.33698030634573306,0.6425162810710581,1.0,2/10,1.79%,ROCK2;IL18
prerank,positive regulation of nervous system process (GO:0031646),0.4435449079747862,1.1120537541412516,0.34465195246179964,0.9212939570395701,1.0,5/18,13.25%,HCRT;TENM4;RIMS2;RIMS1;MYRF
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.26897725989487614,-1.1114598316252127,0.27722772277227725,0.6432155900355568,1.0,25/101,12.62%,VIM;LARP4;EZR;THBS1;KLF4;ELAVL1;RDX;VPS35;PRKDC;NIBAN1;SAMD4A;RPL5;LARP4B;SOX4;BAD;CASP8;PYM1;PERP;NFKBIA;CPEB3;IST1;RPS4X;EIF3D;RPL26;VPS11
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3972581297290657,1.1110838105208312,0.3127962085308057,0.9233201054189237,1.0,12/31,22.39%,DNAJC19;PEX2;PEX7;TIMM44;DNAJC15;PAM16;PEX12;PEX6;PEX14;GRPEL1;TIMM21;CHCHD4
prerank,Rho protein signal transduction (GO:0007266),0.3652104791040758,1.110991220722708,0.31564625850340133,0.9223636288687111,1.0,19/53,19.68%,ARHGEF3;RHOJ;ARHGAP6;NGFR;CTNNAL1;COL1A2;LIMK1;EPS8L1;ARHGAP4;RTKN;ARHGAP1;CDC42EP1;CDC42EP4;ADRA2A;RHOG;RHOA;CDC42EP3;ARHGAP29;PLEKHG5
prerank,regulation of centriole replication (GO:0046599),0.43806602226757385,1.1108935772205786,0.33500837520938026,0.9214228696636795,1.0,4/17,10.02%,MDM1;CEP295;TRIM37;KAT2A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.42475420858878943,-1.1108897800196433,0.3131067961165049,0.6438076691241248,1.0,7/13,25.39%,NBL1;FSTL1;CHRDL1;GREM2;CD46;NRROS;GREM1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.24916694699426273,-1.1106988338981028,0.1893491124260355,0.6434348272614683,1.0,49/166,19.62%,SORBS1;IGF1;VIM;LARP4;EGFR;THBS1;KLF4;LPGAT1;ELAVL1;PRKDC;NIBAN1;INSR;SAMD4A;RPL5;LARP4B;GIPC1;KLF2;SCARB1;GLI2;SOX4;SMAD3;DYRK2;PYM1;STARD4;CPEB3;PTPN2;RPS4X;STN1;EIF3D;PCNA;RPL26;PTH1R;ASS1;DDAH1;MFSD2A;ZNF205;EDN1;PTGS2;SIRT1;NOS1AP;EIF3E;EPM2AIP1;ABCB10;ERBB2;AKT1;EGF;HGF;NPM1;RGCC
prerank,regulation of cytoplasmic translation (GO:2000765),0.4637587340544591,1.1099034349152166,0.34192439862542956,0.9234989520135896,1.0,5/14,15.16%,CPEB1;RBM24;FMR1;DHX36;DHX9
prerank,regulation of viral transcription (GO:0046782),-0.3250504099647734,-1.109215189983531,0.2915451895043732,0.646434311668246,1.0,17/39,29.16%,TRIM11;IFITM3;TRIM14;POLR2B;POLR2H;POLR2G;POLR2C;TRIM27;CDK9;UBP1;NELFCD;HEXIM1;CTDP1;GTF2F2;POLR2I;POLR2K;MID2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4321166320171092,1.1088331357997925,0.33666666666666667,0.9258536589365483,1.0,3/21,3.48%,DCN;BGN;VCAN
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.4470811592491618,-1.1080303562843683,0.31827956989247314,0.6485442003143894,1.0,5/11,22.34%,TGFB2;ACVR1;TGFBR3;TGFBR2;SMAD7
prerank,cellular amino acid catabolic process (GO:0009063),0.3307235606933434,1.1078705560887085,0.28870292887029286,0.9279133761067916,1.0,16/87,12.14%,GLDC;SLC25A21;MCCC1;FAH;KYNU;ACADSB;MTRR;ABAT;BLMH;HNMT;ASPA;DLST;HOGA1;ALDH5A1;BCAT1;AMT
prerank,prostaglandin metabolic process (GO:0006693),-0.3538314487950104,-1.1076439503344921,0.2873900293255132,0.6486939494165447,1.0,4/26,4.12%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,receptor internalization (GO:0031623),-0.30889191735928273,-1.1072580092503277,0.2861736334405145,0.6488545789956965,1.0,13/44,16.48%,PICALM;CAV1;ITGB1;ACKR3;TFRC;RAMP1;DNM3;RAB5A;RAB31;CEACAM1;RAMP2;GRB2;CD9
prerank,nuclear pore complex assembly (GO:0051292),-0.4690103817153162,-1.1070735042682278,0.3400900900900901,0.6484695180460692,1.0,5/10,21.21%,NUP98;NUP153;TMEM170A;NUP205;RTN4
prerank,cellular response to ketone (GO:1901655),0.39141441096096813,1.1070704589747848,0.3186490455212922,0.9294100502960109,1.0,10/35,16.42%,PTGFR;ADCY5;SPP1;ADCY8;ADCY3;ADCY2;MAP4K1;GNG2;AR;PTGER4
prerank,peptidyl-asparagine modification (GO:0018196),0.38862159370168925,1.1070336273484673,0.308259587020649,0.9282931899045572,1.0,7/31,12.10%,HIF1AN;OSTC;RPN2;DAD1;ALG5;MCFD2;TUSC3
prerank,ESCRT complex disassembly (GO:1904896),-0.47210601330987684,-1.1069256018617115,0.33985330073349634,0.647139327635053,1.0,5/10,26.89%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),-0.47210601330987684,-1.1069256018617115,0.33985330073349634,0.647139327635053,1.0,5/10,26.89%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,chromatin assembly or disassembly (GO:0006333),0.4893243640214441,1.106892013181732,0.3356164383561644,0.9275046435893863,1.0,5/11,21.33%,CHAF1B;NOC2L;TP53;SUV39H2;HIRIP3
prerank,positive regulation of protein binding (GO:0032092),-0.30455612636681084,-1.106612973811677,0.27340823970037453,0.6471072887247926,1.0,16/56,14.86%,RAPGEF2;CAV1;APP;CLDN5;HIP1R;VTN;B2M;GSK3B;APOE;RPL11;RALB;HIPK2;TERT;RAN;AMFR;MARK3
prerank,regulation of ossification (GO:0030278),0.3888748640957992,1.1063508274598706,0.3263785394932936,0.9281275469832033,1.0,3/36,1.65%,ENPP1;PTN;WNT5A
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4616974699970341,1.1062940512005957,0.32068965517241377,0.9270440479342805,1.0,5/15,11.26%,HRG;SEMA5A;PRKD1;LGMN;P2RX4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.29220887917223337,-1.1062581245373577,0.2681992337164751,0.6472561406575404,1.0,19/65,18.18%,AFAP1L2;PTPRJ;EGFR;FER;PTPN3;HIP1R;CDC42;ERRFI1;MVP;ITGA1;PTPN2;CCDC88A;CEACAM1;RHBDF2;HIP1;GRB2;GPER1;AKT1;EGF
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.45060361987450415,1.1062238234381883,0.33713355048859933,0.926025900034299,1.0,5/16,18.08%,TOP2B;ERCC4;HFM1;EME2;TOP2A
prerank,early endosome to late endosome transport (GO:0045022),-0.3883204861644001,-1.1058932904374181,0.2966751918158568,0.6473806347871516,1.0,4/20,7.83%,EEA1;BECN1;HOOK1;RAB5A
prerank,cell-matrix adhesion (GO:0007160),0.3264359482427348,1.1058479163917385,0.2877237851662404,0.9260670503167893,1.0,12/95,7.73%,COL13A1;DLC1;ITGA11;ITGA8;PEAK1;ITGAV;ITGA3;ITGB5;SGCE;ACTN1;ADAMTS12;PPFIA2
prerank,tube closure (GO:0060606),0.3961396924241981,1.105478027220774,0.3200636942675159,0.926090465355212,1.0,4/31,6.37%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,negative regulation of heart contraction (GO:0045822),0.4970463953897699,1.1048765580697095,0.3784246575342466,0.9268800700299127,1.0,2/11,6.65%,ATP1A2;SPX
prerank,regulation of DNA repair (GO:0006282),-0.3108191960802433,-1.1048554732632376,0.26586102719033233,0.6491661332824916,1.0,11/44,15.75%,EYA2;EYA1;EGFR;EYA4;TRIP12;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;SIRT1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3905319244628138,-1.1046220850995319,0.3383838383838384,0.648887770695199,1.0,3/18,4.67%,FLT1;MEF2C;COL4A3
prerank,cardiac myofibril assembly (GO:0055003),0.45020540380930196,1.1038867416856626,0.314878892733564,0.9290480257126841,1.0,1/15,0.15%,PDGFRA
prerank,negative regulation of ossification (GO:0030279),-0.3676622094417765,-1.1032332113952794,0.35278514588859416,0.6515914819004135,1.0,6/23,4.25%,SMAD6;MEF2C;RBPJ;ECM1;SRGN;NOTCH1
prerank,negative regulation of signal transduction (GO:0009968),0.29580422104796394,1.103217061982419,0.2809734513274336,0.9301066029421873,1.0,39/249,14.21%,APOD;ENPP1;DCN;LRP1;SULF1;HRG;SPRY4;PTPRT;SPRY1;PTEN;HIF1AN;PIP4K2A;NKD1;PTCH2;IRS1;NEDD4;LRRK2;ADAMTS12;RPS6KB1;LRRC14;BEND6;NKD2;DCC;TLE1;GLI3;LGMN;PRKCB;TNS2;UBASH3B;CREB3L1;HGS;IL12A;CBLN1;GSK3A;HERC4;CNOT1;ASXL1;LYN;CTNNBIP1
prerank,male gonad development (GO:0008584),-0.32842159430021284,-1.1031601145643486,0.28695652173913044,0.6509212223411337,1.0,5/34,4.50%,KITLG;CSDE1;WNT4;TGFB2;NCOA4
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3633386042416663,1.102888721252157,0.3021897810218978,0.9299164775319766,1.0,6/44,8.16%,CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D;PER2
prerank,lipoxygenase pathway (GO:0019372),-0.41029696764679136,-1.1027854899805338,0.3170731707317073,0.6510353997627661,1.0,4/14,19.46%,PON3;GPX1;PTGS2;ALOX12
prerank,ceramide catabolic process (GO:0046514),-0.431072597997508,-1.1026899582458705,0.3501144164759725,0.6504262600026269,1.0,8/14,28.90%,ACER2;ACER3;HEXB;NAGA;GM2A;ASAH1;ASAH2;NEU1
prerank,muscle tissue development (GO:0060537),-0.43199647347017156,-1.1026497792684293,0.3472906403940887,0.6496793440023891,1.0,4/13,15.08%,PGM5;SMO;CSRP2;STRA6
prerank,pancreas development (GO:0031016),0.4854872461111354,1.1026157031207695,0.33907056798623064,0.929598466644762,1.0,2/12,3.07%,TCF7L2;NPHP3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.48155121264209744,1.1025988609970971,0.36879432624113473,0.9284292160824368,1.0,4/11,19.28%,REST;PINK1;FYN;STK26
prerank,potassium ion homeostasis (GO:0055075),0.4158381458114769,1.1021960098931398,0.33442088091353994,0.9285587059262823,1.0,4/23,5.24%,ATP1A2;SLC12A6;KCNMA1;ATP1A3
prerank,response to interleukin-4 (GO:0070670),0.5080569609803858,1.1019507874601226,0.3688969258589512,0.9281530778008528,1.0,1/10,0.63%,XCL1
prerank,T cell migration (GO:0072678),0.47058383898917505,1.1019000075225722,0.351493848857645,0.9270612010163003,1.0,4/13,17.33%,CXCL10;GPR183;MYO1G;PIK3CG
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.380776917596387,-1.1014130914178883,0.3208955223880597,0.6520530385216128,1.0,10/20,28.06%,ROCK2;RHOQ;RAB13;FHOD1;LLGL2;DLG1;STRIP1;IKBKB;FMNL1;NCKAP1L
prerank,urogenital system development (GO:0001655),-0.4579501931490492,-1.1008105072314565,0.3700980392156863,0.6526674321472502,1.0,4/11,18.77%,OSR1;ANXA1;EPHB2;EPHB3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.3907293603517241,-1.100784943613607,0.352,0.6519110511320834,1.0,2/17,4.12%,LPGAT1;PLA2G4A
prerank,negative regulation of protein secretion (GO:0050709),-0.330394312246831,-1.1004581315274995,0.2926829268292683,0.6518608111837699,1.0,12/38,23.49%,CD200;PSMD9;CCN3;APOE;KCNB1;SFRP1;RHBDF2;CYP51A1;CHGA;RAB11FIP1;RAB11FIP5;INHBB
prerank,positive regulation of programmed cell death (GO:0043068),-0.2324156851474807,-1.1002126165047381,0.1875,0.6516690976707001,1.0,79/272,22.46%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;ITGA6;MCF2L;TNFSF10;MARK4;HIP1R;MAP3K5;IGFBP3;SQSTM1;FAS;UNC13B;CYP1B1;APC;ATF6;CRADD;JMY;UBB;SOX4;NGF;IP6K2;CASP2;CASP3;NGEF;BAD;CASP8;BNIP3L;BAX;SFRP1;ADAMTSL4;TNFAIP8;APH1A;BID;TGM2;GADD45B;APH1B;BOK;ATM;ARHGEF11;PLEKHG2;ING4;STK17B;TRIM35;SMPD1;SIRT1;GPER1;DCUN1D3;ING5;UBC;AIFM1;LAPTM5;MAP3K10;APBB1;STPG1;ITGB3BP;TFPT;SOS1;VAV1;RASGRF2;EEF1E1;GADD45G;TRADD;HDAC6;ARHGEF12;E2F1;SPHK2;UBA52;TIAM1;CCAR2;DDX20;ARHGEF1
prerank,brain morphogenesis (GO:0048854),0.48975395824997237,1.099060805984774,0.36823104693140796,0.935477648655415,1.0,2/12,1.96%,CTNNA2;PTEN
prerank,phosphorylation (GO:0016310),-0.22371070421691616,-1.0990404145513382,0.10909090909090909,0.6537688960728434,1.0,125/384,24.39%,PRKAG2;DAPK1;MAP3K1;ROCK2;PRKCH;MARK1;ERG;DCLK1;TRIB2;FER;APP;BMPR2;CSNK1D;MARK4;MAP3K5;IGFBP3;NEK6;PRKDC;INSR;CAMK2D;DGKH;TOP1;TGFB2;WNK4;MINK1;SIK3;PRKAA2;HK1;TLK1;ADAM10;SNRK;CDK17;MAPK9;WNK1;CDK6;HIPK3;TOLLIP;PRAG1;NRBP2;SIK1;PGK1;BMX;HIPK1;GSK3B;FNIP2;ACVR1;CDC42BPB;ACVRL1;DGKG;TLK2;NEK7;STK38L;RPS6KA5;CDK19;DYRK2;LIPE;PIK3CB;PIK3CD;CAMK2B;GNPTAB;EPHB2;CDKL2;RET;FASTK;SRPK1;PRKCZ;DGKZ;HIPK2;PRKAG3;PRKG1;BCR;PTK2B;ATM;RNASEL;TBCK;ERN1;CDC42BPG;MARK3;STK17B;CREB1;STK25;PRKCD;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;ACVR2B;ERBB2;AATK;AKT1;TEC;CDK9;WNT11;PRKG2;NUAK2;MAP4K3;MARK2;VRK2;CSNK1A1;MKNK1;PKN3;PIM2;TGFBR2;SHPK;SPHK2;NEK10;TTBK1;CDKL4;CERKL;BRD2;PASK;STK39;PLK4;IKBKB;TAOK2;NIM1K;PAK4;COQ8A;CDK16;ACVR2A;IKBKE;RSKR;TKFC;GRK4
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4470911149944924,1.098991857751979,0.3647469458987784,0.9345109964434787,1.0,6/17,18.94%,GJA1;N4BP2L2;LTBP3;FERMT2;KAT7;CCNE1
prerank,amyloid fibril formation (GO:1990000),-0.30551765755110166,-1.0989771550119525,0.2753623188405797,0.6531028612673123,1.0,17/51,19.08%,TSPAN5;SNCAIP;APP;CST3;GSN;ADAM10;UBB;B2M;MAPT;APH1A;APH1B;FURIN;UBE2L6;UBC;SIAH2;MFGE8;USP9X
prerank,vasoconstriction (GO:0042310),0.4870484675626451,1.098751774044475,0.36971830985915494,0.9341181665752147,1.0,2/11,4.84%,EDN3;HTR2B
prerank,amyloid-beta metabolic process (GO:0050435),-0.4085675181979213,-1.0987016271136807,0.3241206030150754,0.6530011998226971,1.0,7/16,25.92%,ACE;APH1A;APH1B;APEH;BACE2;MME;PSEN2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.44274097104239163,-1.0986538696067514,0.33185840707964603,0.6522971482847922,1.0,5/12,27.66%,TMEFF2;AP2A1;EDN1;SELENOS;TAF7
prerank,negative regulation of endocytosis (GO:0045806),-0.3590390547769736,-1.098528068941238,0.2830188679245283,0.6518153219711156,1.0,4/24,5.43%,PICALM;CAV1;MCTP1;RAC1
prerank,base conversion or substitution editing (GO:0016553),0.4884455885232365,1.0984798066817596,0.37435008665511266,0.9337956648210972,1.0,2/11,16.10%,ADARB2;ADAR
prerank,neuromuscular process (GO:0050905),0.4463432307355881,1.0984174994036917,0.3515358361774744,0.9328281132264652,1.0,2/16,3.11%,MYCBP2;NRXN1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.46573955929824445,1.098371890088068,0.35767790262172283,0.9317582805481281,1.0,3/13,7.16%,GPR37L1;LRRK2;PYCR1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.29561241276497924,-1.0983433128106108,0.2777777777777778,0.6514440167588599,1.0,17/54,22.29%,RNF152;RNF146;UBE2G1;PELI1;UBE2D3;IFI27;UBE2H;RNF8;UBE2A;AMFR;CUL3;KLHL3;CDC34;KBTBD7;RNF5;RFFL;TNFAIP3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3192050646245088,-1.0982284614636286,0.282798833819242,0.650884975048588,1.0,9/39,10.56%,SLIT2;TIE1;NRP1;KDR;RASIP1;SIX1;GLI2;LRP6;NPNT
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.49586884739354753,1.097947522149883,0.37992831541218636,0.932009570372206,1.0,2/11,7.89%,LIPC;PLA2G7
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.41253629122911506,1.0978321895950103,0.3305785123966942,0.9312089961758302,1.0,3/23,4.17%,TXK;JAK1;NR1H2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4585601809936001,1.0975562128011793,0.36,0.9297252669800141,1.0,6/15,15.38%,NANOS3;ZFP36L2;DHX36;CNOT1;TNRC6B;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4585601809936001,1.0975562128011793,0.36,0.9297252669800141,1.0,6/15,15.38%,NANOS3;ZFP36L2;DHX36;CNOT1;TNRC6B;CNOT7
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4428223696926584,-1.0971638815828353,0.35454545454545455,0.6526166852254481,1.0,5/12,17.66%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,cellular response to type I interferon (GO:0071357),-0.32041265061299773,-1.096622505718845,0.31545741324921134,0.6523247467931123,1.0,13/41,17.75%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IFITM1;IRF1;RNASEL;ISG15;IFIT1
prerank,type I interferon signaling pathway (GO:0060337),-0.32041265061299773,-1.096622505718845,0.31545741324921134,0.6523247467931123,1.0,13/41,17.75%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IFITM1;IRF1;RNASEL;ISG15;IFIT1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.24611862895916378,-1.0966135767087466,0.1956521739130435,0.6515253939853054,1.0,64/193,23.23%,FBXL7;NPLOC4;RNF146;UBE2G1;ASB2;RNF185;RNF43;SQSTM1;PSMD9;ARIH1;CDC23;PSMF1;TRIM25;TRIP12;ANAPC10;PTTG1;TOLLIP;UBB;UBE2H;RNF8;MIB1;UBA6;SMURF2;RC3H1;KCTD21;UBE2A;RNF125;RNF144B;RNF11;SPSB4;RNF114;RCHY1;KCTD6;FBXL4;AMFR;ELOC;UBE2L6;FBXL14;ANAPC16;NEDD8;CUL3;UBC;ISG15;ANAPC15;SIAH2;BUB3;PPP1R11;ANAPC11;ANKIB1;CHFR;WDR91;KLHL25;KLHL3;CDC34;FZR1;RNF166;RNF5;RFFL;ANAPC2;UBA52;FBXO22;ADRM1;RLIM;FBXO10
prerank,cytosolic calcium ion transport (GO:0060401),-0.35127333957656326,-1.0962655767280713,0.2975206611570248,0.6515802832939265,1.0,9/28,15.74%,CACNA1C;SLC35G1;MICU1;ATP2B1;MCUB;SMDT1;JPH1;ATP2A3;JPH2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3591504351417043,-1.0962423318591297,0.31215469613259667,0.6508163872950985,1.0,12/23,39.42%,MBOAT1;PLA2G4A;PLA2G6;PLAAT3;PLA2G4E;PLA2G4C;PLA2G4F;LPCAT3;PLA2G4B;LPCAT4;PLA2G5;PLBD1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3716851435399892,-1.095607732571096,0.29396984924623115,0.6516819186834695,1.0,7/22,6.80%,IGF1;ROCK2;MEF2A;CAMK2D;NOTCH1;IL6ST;LMCD1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3849424354132509,1.0951976438585032,0.3281733746130031,0.9365019254470455,1.0,6/31,13.45%,CDC14B;PTEN;GOLGA2;PINK1;DCUN1D5;AXIN1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.45731158405259076,1.095067017291652,0.3395904436860068,0.9357156717454796,1.0,5/15,13.46%,ENTPD2;ENTPD5;AK4;ENTPD7;AK8
prerank,regulation of dendritic spine development (GO:0060998),-0.38584246934753297,-1.0950042714532788,0.33578431372549017,0.6524171479201781,1.0,7/19,12.23%,MEF2C;SHANK3;SHANK1;APOE;CPEB3;CAMK2B;DLG5
prerank,positive regulation of chromosome organization (GO:2001252),0.44826417796951934,1.0947176365634992,0.3185550082101806,0.9356425485145367,1.0,4/15,10.93%,GNL3;FEN1;SIRT6;DHX36
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4353637446512272,1.0942794267960232,0.33116883116883117,0.9358614314260945,1.0,4/18,10.36%,CACNG3;NRXN1;RELN;CACNG4
prerank,maturation of SSU-rRNA (GO:0030490),-0.3250002436548984,-1.0941420225728316,0.3024523160762943,0.6537857064946407,1.0,9/34,13.09%,RPS14;RPS16;DDX52;RPS19;LSM6;RIOK1;RIOK3;UTP3;RPS8
prerank,regulation of myotube differentiation (GO:0010830),-0.356998020981709,-1.0933450939984832,0.30303030303030304,0.6550846168114594,1.0,10/24,23.00%,HDAC4;NOTCH1;CCN3;MAPK14;SIK1;HDAC3;TMEM119;PIEZO1;FBXO22;BHLHE41
prerank,regulation of ion transmembrane transport (GO:0034765),-0.33390521739414886,-1.0926312689352997,0.30913978494623656,0.656092693834029,1.0,8/33,14.95%,ANO6;WWP2;KCNJ13;WNK1;KCNJ2;KCNQ1;KCNJ12;P2RX7
prerank,peptide metabolic process (GO:0006518),-0.27808941821303895,-1.0925278050043488,0.29554655870445345,0.6555131948459474,1.0,29/75,31.14%,AEBP1;CPE;CPD;ERAP1;ACE;DMD;SPCS2;GPX1;SEC11C;ETHE1;CLN5;FURIN;GSTA4;APEH;PCSK5;GSTT1;ABCB9;TRHDE;GSTM5;BACE2;MME;TPP1;PSEN2;GGT1;CARNMT1;THOP1;GSTK1;CPZ;SPPL3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.42875062447338497,-1.0923326251010528,0.3541666666666667,0.6552066605955779,1.0,4/12,10.75%,ELF1;RUNX1;RC3H1;ELF2
prerank,nucleic acid-templated transcription (GO:0097659),-0.31337434719074925,-1.0920868566134967,0.3106796116504854,0.6550295857988165,1.0,12/42,18.40%,MEF2A;PTMA;DRG1;RRAGC;NR4A2;POLR2B;POLR2H;POLR2G;TERT;POLR2C;HOXD3;CREBL2
prerank,kinetochore organization (GO:0051383),0.4609247269081959,1.091956734361923,0.34507042253521125,0.9422614138435313,1.0,5/13,15.90%,CENPE;CENPC;CDT1;CENPW;CENPF
prerank,negative regulation of protein modification process (GO:0031400),-0.2710154232253897,-1.0919403042549052,0.2644628099173554,0.6546295514928929,1.0,24/79,16.09%,OCLN;SLIT2;PLPP3;SNTA1;SIRPA;IGFBP3;PRKDC;NIBAN1;PRKAA2;YWHAB;PRR5L;PPP1R16B;GSK3B;XDH;LRP6;MAPT;DMD;EPHB2;TARDBP;CRTAP;PPIA;CDYL;SIRT1;PRKAA1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.35937374954070844,-1.0914117210687406,0.3027027027027027,0.6551657978592104,1.0,7/23,16.20%,IGF1;MEF2C;EFNB2;MAPK14;NIBAN2;EDN1;MYOCD
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.24956920702842414,-1.0912895751113525,0.22857142857142856,0.6546185355688666,1.0,41/151,18.25%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;PLA2G4A;ACER3;CERT1;SGMS2;B4GALT5;ALAS1;DEGS2;NFS1;SPNS2;VAPA;APOE;GCH1;LARGE1;DMD;VAPB;ELOVL4;ELOVL7;ASS1;MFSD2A;FURIN;CHKB;MOCS1;KDSR;GSTA4;SPTSSA;GCNT1;ST3GAL2;PCSK5;ESD;GSTT1;PCTP;CSNK2B;MGST3
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.310444499400885,-1.0912104361136494,0.29333333333333333,0.6539735461097492,1.0,16/47,20.51%,APP;KLF4;NFKB1;VPS35;APOE;RPL10;TCOF1;SSH1;NFKBIA;EIF2B4;NOLC1;AGTR1;EDN1;AKT1;WDR91;AGT
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4310048577510358,-1.0911659257205124,0.36036036036036034,0.6532509867677727,1.0,5/12,22.68%,UPP2;TK2;DCK;CDA;CAD
prerank,positive regulation of response to external stimulus (GO:0032103),0.3100540554120496,1.0909035748115994,0.3184634448574969,0.944531316600556,1.0,13/128,10.01%,IL33;PTN;HRG;WNT5A;IL16;TSLP;DHX58;TLR8;AKIRIN2;PLA2G7;PRKCA;TLR4;CYBA
prerank,cellular response to organic cyclic compound (GO:0071407),0.3063428464867434,1.0905288295766278,0.301909307875895,0.9444812317933853,1.0,29/141,14.49%,RORA;ADCY5;ATP1A2;NR1H4;P2RY1;SPP1;JUP;NCOA3;CASP6;ATP1A3;LRRK2;ADCY8;ADCY3;PDE12;ADCY2;HCN2;HCN1;GABRG2;HCN3;P2RX4;SPIDR;TRPM2;NRIP1;HSP90B1;AKAP6;MED1;RYR3;GNG2;GABRB1
prerank,spindle assembly (GO:0051225),0.3397076346981899,1.0904982078985697,0.31950207468879666,0.9433562291551781,1.0,21/67,18.45%,CCDC61;HAUS3;HAUS1;LSM14A;AAAS;STARD9;HAUS8;GOLGA2;CEP192;RCC1;TUBGCP4;MAP9;CLASP2;TUBGCP6;KIFC2;KIF2A;CLASP1;SMC1A;GOLGA8B;RHOA;KPNB1
prerank,retinoic acid metabolic process (GO:0042573),-0.413718524960195,-1.090019182701714,0.35091743119266056,0.6552750044719959,1.0,2/14,1.56%,ALDH1A2;CYP26B1
prerank,negative regulation of receptor binding (GO:1900121),-0.4565100610738054,-1.0899570924468507,0.3522975929978118,0.6546027426130805,1.0,4/10,16.82%,PTPRF;B2M;ATP2A3;HFE
prerank,negative regulation of endothelial cell migration (GO:0010596),0.38125407041574894,1.0897005218059166,0.34887218045112783,0.9447280111011337,1.0,5/36,5.54%,DCN;HRG;NR2F2;JUP;ADGRB1
prerank,proteoglycan metabolic process (GO:0006029),0.41501033107675056,1.0895688204191236,0.3446676970633694,0.9439279515483515,1.0,2/26,0.61%,CHST8;SULF1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.45802305871066096,-1.0893685109238858,0.3811659192825112,0.6552351550037784,1.0,5/10,20.65%,PRKCH;FOXC1;TRIM16;NUMA1;ETV4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3002949589539937,-1.089195553717235,0.3170731707317073,0.6548403374518538,1.0,16/53,15.75%,EYA2;DDX5;EYA1;EGFR;EYA4;RNF8;ATR;SPRED3;PCNA;BRCC3;SMCHD1;UBE2N;ATM;NSMCE4A;PRKCD;SIRT1
prerank,positive regulation of heart rate (GO:0010460),0.43691304001349796,1.0887905498990174,0.3482587064676617,0.9454005230175867,1.0,3/17,5.69%,EDN3;RYR2;ATP2A2
prerank,striated muscle tissue development (GO:0014706),-0.34013969234375335,-1.0884096836464043,0.3203342618384401,0.6560065488984671,1.0,7/29,5.84%,MEF2C;CAV1;PGM5;BMPR2;MYL6;RBP4;SIX1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4366029887487382,1.0879464222487842,0.3516295025728988,0.9470836642331057,1.0,6/17,18.91%,ERCC5;NEIL3;TERF1;MUTYH;MBD4;TERF2IP
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3691807882252038,-1.087372211996963,0.33915211970074816,0.6577456823525665,1.0,5/21,7.77%,MEF2C;MAGI2;CALM1;MTMR9;ITGA1
prerank,chordate embryonic development (GO:0043009),0.35490897815572586,1.0873088571928482,0.359375,0.948017710727128,1.0,5/55,2.95%,CHD7;SULF1;WNT5A;PTPRR;FGFR1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4690859837417465,1.086610294543476,0.36649214659685864,0.9491136549913404,1.0,2/13,2.91%,PTPRT;TSLP
prerank,mesonephric tubule development (GO:0072164),0.44712464617277164,1.086567796742888,0.35,0.9480782169593923,1.0,2/15,2.49%,ROBO2;SALL1
prerank,regulation of microtubule-based movement (GO:0060632),0.49297222348209757,1.0864797867486211,0.3770197486535009,0.947162158255948,1.0,3/11,9.82%,NEFH;TTC21B;CCDC65
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4168224783781097,1.0863596094578905,0.36421725239616615,0.9463313920464059,1.0,3/22,2.73%,NR2F2;PTEN;CDKN2A
prerank,regulation of telomere maintenance (GO:0032204),0.4024835791196248,1.0863587555425764,0.33015873015873015,0.9451265758025973,1.0,8/26,15.59%,GNL3;ERCC1;SIRT6;ERCC4;PIF1;DHX36;HNRNPD;MYC
prerank,regulation of membrane repolarization (GO:0060306),-0.42578509748620913,-1.0863137465212442,0.3788235294117647,0.6596239270919457,1.0,3/13,10.80%,CAV1;KCNJ2;KCNQ1
prerank,vasculature development (GO:0001944),0.438572167152762,1.0856444116085981,0.3606010016694491,0.9462572387686086,1.0,1/16,0.15%,PDGFRA
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4111609272583152,1.0850084939648097,0.3497536945812808,0.9471572173455827,1.0,5/23,13.61%,ENPP1;PTCH2;GLI3;HERC4;RFX4
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4798338805304303,1.0848818525866077,0.37683823529411764,0.9463886746241745,1.0,5/11,15.33%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,negative regulation of cell death (GO:0060548),-0.2687134258378681,-1.0848809624617934,0.3017241379310345,0.662519679036816,1.0,26/88,19.28%,MECOM;CD200;CCN2;KANK2;BECN1;VPS35;CCN3;CD34;SRGAP2;NCK1;SOX4;CCN5;CCN1;GSK3B;BNIP3L;CCN4;NENF;WNT16;TMEM109;AKT1;CHMP4B;CHMP4A;SOX11;WNT11;DCPS;CHGA
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.35074916897342817,1.0847092272133052,0.33520336605890605,0.9457501774068547,1.0,14/57,13.47%,GRIA3;CACNG3;GRIN2B;GRIA4;DLG3;GRIA1;DLG2;GRIN2A;RELN;CACNG4;DLG4;SHISA6;LRRC7;DLGAP3
prerank,DNA strand elongation (GO:0022616),0.42317858856030366,1.0845590940655678,0.3651050080775444,0.9450799249815844,1.0,5/18,10.82%,MCM7;GINS3;POLA1;RFC3;MCM4
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4355646066623827,-1.0840715747378777,0.3493150684931507,0.6638529166633974,1.0,5/12,13.50%,HDAC4;NOTCH1;CCN3;HDAC3;TMEM119
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3020919385182356,1.0838589718390093,0.309048178613396,0.9461679373470676,1.0,29/158,16.66%,ROR1;MAP3K14;EDA2R;CCDC22;CD40;TSPAN6;LURAP1;GJA1;HTR2B;TLR6;TNFRSF19;TRIM8;PRKD1;PINK1;PRKCB;BIRC2;LPAR1;IRAK1;NDFIP2;DHX36;LGALS1;RNF31;TIRAP;RIPK1;UBE2V1;F2R;MAP3K3;NDFIP1;LGALS9
prerank,positive regulation of immune effector process (GO:0002699),-0.3409628532368822,-1.0837301312750978,0.33062330623306235,0.663999341976176,1.0,4/27,6.48%,PTPRJ;DDX60;LBP;RPS19
prerank,B cell activation (GO:0042113),-0.27994376661259124,-1.0836270674783715,0.2977941176470588,0.663445466841996,1.0,17/68,18.32%,MEF2C;PTPRJ;TPD52;HDAC4;ITGB1;CTPS1;DNAJB9;CASP8;PIK3CD;PTPN2;EPHB2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3917536586232776,1.0833726776933084,0.3343701399688958,0.9465996183826798,1.0,4/30,3.48%,DCN;BGN;DSE;VCAN
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.29896073662777817,-1.082903140546615,0.3069620253164557,0.6644681387458713,1.0,10/49,13.67%,SGMS1;CAV1;BCL2L1;MCL1;BECN1;BAD;BAX;BID;CYLD;BOK
prerank,regulation of phosphatase activity (GO:0010921),0.4177185054308774,1.0827957849908685,0.36142625607779577,0.9472518579132145,1.0,9/24,18.20%,GPATCH2;PPP6R2;PTPA;PPP1R26;HSP90B1;ZCCHC9;TSC1;PPP6R3;BMP2
prerank,regulation of neuroinflammatory response (GO:0150077),0.4194272804152383,1.0825788214280503,0.35537190082644626,0.9467690426995921,1.0,1/19,0.09%,IL33
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.4481485575675481,-1.082565332373027,0.37861915367483295,0.6645398558845514,1.0,5/11,25.94%,ANXA1;RC3H1;SOCS5;SMAD7;JAK3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.37464467399807766,-1.0824418535205815,0.35167464114832536,0.6640472103733284,1.0,5/17,15.97%,SNTA1;ANK2;KCNQ1;NOS1AP;SCN4B
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.41686614801220134,-1.082189164350244,0.363855421686747,0.663839758218365,1.0,5/13,24.02%,PARP10;PARP9;PTGS2;NAXE;NAPRT
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3455000098059285,1.081650001062823,0.34788732394366195,0.9486265789105987,1.0,17/56,18.34%,CECR2;UNC119;DCTN3;SPTBN1;ANK3;EFHC1;SEPTIN9;JTB;INCENP;NUSAP1;RTKN;STMN1;CEP55;SPIRE1;STAMBP;CUL7;RHOA
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3997403839584531,1.0813949850762574,0.34603658536585363,0.9482359902369144,1.0,3/25,3.79%,GLMN;PDE4B;SPTBN1
prerank,regulation of potassium ion transport (GO:0043266),0.3879737588701207,1.0812316982606227,0.3630769230769231,0.9476060000245277,1.0,9/31,13.34%,DPP6;DPP10;ANK3;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2586365680873673,-1.0811255613714401,0.2676056338028169,0.6656571472319717,1.0,18/99,10.80%,RAPGEF2;MEF2C;SLIT2;ACTB;EZR;DIAPH1;IGFBP5;CDH1;RAP1A;SH3BP4;RAPGEF1;PDE3A;LAMTOR5;SSH1;CPEB3;RRAGC;SFRP1;KCNQ1
prerank,protein modification process (GO:0036211),-0.2781538136904301,-1.080660934325208,0.29411764705882354,0.6660625566943309,1.0,34/76,30.37%,ST3GAL6;ST8SIA4;CPE;PRKDC;WWP2;UBE2D3;ST3GAL1;FBXL2;MANBA;ST8SIA2;CSNK1G3;MMP15;USP25;PARP4;UBE2L6;NEDD8;QPCT;YES1;MCRS1;CDC34;ICMT;FBXW2;UBA52;FBXO22;PHEX;BAP1;PARP1;ADPRH;NAGPA;RABGGTA;PHKA2;FBXO11;LCMT1;AKT2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.31055674917377174,1.080386123345166,0.3173076923076923,0.9492066024893432,1.0,19/140,11.26%,PDGFRA;PTGFR;ADCY5;C5AR1;P2RY1;ACKR2;CCR9;RYR2;ADCY8;CALCA;C1QTNF1;LPAR3;TRPC3;CCKBR;HTR2C;LPAR1;IAPP;DLG4;P2RX4
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.44119894862773124,-1.0803307965586837,0.3689095127610209,0.6660842449588825,1.0,3/11,3.86%,PICALM;ACTN2;GOPC
prerank,neutrophil activation involved in immune response (GO:0002283),-0.21753764136734274,-1.0801319766194906,0.14285714285714285,0.6657950060829595,1.0,118/428,21.09%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;CST3;NFKB1;BRI3;HMOX2;PYGB;IQGAP1;SIRPA;GSN;RAP1A;CD55;KCMF1;STOM;HSPA8;DERA;FUCA1;S100A11;PSMB7;RAC1;PLEKHO2;CD93;ADAM10;TOLLIP;CYB5R3;ATP11B;MAPK14;VAPA;YPEL5;CAT;B2M;CD44;MVP;VCP;RAB5C;PGLYRP1;CEP290;GYG1;RAB31;MANBA;HEXB;CAP1;EEF1A1;SRP14;PSMD12;CAB39;IST1;COTL1;GAA;CTSH;PGM2;TMC6;CD63;CMTM6;CEACAM1;DYNC1H1;PAFAH1B2;PGRMC1;PKM;ALDOC;SURF4;NIT2;GCA;LAMTOR3;GHDC;OSTF1;NBEAL2;PFKL;PPIA;PSMD7;HGSNAT;CPNE3;IGF2R;CTSZ;RAP2C;RAB3D;APEH;ARSB;CYSTM1;PRKCD;KCNAB2;FTL;RAB6A;ALDOA;CSNK2B;CTSS;GM2A;QPCT;ATP6AP2;RAP2B;MLEC;LAMP2;SDCBP;STK11IP;ARSA;DYNC1LI1;LRG1;RAB37;APRT;DNAJC3;DOK3;PSMC3;AGPAT2;MIF;PSAP;FAF2;IQGAP2;PGM1;GALNS
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.25800006397586844,-1.0801113890054905,0.3033175355450237,0.6650384934177092,1.0,33/118,19.34%,PHLDB2;EPHA4;MEF2C;PDLIM5;BMPER;SIPA1L1;LARP4;SHANK3;SPARC;RUFY3;CAPZB;EFNA5;TBX1;GSK3B;MAPT;RC3H1;CFL1;SFRP1;BCL9L;ETS1;DAG1;CEACAM1;FLT4;LFNG;ARHGAP44;LZTS3;PAK2;EPHA2;ERBB2;EPHB3;MARK2;VASH1;SARM1
prerank,positive regulation of histone acetylation (GO:0035066),-0.352477257185027,-1.0800805310158015,0.3648293963254593,0.6643045862097567,1.0,9/23,26.27%,GLYR1;WBP2;RPS6KA5;NOS1;TADA2B;RUVBL2;SPHK2;BRCA1;SMAD4
prerank,positive regulation of protein secretion (GO:0050714),-0.2816982632977959,-1.079168207934535,0.2909090909090909,0.6657955168838466,1.0,16/69,13.99%,IGF1;MYRIP;EZR;PSMD9;RBP4;UNC13B;TGFB2;SOX4;WLS;NNAT;BAD;CD2AP;ACSL4;GOLPH3L;MYH10;PPIA
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2798393064607447,-1.079042877112788,0.27956989247311825,0.6653141109768688,1.0,21/71,15.56%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ACER3;CERT1;SGMS2;DEGS2;SPNS2;VAPA;LARGE1;VAPB;ELOVL4;ELOVL7;ST3GAL5;KDSR;SMPD1;SPTSSA
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.46667357853329683,1.0787634259336367,0.37279151943462896,0.9534396785009241,1.0,2/12,5.70%,GNL3;CCT5
prerank,ncRNA transcription (GO:0098781),-0.4176170254345062,-1.077969184334196,0.37163814180929094,0.6671521019822547,1.0,5/13,22.70%,CAVIN1;SNAPC3;NIFK;POLR1G;GTF3A
prerank,regulation of cartilage development (GO:0061035),0.44090755798151154,1.0779051816834588,0.37099494097807756,0.9550762101771972,1.0,6/18,12.20%,TRPS1;SOX6;ZBTB16;TAPT1;KAT2A;SOX9
prerank,regulation of postsynapse organization (GO:0099175),0.3902356376813988,1.0770623820818028,0.36363636363636365,0.9566077117525011,1.0,8/28,8.33%,ARHGAP22;WNT5A;CDKL5;LRRK2;ABHD17C;PPFIA2;ABHD17B;TANC2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3969744011197819,1.0770413860690273,0.3515625,0.9554682344875322,1.0,3/27,3.48%,DCN;BGN;VCAN
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2217428508147208,-1.0769161651620913,0.16176470588235295,0.6691407160430283,1.0,85/348,18.42%,PDGFD;PRKAG2;IGF1;RAPGEF2;ROCK2;TEK;LEPR;CAV1;PTPRJ;PECAM1;KRAS;FNIP1;EGFR;APP;BMPR2;NRP1;LIMCH1;CSNK1D;IQGAP1;CSPG4;KDR;RAP1A;NIBAN1;INSR;CCND2;FAS;TGFB2;VEGFD;VTN;DAB2;MAVS;RAC1;VEGFC;TFRC;NGF;PDGFA;EFNA5;CALM1;CARD14;TBX1;CCN1;CD44;FGF1;FNIP2;RALBP1;ACVR1;ACVRL1;PDGFC;RPS6KA5;ENPP2;CAB39;CX3CR1;HDAC3;ITGB3;RALB;PLCG2;TAB2;NOS1;ALS2;FLT4;TMEM119;PTK2B;RAPGEF3;PPIA;NBN;CCND1;RAP2C;CX3CL1;CDKN1A;SIRT1;GPER1;TBK1;PAK2;GDF11;HFE;CD74;TWSG1;ERBB2;CSNK2B;AKT1;EGF;TEC;CDK9;CREBL2;LCP2
prerank,renal absorption (GO:0070293),-0.4541604725178945,-1.076843311567163,0.3577981651376147,0.6685198560873039,1.0,6/10,28.33%,GSN;WNK4;KCNQ1;KLHL3;HYAL2;HAS2
prerank,positive regulation of developmental process (GO:0051094),0.3000860393412252,1.0765415405718493,0.32667450058754405,0.9559776132620965,1.0,26/164,10.06%,PTN;DCN;EDN3;WNT5A;BASP1;FGFR1;NRXN1;PHLDB1;GRIP1;GJA1;FBXO5;REST;SOX6;NCOA3;FOXO6;FMR1;SORL1;ZBTB16;SRF;HMCES;PINK1;RELN;ADGRL1;TAPT1;BMP7;ZBED3
prerank,response to fatty acid (GO:0070542),0.4474236876313308,1.0761486199662824,0.39865996649916247,0.9560976864857419,1.0,3/17,5.14%,NR1H4;GLDC;IRS1
prerank,neutrophil degranulation (GO:0043312),-0.21782415338655878,-1.0761286596233972,0.171875,0.6694958943386027,1.0,118/425,21.09%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;CST3;NFKB1;BRI3;HMOX2;PYGB;IQGAP1;SIRPA;GSN;RAP1A;CD55;KCMF1;STOM;HSPA8;DERA;FUCA1;S100A11;PSMB7;RAC1;PLEKHO2;CD93;ADAM10;TOLLIP;CYB5R3;ATP11B;MAPK14;VAPA;YPEL5;CAT;B2M;CD44;MVP;VCP;RAB5C;PGLYRP1;CEP290;GYG1;RAB31;MANBA;HEXB;CAP1;EEF1A1;SRP14;PSMD12;CAB39;IST1;COTL1;GAA;CTSH;PGM2;TMC6;CD63;CMTM6;CEACAM1;DYNC1H1;PAFAH1B2;PGRMC1;PKM;ALDOC;SURF4;NIT2;GCA;LAMTOR3;GHDC;OSTF1;NBEAL2;PFKL;PPIA;PSMD7;HGSNAT;CPNE3;IGF2R;CTSZ;RAP2C;RAB3D;APEH;ARSB;CYSTM1;PRKCD;KCNAB2;FTL;RAB6A;ALDOA;CSNK2B;CTSS;GM2A;QPCT;ATP6AP2;RAP2B;MLEC;LAMP2;SDCBP;STK11IP;ARSA;DYNC1LI1;LRG1;RAB37;APRT;DNAJC3;DOK3;PSMC3;AGPAT2;MIF;PSAP;FAF2;IQGAP2;PGM1;GALNS
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4057198631776661,-1.0761173448520143,0.37054631828978624,0.6687260192206476,1.0,5/14,13.53%,LIMS2;ITGB1BP1;PHACTR4;CD63;FLNA
prerank,neurotransmitter secretion (GO:0007269),0.3601155683884794,1.075910957435381,0.3514705882352941,0.9557087278632882,1.0,14/44,18.66%,NRXN2;PTPRN2;NRXN1;VAMP2;RIMS2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,glucose homeostasis (GO:0042593),-0.2710636384589518,-1.0756867867078135,0.3236514522821577,0.6690028779231807,1.0,16/83,10.54%,FOXO1;LEPR;IGF1R;FOXK1;ADIPOR2;KLF7;INSR;RBP4;PRKAA2;HK1;SOX4;LRRC8D;KCNB1;HK2;BAD;PTPN2
prerank,fatty acid beta-oxidation (GO:0006635),0.3482818287346981,1.0755819245701455,0.3485064011379801,0.9556260324499213,1.0,7/51,6.52%,ACOX2;ABCD2;PEX2;PPARD;ACADL;CRAT;ACADS
prerank,gastrulation (GO:0007369),-0.3947830262532147,-1.0754922657440502,0.3239795918367347,0.6687154218537412,1.0,4/15,15.68%,GPC3;MEGF8;UGDH;MKKS
prerank,regulation of protein localization to membrane (GO:1905475),0.3928316568916357,1.0753092212991813,0.37404580152671757,0.9552898068404235,1.0,10/28,17.65%,GPC4;SPTBN1;GPC5;NECAB2;FYN;AR;LDLRAP1;ZDHHC2;CDK5;GPC6
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4486771155867795,-1.0749499819353228,0.38461538461538464,0.6684046863712032,1.0,3/10,22.29%,AP2A1;AP2S1;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4486771155867795,-1.0749499819353228,0.38461538461538464,0.6684046863712032,1.0,3/10,22.29%,AP2A1;AP2S1;AP2B1
prerank,response to thyroid hormone (GO:0097066),-0.42151045730341313,-1.0747884985097913,0.38636363636363635,0.6680165920532816,1.0,5/13,17.66%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,response to endoplasmic reticulum stress (GO:0034976),0.31487657483948667,1.074315063975406,0.34776902887139105,0.9574527320381657,1.0,39/107,24.52%,PIK3R1;ITPR1;MBTPS2;SEC16A;PIK3R2;CASP4;SEL1L;CREB3L2;ATP2A2;HERPUD1;TMX1;DNAJB12;RCN3;TP53;DNAJC10;USP19;CREB3L1;HSP90B1;EIF2S1;BAG6;HSPA5;BAK1;BRSK2;UBXN6;BBC3;EIF2AK3;DDRGK1;RHBDD1;MBTPS1;TNFRSF10B;ATG10;ATF6B;DDIT3;EIF2B5;ATF4;TMEM117;GORASP2;CCDC47;OS9
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.43965153841563953,1.0741664504936932,0.37435008665511266,0.956764203782876,1.0,4/16,18.00%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,cellular response to drug (GO:0035690),-0.3498842490899282,-1.074117163804335,0.3542713567839196,0.668951487366789,1.0,7/25,10.80%,PPM1E;MEF2C;ACER2;TFRC;PPM1F;RBM22;KCNQ1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.39389543161411883,1.0739225337574734,0.358974358974359,0.9564419225186798,1.0,8/29,15.04%,RBM24;FMR1;DND1;TAF15;PAIP1;TENT5A;EIF4ENIF1;GDNF
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.40904905940571246,-1.0737982761489795,0.35903614457831323,0.6689167696957375,1.0,5/14,19.40%,RAPGEF2;PRKAR2A;PRKAR2B;SIRT1;ADRB2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3347447558130428,1.073501546279528,0.3524590163934426,0.9566535757730651,1.0,7/68,6.37%,ENPP1;MMAB;PDXK;MCCC1;GSTO2;MTRR;MTHFD1L
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2816964878103351,-1.07331687851776,0.30716723549488056,0.6693470358347452,1.0,23/59,24.33%,ROCK2;ERC1;IRAK2;UBB;AZI2;NFKBIA;NKIRAS1;TAB2;TICAM1;TBK1;UBC;TNFRSF1A;AKT1;TRADD;TIFA;LY96;UBA52;TLR7;IKBKB;BCL10;IKBKG;BIRC3;REL
prerank,regulation of autophagy (GO:0010506),-0.23326066817461383,-1.0729325015267057,0.22556390977443608,0.6695317324713186,1.0,64/216,20.92%,PRKAG2;DAPK1;FOXO1;LEPR;RNF152;FOXK1;KDM4A;MCL1;ACER2;VPS35;EXOC4;ATG13;RASIP1;SREBF2;PRKAA2;ATF6;SH3BP4;TRIM5;FBXL2;TRIM14;GSK3B;MTMR9;SNX32;CASP3;DAPL1;MAPT;LAMTOR5;TLK2;BAD;SNX6;PIK3CB;EEF1A1;RRAGC;TMEM59;OPTN;PIP4K2C;HSPB1;GAPDH;TAB2;PRKAG3;LAMTOR3;VPS29;BOK;ATM;RAB39B;KAT5;TICAM1;ERN1;UCHL1;MET;PRKAA1;TRIM27;GPR137;ATP6V0E2;AKT1;RRAGB;ATP6V0A2;HGF;TBC1D14;EXOC8;HDAC6;PIM2;PSAP;ATG101
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4340373471638565,1.0727169409041246,0.3864406779661017,0.9580627901716152,1.0,6/15,22.34%,TLR6;TLR4;EIF2AK2;MYD88;DHX33;NLRP2B
prerank,import into cell (GO:0098657),0.36213648404365467,1.0725183057531051,0.35066864784546803,0.9575131016202901,1.0,5/41,4.79%,SLC1A3;SLC6A13;ATP1A2;SLC12A6;SLC7A8
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.42686754551161327,-1.0724433922618197,0.37757437070938216,0.6699849648423216,1.0,11/12,57.35%,SLC11A1;CCR2;ZBTB1;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A;IL1B;PRKCQ
prerank,positive regulation of cell population proliferation (GO:0008284),0.27710157736865204,1.0722030486891183,0.29957805907172996,0.9573329146417051,1.0,76/423,15.69%,PDGFRA;PTN;IL34;NTRK3;LAMC1;LAMB1;NRG1;EDN3;HOXC10;PTGFR;MEIS1;HDAC1;WNT5A;NTRK2;TCF7L2;PTEN;PHIP;ERBB4;C5AR1;ITGAV;FLT3LG;TSLP;FGFR1;GAB2;MEIS2;TIPIN;GJA1;POU3F3;FBXO5;TBX3;GCNT2;HTR2B;CDC7;IRS1;PRKCI;SIRT6;IRS2;FXN;PTK2;CDK13;HTR1A;GLI1;CCKBR;LGMN;CACUL1;TSPYL5;ZFPM2;SLC25A33;NAP1L1;RTKN2;TGFBR1;SOX9;CD86;IGF2;GAREM1;FAM98B;S1PR2;CD81;DHPS;LYN;PIM1;FOXM1;DOT1L;CLEC11A;NME1;F2R;GDNF;DHX9;FGF5;CIAO1;CNOT7;MAP3K3;AREG;AR;MYC;FGFR2
prerank,regulation of vasoconstriction (GO:0019229),-0.3441547756295923,-1.0719860355444109,0.35638297872340424,0.6703645136802956,1.0,7/27,6.59%,CAV1;BMPR2;ADRA1B;ZDHHC21;ACE;BDKRB2;ATP2B1
prerank,positive regulation of neuron differentiation (GO:0045666),0.36169262836409394,1.071875363641714,0.36615384615384616,0.9571898322592697,1.0,15/40,25.12%,ZEB1;TCF4;FGFR1;REST;BEND6;NRCAM;IMPACT;BRINP1;BMP2;RHOA;MMD2;ZC4H2;TRIM32;CPNE1;VWC2
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3036082602336386,-1.0716895723293034,0.3460410557184751,0.6703747443190758,1.0,15/44,17.74%,ROCK2;PRR5L;ZC3HAV1;CELF1;CNOT8;BTG2;RC3H1;CPEB3;TNRC6A;TNRC6C;POLR2G;TOB1;PABPC1;GTPBP1;AGO2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.40776915877136266,1.0713771709015052,0.3859060402684564,0.9576609724307079,1.0,4/22,10.02%,IL2RA;FANCA;BCL6;KAT2A
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.489123744966791,1.0713498281322675,0.38825757575757575,0.9565798739923387,1.0,5/10,15.33%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,synaptic vesicle recycling (GO:0036465),0.38501145546603643,1.0711397570573813,0.3786707882534776,0.9561266827203369,1.0,10/31,19.06%,CEL;VAMP2;OPHN1;SYT7;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3008678190775697,1.0710837447653587,0.336094674556213,0.9551659891220827,1.0,33/149,18.13%,ROR1;EDA2R;EDA;WNT5A;CD40;IL18RAP;MTPN;TLR6;PRKCI;FLOT2;CAPN3;TRIM37;TRIM8;PRKD1;PRKCB;IL1RAP;TLR4;IRAK1;EIF2AK2;PYCARD;RTKN2;RNF31;TIRAP;RIPK1;UBE2V1;CLU;DHX9;AR;ZBTB7A;LGALS9;MYD88;ADAM8;CAMK2A
prerank,negative regulation of growth (GO:0045926),-0.24732002629498237,-1.071029589757758,0.2978723404255319,0.6712034986911202,1.0,60/121,30.47%,APBB2;PTPRJ;SLIT2;FHL1;NOTCH2;BMPR2;OSGIN2;SMARCA4;SMARCA2;NOTCH1;TGFB2;CCN3;SH3BP4;PPP2R1A;PRDM11;IP6K2;SOX17;ACVRL1;SMAD3;MT2A;NPR1;HYAL1;SFRP1;ENO1;ING4;CDKN2AIP;CDKN1A;SIRT1;VGLL4;DCUN1D3;ING5;RBBP7;FGFR3;APBB1;WNT11;RERG;RTN4;SPHK2;NDUFA13;CCAR2;CDA;BTG1;HYAL2;PNPT1;MT3;RB1;HSPA1A;SMAD4;DNAJB2;SESN2;HSPA1B;MINAR1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3230981794572436,1.0710044788692876,0.3293172690763052,0.9542537249628484,1.0,22/84,18.01%,RBFOX1;TRA2B;NOVA1;RBM24;REST;FMR1;PRDX6;KHDRBS3;DDX17;WTAP;CELF4;SMU1;CWC22;RBFOX3;SNW1;SRSF10;ZBTB7A;SRSF9;HNRNPL;RBM5;SRSF6;KHDRBS1
prerank,cellular glucose homeostasis (GO:0001678),0.3613672946642179,1.0709251935454618,0.34911242603550297,0.9533436858381488,1.0,10/41,13.67%,PIK3R1;ZBTB20;TRA2B;NGFR;PIK3R2;ADCY8;PRKACA;GCK;LRRC8A;SLC39A14
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3086206756617999,-1.0707106206576158,0.3494809688581315,0.6712503378553095,1.0,6/41,9.68%,PTGS1;PLA2G4A;MGLL;ACOT8;CYP1B1;GPX1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4381005262109481,-1.0705587424282403,0.41517857142857145,0.670870691102728,1.0,6/11,24.71%,YBX3;PELI1;CASP8;NUPR1;BIRC3;SLC25A4
prerank,regulation of ruffle assembly (GO:1900027),-0.35042339779169357,-1.0705332495099753,0.34574468085106386,0.6701440219078819,1.0,5/23,8.57%,CAV1;RDX;KANK1;NDEL1;EPS8L2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3376762230760595,-1.0703543487286713,0.3314447592067989,0.6698112701205662,1.0,12/26,30.18%,ST3GAL4;B4GALT5;TPI1;LARGE1;RRM2B;GCNT1;ST3GAL2;GAL3ST2;ST8SIA6;SCCPDH;RRM1;GK5
prerank,skeletal muscle tissue development (GO:0007519),0.3808690100948448,1.070321794356609,0.37883435582822084,0.9541998732922086,1.0,2/32,0.78%,SVIL;MSC
prerank,cardiac muscle cell development (GO:0055013),0.4159378944711391,1.0702690715003356,0.38202247191011235,0.9532152325634967,1.0,1/20,0.15%,PDGFRA
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4326583847308031,1.0697922609497297,0.3733108108108108,0.9536077014992191,1.0,8/16,17.55%,CDK13;DDX17;CELF4;SLU7;RBM17;DHX9;SRSF9;SRSF6
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.34553622269342593,-1.0695358076735202,0.34864864864864864,0.67103044453707,1.0,8/25,22.74%,LAPTM4B;CHMP2B;VCP;CHMP7;CHMP4B;CHMP4A;CHMP1A;CHMP4C
prerank,N-terminal protein amino acid modification (GO:0031365),0.4553166829792205,1.0691469141377072,0.3606837606837607,0.9545435373041239,1.0,3/14,9.40%,NAA10;METAP1D;NAA50
prerank,chromosome organization (GO:0051276),0.31371629580349186,1.0690633807243042,0.3474358974358974,0.9536822827245666,1.0,28/99,22.42%,HDAC1;L3MBTL1;TCF7L2;COPS3;TOP2B;MSH3;SOX2;XPC;POLE3;HMGN3;CDT1;COPS4;CENPW;HDAC10;DOT1L;MYC;ZBTB7A;SAFB;LDB1;TOP2A;MSH6;NUP155;CUL4A;DDB1;GATAD1;PWWP3A;EHMT1;ABL1
prerank,placenta development (GO:0001890),0.4624600261147326,1.0689125564009025,0.38286713286713286,0.953030325429462,1.0,3/12,17.54%,ADAM19;PTK2;CUL7
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3224209563976836,-1.068863411752686,0.3386243386243386,0.6718324532414526,1.0,15/33,26.92%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;ANKZF1;PRKCD;SIRT1;HDAC6;TNFAIP3;PPIF;OSER1;RHOB;PARK7;ECT2
prerank,positive regulation of ossification (GO:0045778),0.36753357972592915,1.0686408763624244,0.34915773353751917,0.9527737020758722,1.0,4/39,1.69%,PTN;GPM6B;WNT5A;ADGRV1
prerank,bone development (GO:0060348),-0.3102844390438554,-1.0685987808265953,0.36303630363036304,0.6716856852297264,1.0,8/39,8.04%,RANBP3L;CYP26B1;GNAS;RPL13;SKI;SULF2;SH3PXD2B;LRP6
prerank,regulation of NMDA receptor activity (GO:2000310),0.3827839847104886,1.0685344966812769,0.3793103448275862,0.9519781288014252,1.0,10/32,13.37%,GRIA3;GRIN2B;GRIA4;DLG3;GRIA1;DLG2;GRIN2A;RELN;DLG4;LRRC7
prerank,toxin transport (GO:1901998),0.5003189487257771,1.0683809604942969,0.41320754716981134,0.9513305864952329,1.0,4/10,16.25%,ANTXR2;RAB40B;RAB29;ANTXR1
prerank,fatty acid catabolic process (GO:0009062),0.3345624007498325,1.0682311865251959,0.36666666666666664,0.9506708569779071,1.0,17/67,19.10%,LPIN3;CEL;ABCD2;PEX2;PPARD;ACADL;ACADS;ACAT2;SLC25A17;NUDT19;PECR;LPIN2;MCEE;MMAA;MMUT;ALDH3A2;ECI2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.37920493381685916,-1.0679129452508105,0.34430379746835443,0.6726027336750915,1.0,8/18,14.21%,HIP1R;GSK3B;BAX;BID;SLC25A5;BOK;ZNF205;ACAA2
prerank,pre-miRNA processing (GO:0031054),0.4503852544976686,1.0677558943444867,0.3754325259515571,0.9510372598983392,1.0,6/14,17.43%,AGO4;LIN28B;MRPL44;AGO3;ADAR;AGO1
prerank,ventricular septum morphogenesis (GO:0060412),-0.3316543272908487,-1.0675462846625277,0.3305084745762712,0.6727234739329241,1.0,15/27,22.41%,SLIT2;ROBO1;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;CITED2;HEYL;HEY2;TGFBR3;SOX11;TGFBR2;SMAD7;APLNR
prerank,regulation of lipid metabolic process (GO:0019216),0.3206966556456677,1.0675042867798752,0.34296977660972405,0.9507086169941258,1.0,25/88,21.45%,RORA;PPARA;NCOA2;PPARD;C1QTNF2;SC5D;IRS2;CHD9;NCOA1;EDF1;HMGCS1;MBOAT7;CARM1;SREBF1;MED1;ELOVL6;NR1D2;IDI1;PANK2;NPC2;SP1;RARRES2;BBS4;CREBBP;ACACA
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.31855038203468566,1.0674521492322018,0.34536082474226804,0.9497306329518624,1.0,16/90,10.24%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;FABP5;SIRT6;EPAS1;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2
prerank,regulation of receptor internalization (GO:0002090),-0.30752938950761394,-1.0671754283584345,0.33516483516483514,0.6728496594179239,1.0,14/35,27.47%,MAGI2;RIN3;INSR;CD63;EGF;TBC1D5;SDCBP;MTMR2;ANKRD13D;GREM1;NTF3;FLOT1;ARRB2;ARF1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.37124393637845515,1.0669699469787892,0.3746031746031746,0.9501126317260338,1.0,11/37,13.76%,TENM3;GRID2;TENM4;DCHS1;TENM2;ADGRL1;TENM1;AMIGO3;CBLN1;CADM3;NECTIN3
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.36442981991863893,-1.0668040228766884,0.3394736842105263,0.6730384775443568,1.0,6/21,11.51%,PGM2L1;DERA;HK1;TALDO1;HK2;PGM2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.378524010384635,1.066089857741518,0.36959761549925485,0.951854983009816,1.0,11/32,17.54%,CDKL5;NEDD4;CAPRIN1;CDKL3;ADGRB3;CUX2;SDC2;TNIK;IL1RAPL1;HECW1;CUL7
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4360165503678518,-1.0660083264665143,0.3775280898876405,0.6742325160421183,1.0,4/11,24.58%,PARP10;PARP9;PARP4;PARP12
prerank,DNA methylation (GO:0006306),0.4050021231606372,1.065816178870872,0.37694704049844235,0.9515783802282911,1.0,9/23,22.26%,KMT2E;FOS;MTRR;N6AMT1;DMAP1;DNMT3A;EHMT2;EHMT1;ATRX
prerank,response to organophosphorus (GO:0046683),0.4342146317381943,1.0655907078708842,0.3567753001715266,0.9511797451610837,1.0,7/16,22.56%,DGKQ;TRPC3;RFC3;P2RX4;NDUFS4;ABCC9;STAT1
prerank,response to zinc ion (GO:0010043),0.395813489332738,1.06518573966442,0.37209302325581395,0.9513874636909871,1.0,6/25,13.25%,PAM;SLC30A5;SLC30A3;GLRA1;P2RX4;GLRA2
prerank,regulation of cell projection organization (GO:0031344),0.45581172872582987,1.065100597007493,0.37544483985765126,0.9505286497681321,1.0,4/13,18.47%,ERMN;NTNG2;NTNG1;SPRY2
prerank,miRNA metabolic process (GO:0010586),-0.3661426849484798,-1.0650911824398426,0.35141509433962265,0.67570057989388,1.0,5/20,7.09%,DGCR8;TUT7;PARN;DROSHA;DICER1
prerank,defense response to tumor cell (GO:0002357),0.48629382943099136,1.0648444988044778,0.38420107719928187,0.9502089668586987,1.0,2/10,4.08%,DLEC1;RBMS3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4238051619587522,-1.0647955049539388,0.39400921658986177,0.6756830497687816,1.0,6/12,25.57%,SMCHD1;CDYL;PCGF5;RBM15B;RLIM;BRCA1
prerank,regulation of hormone secretion (GO:0046883),0.4355713064036031,1.064667857478279,0.3976311336717428,0.949629126105337,1.0,2/15,4.74%,EDN3;VAMP2
prerank,response to muscle stretch (GO:0035994),0.43520152124812483,1.0645458403889494,0.36502546689303905,0.9489120190783691,1.0,3/15,7.60%,RYR2;SLC9A1;PTK2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.47577467538766716,1.064183801069102,0.39473684210526316,0.9489400275051761,1.0,4/10,17.70%,GALNT13;POGLUT3;GALNT2;POGLUT2
prerank,neuron remodeling (GO:0016322),-0.45070540760450034,-1.0640594255441962,0.397196261682243,0.676679104968938,1.0,3/10,5.81%,ANKS1A;APP;SCARF1
prerank,cellular protein modification process (GO:0006464),-0.20127929312073978,-1.0632672686142195,0.0,0.6778918165449341,1.0,293/982,24.12%,PRKAG2;FN1;ST3GAL6;DAPK1;PTPRB;FBXL7;MAP3K1;ROCK2;PRKCH;PPM1E;MARK1;ERG;PTPRJ;ST8SIA4;B3GALT1;DCLK1;TRIB2;FER;PTPRK;LMO7;THBS1;PTPN3;IGFBP5;GAN;APP;MTM1;CPE;CST3;PTP4A2;FSTL1;BMPR2;ASB2;KLHL13;PTPN4;CSNK1D;MARK4;PSMC6;PPM1L;ST3GAL4;MAP3K5;IGFBP3;NEK6;PRKDC;INSR;PTPN14;CAMK2D;WWP2;PTPRG;PSMD9;TGFB2;SOCS2;ART3;EGLN3;GPC3;WNK4;MINK1;HIF3A;UBE2D3;B4GALT5;SIK3;PSMF1;PRKAA2;PSMB7;ST3GAL1;ANXA1;TLK1;ADAM10;OGA;SERPIND1;SNRK;CDK17;MAPK9;PPP2R1A;WNK1;CUL1;CDK6;PTPRF;ST6GALNAC2;HIPK3;PRSS23;FBXL2;SIRT3;PRAG1;NRBP2;SIK1;NUCB1;PPM1F;CCN1;BMX;HIPK1;TNKS2;GSK3B;APOE;UST;ZC3HAV1;FNIP2;RAB5A;MSLN;ACVR1;CDC42BPB;MGAT1;UBE2F;ACVRL1;LARGE1;TNC;LAMB2;TLK2;NEK7;STK38L;MANBA;ST3GAL3;RPS6KA5;KLHL11;CDK19;DYRK2;PSMD8;NGLY1;CTTNBP2NL;DCAF8;LIPE;PIGU;FBXL19;PIK3CD;SSH1;PSMD12;ASB5;PPEF2;PPM1D;KLHL20;RAB13;SHISA5;CAMK2B;PARP10;PARP9;ST8SIA2;PPP3CC;VHL;PTPN1;CDKL2;CUL9;SPSB4;GPAA1;NEURL2;RET;LHPP;FASTK;SRPK1;PRKCZ;TGM2;KCTD6;PSMA3;HIPK2;CSNK1G3;UGCG;PRKAG3;B3GALNT1;FUT9;PRKG1;GOLM1;FBXL4;PSME3;BCR;PSMA6;LOXL1;MMP15;RAB38;PTK2B;PSMD4;ATM;PSMD7;PPP2R5D;RNASEL;ST3GAL5;ELOC;F5;TBCK;ERN1;USP25;PSMB6;PSMC1;CDC42BPG;MARK3;STK17B;CREB1;STK25;CHRDL1;PRKCD;SIRT1;SBF1;FBXO32;PARP4;PRKAA1;UBE2L6;DYRK1B;ST3GAL2;TBK1;PAK2;PKN2;PSMB10;DCUN1D3;FBXL14;NEDD8;CUL3;RAB1A;ISG15;OARD1;ASB7;FNTB;NAA80;ACVR2B;RBBP7;B3GNT2;ERBB2;QPCT;AATK;MFGE8;AKT1;YES1;STT3B;TEC;PPP2R5B;CDK9;MAN2A1;CCDC8;WNT11;PRKG2;SIRT5;NUAK2;PPP1CB;MAP4K3;MARK2;VRK2;PSME2;MTMR2;CSNK1A1;KLHL25;MCRS1;NUS1;KLHL3;MKNK1;DNAJC3;PTPN5;RAB1B;MACROD1;ASB8;PKN3;GPS1;PSMC3;CDC34;PIM2;TGFBR2;ICMT;KBTBD7;ASB6;PENK;SOCS5;WDR45;NEK10;PIGK;TTBK1;CDKL4;FBXW2;UBA52;FBXL8;FBXO22;ST8SIA6;B3GNT9;BRD2;CISH;PHEX;FSTL3;PASK;STK39;SOCS3;PLK4;FN3K;PSMA8;CTDP1;IKBKB;FBXO10;TAOK2;NIM1K;PAK4;F13A1;COQ8A;MPI;FBXL18;CDK16;ACVR2A;PTPRE;IKBKE;RSKR;BAP1
prerank,cellular iron ion homeostasis (GO:0006879),-0.289946507274275,-1.063256357252706,0.3501683501683502,0.6771290338836805,1.0,28/55,32.56%,ABCG2;HMOX2;TFRC;CUL1;SCARA5;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;FTH1;CCDC115;TMEM199;NUBP1;ATP6V1G1;SLC11A2;SMAD4;SLC11A1;ALAS2;BMP6;LCN2;IREB2;HMOX1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.26157567347861305,-1.0630374436357795,0.3574468085106383,0.6769141682724935,1.0,34/95,22.34%,SMAD6;DKK3;CAV1;LEMD3;LTBP4;THBS1;SKIL;SKI;DAB2;GIPC1;CD109;UBB;ASPN;SNX25;SMAD3;SMURF2;PRDM16;CITED2;SNX6;BCL9L;SPRED3;HIPK2;SIRT1;UBC;TGFB1I1;TGFBR3;SOX11;HTRA4;SDCBP;VASN;TGFBR2;ADAMTSL2;UBA52;SMAD7
prerank,cellular response to ATP (GO:0071318),0.45097877845933404,1.0629055032068326,0.3961352657004831,0.9520524986886026,1.0,4/14,13.85%,P2RY1;P2RX4;HSP90B1;RYR3
prerank,sterol transport (GO:0015918),0.4219702709835503,1.062823768800533,0.387987012987013,0.9511792599231262,1.0,8/19,26.27%,NPC1L1;LDLRAP1;ARV1;NPC2;OSBP;OSBPL5;MSR1;LCAT
prerank,protein polyubiquitination (GO:0000209),-0.2218324724891721,-1.0625815486937702,0.23809523809523808,0.6773133322992332,1.0,88/297,23.81%,FBXL7;WWP1;RNF152;LMO7;UNKL;RNF146;UBE2G1;PSMC6;PELI1;WWP2;PSMD9;ARIH1;CDC23;UBE2D3;PSMF1;PSMB7;TRIP12;ANAPC10;TRIM5;CUL1;UBB;TRIM14;TNKS2;HERC6;IFI27;UBE2H;RNF8;TRIM36;SMURF2;PSMD8;RC3H1;FBXL19;UBE2A;RNF125;PSMD12;ZFP91;RNF144B;KLHL20;RNF41;RNF114;UBR2;PSMA3;FBXL4;PSME3;UBE3D;PSMA6;AMFR;UBE2N;PSMD4;PSMD7;PSMB6;PSMC1;TRAF3;ANAPC13;FBXO32;UBE2L6;PSMB10;TRIM27;FBXL14;CUL3;UBC;SIAH2;ANAPC11;ANKIB1;CHFR;PSME2;KLHL3;PSMC3;CDC34;FZR1;PRPF19;RNF166;KBTBD7;RNF5;TRAF1;RFFL;ANAPC2;FBXW2;MKRN1;UBA52;FBXL8;TNFAIP3;FBXO22;RLIM;PSMA8;FBXO10;FBXL18;RNF20
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4009211352596279,1.0624378286700908,0.3744,0.9512376892060596,1.0,7/24,12.20%,TRPS1;LOXL2;SOX6;ZBTB16;ADAMTS12;TGFBR1;SOX9
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3928957369298198,1.0623938193299423,0.3748125937031484,0.950253483684368,1.0,7/28,15.08%,CCDC22;PTEN;FMR1;PTK2;PSMC5;AXIN1;CLU
prerank,cytoplasmic microtubule organization (GO:0031122),-0.28690606416503917,-1.0623873828858965,0.3377049180327869,0.677069028823393,1.0,18/54,19.93%,FIGN;EZR;HOOK1;TUBGCP5;MAPT;KATNAL2;FIGNL2;CRIPT;CCDC88A;SLAIN2;DYNC1H1;TRPV4;CCDC88C;DST;DLG1;CAMSAP2;CIB1;NUMA1
prerank,cellular response to interferon-gamma (GO:0071346),-0.2643780265363869,-1.0623265775200939,0.28773584905660377,0.6764294623244835,1.0,20/88,11.80%,DAPK1;GBP7;SIRPA;NCAM1;CAMK2D;TRIM25;GBP5;TRIM5;B2M;IRF2;CD44;GBP4;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G;GBP6;GAPDH
prerank,mitotic DNA replication (GO:1902969),0.4826339965903503,1.0622227377588318,0.39862542955326463,0.9497001130558923,1.0,7/10,27.05%,GINS3;POLA1;MCM4;MCMDC2;GINS1;MCM3;MCM2
prerank,cilium assembly (GO:0060271),0.28141298900082756,1.0613910093396708,0.33837837837837836,0.9513325456743357,1.0,75/296,20.62%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;DCTN3;HAUS3;DYNC2LI1;RSPH9;HAUS1;GBF1;RAB8A;CCDC57;DCTN2;DISC1;DNAAF3;E2F4;IFT81;FAM161A;HAUS8;KIFAP3;CEP192;PRKACA;TTC21B;SNAP29;CEP135;CCDC65;AHI1;RPGRIP1;TCTN2;IFT74;EXOC7;EXOC1;ASAP1;SSNA1;BBIP1;TMEM67;IQCB1;TNPO1;GAS8;IFT88;SSX2IP;RFX2;CEP126;ACTR2;RAB11FIP3;TXNDC15;TRIP11;SCLT1;KIF3C;DYNLL2;CEP250;CEP152;PTPDC1;CCDC39;CSNK1E;CLASP1;ALMS1;CLUAP1;IFT43;PCM1;BBS1;CEP19;WDR90;ATP6V0D1;TUBA1A;MKS1;DZIP1L;NUDCD3;KIF3A;CEP43;UNC119B;TTC39C
prerank,regulation of superoxide anion generation (GO:0032928),-0.39753189137648604,-1.0611069203847847,0.37948717948717947,0.6787834774140017,1.0,9/14,50.70%,MAPT;PRKCD;TYROBP;ITGB2;AATF;CRP;GSTP1;F2RL1;CD177
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.469603840555668,1.061095908605754,0.409009009009009,0.9511860605619367,1.0,3/12,5.30%,NUP214;AAAS;NEDD4
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.3740294032916725,-1.0610233106081082,0.37965260545905705,0.6782252139202511,1.0,13/19,39.44%,DRG1;CHMP2B;CHMP4B;CHMP1A;PDCD6IP;CHMP4C;HSPA1A;CHMP2A;HSPA1B;TPR;HNRNPU;PLK1;CHMP3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.37219025370478526,-1.0608873181934335,0.35789473684210527,0.6777893898734646,1.0,6/19,9.95%,MEF2C;RBPJ;RBP4;NOTCH1;RUNX1;TBX2
prerank,positive regulation of protein polymerization (GO:0032273),-0.2812298059239949,-1.0608547099146795,0.3333333333333333,0.6770900178180308,1.0,18/65,21.83%,BAIAP2L1;OCLN;FER;DRG1;RAC1;NCK1;MAPT;ARL2;SLAIN2;LMOD1;PTK2B;BAIAP2;MET;TPPP3;CDK5RAP2;NUMA1;FES;TTBK1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3904546965041663,1.0606754175141069,0.39622641509433965,0.9514576400706609,1.0,4/29,14.10%,STAG3;ZCWPW1;TEX11;BAG6
prerank,purine nucleotide biosynthetic process (GO:0006164),0.45989479664231775,1.0606008040270245,0.3957597173144876,0.950588153202104,1.0,8/12,29.61%,AMPD2;PRPS1L1;PRPS1;MTHFD1;HPRT1;PRPSAP2;GART;PRPSAP1
prerank,GTP metabolic process (GO:0046039),0.4458407122408073,1.0603781704188213,0.38581314878892736,0.9501714025996034,1.0,9/15,21.89%,LRRK2;AK4;OPA1;ENTPD7;MFN1;AK3;EFL1;IMPDH2;GNAI3
prerank,tetrapyrrole metabolic process (GO:0033013),0.4230694653159885,1.060198700674577,0.4022801302931596,0.9496497661315635,1.0,5/18,17.26%,MMAB;MTRR;ABCB6;MMAA;MMUT
prerank,regulation of immune response (GO:0050776),0.3008152908955248,1.0600420725615853,0.3546099290780142,0.9490102662397893,1.0,17/135,10.03%,COLEC12;TREML4;CD40;CD8B;PIANP;CD276;PTPN22;COL1A2;DHX58;SH2D1A;BCL6;OSCAR;ADCY7;CD200R1;APPL2;BIRC2;FGR
prerank,determination of left/right symmetry (GO:0007368),-0.3100952302671487,-1.0594991968162173,0.3457142857142857,0.6797627838693381,1.0,15/36,20.78%,NOTCH1;OFD1;SMO;MEGF8;ARL6;TBX1;CITED2;RFX3;GALNT11;ZIC3;MKKS;ENKUR;DNAH11;BBS7;DNAH5
prerank,positive regulation of axon extension (GO:0045773),-0.3557049993621361,-1.0591583649965508,0.38571428571428573,0.679854581620309,1.0,8/22,13.42%,NTN1;SEMA7A;NRP1;RUFY3;MEGF8;MAPT;GOLGA4;MACF1
prerank,cellular response to insulin stimulus (GO:0032869),0.30398740947093195,1.058815433262441,0.3615477629987908,0.9519006058306,1.0,23/124,13.67%,ENPP1;LPIN3;PIK3R1;CPEB1;PHIP;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;GCK;SLC25A33;RAB15;PDK2;GSK3A;IGF2;ATP6V0E1;SLC39A14
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2676506679957576,-1.058461006214877,0.2972972972972973,0.6807917827995859,1.0,20/79,16.33%,ST3GAL6;IGF1;CSGALNACT1;ST8SIA4;B3GALT1;BMPR2;ST3GAL4;B4GALT5;ST6GALNAC2;CHST11;MGAT1;LARGE1;ST3GAL3;FOXL1;ST8SIA2;B3GALNT1;FUT9;ST3GAL5;GCNT1;ST3GAL2
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.47646923004471453,1.0581562679750944,0.40640809443507586,0.9529642194759321,1.0,2/10,5.21%,SEMA5A;CARMIL2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4520817985752007,1.0580259386911122,0.3912310286677909,0.9522647819672193,1.0,1/13,0.09%,IL33
prerank,positive regulation of exocytosis (GO:0045921),0.3666415851865437,1.0578884292906072,0.37329286798179057,0.9516190848845602,1.0,12/35,19.32%,CADPS2;CADPS;RAB15;HGS;TSG101;CLASP2;SNF8;CLASP1;RAB2B;VPS4B;STXBP5;ATP6AP1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.40376289442777197,1.0578470681334144,0.39907550077041604,0.9506717669233445,1.0,4/22,9.21%,ZBTB20;PPARA;PPARD;MTOR
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4752513740749141,1.0577642866529526,0.4010889292196007,0.949856116963411,1.0,3/10,14.97%,ADGRV1;IFT88;PDZD7
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3700111985792026,1.0577018246418115,0.3993993993993994,0.9489608997458209,1.0,3/34,4.98%,XCL1;WNT5A;PTPN22
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3262556680957434,1.0576463788487274,0.37467362924281983,0.948059620658976,1.0,13/70,15.90%,LPIN3;GPLD1;NR1H2;CHAT;LIPC;PLA2G7;CHKA;MBOAT7;PLA2G12A;STARD10;CSNK2A2;LPIN2;ABHD4
prerank,response to cAMP (GO:0051591),-0.31377648456451057,-1.0574702440418575,0.35435435435435436,0.6824860436544955,1.0,11/37,23.70%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,regulation of cellular protein localization (GO:1903827),-0.2995115202834973,-1.056578303434372,0.35555555555555557,0.6839105992778746,1.0,16/45,18.18%,VCPIP1;NDEL1;GPC3;PRKAA2;DVL1;PPM1F;VCP;MAPT;PTPN1;SUMO3;RALB;TOR1A;PRKAA1;KCNAB2;HFE;EGF
prerank,protein localization to kinetochore (GO:0034501),-0.4056272927861586,-1.0565301723191889,0.40271493212669685,0.6832537537705526,1.0,8/14,31.82%,MTBP;ZW10;CENPT;BUB3;RCC2;IK;TTK;ZWILCH
prerank,regulation of macroautophagy (GO:0016241),-0.257096247823235,-1.056448354255348,0.3033175355450237,0.6826975173198887,1.0,33/105,21.84%,PRKAG2;KDR;VPS35;EXOC4;ATG13;SESN1;PRKAA2;NRBP2;SNX32;CASP3;LAMTOR5;SNX6;BNIP3L;RRAGC;CLEC16A;GAPDH;PAFAH1B2;PRKAG3;LAMTOR3;ERN1;UCHL1;SIRT1;PRKAA1;TBK1;ATP6V0E2;AKT1;RRAGB;ATP6V0A2;EXOC8;HDAC6;ATG101;ATP6V0D2;ATP6V0A1
prerank,regulation of telomerase activity (GO:0051972),-0.2957956665555171,-1.0564471751522837,0.358974358974359,0.6819236308354353,1.0,11/45,15.98%,HMBOX1;KLF4;PTGES3;SMG6;PARN;NEK7;MAP2K7;CCT4;ATM;MAP3K4;PARP4
prerank,cellular response to peptide (GO:1901653),0.33821335411849784,1.0564252466918336,0.3594405594405594,0.9510086169514361,1.0,13/56,11.33%,LRP1;GJA1;NGFR;CASP4;PTPN22;ATP1A3;TLR6;GRIN2A;LGMN;TLR4;GRM5;TP53;FYN
prerank,mRNA modification (GO:0016556),-0.35681002539790985,-1.0563707741647623,0.372972972972973,0.6813297793646559,1.0,4/22,8.56%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,apoptotic DNA fragmentation (GO:0006309),0.42399271008026973,1.0563611207152548,0.39057239057239057,0.9501151721635162,1.0,1/16,0.49%,CECR2
prerank,regulation of establishment of planar polarity (GO:0090175),0.31701541069596073,1.0559938423101871,0.37242268041237114,0.9502363204603251,1.0,22/88,18.76%,PRICKLE2;ROR2;PRICKLE1;WNT5A;NPHP3;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMD14;PSMA7;RHOA;PSMD11;PSMA2;SPEF1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.40650412508936207,1.055771273039404,0.39052287581699346,0.9498277175736576,1.0,5/24,6.86%,PIK3R1;HRG;MAP4K4;IQSEC1;COL16A1
prerank,regulation of insulin secretion (GO:0050796),0.31177878769727435,1.0556653990360756,0.3669609079445145,0.9490924248112901,1.0,17/101,10.61%,RAPGEF4;ADCY5;NR1H4;CACNA1E;TCF7L2;ITPR1;REST;IRS1;TM7SF3;IRS2;TRH;PER2;PRKCA;KCNC2;GCK;SYT7;PPP3CB
prerank,DNA-dependent DNA replication (GO:0006261),0.30152325039257555,1.0555362426004582,0.3647342995169082,0.9484103365788276,1.0,36/128,19.00%,POLG;MCM7;PSMD1;CDC7;GINS3;PSMD10;POLA1;GMNN;PSMA5;RPA1;PSMB5;POLE4;RFC3;PSMC4;NOC3L;PSMA4;REV3L;MCM4;POLE3;RECQL;TEFM;PSMC5;CDT1;POLG2;POLB;PSMB9;DBF4;MCM10;ORC2;PSMD14;PSMA7;MCMDC2;PSMD11;WRN;PSMA2;SSBP1
prerank,bile acid and bile salt transport (GO:0015721),0.3978134788068913,1.0554695829752354,0.39184952978056425,0.947525013060232,1.0,4/24,9.08%,ABCC3;NR1H4;NCOA2;NCOA1
prerank,DNA replication (GO:0006260),0.3071169767748928,1.0554621198463112,0.35353535353535354,0.9464653705614339,1.0,21/105,14.27%,RBMS1;POLG;MCM7;TIPIN;FEN1;CDC7;POLA1;RPA1;PIF1;POLL;RFC3;REV3L;MCM4;TOP3A;NAP1L1;POLE3;POLG2;POLB;REV1;DBF4;MCM10
prerank,neutrophil mediated immunity (GO:0002446),-0.21640148079066113,-1.0553880105584552,0.21052631578947367,0.6829256363787696,1.0,120/432,21.09%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;CST3;NFKB1;BRI3;HMOX2;PYGB;IQGAP1;SIRPA;GSN;RAP1A;CD55;KCMF1;STOM;HSPA8;DERA;FUCA1;S100A11;PSMB7;ACE;RAC1;PLEKHO2;CD93;ADAM10;TOLLIP;CYB5R3;ATP11B;MAPK14;VAPA;YPEL5;CAT;B2M;CD44;MVP;VCP;RAB5C;PGLYRP1;CEP290;GYG1;RAB31;MANBA;HEXB;CAP1;EEF1A1;SRP14;PSMD12;CAB39;IST1;COTL1;GAA;CTSH;PGM2;TMC6;CD63;CMTM6;CEACAM1;DYNC1H1;PAFAH1B2;PGRMC1;PKM;ALDOC;SURF4;NIT2;GCA;LAMTOR3;GHDC;OSTF1;NBEAL2;IRAK4;PFKL;PPIA;PSMD7;HGSNAT;CPNE3;IGF2R;CTSZ;RAP2C;RAB3D;APEH;ARSB;CYSTM1;PRKCD;KCNAB2;FTL;RAB6A;ALDOA;CSNK2B;CTSS;GM2A;QPCT;ATP6AP2;RAP2B;MLEC;LAMP2;SDCBP;STK11IP;ARSA;DYNC1LI1;LRG1;RAB37;APRT;DNAJC3;DOK3;PSMC3;AGPAT2;MIF;PSAP;FAF2;IQGAP2;PGM1;GALNS
prerank,cellular response to hormone stimulus (GO:0032870),0.3286127421852577,1.0553774205660418,0.3588317107093185,0.9456205445626359,1.0,9/69,10.07%,ROBO2;GHR;ATP1A2;NCOA2;NCOA3;ATP1A3;BRD8;NCOA1;GCK
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.33226174861551244,1.055321290909403,0.3587994542974079,0.9436404338272474,1.0,24/56,25.16%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFAF7;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFB6;NDUFAF2;DMAC1;NDUFB8
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.33226174861551244,1.055321290909403,0.3587994542974079,0.9436404338272474,1.0,24/56,25.16%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFAF7;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFB6;NDUFAF2;DMAC1;NDUFB8
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.22396264677019712,-1.0550473580548405,0.2558139534883721,0.6830379246570651,1.0,47/259,12.04%,ABLIM1;RAPGEF2;ABCC4;ANO6;FGD5;ACTN2;VCL;FNBP1L;BBS9;EXOC6;RAPGEF6;MYLK;ITGB1;EZR;NTN1;CDC14A;NRP1;PARVB;S1PR1;FXYD5;GSN;EXOC4;RAP1A;RAB23;NOTCH1;MINK1;OFD1;EXOC5;RAC1;SRGAP2;ARL6;KIF24;DNM3;CYS1;CEP290;EHD4;EXOC2;CEP162;IFT140;RFX3;SPATA13;RAB3IP;CCDC88A;CD2AP;RP2;TMEM237;GALNT11
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2694986890785472,-1.0548367350865724,0.3281853281853282,0.6827918415285992,1.0,19/70,14.82%,FOXC1;PSMC6;LMO2;PRKDC;PSMD9;PSMF1;PSMB7;RUNX1;PSMD8;GATA2;PSMD12;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;TAL1;PSMB6;PSMC1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2878204285164178,1.0545183387471297,0.3684820393974508,0.9451038892090821,1.0,43/184,18.61%,DYNLL1;CDC14B;BUB1B;DCTN3;HAUS3;PSMD1;FBXO5;HAUS1;HMMR;DCTN2;CDC16;CENPE;PSMD10;ZFP36L2;PSMA5;PSMB5;HAUS8;CEP192;PRKACA;APPL2;XPC;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;CEP250;CEP152;TFAP4;CENPF;CSNK1E;CLASP1;ALMS1;PSMD14;PSMA7;PCM1;CDC26;PSMD11;PSMA2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.35767046981942124,1.0542670647138497,0.37280701754385964,0.9448205701454854,1.0,10/39,14.82%,ERCC1;FAN1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,monocarboxylic acid transport (GO:0015718),0.3455637852948816,1.0541710876094346,0.3732394366197183,0.9440254719160952,1.0,6/51,3.56%,ABCC3;SLC6A13;SLC16A12;SLC6A8;NR1H4;NCOA2
prerank,response to organic cyclic compound (GO:0014070),0.34580687670984367,1.0540968335919214,0.38764044943820225,0.9431951962878435,1.0,7/52,6.09%,GGT5;GLDC;GGT7;SPP1;KYNU;LRRK2;CDKN2D
prerank,DNA biosynthetic process (GO:0071897),0.4228041829361527,1.0537468314280312,0.38898163606010017,0.943251528120545,1.0,7/16,20.24%,CDKN2D;POLA1;POLL;RFC3;POLH;WRN;POLE
prerank,synaptic vesicle endocytosis (GO:0048488),0.3675253644165305,1.053044765262083,0.3987823439878234,0.9444158640947942,1.0,13/33,21.20%,CEL;VAMP2;ITSN1;OPHN1;DNM1;SYT5;DNAJC6;CDK5;AMPH;FCHO2;SYT1;CANX;SNAP91
prerank,negative regulation of protein polymerization (GO:0032272),-0.3425835318477993,-1.0528624054903024,0.39204545454545453,0.6870717874299892,1.0,9/27,20.75%,SLIT2;KANK3;HIP1R;KANK1;SSH1;CDH5;PRKCD;EML2;TWF2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4669238703561789,1.0526860390442554,0.39469026548672564,0.9434257281409952,1.0,2/11,8.95%,PTEN;INPP5J
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4669238703561789,1.0526860390442554,0.39469026548672564,0.9434257281409952,1.0,2/11,8.95%,PTEN;INPP5J
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4117730548196985,1.0526522974173835,0.3949579831932773,0.942461668978068,1.0,7/19,16.71%,CAMKK2;PINK1;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,positive regulation of viral process (GO:0048524),0.3330026612786235,1.0526516022398842,0.3682008368200837,0.9413975216793378,1.0,17/60,22.11%,PPARA;PPID;MDFIC;PPIH;PDE12;STAU1;AXL;NELFA;DHX9;CNOT7;ADAR;HACD3;TBC1D20;POLR2L;DDB1;NELFB;KPNA2
prerank,error-prone translesion synthesis (GO:0042276),0.4014783051547056,1.052544695833032,0.38333333333333336,0.9406591006736909,1.0,7/21,13.66%,POLK;RPA1;RFC3;POLH;REV3L;REV1;POLI
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.45337162738021086,1.0523120421198366,0.38209982788296043,0.9403542761085859,1.0,7/13,16.52%,LRRK2;AK4;OPA1;ENTPD7;MFN1;AK3;EFL1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.43531148663960073,-1.0520960242213495,0.39069767441860465,0.6882121558734369,1.0,5/12,21.44%,CSGALNACT1;FUT8;UGP2;EXTL2;GFUS
prerank,central nervous system neuron development (GO:0021954),0.4371002215701946,1.0519501458422922,0.39603960396039606,0.9403588776151925,1.0,5/15,13.86%,NTRK2;PTEN;NPY;ARHGAP35;ATP7A
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4048272777529528,1.051653413944662,0.37152209492635024,0.9402320071770961,1.0,10/21,18.34%,GPM6B;PEAK1;SLC9A1;PTK2;EPHA3;PTPRA;SLK;CLASP1;LDB1;RHOA
prerank,cell chemotaxis (GO:0060326),0.3361365131020763,1.051390866549009,0.3816689466484268,0.9399592986402809,1.0,5/60,3.25%,PDGFRA;SEMA5A;EPHB1;ACKR2;CCR9
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4598422758663387,1.0513351425775148,0.41852487135506006,0.9390678619577544,1.0,1/12,0.63%,XCL1
prerank,autophagy of nucleus (GO:0044804),0.4270127644066487,1.0511047780889946,0.4128113879003559,0.93875865303119,1.0,6/16,17.66%,ATG9B;WDR45B;RB1CC1;ATG9A;ULK2;WIPI2
prerank,neuromuscular synaptic transmission (GO:0007274),0.4196440092850454,1.0511038484699982,0.39429530201342283,0.9377091850180953,1.0,4/18,10.61%,CHRNB4;CHAT;FCHSD2;ERC2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.32296277630724946,-1.0510822611268036,0.3652694610778443,0.6900084250670344,1.0,10/31,13.77%,IGF1;CSGALNACT1;BMPR2;NDST3;EXT1;UGDH;CHST11;FOXL1;GLCE;HS3ST3B1
prerank,organelle fusion (GO:0048284),-0.36562486596139265,-1.051018130844155,0.3484848484848485,0.6893880367148355,1.0,8/22,20.14%,EEA1;VPS18;MIEF1;USP30;BAX;VPS11;CHCHD3;MIGA1
prerank,neuronal action potential (GO:0019228),0.40440569968380274,1.0509950641471397,0.38366718027734975,0.9370119793390601,1.0,6/22,21.63%,ANK3;CACNA1G;SCN1A;SCN2A;SCN8A;CACNA1I
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.28559168928259515,-1.0507044768281242,0.3464285714285714,0.6894246572922328,1.0,27/57,30.02%,RPS16;RPL5;RPS7;RPS19;RPS24;RPS15;RIOK1;RPL35A;RPL11;RPL26;WDR12;PES1;NIP7;NPM1;PAK1IP1;GTF3A;GLUL;RPL38;WDR74;LTV1;RPF2;MRPL36;RPS25;LTO1;RRP36;NOP16;TGS1
prerank,regulation of cytokine production (GO:0001817),0.30181316960524995,1.0505690765906388,0.36764705882352944,0.937277514783238,1.0,17/126,11.60%,IL33;PLA2R1;GLMN;TXK;LURAP1;DTX4;ICOSLG;HTR2B;CD276;TRIM56;POLA1;BCL6;CIDEA;KAT2A;FGR;EIF2AK2;ASB1
prerank,DNA alkylation (GO:0006305),0.41486608674772685,1.050503677608335,0.3990066225165563,0.9353950135095627,1.0,8/19,22.26%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;EHMT1;ATRX
prerank,DNA methylation or demethylation (GO:0044728),0.41486608674772685,1.050503677608335,0.3990066225165563,0.9353950135095627,1.0,8/19,22.26%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;EHMT1;ATRX
prerank,regulation of cell development (GO:0060284),-0.3069827677134564,-1.0503822796827094,0.3575757575757576,0.6894584381186288,1.0,15/36,25.96%,FOXO1;NOTCH2;RPS19;CX3CR1;HEYL;HEY2;CX3CL1;CLOCK;HMGB2;AKT1;BHLHE40;FBXO22;BHLHE41;YTHDF2;HES6
prerank,chloride transport (GO:0006821),0.31702490687349505,1.0503641986547425,0.3789329685362517,0.9348179831068975,1.0,17/74,15.07%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;SLC4A1;CLCN6;GLRA2;LRRC8A;GABRB1;GLRB
prerank,positive regulation of cyclase activity (GO:0031281),-0.39589170700274845,-1.0501248932905176,0.3815165876777251,0.6893282641562238,1.0,5/14,12.70%,CACNA1C;NOS3;MAPK14;ORAI1;NOS1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.43333214219523963,1.0500620628008588,0.40456769983686786,0.9347338830731419,1.0,5/16,21.60%,BOD1;SGO1;NAA50;SMC1A;MAU2
prerank,regulation of cellular response to stress (GO:0080135),-0.24799479997265997,-1.0498947188743482,0.33004926108374383,0.6891571147568314,1.0,29/115,16.03%,ROCK2;MCL1;PTGES3;ARMT1;NEK6;CAMK2D;HSPA8;HSPH1;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;NUP98;CAMK2G;ATR;AJUBA;NUP153;CHCHD2;BAG3;AMFR;ATM;NUP43;HIKESHI;NUP205;MANF;SIRT1;RAE1
prerank,Ras protein signal transduction (GO:0007265),-0.2397529386962734,-1.0497980356699248,0.3275862068965517,0.6886304712704913,1.0,30/137,15.34%,PLCE1;IGF1;RAPGEF2;ROCK2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;RAP1A;RAC1;RASGRP3;RAPGEF1;MAPK14;ARHGDIB;EPS8L2;CFL1;PHACTR4;RGL2;RALB;AGTR1;RAPGEF3;RRAS;ARHGEF11;ADGRG1;RAP2C;GRB2;CDKN1A;GRAP
prerank,positive regulation of protein transport (GO:0051222),-0.27760904791575514,-1.0490931589599404,0.3106060606060606,0.6896353525714639,1.0,19/67,21.59%,IGF1;EZR;CNST;RUFY3;UNC13B;TGFB2;PRR5L;CEP290;CD2AP;GOLPH3L;MYH10;PPIA;OAZ1;BCAS3;OAZ2;APBB1;ADAM9;VPS28;MYO18A
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3177153361785622,1.0488746495129722,0.3820078226857888,0.9373700496272208,1.0,27/83,21.06%,CDK14;CDKN2A;FBXO5;CDC7;CDKN2D;POLA1;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CUL5;CDT1;DBF4;CDKN2C;MYC;KLF11;CDK5;KHDRBS1;CAMK2A;CCNE1;TFDP1;CUL4A;LATS2;POLE;INHBA;CDK7
prerank,positive regulation of endocytosis (GO:0045807),-0.30239782852536967,-1.0482575571065513,0.375,0.6909793577810804,1.0,18/45,21.24%,ANO6;GPC3;VTN;DAB2;CDC42;B2M;RAB21;APOE;RAB31;SERPINE1;CD151;HIP1;TOR1A;SMPD1;HFE;HNRNPK;CALY;VPS28
prerank,acute inflammatory response (GO:0002526),-0.34024588229406905,-1.0482036602151497,0.365,0.690325085640399,1.0,2/23,3.08%,ANO6;LBP
prerank,protein export from nucleus (GO:0006611),0.3761019719664152,1.0481387428569982,0.3960546282245827,0.9386311016510124,1.0,9/27,17.27%,CSE1L;ANKLE1;NUP214;NUTF2;NUP42;RANBP3;STRADB;CALR;XPO6
prerank,peptidyl-serine modification (GO:0018209),-0.23427771154563828,-1.0481074316296806,0.3103448275862069,0.6898022255252051,1.0,48/166,20.39%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;PRKDC;CAMK2D;TOP1;TLK1;VRK3;MAPK9;WNK1;HIPK3;MAPK14;NTMT1;HIPK1;GSK3B;TLK2;STK38L;RPS6KA5;DYRK2;MAST3;CAB39;RPS6KA1;ATR;PRKCZ;HIPK2;CSNK1G3;GALNT1;ATM;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;STK32B;MAP3K10;AKT1;SBK1;MARK2;VRK2;CSNK1A1;ULK3;MKNK1;GALNT3;PKN3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.42836040506554357,1.048105652081987,0.3968531468531469,0.937685778693103,1.0,1/15,0.63%,XCL1
prerank,regulation of apoptotic process (GO:0042981),-0.20518452198883447,-1.0478283919628328,0.35714285714285715,0.6896904471748239,1.0,197/676,23.23%,PAWR;DAPK1;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;ARHGEF18;MEF2C;IL31RA;LEF1;ANO6;ACTN2;SLIT2;TIAM2;BCL2L1;EGFR;IGF1R;ITGB1;OSR1;NET1;PPP1R13B;XIAP;THBS1;ARL6IP5;NOTCH2;ANXA5;ITGA6;GAS1;NFKB1;FSTL1;MCL1;MCF2L;TNFSF10;ACER2;PTMA;HIP1R;KDR;MAP3K5;IGFBP3;TMBIM6;PRKDC;SQSTM1;CCND2;FAS;NDRG1;ARHGAP10;GCLC;UNC13B;SOCS2;EGLN3;CYP1B1;APC;PRKAA2;DAB2;TRIM24;ANXA1;ATF6;AVEN;CRADD;ADAM10;TFRC;IL6ST;CRYAB;CD38;JMY;HIPK3;DDX42;BNIP2;UBB;SOX4;NGF;CAT;IP6K2;CASP2;CARD14;CD44;SH3RF2;GSK3B;RPL10;CASP3;VCP;GLO1;NGEF;MADD;CFL1;BAD;CITED2;CASP8;PERP;BNIP3L;NFKBIA;RNF144B;NIBAN2;BAX;KLHL20;SFRP1;VHL;HDAC3;RPS6KA1;ADAMTSL4;TNFAIP8;TARDBP;CTSH;HSPB1;APH1A;BID;TGM2;GADD45B;BAG3;APH1B;FLT4;FLNA;HIP1;BOK;PTK2B;TPT1;ATM;PPIA;ARL6IP1;ARHGEF11;PLEKHG2;GATA6;ING4;PLK5;STK17B;CX3CL1;TRIM35;SMPD1;PRELID1;FLT3;SIRT1;GPER1;PRKAA1;PRDX3;ANXA4;PAK2;DCUN1D3;YME1L1;ING5;PDPN;UBC;CD74;AIFM1;MAP3K10;PLSCR3;SIAH2;RASA1;HNRNPK;AKT1;APBB1;WNT11;STPG1;NUAK2;ITGB3BP;TFPT;SOS1;HGF;VAV1;RASGRF2;NPM1;EEF1E1;CIB1;GADD45G;TRADD;DNAJC3;AGT;MIF;PIM2;SON;ARHGEF12;RTN4;NAA35;ASNS;E2F1;SPHK2;MYO18A;HIGD1A;UBA52;TIAM1;CCAR2;SIX4;DDAH2;DDX20;UFM1;ARHGEF1;NUPR1;VDAC1;SOX8;CFLAR;PPIF;APAF1;MGMT;IKBKB;FBXO10;BCL10
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3052668618082494,-1.0476099937916432,0.38924050632911394,0.6895024853357011,1.0,13/42,22.41%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.40425864889656116,1.0475659308007426,0.3977272727272727,0.9382800362200165,1.0,5/20,11.29%,AGO4;SPOUT1;ZC3H7B;MRPL44;AGO3
prerank,response to cholesterol (GO:0070723),0.4292470122304992,1.0475356287444018,0.4110535405872193,0.9373313636947157,1.0,2/17,2.31%,GRAMD1B;GPLD1
prerank,heterochromatin assembly (GO:0031507),0.4083603373160296,1.0474997558435284,0.4130781499202552,0.9363983831421514,1.0,4/20,11.20%,HDAC1;CDKN2A;RRP8;POLE3
prerank,regulation of acute inflammatory response (GO:0002673),0.4054870198126509,1.0472685833949829,0.3983333333333333,0.9361036963182824,1.0,4/18,19.64%,KLKB1;PTGES;ADAM8;OSMR
prerank,regulation of axon regeneration (GO:0048679),0.4603415192121422,1.0460116752083437,0.42589437819420783,0.9390599679096839,1.0,1/12,0.18%,PTN
prerank,glycine metabolic process (GO:0006544),0.45266266806377353,1.0459819065275293,0.4270650263620387,0.9381088129011526,1.0,2/12,12.14%,GLDC;AMT
prerank,regulation of interleukin-4 production (GO:0032673),-0.3569445164980053,-1.045912174167341,0.40369393139841686,0.6932209301389382,1.0,4/21,16.47%,LEF1;SLC7A5;PRKCZ;HAVCR2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.2756207713887487,-1.0451988597576458,0.379182156133829,0.6942278753379045,1.0,15/66,10.22%,NFIB;CAV1;ROBO1;PTPRK;THBS1;SPARC;TGFB2;CAV2;CDK6;B2M;APOE;XDH;ATOH8;KLF9;SFRP1
prerank,generation of neurons (GO:0048699),0.28867688461542196,1.0451306039297064,0.3739930955120829,0.939669205653486,1.0,26/190,11.40%,SH3RF1;ADGRL3;RUNX2;AUTS2;WNT5A;NTRK2;ASTN2;DNAAF4;FGFR1;MYEF2;LRP12;CDKL5;MTPN;DISC1;DOCK7;ASTN1;SNPH;PER2;RELN;BHLHE22;OLIG2;MAP2K1;OPHN1;WNT3;SMARCA1;PLXNB2
prerank,innate immune response in mucosa (GO:0002227),-0.43522734594964146,-1.045100913476829,0.44711538461538464,0.693744394771167,1.0,8/10,53.29%,RPL39;RNASE3;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,nucleus organization (GO:0006997),-0.2964867594555282,-1.0448226946325798,0.3433333333333333,0.6937063178629578,1.0,16/47,20.05%,LEMD3;ATXN7;CHMP2B;RPS19;NUP98;REEP3;TOR1A;TMEM170A;NUP205;CHMP7;CHMP4B;CHMP4A;SEH1L;NUMA1;CHMP1A;PDCD6IP
prerank,protein deneddylation (GO:0000338),0.47654724535234483,1.0448061376659061,0.4283185840707965,0.9395846488448412,1.0,2/10,12.85%,COPS3;COPS4
prerank,cellular component assembly (GO:0022607),0.28119408980811345,1.0447576245432746,0.379041248606466,0.9387170740274213,1.0,40/253,12.20%,LAMC1;GPM6B;WIPF1;TEAD1;WNT5A;PPID;CD40;STAG3;RHOJ;EPRS1;SPTBN1;RSPH9;ANK3;YWHAZ;FSCN1;LRRTM3;TEAD2;MYO1B;KMT2A;RAC3;VAMP2;FANCA;PPIH;NEFH;LLGL1;CAPN3;WASF3;TEX11;MDM4;CHAF1B;NOC2L;KIFAP3;IL1RAP;OPHN1;TP53;DLG4;RIMS1;TUBGCP4;GAS8;SOX9
prerank,cellular response to calcium ion (GO:0071277),0.3197915931651842,1.044593677784197,0.3875338753387534,0.9382396855053752,1.0,22/67,18.88%,WNT5A;ADGRV1;GPLD1;ADCY8;CAPN3;RASGRP2;SYT3;LGMN;CPNE7;SYT7;TRPM2;SYT5;CPNE4;CPNE8;RYR3;CPNE9;DPEP1;MCOLN1;CARF;SYT1;SYT6;KCNH1
prerank,response to interferon-gamma (GO:0034341),0.32394452174910526,1.0445834681157806,0.4,0.9372368993021419,1.0,10/67,10.64%,XCL1;WNT5A;CD40;EPRS1;KYNU;CCL15;PDE12;SP100;TLR4;CCL25
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3685629829926894,1.0445585383537,0.3903177004538578,0.9363007213996463,1.0,4/33,3.91%,PPARA;TCF7L2;SEMA5A;PDPK1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3959247578565378,-1.044366868613801,0.40350877192982454,0.6940538006410608,1.0,6/14,14.92%,ELAVL1;YBX3;MAPK14;TARDBP;HNRNPC;ANGEL2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.26572628222271705,-1.0442588769373402,0.34814814814814815,0.6935612706566856,1.0,27/69,26.04%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFA8;NDUFS6;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;COA6;NDUFA1;NDUFS2;NDUFS8
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3822500866362963,1.0438125679253956,0.3931888544891641,0.9375705163080127,1.0,4/30,11.00%,XCL1;TSLP;TLR4;PYCARD
prerank,sodium ion transport (GO:0006814),0.31974761898674375,1.0437802086937886,0.4046997389033943,0.9366350608211986,1.0,14/85,14.26%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;CATSPER3;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.42363633841217374,-1.043720833554342,0.4004524886877828,0.6941370238427053,1.0,5/12,12.70%,ATP1B3;WNK4;WNK1;DMD;NOS1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3243703610879634,-1.043514771885614,0.3972602739726027,0.6938795259435974,1.0,8/30,12.04%,FOXP1;DDX5;KDM4C;SMARCA4;DAB2;KLK2;SFRP1;HEYL
prerank,amino acid import (GO:0043090),0.4087195486037976,1.0434046036407572,0.40298507462686567,0.9367259837451821,1.0,3/21,4.79%,SLC1A3;SLC6A13;SLC7A8
prerank,histone H4 deacetylation (GO:0070933),0.47397457328323833,1.0431833631366112,0.41697416974169743,0.9364280957676941,1.0,2/10,4.38%,HDAC1;REST
prerank,cellular response to starvation (GO:0009267),-0.24142932613787893,-1.0431228693015016,0.3575418994413408,0.6940550187759763,1.0,44/147,23.49%,PRKAG2;FOXO1;XPR1;FNIP1;RNF152;BMPR2;BECN1;MAP3K5;FAS;HSPA8;SREBF2;GABARAP;SESN1;PRKAA2;GABARAPL1;SIK1;DAPL1;LAMTOR5;RRAGC;SFRP1;CLEC16A;MYBBP1A;RALB;PRKAG3;LAMTOR3;MFSD2A;CDKN1A;SIRT1;PRKAA1;ATP6V0E2;MAP1LC3A;SEH1L;NUAK2;LAMP2;RRAGB;HNRNPA1;MAP1LC3B;ASNS;WDR45;ATP6V0D2;KLF10;NPRL3;NIM1K;INHBB
prerank,metal ion homeostasis (GO:0055065),-0.2929180939784619,-1.0431000878103782,0.3895705521472393,0.6933459841720934,1.0,3/40,1.07%,TMTC2;SLC12A7;CAV1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3993295494921215,1.0422820245163813,0.4096185737976783,0.9381817582278321,1.0,9/21,24.91%,BUB1B;FBXO5;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,ceramide metabolic process (GO:0006672),-0.28814063047634764,-1.0421653237851776,0.36875,0.6949131734385333,1.0,9/49,7.07%,SGMS1;SPTLC2;PLPP3;ACER2;ACER3;SGMS2;PPP2R1A;DEGS2;ST6GALNAC3
prerank,mitotic nuclear membrane organization (GO:0101024),-0.2870968508303037,-1.0420277494438455,0.36619718309859156,0.6937158429734828,1.0,21/51,26.89%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;LMNA;NUP98;RAN;REEP3;NUP43;NUP205;CHMP7;CHMP4B;CHMP4A;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.2870968508303037,-1.0420277494438455,0.36619718309859156,0.6937158429734828,1.0,21/51,26.89%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;LMNA;NUP98;RAN;REEP3;NUP43;NUP205;CHMP7;CHMP4B;CHMP4A;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3834411598463507,1.0417974850178373,0.3996710526315789,0.9386794801839466,1.0,5/24,8.44%,NAT10;ERCC4;TERF1;PIF1;TENT4B
prerank,cell projection assembly (GO:0030031),-0.3447469337512227,-1.0414655633261853,0.40214477211796246,0.694390488822406,1.0,6/22,6.77%,PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,positive regulation of histone deacetylation (GO:0031065),-0.41924145873003904,-1.0410796128258994,0.4328018223234624,0.6945414472095508,1.0,4/12,22.41%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,heterochromatin organization (GO:0070828),-0.39896326200404647,-1.0406609524587382,0.3856041131105398,0.6948221495915167,1.0,6/14,18.13%,MECOM;PRDM16;SMCHD1;SIRT1;BAHD1;SNAI1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4125651984164591,-1.0406113787276385,0.4187192118226601,0.6941886947633432,1.0,3/13,4.25%,RBPJ;CPE;NOTCH1
prerank,metanephric mesenchyme development (GO:0072075),-0.44344597106906175,-1.0404553783680985,0.41647597254004576,0.6937947949415615,1.0,3/10,5.84%,OSR1;WNT4;SIX1
prerank,potassium ion export across plasma membrane (GO:0097623),0.4537259559822816,1.0401306352936723,0.43500866551126516,0.9427604959918826,1.0,3/13,11.23%,KCNT2;KCNIP2;KCNE4
prerank,regulation of osteoclast differentiation (GO:0045670),0.3665567685875952,1.0401130634645537,0.4169230769230769,0.9417864258327308,1.0,9/33,17.95%,MTOR;TLR4;CAMK4;UBASH3B;LRRC17;BGLAP;FBN1;MAFB;GPR137B
prerank,regulation of fatty acid oxidation (GO:0046320),0.4198121479134949,1.039851735678215,0.41708542713567837,0.94152179209316,1.0,5/16,12.34%,PPARA;ACADL;APPL2;SOX9;FABP3
prerank,hepaticobiliary system development (GO:0061008),-0.3617293735339524,-1.0397804570779772,0.37721518987341773,0.6946928956487665,1.0,7/20,18.27%,ARID5B;WNT4;COBL;LSR;CITED2;MET;TGFBR3
prerank,negative regulation of cell adhesion (GO:0007162),0.32181955699949955,1.0394785252756915,0.39261285909712723,0.9416238481919699,1.0,12/72,8.09%,PLXNC1;HRG;TGFBI;SEMA5A;CORO2B;SIPA1;DUSP1;GCNT2;DSCAM;PTPRO;PTK2;JAM3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.43598933537754736,1.0393620574977371,0.4056761268781302,0.9409429471964037,1.0,5/14,19.58%,XCL1;PTPN22;CD81;LGALS9;RASAL3
prerank,negative regulation of MAPK cascade (GO:0043409),0.3135666130437492,1.0388497783553994,0.4078780177890724,0.9414724114414962,1.0,15/87,9.69%,SPRY4;SPRY1;PTEN;PTPRR;CNKSR3;DUSP1;SPRED1;PIK3R2;SORL1;NF1;PSMD10;RPS6KA6;SPRED2;BMP7;TLR4
prerank,regulation of axonogenesis (GO:0050770),0.3342880534928737,1.0384881228096725,0.398110661268556,0.9414993084310032,1.0,6/51,3.93%,ROBO2;PLXNC1;CHN1;NTRK2;PTEN;NGFR
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.27104980747453467,1.0383325148414322,0.3829787234042553,0.9409902312060329,1.0,60/390,14.16%,ROR1;COL4A6;PDGFRA;FLRT2;NTRK3;GHR;PIK3R1;EPHA7;ROR2;SULF1;NRG1;MERTK;CHN1;PTPRT;NTRK2;PHIP;ERBB4;GPLD1;ITGAV;EPHB1;CD8B;FGFR1;GRIN2B;NGFR;SPRED1;PIK3R2;ELMO1;EPHA6;IRS1;IRS2;COL4A2;PTK2;ANKS1B;SPRED2;EFS;PRKD1;AXL;EPHB6;ITSN1;CYBA;FGR;AHI1;EPHA3;FYN;UBASH3B;DNM1;MAPKAPK3;PDK2;GSK3A;ACTR2;IGF2;CASS4;MTSS1;ATP6V0E1;SLC39A14;GFRA2;SH2D2A;STMN1;CRK;LYN
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4158074092101416,-1.0380585392813964,0.4088785046728972,0.698132461120032,1.0,6/12,15.75%,FOXP1;SMARCA4;DAB2;SFRP1;HEYL;SIRT1
prerank,regulation of phosphorylation (GO:0042325),0.2942518780444489,1.0378327232251474,0.398989898989899,0.941466858152571,1.0,31/120,18.14%,DYNLL1;OGT;GLMN;PHIP;SRPX2;CDKN2A;MCM7;NUP214;AAAS;DSCAM;CDKN2D;POM121;PTK2;BMP7;GCK;GRM5;NUP42;PLXNB2;ANKLE2;NUP107;CDKN2C;LYN;ATG14;AR;ZBTB7A;NDUFS4;PRKRIP1;NUP54;LDB2;LDB1;NUP155
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.33925494549076246,1.0378324805734063,0.40988372093023256,0.9404553281189306,1.0,15/49,21.75%,KMT2E;HDAC1;L3MBTL1;AGO4;KMT2A;WDR5;AGO3;TESC;TNRC6B;AGO1;ASH2L;CBFB;KMT2C;RBBP5;RBM15
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3506554711167553,-1.0377587074171395,0.38,0.6981316577179316,1.0,9/21,22.08%,SLC8A3;MICU1;MCUB;SMDT1;TGM2;RAP1GDS1;MCUR1;LETM1;MCU
prerank,regulation of ATP metabolic process (GO:1903578),0.3373669879973542,1.0374938231157065,0.40793201133144474,0.9404850906485075,1.0,20/54,22.95%,OGT;NUP214;AAAS;POM121;PINK1;AK4;GCK;SLC25A33;NUP42;NUP107;ATP7A;COX7A2L;ZBTB7A;NUP54;NUP155;HIF1A;UQCC2;RANBP2;NUP35;FIS1
prerank,protein-DNA complex disassembly (GO:0032986),-0.3783428551617616,-1.0374844112226789,0.40865384615384615,0.6980722380790118,1.0,12/16,43.06%,ARID2;SMARCA4;SMARCC2;RPL23;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;HMGA1;SMARCB1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.41256400331557447,1.0374164212843464,0.4033333333333333,0.9396889137071092,1.0,2/19,0.88%,DCN;HRG
prerank,renal filtration (GO:0097205),0.48234124818487245,1.037190621418738,0.43462246777163904,0.9393672131990887,1.0,3/10,9.30%,SULF1;ITGA3;TBC1D8B
prerank,calcium ion transport (GO:0006816),0.2973025397510166,1.0371265222011092,0.40258064516129033,0.9385494813719729,1.0,18/113,11.77%,TRPA1;MCOLN2;SLC24A5;NALCN;CALCRL;CACNA1E;ITPR1;ITGAV;CACNG3;RYR2;ATP2A2;CACNA1G;TRPV3;TRPC3;P2RX4;FYN;TRPM2;TRPC7
prerank,negative regulation of insulin secretion (GO:0046676),-0.37378058921907464,-1.0369738175540848,0.4110576923076923,0.6985745367991498,1.0,5/17,10.22%,KLF7;PSMD9;CCN3;KCNB1;SFRP1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4191552654882835,1.0364644183428238,0.4320785597381342,0.939497415245899,1.0,3/17,9.24%,CXCL10;PLA2G7;LGMN
prerank,detection of calcium ion (GO:0005513),0.4392224215300971,1.0359910989868308,0.42095914742451157,0.939957050504876,1.0,4/13,18.66%,RYR2;KCNIP2;STIM1;SYT1
prerank,histone H4-K16 acetylation (GO:0043984),0.41834072268166905,1.0359410816650483,0.3950413223140496,0.9390925467533615,1.0,6/19,11.69%,OGT;KMT2A;WDR5;MSL1;KANSL1;JADE1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.36958067992468546,1.0359253964865756,0.41194029850746267,0.9381512018254136,1.0,13/29,23.40%,COPA;COPZ2;COPB1;COG6;COG1;TRAPPC10;GOLGA5;COPG1;COPB2;NAPG;RAB33B;COPZ1;GOSR1
prerank,regulation of microtubule nucleation (GO:0010968),-0.44128457551641936,-1.0358455575202137,0.45353982300884954,0.7005433340165634,1.0,7/10,41.39%,GIT1;EML2;HSPA1A;HSPA1B;RANGRF;MECP2;ARHGEF7
prerank,nitrogen compound transport (GO:0071705),0.2909235947834564,1.035782764577701,0.41502463054187194,0.9375899048545626,1.0,19/141,13.20%,SLC1A5;HRG;SLC48A1;SLC6A13;SLC6A8;LRP1B;CALCRL;SLC7A11;SLC43A1;VAMP2;SLC7A8;RUFY1;ABCB6;TMEM30A;SEC14L1;RCN3;HSP90B1;SLC7A3;SLC25A29
prerank,cellular response to pH (GO:0071467),0.4314129647927679,1.0348610131034666,0.42016806722689076,0.9394423882074986,1.0,5/17,17.90%,GPLD1;SLC9A1;ASIC1;IMPACT;MCOLN1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.38274380773555183,-1.034656286336326,0.4027777777777778,0.7027707887167695,1.0,7/14,17.25%,SEMA7A;MAVS;PLCG2;TICAM1;SIRT1;CD74;LAPTM5
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.30055669406843805,-1.0344768408228617,0.40372670807453415,0.7024651899397406,1.0,8/39,7.13%,PODXL;CDH1;KLF4;RDX;FXYD5;NOTCH1;WNK1;PPM1F
prerank,positive regulation of cell junction assembly (GO:1901890),0.3295432088549165,1.0342465678531456,0.3938953488372093,0.9403207600428652,1.0,10/56,9.55%,HRG;SRPX2;EPHB1;CNTNAP2;GRID2;NRXN1;MAP4K4;COL16A1;SYNDIG1;IL1RAP
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.2894171912044919,-1.03383295749056,0.40863787375415284,0.7032904988114337,1.0,22/48,28.30%,ACTB;DDX21;SF3B1;WBP2;SMARCA5;MYO1C;MYBBP1A;POLR2H;SERTAD1;ARID1B;POLR1H;TAF1C;POLR1G;POLR1C;SPHK2;PHF2;SMARCD1;ELOF1;CDCA4;PADI2;CHEK1;POLR2K
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3991612285285905,1.0336697293771384,0.424390243902439,0.94100231786147,1.0,5/20,8.81%,ATP1A2;RYR2;SLC9A1;ATP2A2;PRKACA
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.29763373799277626,-1.0334950841171833,0.40705128205128205,0.7033595761484872,1.0,14/43,22.41%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;SOX17;ACVR1;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,mitochondrion localization (GO:0051646),-0.35786374909462326,-1.0334553304735918,0.38992042440318303,0.7027052791415012,1.0,3/19,2.53%,MARK1;MEF2A;MTM1
prerank,cellular metal ion homeostasis (GO:0006875),0.3026763019296898,1.033032142200066,0.40076335877862596,0.9419144396593475,1.0,13/102,9.26%,EDN3;SLC24A5;ATP1A2;CD40;RYR2;HTR2B;KCNMA1;ATP1A3;CCL15;SLC9A1;ATP2A2;ATP13A3;HTR2C
prerank,telomere capping (GO:0016233),-0.37700817294667804,-1.0326934846671443,0.41134751773049644,0.7037957719344752,1.0,11/16,35.58%,PRKDC;DCLRE1A;STN1;TEN1;NBN;DCLRE1B;ACD;RAD50;CTC1;MRE11;TINF2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4423895880671763,1.0323194535426758,0.4375,0.9430340531409054,1.0,1/13,0.55%,COL4A1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.28633085509577233,-1.0316956671449595,0.41333333333333333,0.7055145522553495,1.0,18/47,25.67%,THBS1;MAPK14;XDH;MAPT;RNF41;PLCG2;AGTR1;GRB2;CDKN1A;PRKCD;ACE2;PID1;ROMO1;AGT;TGFBR2;TYROBP;CBR1;ITGB2
prerank,carboxylic acid transport (GO:0046942),-0.2860854077122245,-1.031552244288876,0.3674911660777385,0.7051460334118876,1.0,17/55,16.03%,SLC13A3;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC7A1;SLC3A2;SLC16A1;SLC16A4;SLC38A5;SLC7A5;SLC1A1;SLC6A17;SLC6A7;SLC16A9;SLC36A4;LLGL2
prerank,myelination in peripheral nervous system (GO:0022011),-0.4005359747480488,-1.0313709218054226,0.39901477832512317,0.70487572621681,1.0,4/13,7.09%,ADGRG6;PARD3;SKI;DICER1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.348728545842646,-1.0312489434940042,0.3858267716535433,0.7044113681638704,1.0,6/21,8.64%,CACNA1C;CAMK2D;CALM1;SRI;ANK2;DMD
prerank,cell-cell junction maintenance (GO:0045217),-0.4080230032163287,-1.031089670568291,0.42995169082125606,0.7040741172871405,1.0,1/11,0.31%,TJP1
prerank,response to gamma radiation (GO:0010332),-0.3398992604467157,-1.030948489016303,0.4052631578947368,0.7036759124605684,1.0,11/24,26.06%,CRYAB;TLK2;ATR;RPL26;ATM;TMEM109;PRKAA1;DCUN1D3;FANCD2;LIG4;KDM1A
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.23402682319365717,-1.030923500773065,0.35542168674698793,0.7029888606152997,1.0,34/170,15.21%,PRDM6;IGF1;ROCK2;FOXP1;CDH1;APP;ZNF462;SIRPA;YBX3;NFKBIZ;TAPBP;TRIM5;CDK6;MEGF8;PRDM2;TRIM11;AFF4;NOVA2;PRDM11;TRIM14;MTMR9;APOE;PCBP2;CRIP1;HMG20B;UBAP2;TARDBP;HNRNPDL;PTHLH;YBX1;TOB1;CIAO3;CAVIN4;POGZ
prerank,response to peptide hormone (GO:0043434),-0.2898292477556671,-1.0309121130206027,0.4067796610169492,0.7022600648546271,1.0,13/43,19.50%,ROCK2;CAV1;IGFBP5;ANXA1;TRIM16;EIF2B4;CREB1;SIRT1;GPER1;EPM2AIP1;AKT1;TGFBR3;ZBTB7B
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.33811048377207803,1.0308340744701312,0.427972027972028,0.9465380836826619,1.0,4/49,2.91%,GHR;CD40;ERBB4;TSLP
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.40252371011583754,1.0306594851018847,0.41522491349480967,0.9460695948432553,1.0,4/19,8.44%,NAT10;TERF1;PIF1;TENT4B
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4617298735583147,1.030595511650836,0.42334494773519166,0.9452652936890897,1.0,5/11,15.69%,WNT5A;SOX9;CTNNBIP1;MYC;FGFR2
prerank,cholesterol biosynthetic process (GO:0006695),0.3720047135743876,1.0304628122000503,0.415748031496063,0.9446879160995694,1.0,7/31,12.24%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,cellular response to light stimulus (GO:0071482),0.324216384047233,1.0302657750939204,0.41336971350613916,0.9442682292940905,1.0,12/66,15.59%,GPR88;POLK;FMR1;NEDD4;ERCC4;NOC2L;GPR52;TP53;DHX36;EIF2S1;BAK1;MYC
prerank,cellular response to gamma radiation (GO:0071480),-0.37419724028376566,-1.0302626831519786,0.4025,0.7031862078370492,1.0,6/17,16.06%,CRYAB;TLK2;ATR;RPL26;ATM;TMEM109
prerank,calcineurin-mediated signaling (GO:0097720),0.4612703862838344,1.0299634312343255,0.4321880650994575,0.9432347103788482,1.0,4/10,18.25%,NFATC3;ADGRB2;PPP3CB;NFAT5
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4612703862838344,1.0299634312343255,0.4321880650994575,0.9432347103788482,1.0,4/10,18.25%,NFATC3;ADGRB2;PPP3CB;NFAT5
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.38311928072976353,-1.0295000983176108,0.419953596287703,0.7043769351025669,1.0,8/15,32.53%,JMY;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4;WHAMM;ACTR3
prerank,iron ion transmembrane transport (GO:0034755),0.47454046394400934,1.0293996417034061,0.4423076923076923,0.9439983326732709,1.0,4/10,14.88%,SLC25A37;ABCB6;SLC39A14;ABCB7
prerank,regulation of interleukin-2 production (GO:0032663),0.3426012413367431,1.0291759775796367,0.4158273381294964,0.9436687220583613,1.0,4/43,3.79%,XCL1;GLMN;PDE4B;SPTBN1
prerank,androgen metabolic process (GO:0008209),0.41368876084974066,1.0289995999021442,0.41455160744500846,0.9431758622903409,1.0,3/18,17.72%,SPP1;MED1;HSD17B11
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.32053288606846325,-1.0288959709513568,0.3848396501457726,0.7052127032466182,1.0,7/33,8.29%,MEF2C;THBS1;KLF4;NOTCH1;APOE;ACVRL1;ITGB1BP1
prerank,aminoglycan catabolic process (GO:0006026),0.37140242549397545,1.0286995018185678,0.4124809741248097,0.9431192197932889,1.0,8/28,17.65%,HSPG2;GPC4;GPC5;GNS;GUSB;IDUA;SDC2;GPC6
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.33889023374314675,-1.0284419942316485,0.4034090909090909,0.7055981578760173,1.0,14/23,44.08%,TPM1;TGFBR3;PKP2;HOPX;SMAD7;DSG2;FKBP1A;TNNI3;TNNC1;IRX3;MYL3;MYH6;ID2;ISL1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.45166053912992965,1.0282995953776084,0.4064748201438849,0.9434036773381606,1.0,1/12,0.21%,COLEC12
prerank,sulfur compound biosynthetic process (GO:0044272),0.30034499330662845,1.0281815123424407,0.4239401496259352,0.9427758406715386,1.0,13/104,7.70%,DCN;GGT5;LUM;BGN;GGT7;DSE;VCAN;SLC35B3;B4GALT2;GSTO2;B4GALT3;PAPSS2;GSTA3
prerank,regulation of phosphate metabolic process (GO:0019220),0.41099260154554995,1.0281313502568632,0.43074324324324326,0.9419328647771992,1.0,2/16,3.36%,SRPX2;MCM7
prerank,glial cell differentiation (GO:0010001),-0.31525532220549213,-1.0280411578361976,0.3971830985915493,0.7059202734523795,1.0,3/28,1.54%,NFIB;SLC8A3;ADGRG6
prerank,positive regulation of protein metabolic process (GO:0051247),-0.24477821941949718,-1.027995370371732,0.39622641509433965,0.7052957957515787,1.0,32/110,22.29%,FOXO1;ROCK2;WWP1;IL18;APP;KLF4;WWP2;GPC3;APC;KLF2;GSK3B;APOE;VCP;SMURF2;NFKBIA;ASB5;RNF41;APC2;AGTR1;MAP2K5;OAZ1;PAEP;RAB1A;OAZ2;ABCB10;AKT1;RAB1B;AGT;FZR1;VPS28;NDUFA13;TNFAIP3
prerank,replication fork processing (GO:0031297),-0.2982752886437739,-1.0278926844549527,0.40057636887608067,0.7048221118586367,1.0,16/38,27.70%,SAMHD1;THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;ALYREF;SETMAR;CDK9;RFWD3;ZRANB3;RAD51;CENPX;GEN1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.42235744983078494,1.0277568557402854,0.4158249158249158,0.9420774898893914,1.0,1/16,0.63%,XCL1
prerank,positive regulation of cell development (GO:0010720),-0.3216109307101164,-1.0275140770875166,0.4032697547683924,0.7050726162257198,1.0,13/31,26.68%,PDE3A;BAD;RFX3;NIBAN2;CX3CR1;TGM2;GPER1;SOX11;TYROBP;MME;SPEN;LIG4;NUMB
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3658146892067618,-1.027442283184684,0.43509615384615385,0.7044678787619391,1.0,7/18,13.50%,HDAC4;NOTCH1;CCN3;FZD7;HDAC3;FRS2;TMEM119
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.33473347213243054,-1.0269484971043485,0.4173441734417344,0.7050317660255265,1.0,11/23,20.27%,IGF1;APP;NFKB1;INSR;PRKAA2;PFKFB2;P2RX7;PRKAA1;EGF;PRXL2C;GAPDHS
prerank,negative regulation of cytokine production (GO:0001818),0.2847526589816046,1.0266995461545372,0.4107142857142857,0.9442609989817004,1.0,23/163,12.66%,APOD;XCL1;PPARA;NR1H4;TRAF3IP1;ABCD2;PTPN22;PDCD1LG2;TLR6;DHX58;TLR8;ADCY7;CIDEA;CD200R1;NAV3;AXL;TNFRSF21;APPL2;TLR4;PYCARD;ASB1;IL12A;PDCD4
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4031564999302566,-1.0266374913551943,0.42462311557788945,0.7050897073712935,1.0,2/13,4.72%,ITGB1;SREBF2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.31002899028431513,1.0265026782598803,0.4148936170212766,0.9438652889760013,1.0,18/77,15.47%,SH3RF1;TCF7L2;PHIP;ITGAV;NOL3;PSMD10;FXN;HERPUD1;NOC2L;PINK1;OPA1;RTKN2;BCL2L2;TGFBR1;RIPK1;CLU;CSNK2A2;AR
prerank,regulation of cell differentiation (GO:0045595),0.28519026086669574,1.0261530275480606,0.4147521160822249,0.9439590442573936,1.0,33/148,16.53%,RUNX2;TRPS1;ZFHX3;EDN3;PTPRQ;FGFR1;PHLDB1;ST7;REST;NF1;FLOT2;BCL6;SRF;PTK2;PRKACA;DDX17;PRKCB;BIRC2;EPHA3;OCIAD1;EIF2AK2;MCRIP1;TGFBR1;IGF2;SMYD5;CLASP2;MAFB;GDNF;AR;FGFR2;CLASP1;TRIP4;NR1D2
prerank,lipid transport (GO:0006869),0.3041517590584294,1.0261273616686923,0.42528735632183906,0.9430489650212837,1.0,9/97,5.76%,ABCA9;NPC1L1;ABCA6;ABCC3;NR1H4;ABCD2;NCOA2;PPARD;FABP5
prerank,antibacterial humoral response (GO:0019731),-0.3758900451891891,-1.0261123082442878,0.4028776978417266,0.7056414060345877,1.0,6/16,36.03%,PLA2G6;RNASE7;SLPI;RPL39;RNASE3;JCHAIN
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3063796830147069,-1.02568707437481,0.3864306784660767,0.706005963690217,1.0,7/36,14.95%,CAV1;MYLK;ATP2B1;ORAI1;ANK2;TRPC6;P2RX7
prerank,phospholipid dephosphorylation (GO:0046839),0.34892668698890195,1.0256627115043662,0.42406015037593986,0.9434523555654243,1.0,8/37,10.79%,PTEN;SACM1L;MTMR4;MTMR1;PLPPR3;INPP5J;PLPPR2;PLPP6
prerank,negative regulation of peptidase activity (GO:0010466),0.33439080355252293,1.0255158937508746,0.40308988764044945,0.9429416709885186,1.0,4/47,5.26%,LRP1;HRG;SPOCK3;SERPINF1
prerank,regulation of cell morphogenesis (GO:0022604),-0.31791306998174573,-1.0253420089481018,0.4,0.706154297708646,1.0,9/30,13.66%,LARP4;SPARC;CAPZB;EFNA5;CD44;CFL1;BCL9L;MACF1;MFSD2A
prerank,Fc receptor signaling pathway (GO:0038093),-0.24391901339003982,-1.0251957416165685,0.38860103626943004,0.7057507133990966,1.0,36/110,20.53%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;PSMB7;RAC1;MAPK9;CUL1;CALM1;MAP2K4;PSMD8;MAP2K7;PIK3CB;PSMD12;PPP3R1;PSMA3;PLCG2;TAB2;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;GRB2;PAK2;PSMB10;TEC;LCP2;SOS1;PSME2;VAV1;NFATC1;PSMC3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.34203843799962175,-1.0247552309039691,0.40512820512820513,0.7060856836044418,1.0,6/23,13.76%,NMI;UACA;CCN3;IFI35;CYLD;TMSB4X
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2438383905469959,-1.0246363380257344,0.36787564766839376,0.7056251439846115,1.0,36/109,20.53%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;PSMB7;RAC1;MAPK9;CUL1;CALM1;MAP2K4;PSMD8;MAP2K7;PIK3CB;PSMD12;PPP3R1;PSMA3;PLCG2;TAB2;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;GRB2;PAK2;PSMB10;TEC;LCP2;SOS1;PSME2;VAV1;NFATC1;PSMC3
prerank,protein prenylation (GO:0018342),0.4641331879277117,1.0243491570520242,0.4272890484739677,0.9454890866089632,1.0,3/10,14.00%,PTAR1;PGGT1B;CHML
prerank,apoptotic cell clearance (GO:0043277),0.3682877714538202,1.0243141662710153,0.4294478527607362,0.9446111764343966,1.0,5/30,7.76%,LRP1;ITGAV;TXNDC5;ADGRB1;XKR6
prerank,regulation of cellular respiration (GO:0043457),-0.3660619749731784,-1.0241644990769454,0.4072289156626506,0.7061252759476198,1.0,6/17,16.32%,IL10RB;IFNAR1;VCP;PRDM16;PRELID1;NOA1
prerank,embryonic organ development (GO:0048568),0.3217094623890547,1.0238854847469558,0.40525587828492393,0.944885115036268,1.0,6/61,4.57%,COL13A1;TEAD1;SALL1;FLT3LG;TEAD2;KMT2A
prerank,positive regulation of bone mineralization (GO:0030501),0.3613953699911982,1.0238040953582879,0.4121306376360809,0.9441384003491574,1.0,3/35,1.69%,PTN;GPM6B;ADGRV1
prerank,glycerolipid metabolic process (GO:0046486),-0.41328672952054796,-1.0236807606028262,0.4462242562929062,0.706558907020782,1.0,5/11,21.13%,DGKG;DGKZ;PGP;PNPLA3;PIP5K1A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.42330180049549937,1.0235863582529523,0.4065180102915952,0.94386424729621,1.0,6/16,19.65%,NECAB2;PRKCA;GSK3A;SLC39A14;MRAP;PDE6H
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3321999374391768,-1.0235254547668216,0.37534246575342467,0.7062057285317951,1.0,10/25,19.93%,RBPJ;BMPR2;FOXD1;NOTCH1;CCN1;ACVRL1;CDH5;ACVR2B;SOX11;NUMA1
prerank,dephosphorylation (GO:0016311),0.2903211579564277,1.0235119370518575,0.41728395061728396,0.9431490806580913,1.0,23/147,10.80%,CDC14B;PTPRT;THNSL2;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;PLPPR3;PTPN13;PTPRU;PTPRO;SSH2;PLPPR2;PPP2R2A;PPP6C;PPP2R3A;PTPRA;PPP3CB;PLPP6;PDP1
prerank,endothelial cell migration (GO:0043542),-0.30144570801861653,-1.0229741938867056,0.391304347826087,0.7068458458971044,1.0,10/37,10.25%,NOS3;ID1;FSTL1;DPP4;NRP1;CCN3;CYP1B1;GIPC1;NR4A1;RAB13
prerank,calcium import into the mitochondrion (GO:0036444),-0.4269153779019124,-1.0229256502740283,0.4279475982532751,0.7062308317357278,1.0,5/10,22.08%,MICU1;MCUB;SMDT1;MCUR1;MCU
prerank,cell cycle G1/S phase transition (GO:0044843),0.3230967905078324,1.0226550850766585,0.4140302613480055,0.9447567121595375,1.0,21/61,21.06%,CDKN2A;CDC7;CDKN2D;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CUL5;DBF4;CDKN2C;CCNA2;MYC;KHDRBS1;CAMK2A;CCNE1;CUL4A;LATS2;POLE;INHBA;CDK7
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4095953735123665,-1.0220882562640348,0.4452380952380952,0.7076568659806636,1.0,7/12,38.15%,HUS1;SETMAR;ORC1;CHEK2;HUS1B;CDC6;TICRR
prerank,positive regulation of protein import (GO:1904591),0.3686549106640329,1.021771864707079,0.4090909090909091,0.9464251496866677,1.0,4/30,4.50%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,positive regulation of cation channel activity (GO:2001259),-0.2880307906665072,-1.0210629204750954,0.42443729903536975,0.7095612517959159,1.0,11/40,19.40%,ACTN2;SHANK3;CALM1;ANK2;STAC;EPHB2;LRRC38;TMSB4X;JPH2;CTSS;ADRB2
prerank,neural tube closure (GO:0001843),0.35995792013392386,1.0210128733914894,0.43206106870229005,0.9477627009830735,1.0,4/34,6.37%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,protein transport (GO:0015031),0.26615935789705997,1.0208971059722078,0.4299781181619256,0.9471230673338017,1.0,77/332,20.59%,LRP1;VAMP5;STEAP3;UNC93B1;GGA2;LRP1B;CALCRL;UNC119;RAB34;RABGAP1L;RAB20;TBC1D16;COPA;RABL3;SPTBN1;NGFR;ANK3;COPZ2;VAMP2;SEL1L;RAB8A;NAPB;RUFY1;RAB3C;MYO6;TBC1D1;VIPAS39;SYNDIG1;TRIM23;VPS26C;RAB29;TBC1D8B;PRKCB;RAB24;SLU7;SAR1A;RCN3;SCFD1;VAMP4;RAB15;LTBP2;HSP90B1;ARHGAP1;ARFIP1;ATP6V0E1;AP3D1;TBC1D9;CTTN;TMEM167A;CLU;VPS33B;MTTP;CENPF;USP6NL;SCAMP2;TVP23B;TMED3;TMED9;BBS1;MCOLN1;TBC1D17;COPG1;ATP6V1G2;MIA3;ATP6V0D1;SVBP;CANX;RAB3GAP2;ATP6AP1;COPB2;VPS45;ARL5C;ARL4A;KIF3A;SCAMP3;NAPG;UNC119B
prerank,response to glucocorticoid (GO:0051384),0.3794603826798356,1.0205602278118118,0.42038216560509556,0.9471401163297405,1.0,3/26,6.74%,IL1RN;REST;ZFP36L2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.37420741912055333,1.0204226439419197,0.4015503875968992,0.9465671817587166,1.0,4/28,4.50%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,protein localization to nucleus (GO:0034504),0.2982670835597666,1.0201644350652859,0.4240506329113924,0.9463790331829829,1.0,26/102,18.45%,PRICKLE1;CSE1L;NUP214;FAM53C;NUTF2;POM121;TAF3;APPL2;BMP7;FAM53A;TNPO1;MSX1;PTTG1IP;NUP107;NXT2;EIF4ENIF1;RRS1;ZBTB7A;CALR;TNPO2;IPO9;TAF8;CTDNEP1;NUP155;WRN;KPNB1
prerank,negative regulation of chemotaxis (GO:0050922),0.3582472235936349,1.0196536959651568,0.42836041358936483,0.946927197108636,1.0,3/31,2.10%,ROBO2;HRG;SEMA5A
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.2582379482393591,-1.0194164457912016,0.436,0.7130316780176398,1.0,22/75,18.18%,TEK;NRP2;BMPR2;NRP1;ECM1;KDR;JCAD;VEGFD;VEGFC;PPP1R16B;GATA2;NR4A1;PIK3CD;FGFBP1;ITGB3;MDK;FLT4;AGTR1;SIRT1;HMGB2;AKT1;EGF
prerank,positive regulation of biomineral tissue development (GO:0070169),0.3494437562491922,1.019287431263729,0.4279141104294479,0.947018790676191,1.0,6/40,9.54%,PTN;GPM6B;ADGRV1;FBXO5;AMELX;BMP7
prerank,heart looping (GO:0001947),-0.3026912163039409,-1.019133940827651,0.43202416918429004,0.7130421781009753,1.0,12/39,22.41%,MEF2C;MICAL2;NOTCH1;SMO;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,nuclear pore organization (GO:0006999),-0.39412898479976477,-1.0190802805228834,0.43414634146341463,0.7124468320766403,1.0,6/14,21.21%,NUP98;NUP153;TMEM170A;NUP205;SEH1L;RTN4
prerank,manganese ion transport (GO:0006828),0.4203627935247714,1.0189477166147705,0.4362068965517241,0.9470681021781369,1.0,6/14,19.93%,SLC30A10;TRPC3;TRPC7;SLC39A14;ATP2C1;TRPC1
prerank,regulation of MAP kinase activity (GO:0043405),0.3012415756450368,1.0189402112778199,0.4089121887287025,0.9461268489324474,1.0,11/92,5.46%,IL34;EDN3;SPRY4;SPRY1;CD40;FGFR1;DUSP1;HTR2B;LRRK2;SORL1;NF1
prerank,negative regulation of cell population proliferation (GO:0008285),0.26663059973238135,1.0189069971973104,0.43418259023354566,0.9452760005982305,1.0,66/351,15.61%,APOD;DLC1;COL18A1;ROR2;KDF1;ATF5;HRG;CXCL1;WNT5A;PTEN;GLMN;FAP;ERBB4;GPLD1;CDKN2A;PEX2;MCC;DLG3;TBX3;REST;TMEM115;NF1;ADGRB1;CDKN2D;CBFA2T3;PTPRU;MDM4;PER2;SOX2;P3H1;IFNLR1;APPL2;TENM1;MAP2K1;TNS2;EIF2AK2;TP53;FKTN;SPEG;GAS8;HGS;SOX9;IL12A;FABP3;DIS3L2;ST18;MTSS1;TESC;BNIPL;B4GALT7;P3H3;CDKN2C;LYN;CTNNBIP1;WNK2;THAP12;NME1;IGFBP7;MED25;F2R;TFAP4;CDK10;CNOT7;AR;MYC;MN1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2909485758896749,-1.0185297059272764,0.4169014084507042,0.7131037983498721,1.0,13/40,20.29%,LBP;GBP7;DROSHA;GBP4;GBP2;PGLYRP1;GBP6;RNASE7;MPEG1;HMGB2;PPP1R11;CHGA;ROMO1
prerank,protein processing (GO:0016485),0.3030411262779646,1.0184723889341483,0.4356687898089172,0.9456010572576521,1.0,16/102,13.25%,ECE1;ECE2;OGT;PCSK2;CASP4;KLKB1;ADAM19;FXN;OMA1;CPM;LGMN;PITRM1;SEC11A;HTRA2;SPRTN;MYRF
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3464212373832326,1.0182750622213228,0.42302158273381296,0.9452430728827651,1.0,11/46,16.16%,SPRY1;PTEN;PTPRR;CNKSR3;SPRED1;RPS6KA6;SPRED2;TLR4;LYN;WNK2;FBLN1
prerank,negative regulation of developmental growth (GO:0048640),0.36650053638108093,1.0181068676605403,0.4259541984732824,0.9447842305641434,1.0,4/30,8.78%,PTEN;NKD1;CDKL3;DCC
prerank,glycogen catabolic process (GO:0005980),-0.3821491611266581,-1.018018331611118,0.43765281173594134,0.7136069907560895,1.0,5/15,11.51%,PYGB;PGM2L1;CALM1;GAA;PGM2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.37475883147321787,1.0179561935065002,0.4453004622496148,0.9442702369192251,1.0,6/28,9.24%,PTN;AKAP5;ADCY8;CALB1;RELN;LGMN
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.42513962308105446,-1.0179531892505904,0.41418764302059496,0.7130078337901884,1.0,3/10,4.25%,CST3;DPP4;NOTCH1
prerank,glutathione biosynthetic process (GO:0006750),-0.41662102880316365,-1.0173296622381833,0.45916114790286977,0.7138396283193078,1.0,6/11,36.09%,GCLC;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,response to calcium ion (GO:0051592),0.2921366818302789,1.0172766518145415,0.4298245614035088,0.9453162087865431,1.0,28/102,18.88%,WNT5A;ADGRV1;GPLD1;RYR2;KCNMA1;NEDD4;KCNIP2;ADCY8;CAPN3;RASGRP2;SYT3;TRPC3;LGMN;CPNE7;SYT7;TRPM2;SYT5;CPNE4;CPNE8;RYR3;STIM1;CPNE9;DPEP1;MCOLN1;CARF;SYT1;SYT6;KCNH1
prerank,negative regulation of cell projection organization (GO:0031345),-0.2770343968737016,-1.0164916534772146,0.4229390681003584,0.7152306158277173,1.0,10/48,13.18%,EPHA4;RAPGEF2;DPYSL3;EFNB2;KANK1;PRAG1;APOE;ADCY6;GAK;TRPV4
prerank,regulation of neurotransmitter secretion (GO:0046928),0.36169781443419874,1.016208442478946,0.43870014771048743,0.9475105272118964,1.0,6/32,6.77%,HCRT;CHRNB4;PNKD;FMR1;LRRK2;RIMS2
prerank,L-amino acid transport (GO:0015807),0.36463841869303343,1.0159959413636226,0.4194053208137715,0.9472021214468519,1.0,3/28,8.53%,SLC1A3;SLC7A8;SLC25A22
prerank,regulation of endopeptidase activity (GO:0052548),-0.2694663865202085,-1.0158000899009976,0.437984496124031,0.7162721608897763,1.0,19/59,20.51%,PICALM;SPOCK2;VTN;SERPIND1;SERPINE1;SERPINI1;SERPINA2;GAPDH;APH1A;PSMA3;APH1B;PSME3;FURIN;SERPINE2;PRELID1;AKT1;PSME2;TIMP3;AGT
prerank,regulation of biomineral tissue development (GO:0070167),0.3724081150086398,1.0157471959890674,0.44290123456790126,0.9470193485333379,1.0,3/26,8.12%,ENPP1;FBXO5;TWIST1
prerank,cholesterol transport (GO:0030301),0.3355582697546826,1.0156135627938976,0.45673758865248226,0.9464941786829726,1.0,11/45,19.96%,NPC1L1;CEL;LIPC;SOAT2;ABCA5;RELCH;SERAC1;CLU;LDLRAP1;NPC2;OSBP
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3268691021658226,-1.015110835240621,0.4289405684754522,0.7172546984430259,1.0,7/26,9.95%,ACTN2;FHL1;ITGB1;WWP2;ATP1B3;ANK2;CAB39
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.34734068338938096,-1.014933709879619,0.41935483870967744,0.7169451885296079,1.0,11/22,20.67%,DDX5;RPS7;RPS20;UBB;RPS15;ATR;SPRED3;ATM;HEXIM1;EEF1E1;RPL23
prerank,negative regulation of microtubule polymerization (GO:0031115),0.44798518681605426,1.0146000416440932,0.44101633393829404,0.9485501645792089,1.0,3/12,14.01%,CLIP3;STMN2;STMN1
prerank,stress-activated MAPK cascade (GO:0051403),-0.2659293803031224,-1.0144428747126795,0.4425087108013937,0.7174395441191936,1.0,22/61,24.06%,NFKB1;IRAK2;MAP3K5;MINK1;MAPK9;CUL1;MAPK14;UBB;MAP2K4;MAP2K7;MAP3K8;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKB;TAOK2;IKBKG;NOD2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.2955727210532542,-1.0137522160815573,0.41,0.71846320023241,1.0,14/42,15.12%,TEK;PTPRJ;NRP1;KDR;S100A10;RAC1;CDK6;PPM1F;GSK3B;SFRP1;PLEKHA2;PTK2B;RRAS;CX3CL1
prerank,protein-DNA complex assembly (GO:0065004),0.2907519722958442,1.0137419543433548,0.4349939246658566,0.9501520963435525,1.0,32/116,18.98%,TCF4;MCM7;PSMD1;NAP1L3;ERCC5;ASF1A;PSMD10;GMNN;PSMA5;RPA1;PSMB5;CHAF1B;SPTY2D1;XPC;DAXX;PSMC4;PSMA4;MCM4;NAP1L1;PSMC5;GTF2H3;SOX9;CDT1;PSMB9;ERCC2;GTF2H1;ORC2;PSMD14;PSMA7;PSMD11;PSMA2;CUL4A
prerank,regulation of monocyte differentiation (GO:0045655),0.4320582182905103,1.0136508003626192,0.4468802698145025,0.949484958624124,1.0,1/14,0.28%,IL34
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3403278928325065,1.013524178945491,0.4370477568740955,0.9489267828608455,1.0,6/46,5.30%,PIK3R1;TCF7L2;JUP;PIK3R2;ZIC1;NEDD4
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3657762960384341,1.0134562346448022,0.44881889763779526,0.9481970022534685,1.0,10/31,18.34%,SCRIB;DLG3;MTCL1;PARD3B;DLG2;PRKCI;OPHN1;LRRC7;PDZD11;RHOA
prerank,positive regulation of cilium assembly (GO:0045724),0.40417699490148035,1.0131307607819948,0.42978003384094754,0.9481976315939563,1.0,5/18,12.46%,SEPTIN9;TAPT1;CEP135;ARHGAP35;ENTR1
prerank,anion transmembrane transport (GO:0098656),0.3162651899334837,1.0129876942643852,0.43472222222222223,0.9476828800421323,1.0,6/67,4.79%,SLC1A3;SLC6A13;SLC16A12;SLC6A8;SLC25A21;SLC7A8
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3989237878111212,-1.0129842668522215,0.44666666666666666,0.7196294665028983,1.0,1/12,0.01%,SORBS1
prerank,activin receptor signaling pathway (GO:0032924),-0.3697901084177856,-1.0128601219163196,0.4292803970223325,0.7191805123945039,1.0,5/15,23.87%,ACVR1;SMAD3;ACVR2B;INHBB;ACVR2A
prerank,neutral amino acid transport (GO:0015804),0.37203484128766434,1.0128028530235953,0.43548387096774194,0.9472385689814729,1.0,3/28,4.79%,SLC1A5;SLC43A1;SLC7A8
prerank,cellular biogenic amine metabolic process (GO:0006576),0.4587068941658206,1.0127016310717964,0.45652173913043476,0.9466055571976807,1.0,4/12,13.86%,ODC1;HNMT;TRH;ATP7A
prerank,telomere organization (GO:0032200),-0.2854597214539994,-1.0125949673446162,0.40186915887850466,0.7191192608690652,1.0,27/43,36.87%,PTGES3;PRKDC;ATR;RTEL1;STN1;PCNA;TERT;ATM;NBN;RAD51D;DCLRE1B;HUS1;POLD2;RPA2;ACD;PARP1;LTO1;POLD4;POLD1;RAD50;CTC1;H3-3A;MRE11;HUS1B;TINF2;RPA3;APEX1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.35822373805032026,-1.0124785504038416,0.4326923076923077,0.7186654755120908,1.0,3/18,0.63%,EPHA4;PICALM;ROCK2
prerank,positive regulation of neurogenesis (GO:0050769),0.316093466094215,1.0124531826000633,0.4281767955801105,0.9464060980108324,1.0,12/68,11.48%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;SERPINF1;CAPRIN1;DISC1;CDKL3;NAP1L1;PLXNB2;SNW1
prerank,cellular protein catabolic process (GO:0044257),-0.2740828660855753,-1.0122710719786354,0.3938356164383562,0.7184507298604585,1.0,19/59,22.29%,CTSC;UBE2G1;DENND3;AP2A1;CASP8;BNIP3L;CTSO;CTSH;CLPX;PSMA6;CTSZ;AFG1L;YME1L1;SIAH2;CTSS;CLPP;AP2S1;RNF5;AP2B1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3094192440411112,1.0121623322590971,0.4450402144772118,0.9463139060787785,1.0,22/76,19.82%,PRICKLE1;CCDC22;PTEN;LRRK2;RNF180;PSMD10;CBFA2T3;PTK2;NKD2;ZYG11B;HECTD1;GSK3A;AXIN1;DDA1;CLU;DET1;CSNK1E;RNF19B;RNF217;DDRGK1;RNF144A;SUMO2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3777247841391902,-1.01209830327582,0.44956140350877194,0.7181262522394155,1.0,5/15,5.63%,IGF1;ROCK2;MEF2A;CAMK2D;IL6ST
prerank,positive regulation of macroautophagy (GO:0016239),-0.28114107587773196,-1.0120404936960221,0.43548387096774194,0.7175060299277853,1.0,16/48,16.62%,SPTLC2;KDR;UVRAG;SESN1;PRKAA2;HSPB8;BNIP3L;OPTN;PIP4K2C;RALB;PAFAH1B2;BAG3;SLC25A5;SIRT1;TBK1;VPS13D
prerank,regulation of catabolic process (GO:0009894),0.4068793762328348,1.0120333783756785,0.4328097731239092,0.9457589684175943,1.0,8/18,23.15%,FAP;ODC1;HGS;SNF8;ZDHHC2;CENATAC;RARRES2;FAF1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2917417936990848,-1.0119419980188744,0.40540540540540543,0.7170182577309419,1.0,14/41,24.13%,TJP1;PODXL;AFDN;PLPP3;CD44;CITED2;MDK;DENND6A;CX3CL1;SKAP1;PIEZO1;SMAD7;FSTL3;MAGI1
prerank,UV-damage excision repair (GO:0070914),0.4467599539930643,1.0117029233331354,0.43902439024390244,0.94579699095177,1.0,3/12,9.25%,ERCC1;POLA1;XPC
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3849519928505173,-1.0113003175317077,0.463302752293578,0.7178819391837753,1.0,4/13,13.03%,ZDHHC21;ETS1;MDK;FUT9
prerank,establishment of skin barrier (GO:0061436),0.413476672157268,1.011009762775515,0.44206773618538325,0.9459295213223687,1.0,3/15,14.01%,KDF1;FA2H;STMN1
prerank,regulation of water loss via skin (GO:0033561),0.413476672157268,1.011009762775515,0.44206773618538325,0.9459295213223687,1.0,3/15,14.01%,KDF1;FA2H;STMN1
prerank,calcium ion transmembrane transport (GO:0070588),0.29703383016699964,1.0109971274574607,0.4291139240506329,0.9450215458535371,1.0,16/86,11.77%,TRPA1;MCOLN2;SLC24A5;NALCN;ITGAV;GRIN2B;ATP2A2;GRIN2A;CACNA1G;TRPV3;TRPC3;MICU3;PMPCA;P2RX4;TRPM2;TRPC7
prerank,sympathetic nervous system development (GO:0048485),-0.3783663790620946,-1.0108138262552682,0.4334862385321101,0.7183972404602373,1.0,5/15,18.46%,NRP2;NRP1;SOX4;FZD3;SOX11
prerank,aerobic electron transport chain (GO:0019646),-0.25864282975913044,-1.0104198944388356,0.4222222222222222,0.7187009916959807,1.0,26/68,26.04%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFA8;NDUFS6;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;NDUFA1;NDUFS2;NDUFS8
prerank,negative regulation of catabolic process (GO:0009895),0.33107414107482314,1.010348948578982,0.4434907010014306,0.9459944770777379,1.0,7/47,8.42%,PPARA;PFKFB1;ADGRB1;CBFA2T3;MDM4;CIDEA;BSCL2
prerank,protein O-linked mannosylation (GO:0035269),-0.361460105894308,-1.0103090318682046,0.4254278728606357,0.7182687369323325,1.0,4/18,8.47%,TMTC2;TMTC1;LARGE1;TMTC4
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3836051523107051,1.0097871773543217,0.4411302982731554,0.9466766732098362,1.0,2/25,1.65%,XCL1;WNT5A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.25206754250982394,-1.0097086465795448,0.4027777777777778,0.7190493341297887,1.0,19/86,15.49%,BAIAP2L1;OCLN;FER;APP;DRG1;RAC1;NCK1;APOE;MAPT;GPX1;ARL2;SLAIN2;LMOD1;TRPV4;PTK2B;EDN1;CX3CL1;BAIAP2;MET
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3938058273215217,1.0094517887146264,0.4352,0.9467118231728259,1.0,7/18,19.66%,PEX2;NF1;TP53;B4GALT7;MED25;MYC;CDC73
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.39704350155729573,1.0092066448634431,0.4344262295081967,0.946501209088984,1.0,2/19,6.73%,CHRNB4;COLQ
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3866931978276294,1.008981974176113,0.4442595673876872,0.9462120850636353,1.0,8/24,16.82%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1;ACTR2;CYFIP1;AKIRIN1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.25037901155324593,-1.0087542279855362,0.4292237442922374,0.7207236816302676,1.0,16/80,11.06%,DAPK1;FNIP1;XIAP;THBS1;ARL6IP5;KLF4;TNFSF10;MAP3K5;UACA;NGF;PPM1F;CD44;LAMTOR5;BAD;GPX1;RPS6KA1
prerank,regulation of extracellular matrix organization (GO:1903053),0.42131436806150924,1.0082306318068426,0.4752981260647359,0.9474944318461378,1.0,2/15,2.01%,LRP1;FAP
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2785181013774638,-1.0080732480356964,0.4394904458598726,0.7218140693062738,1.0,15/44,20.45%,FNIP1;XIAP;THBS1;KLF4;NGF;CD44;LAMTOR5;GPX1;RPS6KA1;ARL6IP1;MAP2K5;SIAH2;AKT1;HGF;CAST
prerank,coenzyme A metabolic process (GO:0015936),0.4148844147836806,1.008037356630066,0.45896147403685095,0.9471209344141018,1.0,5/14,21.65%,COASY;ACOT7;ACLY;PANK2;SLC25A16
prerank,Golgi localization (GO:0051645),-0.40803338807758194,-1.0079019492715262,0.4470046082949309,0.721510539577435,1.0,4/11,15.11%,UVRAG;CDC42;ARCN1;STK25
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.26086274785222996,1.0078692307321264,0.4587628865979381,0.9466513201430868,1.0,120/497,19.51%,ENPP1;ZEB1;RUNX2;XCL1;ATF5;NRG1;PRICKLE1;HDAC1;WNT5A;L3MBTL1;NR2F2;TCF7L2;BASP1;SALL1;EIF4A3;THRA;NANOS3;CDKN2A;EPRS1;POU3F3;PPARD;LOXL3;NR1H2;MDFIC;LOXL2;TBX3;REST;LSM14A;SCML4;RUNX1T1;FMR1;ZNF423;CAPRIN1;ZBTB16;TLE2;FOXS1;BCOR;CAPN3;CALCA;BCL6;GMNN;CBFA2T3;BRMS1;PAX9;TERF1;ZKSCAN3;TWIST1;PER2;TLE1;GLI3;L3MBTL4;BMP7;DAXX;ZFPM2;DAP;EIF2AK2;EIF2AK1;MPHOSPH8;TP53;DHX36;ZC3H8;SNW1;ZNF318;CREB3L1;EPC1;SOX9;TWIST2;GSK3A;PDCD4;DPF2;PRDM5;ZMYND15;CNOT1;HIC2;PHC1;BTAF1;MALSU1;HDAC10;EIF4ENIF1;FOXM1;PUS7;CHD8;KDM5C;TSPYL2;PRMT2;TFAP4;CNOT7;DMAP1;CRY2;SPINDOC;CENPF;ZHX3;NONO;ZBTB7A;CBFA2T2;TSC1;NR1D2;CIART;MBD2;CALR;IGF2BP3;MBTD1;CDK5;ILF3;MBD1;KHDRBS1;LDB1;BMP2;KAT7;SUV39H2;EIF2AK3;BRD7;HEY1;THAP7;CREBZF;PEX14;DEDD2;NACC1;MTA3;FXR1
prerank,membrane depolarization during action potential (GO:0086010),0.37329299485192047,1.0077530813695734,0.4366412213740458,0.946072050347377,1.0,9/26,21.63%,ATP1A2;SCN2B;CACNA1G;HCN2;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,mRNA stabilization (GO:0048255),0.3416303574447791,1.007645981105847,0.44642857142857145,0.9454654388611393,1.0,11/40,15.16%,RBM24;DND1;BOLL;ELAVL4;TAF15;PAIP1;TENT5A;EIF4ENIF1;TIRAP;GDNF;DHX9
prerank,histone lysine methylation (GO:0034968),0.36123370385181375,1.0076036892342066,0.4487369985141159,0.9446410181377789,1.0,13/33,20.86%,CXXC1;KMT2A;WDR5;DYDC2;PRDM5;DOT1L;PAXIP1;N6AMT1;ASH2L;SUV39H2;EHMT2;RBBP5;MEN1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3648504897369789,1.0074897194893404,0.4382716049382716,0.9440395856903369,1.0,12/29,21.13%,HDAC1;TCF7L2;PYGO1;BCL9;TLE2;TLE1;MYC;ASH2L;CDC73;RBBP5;MEN1;CREBBP
prerank,determination of bilateral symmetry (GO:0009855),-0.32896802267961284,-1.0073527287871347,0.45066666666666666,0.7221633814534585,1.0,10/24,20.78%,NOTCH1;ARL6;TBX1;CITED2;GALNT11;ZIC3;MKKS;DNAH11;BBS7;DNAH5
prerank,DNA double-strand break processing (GO:0000729),-0.35368848835653643,-1.0069885629972095,0.43609022556390975,0.7222645387944178,1.0,11/18,35.32%,RBBP8;UBE2N;ATM;NBN;KAT5;SETMAR;BRCA1;RNF138;RAD50;BARD1;MRE11
prerank,negative regulation of endopeptidase activity (GO:0010951),0.33082162228900447,1.0065794155380556,0.44600280504908835,0.9457274501194721,1.0,5/47,5.39%,HRG;RECK;SPOCK3;SERPINF1;SORL1
prerank,signal release from synapse (GO:0099643),0.33857278361739157,1.0063827037059594,0.4419970631424376,0.945355665007123,1.0,13/43,18.66%,NRXN2;PTPRN2;NRXN1;VAMP2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,phospholipid homeostasis (GO:0055091),0.45010735879546493,1.0063563549963617,0.4500875656742557,0.9445079545330677,1.0,3/11,20.91%,RCN3;FABP3;TLCD1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4081876681348682,-1.0057502819314534,0.45739910313901344,0.7247278312980169,1.0,7/11,19.51%,CD200;THBS1;CD34;GATA6;PTGS2;ATP6AP2;CD46
prerank,cellular response to glucose stimulus (GO:0071333),0.35766846441566535,1.0056691319013689,0.4462686567164179,0.9456378628682723,1.0,5/30,8.81%,ZBTB20;TRA2B;PTPRN2;ADCY8;PRKACA
prerank,substrate-dependent cell migration (GO:0006929),-0.3868457392089411,-1.0052659206705152,0.4489311163895487,0.7252594377267478,1.0,6/14,11.24%,ANKS1A;NTN1;NRP1;VEGFC;ITGB1BP1;CD2AP
prerank,cellular response to interleukin-1 (GO:0071347),-0.22806016791413103,-1.0050593934017198,0.4601226993865031,0.7250020574759661,1.0,35/143,15.12%,PLCB1;NFKB1;IRAK2;PSMC6;SIRPA;SQSTM1;PELI1;PSMD9;IL1R1;PSMF1;PSMB7;CUL1;TOLLIP;UBB;GBP2;RPS6KA5;PSMD8;RC3H1;HYAL1;PSMD12;NFKBIA;SFRP1;RBMX;MAP3K8;PSMA3;TAB2;PSME3;PSMA6;UBE2N;IRAK4;PSMD4;PSMD7;PSMB6;PSMC1;CX3CL1
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3064550282571868,-1.0049180240887392,0.4487534626038781,0.7238797147995774,1.0,12/31,28.30%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;CMTR2;POLR2K
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3064550282571868,-1.0049180240887392,0.4487534626038781,0.7238797147995774,1.0,12/31,28.30%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;CMTR2;POLR2K
prerank,regulation of intracellular signal transduction (GO:1902531),0.2616657381178312,1.0048258163180965,0.46891464699683877,0.947175285248935,1.0,92/420,19.28%,DLC1;NTRK3;CHN1;ARHGAP32;ARHGAP22;HDAC1;AKAP5;WNT5A;TAGAP;FBXO9;L3MBTL1;TAF9B;NTRK2;PTEN;TRAF4;ARHGEF3;PIP4K2A;ITGAV;RHOJ;TAF12;AKAP7;MAP4K4;ABR;ARHGAP6;PDPK1;SPRED1;PIK3R2;ENTPD5;RAC3;ARHGAP24;PTPN22;PRR5;ANKRD54;LRRK2;CHD4;CAPN3;MBD3;TAF15;ARHGEF6;PTPN13;RPA1;TAF3;MDM4;NOC2L;ITSN1;MTOR;OPHN1;DAXX;BIRC2;RFC3;ARAP2;RCN3;ARHGAP4;TP53;PYCARD;TOP3A;ARHGAP31;ARHGAP35;ARHGAP1;FAM13B;PREX1;SSRP1;AKAP6;ARHGEF19;CRK;LYN;GPAT3;RRS1;PRKAR1A;ARAF;CSNK2A2;SGK1;MAPK11;TNIK;FGD2;SYDE1;CDK5;A2M;PAK5;CASTOR1;TTI1;RHOG;RHOA;KALRN;WRN;BRD7;TAF10;ARHGAP29;WWC1;ULK4;EHMT2;CMKLR1
prerank,regulation of multicellular organism growth (GO:0040014),0.4204057247865178,1.0047724254878423,0.4669887278582931,0.9464113437220548,1.0,1/15,0.32%,GHR
prerank,peptidyl-lysine modification (GO:0018205),0.295035753409435,1.0046962491113745,0.4375804375804376,0.9457027869665385,1.0,25/99,19.82%,LOXL4;PLOD1;NUP214;LOXL3;LOXL2;AAAS;VCPKMT;POM121;VIPAS39;PIAS2;SAE1;NUP42;NUP107;P3H3;ATP7A;HDAC10;SENP6;NDUFAB1;VPS33B;PLOD2;NUP54;NUP155;USPL1;ATPSCKMT;SUMO2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.34372215155840125,-1.0043850646543608,0.44,0.7244788819307897,1.0,3/21,6.66%,FOXP1;PRKCH;SLC39A10
prerank,response to tumor necrosis factor (GO:0034612),0.297842082101871,1.0041824760985028,0.45144356955380577,0.9462536590253151,1.0,11/91,11.00%,GGT5;XCL1;CD40;GGT7;CCL15;SMPD4;ZFP36L2;ADAMTS12;TNFRSF21;CCL25;PYCARD
prerank,digestive tract development (GO:0048565),0.35826418087633555,1.0040847536174855,0.4414976599063963,0.9456081093190456,1.0,8/32,15.73%,CLMP;SALL1;NPY;GLI1;GLI3;CHD8;FGFR2;CCDC39
prerank,membrane organization (GO:0061024),-0.21889164765824193,-1.003958388482476,0.4095238095238095,0.724772278298025,1.0,69/227,23.53%,MYOF;PICALM;FNBP1L;LEMD3;ACTB;EGFR;AGFG1;PACSIN2;STX18;HIP1R;SYT9;HSPA8;ACTG1;CERT1;DAB2;CHMP2B;TFRC;MITD1;EPN2;FZD4;UBB;VAPA;DNM3;RAB5A;ANK2;AP2A1;VAPB;NAPA;CLTB;CCDC88A;GAPVD1;USO1;GAK;GCA;HIP1;REEP3;TOR1A;TMEM170A;IGF2R;SYNJ1;GRB2;DYSF;UBC;SYNGR2;WASL;CHMP7;REPS1;EGF;CHMP4B;CHMP4A;SNX3;ADRB2;CHMP1A;AP2S1;PDCD6IP;GLTP;COX18;A4GALT;TOR1AIP1;CFTR;UBA52;AP2B1;TMEM33;PIK3C2A;ARPC5;CHMP4C;ARPC4;OXA1L;EMD
prerank,regulation of AMPA receptor activity (GO:2000311),-0.32572408007982867,-1.0039247813073613,0.42134831460674155,0.7241265274371408,1.0,5/25,8.42%,MEF2C;SHANK3;MINK1;SHANK1;CACNG2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2836334752040796,1.003378504430913,0.44014510278113667,0.9467738626942558,1.0,25/140,12.87%,DLC1;CHN1;ARHGAP32;ARHGAP22;TAGAP;ARHGEF3;ITGAV;RHOJ;RABL3;ABR;ARHGAP6;PIK3R2;RAC3;ARHGAP24;ARHGEF6;RELN;ITSN1;OPHN1;ARAP2;ARHGAP4;ARHGAP31;ARHGAP35;ARHGAP1;FAM13B;PREX1
prerank,chromatin organization (GO:0006325),-0.23301806867326305,-1.0028041347696632,0.4426229508196721,0.7262275212616012,1.0,43/132,26.46%,MECOM;HDAC4;PBRM1;KDM4C;KDM4A;SMARCA4;SMARCA2;CBX3;TOP1;PRDM16;HDAC8;SMARCA5;INO80;HDAC3;SMARCC2;JARID2;DDX11;EZH2;SIRT1;ESR1;CHD1;FAM50A;INO80C;HMGB2;KDM4B;SNAI1;BAZ1A;BAZ2B;NPM1;CHD1L;TADA2B;SMARCD3;RUVBL2;MTF2;PHF1;TAF6L;SMARCD1;HDAC11;RB1;MYSM1;ACTL6B;SPI1;PADI2
prerank,mitochondrion morphogenesis (GO:0070584),-0.40869825870898935,-1.002785709383751,0.47577092511013214,0.7255387519719099,1.0,7/11,42.15%,MTM1;PID1;PNPT1;DNM1L;NUBPL;WASF1;SLIRP
prerank,regulation of protein sumoylation (GO:0033233),0.3973411524595306,1.0025533356242307,0.4574829931972789,0.9483293477008876,1.0,3/17,9.84%,GNL3;CAPN3;SAE1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.29653871729745,1.0022260293697796,0.45300261096605743,0.9482949231039514,1.0,22/88,16.59%,CCDC22;STXBP6;TXNDC5;GBF1;MYO1B;VAMP2;SORL1;LLGL1;EPS15;SNAP23;COMMD1;AP1S1;EXOC1;SCFD1;VAMP7;HGS;ACBD3;RABIF;CLVS1;SH3D19;SCAMP2;DNAJC6
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3439267704368068,-1.0020312424913411,0.4725,0.726782793962942,1.0,4/19,6.27%,EZR;CYTH1;PARD3;CDC42
prerank,negative regulation of cellular component movement (GO:0051271),0.4141656800290507,1.002000275497575,0.4600694444444444,0.9480717515430991,1.0,5/15,16.16%,SPOCK3;ACTN1;SP100;CRK;FBLN1
prerank,Golgi organization (GO:0007030),0.2896979146496621,1.0018665344589677,0.44360902255639095,0.9475057378227314,1.0,29/112,19.41%,SEC16B;SEC16A;YWHAZ;GBF1;LRRK2;DNAJC28;GOLGA2;PRKD1;RAB30;RAB29;VAMP4;RAB2A;SYNE1;TRIP11;CLASP2;COG1;VRK1;HACE1;CLASP1;USP6NL;GOLGA8B;GOLGA5;UBXN2B;CUL7;TMED3;TMED9;TBC1D20;TRAPPC12;PLEKHM2
prerank,peroxisomal membrane transport (GO:0015919),0.3687747188125358,1.0017599320067763,0.45751633986928103,0.9469077130945118,1.0,12/27,22.95%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;ALDH3A2;PEX3;PEX6;PEX14;GDAP1;FIS1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.31329585487637013,-1.0017543520013565,0.43641618497109824,0.7268292561390871,1.0,9/27,21.73%,CDC23;UBE2D3;ANAPC10;UBE2H;UBE2A;ANAPC13;ANAPC11;FZR1;ANAPC2
prerank,mammary gland epithelium development (GO:0061180),0.42242534647847296,1.00173788517696,0.46245733788395904,0.9460538857856455,1.0,3/14,10.11%,ERBB4;SCRIB;WNT3
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.336429423054969,-1.0016650019710516,0.4740932642487047,0.72634825498735,1.0,9/21,25.92%,ERAP1;ADAM10;RBMX;DAG1;APH1A;ADAM9;BACE2;MYH9;PSEN2
prerank,ion transport (GO:0006811),0.2890671090826218,1.00114463241636,0.4465894465894466,0.9468436351092134,1.0,9/111,5.55%,SLC1A3;SLC15A1;VDAC2;TRPA1;SLC24A5;CHRNB4;SLC12A6;SLC9A9;SLC9A1
prerank,regulation of MAPK cascade (GO:0043408),0.2814810217151878,1.0009446911722746,0.4720873786407767,0.9465002094697811,1.0,13/157,4.13%,ROR1;NTRK3;EPHA7;ROR2;NTRK2;EPHB1;FGFR1;MAP4K4;GPR37L1;DUSP1;SPRED1;PIK3R2;YWHAZ
prerank,cellular response to cytokine stimulus (GO:0071345),0.2598762409018772,1.0008189309994573,0.47674418604651164,0.9459291346682211,1.0,54/416,12.61%,RORA;IL34;GHR;ZEB1;PIK3R1;XCL1;IL1RN;IL2RA;CXCL10;CXCL1;PTPRT;WNT5A;CD40;IL16;IL1R2;FLT3LG;JAK1;GAB2;EPRS1;DUSP1;YWHAZ;FSCN1;FOS;COL1A2;CCL15;SMPD4;PDE12;ZFP36L2;ADAMTS12;BCL6;PTPN13;IL5;UBE2G2;TWIST1;PLP2;AXL;SOX2;PRKACA;IFNLR1;TNFRSF21;IL1RAP;TLR4;IRAK1;CCL25;TP53;PYCARD;FYN;PTGIS;SOX9;IL12A;HTRA2;HSP90B1;GSK3A;CD86
prerank,ureteric bud development (GO:0001657),0.40404014534499577,1.0005994664461562,0.4444444444444444,0.9456396267531735,1.0,2/17,2.49%,ROBO2;SALL1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.25407761692598535,1.0003904958282388,0.49447236180904525,0.9453464557357976,1.0,133/834,15.78%,RORA;IL33;DCN;LPIN3;PIK3R1;RUNX2;ZFHX3;ATF5;CXCL10;ETV1;PPARA;AUTS2;HOXC10;MEIS1;TEAD1;OGT;ETV5;NR1H4;GNL3;HDAC1;WNT5A;NR2F2;TCF7L2;TCF4;CD40;TXK;PHIP;RGMA;SALL1;THRA;SMAD5;MAML3;CDK8;MEIS2;NCOA2;METTL23;MED12;PGR;NFATC3;NGFR;JUP;THAP3;PPARD;PIK3R2;NR1H2;TBX3;REST;FOS;KMT2A;NCOA3;SLC9A1;MYCN;BCL9;SSBP4;GLIS1;HLF;EPAS1;BRD8;E2F4;CRTC2;NPAS2;SRF;CSRNP3;MYO6;AKIRIN2;FIZ1;CSRNP2;TWIST1;MED6;CDK13;PRKD1;PFKM;SOX2;GLI1;NCOA1;DDX17;GLI3;TLR4;KAT2A;ZBED3;AHI1;ZFPM2;PPP3CB;SMARCA1;TP53;DHX36;MED10;SNW1;FOXJ2;EPC1;SOX9;NRIP1;NFIX;ST18;ACTR2;TFEB;HOXB4;PLAC8;DPF2;IGF2;KDM1B;CD81;RFX4;ASXL1;SREBF1;HOXC4;MED1;MYDGF;ZFP64;SSBP2;ELK1;PEG3;ARNT2;FOXM1;DOT1L;LAGE3;BPTF;CHD8;RIPK1;MED25;GDNF;ATF2;DHX9;FOXJ3;PAXIP1;PRDM10;LPIN2;EAF2;AR;PBX2;MYC;FGFR2;JAG1
prerank,tryptophan catabolic process (GO:0006569),0.43822473144646956,1.0003464198497336,0.4550359712230216,0.9445605999908893,1.0,2/11,17.64%,KYNU;KMO
prerank,histone monoubiquitination (GO:0010390),0.37007037782482555,1.0002272016850002,0.4616588419405321,0.9439893670956958,1.0,4/24,9.16%,RNF40;BCOR;TRIM37;RNF168
prerank,protein homotetramerization (GO:0051289),-0.2716822606684196,-1.0001343079606586,0.44954128440366975,0.7294597887107588,1.0,13/49,17.27%,ALDH1A2;SAMHD1;SOD2;GBP5;B2M;UPB1;KCNJ2;CBR4;KCNJ12;CBY1;ACOT13;ACACB;ALDOA
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3263779607610153,-0.9992528219736021,0.4417989417989418,0.7309142875298037,1.0,7/24,12.42%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.37002768950521936,-0.998928141851237,0.4513064133016627,0.7309990618844223,1.0,3/15,7.60%,PLTP;SCARB1;APOE
prerank,gene silencing by miRNA (GO:0035195),0.3566120212136251,0.9986110045925621,0.46261682242990654,0.9476404049313201,1.0,10/32,17.43%,AGO4;SPOUT1;ZC3H7B;AGO3;CNOT1;WTIP;TNRC6B;CNOT7;ADAR;AGO1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3580689411622085,0.9984075385037271,0.45121951219512196,0.9472758188910232,1.0,7/29,13.68%,ZBTB20;PPARA;GPLD1;NR1H2;MTOR;FABP3;SREBF1
prerank,regulation of neuron death (GO:1901214),0.3060468188833311,0.9981827671238456,0.4588688946015424,0.9470219616536576,1.0,19/82,13.64%,WNT5A;EPHB1;GRID2;GRIN2B;REST;FOS;LRRK2;SORL1;DHCR24;EGLN2;C1QA;CD200R1;DCC;RAB29;DAXX;FYN;HTRA2;EIF2S1;TRIM2
prerank,indolalkylamine catabolic process (GO:0046218),0.446931205304395,0.9976954687874047,0.463768115942029,0.9475590488853264,1.0,2/10,17.64%,KYNU;KMO
prerank,myoblast differentiation (GO:0045445),0.415000059071017,0.9976665063028038,0.4874551971326165,0.9467353436425268,1.0,5/14,9.10%,NRG1;TCF7L2;REST;EPAS1;DDX17
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3726924542744413,-0.9976023536450417,0.46568627450980393,0.7336650691081071,1.0,6/16,22.74%,CHMP7;CHMP4B;CHMP4A;VPS28;VPS36;CHMP4C
prerank,carbohydrate derivative transport (GO:1901264),-0.35615973616318,-0.9972453785666221,0.4563106796116505,0.7338465559172479,1.0,4/18,13.66%,LBP;PLTP;SCARB1;MFSD2A
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.36655895554630546,0.996730304296504,0.4504643962848297,0.9484710182638001,1.0,5/26,9.24%,MEIS2;CCDC57;RPS6KB1;PRKCA;LGMN
prerank,response to lipid (GO:0033993),-0.24488297086740732,-0.9965660910764406,0.4682926829268293,0.7348091861092333,1.0,20/105,12.70%,SMAD6;FOXO1;FOXP1;FER;NOS3;ACER2;LBP;PELI1;RBP4;SOCS2;ANXA1;RXRA;ALPL;PAQR7;IFNAR1;GCH1;TRIM16;CTSH;TAB2;NOS1
prerank,lipoprotein catabolic process (GO:0042159),0.45044405192271475,0.9961750413718343,0.44760213143872113,0.9490930446460608,1.0,3/11,10.12%,ABHD17C;ABHD17B;LYPLA2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45393656294862306,0.9958777732545613,0.5045207956600362,0.9490409610709736,1.0,3/10,18.68%,HNMT;DMGDH;SLC44A1
prerank,membrane depolarization (GO:0051899),0.35419727328150025,0.9952384828333329,0.47049924357034795,0.9500145242171582,1.0,12/32,22.42%,CACNA1E;CACNA1G;CACNB4;CACNG4;P2RX4;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1A;CACNA1I;ABL1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.31825591981519197,0.9949716069564515,0.46799431009957326,0.9498448557604589,1.0,14/54,17.05%,DPP6;DPP10;KCNIP1;KCNMA1;NEDD4;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3;AKAP6;GNG2;GABBR2;KCNJ10
prerank,organic acid transport (GO:0015849),0.29493988814700023,0.9949647180349371,0.47381864623243936,0.9489586563158191,1.0,9/94,4.79%,SLC1A5;ABCC3;SLC6A13;NR1H4;NCOA2;SLC7A11;PPARD;SLC43A1;SLC7A8
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3109687633666112,0.9947410388749672,0.4784366576819407,0.9486920459688781,1.0,9/75,6.89%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;SERPINF1;ADGRB1;COL4A2
prerank,regulation of vacuole organization (GO:0044088),-0.3364632267073314,-0.9943475400398405,0.5012987012987012,0.7397281149011145,1.0,8/20,25.39%,MTM1;LAPTM4B;RAB5A;ENO1;TBC1D14;RAB1B;NPRL3;ADPRH
prerank,positive regulation of apoptotic process (GO:0043065),-0.2074382951815711,-0.993968967838107,0.47368421052631576,0.7398885391696104,1.0,85/293,22.48%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;TPD52L1;ITGA6;MCF2L;TNFSF10;HIP1R;MAP3K5;IGFBP3;SQSTM1;FAS;UNC13B;TGFB2;CYP1B1;APC;ATF6;CRADD;JMY;UBB;PRDM11;SOX4;NGF;IP6K2;CASP2;SIK1;CASP3;NGEF;BAD;CASP8;BNIP3L;BAX;SFRP1;ADAMTSL4;TNFAIP8;MYBBP1A;APH1A;BID;TGM2;GADD45B;PTRH2;APH1B;TLE5;BOK;ATM;ARHGEF11;PLEKHG2;ING4;STK17B;TRIM35;SMPD1;SIRT1;GPER1;DCUN1D3;ING5;UBC;AIFM1;MAP3K10;APBB1;STPG1;ITGB3BP;TFPT;SOS1;VAV1;RASGRF2;EEF1E1;GADD45G;TRADD;ARHGEF12;E2F1;SPHK2;UBA52;TIAM1;CCAR2;DDX20;BTG1;ARHGEF1;NUPR1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3484365392728811,-0.9939428522411912,0.4674698795180723,0.7392295310123044,1.0,9/18,22.64%,FOXC2;KDR;JCAD;ANXA1;GATA2;FGFBP1;PTGS2;CIB1;PIK3C2A
prerank,male meiosis I (GO:0007141),0.4000437053372705,0.9937668074608149,0.4719710669077758,0.9505724238895562,1.0,4/16,15.22%,SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,protein deacylation (GO:0035601),0.37972490333932213,0.9936202718313228,0.4568106312292359,0.950102813012037,1.0,6/23,13.97%,HDAC1;SIRT6;ABHD17C;ABHD17B;LYPLA2;HDAC10
prerank,regulation of lamellipodium assembly (GO:0010591),0.3510780808496966,0.9935998428929265,0.46296296296296297,0.949273698893597,1.0,5/34,5.21%,PIK3R1;HRG;AUTS2;FSCN1;CARMIL2
prerank,positive regulation of defense response (GO:0031349),0.2952048798401236,0.9931056629069294,0.4594240837696335,0.9498042253245857,1.0,10/89,10.01%,IL33;WNT5A;IL16;TSLP;TLR8;NPAS2;AKIRIN2;PLA2G7;TLR4;CYBA
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.35861584010782716,0.9930001296674302,0.44136807817589574,0.9491874812177489,1.0,2/27,1.65%,PDGFRA;WNT5A
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.263444857126457,-0.9929717049904441,0.4806201550387597,0.74085631589247,1.0,16/56,20.18%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;CDC23;ANXA1;HYAL1;CCND1;RAD51C;ANKRD17;CUL3;ANAPC11;AKT1;RGCC;RCC2
prerank,regulation of cell growth (GO:0001558),-0.21604683559862292,-0.9929711008333907,0.4608695652173913,0.7401264081920833,1.0,68/204,24.30%,PLCE1;APBB2;PTPRJ;SLIT2;EGFR;FHL1;LTBP4;NET1;BMPR2;OSGIN2;SMARCA4;SMARCA2;CAMK2D;TGFB2;SOCS2;CCN3;SH3BP4;ADAM10;TFRC;PPP2R1A;CDC42;PRDM11;IP6K2;SOX17;ACVRL1;SMAD3;NPR1;HYAL1;FAM107A;SFRP1;INO80;RPS6KA1;CEACAM1;ENO1;EXOSC2;MFSD2A;AGTR1;ARHGEF11;CDKN2AIP;CDKN1A;SIRT1;VGLL4;DCUN1D3;OGFR;PABIR1;RBBP7;ERBB2;AKT1;APBB1;WNT11;SDCBP;RERG;LGI1;CIB1;AGT;RTN4;SPHK2;NDUFA13;CCAR2;CDA;BTG1;CISH;TAOK2;PAK4;HYAL2;BAP1;MT3;NUBP1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3196772903429595,0.9928279515690646,0.453015427769986,0.948786364617354,1.0,10/56,12.43%,CLEC4E;UNC93B1;TLR6;TLR8;LGMN;TLR4;IRAK1;MAPKAPK3;S100A1;HSP90B1
prerank,mRNA destabilization (GO:0061157),0.3407944851266005,0.9928236476090893,0.45524691358024694,0.9479020539451445,1.0,10/38,14.94%,RBM24;ZC3H12D;DND1;PDE12;ZFP36L2;DHX36;DIS3L2;FTO;CNOT1;RC3H2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.3512233137376797,-0.9926405957723898,0.4543147208121827,0.7402689199873874,1.0,3/19,15.10%,LRP6;NR4A2;MANF
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3754440598252162,0.9924695466221126,0.4707740916271722,0.9480574754338181,1.0,5/23,8.95%,PTEN;SACM1L;MTMR4;MTMR1;INPP5J
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4568852395909585,0.992469396541625,0.4666666666666667,0.9471664314573519,1.0,3/10,16.66%,XCL1;CD81;LGALS9
prerank,response to cytokine (GO:0034097),-0.2267409201664896,-0.9923811700367504,0.45930232558139533,0.7402062741525565,1.0,23/141,10.54%,ALDH1A2;DPYSL3;LEF1;BCL2L1;HDAC4;APP;MCL1;PTPN4;IRAK2;PTPN14;IL1R1;ANXA1;ADAM10;IL6ST;IFITM3;CASP3;GCH1;SMAD3;MAP2K7;CASP8;IFITM1;KLHL20;PTPN2
prerank,protein kinase A signaling (GO:0010737),-0.39730973588695406,-0.9923562132922257,0.4680365296803653,0.7395489866799859,1.0,3/12,10.25%,EZR;RDX;RAB13
prerank,regulation of double-strand break repair (GO:2000779),0.3323704512380711,0.9923478756434335,0.47477744807121663,0.9466392078545817,1.0,13/39,20.27%,SIRT6;ZCWPW1;MRNIP;TWIST1;SLF1;SPIDR;ACTR2;FIGNL1;FOXM1;SLF2;SPIRE1;TERF2IP;PPP4R2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.35001362830672367,-0.9923044238954122,0.4645669291338583,0.7389651570086978,1.0,8/19,23.67%,RENBP;UGDH;UAP1;UGP2;PMM1;UAP1L1;NANS;MPI
prerank,hippo signaling (GO:0035329),-0.31954501763541776,-0.9921673921738122,0.4367816091954023,0.738592754973991,1.0,6/26,7.87%,TJP1;AMOT;TEAD4;TJP2;YWHAB;CASP3
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3119623627601256,-0.9920707839053241,0.43567251461988304,0.7381178446260602,1.0,9/30,14.35%,DDX5;PPP1R13B;ACER2;NDRG1;JMY;MYBBP1A;BOK;HINT1;NBN
prerank,T cell activation involved in immune response (GO:0002286),-0.397447868495041,-0.9918174585434602,0.48507462686567165,0.7380192335708469,1.0,5/12,35.05%,ICAM1;MDK;CD74;SLC11A1;LILRB1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3120905692290085,-0.9911008183235944,0.4632768361581921,0.7391943877508129,1.0,6/26,12.61%,IGF1;LMCD1;GSK3B;DYRK2;CAMTA1;PLCG2
prerank,cellular response to UV-A (GO:0071492),0.44256172799235577,0.9904880636858701,0.4684014869888476,0.9508947400410643,1.0,1/11,1.66%,PPID
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3191923731028635,-0.9904623173666101,0.45144356955380577,0.7400871668193054,1.0,7/24,14.01%,TEK;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5
prerank,sensory perception of chemical stimulus (GO:0007606),0.4138514562510033,0.9903957776246924,0.4906303236797274,0.9502587914556858,1.0,2/15,6.67%,C5AR1;ADCY3
prerank,RNA metabolic process (GO:0016070),0.2804295247050239,0.9903444611912454,0.4783683559950556,0.9495146273251224,1.0,38/127,22.68%,RBMS1;RNASEH2C;AGO4;NOVA1;ADARB2;ELAVL4;PCBP3;HNRNPA2B1;MPHOSPH10;MRPL44;DDX17;WTAP;NOL9;DHX36;AGO3;MTREX;TENT2;RNASEH2B;FTO;LAGE3;HNRNPUL1;HNRNPD;DHX9;RNASEH1;ADAR;HNRNPL;RBM5;PPP1R8;AGO1;RBM6;DEDD2;POLR2L;TFIP11;DDX39B;RBPMS;SND1;RNGTT;HNRNPH3
prerank,regulation of cytoplasmic transport (GO:1903649),0.43680820983305185,0.9899405963180253,0.46924428822495606,0.9497449190123087,1.0,5/11,21.95%,LRRK2;MAP2K1;ATP9A;MAPK1;DENND10
prerank,diol biosynthetic process (GO:0034312),-0.3692879179616396,-0.9897912116913388,0.463302752293578,0.7410320128490504,1.0,8/15,26.03%,SPTLC2;ACER2;ACER3;GCH1;DHFR;SPHK2;ASAH1;ASAH2
prerank,cellular response to superoxide (GO:0071451),-0.41392006892248717,-0.9897674024323113,0.48711943793911006,0.7403599321807696,1.0,4/10,16.00%,NOS3;SOD2;PRDX1;SOD3
prerank,ganglioside metabolic process (GO:0001573),-0.3400484284084354,-0.9896530745564937,0.4318766066838046,0.7399206850250672,1.0,8/20,24.24%,ST8SIA4;ST6GALNAC3;HEXB;ST8SIA2;ST3GAL5;GM2A;ST8SIA6;CLN6
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.40002258690668335,-0.9894900061042724,0.48775055679287305,0.7396182106816004,1.0,2/10,5.33%,RAPGEF2;GIPC1
prerank,protein targeting to peroxisome (GO:0006625),0.35803124533664765,0.989401648063894,0.4673202614379085,0.9503426211413447,1.0,12/29,22.95%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;ALDH3A2;PEX3;PEX6;PEX14;GDAP1;FIS1
prerank,response to amino acid (GO:0043200),0.35482756985790725,0.9888478101120217,0.4679878048780488,0.9510031900132421,1.0,10/31,18.65%,CPEB1;MTOR;GLRA3;GLRA1;MEAK7;GLRA2;GLRB;RRAGA;CAPN2;RRAGD
prerank,regulation of cellular senescence (GO:2000772),0.3576799320420761,0.9886712812437892,0.460093896713615,0.9506061369335841,1.0,5/28,8.12%,SLC30A10;CDKN2A;FBXO5;ZKSCAN3;TWIST1
prerank,myelination (GO:0042552),0.32319398706173397,0.9880718521853388,0.4556786703601108,0.9514216139029269,1.0,12/46,14.26%,EPB41L3;ABCD2;NF1;SBF2;TNFRSF21;DEGS1;MBP;LGI4;PLP1;SOX10;MYRF;SCN2A
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.2823676498253175,-0.9878126743591655,0.46540880503144655,0.7430444880517413,1.0,10/43,10.56%,IGF1;MEF2C;BMPR2;WNT4;IL6ST;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,regulation of autophagosome maturation (GO:1901096),-0.37774080532960175,-0.987629811550999,0.45916114790286977,0.7427669370740432,1.0,4/13,19.40%,UVRAG;CLEC16A;TMEM39A;ADRB2
prerank,primary alcohol metabolic process (GO:0034308),0.3719705056912836,0.9873836938922411,0.4812398042414356,0.952524329631822,1.0,3/25,2.43%,ADH1A;RDH10;RDH11
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3653651338678532,-0.9873066928651455,0.46534653465346537,0.7428406193466349,1.0,4/16,10.38%,DPYSL3;UPP2;UPB1;NT5E
prerank,regulation of T cell activation (GO:0050863),0.3325365023553434,0.9870924185718043,0.4763271162123386,0.9524890118622953,1.0,5/42,11.00%,PAG1;TNFAIP8L2;PTPN22;KAT2A;PYCARD
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3890979671993341,-0.9868669562647585,0.48253275109170307,0.7432502621130596,1.0,4/12,7.23%,ACTB;ACTG1;LAMA3;LAMA5
prerank,cellular response to oxygen-containing compound (GO:1901701),0.26235433089159604,0.9867536756925405,0.5163043478260869,0.9525786830122358,1.0,49/291,14.53%,RORA;PDGFRA;CXCL10;CXCL1;CPEB1;NR1H4;WNT5A;GPLD1;ERCC6L2;PDE4B;P2RY1;FOS;NCOA3;PDCD1LG2;IRS1;CAMKK2;CD68;PRDX5;PRKD1;AXL;KCNC2;MTOR;HCN2;TLR4;WNT3;HCN1;PLAA;IRAK1;EPHA3;HCN3;DHX36;PYCARD;GLRA1;P2RX4;SNW1;PDK2;SOX9;HTRA2;NRIP1;HSP90B1;CD86;PDCD4;GLRA2;TESC;AKAP6;RYR3;LYN;GNG2;TIRAP
prerank,positive regulation of phagocytosis (GO:0050766),0.3231502338014973,0.9865397616123808,0.48787446504992865,0.9522888717535648,1.0,7/47,11.00%,IL15RA;MERTK;TUB;LYAR;APPL2;CYBA;PYCARD
prerank,positive regulation of metabolic process (GO:0009893),0.29097166277417597,0.9865088434470749,0.47435897435897434,0.9514934989859916,1.0,19/103,12.79%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;FABP5;SIRT6;EPAS1;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2;ACLY;PIGA;PLAC8
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.23340857028131884,-0.9863852031354898,0.45652173913043476,0.7437243689601378,1.0,38/109,22.95%,PLCB1;PITPNM2;MTM1;LPGAT1;PLA2G4A;CDS1;PIK3C2B;INPP5F;INPP4B;INPP5D;BMX;MTMR9;INPPL1;RAB5A;PIK3CB;PIK3CD;LCLAT1;PIP4P1;PIP4K2C;PLCG2;PLEKHA2;PLAAT3;VAC14;SYNJ1;PIK3R6;INPP5B;SBF1;MTMR14;RAB4A;MTMR2;PLA2G4E;PLA2G4C;PIP5K1A;CSF1R;MTMR11;PITPNM1;PIK3C2A;PIP5K1B
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.30129755135623393,-0.9862282095121447,0.49299719887955185,0.743411673747161,1.0,5/29,7.81%,IL31RA;FER;NMI;SOCS2;IFNAR1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.3080375687274925,-0.9861619758056691,0.47058823529411764,0.7428485320191853,1.0,7/27,14.77%,KHNYN;NYNRIN;PARN;RPP30;DICER1;ERN1;RNASE4
prerank,mesoderm formation (GO:0001707),0.4054570188443717,0.985874042126616,0.4794745484400657,0.9524509876674186,1.0,2/17,2.64%,ITGA8;ITGA3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.27034784871998285,0.9854726597890053,0.5056306306306306,0.9526802775690163,1.0,26/198,10.61%,ENPP1;EPHA7;PLA2G2C;THNSL2;PTEN;PIP4K2A;PFKFB1;DUSP12;HTR2B;LRRK2;IPMK;GFPT2;NADK;PLPPR3;ALDOB;PI4KA;ENPP3;PFKM;INPP5J;PLPPR2;MTOR;ACYP2;GK;GCK;PLAA;PPP3CB
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.34756877606401093,-0.985269609719148,0.47692307692307695,0.74434736557424,1.0,7/18,22.04%,RNF185;UBB;AMFR;UBC;RNF5;UGGT1;UBA52
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3505521592530811,-0.9852336858990726,0.49875311720698257,0.7437170383238877,1.0,6/17,24.95%,ARL6IP5;TGFB2;STK25;TAOK2;NOD2;MID1
prerank,RNA transport (GO:0050658),0.3065927078323739,0.9851701085679985,0.4616457461645746,0.9526498878822502,1.0,16/71,18.14%,RBFOX1;EIF4A3;NUP214;FMR1;THOC7;POM121;HNRNPA2B1;SRSF11;SLU7;CASC3;KIF5C;SLBP;SRSF9;THOC5;SRSF6;NUP155
prerank,P-body assembly (GO:0033962),0.43107431490407094,0.985127367662516,0.4720812182741117,0.9518871667590811,1.0,4/12,14.11%,LSM14A;LSM4;EDC3;EIF4ENIF1
prerank,regulation of cellular metabolic process (GO:0031323),0.33070033597870097,0.98477886365641,0.49117647058823527,0.9519443656438124,1.0,13/45,21.45%,PPARA;TBC1D16;PINK1;PDK2;ACLY;MBOAT7;FOXM1;ABCA2;PANK2;NPC2;COQ7;PDK3;ACACA
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.23940450215135642,-0.9846559155180798,0.4748858447488584,0.7444682563863522,1.0,27/86,20.59%,IGF1;PTPRJ;PECAM1;EGFR;APP;NRP1;CSPG4;VTN;PDGFA;EFNA5;CD44;ACVR1;ENPP2;SFRP1;ITGB3;PRKCZ;PLCG2;PTK2B;RAP2C;PRKCD;PAK2;CD74;RAP2B;TEC;HGF;AGT;MIF
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.29898037865239885,0.9844112906066904,0.4743758212877792,0.9520549492745707,1.0,24/84,18.45%,NTRK2;EIF4A3;NANOS3;EPRS1;LSM14A;FMR1;CAPRIN1;SORL1;EIF2AK2;DHX36;CNOT1;MALSU1;RTN2;EIF4ENIF1;PUS7;CLU;CNOT7;TSC1;CALR;IGF2BP3;ILF3;RTN3;ORMDL3;EIF2AK3
prerank,covalent chromatin modification (GO:0016569),0.4083591800030879,0.9841704480082399,0.48032786885245904,0.9518722129180115,1.0,2/14,5.97%,HDAC1;SETD5
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2523731401296071,0.9835216013083984,0.5532574974146846,0.9528207483090673,1.0,106/509,19.08%,ROR1;PDGFRA;NTRK3;DCN;MAP3K14;PIK3R1;ROR2;NRG1;EDA2R;CCDC22;WNT5A;ADGRV1;NTRK2;TCF7L2;CD40;SEMA5A;ERBB4;ITGAV;FLT3LG;NRG2;TSPAN6;FGFR1;GAB2;LURAP1;GPR37L1;GJA1;PDPK1;PIK3R2;GCNT2;HTR2B;IRS1;TLR6;NEDD4;DHX58;IRS2;NRG4;PTK2;WDR24;TNFRSF19;TRIM8;PRKD1;PINK1;RELN;AXL;SOX2;PRKCB;TSPYL5;TLR4;BIRC2;LPAR1;FGR;IRAK1;NDFIP2;IAPP;EIF2AK2;TP53;DHX36;RTKN2;RPL37;P2RX4;TGFBR1;FYN;SOX9;CD86;PDCD4;IGF2;CASS4;TRIM44;LGALS1;MYDGF;RNF31;LYN;TIRAP;MIOS;RIPK1;UBE2V1;F2R;FERMT2;FGF5;MAP3K3;AREG;FGFR2;GPR37;NDFIP1;LGALS9;HAX1;ZCCHC3;RRAGA;MAZ;PIK3CG;HTR6;BBC3;MYD88;ADAM8;ADRA2A;RHOG;BMP2;NFAT5;PDGFRB;RHOA;SPRY2;ATP2C1;RRAGD;TERF2IP;KSR1;WWC1
prerank,protein deacetylation (GO:0006476),0.33193657624850015,0.9834599538032952,0.4869831546707504,0.9521236145117344,1.0,6/41,7.26%,MIER2;HDAC1;MORF4L1;SIRT6;BRMS1L;BRMS1
prerank,regulation of mononuclear cell migration (GO:0071675),0.36745338909402336,0.9834583404770597,0.4611801242236025,0.9512549631240071,1.0,8/23,21.30%,IL34;PTK2;LYN;AKIRIN1;CMKLR1;BMP5;RARRES2;MAPK1
prerank,regulation of interleukin-10 production (GO:0032653),0.33443602081259405,0.9832202327891341,0.46805349182763745,0.9510591126309338,1.0,6/44,11.00%,XCL1;TSLP;PDCD1LG2;TNFRSF21;TLR4;PYCARD
prerank,regulation of store-operated calcium entry (GO:2001256),0.4550375570687546,0.9830922065443088,0.5141843971631206,0.9505654037121428,1.0,4/10,21.74%,GRAMD2A;STIM1;HOMER3;HOMER2
prerank,atrial septum development (GO:0003283),-0.387382404312386,-0.9828046684247512,0.46568627450980393,0.7484691236294952,1.0,5/13,12.55%,NOTCH2;BMPR2;TGFB2;ANK2;HEY2
prerank,regulation of protein export from nucleus (GO:0046825),-0.3244018951534723,-0.982577431862051,0.5094339622641509,0.7483163043233451,1.0,7/23,13.90%,PTPN14;RBM22;GSK3B;IFI27;RANGAP1;BAG3;RAPGEF3
prerank,histone H3-K4 trimethylation (GO:0080182),0.43938780413092515,0.982127141876391,0.46835443037974683,0.952475482970767,1.0,2/11,4.57%,OGT;KMT2A
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3273267242680762,0.9820329596939187,0.48914616497829233,0.951871161998643,1.0,6/42,7.60%,FBLN2;CORO2B;GCNT2;NF1;PTPRO;PTK2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.45154302865927776,0.9817574322336761,0.49534450651769085,0.9509404789343749,1.0,2/10,9.35%,IL1RN;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.45154302865927776,0.9817574322336761,0.49534450651769085,0.9509404789343749,1.0,2/10,9.35%,IL1RN;MBP
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2923136447853645,0.9815521026513566,0.4889753566796368,0.9506585381177829,1.0,20/94,16.45%,DYNLL1;DCTN3;HAUS3;HAUS1;DCTN2;HAUS8;CEP192;PRKACA;CEP135;AHI1;TCTN2;SSNA1;TMEM67;IQCB1;SCLT1;CEP250;CEP152;CSNK1E;CLASP1;ALMS1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.22593917803120533,-0.9814239609804235,0.5248618784530387,0.7504690814406306,1.0,47/132,27.95%,RPS14;PTGES3;PRKDC;EIF5;SF3B1;RPL5;EIF2S2;SCAF11;RPS19;RPS27;PRMT7;KHDC4;DICER1;RPS15;MCTS1;RPL10;CELF1;RPS5;RPL11;SNRPC;GCFC2;SNRPE;RPLP0;SRPK1;SNRNP200;MRPS7;SNRPD1;SART1;RPL23A;EIF4H;MRPL20;CLP1;PRPF19;DDX20;PUF60;SF3A2;USP39;PWP2;RPL38;CELF5;RPF2;NOP2;CPSF6;SMN1;CPSF7;STRAP;RPL24
prerank,phospholipid translocation (GO:0045332),-0.30698190605137937,-0.9809199901873858,0.4792746113989637,0.7510050927417351,1.0,10/28,18.29%,ATP10A;ANO6;ATP8A1;ATP11B;ATP8B1;MFSD2A;ABCB4;P2RX7;PLSCR3;ATP8A2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.32536320099714766,-0.9808499932762546,0.45698924731182794,0.7504742436092625,1.0,7/24,20.02%,ERAP1;TAPBP;ACE;B2M;TAP2;HFE;ABCB9
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2672293333849958,-0.9808224264785744,0.5183946488294314,0.7498270121242957,1.0,17/50,17.04%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;OAZ1;PSMB10;OAZ2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.38278128392194044,-0.9803964091295366,0.4650602409638554,0.7501404267010413,1.0,5/13,16.94%,PRR5L;ZC3HAV1;CNOT8;RC3H1;GTPBP1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.32405600791687755,0.980344732562173,0.4918276374442793,0.9531890496163591,1.0,2/46,1.93%,APOD;TCF7L2
prerank,cardiac ventricle development (GO:0003231),0.38877529009734585,0.9803079915335975,0.4713375796178344,0.9524242625519121,1.0,7/20,18.77%,SALL1;TMEM65;MDM4;HECTD1;DAND5;GJA5;HEY1
prerank,artery development (GO:0060840),0.3695340770295846,0.9798939267640013,0.48177496038034867,0.9526426134843528,1.0,5/23,15.41%,ROBO2;NF1;TGFBR1;HECTD1;GJA5
prerank,positive regulation of innate immune response (GO:0045089),-0.30713489568605806,-0.9796944819980776,0.49279538904899134,0.7512804963286325,1.0,10/30,16.45%,LBP;NMI;MAVS;GBP5;RPS19;IFI35;RIOK3;POLR3G;NLRC5;POLR3D
prerank,endothelial tube morphogenesis (GO:0061154),-0.41236168999394385,-0.979553928391984,0.5193621867881549,0.7509293478664865,1.0,3/10,17.63%,RBPJ;ACVRL1;CSNK2B
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2477170463056077,-0.9795424237882597,0.5182481751824818,0.7502350329602312,1.0,19/82,12.75%,EPHA4;ROCK2;ANKS1A;SIPA1L1;ACTB;ARHGEF28;EFNB2;ACTG1;EPHB4;RAC1;CDC42;EFNA5;EFNB1;AP2A1;NGEF;GIT1;EPHB2;APH1A;APH1B
prerank,regulation of osteoblast proliferation (GO:0033688),-0.35308205720384506,-0.9792277664458017,0.47959183673469385,0.7502956580624096,1.0,5/17,13.50%,NPR3;CCN1;PLXNB1;SFRP1;TMEM119
prerank,proteolysis (GO:0006508),0.26551175211336764,0.9790272757118004,0.5279017857142857,0.9542243232822405,1.0,31/252,12.65%,ECE1;GGT5;PGPEP1L;ECE2;OGT;ADGRV1;FAP;ATG4A;MMP24;MMP25;PCSK2;CAPN5;HTRA3;CPQ;CASP4;CASP6;KLKB1;ADAM19;CAPN3;ADAMTS12;CPM;PSMB5;PLAU;LGMN;CAPN6;PITRM1;PSMC4;ERMP1;HTRA2;ENDOU;SPRTN
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.26242452631718305,0.9789205123719071,0.530454042081949,0.9536747230350769,1.0,61/248,18.61%,PRICKLE1;HDAC1;WNT5A;LYPD6;CDK14;TCF7L2;SEMA5A;BICC1;ADGRA2;RNF220;NKD1;NPHP3;PSMD1;MCC;JUP;RBMS3;GPC5;LRRK2;CDH3;TLE2;PSMD10;KREMEN1;PSMA5;PTPRU;PTPRO;PSMB5;NKD2;SOX2;TLE1;GLI1;GLI3;ZBED3;PSMC4;PSMA4;SHISA6;PSMC5;JADE1;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;WNK2;CHD8;DAAM2;LGR5;FGFR2;AMER2;USP34;CSNK1E;DVL3;PSMD14;PSMA7;FRZB;HECW1;LRRK1;BMP2;ZEB2;PSMD11;LZTS2;PSMA2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4223623562897887,0.9785829286278437,0.4810344827586207,0.9537596824151795,1.0,2/13,10.03%,GAB2;FGR
prerank,negative regulation of DNA binding (GO:0043392),-0.3084576296175087,-0.9784981937760084,0.4794520547945205,0.7513962181927129,1.0,10/28,26.06%,LEF1;SMO;NFKBIA;SUMO3;HEY2;SOX11;E2F1;ILRUN;SUMO1;KDM1A
prerank,histone methylation (GO:0016571),-0.31258862913067975,-0.9784686615297354,0.48641304347826086,0.7507407585044962,1.0,5/26,10.72%,SMYD3;PRMT7;NTMT1;SMYD2;PRMT8
prerank,fatty acid transport (GO:0015908),0.3932972398569966,0.9783031073363919,0.49114331723027377,0.9536483737503032,1.0,5/17,14.90%,PPARD;FABP5;FABP4;FABP3;SLC25A17
prerank,establishment of spindle localization (GO:0051293),0.416534956813157,0.9782569071519585,0.4830508474576271,0.9529199898298792,1.0,6/14,18.45%,LLGL1;ZBED3;NUSAP1;CLASP2;CLASP1;KPNB1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4199487237182469,0.9781996902846144,0.4831858407079646,0.9522120249943571,1.0,4/12,15.78%,REST;ZFP36L2;N4BP2L2;JAG1
prerank,protein modification by small protein removal (GO:0070646),0.2628799148985118,0.9779289012220341,0.5055803571428571,0.9520419973269414,1.0,58/252,18.78%,IL33;STAMBPL1;OGT;TAF9B;PTEN;COPS3;MBD6;PSMD1;USP1;OTULINL;PSMD10;UCHL3;USP42;PSMA5;PSMB5;MDM4;BIRC2;KAT2A;RNF128;PSMC4;PSMA4;TP53;USP33;TGFBR1;JOSD1;PSMC5;USP19;HGS;POLB;COPS4;PSMB9;KDM1B;ASXL1;UBE2D1;SENP6;ATXN3;RIPK1;CCNA2;AR;MYC;YOD1;USP34;USP4;PSMD14;PSMA7;USP21;USP16;USP13;STAMBP;USP14;INO80E;USP49;RHOA;PSMD11;USPL1;TAF10;PSMA2;HIF1A
prerank,cellular response to organic substance (GO:0071310),-0.22635142583418016,-0.9778444615731123,0.5208333333333334,0.7515999648202046,1.0,42/116,23.87%,DPYSL3;LEF1;SLIT2;IL18;ARL6IP5;IGFBP5;KLF4;BMPR2;PTPN4;PTPN14;SOCS2;CYP1B1;RAMP1;ACVR1;ACVRL1;SMAD3;SFRP1;PTPN2;SLC1A1;NOS1;RAMP2;CPNE3;MAP2K5;PLK5;FLT3;TBK1;ACVR2B;ERBB2;NDOR1;CDK9;DCPS;CIB1;PID1;PTPN5;HDAC6;TWF2;TGFBR2;CSF1R;SIGIRR;MME;EMD;ACVR2A
prerank,nucleic acid metabolic process (GO:0090304),0.30071554307569925,0.9777327944761645,0.4774281805745554,0.9517380365801072,1.0,7/69,9.10%,ENPP1;POLG;ANKLE1;FEN1;PDE12;HNRNPA2B1;WTAP
prerank,cellular response to metal ion (GO:0071248),0.2804732424861215,0.9774532930782334,0.5037688442211056,0.9516068380350795,1.0,32/123,18.88%,WNT5A;ADGRV1;GPLD1;ANK3;FOS;DLG2;LRRK2;ADCY8;CAPN3;RASGRP2;SYT3;ADCY7;LGMN;DAXX;CPNE7;SYT7;GLRA1;DLG4;P2RX4;TRPM2;SYT5;GLRA2;CPNE4;CPNE8;RYR3;CPNE9;DPEP1;MCOLN1;CARF;SYT1;SYT6;KCNH1
prerank,negative regulation of response to stimulus (GO:0048585),0.3063624309277926,0.9773881821864077,0.47752808988764045,0.9509264042425967,1.0,16/60,19.09%,CASK;SLC30A10;GGT7;NR1H2;FBXO5;ZKSCAN3;TWIST1;APPL2;UBASH3B;LYN;COL3A1;CLU;MAP3K3;ADRA2A;ALOX5;HHIP
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.29618077632978185,0.976881653136482,0.4980237154150198,0.9505996981048624,1.0,31/78,27.72%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;DCTN4;LGMN;AP1S1;SEC24B;KIF3C;DYNLL2;KIF2A;SEC23A;SEC24A;CANX;KIF3A;ACTR10;KIF11;KIF15;KIF23;RAB7A;SEC24C;SAR1B;SH3GL2;AP1B1;KLC2;SEC24D;CAPZA2;DCTN1;CTSL
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.29618077632978185,0.976881653136482,0.4980237154150198,0.9505996981048624,1.0,31/78,27.72%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;DCTN4;LGMN;AP1S1;SEC24B;KIF3C;DYNLL2;KIF2A;SEC23A;SEC24A;CANX;KIF3A;ACTR10;KIF11;KIF15;KIF23;RAB7A;SEC24C;SAR1B;SH3GL2;AP1B1;KLC2;SEC24D;CAPZA2;DCTN1;CTSL
prerank,positive regulation of ion transport (GO:0043270),-0.2746450635630103,-0.9768547088391618,0.48484848484848486,0.7533479677888336,1.0,7/48,8.00%,ANO6;ACTN2;FHL1;MYLK;ATP2B1;ORAI1;ANK2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3820424433987848,-0.9767784802775049,0.4790697674418605,0.7528227616951614,1.0,4/13,10.80%,CACNA1C;ANK2;GJC1;KCNQ1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2548052477270887,-0.9764458270041304,0.47808764940239046,0.7529131182527399,1.0,12/66,15.12%,IGF1;FOXP1;APP;SIRPA;GBP5;CASP8;GIT1;TRIM16;CX3CR1;HSPB1;P2RX7;CX3CL1
prerank,hemopoiesis (GO:0030097),-0.23935273609274849,-0.976398762522781,0.4892703862660944,0.752303430392746,1.0,13/87,7.85%,FLT1;MECOM;KITLG;TEK;NOTCH2;KDR;TGFB2;CD34;RUNX1;SNRK;MFAP5;HIPK1;ETV6
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.33038671882662707,-0.9763850503015692,0.47780678851174935,0.7516311206735964,1.0,3/22,0.63%,EPHA4;PICALM;ROCK2
prerank,regulation of protein localization (GO:0032880),-0.2594425676448046,-0.9758768876025227,0.5404411764705882,0.7521000046994786,1.0,8/58,8.26%,PICALM;AFDN;DVL1;TRIM25;TRIM5;TRIM14;PPM1F;CEP290
prerank,cellular response to oxidative stress (GO:0034599),0.2815629557610299,0.9755522647480745,0.5163727959697733,0.9533878519148588,1.0,23/118,14.86%,PDGFRA;ETV5;PLA2R1;ERCC6L2;FOS;PRDX6;ALDH3B1;LRRK2;CAMKK2;PRDX5;CCS;PYCR1;PRKD1;PINK1;CYBA;TP53;ERMP1;PDK2;HTRA2;RAD52;EIF2S1;LONP1;VKORC1L1
prerank,response to X-ray (GO:0010165),-0.3693007102865942,-0.9747838771601186,0.48905109489051096,0.7541987294339507,1.0,8/14,40.21%,ANXA1;BRCC3;ATM;LIG4;MSH2;XRCC4;XRRA1;XRCC5
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3311523023413985,-0.9746796340750924,0.49736842105263157,0.7537693516639338,1.0,8/21,14.31%,AMPD3;NUDT3;NUDT4;XDH;NUDT7;NT5E;ACAT1;HINT1
prerank,MAPK cascade (GO:0000165),0.2583230225666894,0.9746440408935702,0.532258064516129,0.9550262263980938,1.0,62/295,17.06%,PDGFRA;PIK3R1;IL2RA;NRG1;ERBB4;ITGAV;FLT3LG;NRG2;FGFR1;GRIN2B;JAK1;MAP4K4;PSMD1;SPTBN1;DLG3;SPRED1;PIK3R2;HTR2B;IRS1;DLG2;LRRK2;NF1;IL17RD;CAMKK2;IRS2;PSMD10;ZFP36L2;ABHD17C;NRG4;PSMA5;PTK2;PSMB5;IL5;ABHD17B;MBP;MAP2K1;PSMC4;PTPRA;PSMA4;DLG4;FYN;PSMC5;GFRA1;SOX9;PSMB9;LRRC7;GFRA2;GDNF;ARAF;FGF5;MAP3K3;AREG;MYC;FGFR2;MAPK11;TNIK;PTGER4;RASA3;LGALS9;PSMD14;PSMA7;CCM2
prerank,heart process (GO:0003015),-0.35966180000445525,-0.9743670046260363,0.5036319612590799,0.7538721672748565,1.0,3/14,12.98%,ACE;GPX1;NOX4
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2510837216272848,0.9739229680731472,0.5531475748194015,0.9561185991522478,1.0,61/532,12.66%,RORA;IL33;IL34;GHR;IL15RA;ZEB1;MAP3K14;PIK3R1;XCL1;IL1RN;IL2RA;CXCL10;EDA2R;CXCL1;EDA;CD40;IL16;IL1R2;FLT3LG;IL18RAP;TSLP;JAK1;GAB2;PSMD1;YWHAZ;FSCN1;FOS;IRS1;COL1A2;CCL15;IFIT2;IRS2;PSMD10;BCL6;PSMA5;HNRNPA2B1;PSMB5;IL5;TWIST1;TRIM8;PLP2;SOX2;PRKACA;IFNLR1;APPL2;SP100;IL1RAP;BIRC2;IRAK1;PSMC4;PSMA4;CCL25;TP53;PYCARD;FYN;PSMC5;IL12A;HSP90B1;CD86;ST18;PDCD4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3279047813955361,-0.973818106487148,0.46774193548387094,0.7544768205240537,1.0,9/22,22.04%,RNF185;UBB;AMFR;UBC;EDEM1;MAN1A2;RNF5;UGGT1;UBA52
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4166108158221814,0.9736230435363075,0.4974271012006861,0.9560300296075412,1.0,5/12,18.00%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.4235983009022309,0.9730545880773003,0.4875886524822695,0.956668857278876,1.0,1/11,1.65%,WNT5A
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2577985762572081,-0.9727811960222787,0.5036231884057971,0.7564524170444655,1.0,22/61,19.30%,PRKAG2;CAV1;PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;OAZ1;SIRT1;PSMB10;OAZ2;SIRT5;PSME2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.4437795684444835,0.9727648225609115,0.5196998123827392,0.9566106539140102,1.0,3/10,10.62%,GABRA1;GABRG3;GABRG2
prerank,lipid translocation (GO:0034204),-0.33062143536136746,-0.9727240747614145,0.49148418491484186,0.7558889119899728,1.0,6/21,18.29%,ATP10A;ATP8A1;ATP11B;ATP8B1;ABCB4;ATP8A2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.24327035501597213,-0.972585783323713,0.50199203187251,0.7555267119977681,1.0,23/80,19.44%,ERC1;VTI1A;VPS35;SNX32;ARFRP1;SNX6;SGSM2;SPAG9;SURF4;CLN5;VPS29;VPS51;TBC1D10B;ARL1;TRIM27;LMAN1;RAB6A;TMEM87B;TBC1D5;SNX3;PLEKHJ1;VPS54;TBC1D14
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.25051123723597,0.9724754981918186,0.5561277033985582,0.9565572738264129,1.0,88/476,15.59%,RORA;RUNX2;ZFHX3;ATF5;PPARA;TEAD1;RGMB;NR1H4;KMT2E;HDAC1;WNT5A;NR2F2;TCF4;PHIP;ERBB4;SALL1;SMAD5;MED12;CXXC1;SPP1;POU3F3;PPARD;NR1H2;MDFIC;TEAD2;REST;FOS;ZIC1;KMT2A;ZNF423;ZBTB16;MYCN;CREB3L2;CAMKK2;TRIM56;CAPN3;TAF15;NPAS2;SPIN1;ZKSCAN3;SOX2;GLI1;BICRAL;NCOA1;SP100;GLI3;EDF1;XPC;BMP7;MAP2K1;NSD1;BRCA2;KAT2A;ENY2;CAMK4;SOX10;PPP3CB;SMARCA1;TP53;TGFBR1;PSMC5;ZNF318;EPC1;ESR2;SOX9;CD86;TFEB;HIVEP3;TRIM44;MYRF;TESC;AXIN1;BICRA;MED1;ELK1;ARNT2;FOXM1;CHD8;GTF2H1;MAFB;HNRNPD;UBE2V1;F2R;PRMT2;TFAP4;AR;MMS19;MYC
prerank,regulation of cell population proliferation (GO:0042127),0.24658141123958185,0.972468603975194,0.5838383838383838,0.9557229131485082,1.0,118/691,15.78%,PDGFRA;PTN;DLC1;IL34;NTRK3;COL18A1;ROR2;ATF5;CXCL10;HRG;NRG1;EDN3;HOXC10;PTGFR;CXCL1;MEIS1;GNL3;HDAC1;NTRK2;TCF7L2;PTEN;GLMN;PHIP;ERBB4;GPLD1;ITGAV;FLT3LG;CDKN2A;TSLP;FGFR1;GAB2;MEIS2;TIPIN;DLG3;POU3F3;JUP;FBXO5;TBX3;REST;GCNT2;TMEM115;HTR2B;CDC7;IRS1;ADGRB1;CDKN2D;IRS2;FXN;DUSP22;BCL6;HP1BP3;AMELX;CBFA2T3;PTPRU;PTK2;MDM4;CDK13;HTR1A;P3H1;IFNLR1;GLI1;CCKBR;LGMN;TENM1;CACUL1;TSPYL5;MAP2K1;BIRC2;TNS2;SLC25A33;EIF2AK2;TP53;NAP1L1;RTKN2;TGFBR1;AGO3;FKTN;SPEG;GAS8;HGS;SOX9;FABP3;DIS3L2;CD86;ST18;IGF2;GAREM1;FAM98B;S1PR2;MEAK7;TESC;BNIPL;CD81;P3H3;CDKN2C;DHPS;LYN;FOXM1;DOT1L;WNK2;THAP12;CLEC11A;NME1;IGFBP7;F2R;GDNF;CLU;FGF5;CIAO1;TFAP4;CDK10;CNOT7;AREG;AR;MYC;SGK1;FGFR2;JAG1
prerank,regulation of filopodium assembly (GO:0051489),0.33739352177927806,0.9723734127908779,0.5112107623318386,0.9551397030685779,1.0,8/38,11.77%,PIK3R1;ABITRAM;MYO10;FSCN1;FMR1;TENM2;TENM1;TRPM2
prerank,positive regulation of DNA repair (GO:0045739),-0.2762078058693015,-0.9723280735343812,0.47987616099071206,0.755445734044213,1.0,11/46,15.75%,EYA2;EYA1;EGFR;EYA4;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;DDX11;SIRT1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.29608786206728194,0.9722453840104994,0.5033112582781457,0.9546304833068183,1.0,31/79,27.72%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;DCTN4;LGMN;AP1S1;SEC24B;KIF3C;DYNLL2;KIF2A;SEC23A;SEC24A;CANX;KIF3A;ACTR10;KIF11;KIF15;KIF23;RAB7A;SEC24C;SAR1B;SH3GL2;AP1B1;KLC2;SEC24D;CAPZA2;DCTN1;CTSL
prerank,protein autophosphorylation (GO:0046777),0.27054940645040465,0.9719757871326166,0.5145278450363197,0.9544677784433476,1.0,35/157,16.47%,PDGFRA;PEAK1;NTRK2;TXK;ERBB4;EPHB1;FGFR1;PDPK1;CDKL5;LRRK2;PRKX;CAMKK2;PTK2;PRKD1;PINK1;MTOR;FGR;IRAK1;CAMK4;EIF2AK2;EIF2AK1;SLK;MAPKAPK3;STK16;MAP4K1;LYN;PIM1;MELK;WNK2;RIPK1;MAP3K3;VRK1;FGFR2;TNIK;ULK2
prerank,tRNA metabolic process (GO:0006399),0.3917005026268236,0.971906135188179,0.4973821989528796,0.9538034691847985,1.0,9/17,26.40%,POP5;DTD1;POP7;SARS1;RPP21;DTD2;AARS1;SSB;YARS2
prerank,adipose tissue development (GO:0060612),-0.3974188467166515,-0.9716632674934201,0.490521327014218,0.7563918338149979,1.0,3/11,7.95%,SPTLC2;ARID5B;SH3PXD2B
prerank,nucleosome assembly (GO:0006334),0.3457592392538552,0.9714870846727633,0.4655436447166922,0.9540681390354412,1.0,8/31,12.20%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;UBN1;NAP1L1;SOX9
prerank,regulation of translational initiation (GO:0006446),0.3066030404123108,0.9714584393879249,0.4986301369863014,0.9532990721532864,1.0,23/63,24.50%,EIF4G3;EIF3H;FMR1;BOLL;RPS6KB1;GLE1;EIF4A2;PAIP1;IMPACT;EIF5B;MTIF2;HABP4;KHDRBS1;CTIF;EIF2AK3;YTHDF1;NCK2;DDX1;EIF4B;EIF2B5;MIF4GD;ATF4;POLR2D
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2722119863505492,-0.9714231265903556,0.5105740181268882,0.7563079022440313,1.0,17/45,31.81%,BMPR2;TGFB2;DAB2;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;INHBB;ACVR2A;SMAD4;TTK;GDF10;BMP6;BMP3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.42347785173173974,0.971320686110674,0.4973821989528796,0.9528132776059219,1.0,3/12,10.82%,MCM7;CDC7;MCM4
prerank,protein polymerization (GO:0051258),-0.2614990114951199,-0.9710051445667657,0.5523465703971119,0.7566987942863621,1.0,15/55,18.35%,DIAPH1;GSN;COBL;RAC1;ARL6;MAPT;FAM107A;GAS7;MAP7D3;TRPV4;TPPP3;PSTPIP1;WASL;CHMP4B;CHMP4A
prerank,positive regulation of protein catabolic process (GO:0045732),-0.24085058559342287,-0.9709115783085766,0.5125,0.7562195469083328,1.0,26/84,22.29%,FOXO1;WWP1;EZR;RDX;VPS35;WWP2;GPC3;APC;GSK3B;APOE;VCP;SMURF2;ASB5;RNF41;APC2;VPS11;FURIN;OAZ1;VGLL4;OAZ2;MSN;ADAM9;FZR1;VPS28;NDUFA13;TNFAIP3
prerank,regulation of gluconeogenesis (GO:0006111),0.3563338411421796,0.9708616120174345,0.5086614173228347,0.9532521071245048,1.0,5/27,11.83%,OGT;DGKQ;GCK;ERFE;PDK2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.28960850456345727,0.9703893897133964,0.5052910052910053,0.9537010703369299,1.0,34/87,25.16%,TIMMDC1;DMAC2;OMA1;NDUFS7;IMMP2L;TMEM126A;NDUFS5;BCS1L;SLC25A33;NDUFAF7;NDUFV2;NDUFV3;COX16;SURF1;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;UQCC2;TMEM126B;TIMM21;NDUFA10;CHCHD4;LYRM7;NDUFS1;NDUFB6;COX17;NDUFAF2;DMAC1;SAMM50;NDUFB8
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3385762561518743,0.9701982642983671,0.4985207100591716,0.9533423808422709,1.0,9/34,17.33%,PDE4B;RYR2;SLC9A1;ATP2A2;PRKACA;P2RX4;GJA5;STC1;PIK3CG
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2303227800877845,-0.9699926894756881,0.529126213592233,0.757763343249339,1.0,34/121,18.05%,VIM;ELAVL1;PSMC6;PSMD9;HSPA8;SAMD4A;PSMF1;PSMB7;YWHAB;PARN;UBB;PRR5L;ZC3HAV1;CNOT8;PSMD8;RC3H1;PSMD12;HSPB1;PSMA3;PSME3;PSMA6;EXOSC2;PSMD4;PSMD7;PSMB6;PSMC1;PRKCD;PABPC1;EXOSC3;PSMB10;UBC;GTPBP1;SERBP1;AKT1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.33448752825009137,0.9697641060337256,0.46824224519940916,0.9536838644466934,1.0,9/37,14.82%,ERCC1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3478403712790364,-0.9695972332396323,0.475,0.7579837143193682,1.0,5/18,16.19%,DDX5;EGFR;MAP2K2;TERT;ESR1
prerank,snRNA 3'-end processing (GO:0034472),0.3829011867570448,0.9694483659884324,0.49917898193760263,0.9536997736849392,1.0,5/19,15.78%,INTS8;INTS14;EXOSC9;EXOSC8;EXOSC5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.26163280172496284,-0.9693653709943508,0.55,0.757868991425047,1.0,17/53,17.04%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSME3;PSMA6;PSMD4;PSMD7;PSMB6;PSMC1;OAZ1;PSMB10;OAZ2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.35789473099770946,-0.9693001210660337,0.4975609756097561,0.7573288145873046,1.0,3/16,5.37%,VIM;WNT4;RUNX1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.44149867299724754,0.9691294063901073,0.5101663585951941,0.9537226455228097,1.0,5/10,16.39%,CORO2B;TERF1;NDFIP2;SNX12;NDFIP1
prerank,regulation of endocytosis (GO:0030100),-0.2572332163500148,-0.9689338368578481,0.4913494809688581,0.7575124904533206,1.0,18/61,20.91%,PICALM;PACSIN2;MCTP1;HIP1R;GPC3;DAB2;APOE;RAB5A;RAB5C;PTPN1;CD151;SNX17;HIP1;SMPD1;RAB4A;MTMR2;AP2S1;CALY
prerank,negative regulation of viral genome replication (GO:0045071),-0.2840066796807592,-0.968766968956027,0.5303514376996805,0.7572162727576228,1.0,12/40,25.86%,MAVS;IFITM3;ZC3HAV1;IFITM1;PARP10;SRPK1;RNASEL;ISG15;IFIT1;IFITM2;BANF1;TRIM6
prerank,actin filament capping (GO:0051693),0.38873336593171315,0.9678540834716456,0.5205696202531646,0.9554857313242362,1.0,1/18,0.31%,SVIL
prerank,barbed-end actin filament capping (GO:0051016),0.38873336593171315,0.9678540834716456,0.5205696202531646,0.9554857313242362,1.0,1/18,0.31%,SVIL
prerank,endodermal cell fate commitment (GO:0001711),0.43855634726881887,0.9678432045294065,0.49731663685152055,0.9546664231606294,1.0,2/10,8.72%,RTF1;SOX2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.37273222086357705,0.9677370987636,0.49375,0.9541032095970751,1.0,2/20,2.75%,RUNX2;SMAD5
prerank,regulation of signal transduction (GO:0009966),0.26310296094677765,0.9675957598390346,0.5405092592592593,0.953642294583397,1.0,28/190,11.52%,RORA;SULF1;TMEM204;MTCH1;OGT;TSPEAR;SEMA5A;ITGA3;RGS20;MDFIC;ZIC1;ANKRD54;LRRK2;LLGL1;TMEM108;IFT81;KCTD8;DGKQ;PRKD1;RGS8;GLI1;SP100;IRAK1;DOK5;USP33;FYN;SNW1;UBASH3B
prerank,cellular response to tumor necrosis factor (GO:0071356),0.26378793301150427,0.9673007161872463,0.5345029239766081,0.953587058740457,1.0,23/175,13.14%,MAP3K14;XCL1;EDA2R;EDA;CD40;PSMD1;CCL15;SMPD4;PSMD10;ZFP36L2;ADAMTS12;PSMA5;PSMB5;TNFRSF21;BIRC2;PSMC4;PSMA4;CCL25;TP53;PYCARD;PSMC5;ST18;PSMB9
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24468835718340748,0.9671647752096227,0.6382765531062125,0.9531073372546395,1.0,183/1082,15.78%,RORA;IL33;DCN;LPIN3;PIK3R1;RUNX2;ZFHX3;ATF5;CXCL10;ETV1;PPARA;AUTS2;HOXC10;MEIS1;TEAD1;RGMB;OGT;ETV5;NR1H4;KMT2E;HDAC1;WNT5A;NR2F2;TCF7L2;TCF4;CD40;TXK;PHIP;RGMA;ERBB4;SALL1;THRA;SMAD5;MAML3;CDK8;MEIS2;NCOA2;METTL23;MED12;PGR;NFATC3;CXXC1;SPP1;POU3F3;JUP;THAP3;PPARD;PIK3R2;NR1H2;MDFIC;TEAD2;TBX3;REST;FOS;ZIC1;KMT2A;NCOA3;ZNF423;ZBTB16;SLC9A1;MYCN;CREB3L2;CAMKK2;BCL9;SERTAD2;SSBP4;GLIS1;HLF;EPAS1;ASF1A;TRIM56;BRD8;E2F4;CRTC2;CAPN3;TAF15;NPAS2;SRF;CSRNP3;MYO6;AKIRIN2;LYAR;SPIN1;FIZ1;ZKSCAN3;CSRNP2;TWIST1;MED6;PRKD1;PFKM;SOX2;GLI1;BICRAL;NCOA1;DDX17;SP100;GLI3;EDF1;MTOR;XPC;BMP7;MAP2K1;NSD1;TLR4;BRCA2;KAT2A;ZBED3;ENY2;AHI1;ZFPM2;CAMK4;SOX10;PPP3CB;SMARCA1;TP53;DHX36;ZC3H8;TGFBR1;MED10;SNW1;PSMC5;ZNF318;FOXJ2;EPC1;ESR2;SOX9;NRIP1;UTP15;NFIX;CD86;ST18;ACTR2;TFEB;HOXB4;PLAC8;DPF2;IGF2;HIVEP3;TRIM44;KDM1B;MYRF;TESC;CD81;AXIN1;RFX4;ASXL1;BICRA;SREBF1;HOXC4;MED1;MYDGF;ZFP64;SSBP2;ELK1;PEG3;ARNT2;FOXM1;DOT1L;LAGE3;BPTF;CHD8;RIPK1;MED25;GTF2H1;MAFB;HNRNPD;UBE2V1;F2R;GDNF;ATF2;DHX9;FOXJ3;PRMT2;PRDM10;TFAP4;LPIN2;EAF2;AR;PBX2;MMS19;MYC;FGFR2;JAG1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2917974097666642,0.9670413706018931,0.5096277278562259,0.9526099478955056,1.0,20/85,18.61%,PRICKLE2;ROR2;PRICKLE1;WNT5A;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMD14;PSMA7;RHOA;PSMD11;PSMA2
prerank,hemidesmosome assembly (GO:0031581),-0.3965368844252245,-0.9669005775269547,0.49884526558891457,0.7611130749351437,1.0,7/11,16.77%,ITGA6;PLEC;LAMA3;ITGB4;CD151;DST;LAMC2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.34320633016184354,0.9667808594349052,0.506006006006006,0.9524378600783148,1.0,6/33,10.84%,TEAD1;GNL3;NGFR;FOS;SRF;TP53
prerank,respiratory chain complex IV assembly (GO:0008535),-0.32606738697772475,-0.9664512145181737,0.5089974293059126,0.7615610530417244,1.0,9/21,24.06%,COX15;PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L;COA6
prerank,intracellular protein transport (GO:0006886),0.25472981495276964,0.9664069962025347,0.5521405049396267,0.9525956073070375,1.0,73/304,20.45%,PRICKLE1;UNC93B1;GGA2;RABGAP1L;RAB20;CSE1L;TBC1D16;CACNG3;COPA;SEC16A;RABL3;ANKLE1;NUP214;NGFR;COPZ2;FAM53C;SORL1;NUTF2;CLIP3;POM121;NAPB;MYO6;TBC1D1;VIPAS39;SYNDIG1;TRIM23;VPS26C;RAB29;APPL2;TBC1D8B;FAM53A;BCS1L;RAB24;SLU7;SRPRA;SAR1A;SCFD1;NUP42;RANBP3;TNPO1;LTBP2;PTTG1IP;NUP107;ARFIP1;AP3D1;NXT2;RTN2;AKAP6;EIF4ENIF1;TBC1D9;STRADB;SNF8;CTTN;VPS33B;USP6NL;CALR;TNPO2;XPO6;IPO9;TMED3;TMED9;TBC1D17;NUP155;KPNB1;KIF13B;RAB3GAP2;COPB2;HOMER3;VPS45;XPO1;ARL5C;ARL4A;NAPG
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.30056619213118324,-0.9663887484271722,0.5223097112860893,0.760997239362201,1.0,12/29,27.48%,SAMHD1;MAVS;PTPN2;PTPN1;RNASEL;NLRC5;ISG15;USP18;PTPN6;YTHDF2;TRIM6;TTLL12
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3871733158190249,0.9661479085081873,0.4848993288590604,0.9524830669104356,1.0,6/17,15.49%,UBL4A;EMC2;EMC9;EMC8;BAG6;GET3
prerank,defense response to virus (GO:0051607),0.28779203457234515,0.9658687174717042,0.5,0.9524206818816617,1.0,12/100,11.63%,MAP3K14;CXCL10;RTP4;CD40;IFIT2;TRIM56;TLR8;PDE12;IFNLR1;EIF2AK2;PYCARD;AGBL4
prerank,smooth muscle tissue development (GO:0048745),-0.4021533877782263,-0.9658184408962187,0.4898876404494382,0.761655579084985,1.0,3/10,15.08%,MYLK;SMO;STRA6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.33421132799934283,0.9650481771867703,0.5205047318611987,0.9538228225962682,1.0,7/36,14.72%,WNT5A;TXK;TSLP;CASP4;AXL;TRIM44;RIPK1
prerank,mitotic cell cycle phase transition (GO:0044772),0.2627897548683272,0.9645974413188503,0.5318181818181819,0.954167549936292,1.0,52/203,21.06%,DYNLL1;CDK14;CDKN2A;CCNJ;DCTN3;HAUS3;PKMYT1;HAUS1;CDC7;CCDC57;DCTN2;CDC16;CDKN2D;RPS6KB1;HAUS8;CCNB2;CEP192;PRKACA;PPP2R2A;CACUL1;CEP135;PPP6C;BCAT1;RCC1;SSNA1;CUL5;DBF4;CDKN2C;CLASP2;MELK;FOXM1;CEP250;CCNA2;CEP152;BRSK2;MYC;CSNK1E;CLASP1;ALMS1;PCM1;KHDRBS1;CAMK2A;CCNE1;CUL4A;TUBA1A;LATS2;POLE;INHBA;CEP43;FBXL22;CCND3;CDK7
prerank,positive regulation of protein sumoylation (GO:0033235),0.43658626673905,0.9644952271972482,0.5036764705882353,0.9536094162801378,1.0,2/10,9.84%,GNL3;SAE1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.25290149453554517,-0.9641922945712216,0.541501976284585,0.7649703517156478,1.0,28/69,27.42%,MEF2C;RETREG1;SOD2;SIX1;NGF;NRBP2;APOE;SNX6;CX3CR1;FOXQ1;MDK;PTK2B;CX3CL1;ZPR1;RASA1;ERBB3;SIX4;KDM2B;CLCF1;MT3;CRLF1;NTF3;LIG4;VSTM2L;PARK7;BDNF;MSH2;NDNF
prerank,regulation of organelle assembly (GO:1902115),-0.24444951788931057,-0.964104474340446,0.46096654275092935,0.7644502608568936,1.0,21/72,20.24%,TBC1D19;EZR;RABEP2;STX18;RDX;TBC1D8;GSN;TBC1D22B;RAB5A;IFT140;VPS11;TBC1D22A;CYLD;TBC1D10B;TBC1D13;TBC1D5;MSN;TBC1D14;NPM1;PDCD6IP;RAB1B
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.357515238504247,0.963624897141662,0.49920255183413076,0.9551355214128069,1.0,3/23,6.91%,ZFYVE28;CBLB;DUSP22
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2534928156655312,-0.9635595272779534,0.5179282868525896,0.765023236681807,1.0,28/72,24.60%,ELF1;IRAK2;OTULIN;RUNX1;HIPK1;MADD;CASP8;PTPN2;PTPN1;CYLD;RNASEL;CD74;TNFRSF1A;IFNGR1;VRK2;TRADD;USP18;AGPAT2;TRAF1;TNFAIP3;CFLAR;SOCS3;SIGIRR;IKBKB;IKBKG;BIRC3;SUMO1;PTPN6
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.35294001562248584,-0.9633741894206594,0.4916467780429594,0.7647573272023089,1.0,5/16,8.64%,CACNA1C;CAMK2D;CALM1;ANK2;DMD
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.27760389266259594,0.9633406747783797,0.5372005044136192,0.9550420167585159,1.0,12/113,8.81%,PTN;LAMC1;LAMB1;WNT5A;TCF7L2;SEMA5A;C5AR1;HTR2B;CDH3;PDCL3;PRKD1;PRKCA
prerank,positive regulation of cell growth (GO:0030307),-0.234446496637581,-0.9633342038587861,0.540084388185654,0.7641564077157883,1.0,27/96,20.75%,IGF1;EGFR;NTN1;SEMA7A;RUFY3;TGFB2;ADAM10;CDC42;NGF;MAPT;HYAL1;SFRP1;INO80;RPS6KA1;GOLGA4;MACF1;EXOSC2;MFSD2A;CDKN2AIP;EDN1;PABIR1;ERBB2;AKT1;SDCBP;LGI1;CIB1;TWF2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.42097243757913483,0.9632366328875196,0.5081374321880651,0.9545205147846856,1.0,3/12,10.61%,GPLD1;ADCY8;PPP3CB
prerank,plasma membrane organization (GO:0007009),0.305929560042032,0.9630636393010766,0.5182584269662921,0.9541588130907505,1.0,9/61,10.53%,PLSCR4;EPB41L3;ABCD2;SPTBN1;ANK3;DEGS1;FA2H;ARL8B;SYT7
prerank,positive regulation of axonogenesis (GO:0050772),0.3238826733742998,0.96306086913272,0.5118881118881119,0.9533352157120649,1.0,6/43,6.57%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;LIMK1
prerank,activation of GTPase activity (GO:0090630),0.2881432401609322,0.9630372209949373,0.522020725388601,0.9525710054376154,1.0,12/89,7.40%,NTRK3;ARHGAP22;RABGAP1L;TBC1D16;SIPA1;ABR;SCRIB;ARHGAP24;GARNL3;SIPA1L3;DOCK7;TBC1D1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.22884523218243136,-0.9629637133879589,0.5397727272727273,0.7643522508467341,1.0,31/128,17.41%,SMAD6;DDX5;ARHGEF18;ITGB1;PTPRK;ID1;F11R;BMPR2;CLDN5;PARD3;TGFB2;SKI;MEGF8;UBB;ACVR1;ACVRL1;SMAD3;SMURF2;LRRC32;ZYX;SLC33A1;PRKCZ;SMAD1;CDH5;FURIN;SIRT1;HFE;UBC;TGFB1I1;ACVR2B;TWSG1
prerank,regulation of JNK cascade (GO:0046328),-0.23357817271177042,-0.9628836886808151,0.572139303482587,0.7638396311472563,1.0,35/101,24.70%,MECOM;PLCB1;EGFR;IGF1R;CCN2;TPD52L1;APP;SIRPA;MAP3K5;MAPK8IP3;MINK1;FZD7;SH3RF2;HDAC3;HIPK2;GADD45B;CYLD;FLT4;PTK2B;WNT16;TRAF3;MAPK8IP1;PER1;MAP3K10;TGFBR3;SDCBP;MFHAS1;GADD45G;DUSP19;TRAF1;TAOK2;CCL19;NOD2;EDAR;CD27
prerank,regulation of T cell differentiation (GO:0045580),0.34184565554443785,0.9626531681128091,0.5069984447900466,0.9527925187554158,1.0,4/33,10.34%,IL2RA;FANCA;KAT2A;CAMK4
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.41485026120011625,0.9626341504657033,0.5060240963855421,0.9520194471793203,1.0,4/14,12.34%,ENTPD2;ENTPD5;NUDT9;ENTPD7
prerank,negative regulation of hormone secretion (GO:0046888),0.4397285571970472,0.9625719982595758,0.49731663685152055,0.9513762562368855,1.0,2/10,12.89%,GJA1;RAB11FIP3
prerank,T cell homeostasis (GO:0043029),-0.40370412824638824,-0.9624084059580523,0.5096774193548387,0.7642945039667361,1.0,7/10,35.29%,FAS;AKT1;PPP2R3C;JAK3;NCKAP1L;FADD;PMAIP1
prerank,ganglion development (GO:0061548),-0.3944209981973882,-0.9620623691247719,0.5058275058275058,0.7644930572175938,1.0,3/11,13.56%,NRP2;NRP1;FZD3
prerank,protein localization to organelle (GO:0033365),-0.22015918972212437,-0.9619852435127298,0.5920398009950248,0.7639592302501105,1.0,31/133,17.21%,BBS9;APP;PACSIN2;CSNK1D;VPS35;DVL1;GBP5;SIX1;TOLLIP;VAPA;ARL6;STX1A;UBAC2;ANK2;GBP2;TSPAN17;ARFRP1;RPL11;IFT140;OPTN;LMNA;RAB35;GAK;TOR1A;BICD2;YBX1;CROCC;ARL1;RAB6A;ISG15;HHEX
prerank,lipid droplet formation (GO:0140042),-0.3969630736729879,-0.96196212470544,0.5288683602771362,0.7633072996045427,1.0,4/10,23.10%,CDS1;CDS2;PLA2G4C;FITM2
prerank,regulation of dephosphorylation (GO:0035303),-0.3687168474163449,-0.9617705399127152,0.4855072463768116,0.7630740916637105,1.0,5/15,12.95%,SMG6;PPP1R16A;PPP1R16B;MTMR9;SMG5
prerank,regulation of ERAD pathway (GO:1904292),0.4256826126799532,0.9615702124073787,0.5009276437847866,0.953233615298569,1.0,5/11,17.02%,HERPUD1;USP19;BAG6;ATXN3;USP13
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.35305474134184944,0.961385883730011,0.49768160741885625,0.9528964769333109,1.0,5/27,15.90%,LPIN3;CHKA;SELENOI;LPIN2;ABHD4
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2506976965190572,0.9611874812833626,0.593945720250522,0.9526016456912111,1.0,100/417,19.50%,ZEB1;RUNX2;XCL1;ATF5;NRG1;PRICKLE1;HDAC1;WNT5A;L3MBTL1;NR2F2;TCF7L2;BASP1;SALL1;THRA;CDKN2A;POU3F3;PPARD;LOXL3;NR1H2;MDFIC;LOXL2;TBX3;REST;SCML4;RUNX1T1;ZNF423;ZBTB16;TLE2;FOXS1;BCOR;CAPN3;CALCA;BCL6;GMNN;CBFA2T3;BRMS1;PAX9;ZKSCAN3;TWIST1;PER2;EIF4A2;TLE1;GLI3;L3MBTL4;BMP7;DAXX;ZFPM2;DAP;MPHOSPH8;TP53;ZC3H8;SNW1;ZNF318;CREB3L1;EPC1;SOX9;TWIST2;PDCD4;DPF2;PRDM5;ZMYND15;HIC2;PHC1;BTAF1;HDAC10;FOXM1;CHD8;KDM5C;PRMT2;TFAP4;CNOT7;DMAP1;CRY2;SPINDOC;CENPF;ZHX3;NONO;ZBTB7A;CBFA2T2;NR1D2;CIART;MBD2;CALR;MBTD1;CDK5;ILF3;MBD1;KHDRBS1;LDB1;BMP2;KAT7;SUV39H2;BRD7;HEY1;THAP7;CREBZF;PEX14;DEDD2;NACC1;MTA3
prerank,regulation of glycolytic process (GO:0006110),0.3003213559254554,0.9609878400550576,0.524966261808367,0.9523353685209106,1.0,9/68,7.11%,ZBTB20;PPARA;OGT;PFKFB1;NUP214;ENTPD5;AAAS;POM121;CBFA2T3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.27750949571209615,0.960744661551726,0.5288944723618091,0.9521589140524828,1.0,27/113,15.34%,NRG1;ERCC1;FSCN1;ERCC5;TLR6;RPA1;ERCC4;IL5;TERF1;MPP7;TLR4;PSMC4;SLF1;TP53;ASAP1;PSMC5;SPIDR;GTF2H3;CDT1;ERCC2;TIRAP;MED25;GTF2H1;BAK1;FERMT2;CLU;SLF2
prerank,organic substance transport (GO:0071702),0.2755984748311529,0.9605425730949322,0.5297092288242731,0.9518473212360736,1.0,7/121,2.37%,ABCA9;ABCA6;HRG;SLC48A1;LRP1B;CALCRL;ABCD2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.28886147645995386,-0.9602893951582671,0.5285714285714286,0.766027100094205,1.0,7/31,10.39%,EPHA4;PDLIM5;SIPA1L1;SHANK3;NGEF;CFL1;CAMK2B
prerank,nuclear membrane reassembly (GO:0031468),-0.2603259918368349,-0.9602583720044447,0.5292096219931272,0.7654030754273025,1.0,21/54,26.89%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;LMNA;NUP98;RAN;REEP3;NUP43;NUP205;CHMP7;CHMP4B;CHMP4A;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3410879139074799,0.959955417638439,0.5067466266866567,0.9525341993412516,1.0,6/33,16.71%,IL34;PRKCA;TESC;CTNNBIP1;RIPK1;HAX1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2863650466155802,-0.9590994984887845,0.5247252747252747,0.7674911688463595,1.0,14/33,22.19%,FHL1;KANK2;KLF4;APC;CDK6;FAM107A;WEE1;PLK5;CDKN1A;DCUN1D3;DLG1;RBL1;RBL2;CDK2AP2
prerank,camera-type eye morphogenesis (GO:0048593),0.4463719369877459,0.9586281360789387,0.5263157894736842,0.9552510585535818,1.0,2/10,5.46%,TENM3;NF1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.25448722675569174,-0.9585696556363643,0.5227272727272727,0.7680064872902064,1.0,9/57,9.87%,DAPK1;ARL6IP5;TNFSF10;MAP3K5;UACA;PPM1F;BAD;CASP8;PERP
prerank,sphingoid biosynthetic process (GO:0046520),-0.3958794260765684,-0.9584270810819157,0.5111111111111111,0.7670027228824936,1.0,3/11,4.50%,SPTLC2;ACER2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),-0.3958794260765684,-0.9584270810819157,0.5111111111111111,0.7670027228824936,1.0,3/11,4.50%,SPTLC2;ACER2;ACER3
prerank,peptidyl-tyrosine modification (GO:0018212),-0.260412609485538,-0.9583436243473099,0.5365853658536586,0.766522285013469,1.0,7/56,3.82%,FLT1;EPHA4;TEK;EGFR;FER;KDR;INSR
prerank,membrane repolarization (GO:0086009),0.40288504437296596,0.9581628035737675,0.5201401050788091,0.9557345851502524,1.0,3/15,11.23%,ATP1A2;KCNIP2;KCNE4
prerank,nucleotide metabolic process (GO:0009117),0.3618169845776414,0.9578364537919267,0.5100775193798449,0.9557520245415992,1.0,7/23,13.46%,NMNAT3;ENPP3;AK4;FHIT;DCTD;RNASEH2B;AK8
prerank,oligodendrocyte differentiation (GO:0048709),0.3714955244841786,0.9574902212096309,0.4889240506329114,0.9558538164716971,1.0,9/19,23.63%,SOX6;EIF2B1;SOX10;SOX9;MYRF;CDK5;PTPRZ1;EIF2B5;NSUN5
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3385950407855138,0.9573079846007069,0.48632218844984804,0.9555240972646996,1.0,10/31,23.38%,REST;CACNA1G;SYT3;SYT7;SYT5;ADRA2A;SYT1;SYT6;CACNA1I;SYT4
prerank,AMP metabolic process (GO:0046033),-0.3625852797293627,-0.9571711199489156,0.528344671201814,0.7687313483188494,1.0,4/13,10.38%,AMPD3;ADSS2;XDH;NT5E
prerank,positive regulation of filopodium assembly (GO:0051491),0.36594405466194,0.9569999678272518,0.5385852090032154,0.9555672443998506,1.0,5/24,9.47%,PIK3R1;FSCN1;FMR1;TENM2;TENM1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.274782922295579,0.9568269071136368,0.530562347188264,0.9552157907382112,1.0,30/124,18.61%,PRICKLE2;ROR2;PRICKLE1;WNT5A;TCF7L2;AGO4;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PPP3CB;AGO3;PSMC5;GNAO1;PSMB9;ARHGEF19;GNG2;TNRC6B;DVL3;PSMD14;PSMA7;FRZB;AGO1;CAMK2A;RHOA;PSMD11;PSMA2
prerank,RNA splicing (GO:0008380),0.28288835104868093,0.9567958024383288,0.5576679340937896,0.954476755638201,1.0,26/95,20.93%,TRA2B;GEMIN2;NOVA1;SNRNP35;ZRSR2;NOL3;LSM4;BCAS2;MPHOSPH10;SRSF11;SMU1;RP9;SLU7;DBR1;SNRNP48;PRPF18;SRSF10;SNRPF;NONO;SF3A3;ZCRB1;PPIG;PRPF8;LUC7L3;DHX15;DDX39B
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.31192349585098855,0.9565527231515519,0.5289855072463768,0.9543136334126273,1.0,13/52,19.85%,KDELR3;FKBP14;CXXC1;EXTL3;SRPRA;GSK3A;TATDN2;MYDGF;HSPA5;TSPYL2;CUL7;ATP6V0D1;SSR1
prerank,histone H3 deacetylation (GO:0070932),0.39979134161326396,0.9562651027655017,0.5017421602787456,0.9542354894614596,1.0,3/15,8.16%,HDAC1;SIRT6;PER2
prerank,phospholipid catabolic process (GO:0009395),-0.3079893387781634,-0.9560547109929542,0.5284090909090909,0.7707226616830792,1.0,9/24,23.50%,GPCPD1;PLA2G4A;GDPD3;ENPP2;SMPD1;SMPDL3A;PLA2G4E;PLA2G4C;GDPD1
prerank,chromatin remodeling (GO:0006338),-0.22983515425523976,-0.9560423894934592,0.5462555066079295,0.770039959386761,1.0,36/100,26.11%,ACTB;HDAC4;PBRM1;KDM4C;KDM4A;SMARCA4;SMARCA2;CBX3;TOP1;ACTR8;SMARCA5;INO80;ACTR5;HNRNPC;SMARCC2;JARID2;SIRT1;CHD3;ESR1;INO80C;BAHD1;ARID1B;KDM4B;BAZ1A;BAZ2B;NPM1;CHD1L;TADA2B;SMARCD3;RUVBL2;INO80B;TAF6L;SMARCD1;RB1;MYSM1;ACTL6B
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2727052020906949,-0.9559979566830556,0.5348101265822784,0.7694407234653761,1.0,12/39,19.62%,TEK;ANO6;THBS1;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5;GPER1;ECSCR;RGCC
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.28901939012299127,-0.9558493567020229,0.5226586102719033,0.7691145694405506,1.0,12/33,19.24%,IGF1;BCL2L1;TFRC;MAPT;GPX1;SLC25A5;ACAA2;ADCK1;PRELID1;GHITM;AKT1;HGF
prerank,negative regulation of complement activation (GO:0045916),0.4327684640548658,0.9557758836261351,0.5282685512367491,0.9546734813380433,1.0,3/10,17.61%,SUSD4;CR2;A2M
prerank,long-term memory (GO:0007616),-0.33514060994697625,-0.9553456035331311,0.5309973045822103,0.7696020378921418,1.0,4/19,9.96%,RASGRF1;SHANK1;APOE;CPEB3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.35156916272143485,0.9553402722646788,0.5168,0.9550770539784681,1.0,5/27,10.03%,PDGFRA;IRS1;PTK2;PRKD1;FGR
prerank,glycerophospholipid metabolic process (GO:0006650),0.29695433728173626,0.9551602843059408,0.5461741424802111,0.9547539814140604,1.0,15/75,14.09%,PIGV;GPLD1;PIGQ;SERINC1;PRDX6;SMPD4;PIGP;ENPP6;PLA2G7;CPNE7;ABHD12;AGK;PIGA;PIGL;SERINC5
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2326836146947527,-0.9550109933315707,0.5622641509433962,0.7697340067645616,1.0,24/88,20.05%,TRABD2B;FNIP1;STX18;SMPD3;TFRC;GSK3B;FNIP2;VCP;RHOC;SMAD3;HYAL1;BAX;SDC4;AJUBA;BID;CDH5;TAL1;CX3CL1;MMP1;SDC1;SDCBP;CHGA;RGCC;PDCD6IP
prerank,proteasome assembly (GO:0043248),-0.38753311957260683,-0.9549496815229754,0.5011547344110855,0.7691958930470341,1.0,5/11,22.66%,PSMD9;PSMG2;PSMD4;POMP;ADRM1
prerank,glucose import (GO:0046323),-0.3716893939124615,-0.9549174920254362,0.49516908212560384,0.7685934859645397,1.0,8/13,48.72%,SLC2A1;SLC2A4;RAB4B;SLC27A4;SLC27A1;SLC2A10;SLC2A3;TRARG1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.27382283735275625,-0.954558742926446,0.5191082802547771,0.7688022649438628,1.0,13/40,19.24%,IGF1;BCL2L1;TNFSF10;BAD;GPX1;BAX;BID;PRELID1;GPER1;GHITM;PLSCR3;AKT1;HGF
prerank,fatty acid elongation (GO:0030497),-0.3730928090921404,-0.9544701170262797,0.535632183908046,0.7683514674751286,1.0,4/13,12.95%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,cellular response to hexose stimulus (GO:0071331),0.35717411285135303,0.954220637728346,0.5355521936459909,0.9565096209294173,1.0,4/23,8.81%,ZBTB20;TRA2B;ADCY8;PRKACA
prerank,cellular protein localization (GO:0034613),0.2513931623152017,0.9541818565439782,0.583610188261351,0.9558052320967702,1.0,38/285,10.29%,EPB41L3;UNC93B1;GGA2;RTP4;WNT5A;MYO7A;ATG9B;RABGAP1L;RAB20;CNTNAP2;TBC1D16;GRID2;COPA;RABL3;WDR45B;GJA1;NGFR;COPZ2;LRRK2;SEPTIN9;NAPB;CAPN3;CEP68;MYO6;TBC1D1;PTPRU;VIPAS39;SYNDIG1;JAM3;TRIM23;VPS26C;RAB29;ITSN1;TBC1D8B;RAB24;SLU7;AHI1;SAR1A
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.32707455089766757,0.9540459586018543,0.5252976190476191,0.9553488780089812,1.0,12/40,19.51%,ANKLE1;FBXO5;USP1;FMR1;NPAS2;UBE2V2;POLH;UBE2V1;MYC;WDR76;FEM1B;FXR1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.27999455497446607,0.9537702551793086,0.5300127713920817,0.9552949079134333,1.0,27/100,19.94%,PRICKLE1;OGT;GLMN;EIF3H;LRRK2;RNF180;PSMD10;HERPUD1;CBFA2T3;NKD2;COMMD1;FHIT;ZYG11B;HECTD1;GSK3A;DDA1;BAG6;CLU;ARAF;DET1;CSNK1E;RNF19B;RNF217;DDRGK1;RNF144A;SUMO2;XPO1
prerank,protein insertion into ER membrane (GO:0045048),0.330588327945483,0.9535437620162533,0.5125184094256259,0.9551159586495644,1.0,16/37,24.27%,VAMP2;UBL4A;EMC2;SEC61B;TRAM2;EMC9;EMC8;BAG6;GET3;ALDH3A2;EMC10;SERP1;TRAM1L1;UBE2J2;EMC4;CCDC47
prerank,RNA stabilization (GO:0043489),0.34067275774423156,0.9535111854956306,0.5007949125596184,0.9544084441063734,1.0,9/33,15.04%,RBM24;DND1;TAF15;PAIP1;TENT5A;DHX36;TENT2;EIF4ENIF1;GDNF
prerank,apoptotic process (GO:0006915),0.2607642578920206,0.9534206828202758,0.5780542986425339,0.9538589445776523,1.0,48/203,18.02%,DLC1;IL2RA;MAGI3;OGT;FAP;NGFR;PPARD;ELMO1;CASP4;CASP6;ZBTB16;IFIT2;ADORA2A;DHCR24;CAPN3;KREMEN1;ARHGEF6;TNFRSF19;DCC;TNFRSF21;MTOR;DDX41;DAP;IAPP;PYCARD;JADE1;CASP12;FAM162A;PDCD4;DPF2;MRPS30;BNIPL;ATN1;ERCC2;BAG6;YARS1;MELK;SCN2A;AIFM2;RIPK1;BAK1;MYC;CDK5;NUDT2;BBC3;MYD88;PAK5;FEM1B
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.2650300527908015,-0.9533573870690055,0.5445859872611465,0.7702248084825778,1.0,18/48,19.90%,NOS3;THBS1;FOXC2;ATP5F1B;KDR;JCAD;ANXA1;MAPK14;GATA2;ETS1;FGFBP1;HSPB1;TMSB4X;PTGS2;SIRT1;AKT1;NUS1;CIB1
prerank,ncRNA catabolic process (GO:0034661),0.34426613838457076,0.9528527692162522,0.5270700636942676,0.95456607602053,1.0,10/28,19.31%,LIN28B;TENT4B;MTREX;EXOSC9;DIS3L2;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,regulation of lipid catabolic process (GO:0050994),0.3712993863607344,0.9522956988659539,0.5223367697594502,0.9552082041585834,1.0,6/19,22.96%,CIDEA;BSCL2;ADRA2A;PDE3B;RARRES2;TYSND1
prerank,aerobic respiration (GO:0009060),0.3806993891286169,0.9521893871787029,0.5145631067961165,0.9547009356532983,1.0,6/20,15.37%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14
prerank,negative regulation of axonogenesis (GO:0050771),0.351876269371594,0.9520722186230605,0.5291411042944786,0.9542241512619544,1.0,9/27,22.34%,PTEN;NGFR;CDKL3;DCC;ULK2;RHOA;EFNB3;MCF2;GDI1
prerank,positive regulation of receptor internalization (GO:0002092),-0.3082019913431115,-0.9520680784338867,0.5196850393700787,0.7727164221598665,1.0,8/22,26.13%,MAGI2;INSR;CD63;EGF;TBC1D5;GREM1;NTF3;ARRB2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.35296591011883,0.95192054441642,0.5094637223974764,0.9538125573798469,1.0,10/26,23.71%,OGT;KMT2A;VCPKMT;SETD5;SMYD5;SUV39H2;SETD4;ATPSCKMT;ANTKMT;TET2
prerank,lytic vacuole organization (GO:0080171),0.33689057049287024,0.9514178351414714,0.5077160493827161,0.954317097456605,1.0,8/32,15.88%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4475180717188975,0.951393546503312,0.5285714285714286,0.95358103364475,1.0,4/10,11.51%,THRA;PSMC4;TP53;PSMC5
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.34588620059108005,0.9513296753432953,0.5097087378640777,0.9529584154612057,1.0,5/27,13.20%,SLC1A3;SLC7A8;SLC25A22;SLC7A3;SLC25A29
prerank,protein modification by small protein conjugation (GO:0032446),-0.19839678919045298,-0.951288629487956,0.6557377049180327,0.7739030273982783,1.0,76/361,17.04%,FBXL7;WWP1;EYA1;RNF152;LMO7;GAN;MGRN1;VCPIP1;UBE2G1;ASB2;KLHL13;KLHL24;RNF43;PRKDC;WWP2;ARIH1;OTULIN;CDC23;HIF3A;UBE2D3;TRIM24;HLTF;NUP50;TRIM5;CUL1;FBXL2;TRIM11;UBB;STX1A;TRIM14;VPS18;RANGAP1;MSL2;UBE2H;VCP;RNF8;UBE2F;UBR1;MIB1;UBA6;FBXO25;SMURF2;TSPAN17;UBE2A;ASB5;KLHL20;VHL;RNF41;NUP98;CUL9;SPSB4;RCHY1;SUMO3;UBR2;NUP153;PCNA;VPS11;HERC2;TRIM63;AMFR;UBE2N;NUP43;ELOC;CAND2;NUP205;TRIM35;SIRT1;FBXO32;RAE1;TRIM27;DCUN1D3;ANAPC16;NEDD8;CUL3;UBC;ISG15
prerank,cAMP-mediated signaling (GO:0019933),0.36312299197633247,0.9510736033643026,0.5292259083728278,0.9528465162654679,1.0,7/24,15.01%,PDE7B;RIMS2;ADCY2;DGKQ;SOX9;AKAP6;EPHA5
prerank,ATP transport (GO:0015867),-0.4016964446895033,-0.950944796974383,0.51931330472103,0.7740389894928309,1.0,4/10,24.71%,ABCC6;SLC25A5;SLC17A9;SLC25A4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.38919435598683083,0.9499320833128789,0.5240641711229946,0.9550253003793584,1.0,5/16,8.81%,PDE9A;MTPN;SLC9A1;TRPC3;PRKCA
prerank,regulation of cardiac conduction (GO:1903779),0.3063131304448513,0.949859758765669,0.5471428571428572,0.9544052466028333,1.0,12/54,15.41%,ATP1A2;ITPR1;RYR2;ATP1A3;TMEM65;ATP2A2;PRKACA;FXYD4;ASPH;RYR3;STIM1;GJA5
prerank,cellular senescence (GO:0090398),0.3498055527999379,0.9496432621811606,0.5275590551181102,0.9541967708504429,1.0,5/27,9.60%,CDKN2A;TBX3;SRF;OPA1;MAP2K1
prerank,peptidyl-threonine modification (GO:0018210),-0.24514926313566582,-0.9496071410533596,0.5318352059925093,0.7765446616905655,1.0,27/66,22.82%,ROCK2;PRKDC;CAMK2D;WNK1;HIPK3;HIPK1;GSK3B;ACVR1;CDC42BPB;DYRK2;GALNT11;HIPK2;GALNT1;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;CSNK2B;AKT1;SBK1;MARK2;GALNT3;TGFBR2;TTBK1;CAD;STK39
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.27249211979300864,-0.9494084151772028,0.5335365853658537,0.7763595201167837,1.0,11/41,18.06%,ACTN2;ANK2;STAC;KCNJ2;KCNQ1;KCNJ12;NOS1;FLNA;NOS1AP;CTSS;ACE2
prerank,positive regulation of potassium ion transport (GO:0043268),-0.28179262640574937,-0.9493059637675695,0.5495495495495496,0.7759289219313505,1.0,10/38,20.84%,ACTN2;FHL1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP;DLG1;KCNJ15
prerank,protein targeting to lysosome (GO:0006622),0.3717402927543791,0.9491260815868522,0.5170178282009724,0.9547627214042645,1.0,6/20,15.08%,NEDD4;SORL1;SNX16;AP3M1;HGS;CLU
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.35869089393901193,0.9490217904851614,0.514018691588785,0.9542090800494353,1.0,6/24,12.54%,LIG3;POLK;RPA1;RFC3;XRCC1;POLB
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.2899226071748591,0.9488014787484381,0.5291005291005291,0.9540467922215647,1.0,21/74,18.47%,SPRY1;PTEN;PHLDB1;SPRED1;LOXL2;GCNT2;IL17RD;GLIPR2;SPRED2;TWIST1;MTOR;EPHA3;MCRIP1;TGFBR1;OLFM1;CLASP2;FERMT2;CLASP1;EFNA1;BMP2;SPRY2
prerank,response to exogenous dsRNA (GO:0043330),0.3814698253671753,0.9487652297382846,0.5141903171953256,0.9533421531175629,1.0,1/18,0.21%,COLEC12
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3416399945168672,-0.948583485850157,0.5190476190476191,0.7769823702085548,1.0,3/17,5.37%,VIM;WNT4;RUNX1
prerank,UV protection (GO:0009650),0.42691593474727946,0.9477460493573158,0.5196581196581197,0.9551854216690505,1.0,3/10,5.09%,FEN1;MFAP4;ERCC5
prerank,regulation of translation (GO:0006417),0.26319084995687336,0.9475866269764828,0.5630841121495327,0.954792129721109,1.0,43/173,18.90%,EIF4G3;PRR16;PLD1;NAT10;EIF4A3;NANOS3;EPRS1;EIF3H;LSM14A;FMR1;MTPN;CAPRIN1;LARP6;RPS6KB1;GLE1;EIF4A2;PAIP1;MTOR;MTRF1;EIF2AK2;GRM5;DHX36;PLXNB2;CNOT1;MALSU1;RBM4B;EIF4ENIF1;PUS7;HNRNPD;DHX9;CNOT7;IMPACT;EIF5B;TSC1;CYFIP1;MTIF2;CALR;IGF2BP3;ILF3;EIF3C;CTIF;EIF2AK3;YTHDF1
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.23044615547804964,-0.947411046615578,0.5380952380952381,0.7791423865206533,1.0,32/98,21.04%,SLCO1C1;THBS1;KLF4;MAGI2;INSR;INPP5F;IL10RB;MAPK14;APOE;XDH;IFNAR1;STARD4;NFKBIA;RNF41;CD63;CHCHD2;AGTR1;GRB2;CDKN1A;PRELID1;ACACB;GHITM;RAB1A;AKT1;ACE2;EGF;TBC1D5;PID1;RAB1B;ROMO1;AGT;TGFBR2
prerank,cell proliferation in forebrain (GO:0021846),0.41752095838358494,0.9473466038910758,0.5263157894736842,0.9546174624915599,1.0,4/10,24.48%,DOCK7;PCM1;KIF14;NUMBL
prerank,positive regulation of lipid kinase activity (GO:0090218),0.34207143432373954,0.9471978183056436,0.5391849529780565,0.9541894876535363,1.0,7/29,14.20%,PDGFRA;IRS1;PTK2;PRKD1;FGR;CD81;ATG14
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.23918923947662518,0.947051982135755,0.74,0.9537622249200687,1.0,332/1668,19.81%,TBX18;RORA;IL33;GBX1;ZNF367;DCN;LPIN3;ZEB1;PIK3R1;ZBTB20;RUNX2;ISL2;BHLHA9;TRPS1;ZFHX3;PKNOX2;MSC;ATF5;CXCL10;ETV1;ARID3A;PPARA;AUTS2;HOXC10;MIER2;MEIS1;TEAD1;OGT;ETV5;NR1H4;HDAC1;TEF;WNT5A;PPID;TAF9B;NR2F2;TCF7L2;TCF4;PTEN;CD40;TXK;PHIP;RGMA;SALL1;AGO4;THRA;CDKN2A;SMAD5;MAML3;ZFHX4;PEX2;CDK8;ZIC4;MEIS2;PER3;HTATSF1;NCOA2;METTL23;MED12;PGR;ZNF740;NFATC3;POU3F3;JUP;THAP3;PPARD;MYT1;PIK3R2;NR1H2;LOXL2;TEAD2;TBX3;REST;FOS;ZIC1;ZBTB24;KMT2A;SOX6;NCOA3;FOXO6;HOXC9;IFRD1;CHD4;ZBTB16;SLC9A1;MYCN;ZFP37;CREB3L2;RTF1;DMRTA2;BCL9;SIRT6;SSBP4;GLIS1;HLF;EPAS1;FOXS1;PSMD10;ZBTB46;BRD8;E2F4;BCOR;CRTC2;DUSP22;TENM2;BCL6;NPAS2;SRF;CSRNP3;BRMS1L;BRMS1;MYO6;PAX9;ZBTB2;AKIRIN2;TRIM37;LYAR;TAF3;NR2C1;ALX4;DGKQ;FIZ1;ZKSCAN3;PIAS2;MDM4;CSRNP2;TWIST1;PER2;MED6;CDK13;NOC2L;CHD2;PRKD1;MXI1;PFKM;SOX2;BHLHE22;GLI1;NCOA1;DDX17;OLIG2;PHF6;SP100;GLI3;TTC21B;PRKCB;NSD1;TLR4;WIZ;KAT2A;ZBED3;ENY2;ZBTB43;HOXC8;AHI1;ZFPM2;SOX10;PPP3CB;SMARCA1;N4BP2L2;TP53;ZNF292;ZNF25;DHX36;AGO3;MED10;SNW1;PSMC5;ZBTB39;ZBTB26;HOXB9;MSX1;MED8;GTF2H3;PROX2;FOXJ2;CREB3L1;EPC1;RFX2;ESR2;SOX9;MYT1L;ZNF112;NRIP1;TWIST2;NFIX;ST18;ACTR2;TFEB;ELP4;HOXB4;PLAC8;SAP30;DPF2;IGF2;HIVEP3;PRDM5;PPIL4;KDM1B;CNOT1;HIC2;DMRTA1;CD81;ATN1;RFX4;ASXL1;SREBF1;HOXC4;MED1;ZFP1;MYDGF;HDAC10;UBE2D1;ZFP64;SSBP2;ELK1;CRK;PEG3;ARNT2;FOXM1;DOT1L;LAGE3;CUX2;BPTF;CHD8;SNF8;ZBTB32;MYNN;RIPK1;SAFB2;MED25;GTF2H1;PRKAR1A;ZSCAN18;MAFB;GDNF;ATF2;ZBTB25;DHX9;HOXC5;TNRC6B;CIAO1;FOXJ3;PRDM10;TFAP4;LPIN2;DMAP1;EAF2;AR;PBX2;MYC;ORC2;FGFR2;KDM2A;JAG1;DCAF1;CRY2;AASS;ZHX3;ZKSCAN5;ZBTB7A;KLF11;IMPACT;ZNF467;HOXA9;ZNF3;ZBTB12;ZFP62;EFNA1;NR1D2;ATMIN;SRA1;DVL3;HAX1;MBD2;ONECUT2;AKIRIN1;CALR;CCNK;USP16;DNMT3A;MAZ;ZIC5;TOX2;SARS1;AGO1;ZNF32;SAFB;ABCA2;CREG1;RAI1;LDB2;LDB1;SKOR2;BMP2;NFAT5;KAT7;PHF20L1;SUV39H2;SMARCAL1;ZXDB;ZEB2;RRP1B;ARNT;RIF1;BRD7;CBFB;CARF;HEY1;HIF1A;THAP7;HDGFL2;TFDP1;CREBZF;NR2C2;WWC1;MED13L;CRTC3;EHMT2;DDRGK1;NACC1;HIVEP2;MTA3;HOXB2;CDC73;SP1;DVL2;MED15;FHL2;IKZF4;BMP5;CNBP
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4050965189003906,0.9469487895062555,0.5045871559633027,0.9532306077631855,1.0,1/13,0.98%,VDAC2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3935744153111422,-0.946824362437493,0.5209302325581395,0.7797621074154668,1.0,3/10,10.22%,MLLT3;ACE;SFRP1
prerank,cellular response to alkaloid (GO:0071312),0.3828218015686533,0.946816637634642,0.5173010380622838,0.9527902709735317,1.0,4/17,13.85%,RYR2;CASP6;SPIDR;RYR3
prerank,positive regulation of peptidase activity (GO:0010952),-0.32309628758267356,-0.9468139296786159,0.543424317617866,0.779090566081768,1.0,8/20,21.94%,VCP;CTSH;APH1A;APH1B;PSME3;PRELID1;PSME2;NDUFA13
prerank,leukotriene metabolic process (GO:0006691),0.3736085427845909,0.9464467480382147,0.5264026402640264,0.9529428585852329,1.0,1/19,0.55%,GGT5
prerank,positive regulation of integrin activation (GO:0033625),-0.38543014997137265,-0.9459464277234161,0.5441860465116279,0.7805754846874562,1.0,5/11,25.24%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC
prerank,regulation of mast cell activation (GO:0033003),0.4373333379797779,0.9456295412196716,0.5342706502636204,0.9542909707977109,1.0,4/10,24.63%,TSLP;LYN;NECTIN2;MILR1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.31613368170806894,0.9455860986050811,0.5529753265602322,0.9536101472891689,1.0,13/45,17.98%,PIK3R1;MYCN;LIN28B;NMD3;MAP2K1;TP53;UTP15;RBM20;DIMT1;RIPK1;HNRNPLL;DXO;HABP4
prerank,cellular response to dsRNA (GO:0071359),0.3938394699998369,0.9453528827215854,0.5114638447971781,0.9534179971557386,1.0,2/15,6.69%,COLEC12;PDE12
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.26014887831857036,0.945256960494916,0.5847554038680318,0.9528856730414147,1.0,24/190,11.18%,RORA;PPARA;CCDC22;NR1H4;PTEN;ITPR1;TSPAN6;DUSP1;SPRED1;PIK3R2;NPRL2;NF1;PSMD10;HERPUD1;CARD19;TWIST1;PLEKHA1;NOC2L;PINK1;TLE1;BMP7;PYCARD;RTKN2;BCL2L2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.36455876226149037,0.9451085109756061,0.5333333333333333,0.9524869761623175,1.0,4/22,8.83%,NTRK3;NTRK2;TMEM108;STMN2
prerank,protein deubiquitination (GO:0016579),0.2537976757462332,0.9450221511523517,0.5853658536585366,0.951924408957499,1.0,55/242,18.78%,IL33;STAMBPL1;OGT;TAF9B;PTEN;MBD6;PSMD1;USP1;OTULINL;PSMD10;UCHL3;USP42;PSMA5;PSMB5;MDM4;BIRC2;KAT2A;ENY2;RNF128;PSMC4;PSMA4;TP53;USP33;TGFBR1;JOSD1;PSMC5;USP19;HGS;POLB;PSMB9;KDM1B;ASXL1;UBE2D1;ATXN3;RIPK1;CCNA2;AR;MYC;YOD1;USP34;USP4;PSMD14;PSMA7;USP21;USP16;USP13;STAMBP;USP14;INO80E;USP49;RHOA;PSMD11;TAF10;PSMA2;HIF1A
prerank,thymus development (GO:0048538),-0.369191212388846,-0.9449485074004643,0.5471698113207547,0.7822356578860623,1.0,3/13,18.77%,SIX1;TBX1;EPHB3
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3760185510978239,0.9448549928164901,0.5394045534150613,0.95158002959879,1.0,3/17,12.20%,KDF1;AHI1;SOX9
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.32428552046824477,-0.9445929785751765,0.5407407407407407,0.7824295135054109,1.0,4/21,6.73%,ROCK2;KLF7;RUNX1;ERRFI1
prerank,regulation of fibroblast proliferation (GO:0048145),0.3083724803348427,0.9441075177877924,0.5312046444121916,0.9527470976950181,1.0,10/45,16.23%,PDGFRA;WNT5A;PEX2;NF1;TP53;B4GALT7;MED25;DHX9;MYC;NDUFS4
prerank,cobalamin metabolic process (GO:0009235),0.37984379148503566,0.9440815755999632,0.5345394736842105,0.9520280912627921,1.0,5/17,21.69%,MMAB;MTRR;MMAA;MMUT;ABCC1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.37833069591027113,-0.9439088332540668,0.5375586854460094,0.7833736662558474,1.0,4/12,17.09%,FOXP1;KLF4;MAP2K5;CD74
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.38382750389727005,-0.943870316828848,0.5348837209302325,0.7827639438619011,1.0,2/11,1.69%,DDX5;EGFR
prerank,protein acetylation (GO:0006473),-0.29072328855611224,-0.9436470212332884,0.5406976744186046,0.7825848786979017,1.0,10/30,17.36%,FOXO1;NAA40;MAPT;ESCO1;ING4;KAT5;SIRT1;ING5;CLOCK;NAA80
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2713069408406028,0.9436157926112183,0.5865504358655044,0.9524719040576162,1.0,16/114,13.14%,MAP3K14;EDA2R;EDA;CD40;PSMD1;PSMD10;PSMA5;PSMB5;BIRC2;PSMC4;PSMA4;TP53;PYCARD;PSMC5;ST18;PSMB9
prerank,negative regulation of interleukin-17 production (GO:0032700),0.43822496314520737,0.9435969912234924,0.5397111913357401,0.9517297647628847,1.0,3/10,21.96%,TLR4;IL12A;DDIT3
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.42925555957142353,0.9435457579630213,0.531578947368421,0.9510833253083937,1.0,4/10,12.20%,LOXL2;SOX6;ZBTB16;SOX9
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.37321714066129685,-0.94333819143354,0.5235849056603774,0.7826549551051819,1.0,2/12,11.09%,PPHLN1;ATF7IP
prerank,positive regulation of translation (GO:0045727),-0.23211922455428968,-0.9431209511730633,0.5872340425531914,0.7824643620252525,1.0,20/94,13.57%,VIM;LARP4;THBS1;RPS9;ELAVL1;PRKDC;NIBAN1;YBX3;SAMD4A;RPL5;LARP4B;SOX4;PYM1;CPEB3;RPS4X;EIF3D;RPL26;PKM;POLR2G;NGRN
prerank,positive regulation of behavior (GO:0048520),-0.3975287682048887,-0.9429656766382838,0.5233853006681515,0.7821645571427995,1.0,1/10,0.85%,MEF2C
prerank,protein localization to cell surface (GO:0034394),-0.2972468302227544,-0.9429556666025095,0.5286103542234333,0.7814935781586865,1.0,8/26,18.52%,VCL;PTPRK;MESD;ANK2;PIGU;FLNA;UNC50;WNT11
prerank,endoplasmic reticulum organization (GO:0007029),0.2931161485632151,0.9428475830888582,0.5710455764075067,0.9520917952728118,1.0,19/72,22.10%,SEC16B;SEC16A;REEP2;VAMP2;LRRK2;SMPD4;ZBED3;SEC61B;TRAM2;LNPK;RTN3;ALDH3A2;MIA3;EIF2AK3;MOSPD3;ATL1;SERP1;TRAM1L1;BNIP1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.34467648073892176,-0.9422005664571189,0.5233415233415234,0.7825907976781392,1.0,3/15,7.60%,APP;CRYAB;APOE
prerank,lymphocyte differentiation (GO:0030098),-0.24571008073755254,-0.9421597687942226,0.5833333333333334,0.7820050052071441,1.0,20/68,20.85%,PBX1;LEPR;PTPRJ;TPD52;HDAC4;ITGB1;SOX4;DNAJB9;PIK3CD;PTPN2;PLCG2;SLC25A5;LFNG;FLT3;VCAM1;HHEX;BLNK;NFIL3;KLF6;RHOH
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.29800234481985877,-0.9418698795558158,0.556786703601108,0.7819811909393214,1.0,8/28,18.18%,EGFR;NOTCH3;WWP2;GATA2;NIBAN2;LFNG;AKT1;EGF
prerank,defense response to bacterium (GO:0042742),-0.23060760081207213,-0.9416731314439156,0.6197183098591549,0.7817630426229099,1.0,23/105,17.98%,ANXA3;LBP;GBP7;MAVS;RPS19;DROSHA;GBP4;GBP2;PGLYRP1;STAB1;SERPINE1;OPTN;PLA2G6;GBP6;RPL30;PRKCD;ANKRD17;RNASE7;MPEG1;RAB1A;ISG15;HMGB2;PPP1R11
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2849860446285127,0.9416682573985264,0.5420439844760673,0.9544314042212197,1.0,16/73,20.46%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;CD86;TIRAP;RIPK1;CLU;DHX9;LGALS9;ADAM8;SETD4;ARFGEF2;PTPN11
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.380908186781313,-0.9415546786346984,0.5199115044247787,0.7813855987807192,1.0,2/11,3.95%,GSN;FAS
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3650310301397942,-0.9410879133440438,0.5380952380952381,0.7817666298319275,1.0,4/14,22.41%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,negative regulation of cell activation (GO:0050866),0.3981000376703313,0.9409236715382405,0.5280135823429541,0.9556002305760198,1.0,2/14,7.23%,PDGFRA;C1QTNF1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3476893627911605,0.9409223978399912,0.5300813008130081,0.9548197497854993,1.0,2/26,1.86%,ZFYVE28;CBLB
prerank,regulation of B cell apoptotic process (GO:0002902),-0.36788985828019466,-0.9408475087151293,0.5547619047619048,0.7816924887992015,1.0,2/12,1.62%,FOXP1;FNIP1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2551536362314109,-0.9404535774034952,0.5738831615120275,0.781918702710528,1.0,12/52,12.62%,PPP1R13B;ATG13;SREBF2;UBE2D3;YWHAB;YWHAG;BAD;CASP8;PPP3CC;PPP3R1;BID;VPS11
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3995412238446969,-0.9402711532895407,0.5355555555555556,0.7817262940001627,1.0,5/10,26.06%,JARID2;SIRT1;DNMT3B;BRCA1;KDM1A
prerank,cellular response to glucose starvation (GO:0042149),-0.2652774803533335,-0.9402218276629954,0.5579268292682927,0.7811561083046916,1.0,10/41,19.15%,PRKAG2;BECN1;SESN1;PRKAA2;SIK1;MYBBP1A;PRKAG3;PRKAA1;NUAK2;HNRNPA1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3641573038469502,-0.9396464553847095,0.5237020316027088,0.7817921782216816,1.0,1/13,0.01%,SORBS1
prerank,negative regulation of RNA splicing (GO:0033119),-0.3176551093460309,-0.9395626032523146,0.5436893203883495,0.7813022834222106,1.0,5/19,15.70%,TMBIM6;PTBP3;RBMX;SRSF4;SRSF7
prerank,response to interleukin-6 (GO:0070741),-0.3960895530710096,-0.9393451145880222,0.55119825708061,0.7811218000104089,1.0,2/10,2.67%,ST3GAL6;NFKB1
prerank,glycerolipid catabolic process (GO:0046503),-0.32220508989329366,-0.939253101460094,0.5461741424802111,0.7806590368595275,1.0,5/19,9.84%,GPCPD1;PLA2G4A;MGLL;GDPD3;ABHD2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.37984125545362657,0.9391865414748625,0.5393442622950819,0.958420569364213,1.0,2/17,5.18%,NR1H2;LIPC
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.421110003092844,0.9389158650296787,0.5196428571428572,0.958340236831,1.0,1/10,1.53%,ATP1A2
prerank,cilium-dependent cell motility (GO:0060285),0.362282783632511,0.9388827346047978,0.5281803542673108,0.9576261205682491,1.0,5/22,15.73%,RSPH9;EFHC1;CCDC65;GAS8;CCDC39
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2962255274345423,0.9388220764187106,0.5483405483405484,0.9569826719726,1.0,12/59,13.76%,ROBO2;TENM3;PTPRT;DSCAM;CNTN4;PALLD;DSCAML1;NEXN;CNTN6;PLXNB2;CADM3;NECTIN3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.38176323597311634,-0.9386620112880243,0.5364705882352941,0.7814537456100081,1.0,6/11,28.92%,CYC1;UQCRB;UQCRQ;UQCRC2;UQCC3;UQCRC1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.37026497949705894,0.9382570607420734,0.5354200988467874,0.9576210692943149,1.0,2/18,2.64%,DLC1;ITGA3
prerank,regulation of innate immune response (GO:0045088),-0.25149564573670685,-0.9381493159326123,0.5957446808510638,0.7820386976714521,1.0,12/57,11.89%,XIAP;SAMHD1;ERAP1;NMI;GBP5;IFI35;CASP8;IRF1;PARP9;PTPN1;RIOK3;POLR3G
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.37022748674420425,-0.9378904458549657,0.5491990846681922,0.7819286657722072,1.0,8/11,34.32%,ITM2A;SOAT1;AGO2;BACE2;ITM2B;NECAB3;ITM2C;ABCA7
prerank,positive regulation of protein depolymerization (GO:1901881),0.42046167766348186,0.9374366241457198,0.553415061295972,0.958945157339417,1.0,2/11,8.83%,SEMA5A;STMN2
prerank,lipid homeostasis (GO:0055088),0.3003893762166764,0.9372103598222733,0.5395284327323162,0.9587575103169151,1.0,10/57,18.17%,ZBTB20;ACOX2;TLCD3B;IRS2;RCN3;FABP3;ABHD4;NR1D2;ABCA2;ORMDL3
prerank,positive regulation of telomere maintenance (GO:0032206),0.32838023083177714,0.937165154150289,0.524024024024024,0.9581116644571349,1.0,7/31,16.40%,GNL3;ERCC1;SIRT6;HNRNPA2B1;DHX36;HNRNPD;PKIB
prerank,Golgi inheritance (GO:0048313),0.41842245829277813,0.9365792669043156,0.5301645338208409,0.9588476854615436,1.0,4/11,15.64%,YWHAZ;GBF1;GOLGA2;VRK1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.34520299384073144,-0.9363253779650119,0.5539568345323741,0.7848792137742439,1.0,7/16,22.47%,RBM22;SNRPC;CWC15;SNRNP200;SART1;DCPS;NCBP2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3180317571359691,-0.9358676061887057,0.5352480417754569,0.7853115175751813,1.0,2/22,4.18%,ALDH1A2;RBP1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2365593842203067,0.9355021584016333,0.782,0.9608687999527452,1.0,327/1646,19.09%,TBX18;RORA;CHD7;GBX1;ZNF367;ZEB1;ZBTB20;RUNX2;XCL1;ISL2;BHLHA9;TRPS1;ZFHX3;PKNOX2;MSC;ATF5;ETV1;NRG1;ARID3A;PRICKLE1;PPARA;HOXC10;MEIS1;TEAD1;RGMB;OGT;ETV5;NR1H4;KMT2E;HDAC1;TEF;WNT5A;L3MBTL1;CDK14;NR2F2;TCF7L2;TCF4;PHIP;BASP1;ERBB4;SALL1;THRA;CDKN2A;SMAD5;ZFHX4;ZIC4;MEIS2;HTATSF1;NCOA2;MED12;PGR;ZNF740;NFATC3;CXXC1;SPP1;POU3F3;PPARD;LOXL3;MYT1;NR1H2;FBXO5;MDFIC;LOXL2;TEAD2;TBX3;REST;FOS;ZIC1;ZBTB24;KMT2A;SCML4;SOX6;RUNX1T1;FOXO6;ZNF423;RRP8;HOXC9;FOXN2;IFRD1;CHD4;ZBTB16;MYCN;ZFP37;CREB3L2;DMRTA2;CAMKK2;GLIS1;SETD5;TLE2;HLF;EPAS1;FOXS1;TRIM56;ZBTB46;E2F4;BCOR;CAPN3;POLA1;TAF15;CALCA;BCL6;NPAS2;HP1BP3;GMNN;SRF;CBFA2T3;CSRNP3;BRMS1;PAX9;ZBTB2;SPIN1;NR2C1;ALX4;DGKQ;ZKSCAN3;PIAS2;MDM4;CSRNP2;TWIST1;PER2;MED6;SPTY2D1;CHD2;MXI1;SOX2;TLE1;BHLHE22;GLI1;BICRAL;NCOA1;DDX17;OLIG2;PHF6;SP100;GLI3;L3MBTL4;EDF1;XPC;TTC21B;PRKCB;TENM1;BMP7;MAP2K1;NSD1;DAXX;WIZ;SRRT;BRCA2;KAT2A;ENY2;ZBTB43;HOXC8;ZFPM2;CAMK4;SOX10;DAP;NFXL1;PPP3CB;MPHOSPH8;SMARCA1;TP53;ZNF292;ZNF25;DHX36;ZC3H8;TGFBR1;SNW1;PSMC5;ZBTB39;ZBTB26;HOXB9;MSX1;MED8;ZNF318;PROX2;FOXJ2;CREB3L1;EPC1;RFX2;ESR2;SOX9;SRSF10;MYT1L;ZNF112;CDT1;TWIST2;NFIX;CD86;ST18;PDCD4;TFEB;ELP4;HOXB4;SAP30;DPF2;IGF2;HIVEP3;PRDM5;CARM1;ZMYND15;NUP107;TRIM44;HIC2;MYRF;DMRTA1;TESC;PHC1;BTAF1;AXIN1;ZNF628;RFX4;BICRA;SREBF1;HOXC4;MED1;ZFP1;HDAC10;SSBP2;ELK1;CRK;PEG3;ARNT2;ZNF326;FOXM1;CUX2;BPTF;CHD8;SNF8;KDM5C;ZBTB32;MYNN;TGFBRAP1;SAFB2;GTF2H1;PRKAR1A;ZSCAN18;MAFB;HNRNPD;UBE2V1;F2R;ATF2;ZBTB25;DHX9;WTIP;HOXC5;CIAO1;FOXJ3;PRMT2;TFAP4;CNOT7;DMAP1;AR;MLF1;PBX2;MMS19;MYC;KDM2A;CRY2;SPINDOC;CENPF;ZHX3;NONO;ZKSCAN5;ZBTB7A;KLF11;ZNF467;HOXA9;ZNF3;CBFA2T2;ZBTB12;ZFP62;TRIP4;NR1D2;CIART;ATMIN;SRA1;DVL3;MBD2;ONECUT2;CALR;CCNK;USP21;USP16;MBTD1;USP13;CDK5;MAZ;ILF3;ZIC5;ZBTB11;TOX2;ZNF32;SAFB;ABCA2;MBD1;CREG1;RAI1;RHOG;KHDRBS1;LDB1;SKOR2;BMP2;MLF2;NFAT5;KAT7;PHF20L1;SUV39H2;SMARCAL1;ZXDB;ZEB2;ARNT;BRD7;RNF187;CBFB;CARF;ZNF711;HEY1;HIF1A;THAP7;HDGFL2;TERF2IP;CCNE1;TFDP1;CREBZF;NR2C2;WWC1;MED13L
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.38776522381234246,-0.9353923299366937,0.5691244239631337,0.7857899238409983,1.0,3/10,10.38%,UPP2;UPB1;NT5E
prerank,modulation by host of viral genome replication (GO:0044827),-0.35006210852076924,-0.9353338349452781,0.530952380952381,0.7852429337945404,1.0,3/13,7.60%,FBXL2;VAPA;IFI27
prerank,microtubule polymerization (GO:0046785),-0.299844410051486,-0.9352652504604706,0.5667655786350149,0.7847192157374054,1.0,8/28,15.72%,CSNK1D;NDEL1;TUBGCP5;MAPT;SLAIN2;MAP7D3;TRPV4;TPPP3
prerank,T cell activation (GO:0042110),0.29062944312853467,0.9352521745814075,0.5466847090663058,0.9607136855460214,1.0,6/69,4.98%,CHD7;CD8B;SCRIB;ICOSLG;CD276;PTPN22
prerank,second-messenger-mediated signaling (GO:0019932),0.28283373909500487,0.9351413858130689,0.5807291666666666,0.9602221110191397,1.0,12/82,11.26%,EDN3;ACKR2;CCR9;PDPK1;RYR2;PPP1R9A;HTR2B;LRRK2;CAMKK2;KSR2;RCAN3;P2RX4
prerank,apoptotic nuclear changes (GO:0030262),0.34762641730855276,0.9349781443975493,0.5344827586206896,0.9598714567951371,1.0,6/24,22.26%,CECR2;KPNA1;TOP2A;KPNB1;DEDD2;HMGB1
prerank,autophagy of peroxisome (GO:0030242),-0.37183319883733956,-0.9349091570722456,0.5601750547045952,0.7848464027640137,1.0,5/12,27.31%,SQSTM1;USP30;ATM;MAP1LC3B;PEX5
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.303887748023459,0.9342433864323574,0.562082777036048,0.9609605608061172,1.0,15/53,20.69%,GLMN;DNAAF4;FMR1;PINK1;PRKACA;COMMD1;OPHN1;PSMC5;USP19;ARAF;PSMD14;USP14;DDRGK1;XPO1;PRKCG
prerank,glycolipid biosynthetic process (GO:0009247),0.3183611540674813,0.9341201201626597,0.5417298937784522,0.9605069067709294,1.0,6/38,12.83%,ST8SIA1;PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.34779233796581754,0.9339327609711203,0.5480059084194978,0.9601966082139717,1.0,9/27,15.20%,FMR1;MYCN;MAP2K1;TP53;EIF4ENIF1;RIPK1;DHX9;WTIP;TNRC6B
prerank,cation transmembrane transport (GO:0098655),-0.26274199760906075,-0.9335682881781225,0.5598705501618123,0.7873429571225447,1.0,7/44,12.28%,TRPM3;TRPM6;SLC7A1;SLC3A2;SLC38A5;SLC7A5;SFXN1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.36533174993802053,0.9335043960786213,0.5485519591141397,0.9604901606330043,1.0,4/19,10.61%,EDN3;NFATC3;ADGRB2;PPP3CB
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3781815518498609,0.9331751496602108,0.5478991596638656,0.9605579626468576,1.0,4/17,9.49%,ATP1A2;SCN2B;CACNA1G;HCN2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3025436612319736,-0.9327183723470686,0.5623342175066313,0.7887378336632557,1.0,4/25,5.43%,PICALM;APP;RIN3;RAC1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.24757830953090704,-0.9325643138948773,0.6012658227848101,0.7883898142339415,1.0,17/61,20.68%,EYA2;EYA1;EGFR;EYA4;RNF8;RTEL1;PCNA;BRCC3;SMCHD1;UBE2N;NBN;SIRT1;PPP1R10;USP9X;HGF;RGCC;EYA3
prerank,histone modification (GO:0016570),-0.2207257299681652,-0.9323245624827645,0.6267281105990783,0.7883101757811032,1.0,24/109,16.50%,EYA2;EYA1;HDAC4;EYA4;KDM4A;KAT6B;SIN3B;ATXN7;TBL1X;PRMT7;NTMT1;MIER1;PHF20;RPS6KA5;UBE2A;PRMT8;MIER3;UBE2N;MSL3;KAT5;EZH2;PRKCD;SIRT1;TRRAP
prerank,neuron maturation (GO:0042551),-0.32868118209548774,-0.932224010510837,0.5503875968992248,0.7878658353961493,1.0,7/18,15.63%,ANKS1A;APP;B4GALT5;SCARF1;CLN5;CX3CL1;SRRM4
prerank,glycerophospholipid catabolic process (GO:0046475),0.34126287857429477,0.9321470040453015,0.5337331334332833,0.96242570647116,1.0,7/27,12.05%,PRDX6;LIPC;SMPD4;ENPP6;PLA2G7;ABHD16A;ABHD12
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3340452076559282,0.9318191032390437,0.5432098765432098,0.9624953759244859,1.0,10/30,19.69%,ACOX2;ABCD2;PEX2;ELOVL2;ACSL6;ACOT2;ELOVL6;ELOVL1;HACD3;ACSBG1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3456871008569277,0.9313647386449186,0.5429497568881686,0.9628476154592875,1.0,3/26,7.53%,TRAF3IP1;DHX58;LYAR
prerank,negative regulation of neuron death (GO:1901215),-0.22835709449465036,-0.9313061354100348,0.6063348416289592,0.7893410353538616,1.0,35/93,27.42%,CD200;MEF2C;RETREG1;VPS35;SOD2;CD34;SIX1;NGF;NRBP2;GSK3B;APOE;SNX6;FOXQ1;MDK;NENF;PTK2B;RASA1;AKT1;CHMP4B;CHMP4A;ERBB3;CHGA;SIX4;KDM2B;CLCF1;IKBKG;MT3;CRLF1;NTF3;LIG4;VSTM2L;PARK7;BDNF;MSH2;NDNF
prerank,positive regulation of ERAD pathway (GO:1904294),-0.36046910558663203,-0.930828645124808,0.5377574370709383,0.7897706785866021,1.0,2/13,3.62%,CAV1;RNF185
prerank,nuclear membrane disassembly (GO:0051081),0.3876954511702041,0.9307259993936506,0.5438898450946644,0.963736658591491,1.0,5/14,18.00%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.33644103575549955,0.9305123031791667,0.5514018691588785,0.9634600827291799,1.0,6/30,12.24%,NPC1L1;DHCR24;ACAT2;PLPP6;HMGCS1;ACLY
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.23668315401835016,-0.9304824827602622,0.6308243727598566,0.7899232312366837,1.0,12/76,13.76%,NR3C2;EGFR;EZR;APP;NMI;UACA;CCN3;IFI35;NFKBIA;TRIP6;CYLD;TMSB4X
prerank,transcription by RNA polymerase I (GO:0006360),-0.2748457123148371,-0.9301126395708735,0.5930232558139535,0.7901239994816608,1.0,11/34,21.57%,CAVIN1;GTF2H5;TCOF1;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,RNA interference (GO:0016246),-0.3401138046195443,-0.9297414390759192,0.556390977443609,0.7903370583180659,1.0,8/17,18.96%,TSN;DROSHA;DICER1;NRDE2;CELF1;TERT;AGO2;CLP1
prerank,regulation of axon guidance (GO:1902667),0.42042365643638846,0.9296116180763425,0.5537340619307832,0.964983823240533,1.0,2/10,4.96%,MYCBP2;ZSWIM8
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3834786172397447,0.9294347479348322,0.5517826825127334,0.9646538576136204,1.0,3/16,9.09%,PPARA;PINK1;AK4
prerank,protein secretion (GO:0009306),0.29874335042468436,0.9294270605344893,0.5550906555090656,0.9638957631214728,1.0,15/56,19.06%,STEAP3;SEL1L;RAB8A;RAB3C;RIMS2;RCN3;RAB15;LTBP2;TMEM167A;MTTP;TVP23B;COPG1;MIA3;SVBP;CANX
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.41615473660933344,0.9292905447030287,0.5618374558303887,0.9634391960630118,1.0,3/10,11.23%,ANK3;KCNAB1;KCNE4
prerank,response to steroid hormone (GO:0048545),-0.28065630987828305,-0.9292761726227122,0.58,0.7907696317206078,1.0,9/31,18.48%,CAV1;THBS1;TGFB2;WBP2;PAQR7;ABHD2;NR3C1;CATSPER2;PAQR8
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.40686591086907203,0.9287562292240304,0.5543672014260249,0.9640276391015786,1.0,2/12,8.47%,DOCK10;GPR183
prerank,negative regulation of platelet activation (GO:0010544),0.38788463943977264,0.9286653559779559,0.5525423728813559,0.9634705827321585,1.0,1/16,0.15%,PDGFRA
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2872489001676384,-0.9283974462871931,0.5852941176470589,0.7922147782287643,1.0,11/27,25.71%,CTPS1;CTPS2;DTYMK;AK2;RRM2B;GUK1;TYMS;AK6;AK5;TXNRD1;AK7
prerank,regulation of cell cycle phase transition (GO:1901987),0.2754039753313884,0.9282829547530019,0.5708712613784135,0.9636805875780949,1.0,24/91,18.61%,BUB1B;PSMD1;FBXO5;CDC16;PSMD10;PSMA5;PSMB5;XPC;PSMC4;PSMA4;TP53;PSMC5;ANAPC5;PSMB9;DBF4;UBE2D1;ERCC2;TFAP4;MN1;PSMD14;PSMA7;CDC26;PSMD11;PSMA2
prerank,positive regulation of catabolic process (GO:0009896),-0.24017799588243843,-0.9282368660247882,0.599250936329588,0.7919497318075052,1.0,11/65,11.15%,FOXO1;WWP1;WWP2;GPC3;APC;GSK3B;VCP;SMURF2;ASB5;RNF41;APC2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.26263335664395093,0.9281529412665355,0.5855181023720349,0.9632438786534068,1.0,34/122,19.86%,IL33;SLC25A37;PRR16;PLD1;NAT10;EIF4A3;FMR1;IRS1;MTPN;LARP6;IRS2;RPS6KB1;NMD3;GLI1;MTOR;TLR4;GCK;PLXNB2;CDT1;IGF2;HNRNPD;DHX9;AR;MYC;NOX1;PPP1R3E;EIF3C;LDB1;PDGFRB;KAT7;YTHDF1;ATAD5;FXR1;CCL2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.2929971473159751,0.9278502727993497,0.5763411279229711,0.9632330712348247,1.0,10/67,11.33%,PDGFRA;GHR;TXK;ERBB4;FGFR1;PTK2;RELN;FGR;EPHA3;FYN
prerank,positive regulation of interleukin-1 production (GO:0032732),0.30297762507843345,0.9276750917232439,0.5716312056737589,0.9629276050740435,1.0,7/51,11.00%,WNT5A;IL16;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,receptor-mediated endocytosis (GO:0006898),0.2646052309337343,0.9274330088921403,0.5985130111524164,0.9627680978375439,1.0,12/132,6.28%,COLEC12;LRP1;HSPG2;LRP1B;CALCRL;MASP1;LRP3;NEDD4;SORL1;FCHSD2;EPS15;TMEM108
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3178780138359507,0.9272725950989577,0.5621301775147929,0.9624285468703981,1.0,10/38,16.71%,MICALL2;LRRK2;PINK1;SAE1;HTRA2;GSK3A;SREBF1;RNF31;CSNK2A2;HAX1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.30637589445474933,-0.9271877013325673,0.5593667546174143,0.7936831145805283,1.0,10/25,21.90%,RNF185;VCP;NGLY1;TOR1A;YME1L1;CUL3;CLPP;HDAC6;RNF5;UGGT1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2636719605980987,-0.9271176230795505,0.5796178343949044,0.7931551507690368,1.0,13/41,21.42%,RNF152;UBE2G1;PELI1;WWP2;TRIM5;RNF8;ZFP91;UBE2N;TRAF3;TRIM27;PRPF19;RNF5;TRAF1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.27243331915405716,0.9268516636786559,0.5895806861499364,0.9626900504530925,1.0,14/101,12.66%,CXCL10;CXCL1;WNT5A;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.26523182514463106,0.9265148979333915,0.5813106796116505,0.9627550797101226,1.0,17/119,8.95%,PIK3R1;PIGV;PTEN;PIP4K2A;PIGQ;SACM1L;PIK3R2;MTMR4;EFR3A;MTMR1;RUFY1;PIGP;PTPN13;PI4KA;CDIPT;PLEKHA1;INPP5J
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3534508455746762,0.926438845275559,0.5543478260869565,0.9621827985127905,1.0,3/22,5.46%,AKAP5;ADGRV1;NF1
prerank,cellular response to interleukin-6 (GO:0071354),-0.29193763027101705,-0.926415723656379,0.5729166666666666,0.7940601081189802,1.0,4/26,5.63%,ST3GAL6;FER;NFKB1;IL6ST
prerank,inorganic ion transmembrane transport (GO:0098660),0.41086123441097044,0.9263789132342523,0.559931506849315,0.9615696291054424,1.0,2/12,12.93%,ASIC2;KCNJ8
prerank,mononuclear cell differentiation (GO:1903131),-0.3041392924181635,-0.9258849230096438,0.5706521739130435,0.7946620793437361,1.0,2/24,0.90%,PIR;IL31RA
prerank,cellular amide metabolic process (GO:0043603),-0.22335035109362555,-0.9254324852057239,0.6651982378854625,0.7949942590417681,1.0,24/102,20.02%,AEBP1;ST6GAL1;PLPP3;CPE;CPD;SLC25A32;SMPD3;PCCA;ACOT8;ST3GAL1;PPP2R1A;AASDHPPT;MTHFR;BTD;PLAAT3;ACOT13;DHFR;ACOT6;SMPD1;CLN8;DBI;ORMDL2;PLA2G4E;ABCB9
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.27174256496307025,0.9253875359695087,0.567979669631512,0.9633142827523051,1.0,13/95,12.66%,CXCL10;CXCL1;WNT5A;PDE4B;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,regulation of coagulation (GO:0050818),0.4141564117496002,0.9245019745239001,0.5607985480943739,0.9647612769933045,1.0,3/11,14.99%,HRG;HS3ST5;F2R
prerank,positive regulation of proteolysis (GO:0045862),0.29656970044883696,0.9237713770674634,0.5706371191135734,0.9658466880219039,1.0,15/55,19.43%,OGT;GPLD1;CAPN3;PINK1;NKD2;NRDC;RCN3;ASPH;SH3D19;BAK1;PACSIN3;ADAM8;ADRA2A;MAPK12;RHBDD1
prerank,GPI anchor biosynthetic process (GO:0006506),0.33128658866339966,0.9236806729962066,0.5555555555555556,0.9653047785409371,1.0,5/30,12.83%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2586483347024706,0.9235891679915673,0.6301204819277109,0.9647637258338534,1.0,33/145,18.61%,DYNLL1;DCTN3;HAUS3;PSMD1;FBXO5;HAUS1;CDC7;HMMR;DCTN2;PSMD10;PSMA5;PSMB5;HAUS8;CEP192;PRKACA;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;PSMB9;CEP250;CEP152;CENPF;CSNK1E;CLASP1;ALMS1;PSMD14;PSMA7;VPS4B;PCM1;PSMD11;PSMA2
prerank,sphingolipid catabolic process (GO:0030149),-0.3536888032589959,-0.9235456709202656,0.5452322738386308,0.7987029369298885,1.0,7/15,26.03%,ACER2;ACER3;ENPP2;SMPD1;SMPDL3A;ASAH1;ASAH2
prerank,mRNA polyadenylation (GO:0006378),-0.3023858877321507,-0.9233555992503829,0.5752688172043011,0.7978389175927968,1.0,10/26,26.33%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,RNA polyadenylation (GO:0043631),-0.3023858877321507,-0.9233555992503829,0.5752688172043011,0.7978389175927968,1.0,10/26,26.33%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.28397182239227914,-0.9229027967092279,0.6041666666666666,0.7981849837462579,1.0,11/31,28.88%,NFS1;GCH1;MOCS1;FDXR;CYP51A1;NOXRED1;PYCR2;STAR;MOCS3;PYCR3;FDFT1
prerank,carbohydrate homeostasis (GO:0033500),-0.2414749847137826,-0.9225369179731537,0.6268656716417911,0.7983232366184088,1.0,11/67,10.54%,LEPR;IGF1R;ADIPOR2;KLF7;INSR;RBP4;PRKAA2;SOX4;KCNB1;BAD;PTPN2
prerank,lymphocyte mediated immunity (GO:0002449),-0.3702526652796878,-0.9215678437747973,0.5510688836104513,0.7999137213573246,1.0,4/12,19.51%,CD55;GNL1;BTN3A3;CD46
prerank,autophagy of mitochondrion (GO:0000422),-0.26921305462739004,-0.9209264743479153,0.6084507042253521,0.800729110264777,1.0,15/38,21.55%,BECN1;SQSTM1;ATG13;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;MARK2;AMBRA1;MAP1LC3B;WDR45
prerank,positive regulation of cell killing (GO:0031343),0.4067248344468204,0.9207672104404548,0.5826235093696763,0.9710470692663995,1.0,4/13,19.72%,WNT5A;CYBA;NOX1;DVL2
prerank,positive regulation of type 2 immune response (GO:0002830),0.39267194865364197,0.9204608377259477,0.5603448275862069,0.9710516980713415,1.0,3/14,13.40%,XCL1;CD86;CD81
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.22638806989031274,-0.9203531337083376,0.6666666666666666,0.8013582311603534,1.0,43/91,31.13%,ABCG2;APP;HMOX2;TFRC;SLC39A8;CUL1;SLC31A2;SCARA5;SLC39A10;MT2A;ACO1;CYB561A3;FLVCR1;SLC30A9;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;FTH1;CCDC115;TMEM199;MT3;NUBP1;ATP6V1G1;SLC11A2;SMAD4;ATOX1;SLC11A1;ARF1;ALAS2;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;BMP6;LCN2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.28402423554212003,0.9199963288943326,0.5873015873015873,0.9714453443300929,1.0,14/70,14.16%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,negative regulation of neuron projection development (GO:0010977),-0.2446711692533699,-0.9199601664153872,0.6328125,0.801564937465479,1.0,11/56,13.18%,EPHA4;DPYSL3;EFNB2;RUFY3;KANK1;PRAG1;APOE;NGEF;ADCY6;GAK;TRPV4
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2551327203721005,0.9199538541981716,0.6503496503496503,0.9707752743393951,1.0,31/172,15.90%,LPIN3;PIK3R1;PLD1;PTEN;PIP4K2A;SACM1L;PIK3R2;MTMR4;CHAT;LIPH;MTMR1;RUFY1;PTPN13;PI4KA;DGKQ;CDIPT;PLEKHA1;INPP5J;CPNE7;CHKA;PTDSS2;AGK;MBOAT7;SELENOI;TAMM41;GPAT3;PLA2G12A;STARD10;CSNK2A2;LPIN2;ABHD4
prerank,entry into host (GO:0044409),-0.362690682860305,-0.9199417920155536,0.5693430656934306,0.8009261977994524,1.0,5/13,15.49%,CDH1;CTNND1;PPIA;GRB2;MET
prerank,aggrephagy (GO:0035973),-0.29204690345571976,-0.9197690498111296,0.6015831134564644,0.8006418315067048,1.0,13/27,22.04%,VIM;SQSTM1;WDFY3;UBB;DYNC1H1;UBE2N;DYNC1I1;UBC;DYNC1LI1;ARL13B;HDAC6;CFTR;UBA52
prerank,cardiac muscle cell action potential (GO:0086001),0.33286973505667367,0.9188088114859881,0.5658914728682171,0.9728120130279957,1.0,8/30,14.98%,ATP1A2;SCN2B;KCNIP2;CACNA1G;HCN2;FGF12;SCN1A;CACNA2D1
prerank,regulation of centrosome cycle (GO:0046605),0.3529523883672434,0.9187377599425497,0.5751633986928104,0.972232388275902,1.0,2/21,2.23%,ATF5;NAT10
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3300795452716414,-0.9186990239966917,0.5471204188481675,0.8024065594659558,1.0,6/17,16.09%,ERLIN1;SREBF2;APOE;FGF1;RAN;PRKAA1
prerank,myeloid cell differentiation (GO:0030099),-0.2502058074111408,-0.9186351949714118,0.643598615916955,0.8018659510900645,1.0,21/47,29.16%,RPS14;RUNX1;SNRK;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;PRDX3;MFHAS1;NCOA6;KAT8;JAK3;SPI1;RASGRP4;KAT6A;ALAS2;CEBPA;HCLS1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3242793141811333,0.918631726568186,0.5731166912850812,0.9717254388448229,1.0,6/30,12.10%,OSTC;RPN2;DAD1;ALG5;MCFD2;TUSC3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.36826849140750534,-0.9183335439079394,0.5567928730512249,0.8018429696855867,1.0,4/12,10.79%,NFIB;EPHA4;GLI2;EPHB2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.35654676760034293,0.9179329995294883,0.5680272108843537,0.9726899809166851,1.0,1/21,0.11%,ENPP1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2831111355069133,0.9177867143966846,0.5904887714663144,0.9722888782352997,1.0,14/71,14.16%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.31057924387437674,-0.917654553192386,0.5779569892473119,0.8026925402190874,1.0,9/22,29.51%,MINK1;XDH;GADD45B;MAP3K4;MFHAS1;GADD45G;SPI1;GADD45A;AGER
prerank,pharyngeal system development (GO:0060037),-0.3350135176301242,-0.9174817356109243,0.5535714285714286,0.802420264224283,1.0,3/15,6.99%,BMPR2;TGFB2;TBX1
prerank,negative regulation of angiogenesis (GO:0016525),0.28396098039835765,0.9173061797643909,0.5938337801608579,0.9727447923362461,1.0,9/84,6.89%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;SERPINF1;ADGRB1;COL4A2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.2744543576567061,-0.9171741810854196,0.6135135135135135,0.8024669705789153,1.0,22/36,42.88%,LEF1;GLI2;SOX4;MDK;SART1;SOX12;CD46;RHOH;VSIR;PNP;NCKAP1L;SOCS1;IL7;NKAP;IL4I1;VNN1;ZBTB1;ZAP70;GATA3;TESPA1;IL12RB1;IL4
prerank,aorta morphogenesis (GO:0035909),-0.3288516796661576,-0.9166345857783399,0.563855421686747,0.8030316667695669,1.0,6/17,12.55%,RBPJ;MYLK;TBX1;ACVRL1;TBX2;HEY2
prerank,cellular response to nutrient levels (GO:0031669),-0.2442347562112729,-0.9166185421146735,0.6083650190114068,0.8023965223408958,1.0,22/62,23.49%,FOXO1;FNIP1;BMPR2;HSPA8;SREBF2;PRKAA2;KCNB1;FAM107A;RRAGC;SFRP1;CLEC16A;RALB;MFSD2A;SIRT1;PRKAA1;MAP1LC3A;LAMP2;RRAGB;MAP1LC3B;WDR45;KLF10;INHBB
prerank,positive regulation of cellular respiration (GO:1901857),-0.3765352249347337,-0.9163022751441614,0.5407925407925408,0.8024431310636652,1.0,6/11,26.75%,IL10RB;IFNAR1;VCP;PRELID1;NUPR1;PARK7
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.22657406090455384,-0.916294653338219,0.6304347826086957,0.8017910521397675,1.0,35/86,27.36%,PSMC6;PSMD9;EGLN3;HIF3A;PSMF1;PSMB7;KLF2;UBB;PSMD8;PSMD12;INO80;VHL;PSMA3;BAG3;PSME3;PSMA6;PSMD4;PSMD7;ELOC;PSMB6;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;STOX1;PSMA8;DNAJB1;HSPA1A;LIMD1;ATF3;CHEK1;BACH1
prerank,amide biosynthetic process (GO:0043604),0.30476512427411845,0.9160852557848201,0.5752212389380531,0.975000160611253,1.0,11/47,15.65%,PAM;CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;CERS6;SLC25A2
prerank,regulation of membrane depolarization (GO:0003254),-0.3288877309312418,-0.9156950387224834,0.583941605839416,0.8025135311518541,1.0,3/18,3.93%,FHL1;PTPN3;CAMK2D
prerank,regulation of protein polymerization (GO:0032271),-0.27750718313333833,-0.9153870543642723,0.5752212389380531,0.8025445402377035,1.0,16/35,31.66%,ESAM;MAPT;ARHGAP18;ARL2;ARHGAP28;COTL1;PLEKHG2;TPPP3;RASA1;CAMSAP2;TTBK1;FCHSD1;HCLS1;CAMSAP3;TPPP;PFN2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.32898311989500345,0.9153179333574426,0.5811437403400309,0.9761110183428268,1.0,4/32,4.58%,ZBTB20;PPARA;PFKFB1;ENTPD5
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3084098381238657,0.915209988743626,0.5861027190332326,0.9756082216235406,1.0,11/42,13.66%,POLK;CDKN2D;POLA1;RPA1;RFC3;POLH;FAAP20;POLN;SPRTN;REV1;POLI
prerank,I-kappaB phosphorylation (GO:0007252),-0.3792745444695477,-0.9151930373022464,0.5694760820045558,0.8023264735186657,1.0,1/10,0.79%,ERC1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.36249035902593973,0.9150937817865014,0.5394736842105263,0.9751350341211027,1.0,8/18,24.29%,CRTC2;ADCY8;PRKD1;RELN;EPHA5;CRTC3;CAMK1D;ADCY1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.28154812958915043,-0.9150735101503816,0.5988538681948424,0.8019418699478147,1.0,15/35,29.98%,DRG1;CHMP2B;DYNC1H1;RAE1;CHMP4B;NUMA1;CHMP1A;PDCD6IP;CHMP4C;HSPA1A;TACC3;CHMP2A;HSPA1B;NUP62;FSD1
prerank,erythrocyte differentiation (GO:0030218),-0.255018534295656,-0.9150476793641035,0.564935064935065,0.8013266925800474,1.0,13/44,21.80%,RPS14;ALAS1;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;ABCB10;TGFBR3;MFHAS1;DMTN
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3461828174537209,0.9142208160157463,0.5432300163132137,0.9765778168815961,1.0,6/21,16.62%,RAB34;GLI1;GAS8;TXNDC15;EVC;PDCL
prerank,cortical cytoskeleton organization (GO:0030865),0.31279659917805763,0.9138282471823835,0.5801749271137027,0.9767822642090127,1.0,6/41,7.13%,EPB41L3;RND3;RAC3;LLGL1;FMNL2;RHOBTB3
prerank,response to interferon-beta (GO:0035456),-0.30760072442878805,-0.91366316036443,0.6040100250626567,0.8037649076229587,1.0,10/22,29.17%,IFITM3;IFITM1;IRF1;CDC34;IFITM2;NDUFA13;IKBKE;PNPT1;TRIM6;IRGM
prerank,neuron differentiation (GO:0030182),0.2547459559545895,0.9135852256940441,0.6375598086124402,0.9766159939184574,1.0,20/165,11.27%,RUNX2;ISL2;TENM3;WNT5A;MYO7A;NTRK2;MYEF2;TENM4;MTPN;TENM2;SRF;SNPH;BHLHE22;OLIG2;TENM1;MAP2K1;OPHN1;WNT3;SMARCA1;TGFBR1
prerank,positive regulation of gene expression (GO:0010628),0.2349205801920852,0.9135444955425872,0.7170984455958549,0.975971097459084,1.0,91/442,18.90%,IL33;SEC16B;NTRK3;PIK3R1;PRR16;WNT5A;PLD1;NTRK2;PLA2R1;GLMN;TXK;NAT10;LRP3;EIF4A3;AGO4;LURAP1;GJA1;POU3F3;RBMS3;ANK3;RBM24;HTR2B;FMR1;PTPN22;TLR6;LARP6;ADAM19;MYCN;CDH3;RIMS2;ELAVL4;PDCL3;C1QTNF1;POLR1A;RPS6KB1;DGKQ;TWIST1;TENT4B;TLE1;MTOR;BMP7;MAP2K1;TLR4;TAF1D;KAT2A;FGR;WNT3;EIF2AK2;TAF1B;TP53;DHX36;RIMS1;TGFBR1;AGO3;PLXNB2;HGS;SOX9;OLFM1;GSK3A;RBM20;FAM98B;TESC;MED1;CUX2;SNF8;ACTG2;RIPK1;HNRNPD;ATF2;CLU;FGF5;TNRC6B;AR;MYC;MAPK11;HNRNPLL;PTGER4;LGALS9;MAZ;PIK3CG;AGO1;MYD88;EIF3C;ADRA2A;HABP4;BMP2;EIF2AK3;SPRY2;HEY1;HIF1A;YTHDF1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3393332271542955,0.9134806136265441,0.5611285266457681,0.9753648029137937,1.0,2/24,5.46%,EPHA7;NF1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3478710897062545,0.9133995324539778,0.578538102643857,0.9747854081896707,1.0,6/22,16.86%,NUBP2;FXN;ABCB7;CIAO1;MMS19;ISCA1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2583563843842261,0.9133588004744888,0.6297198538367844,0.9741297891067372,1.0,17/132,8.52%,DCN;ZBTB20;PPARA;GPLD1;ABCD2;PFKFB1;TPCN1;NPRL2;ENTPD5;ZSWIM8;IRS1;LRRK2;LIN28B;IRS2;TWIST1;TRIM8;PRKD1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3541045371218598,0.9131715215665257,0.5714285714285714,0.9723222463112356,1.0,8/20,24.91%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3541045371218598,0.9131715215665257,0.5714285714285714,0.9723222463112356,1.0,8/20,24.91%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3541045371218598,0.9131715215665257,0.5714285714285714,0.9723222463112356,1.0,8/20,24.91%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,regulation of interleukin-13 production (GO:0032656),-0.35757901013403653,-0.9131177318952629,0.5545023696682464,0.8043432225029109,1.0,2/13,1.79%,LEF1;IL18
prerank,neuron projection organization (GO:0106027),0.381556729355882,0.9129640247072695,0.5652173913043478,0.9720577226751258,1.0,3/15,9.24%,ABCD2;ATP1A3;LGMN
prerank,regulation of epithelial cell proliferation (GO:0050678),0.2740265284420838,0.9128947780468517,0.5919689119170984,0.9714577468258857,1.0,6/85,3.77%,LAMC1;LAMB1;TCF7L2;C5AR1;PEX2;MCC
prerank,glycoprotein metabolic process (GO:0009100),-0.2483702212728926,-0.9125416238125953,0.6107142857142858,0.8049328206094679,1.0,17/53,20.48%,FUT8;ST8SIA4;ST3GAL4;B4GALT5;OGA;ST6GALNAC3;LARGE1;MANBA;NGLY1;MGAT4B;ST8SIA2;GCNT1;ST3GAL2;STT3B;MAN2A1;GAL3ST2;MAN1A2
prerank,gonad development (GO:0008406),0.3096490797854573,0.9115209649547735,0.5851851851851851,0.9741495020638807,1.0,4/41,2.49%,WNT5A;NR2F2;BASP1;SALL1
prerank,response to estradiol (GO:0032355),0.32128330609812106,0.911335401957818,0.5614307931570762,0.9738434491223888,1.0,3/31,4.65%,GGT5;GGT7;NCOA3
prerank,copper ion transport (GO:0006825),0.4058705569732588,0.9107521482327753,0.5940959409594095,0.9744908896727696,1.0,5/11,25.39%,STEAP3;ATP7A;STEAP2;COX17;CUTC
prerank,peripheral nervous system development (GO:0007422),0.35238061330498094,0.9105964672628504,0.573170731707317,0.9740854117398392,1.0,8/23,20.89%,ASIC2;ADGRB2;NF1;ADGRB1;SOX10;GDNF;ALDH3A2;SCN8A
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.32503559841832713,-0.9104575337396982,0.6032171581769437,0.8089607997583507,1.0,6/20,30.61%,FDX1;FDXR;STAR;HSD17B10;CYP46A1;TSPO
prerank,regulation of cellular component movement (GO:0051270),0.3018644044249381,0.9101926741230129,0.6150442477876106,0.9742975430461398,1.0,11/49,14.16%,NRG1;MYCBP2;ERBB4;NRG2;ZSWIM8;ACTN1;NRG4;SP100;TGFBR1;MEMO1;LYN
prerank,telomere maintenance (GO:0000723),-0.2508047902931914,-0.910184457801943,0.6329113924050633,0.8089179819056685,1.0,30/50,36.87%,PTGES3;PRKDC;ATR;RTEL1;STN1;PCNA;TERT;ATM;TEN1;NBN;RAD51D;DCLRE1B;HUS1;POLD2;RPA2;ACD;PARP1;RAD51;LTO1;POLD4;POLD1;RAD50;CTC1;XRCC3;MRE11;HUS1B;TINF2;TPRKB;RPA3;APEX1
prerank,negative regulation of translation (GO:0017148),0.2739166721289877,0.9101301614066895,0.6229946524064172,0.973688464735813,1.0,23/87,19.51%,CPEB1;EIF4A3;NANOS3;EPRS1;RBM24;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;FTO;CNOT1;MALSU1;EIF4ENIF1;PUS7;CNOT7;TSC1;CALR;IGF2BP3;ILF3;EIF2AK3;YTHDF1;FXR1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.27987485295303416,0.9099386163322524,0.6084656084656085,0.9734049086232835,1.0,14/73,14.16%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,cilium organization (GO:0044782),0.24796498832397598,0.9094685849357387,0.6621004566210046,0.9738204582303714,1.0,53/209,21.52%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;GBF1;RAB8A;CCDC57;DISC1;IFT81;FAM161A;KIFAP3;SNAP29;CCDC65;AHI1;TCTN2;IFT74;EXOC7;EXOC1;ASAP1;BBIP1;TMEM67;IQCB1;IFT88;SSX2IP;RFX2;CEP126;ACTR2;RAB11FIP3;TXNDC15;SCLT1;FAM161B;DYNLL2;CEP250;PTPDC1;CLUAP1;IFT43;PCM1;BBS1;CEP19;WDR90;ATP6V0D1;MKS1;DZIP1L;NUDCD3;KIF3A;UNC119B;TTC39C;BBS4;ABLIM3;CEP20
prerank,regulation of cellular localization (GO:0060341),0.3038713991366241,0.9094444181995944,0.5774647887323944,0.973126054804402,1.0,10/46,16.65%,ADCY5;NR1H4;TRIM67;LRRK2;PINK1;LYN;EPHA5;BRSK2;CSNK1E;DVL3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3796797971751502,0.9093473419761979,0.5769230769230769,0.9726020577180672,1.0,4/15,18.00%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.33432100471097964,-0.909317219585131,0.5833333333333334,0.8101792684342899,1.0,7/15,19.24%,IGF1;BCL2L1;GPX1;PRELID1;GHITM;AKT1;HGF
prerank,ketone body metabolic process (GO:1902224),-0.37305421219340396,-0.9086734669753185,0.581986143187067,0.8110580527199047,1.0,6/10,17.02%,BDH2;BDH1;ACAT1;OXCT1;HMGCS2;HMGCLL1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2904190324245856,0.9085376108005413,0.6103542234332425,0.9738349965818653,1.0,4/57,2.91%,GHR;CD40;ERBB4;TSLP
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.27502780044440783,-0.9081319859875289,0.6231884057971014,0.8116609806795684,1.0,6/33,12.34%,PTPRJ;EZR;RC3H1;PTPN2;CEACAM1;DGKZ
prerank,natural killer cell activation (GO:0030101),-0.3084145188367845,-0.9080189430659938,0.5935828877005348,0.8112637063039172,1.0,5/23,12.29%,PBX1;ELF4;CASP8;PIK3CD;PRDX1
prerank,photoreceptor cell development (GO:0042461),0.3817494195994485,0.9078982632830049,0.564625850340136,0.9746753426759994,1.0,3/14,15.74%,MYO7A;AHI1;CDHR1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3262798767688698,0.9078756865241319,0.5941807044410413,0.9739830868402974,1.0,5/32,8.77%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1
prerank,negative regulation of response to wounding (GO:1903035),-0.32052152279425533,-0.9078561985018656,0.5742092457420924,0.8109827551943404,1.0,6/19,12.08%,EPHA4;INPP5F;CD109;GIT1;SERPINE1;MDK
prerank,ERK1 and ERK2 cascade (GO:0070371),0.34838626247013715,0.9078101306680144,0.5702341137123745,0.9733941254383954,1.0,8/21,16.66%,ITGAV;HTR2B;ZFP36L2;MAP2K1;SOX9;MYC;PTGER4;LGALS9
prerank,regulation of cell adhesion (GO:0030155),0.2598775208189991,0.9077269392712052,0.6254681647940075,0.9728369813653721,1.0,15/129,8.81%,EPHA7;PLXNC1;ZFHX3;HRG;TMEM102;TGFBI;SEMA5A;ITGAV;SIPA1;DUSP1;DSCAM;PRKX;PTK2;PLAU;PRKCA
prerank,mitochondrion organization (GO:0007005),-0.1994056761528745,-0.9074628060806479,0.759493670886076,0.8111939476268836,1.0,52/165,25.03%,CXADR;BCL2L1;MEF2A;NOS3;MTM1;ATP5F1B;ALAS1;CAV2;SIRT3;DNM3;HK2;MIEF1;USP30;BNIP3L;BAX;TIMM9;BID;CHCHD2;TERT;PYROXD2;TRAK2;RAB38;ADCK1;MTFR1L;AFG1L;PRDX3;VPS13D;ATP5F1D;YME1L1;AIFM1;MSTO1;TIMM13;CHCHD3;SIRT5;TOMM22;TIMM8B;MPV17;PID1;MIGA1;HIGD1A;POLRMT;FANCG;TWNK;OXA1L;PNPT1;TOMM5;TIMM10B;PARP1;HSPD1;VPS13C;SLC25A4;FMC1
prerank,RNA processing (GO:0006396),0.250615461400194,0.9073947700868279,0.66548463356974,0.9728998678350237,1.0,45/176,21.11%,RBMS1;GEMIN2;NOVA1;ADARB2;SNRNP35;ZRSR2;LIN28B;NOL3;LSM4;ELAVL4;BCAS2;HNRNPA2B1;MPHOSPH10;MRPL44;SRSF11;TENT4B;PRKACA;DDX17;SMU1;RP9;SLU7;NUDT21;NOL9;SNRNP48;PRPF18;TENT2;HNRNPUL1;HNRNPD;SNRPF;NONO;ADAR;SRSF9;HNRNPL;RBM5;SF3A3;RBM6;DEDD2;ZCRB1;PPIG;PRPF8;LUC7L3;DHX15;TFIP11;DDX39B;RBPMS
prerank,response to metal ion (GO:0010038),0.281828973210664,0.9072969847732418,0.5947075208913649,0.9724117292048329,1.0,9/67,9.67%,PAM;LOXL2;SLC30A5;KCNMA1;NEDD4;FXN;CAPN3;TRPC3;SLC30A3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.34684629064379535,-0.906905754229382,0.592326139088729,0.8117978089249627,1.0,5/13,16.19%,NR3C2;ABHD2;NR3C1;GPER1;ESR1
prerank,calcium ion transport into cytosol (GO:0060402),0.3496977509223164,0.9067925574108189,0.5836120401337793,0.9729153850182855,1.0,5/21,14.98%,GRIN2B;RYR2;GRIN2A;TRPM2;CACNA2D1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.30295701503021233,-0.9067277113795184,0.6020671834625323,0.8115353305057871,1.0,13/24,32.61%,PPHLN1;PPM1D;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;MTF2;PHF1;SPI1;BMI1;H3-3A;PHF19
prerank,DNA metabolic process (GO:0006259),0.24088909788308616,0.9067213915705882,0.6655665566556656,0.9723388669042728,1.0,72/270,22.27%,TCF7L2;POLG;ERCC1;MCM7;LIG3;TOP2B;FAN1;FEN1;POLQ;POLK;FANCA;CDC7;ERCC5;MSH3;ASF1A;NEIL3;POLA1;GMNN;RPA1;ERCC4;TERF1;POLL;SP100;XPC;POLE4;UBE2V2;RFC3;NOC3L;POLH;MCM4;TOP3A;POLE3;RECQL;GTF2H3;MUTYH;XRCC1;RAD52;CDT1;POLB;DBF4;ALKBH3;POLI;MBD4;LONP1;MCM10;DOT1L;GTF2H1;RNASEH1;MMS19;ORC2;CSNK1E;SMC1A;TOP2A;MSH6;SMARCAL1;WRN;RIF1;TERF2IP;REXO4;CNBP;DDB1;POLE;USP45;MEN1;PWWP3A;ORC5;RFC4;TOPBP1;KPNA2;FANCC;HMGB1;RAD54L
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.24292697142400785,0.906640491480916,0.6810631229235881,0.9718147806185573,1.0,39/234,15.47%,ROR1;EDA2R;EDA;WNT5A;PTEN;CD40;MBTPS2;IL18RAP;TAF12;JUP;MTPN;TLR6;PRKCI;FLOT2;CRTC2;ADCY8;CAPN3;SRF;TRIM37;TRIM8;PRKD1;RELN;PRKCB;IL1RAP;TLR4;IRAK1;EIF2AK2;PYCARD;RTKN2;ESR2;RNF31;TIRAP;RIPK1;UBE2V1;EPHA5;ATF2;CLU;DHX9;AR
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.32167561444285375,-0.9058293678355034,0.5820512820512821,0.8129550128258276,1.0,3/19,5.37%,VIM;WNT4;RUNX1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3902476886094876,0.9056007795076613,0.5791304347826087,0.9735774674175024,1.0,5/14,21.16%,XCL1;HMCES;PAXIP1;RIF1;NECTIN2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.36743417285343694,-0.9055270127584882,0.5783410138248848,0.8129405783832712,1.0,5/11,26.45%,MAVS;TICAM1;TYROBP;ITGB2;SPI1
prerank,regulation of response to external stimulus (GO:0032101),0.26164870346955427,0.9047458580593052,0.6429447852760736,0.9749945334483011,1.0,17/121,12.71%,PDGFRA;XCL1;HRG;WNT5A;ADGRA2;CASP4;PTPN22;DHX58;ADAMTS12;BCL6;PTGES;APPL2;BIRC2;FGR;P2RX4;CASP12;AREL1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3549693731567759,0.9047290136986323,0.5657894736842105,0.9742892674903979,1.0,3/20,5.49%,PLA2R1;CD40;PRKCI
prerank,positive regulation of insulin secretion (GO:0032024),0.31755717295575975,0.90458483261481,0.5877862595419847,0.9738981195363602,1.0,9/36,13.26%,TCF7L2;GPLD1;TM7SF3;IRS2;ADCY8;TRH;GCK;PPP3CB;LRRC8A
prerank,regulation of steroid biosynthetic process (GO:0050810),0.395178080681538,0.9043484402722396,0.5726950354609929,0.9737269981446631,1.0,4/11,19.77%,NR1H4;DGKQ;BMP2;BMP5
prerank,cellular response to heat (GO:0034605),-0.2675153586682302,-0.9041006830116457,0.6023054755043228,0.8155773650833719,1.0,8/35,14.06%,THBS1;ANO1;FGF1;VCP;MAPT;BAG3;TRPV4;HIKESHI
prerank,regulation of adaptive immune response (GO:0002819),-0.32355121985797325,-0.9040695163540258,0.5887096774193549,0.8149555374482347,1.0,10/18,35.28%,IL6ST;IRF1;SIRT1;TRIM27;SKAP1;FCGR2B;SAMSN1;IRF7;FADD;IL4I1
prerank,cellular response to unfolded protein (GO:0034620),-0.29206743078266395,-0.9040447398421199,0.5925925925925926,0.8143397722300248,1.0,12/26,25.44%,TMBIM6;HSPA8;HSPB8;BAX;OPTN;PTPN1;BAG3;ERN1;ABCB10;HSPD1;HSPA14;HSPA1A
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.32213031493707467,0.9037761912164078,0.5882352941176471,0.9743472252064436,1.0,2/35,0.29%,PDGFRA;NTRK3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2780126450792966,-0.9036936080934703,0.6074498567335244,0.8144823631210496,1.0,7/29,13.09%,RPS14;RPS16;RPS19;UTP3;RPS21;NOP9;RPS8
prerank,regulation of mRNA processing (GO:0050684),0.31840791399692464,0.9033357042154042,0.588855421686747,0.9746595059331035,1.0,8/32,18.01%,KHDRBS3;CWC22;SRSF10;SAFB2;DHX9;IWS1;SAFB;KHDRBS1
prerank,regulation of cell killing (GO:0031341),-0.3313722090139311,-0.9030084434101607,0.5775,0.8152969147496226,1.0,5/16,11.02%,CD55;TGFB2;RAC1;FZD7;ICAM1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.25603162554294145,-0.9029562208846588,0.6296296296296297,0.8147497503387251,1.0,16/42,24.24%,SMPD3;ST6GALNAC3;LARGE1;HEXB;UGCG;B3GALNT1;ESYT3;ST3GAL5;SMPD1;GM2A;ARSA;GLTP;PSAP;A4GALT;ASAH1;CLN6
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3376971829446289,0.9028323933686314,0.5786963434022258,0.975114384882167,1.0,7/23,24.14%,CECR2;KPNA1;FBH1;KPNB1;REXO4;HMGB1;DNASE1L2
prerank,regulation of type I interferon production (GO:0032479),-0.22652408221564216,-0.9026702130870882,0.6837944664031621,0.8147178535385473,1.0,23/84,18.16%,NPLOC4;NFKB1;PRKDC;MAVS;POLR3E;TRIM25;CRCP;PCBP2;RNF125;IRF1;GAPDH;POLR2H;POLR3G;CYLD;NLRX1;NLRC5;TRAF3;UBE2L6;TBK1;POLR3D;ISG15;NFKB2;PQBP1
prerank,regulation of T cell cytokine production (GO:0002724),0.38006316059414486,0.9025770470203475,0.5766666666666667,0.9750106850981566,1.0,1/15,0.63%,XCL1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.413323241938904,0.9025043374680172,0.5709459459459459,0.9744214348996386,1.0,2/10,6.52%,ACADL;ACADS
prerank,negative regulation of transport (GO:0051051),0.2940874202982121,0.9020748705165824,0.5832187070151307,0.9747300588589758,1.0,10/51,16.39%,NRG1;PTEN;ITGAV;NR1H2;PRKD1;NDFIP2;EPHA3;SNX12;PACSIN3;NDFIP1
prerank,response to lipopolysaccharide (GO:0032496),0.253037214074275,0.9017772708275056,0.6493349455864571,0.9747005263337355,1.0,19/138,12.66%,GGT5;CXCL10;CXCL1;WNT5A;GGT7;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;LIAS;MAPKAPK3;IL12A;CD86;PDCD4
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.30638882354096986,0.9016085953235321,0.6035767511177347,0.9743786832484427,1.0,11/41,18.78%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.31310196095728826,-0.9014928502426036,0.6020942408376964,0.8167839662926855,1.0,6/18,12.50%,RAP1A;SYN1;VPS18;GSK3B;RAB5A;SLC4A8
prerank,histone H4-K5 acetylation (GO:0043981),0.38358343453238836,0.9009924464179997,0.5494880546075085,0.9743686032079477,1.0,4/15,11.69%,OGT;WDR5;KANSL1;JADE1
prerank,histone H4-K8 acetylation (GO:0043982),0.38358343453238836,0.9009924464179997,0.5494880546075085,0.9743686032079477,1.0,4/15,11.69%,OGT;WDR5;KANSL1;JADE1
prerank,cellular response to oxygen levels (GO:0071453),-0.37425290266885014,-0.9007495758774324,0.5881057268722467,0.8177694906874489,1.0,5/10,25.05%,ATP6V0A2;CCDC115;TMEM199;ATP6V1G1;NDUFS2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.34572950591720447,-0.9007381545147015,0.607981220657277,0.8171359078708557,1.0,4/13,9.95%,MEF2C;RBPJ;NOTCH1;TBX2
prerank,female gonad development (GO:0008585),0.3552640065631546,0.9003929903734329,0.5733333333333334,0.97506635263642,1.0,5/19,23.33%,NR2F2;NUP107;LHCGR;INHBA;EIF2B5
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2597005918544184,-0.9003429222740031,0.6355685131195336,0.8173735308737314,1.0,18/40,24.47%,LEF1;FOXC1;NOTCH1;TGFB2;DAB2;SMAD3;BCL9L;MDK;EZH2;PDPN;TGFB1I1;SNAI1;SDCBP;RGCC;TGFBR2;TIAM1;WWTR1;AXIN2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.33865530884319717,-0.9002612274650102,0.5813953488372093,0.8169103952105761,1.0,2/15,3.02%,LEF1;SMARCA4
prerank,sensory perception of smell (GO:0007608),0.3987019963513697,0.9002378971285316,0.5706806282722513,0.9747002595597277,1.0,3/11,22.79%,ADCY3;BBS4;UBR3
prerank,positive regulation of vacuole organization (GO:0044090),0.4111010111797048,0.9000299710099186,0.5737410071942446,0.9744615224263021,1.0,1/10,2.27%,PIP4K2A
prerank,pyroptosis (GO:0070269),0.3751401214353827,0.8997283777353746,0.5700325732899023,0.9744204682108399,1.0,4/15,20.06%,CASP4;GSDMD;DHX9;GSDME
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2757953491057185,0.8996459531155537,0.6271409749670619,0.973912584818559,1.0,11/69,16.66%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;TIRAP;RIPK1;CLU;DHX9;LGALS9
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3749385534001866,-0.899559815107204,0.6225490196078431,0.8178006274268532,1.0,4/10,16.20%,PRKAA2;SIRT1;PRKAA1;MYOCD
prerank,isotype switching (GO:0045190),-0.3787866424455385,-0.8991205862945247,0.5964523281596452,0.8181080495105488,1.0,6/10,27.20%,RNF8;EXOSC3;BATF;HSPD1;LIG4;MSH2
prerank,ruffle organization (GO:0031529),-0.32844386897748445,-0.8991104384266114,0.6086956521739131,0.8174837573262511,1.0,6/16,23.45%,TPM1;RAC1;LIMA1;PIP5K1A;CSF1R;CORO1B
prerank,regulation of cholesterol efflux (GO:0010874),-0.2790954798068725,-0.8989917427044385,0.6407185628742516,0.8170689111725395,1.0,7/30,9.89%,CAV1;SREBF2;PLTP;RXRA;ABCA3;APOE;NFKBIA
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.40524015736969815,0.8988346104937606,0.5996563573883161,0.9751279731498045,1.0,4/11,19.51%,FMR1;DHX9;WTIP;FXR1
prerank,inositol phosphate catabolic process (GO:0071545),0.38995489133767663,0.898705037253601,0.5933098591549296,0.9747289670689541,1.0,2/12,8.95%,PTEN;INPP5J
prerank,spermatid development (GO:0007286),0.3256440833216692,0.8986388781320873,0.6134328358208955,0.9741739629678652,1.0,5/32,13.29%,CCDC63;SYCP3;RFX2;ZMYND15;DPY19L2
prerank,glutathione metabolic process (GO:0006749),0.30652154244390606,0.8985033704164638,0.6126126126126126,0.9737710094673455,1.0,3/38,7.70%,GGT5;GGT7;GSTA3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.27535557125350135,0.8982824221207127,0.6241426611796982,0.9735979460387857,1.0,9/78,6.00%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,protein mannosylation (GO:0035268),-0.29863821240373467,-0.8980429989918826,0.6155844155844156,0.8185021808409843,1.0,6/22,15.14%,TMTC2;TMTC1;LARGE1;TMTC4;FKRP;DPY19L4
prerank,regulation of protein localization to cell surface (GO:2000008),-0.27209626338078763,-0.8980121897729776,0.6337662337662338,0.8179009942761517,1.0,11/33,22.54%,PICALM;ACTN2;GOPC;STX3;TOR1A;KCNAB2;HFE;EGF;TAX1BP3;RAB11FIP5;TYROBP
prerank,regulation of proteolysis (GO:0030162),-0.2511402485393033,-0.8980073464566131,0.6418439716312057,0.817242087822773,1.0,16/48,24.24%,CAV1;LTBP4;CST3;BAD;CASP8;PERP;IST1;SERPINE2;TRAF3;NEDD8;AKT1;CLN8;HDAC6;CAMK2N1;CYFIP2;CLN6
prerank,regulation of peptidase activity (GO:0052547),-0.31193344376781423,-0.8975452625905028,0.5845771144278606,0.817581270178659,1.0,6/19,14.24%,CAV1;CST3;ECM1;CTSH;PSMA3;FURIN
prerank,ribosomal large subunit assembly (GO:0000027),-0.2950536458651619,-0.8973864408899676,0.6102150537634409,0.8172981393435927,1.0,11/24,29.12%,RPL5;RPL10;RPL11;RPLP0;RPL23A;MRPL20;RPF2;NOP2;RPL24;FASTKD2;NOP53
prerank,protein localization to membrane (GO:0072657),0.245551211808014,0.8972040293854572,0.6768018018018018,0.9754687979374391,1.0,32/187,13.40%,PTN;EPB41L3;DPP6;RAB34;NRXN2;NRXN1;P2RY1;SEC16A;DPP10;SCRIB;SPTBN1;DLG3;JUP;ANK3;DLG2;RAB8A;EFR3A;FLOT2;RAB3C;CAPN3;RAB40B;NKD2;KCNIP4;RAB29;DLG4;RAB15;RAB40C;HGS;AP3D1;TESC;LRRC7;CD81
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.33042753367489563,0.8971176569573642,0.6034755134281201,0.9749490121210657,1.0,4/26,5.88%,DUSP1;FBXO5;CDC16;CENPE
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.304566812702655,-0.89702804017803,0.6151832460732984,0.8174342716915912,1.0,9/23,27.51%,DKK3;LTBP4;SMAD3;SMURF2;TGFBR3;SOX11;SMAD7;SMAD4;TRIM33
prerank,icosanoid biosynthetic process (GO:0046456),-0.3677999417814519,-0.8970031798660637,0.575,0.8168453057421776,1.0,5/10,37.13%,PLA2G4A;MGST3;MGST2;PLA2G5;ALOX5AP
prerank,regulation of transposition (GO:0010528),-0.34320202362675045,-0.8968007447280415,0.5829383886255924,0.8166159701700897,1.0,3/13,11.74%,MYBL1;TEX15;UBR2
prerank,positive regulation of sodium ion transport (GO:0010765),0.3974356404299232,0.8967775149723005,0.5978062157221207,0.9750088183832606,1.0,2/12,4.10%,CNKSR3;ANK3
prerank,protein kinase B signaling (GO:0043491),-0.29673652179035326,-0.8966001701391632,0.5932203389830508,0.8164087856024311,1.0,2/23,3.53%,IGF1;KDR
prerank,regulation of mitochondrion organization (GO:0010821),0.2954967346047725,0.8964728168531785,0.6072463768115942,0.9749748673462688,1.0,10/47,16.71%,TMEM102;LRRK2;OMA1;PINK1;IAPP;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3377973041430871,0.8963063097208774,0.5930047694753577,0.9746752266383397,1.0,5/25,8.29%,ITGAD;ITGAV;JUP;JAM3;CD200R1
prerank,ncRNA metabolic process (GO:0034660),-0.2678648965199438,-0.8959799710005659,0.6175637393767706,0.8170981725682764,1.0,10/37,19.75%,DGCR8;TUT7;PARN;DROSHA;DICER1;MAPT;RAN;NIFK;AGO2;MEPCE
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3330415561378311,0.8958478721780797,0.6043956043956044,0.9750189587679746,1.0,7/27,13.09%,PLA2R1;SPRED1;PSMD10;SPRED2;TWIST1;MSX1;PTTG1IP
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.36301268144163723,-0.8957950682102193,0.6122448979591837,0.8168266855800229,1.0,4/11,16.28%,CAT;GPX1;PRDX1;PRDX3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2605639888830187,0.8954347520396339,0.6369346733668342,0.9752863662777375,1.0,10/107,5.69%,EDN3;SLC24A5;SLC30A10;CD40;RYR2;SLC30A5;SLC39A7;HTR2B;CCL15;ATP2A2
prerank,mitotic chromosome condensation (GO:0007076),-0.2840809737065993,-0.8952413830051245,0.6,0.8174484535775608,1.0,12/26,31.58%,PHF8;SMC2;TENT4A;PHF13;CSNK2B;CHMP1A;NCAPH2;RB1;SMC4;TTN;NCAPG2;SET
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3810128714286374,0.8951440164954206,0.6146953405017921,0.9752503505613579,1.0,4/14,14.39%,ANK3;SLC9A1;TESC;WNK2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2491180292605951,0.8950091177970471,0.6862745098039216,0.9748639496060554,1.0,45/186,18.61%,LRP1;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;KREMEN1;PSMA5;PTPRU;PTPRO;PSMB5;NKD2;SOX2;TLE1;GLI1;GLI3;PSMC4;PSMA4;SHISA6;PSMC5;JADE1;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CTNNBIP1;CHD8;AMER2;DVL3;PSMD14;PSMA7;FRZB;HECW1;BMP2;PSMD11;LZTS2;PSMA2
prerank,rRNA modification (GO:0000154),0.34737407761449407,0.8949870025961378,0.582018927444795,0.9741872855847049,1.0,10/21,30.57%,NAT10;DIMT1;NSUN3;MTERF4;METTL5;ZCCHC4;NOP10;DKC1;NSUN4;FTSJ3
prerank,inner dynein arm assembly (GO:0036159),0.4156027387922079,0.8946448025159438,0.6,0.9742883540360644,1.0,2/10,15.73%,DNAAF4;CCDC39
prerank,positive regulation of MAP kinase activity (GO:0043406),0.2767004663969159,0.894435856649661,0.6482758620689655,0.9740669612709725,1.0,7/66,5.31%,IL34;EDN3;CD40;FGFR1;HTR2B;TLR6;LRRK2
prerank,liver development (GO:0001889),-0.2729683698118045,-0.8944231264630134,0.6328767123287671,0.8185655982108291,1.0,9/32,18.27%,ARID5B;WNT4;ANXA1;COBL;LSR;CITED2;ZIC3;MET;TGFBR3
prerank,positive regulation of inflammatory response (GO:0050729),0.26412764621588447,0.8942552529129181,0.6515353805073432,0.9737821329220451,1.0,4/86,2.91%,IL33;WNT5A;IL16;TSLP
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28887442581939166,0.8935989056560024,0.6295774647887324,0.9746244698034734,1.0,17/58,18.51%,ERCC1;LIG3;POLQ;POLA1;ERCC4;POLL;RNF168;UBE2V2;POLB;CYREN;PAXIP1;KDM2A;ZBTB7A;PSMD14;NHEJ1;SMARCAL1;RIF1
prerank,regulation of exit from mitosis (GO:0007096),0.30463751429105157,0.8935719846817856,0.6176046176046176,0.9739654301746211,1.0,3/38,5.80%,CDC14B;BUB1B;CDC16
prerank,membrane protein proteolysis (GO:0033619),-0.2647169282411907,-0.8935497788364021,0.6625,0.8198337816742264,1.0,9/37,12.75%,NFKB1;ERAP1;ADAM10;RBMX;CTSH;DAG1;APH1A;RET;APH1B
prerank,nuclear export (GO:0051168),0.27009785794878455,0.8934891599415572,0.6296774193548387,0.9734430498100883,1.0,21/80,19.94%,CSE1L;EIF4A3;ANKLE1;NUP214;NUTF2;THOC7;POM121;SRSF11;SLU7;NUP42;RANBP3;CASC3;STRADB;SRSF9;THOC5;CALR;XPO6;SRSF6;NUP155;CHTOP;XPO1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.380143616206543,-0.8934828922187122,0.6108695652173913,0.8193107155526964,1.0,5/10,36.72%,TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,epithelial to mesenchymal transition (GO:0001837),0.2931762267766624,0.8930894494714676,0.6171428571428571,0.9736175263471422,1.0,11/47,12.33%,WNT5A;FGFR1;LOXL3;LOXL2;TBX3;AMELX;DDX17;BMP7;TGFBR1;SOX9;OLFM1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3043937681357225,-0.8929168479034599,0.5994694960212201,0.8198654854606804,1.0,5/20,12.33%,IL18;CD55;IL1R1;B2M;PRKCZ
prerank,regulation of lipase activity (GO:0060191),-0.34202652321463295,-0.8922903824654809,0.5740318906605922,0.8205462578951414,1.0,4/13,16.36%,RHOC;LMF1;FURIN;PCSK5
prerank,regulation of spindle assembly (GO:0090169),-0.28704550146057234,-0.8922339298211748,0.6311881188118812,0.8200337075792015,1.0,12/25,29.34%,DRG1;CHMP2B;DYNC1H1;CHMP4B;NUMA1;CHMP1A;PDCD6IP;CHMP4C;HSPA1A;CHMP2A;SPAG5;HSPA1B
prerank,response to muramyl dipeptide (GO:0032495),-0.3559704404253026,-0.891862398751581,0.62,0.8201898000883096,1.0,1/12,1.12%,VIM
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2626490287582073,0.891830562848743,0.6412903225806451,0.9759296686713818,1.0,11/93,9.61%,NTRK3;PTEN;CNKSR3;SH2D3C;MTCP1;DOCK7;PRKD1;PINK1;INPP5J;TENM1;NSD1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.305397104259204,0.891590083617419,0.6198224852071006,0.9757872362794641,1.0,6/35,14.99%,GHR;ERBB4;OCIAD1;HGS;DOT1L;F2R
prerank,protein import into peroxisome matrix (GO:0016558),0.38708308591536605,0.8914703732732902,0.5701107011070111,0.9753466121834302,1.0,5/12,19.21%,PEX2;PEX7;PEX12;PEX6;PEX14
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3507680789019011,-0.891432785391115,0.6029411764705882,0.8204133526280241,1.0,3/13,13.91%,RNF152;SESN1;ATM
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3882510380933384,0.8913505127213182,0.6119929453262787,0.9749053438657984,1.0,4/13,11.68%,PLA2R1;SPRED1;SPRED2;MSX1
prerank,endosome organization (GO:0007032),-0.25981161361588645,-0.8910164378273959,0.6595092024539877,0.8206855734333827,1.0,12/41,20.39%,EEA1;LAPTM4B;SQSTM1;CHMP2B;VPS18;HOOK1;VPS11;ALS2;TMEM9;SNX3;PLEKHJ1;EXOC8
prerank,innate immune response (GO:0045087),0.2415599937539789,0.8909807628127411,0.7092760180995475,0.9750315647878605,1.0,21/217,10.29%,COLEC12;CLEC4E;CXCL10;MASP1;CD40;CLEC5A;MFAP4;KYNU;DHX58;TRIM56;TLR8;PTK2;TRIM8;IFNLR1;SP100;MBL2;TLR4;CYBA;FGR;CR2;IRAK1
prerank,gas transport (GO:0015669),0.4047464282476,0.8907780553260997,0.5939849624060151,0.9748030209115184,1.0,2/10,15.59%,MB;MYC
prerank,sodium ion import across plasma membrane (GO:0098719),0.36019525534099284,0.8906096705934301,0.59,0.974456061632902,1.0,3/17,9.49%,SLC9A9;SLC9A1;HCN2
prerank,B cell proliferation (GO:0042100),-0.3220186650360318,-0.8905925802863195,0.5940860215053764,0.820931885918261,1.0,2/17,3.12%,MEF2C;CTPS1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3432391645238202,0.8905806137569959,0.5980392156862745,0.9738213354926364,1.0,2/21,7.60%,IL34;PTK2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3929470409475047,0.8903619448583987,0.5731922398589065,0.9736102946061479,1.0,1/12,0.56%,PIK3R1
prerank,negative regulation of cell development (GO:0010721),-0.2901644248472729,-0.8899268639137063,0.6289855072463768,0.8217123130904703,1.0,4/25,7.49%,IGF1;NOTCH1;B2M;GSK3B
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3068628801288602,-0.8895515563717298,0.5825242718446602,0.8218948100253415,1.0,2/19,0.45%,IGF1;PICALM
prerank,DNA conformation change (GO:0071103),0.36185969952278907,0.8894073335333958,0.5750421585160203,0.9751073666557085,1.0,6/17,22.42%,NAA10;TOP2B;TOP3A;TOP2A;HMGB1;ABL1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.35207893325770856,-0.8894059522968838,0.5975903614457831,0.821543360223867,1.0,4/13,12.95%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,regulation of mRNA metabolic process (GO:1903311),0.3993938728288531,0.8894021614012617,0.6039076376554174,0.9743982700203687,1.0,4/11,17.59%,SAFB2;DHX9;IWS1;SAFB
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.24131343249386836,-0.8890765470724287,0.698961937716263,0.821588975194611,1.0,25/54,30.28%,CAV1;NXN;SQSTM1;RPL5;SOX4;SH3RF2;RPL11;HDAC8;DCUN1D3;ISG15;AKT1;COPS9;VPS28;TNFAIP3;SMAD7;BAG2;SENP2;HSPA1A;ARRB2;U2AF2;PARK7;PRR7;HSPA1B;MINAR1;CAMLG
prerank,dendritic cell migration (GO:0036336),0.3632677278190936,0.8889910665116846,0.5918367346938775,0.9746470328189061,1.0,6/16,25.86%,GPR183;TRPM2;PIK3CG;ALOX5;HMGB1;CCR5
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.3654145061137062,-0.8888467280673799,0.6063348416289592,0.8214754564272981,1.0,1/10,0.55%,RAPGEF2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2896621197866204,-0.8883644741158058,0.6128205128205129,0.821884749723323,1.0,10/23,25.92%,DIAPH1;CAMK2D;ANK2;NOS1;PTK2B;NOS1AP;CACNB1;CASQ2;CBARP;PSEN2
prerank,cellular response to nitrogen compound (GO:1901699),0.34413429257337885,0.8878641808357849,0.6003316749585407,0.9765474371401336,1.0,5/20,11.73%,NR1H4;FMR1;PDE12;DAXX;SPIDR
prerank,ether lipid metabolic process (GO:0046485),0.37818446329536365,0.8878437009091613,0.6020583190394511,0.9758696632443942,1.0,3/14,9.82%,PEX7;PLA2G7;AGMO
prerank,B cell homeostasis (GO:0001782),0.4079987837381854,0.8874615347903367,0.6013745704467354,0.9760359615207449,1.0,1/10,0.80%,DOCK10
prerank,regulation of neurotransmitter transport (GO:0051588),0.3654827885579848,0.8872783233587626,0.5889261744966443,0.9757532148652276,1.0,3/16,4.89%,HCRT;CHRNB4;FMR1
prerank,negative regulation of cellular process (GO:0048523),0.226975078035672,0.8869581004573449,0.8072164948453608,0.9757636706878674,1.0,97/521,16.64%,ENPP1;DLC1;CASK;COL18A1;ROR2;PLXNC1;ATF5;HRG;CXCL1;TGFBI;PTEN;GLMN;SEMA5A;ERBB4;GPLD1;CDKN2A;SIPA1;SUSD2;DLG3;GJA1;DUSP1;NR1H2;FBXO5;REST;TMEM115;HTR2B;ADGRB1;DSCAM;SERTAD2;NAIF1;CDKN2D;ACTN1;PDE12;DUS2;BCL6;NPAS2;GMNN;CBFA2T3;PTPRU;MDM4;PRKD1;P3H1;IFNLR1;TNFRSF21;APPL2;SP100;TENM1;BMP7;MAP2K1;TNS2;NME6;NDRG3;EIF2AK2;TP53;FKTN;PLXNB2;SPEG;MSX1;JADE1;GAS8;HGS;ESR2;FABP3;HTRA2;DIS3L2;ST18;PDCD4;SMYD5;TESC;BNIPL;MALSU1;P3H3;TDRD9;ADAM22;CDKN2C;LYN;FOXM1;WNK2;THAP12;NME1;TSPYL2;IGFBP7;F2R;FERMT2;CLU;TFAP4;CDK10;CNOT7;AR;MYC;RNF167;KLF11;FBLN1;IMPACT;BRINP1;TSC1;CHERP
prerank,regulation of neuron migration (GO:2001222),0.3298418132667576,0.8865784270112446,0.6144200626959248,0.9759412061705144,1.0,9/26,19.12%,IGSF10;CTNNA2;PLAA;PLXNB2;COL3A1;NTNG2;NTNG1;CAMK2A;ULK4
prerank,linoleic acid metabolic process (GO:0043651),0.360750158737114,0.8864522893860062,0.6153846153846154,0.9755235211504663,1.0,4/17,22.46%,ELOVL2;ELOVL1;ALOX5;ELOVL5
prerank,intestinal absorption (GO:0050892),0.3774112202068341,0.8860313151296937,0.5936952714535902,0.975792389660759,1.0,1/13,0.66%,NPC1L1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2498005215156408,0.885404761217357,0.6823104693140795,0.9765661675357732,1.0,24/128,16.45%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;CEP192;PRKACA;PPP2R2A;CEP135;SSNA1;MELK;FOXM1;CEP250;CCNA2;CEP152;BRSK2;CSNK1E;CLASP1;ALMS1
prerank,C-terminal protein amino acid modification (GO:0018410),0.3970512181597708,0.8851883878926353,0.6152450090744102,0.9764176838039068,1.0,3/11,16.53%,GPLD1;AGBL4;FOLH1
prerank,stem cell development (GO:0048864),0.3592852935418322,0.8851520211832394,0.6131756756756757,0.9757922786234048,1.0,2/16,9.29%,NRG1;TAPT1
prerank,regulation of mRNA stability (GO:0043488),0.24916985794017898,0.884963702519275,0.673992673992674,0.9755247374534334,1.0,39/145,19.94%,NUP214;PSMD1;YWHAZ;RBM24;FMR1;DND1;PSMD10;PDE12;ZFP36L2;TAF15;PSMA5;PSMB5;PAIP1;PRKCA;TENT5A;PSMC4;PSMA4;DHX36;PSMC5;TNPO1;CSDC2;EXOSC9;FTO;PSMB9;EIF4ENIF1;RC3H2;HNRNPD;GDNF;EXOSC8;EXOSC5;PSMD14;PSMA7;IGF2BP3;PSMD11;PSMA2;YTHDF1;FXR1;ZC3H14;XPO1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2184557223786276,-0.8848902448689153,0.7536231884057971,0.8286895640123202,1.0,32/93,24.95%,PLCB1;CCN2;ARL6IP5;TPD52L1;APP;MAP3K5;TGFB2;MINK1;FZD7;SH3RF2;XDH;HIPK2;GADD45B;FLT4;PTK2B;MAP3K4;WNT16;STK25;TRAF3;MAPK8IP1;MAP3K10;SDCBP;MFHAS1;GADD45G;DUSP19;TRAF1;TAOK2;CCL19;NOD2;EDAR;CD27;MID1
prerank,cellular response to UV (GO:0034644),0.2697253798396477,0.8847174696942387,0.6706192358366272,0.9753760588190833,1.0,15/76,16.17%,PPID;ERCC1;POLK;MFAP4;FMR1;NEDD4;ERCC4;NOC2L;XPC;TP53;DHX36;EIF2S1;BAK1;MYC;IMPACT
prerank,neurogenesis (GO:0022008),-0.2505320490511634,-0.8847134236032509,0.6932907348242812,0.8283993381669857,1.0,9/43,13.10%,THOC2;TGFB2;ANXA1;SIX1;CDK6;MAPT;WDR62;CLN5;TRAK2
prerank,transcription by RNA polymerase II (GO:0006366),0.23443468112122146,0.8844559089683609,0.725,0.9752492366927663,1.0,53/305,17.67%,RORA;PPARA;TEAD1;NR1H4;HDAC1;TAF9B;INTS8;C5AR1;TAF12;THRA;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;RTF1;TAF15;LSM11;TAF3;NR2C1;CDK13;SRRT;NUDT21;TBPL1;NELFA;ZC3H8;SNAPC5;INTS14;SNW1;GTF2H3;ESR2;NFIX;ELP4;SSRP1;ELL2;TRIP11;MED1;NRBF2;SLBP;HDAC10;ERCC2;GTF2H1;SNRPF;EAF2;AR;SYMPK;NR1D2;IWS1;CCNK;MAZ;TAF8;MBD1
prerank,toll-like receptor signaling pathway (GO:0002224),0.2691836525766512,0.8844541783744365,0.662568306010929,0.9745488946984255,1.0,15/84,14.72%,COLEC12;UNC93B1;NR1H4;TLR6;TLR8;LGMN;TLR4;BIRC2;IRAK1;MAPKAPK3;S100A1;HSP90B1;UBE2D1;TIRAP;RIPK1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3773758103582333,-0.8843019712739316,0.6065934065934065,0.828571623118848,1.0,3/10,12.06%,CCT3;CCT4;CCT7
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.3578591215455357,-0.8842204714762821,0.6501128668171557,0.8280875579745814,1.0,5/12,19.58%,ACO1;ACO2;ASS1;IDH3B;IDH3A
prerank,response to prostaglandin E (GO:0034695),-0.37317320355707884,-0.8840673433505677,0.6302895322939867,0.8277625648393058,1.0,4/10,23.96%,ADCY6;SFRP1;TGFBR3;CCL19
prerank,purine-containing compound catabolic process (GO:0072523),-0.3374938465912102,-0.8839299651905465,0.6262626262626263,0.8274021805581799,1.0,5/13,20.08%,XDH;GPX1;NT5E;GDA;NT5C1A
prerank,negative regulation of cell growth (GO:0030308),0.2557414173943497,0.8838127596451573,0.6646115906288532,0.975328548929805,1.0,18/121,12.56%,ENPP1;HRG;CDKN2A;SIPA1;GJA1;SERTAD2;NAIF1;CDKN2D;BCL6;CDKL3;DCC;NME6;NDRG3;TP53;MSX1;JADE1;ESR2;GSK3A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.23456518015234212,-0.883739997587961,0.7098039215686275,0.8270879404696718,1.0,8/63,6.46%,MEF2C;IL18;ANXA1;SLC7A1;TFRC;IL6ST;CD38;NCK1
prerank,actin nucleation (GO:0045010),-0.29603073785109046,-0.8836932549699517,0.6505102040816326,0.826515502962886,1.0,7/21,23.25%,JMY;LMOD1;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4
prerank,lipid droplet organization (GO:0034389),0.33502623522611513,0.8836279180461957,0.600326264274062,0.9750762837811424,1.0,3/22,8.42%,PPID;CIDEA;BSCL2
prerank,dendritic cell differentiation (GO:0097028),0.3423260118053082,0.8832241064790398,0.6101973684210527,0.9753289345025058,1.0,6/22,18.53%,AXL;CAMK4;TRPM2;LYN;LGALS9;PRTN3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.3987709843291983,0.8831300846955722,0.6192982456140351,0.9748493569485581,1.0,2/10,5.30%,ATP1A2;NEDD4
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3493797596646172,0.882892252103832,0.5833333333333334,0.9746886088799049,1.0,3/17,10.14%,CPEB1;RNF40;NUDT21
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.32228113818911286,0.8827814561540545,0.5993537964458805,0.9742171514512695,1.0,15/28,28.81%,ITPR1;CASP4;DNAJC10;BAG6;BAK1;BRSK2;BBC3;TNFRSF10B;DDIT3;ATF4;TMEM117;SELENOK;QRICH1;BCL2;ERO1A
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.32181799905469566,-0.8826395566740793,0.6294277929155313,0.8281871199678092,1.0,4/17,6.27%,BAIAP2L1;TEK;NRP1;CDC42
prerank,high-density lipoprotein particle assembly (GO:0034380),0.390855722322085,0.8825334378520973,0.5771324863883848,0.9740887322392473,1.0,2/10,8.81%,PRKACB;PRKACA
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.31493845778043444,-0.8823663622930099,0.6120906801007556,0.8281254861166312,1.0,5/17,16.35%,KLF4;ANXA1;TMSB4X;MAP2K5;ANXA4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.26865991171706743,0.8822497399680356,0.6729986431478969,0.9740591476645905,1.0,12/76,11.72%,CCDC22;CDKN2A;PSMD10;BRMS1;TRIM37;LRRC14;COMMD1;BMP7;IRAK1;DAP;PYCARD;PTGIS
prerank,positive regulation of dendritic spine development (GO:0060999),0.34674020566372366,0.8817034299014554,0.6187399030694669,0.9745888495173061,1.0,6/20,14.38%,FOXO6;FMR1;CAPRIN1;RELN;DHX36;CUX2
prerank,lysosome organization (GO:0007040),0.3041090717192168,0.8814706267348053,0.6145833333333334,0.9744067660184483,1.0,8/36,15.88%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31870003317539614,0.8807259784618217,0.615506329113924,0.9753620159734712,1.0,8/30,14.98%,GJA1;RYR2;SCN2B;CACNA1G;FGF12;KCNE4;SCN1A;CACNA2D1
prerank,regulation of metal ion transport (GO:0010959),0.3523913221598567,0.880624024756364,0.617056856187291,0.9748744514621284,1.0,2/16,2.07%,SLC30A10;IL16
prerank,regulation of mitochondrial fission (GO:0090140),0.3323442030574041,0.8804991059210261,0.6270903010033445,0.9744487066124489,1.0,3/24,8.54%,DCN;LRRK2;PINK1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.31538670949382797,0.8804197895484286,0.6125,0.9739316440697732,1.0,5/31,14.16%,GLMN;PDCD1LG2;TNFRSF21;CD86;LYN
prerank,positive chemotaxis (GO:0050918),0.3577258035924623,0.8801647918489944,0.6033333333333334,0.9738173790932583,1.0,2/17,3.59%,SEMA5A;SCRIB
prerank,regulation of cytokinesis (GO:0032465),0.2685732046820158,0.8799412193830359,0.6715425531914894,0.9736473194877183,1.0,3/78,0.95%,SVIL;CDC14B;RXFP3
prerank,stabilization of membrane potential (GO:0030322),0.3614653043960931,0.8798889383065509,0.6180327868852459,0.9730760226878344,1.0,1/16,0.62%,KCNK2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.23382690621389407,-0.8793104793379029,0.701067615658363,0.8339157456060998,1.0,15/57,15.85%,TNFSF10;HIP1R;KDR;VPS35;GSK3B;RALBP1;MIEF1;BAD;BAX;BID;DDHD1;BOK;ZNF205;ADCK1;GPER1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3318470950220018,0.87912852527101,0.6221122112211221,0.9741831472131773,1.0,4/24,7.75%,ERCC1;KMT2A;MSH3;ERCC4
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2197934461093824,-0.8790608773282211,0.7535211267605634,0.8337936759905311,1.0,12/75,13.18%,SLC12A7;SLC9A2;SLC8A3;ATP1B3;KCNJ13;SLC39A8;SLC39A10;KCNJ2;KCNK9;SLC12A8;KCNJ12;TRPV4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.34249765238976354,0.8790518818525463,0.6112903225806452,0.9736794156098989,1.0,5/18,17.02%,PIK3R1;BAG6;ATXN3;BAK1;USP13
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.22453512255359057,0.8790290908567654,0.8538071065989847,0.973045371304552,1.0,177/807,19.81%,IL33;ZEB1;RUNX2;XCL1;TRPS1;ZFHX3;ATF5;NRG1;PRICKLE1;PPARA;MIER2;ETV5;NR1H4;HDAC1;WNT5A;PPID;L3MBTL1;TAF9B;NR2F2;TCF7L2;BASP1;SALL1;THRA;CDKN2A;PEX2;MEIS2;PER3;POU3F3;PPARD;LOXL3;NR1H2;MDFIC;LOXL2;TBX3;REST;SCML4;RUNX1T1;ZNF423;ZBTB16;ZFP37;RTF1;SIRT6;GLIS1;TLE2;PRDX5;FOXS1;PSMD10;BCOR;CAPN3;DUSP22;CALCA;TENM2;BCL6;GMNN;CBFA2T3;BRMS1L;BRMS1;PAX9;ZBTB2;TRIM37;LYAR;TAF3;NR2C1;ZKSCAN3;MDM4;TWIST1;PER2;NOC2L;MXI1;SOX2;TLE1;PHF6;SP100;GLI3;L3MBTL4;BMP7;NSD1;DAXX;ZFPM2;SOX10;DAP;MPHOSPH8;N4BP2L2;TP53;ZNF25;ZC3H8;SNW1;ZNF318;CREB3L1;EPC1;ESR2;SOX9;MYT1L;NRIP1;TWIST2;NFIX;PDCD4;SAP30;DPF2;IGF2;PRDM5;ZMYND15;KDM1B;CNOT1;HIC2;PHC1;BTAF1;ATN1;MED1;HDAC10;UBE2D1;PEG3;FOXM1;CUX2;BPTF;CHD8;KDM5C;ZBTB32;MED25;PRMT2;TFAP4;CNOT7;DMAP1;AR;MYC;ORC2;FGFR2;KDM2A;DCAF1;CRY2;SPINDOC;CENPF;AASS;ZHX3;NONO;ZBTB7A;KLF11;IMPACT;ZNF3;CBFA2T2;EFNA1;NR1D2;CIART;MBD2;CALR;MBTD1;DNMT3A;CDK5;MAZ;ILF3;SARS1;MBD1;KHDRBS1;LDB2;LDB1;SKOR2;BMP2;KAT7;SUV39H2;ZEB2;RIF1;BRD7;CBFB;HEY1;THAP7;CREBZF;NR2C2;WWC1;PEX14;EHMT2;DEDD2;NACC1;MTA3;CDC73;FHL2;IKZF4;CNBP
prerank,T cell receptor signaling pathway (GO:0050852),0.2476617399958657,0.8785933916350571,0.6934131736526946,0.973399598324119,1.0,19/138,11.51%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;PDPK1;ICOSLG;PIK3R2;CD276;PTPN22;EIF2B1;PSMD10;PSMA5;PSMB5;TNFRSF21;PSMC4;PSMA4;FYN;PSMC5
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2526948037209396,-0.878479872175096,0.6897689768976898,0.8343425276469307,1.0,5/41,7.09%,IGF1;LBP;SIRPA;CD34;DICER1
prerank,autophagosome organization (GO:1905037),-0.23823476325520043,-0.8781850729323339,0.6809116809116809,0.8343533902765875,1.0,17/50,21.55%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;ATG12;RAB1A;ATG2A;MAP1LC3A;AMBRA1;ULK3;RAB1B;ATG101;MAP1LC3B;WDR45
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3645202216476188,-0.8781180912832941,0.627039627039627,0.8338593302125112,1.0,2/10,6.27%,EZR;CDC42
prerank,regulation of amyloid-beta formation (GO:1902003),0.3092616915357667,0.8773048662499472,0.6240369799691834,0.9756321096697633,1.0,11/34,17.66%,SLC2A13;NTRK2;LRRTM3;SORL1;GSAP;GSK3A;RTN2;CLU;EFNA1;RTN3;ABCA2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.32648086614712046,-0.8772993156783054,0.648989898989899,0.834937341529579,1.0,7/16,22.44%,ST8SIA4;ST6GALNAC3;LARGE1;ST8SIA2;ST3GAL5;A4GALT;ST8SIA6
prerank,amino acid transport (GO:0006865),0.28530511736799713,0.8767162797588941,0.622286541244573,0.9762667629666708,1.0,4/49,4.79%,SLC1A5;SLC7A11;SLC43A1;SLC7A8
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3488525952146765,0.8766824337462017,0.6325581395348837,0.9756358080289278,1.0,4/21,8.64%,SULF1;HS6ST3;HS6ST2;EXTL3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.28447554053163754,0.8764695927344806,0.6390870185449358,0.9753986987175782,1.0,8/54,8.81%,HRG;CD40;FGFR1;PDPK1;JUP;NF1;PRKD1;PRKCA
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38236204454627876,0.8763834374612135,0.6137931034482759,0.974916587228188,1.0,4/13,9.24%,AKAP5;ADCY8;RELN;LGMN
prerank,regulation of immunoglobulin production (GO:0002637),-0.2918107885393101,-0.8756168914318357,0.6378378378378379,0.8377424601998471,1.0,3/23,10.79%,RBP4;DNAJB9;EPHB2
prerank,dicarboxylic acid transport (GO:0006835),0.319799674528931,0.8755842552412163,0.6549079754601227,0.976029669869442,1.0,2/28,3.89%,SLC1A3;GJA1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.31634358606000257,-0.8749546237385738,0.6517647058823529,0.8385552244879811,1.0,3/17,7.77%,MAGI2;CALM1;ITGA1
prerank,response to UV (GO:0009411),0.2616745803602434,0.8748352269613753,0.6851119894598156,0.9770370658512686,1.0,21/95,15.59%,FEN1;POLK;USP1;MFAP4;FMR1;ERCC5;NEDD4;CDKN2D;ERCC4;NOC2L;UVSSA;POLH;TP53;DHX36;IL12A;SPRTN;REV1;EIF2S1;ERCC2;BAK1;MYC
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2897959567791929,-0.874575535822739,0.6618004866180048,0.8387010607923697,1.0,11/23,24.48%,BAD;BAX;TIMM9;TIMM13;TOMM22;TIMM8B;ROMO1;COX18;NDUFA13;BCL2L11;TIMM10B
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.26771979885911623,0.8745199577861426,0.6765847347994826,0.9770282557029173,1.0,8/75,5.46%,SPRY4;SPRY1;NR2F2;PTEN;CDKN2A;DUSP1;SORL1;NF1
prerank,osteoclast differentiation (GO:0030316),-0.2910657357359817,-0.8742344352627046,0.6685552407932012,0.8387660465352902,1.0,13/22,34.17%,FOXP1;MAPK14;OSTM1;GLO1;EPHA2;CSF1R;TYROBP;SRC;SNX10;SBNO2;CSF1;EFNA2;TREM2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.35644909334951935,0.8736430515238885,0.6114864864864865,0.9783242231801123,1.0,2/15,4.65%,KDF1;NCOA3
prerank,JNK cascade (GO:0007254),-0.25556925943616976,-0.873628999793503,0.656891495601173,0.83942073807263,1.0,16/40,24.06%,IRAK2;MAP3K5;MINK1;MAPK9;UBB;MAP2K4;MAP2K7;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKG;NOD2
prerank,cell cycle G2/M phase transition (GO:0044839),0.2465367027390857,0.8732976300403487,0.7054545454545454,0.9784121769082011,1.0,24/129,16.45%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;CEP192;PRKACA;PPP2R2A;CEP135;SSNA1;MELK;FOXM1;CEP250;CCNA2;CEP152;BRSK2;CSNK1E;CLASP1;ALMS1
prerank,positive regulation of glycolytic process (GO:0045821),0.33988910545412926,0.8725351040646707,0.6142625607779578,0.9787274765646181,1.0,3/20,4.58%,ZBTB20;PFKFB1;ENTPD5
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.33988910545412926,0.8725351040646707,0.6142625607779578,0.9787274765646181,1.0,3/20,4.58%,ZBTB20;PFKFB1;ENTPD5
prerank,negative regulation of protein catabolic process (GO:0042177),-0.25130631315004565,-0.8724355826126773,0.6918238993710691,0.8412885551564214,1.0,8/40,19.41%,EGFR;PTPN3;CST3;AZIN1;FLNA;CYP51A1;SNX3;TIMP3
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.25485307790767553,-0.8723978749542711,0.7195121951219512,0.8407117316714444,1.0,10/39,16.82%,MYRIP;PSMD9;RBP4;SOX4;NNAT;BAD;ACSL4;SELENOT;GPER1;HFE
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.289983034621243,0.8721356818721807,0.6628407460545194,0.978906828239007,1.0,11/45,16.64%,NANOS3;SPOUT1;GCNT2;MTPN;ZC3H7B;NUDT21;GRM5;RBM4B;ATG14;TSC1;CYFIP1
prerank,protein stabilization (GO:0050821),-0.19526059999769613,-0.8720123822847697,0.9078947368421053,0.8408926301243571,1.0,59/168,27.21%,EPHA4;IGF1;PLPP3;PTGES3;HIP1R;ATP1B3;CTNND1;TBL1X;RPL5;DVL1;CRYAB;RPS7;SOX4;RAB21;MTMR9;TBRG1;SOX17;ANK2;CCT3;RPL11;VHL;ATF7IP;CCT4;GAPDH;CRTAP;NCLN;CCT7;BAG3;FLNA;HIP1;GLMP;CREB1;CDKN1A;PRKCD;CREBL2;LAMP2;AFM;USP9X;RPL23;PIM2;RTN4;SMAD7;TYROBP;BAG2;SUGT1;TMEM88;TRIM39;MCM8;SUMO1;MT3;HSPD1;GOLGA7;HSPA1A;CHEK2;COG3;FLOT1;PARK7;STK3;ATP1B2
prerank,regulation of cilium assembly (GO:1902017),-0.23011620347993145,-0.8719669658649264,0.7604166666666666,0.8403543010800718,1.0,14/62,15.90%,TBC1D19;RABEP2;MARK4;TBC1D8;TBC1D22B;IFT140;CCDC88A;TBC1D7;TBC1D22A;CYLD;EVI5L;TBC1D10B;CROCC;TBC1D13
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2869833560338847,-0.8719111967462638,0.6763925729442971,0.8398149006099123,1.0,9/23,22.90%,WNT5B;SMO;SIX1;PIK3CD;MDK;EGF;AGT;SIX4;SOX8
prerank,regulation of mitotic cell cycle (GO:0007346),0.24021867447438885,0.8718646045319001,0.7274853801169591,0.9788564143798686,1.0,39/171,18.61%,BUB1B;L3MBTL1;MEIS2;SCRIB;PSMD1;PKMYT1;FBXO5;GBF1;RNF40;CCDC57;CDC16;PSMD10;PSMA5;RPS6KB1;PSMB5;CDK13;PRKCA;LGMN;XPC;PSMC4;PSMA4;RCC1;TTC28;MKI67;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;TFAP4;CDK10;BRINP1;SRA1;PSMD14;PSMA7;CUL7;CDC26;PSMD11;PSMA2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.22854282471171478,0.8718496087790761,0.8002148227712137,0.9781979844317635,1.0,92/366,22.51%,RORA;CHD7;ZFHX3;MSC;ATF5;NANOS3;RABL3;NCOA2;CXXC1;MYT1;FBXO5;TEAD2;REST;SOX6;ZNF423;FOXN2;MTPN;ZFP37;HP1BP3;GMNN;SPIN1;SPTY2D1;SOX2;EDF1;NSD1;DAXX;SRRT;BRCA2;NFXL1;GRM5;TP53;TGFBR1;ESR2;SRSF10;TFEB;SAP30;IGF2;CARM1;NUP107;ZNF628;RBM4B;HDAC10;SSBP2;ARNT2;TGFBRAP1;CCNA2;MAFB;HNRNPD;UBE2V1;ATF2;WTIP;MLF1;NONO;ZKSCAN5;TSC1;TRIP4;NR1D2;CYFIP1;CALR;USP13;ZBTB11;LDB1;SKOR2;BMP2;MLF2;KAT7;HIF1A;THAP7;TERF2IP;NR2C2;WWC1;REXO4;EHMT2;SP1;DVL2;CNBP;TRAPPC2;GON4L;SMC3;HCFC2;UTP4;CREBBP;ORC5;APBB3;ASCC1;LIN54;DDIT3;ATRX;ABL1;NLK;SERTAD3;MLLT6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.32103549741976345,0.8717261620294037,0.6363636363636364,0.9777752467508012,1.0,3/25,11.26%,ITPR1;LRRK2;P2RX4
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3571849555273328,-0.8716038558655514,0.6365638766519823,0.839791800078999,1.0,4/11,13.47%,TPK1;CTPS2;DCK;SLC19A3
prerank,regulation of transport (GO:0051049),0.29755792540368764,0.8714214391141235,0.6380368098159509,0.9777647339603731,1.0,7/36,11.01%,TMEM102;VAMP2;LRRK2;MYO6;PINK1;POFUT2;SCFD1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3954492830805131,0.8713645027224646,0.6376554174067496,0.9772037227237567,1.0,3/10,17.93%,FMR1;GNB5;GPR35
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.33283955207467225,0.871248717007147,0.6282894736842105,0.976795558826038,1.0,7/24,18.78%,TMEM204;NEDD4;PRKCB;HGS;ITGA5;ARNT;HIF1A
prerank,positive regulation of nuclear division (GO:0051785),0.31895034292881314,0.8711964036195665,0.6346749226006192,0.9762230478710207,1.0,2/25,2.13%,EDN3;PHIP
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24382407109284193,-0.8708035441096549,0.7508090614886731,0.8407816841129083,1.0,4/50,4.33%,NR3C2;EGFR;APP;NMI
prerank,cellular response to retinoic acid (GO:0071300),-0.24741364263674404,-0.8706153224770473,0.7166123778501629,0.840485289551785,1.0,10/42,15.06%,WNT5B;WNT9A;FZD4;FZD7;TBX1;WNT6;RET;PTK2B;ATM;CREB1
prerank,establishment of mitotic spindle localization (GO:0040001),0.31505451076571456,0.8705558211988382,0.6666666666666666,0.9769790452974358,1.0,9/28,18.45%,GJA1;GPSM2;SPDL1;INSC;NUSAP1;CLASP2;CLASP1;UBXN2B;KPNB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.2914251803017055,-0.8704840630677632,0.6545961002785515,0.8401188831663907,1.0,4/24,6.01%,RBPJ;NOTCH1;ATF6;KLF2
prerank,chemical homeostasis (GO:0048878),0.27429816761553905,0.8701955809178894,0.6782246879334258,0.9770523990609006,1.0,10/61,16.53%,ZBTB20;ACOX2;TLCD3B;IRS2;SLC66A1;TENT4B;SLC4A1;WNK2;ABHD4;NR1D2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.24532461675752715,-0.8696412352487702,0.7323943661971831,0.8411652062428913,1.0,9/48,13.00%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;PLA2G6;DGKZ;DDHD1
prerank,replicative senescence (GO:0090399),0.3806872861435558,0.8696046425289565,0.6363636363636364,0.9776538894636468,1.0,3/12,10.84%,PLA2R1;CDKN2A;TP53
prerank,regulation of axon extension (GO:0030516),-0.25285560684840325,-0.8689815156021911,0.6881028938906752,0.8419436671827699,1.0,8/37,13.42%,NTN1;SEMA7A;RUFY3;GSK3B;APOE;MAPT;GOLGA4;MACF1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2663426869200625,0.8686728653794675,0.6897470039946738,0.9791094739773692,1.0,19/78,21.06%,NR2F2;PTEN;CDKN2A;CCNJ;PKMYT1;CDKN2D;PSMD10;CCNB2;CDKN2C;CCNA2;GTF2H1;TFAP4;CCNK;CCNE1;LATS2;MEN1;CCND3;CDK5R1;CDK7
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.31440876656407213,-0.8686205113526972,0.628992628992629,0.8420187859965039,1.0,4/16,10.56%,FOXD1;SIX1;FGF1;NPNT
prerank,mitochondrion disassembly (GO:0061726),-0.26284961196672363,-0.868468034347546,0.6863270777479893,0.8416703652464371,1.0,14/34,21.55%,BECN1;SQSTM1;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;MARK2;AMBRA1;MAP1LC3B;WDR45
prerank,primary miRNA processing (GO:0031053),-0.36087782687490116,-0.8684479876666974,0.6127659574468085,0.8410625552440512,1.0,4/10,13.07%,DGCR8;DROSHA;SMAD3;SMAD1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.3446262877016674,0.8682072716474262,0.62,0.9794495452123195,1.0,1/19,0.63%,XCL1
prerank,histone H4 acetylation (GO:0043967),0.2961003852114622,0.8676947409746049,0.6548295454545454,0.979930609720632,1.0,12/47,15.42%,OGT;MORF4L1;KMT2A;BRD8;WDR5;MSL1;KANSL1;BRCA2;JADE1;EPC1;ATF2;DMAP1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.32959468603258746,-0.8676143577496114,0.6634146341463415,0.8421012586502593,1.0,3/15,6.09%,NEK6;CDC23;PTTG1
prerank,organelle organization (GO:0006996),0.22535431519981602,0.8675874411021361,0.8008519701810437,0.9794834849009025,1.0,94/388,20.00%,SEC16B;CECR2;PPID;RAB34;PHIP;MTFR2;ABCD2;SIPA1;PEX2;SEC16A;WDPCP;GBF1;DPYSL2;IRAG2;LRRK2;PRKCI;SMPD4;PEX7;DNAJC28;SIPA1L3;EPS15;FMNL2;WASF3;PALLD;FAM161A;FGD6;CIDEA;GOLGA2;KIFAP3;BSCL2;PRKD1;RAB30;PINK1;RAB29;MTX3;OPA1;BCS1L;WDR73;SAR1A;SLC25A33;ARHGAP4;RAB2A;SH3KBP1;KIF5C;POLG2;PEX11A;LNPK;CENPW;KIF9;SYNE1;TRIP11;ATP7A;FAM161B;CLASP2;LONP1;COG1;PCLO;SH3D19;WTIP;PEX19;PACSIN3;MYC;HACE1;TNIK;CLASP1;USP6NL;CEP55;FGD2;HAX1;PDZD8;GOLGA8B;GOLGA5;VPS4B;UBXN2B;CUL7;TMED3;PEX12;PAK5;TMED9;MCOLN1;MAST1;MIA3;EIF2AK3;PEX3;TBC1D20;YTHDF1;PEX6;SSBP1;PEX14;TRAPPC12;PLEKHM2;CCL2;NIPSNAP2;STRIP2
prerank,mRNA export from nucleus (GO:0006406),0.25690901403283667,0.8666623936633099,0.6870229007633588,0.9808243825023529,1.0,28/102,21.21%,EIF4A3;NUP214;AAAS;THOC7;POM121;HNRNPA2B1;GLE1;SRSF11;DDX19B;DDX19A;SLU7;ENY2;NUP42;CASC3;NUP107;SLBP;FYTTD1;SYMPK;SRSF9;THOC5;IWS1;NUP54;SRSF6;NUP155;CHTOP;DDX39B;MCM3AP;RANBP2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3701681668005685,0.8665339249624324,0.6132404181184669,0.9804189961521863,1.0,3/14,11.30%,EARS2;SLC25A33;TEFM
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.22674436246061708,0.8663469070599258,0.8017148981779206,0.9801270359428627,1.0,56/348,15.59%,IL33;SEC16B;ECE1;NTRK3;WNT5A;NTRK2;LRP3;AGO4;SCRIB;GJA1;POU3F3;RBMS3;ANK3;FMR1;PTPN22;MTPN;TLR6;ADAM19;MYCN;CDH3;RIMS2;PDCL3;C1QTNF1;DGKQ;TWIST1;RAB29;TLE1;MTOR;BMP7;MAP2K1;TLR4;WNT3;AHI1;MPHOSPH8;TP53;DHX36;RIMS1;TGFBR1;AGO3;HGS;SOX9;OLFM1;GSK3A;FAM98B;TESC;MED1;CUX2;RESF1;SNF8;ACTG2;ATF2;CLU;FGF5;TNRC6B;AR;MYC
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.3514047604531783,0.8662448654735643,0.6256410256410256,0.9796810229059942,1.0,1/17,0.63%,XCL1
prerank,protein dephosphorylation (GO:0006470),0.24669886575673464,0.86581886805703,0.7099514563106796,0.9799112321347916,1.0,22/135,11.52%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;DUSP22;PTPN13;PTPRU;PTPRO;SSH2;PPP2R2A;TNS2;PPP6C;PPP2R3A;PTPRA;PPP3CB;PDP1;UBASH3B
prerank,negative regulation of B cell activation (GO:0050869),-0.29733825321833196,-0.8657325594394327,0.6607142857142857,0.8454077958900608,1.0,10/21,33.20%,RC3H1;SFRP1;ATM;LAPTM5;TNFAIP3;TYROBP;FCGR2B;SAMSN1;BANK1;FOXJ1
prerank,N-glycan processing (GO:0006491),0.3489676376780315,0.8656973087798338,0.6188034188034188,0.979492923338992,1.0,4/18,10.48%,ST8SIA1;PRKCSH;MAN1C1;MAN1B1
prerank,protein localization to condensed chromosome (GO:1903083),-0.34810004760562,-0.8653763022385135,0.6343115124153499,0.8455329506936129,1.0,6/12,31.82%,MTBP;ZW10;BUB3;IK;TTK;ZWILCH
prerank,tRNA aminoacylation (GO:0043039),0.2991461651598881,0.8653357674550732,0.6430678466076696,0.9796183493734454,1.0,13/37,26.40%,EPRS1;CARS1;TARS1;YARS1;HARS1;SARS2;SARS1;AIMP1;PPA2;MARS2;AARS1;FARSA;YARS2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.2100604240616127,-0.8649745356161616,0.8262548262548263,0.8457297868203418,1.0,23/87,20.32%,RBFOX2;SHOC2;TBX1;CD44;FGF1;HNRNPF;ITGB1BP1;HYAL1;NR4A1;SFRP1;FGFBP1;FRS2;POLR2B;POLR2H;HNRNPH1;POLR2G;POLR2C;GRB2;FGFR3;FGFRL1;HNRNPA1;FLRT1;GALNT3
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3176518737263453,0.8645093551012993,0.6456086286594761,0.9807655798067488,1.0,6/29,16.84%,CXCL10;PLA2G7;LGMN;IL12A;LGALS9;CALR
prerank,receptor signaling pathway via STAT (GO:0097696),0.32311849809294296,0.8643197374629467,0.6259904912836767,0.9804678785846548,1.0,1/25,0.32%,GHR
prerank,skin development (GO:0043588),0.26866807632394996,0.864227777340248,0.6713483146067416,0.9799941911875409,1.0,13/65,15.78%,KDF1;WNT5A;ITGA3;COL1A2;DHCR24;ABCB6;EVPL;FA2H;MED1;ATP7A;STMN1;COL3A1;JAG1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3327510358797085,0.8642268765077894,0.6179775280898876,0.979313776689461,1.0,2/21,4.17%,LRP1;NR1H2
prerank,tRNA wobble uridine modification (GO:0002098),0.3671444182101896,0.8640581742761465,0.6256239600665557,0.9790140466729791,1.0,4/14,18.16%,ELP1;CTU1;ELP4;TRMU
prerank,DNA repair (GO:0006281),0.2288411990936445,0.8637076403536866,0.77007700770077,0.9791112636940725,1.0,74/284,22.42%,FANCI;ERCC6L2;ERCC1;LIG3;FAN1;FEN1;POLQ;POLK;USP1;FANCA;ERCC5;MSH3;CDKN2D;ASF1A;NEIL3;POLA1;RPA1;ERCC4;POLL;RNF168;XPC;COMMD1;FAAP100;UBE2V2;BRCA2;RFC3;POLH;TEX264;TP53;RECQL;FAAP20;POLN;GTF2H3;MUTYH;XRCC1;RAD52;POLB;SPRTN;FTO;ALKBH3;POLI;MBD4;ERCC2;EME2;ATXN3;DOT1L;GTF2H1;UBE2V1;MMS19;CSNK1E;SMC1A;APEX2;FBH1;MSH6;SMARCAL1;WRN;TRAIP;REXO4;MLH1;DDB1;DDX1;POLE;TRIP13;MTA1;USP45;MEN1;PWWP3A;ASCC1;RFC4;TOPBP1;KPNA2;FANCC;RAD54L;ABL1
prerank,gluconeogenesis (GO:0006094),0.29066128275156994,0.8634423790860467,0.648493543758967,0.9790038266282544,1.0,7/39,13.67%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3;SLC39A14
prerank,sphingoid metabolic process (GO:0046519),-0.3438043299998669,-0.8632075478169245,0.6412037037037037,0.8487678967304257,1.0,5/12,26.03%,PLPP3;DEGS2;KDSR;SPHK2;ASAH2
prerank,mRNA transport (GO:0051028),0.25569309012639924,0.8632033030151717,0.7007772020725389,0.9788314539629596,1.0,27/101,21.21%,EIF4A3;NUP214;AAAS;FMR1;THOC7;POM121;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;KIF5C;NUP107;SLBP;FYTTD1;SYMPK;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;DDX39B;MCM3AP;RANBP2
prerank,mitochondrion transport along microtubule (GO:0047497),0.3738795476151455,0.8629909151987201,0.6464285714285715,0.9786362219238565,1.0,4/13,18.78%,LRPPRC;OPA1;SYBU;HIF1A
prerank,protein N-linked glycosylation (GO:0006487),0.27077477678816936,0.8625350484430956,0.6901595744680851,0.9789879421818488,1.0,14/66,14.50%,OSTC;RPN2;ENTPD5;DAD1;ALG6;GFPT2;MAN1C1;ALG13;ALG5;MCFD2;TUSC3;TMEM258;B4GALT7;PMM2
prerank,negative regulation of immune system process (GO:0002683),-0.32047744047148485,-0.8620485091140648,0.6633416458852868,0.8504444246196594,1.0,1/16,0.41%,CD200
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3166306330432763,0.862047396188988,0.6525157232704403,0.9793847013010121,1.0,3/26,8.50%,ATP1A2;FMR1;GNB5
prerank,regulation of pseudopodium assembly (GO:0031272),-0.36613935907826056,-0.8618704579724182,0.6224256292906178,0.8494990291709639,1.0,2/10,6.27%,APC;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.36613935907826056,-0.8618704579724182,0.6224256292906178,0.8494990291709639,1.0,2/10,6.27%,APC;CDC42
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.22616669915349025,-0.8618643674687595,0.7638376383763837,0.8488554914755418,1.0,23/64,28.39%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;CTDP1;GTF2F2;ELOF1;TCEA1;POLR2I;POLR2K;TCEA2
prerank,wound healing (GO:0042060),0.27453329408199095,0.861541274998508,0.6643356643356644,0.9798154873748579,1.0,9/62,11.27%,PDGFRA;NRG1;WNT5A;NF1;SRF;EVPL;ARL8B;SYT7;TGFBR1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2694958486088677,0.8614944231580594,0.7,0.9792376242878522,1.0,13/67,12.11%,PLD1;ABITRAM;TBC1D16;MYO10;DYNC2LI1;FSCN1;FMR1;CDKL5;TBC1D1;P2RX4;TRPM2;IFT88;CDKL1
prerank,positive regulation of organelle assembly (GO:1902117),0.28514418898794175,0.8611860105453799,0.6626865671641791,0.979240259374113,1.0,9/44,13.22%,PIP4K2A;FSCN1;GPSM2;IL5;TAPT1;ASAP1;ARHGAP35;ENTR1;CNOT1
prerank,regulation of isotype switching (GO:0045191),-0.32955813435180115,-0.8610570578901791,0.6367816091954023,0.8498763227537924,1.0,3/14,9.55%,KMT5B;TFRC;SHLD2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2624778394213373,0.8608992781037059,0.7033678756476683,0.9791914377786883,1.0,27/80,24.02%,KDELR3;COPA;KDELR2;GBF1;COPZ2;TMEM115;DNAJC28;CENPE;COPB1;KIFAP3;SCFD1;ATP9A;RINT1;KIF3C;KIF2A;ERGIC2;TMED3;TMED9;COPG1;COPB2;KIF3A;KIF11;BNIP1;KIF15;COPZ1;KDELR1;KIF23
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.24700228011688558,-0.8604830921150602,0.7222222222222222,0.8503867030478901,1.0,5/43,7.09%,IGF1;LBP;SIRPA;CD34;DICER1
prerank,cell cycle checkpoint signaling (GO:0000075),0.37751291956260846,0.860444924042383,0.6431095406360424,0.9794971623686788,1.0,1/12,0.95%,BUB1B
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2929028225156048,0.8603976520878696,0.6523668639053254,0.9789289688734139,1.0,11/41,18.78%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.2786436147880441,0.8602814096401703,0.6633522727272727,0.9785041203893322,1.0,5/50,6.16%,SH3RF1;NGFR;DHCR24;CDKN2D;NOL3
prerank,cellular response to amino acid starvation (GO:0034198),0.266156558307129,0.8601760784507747,0.6975806451612904,0.9780665756680172,1.0,19/71,18.65%,NPRL2;SZT2;WDR24;PRKD1;MTOR;DAP;EIF2AK2;TFEB;ATP6V0E1;EIF2S1;MIOS;ATF2;IMPACT;RRAGA;CASTOR1;ATP6V1G2;EIF2AK3;ATP6V0D1;RRAGD
prerank,regulation of dopamine secretion (GO:0014059),0.31673577810335735,0.8601600408725427,0.6602564102564102,0.977426940451966,1.0,6/25,18.86%,SYT3;SYT7;SYT5;GDNF;SYT1;SYT6
prerank,response to unfolded protein (GO:0006986),-0.24663723112589175,-0.8601301825710926,0.7124183006535948,0.8504564204798971,1.0,22/48,32.57%,TMBIM6;HSPA8;HSPH1;HSPB8;BAX;OPTN;PTPN1;HSPB1;BAG3;ERN1;STT3B;DNAJB5;DNAJB1;HSPD1;HSPA14;HSPA1A;HSPB2;DNAJB2;HSPA1B;DNAJB4;HSPA2;HSF1
prerank,cellular zinc ion homeostasis (GO:0006882),0.31968027741588695,0.8599053537333712,0.6515397082658023,0.977310239376264,1.0,3/26,4.74%,SLC30A10;SLC30A5;SLC39A7
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3487350189503274,0.8598433883256728,0.6472545757071547,0.9767605572754569,1.0,6/18,17.66%,SPTBN1;AR;LDLRAP1;ZDHHC2;CDK5;ABCA2
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2512836782075838,-0.8595485844779116,0.6858974358974359,0.8510050202290742,1.0,18/38,30.58%,PTPRJ;MAGI2;XDH;PIK3CB;DAG1;PHLPP2;SIRT1;GPER1;EPHA2;AKT1;PPP2R5B;CIB1;HYAL2;ARRB2;PPP2R5C;NOP53;TRIB3;BANK1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.27865353094341416,0.8595417573322606,0.6726519337016574,0.9767720991467922,1.0,13/54,15.44%,HSPG2;GPC4;GCNT2;GPC5;HS6ST2;GNS;GUSB;B4GALT7;IDUA;HS3ST6;HS3ST5;SDC2;HEXA
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.34413863457144256,0.8595047749581329,0.6283333333333333,0.9761898500214594,1.0,3/18,9.33%,ATP1A2;SLC43A1;COMMD1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.22668610204082007,-0.8594875920277648,0.782608695652174,0.8504885488651525,1.0,22/62,28.30%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;CTDP1;GTF2F2;ELOF1;TCEA1;POLR2I;POLR2K
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.31985368701243133,-0.8594813055635965,0.6766917293233082,0.8498481461010395,1.0,4/15,7.09%,KHNYN;NYNRIN;RPP30;DICER1
prerank,response to amino acid starvation (GO:1990928),0.26491794834824867,0.8594270494161045,0.6964047936085219,0.9756883559523827,1.0,19/72,18.65%,NPRL2;SZT2;WDR24;PRKD1;MTOR;DAP;EIF2AK2;TFEB;ATP6V0E1;EIF2S1;MIOS;ATF2;IMPACT;RRAGA;CASTOR1;ATP6V1G2;EIF2AK3;ATP6V0D1;RRAGD
prerank,eye photoreceptor cell development (GO:0042462),0.35575493861254004,0.8592488255450884,0.6277955271565495,0.9754008225869178,1.0,2/15,10.39%,MYO7A;RPGRIP1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.36654963008734337,0.8592288030446065,0.6587436332767402,0.9747828834010993,1.0,7/13,27.49%,UBE2G2;BRSK2;YOD1;EDEM2;UBE2J1;OS9;BCAP31
prerank,establishment of melanosome localization (GO:0032401),-0.29925409291628297,-0.859153840284886,0.6699507389162561,0.8498880767803344,1.0,7/19,28.50%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,protein maturation (GO:0051604),0.2566357164641146,0.858962195503777,0.7113665389527458,0.9747039451026669,1.0,9/95,7.15%,ECE1;ECE2;OGT;NAA10;PCSK2;ADAM19;SORL1;CCS;CPM
prerank,endomembrane system organization (GO:0010256),0.23560721319541358,0.8589531825113046,0.7430555555555556,0.9740585481232993,1.0,49/178,22.14%,SEC16B;PHETA2;SEC16A;SPTBN1;ANK3;GBF1;LRRK2;SMPD4;DNAJC28;SUN2;SYP;GOLGA2;PRKD1;RAB30;RAB29;RAB2A;DNM1;WASHC5;LNPK;AP3D1;SYNE1;TRIP11;CLASP2;COG1;VPS33B;PHETA1;HACE1;CLASP1;USP6NL;GOLGA8B;GOLGA5;UBXN2B;CUL7;TMED3;TMED9;CTDNEP1;NUP155;MIA3;EIF2AK3;TBC1D20;TRAPPC12;PLEKHM2;ARFGEF2;TLCD1;PI4K2A;ATL1;SERP1;BNIP1;BAG5
prerank,regulation of cell-cell adhesion (GO:0022407),0.2910087055849493,0.8577816116102668,0.6618075801749271,0.9759154085321579,1.0,5/39,7.60%,EPHA7;TENM3;PTPRR;FLOT2;PTK2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.38438652932296136,0.8575587838721278,0.6295652173913043,0.9757316813793058,1.0,3/10,9.87%,TSPAN6;DHX58;SEC14L1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.31596531424953556,0.857543637466113,0.6577287066246057,0.9750958783886329,1.0,6/25,13.13%,ADK;GMPS;AMPD2;PRPS1L1;PRPS1;DGUOK
prerank,regulation of sodium ion transport (GO:0002028),0.29305890941340784,0.8573905748819435,0.6289592760180995,0.9747407624011604,1.0,7/34,11.26%,NKAIN1;CNKSR3;ANK3;NKAIN2;NEDD4;FGF12;P2RX4
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2614476082733896,-0.8571756208611755,0.6779661016949152,0.8532996508981804,1.0,10/30,21.57%,CAVIN1;GTF2H5;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3339363597080308,-0.8569903606541291,0.6573426573426573,0.8530421688140382,1.0,8/13,37.79%,UPP2;OGG1;NEIL1;NT5M;NTHL1;SMUG1;NEIL2;DCTPP1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3288333632992722,0.8569677488363419,0.6459627329192547,0.9750021530605104,1.0,1/22,0.63%,XCL1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2847995807364707,0.8568213697655193,0.678939617083947,0.9746690793733864,1.0,14/46,24.24%,TIMM10;DNAJC19;PINK1;PITRM1;TIMM44;DNAJC15;PAM16;GRPEL1;MFN2;TIMM21;GDAP1;CHCHD4;FIS1;TOMM34
prerank,response to molecule of bacterial origin (GO:0002237),-0.22125364392280844,-0.856524620941433,0.8007662835249042,0.8533684546777268,1.0,8/69,8.19%,SMAD6;FOXP1;FER;NOS3;LBP;PELI1;IFNAR1;GCH1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.34278568098501294,-0.8559273776426817,0.6437994722955145,0.853914710458753,1.0,2/12,1.07%,CACNA1C;CAV1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.31982589009010154,-0.8559273369597848,0.6699751861042184,0.8532643565284722,1.0,2/15,5.50%,CD55;HSPH1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.22868802662122842,0.8558230555056602,0.7986651835372637,0.9761420372551473,1.0,65/264,20.93%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;CDK13;SNRPB2;WBP11;SNUPN;DDX17;CELF4;SMU1;SRRT;DDX41;SLU7;NUDT21;CWC22;DBR1;MTREX;SNW1;CASC3;SNRNP48;CWC25;SRSF10;SYF2;CLNS1A;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SYMPK;SNRNP70;NONO;CWF19L2;SRSF9;SRRM2;CHERP;HNRNPL;SNRNP27;RBM5;SF3A3;DNAJC8;SRSF6;USP49;GEMIN8;CTNNBL1;RBM6;ZCRB1;POLR2L;DDX1;PRPF8;DHX15;TFIP11;RAVER2;DDX39B
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3330782427605792,-0.8558020699455707,0.653012048192771,0.8528425863128615,1.0,8/13,26.94%,SERTAD1;ARID1B;SMARCD1;ELOF1;CDCA4;SPI1;PADI2;CHEK1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.307943440803222,0.8556474910975539,0.6621621621621622,0.9758169896967481,1.0,7/30,15.14%,MICALL2;PINK1;SAE1;HTRA2;GSK3A;RNF31;CSNK2A2
prerank,protein lipidation (GO:0006497),0.2725784392877484,0.8555099098787732,0.6909871244635193,0.9754411379621067,1.0,21/59,26.95%,PIGV;GPLD1;PIGQ;WDR45B;PIGP;PIGA;PIGL;HHAT;ZDHHC2;ZDHHC6;WIPI2;ZDHHC9;ZDHHC8;ATG10;PIGN;ZDHHC17;WIPI1;MPPE1;SELENOK;PIK3C3;PIGB
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.2693773896295663,-0.8550194782219803,0.7037037037037037,0.8537953026274061,1.0,9/27,24.59%,MAP3K1;IRAK2;UBB;TAB2;IRAK4;UBC;LY96;UBA52;HSPD1
prerank,regulation of intracellular pH (GO:0051453),-0.251043310307414,-0.854656080507526,0.7369942196531792,0.8538608628728581,1.0,10/34,22.98%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;SLC4A8;SLC9A5;SLC26A6;SLC9B1;CFTR;SLC4A7
prerank,polyol biosynthetic process (GO:0046173),-0.3188047105121907,-0.8546507829349363,0.6691919191919192,0.8532255540038565,1.0,3/16,6.79%,ACER3;ITPKB;IP6K2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.37068506327123485,0.8545269014269088,0.6263157894736842,0.9768295897370373,1.0,4/12,15.49%,SEC63;SEC61B;HSPA5;GET3
prerank,regulation of histone modification (GO:0031056),-0.3260110496914396,-0.8545170704505123,0.6604215456674473,0.8528274115979663,1.0,5/13,18.38%,AKAP8;MTHFR;UBE2N;MYOCD;CDK9
prerank,regulation of TOR signaling (GO:0032006),-0.21954013278421497,-0.8540802193521775,0.8023255813953488,0.8530487372341098,1.0,17/67,18.83%,FNIP1;DEPTOR;RICTOR;PRKAA2;SH3BP4;UBR1;LAMTOR5;RRAGC;HDAC3;UBR2;TBC1D7;LAMTOR3;TBCK;SIRT1;PRKAA1;SEH1L;RRAGB
prerank,oligodendrocyte development (GO:0014003),0.3530786899499773,0.8538282795661656,0.6582064297800339,0.9776800006731713,1.0,4/15,13.25%,EIF2B1;PLP1;SOX10;MYRF
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3501539227574986,-0.8533443468612395,0.6591928251121076,0.853825912071464,1.0,1/11,4.74%,NFKBIZ
prerank,homocysteine metabolic process (GO:0050667),0.3842797226811646,0.8531806902542581,0.644927536231884,0.9784293552397159,1.0,4/11,17.26%,MTRR;BLMH;DPEP1;MMUT
prerank,adherens junction organization (GO:0034332),0.2847726365483202,0.8530523602744932,0.6647646219686163,0.9780438387214873,1.0,12/48,15.06%,CDH6;CADM2;JUP;DCHS1;CDH11;CDH15;CDH3;JAM3;CDH10;CADM3;NECTIN3;FERMT2
prerank,regulation of intracellular transport (GO:0032386),0.293219078162539,0.8526612310507994,0.6568047337278107,0.978173722473491,1.0,11/38,19.75%,NUP214;AAAS;LRRK2;NEFH;TTC21B;SCFD1;ATP9A;RINT1;CAPN10;WWC1;ATPSCKMT
prerank,rRNA catabolic process (GO:0016075),0.3435457613756365,0.8525370318337031,0.6531302876480541,0.9777770309023873,1.0,6/16,19.31%,EXOSC9;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,regulation of RNA metabolic process (GO:0051252),-0.2261743292649187,-0.85233076612908,0.7681660899653979,0.8552550947552816,1.0,17/59,18.16%,MBNL1;AHNAK;AHNAK2;NOVA2;HNRNPF;PCBP2;CELF1;RC3H1;PTBP3;MBNL2;FASTK;HNRNPH1;FUS;SRRM4;FAM50A;RASA1;PQBP1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.31740474491843185,0.8522807706518521,0.6574225122349103,0.977688080358562,1.0,6/24,15.08%,NR1H2;LRRK2;HERPUD1;OPA1;CREB3L1;CLU
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.22232061958664218,-0.8522484186842318,0.7490909090909091,0.854771327042693,1.0,14/64,22.30%,PLA2G4A;MGLL;ACOT8;CYP1B1;AIG1;GPX1;ACSL4;ACSL5;PTGS2;ALOX12;PNPLA3;PLA2G4C;FAAH;SLC27A2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.33913138189457454,-0.8520754725172188,0.6605922551252847,0.854485617317722,1.0,6/12,28.38%,SERINC3;PSAT1;CBS;SEPHS2;CTH;GGT1
prerank,chromosome condensation (GO:0030261),-0.2513571107799838,-0.8518594984065608,0.6838905775075987,0.8542743965042803,1.0,16/36,31.58%,PHF8;SMC2;TENT4A;PHF13;GPER1;AIFM1;CSNK2B;CHMP1A;NCAPH2;RB1;BANF1;SMC4;TTN;NCAPG2;DFFB;SET
prerank,organic hydroxy compound transport (GO:0015850),0.29827894508395186,0.85164409671924,0.6834094368340944,0.9783424447220295,1.0,3/36,3.56%,ABCC3;NR1H4;NCOA2
prerank,defense response to symbiont (GO:0140546),0.2562651887900158,0.8515661090479058,0.7342931937172775,0.9778540498541821,1.0,14/92,15.78%,MAP3K14;RTP4;CD40;IFIT2;TRIM56;TLR8;PDE12;IFNLR1;EIF2AK2;PYCARD;AGBL4;SERINC5;CNOT7;EXOSC5
prerank,regulation of epithelial cell migration (GO:0010632),0.27978796526736915,0.8512327848392826,0.6642958748221907,0.9778534144632676,1.0,6/51,7.61%,PTN;RHOJ;PTPRR;MCC;PTK2;GLIPR2
prerank,positive regulation of lyase activity (GO:0051349),0.3664405257345139,0.8507284428209607,0.6476868327402135,0.9782520162520704,1.0,3/14,6.51%,AKAP5;NF1;FXN
prerank,immunoglobulin mediated immune response (GO:0016064),0.38757444727568235,0.850700137894663,0.6321428571428571,0.9776505937897283,1.0,2/10,13.40%,TLR8;CD81
prerank,zinc ion homeostasis (GO:0055069),0.3093456304091518,0.8506233136545162,0.677115987460815,0.977158072505933,1.0,3/28,4.74%,SLC30A10;SLC30A5;SLC39A7
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.30766080120556455,0.8500894156150719,0.6832797427652733,0.9776041494400357,1.0,10/27,19.12%,CTNNA2;PTEN;DISC1;GSK3A;BRSK2;NTNG2;NTNG1;NCS1;IL1RAPL1;ULK4
prerank,regulation of regulated secretory pathway (GO:1903305),0.3010330069294495,0.8500486381871286,0.6810730253353204,0.9770427165499149,1.0,10/34,19.83%,LRRK2;RIMS2;SYT3;SYT7;RAB15;RIMS1;SYT5;SYT1;SYT6;RIMS4
prerank,response to nitric oxide (GO:0071731),-0.33175100080859576,-0.8500259242766496,0.6410256410256411,0.8572668315682407,1.0,1/13,0.50%,FOXO1
prerank,polyamine metabolic process (GO:0006595),0.3668936553728512,0.8498882245117703,0.6471663619744058,0.9767225436151216,1.0,3/13,14.15%,ODC1;HDAC10;DHPS
prerank,lysine metabolic process (GO:0006553),0.3637250666057025,0.8498277902731192,0.6643717728055077,0.9755430738825428,1.0,3/12,15.93%,SLC25A21;DLST;AASS
prerank,lysine catabolic process (GO:0006554),0.3637250666057025,0.8498277902731192,0.6643717728055077,0.9755430738825428,1.0,3/12,15.93%,SLC25A21;DLST;AASS
prerank,neural crest cell differentiation (GO:0014033),0.336261532251093,0.8496851008860324,0.6584967320261438,0.9751957236470854,1.0,3/18,9.29%,NRG1;HTR2B;TAPT1
prerank,fatty acid biosynthetic process (GO:0006633),0.26391148788227353,0.8493464505781428,0.6953020134228188,0.9752721237027536,1.0,18/63,22.46%,LIPC;LIPH;HSD17B8;DEGS1;ELOVL2;ACOT7;LIAS;ACLY;NDUFAB1;ELOVL6;ELOVL1;HACD3;ALOX5;ACSBG1;ABHD3;ACACA;SCD5;ELOVL5
prerank,protein O-linked glycosylation (GO:0006493),0.2495836426317265,0.8486480468229568,0.7204724409448819,0.9761027744478527,1.0,12/96,11.37%,GALNTL6;PLOD1;OGT;GALNT18;POMT1;RXYLT1;GALNT13;GALNT15;B3GNT8;GALNT10;POFUT2;FKTN
prerank,connective tissue development (GO:0061448),0.30176700774093135,0.8485936897279723,0.6412103746397695,0.9755661105406296,1.0,5/35,5.64%,SULF1;PGRMC2;SOX6;ZBTB16;CREB3L2
prerank,organelle assembly (GO:0070925),0.22070217397752856,0.8485475229496806,0.8234660925726588,0.9750113891584108,1.0,78/384,18.05%,DYNLL1;CDC14B;ATG9B;TRAF3IP1;CCDC61;DZIP1;NPHP3;WDPCP;WDR35;HAUS3;WDR45B;HAUS1;GBF1;LSM14A;RAB8A;CCDC57;ATP2A2;DISC1;CENPE;STARD9;LSM4;E2F4;CAPN3;IFT81;FAM161A;HAUS8;GOLGA2;BSCL2;HPS1;RB1CC1;SNAP29;ABCB6;CCDC65;AHI1;TCTN2;IFT74;RCC1;EXOC7;EXOC1;ASAP1;BBIP1;TMEM67;IQCB1;EDC3;TUBGCP4;IFT88;SSX2IP;HGS;RFX2;CEP126;CENPC;ACTR2;RAB11FIP3;CENPW;ATG9A;TXNDC15;EIF2S1;SCLT1;TSG101;EIF4ENIF1;ATG14;DYNLL2;SNF8;CEP250;TUBGCP6;PTPDC1;CENPF;ULK2;CLUAP1;IFT43;GOLGA8B;VPS4B;UBXN2B;WIPI2;PCM1;BBS1;CEP19;WDR90
prerank,microtubule bundle formation (GO:0001578),0.2881666724689613,0.847909089566493,0.6934984520123839,0.9756734468333613,1.0,6/42,11.86%,NCKAP5L;RSPH9;AAAS;MTCL1;CAPN6;GAS8
prerank,cellular response to amino acid stimulus (GO:0071230),0.3012978513848057,0.8475273473797716,0.6671532846715329,0.975827202136305,1.0,10/33,18.65%,CPEB1;MTOR;GLRA1;FYN;GLRA2;RRAGA;KLHL22;CASTOR1;CAPN2;RRAGD
prerank,keratan sulfate catabolic process (GO:0042340),0.37179813306236115,0.8475231500247474,0.6467576791808873,0.975183243189852,1.0,3/11,15.44%,LUM;GNS;HEXA
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.347882793469522,0.847116345083186,0.6558219178082192,0.9753792512537661,1.0,3/15,13.09%,TAF9B;ARMC10;PTTG1IP
prerank,regulation of cell death (GO:0010941),0.25120230783392056,0.8469709499779378,0.7078947368421052,0.9750048547506439,1.0,13/94,9.54%,LRP1;ACOX2;EPHB1;HTR2B;LRRK2;DHCR24;PDE12;DUS2;NPAS2;PRKD1;DCC;RAB29;BMP7
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.24535011922813166,-0.8468461288578798,0.7463126843657817,0.8628576391731387,1.0,11/40,20.10%,BCL2L1;ARL6IP5;UBB;VCP;MAPT;BAD;BAX;PRELID1;PRDX3;AKT1;PID1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.37316367288440955,0.8466775629463554,0.6462585034013606,0.9749494401372637,1.0,2/12,9.54%,GCNT2;BMP7
prerank,regulation of cell size (GO:0008361),0.3241504553267483,0.846034856652117,0.6661417322834645,0.9756824781100871,1.0,4/23,9.21%,PRR16;PTEN;MTPN;MTOR
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3120427911108083,0.8460029006280217,0.6750392464678179,0.9750979486229978,1.0,12/27,26.10%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,protein K63-linked deubiquitination (GO:0070536),0.30127551910687433,0.8452089530826746,0.6932907348242812,0.976090024671821,1.0,8/31,17.48%,STAMBPL1;USP33;ATXN3;YOD1;PSMD14;USP16;USP13;STAMBP
prerank,mucosal immune response (GO:0002385),0.34676963646637793,0.844755728380148,0.6487394957983194,0.9763819808242652,1.0,15/15,65.36%,IFNLR1;OTUD7B;PLA2G1B;DEFA6;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;RNASE3;RPL39
prerank,response to nutrient levels (GO:0031667),0.3463053263821036,0.8442367854636266,0.6626506024096386,0.9768104215643031,1.0,4/17,13.21%,CD68;RPS6KB1;MTOR;MEAK7
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.33459882075239006,-0.8439513383288131,0.6658767772511849,0.8677528444571853,1.0,5/12,22.90%,SMO;SIX1;AGT;SIX4;SOX8
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.358656023389881,0.843911515432923,0.6682847896440129,0.9768296963537075,1.0,4/14,15.09%,NMNAT3;AK4;AK8;AK3
prerank,defense response to protozoan (GO:0042832),-0.33722202417511693,-0.8436838583086943,0.683371298405467,0.86761994765479,1.0,4/12,11.63%,GBP7;GBP4;GBP2;GBP6
prerank,response to copper ion (GO:0046688),-0.2959931492118294,-0.843554109893136,0.6813725490196079,0.8672115029363232,1.0,15/20,38.38%,MT2A;ATP5F1D;MT3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;HSF1;ATP7B;AQP1;IL1A
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.34320639553750065,-0.8435385858999719,0.6735159817351598,0.8666018550710807,1.0,3/11,12.55%,TGFB2;SOX4;HEY2
prerank,phospholipid metabolic process (GO:0006644),-0.21632155831184477,-0.8432597748698004,0.7991967871485943,0.866481172742544,1.0,19/71,23.10%,PLPP3;MBOAT1;PLA2G4A;SMPD3;AGPAT4;TNFAIP8L3;ENPP2;PIP4P1;PGP;PLAAT3;SMPD1;CLN8;PLA2G4E;PNPLA3;PLA2G4C;AGPAT2;PIP5K1A;PLPPR1;FITM2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.31657949916056916,0.8427588625756648,0.6904761904761905,0.9785898609390156,1.0,3/27,4.17%,PPARA;ITGAV;NR1H2
prerank,cholesterol metabolic process (GO:0008203),0.2634091456374418,0.8418428828913027,0.7116154873164219,0.9798344264840977,1.0,13/68,16.75%,NPC1L1;CEL;PPARD;DHCR24;SOAT2;ACAT2;PLPP6;HMGCS1;ABCA5;ACLY;SCAP;LDLRAP1;IDI1
prerank,positive regulation of actin nucleation (GO:0051127),-0.3452135792528349,-0.8417495051995463,0.6581740976645435,0.8687770031489603,1.0,2/11,3.61%,WASF2;GSN
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.36070303614484667,0.8409013725244859,0.6372712146422629,0.9810814109359047,1.0,2/15,3.93%,NTRK2;NGFR
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.28825325396805695,0.8407812457748463,0.7010159651669086,0.980685649159035,1.0,7/38,12.87%,IL34;UNC119;DLG3;RELN;GRM5;DLG4;CASS4
prerank,detection of visible light (GO:0009584),0.34262921659184176,0.8403253946596563,0.656093489148581,0.9809755376288928,1.0,3/16,14.55%,GNA11;ABCA4;CEP250
prerank,regulation of Wnt signaling pathway (GO:0030111),0.2436302947015313,0.8402840171693166,0.7668789808917198,0.9804244181530426,1.0,13/108,9.00%,LRP1;SULF1;CDK14;SALL1;ITGA3;NKD1;MDFIC;LRRK2;DISC1;KREMEN1;SPIN1;NKD2;TLE1
prerank,regulation of protein processing (GO:0070613),-0.28620612536278467,-0.8400672046479711,0.7142857142857143,0.8713424704764312,1.0,5/21,15.14%,GAS1;RUNX1;CCBE1;TMEM59;SERPINE2
prerank,stress granule assembly (GO:0034063),-0.2864137947716791,-0.8394742733181613,0.6992840095465394,0.8718901319728463,1.0,5/20,15.36%,CSDE1;MAPT;UBAP2L;DYNC1H1;RPS23
prerank,autophagosome maturation (GO:0097352),-0.2539577861750656,-0.8390837028246884,0.7352941176470589,0.872015570176462,1.0,6/32,7.90%,UVRAG;GABARAP;EPG5;GABARAPL1;CALM1;VCP
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.30232725795034765,0.8388096863813086,0.6798780487804879,0.9828287556641395,1.0,1/29,0.63%,XCL1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.26118987172698144,0.8381896896395762,0.7267833109017496,0.9834762012551651,1.0,17/67,18.61%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;CALR;PSMD14;PSMA7;PSMD11;PSMA2
prerank,cellular response to reactive oxygen species (GO:0034614),0.26478046920979326,0.8381580821409399,0.6868965517241379,0.9828886503560359,1.0,9/59,11.83%,PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5;FXN;PLEKHA1;TRPM2;PDK2
prerank,protein autoubiquitination (GO:0051865),0.2620027514362445,0.8377573722283215,0.7195467422096318,0.9830390960813249,1.0,5/61,7.51%,SH3RF1;SH3RF3;RNF220;BFAR;TRIM37
prerank,protein glycosylation (GO:0006486),0.2404901627303373,0.8376054825194307,0.7696078431372549,0.9827120535963721,1.0,22/125,14.50%,PLOD1;ST8SIA1;OGT;GALNT18;RPN2;GCNT2;ENTPD5;DAD1;POMT1;ALG6;GFPT2;B3GNT8;MAN1C1;GOLGA2;GALNT10;ALG5;FKTN;TUSC3;TMEM258;B4GALT7;B3GALT5;PMM2
prerank,cellular calcium ion homeostasis (GO:0006874),0.23629956475927724,0.8373986405230068,0.7723378212974297,0.9824997771101823,1.0,16/133,9.26%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ADCY8;CALCA;HERPUD1;CALB1;ATP13A3;TRPC3;PRKACA;MICU3;HTR2C
prerank,regulation of neurogenesis (GO:0050767),0.26828335197123876,0.8367534668425539,0.7146932952924394,0.983171278934515,1.0,9/55,11.48%,REST;SERPINF1;SORL1;DOCK7;PER2;APPL2;WNT3;NAP1L1;SNW1
prerank,regulation of mast cell degranulation (GO:0043304),0.35136302087634275,0.8365183737416773,0.6563011456628478,0.983025876185423,1.0,4/14,16.66%,GAB2;FGR;LYN;LGALS9
prerank,negative regulation of histone modification (GO:0031057),0.34459404132260674,0.8357778406897897,0.6643835616438356,0.9838794190763713,1.0,4/14,18.80%,TWIST1;NOC2L;AASS;THAP7
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.34440391622542377,0.8357629468597035,0.6753022452504318,0.9832666573326625,1.0,7/13,28.55%,RPP40;NOL9;RRS1;UTP20;ABT1;RCL1;TBL3
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3129136590140196,-0.8356754782587072,0.6853658536585366,0.8777791717754051,1.0,5/15,16.65%,NUDT7;ACAT1;PMVK;ACACB;HMGCS2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.27508196715738253,0.8355801142066147,0.7262872628726287,0.9830230573801979,1.0,9/51,15.94%,EPB41L3;CNTNAP2;MAP4K4;LRRK2;BMP7;ATP7A;CTTN;SGK1;TNIK
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.23397760206727491,-0.8355738090795485,0.7553516819571865,0.8773289038586733,1.0,27/43,38.15%,FOXN3;INTS3;BRCC3;ATM;NBN;CDKN1A;PABIR1;DONSON;HUS1;ORC1;CHFR;FZR1;TAOK2;TRIM39;BRCA1;BRSK1;CHEK1;NOP53;UIMC1;DTL;BABAM2;MRE11;HUS1B;CDK1;PLK1;CDC6;TICRR
prerank,regulation of protein dephosphorylation (GO:0035304),0.28639585252822386,0.8355048190553409,0.7002967359050445,0.9825272715890996,1.0,9/37,17.22%,DLC1;PPP6R2;PTPA;HSP90B1;ANKLE2;SYMPK;TSC1;PPP6R3;PPP1R8
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.29401942500557143,-0.8349534447188234,0.6985645933014354,0.8778466371438194,1.0,4/18,10.22%,PSMD9;CCN3;KCNB1;SFRP1
prerank,endocytic recycling (GO:0032456),0.2747327400003882,0.8349012345945517,0.6864406779661016,0.9831156440824174,1.0,10/50,16.37%,CCDC22;MICALL2;EPS15;VPS39;VPS26C;ENTR1;RAB11FIP3;SNF8;SNX12;VPS52
prerank,regulation of protein transport (GO:0051223),0.306882914521597,0.834801053729371,0.6881028938906752,0.982693399193192,1.0,9/27,17.70%,DNAJC1;LLGL1;P3H1;NDFIP2;SCFD1;ARFIP1;SNX12;NDFIP1;STXBP5
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24956244967337307,0.8339755224068421,0.7398692810457517,0.9837717095232478,1.0,23/88,19.57%,FBXO9;PSMD1;FBXO31;DMAC2;PSMD10;PSMA5;PSMB5;AMN1;FBXO17;PSMC4;PSMA4;PSMC5;FBXW5;FBXL13;CUL5;PSMB9;PSMD14;PSMA7;PSMD11;PSMA2;CUL4A;FBXO4;FBXW4
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.34118234657603896,-0.8339117887944569,0.6793349168646081,0.8792057157439046,1.0,5/10,26.06%,CX3CR1;FZD3;CX3CL1;SMARCD3;KDM1A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.21989240401166074,0.8338343219971986,0.8490770901194354,0.9834149871619089,1.0,83/327,23.09%,RORA;CHD7;ZFHX3;MSC;ATF5;NCOA2;CXXC1;MYT1;TEAD2;REST;SOX6;ZNF423;FOXN2;ZFP37;HP1BP3;SPIN1;SPTY2D1;SOX2;EDF1;NSD1;DAXX;SRRT;BRCA2;NFXL1;TP53;TGFBR1;ESR2;SRSF10;TFEB;SAP30;IGF2;CARM1;NUP107;ZNF628;HDAC10;SSBP2;ARNT2;TGFBRAP1;MAFB;HNRNPD;UBE2V1;ATF2;WTIP;MLF1;NONO;ZKSCAN5;TRIP4;NR1D2;CALR;USP13;ZBTB11;LDB1;SKOR2;BMP2;MLF2;KAT7;HIF1A;THAP7;TERF2IP;NR2C2;WWC1;REXO4;SP1;DVL2;CNBP;TRAPPC2;GON4L;HCFC2;UTP4;CREBBP;APBB3;ZMIZ1;ASCC1;LIN54;DDIT3;ATRX;ABL1;NLK;SERTAD3;MLLT6;RREB1;NUP35;HOXB7
prerank,negative regulation of ATPase activity (GO:0032780),0.34809136176210875,0.8337970812605665,0.6701030927835051,0.9828403019692029,1.0,5/16,19.83%,VCPKMT;TP53;PAM16;TSC1;PXK
prerank,mitotic nuclear division (GO:0140014),0.2565138273194434,0.8334029606617028,0.7225981055480379,0.9829939878614861,1.0,24/71,24.66%,CCDC61;LSM14A;AAAS;SGO1;GOLGA2;CEP192;NSL1;NUSAP1;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;KLHL22;RHOA;KPNB1;SMC3;KIF11;PPP2R2D;KIFC1;TPX2;TOGARAM1;STAG1
prerank,ERAD pathway (GO:0036503),0.2506565108060086,0.8333287871836469,0.7303070761014686,0.982482735656884,1.0,22/83,17.02%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;RCN3;SEC61B;TMEM67;DNAJC10;USP19;HSP90B1;BAG6;HSPA5;ATXN3;BRSK2;YOD1;DNAJB14;UBXN6;USP13
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.26329569455420426,0.8332048576638696,0.728448275862069,0.9820957415029099,1.0,10/63,11.27%,SH3RF1;TCF7L2;PHIP;ITGAV;FGFR1;NOL3;G0S2;SP100;PYCARD;TGFBR1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2473550722081942,0.8330665642868427,0.7441253263707572,0.9817366984589814,1.0,18/91,15.28%,PLD1;ITGAV;VAMP2;LRRK2;RAB8A;RUFY1;RAB3C;RIMS2;MAP2K1;OPHN1;FGR;SYT7;SCFD1;RAB15;ATP9A;RINT1;SNX12;PACSIN3
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.25991196150334733,-0.8327408044658138,0.7351351351351352,0.8807255759253317,1.0,2/27,3.48%,CD200;SIRPA
prerank,regulation of protein secretion (GO:0050708),0.24117927784945958,0.8325759195406724,0.7756410256410257,0.9820792770911884,1.0,17/119,13.12%,RAPGEF4;PPID;CACNA1E;ITPR1;DNAJC1;LLGL1;IER3IP1;PER2;P3H1;PRKCA;KCNC2;GCK;SYT7;PPP3CB;EXOC1;IL12A;ARFIP1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.27602451147252965,-0.8323686966722325,0.7245989304812834,0.8807360144087304,1.0,2/23,6.86%,NMT2;CALM1
prerank,synaptic vesicle cycle (GO:0099504),0.3032798803998104,0.8320268544492555,0.678125,0.9825641764490285,1.0,7/30,17.06%,VAMP2;SYNDIG1;SYT7;RIMS1;DNAJC5;PCLO;CDK5
prerank,epithelial cell-cell adhesion (GO:0090136),0.36881402521579454,0.8320078690104215,0.643510054844607,0.9819698322635086,1.0,2/11,3.98%,ITGB5;JUP
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21426312812992707,0.8319920035847808,0.9031925849639547,0.9813677055969083,1.0,119/572,19.81%,IL33;ZEB1;TRPS1;ZFHX3;PPARA;MIER2;ETV5;NR1H4;HDAC1;PPID;TAF9B;NR2F2;TCF7L2;SALL1;THRA;PEX2;MEIS2;PER3;NFATC3;PPARD;NR1H2;LOXL2;TBX3;REST;NEDD4;ZBTB16;ZFP37;RTF1;SIRT6;GLIS1;PSMD10;BCOR;DUSP22;TENM2;BCL6;SRF;BRMS1L;BRMS1;ZBTB2;TRIM37;LYAR;TAF3;NR2C1;ZKSCAN3;MDM4;TWIST1;PER2;NOC2L;MXI1;SOX2;PHF6;SP100;GLI3;NSD1;ZFPM2;SOX10;N4BP2L2;TP53;ZNF25;SNW1;EPC1;ESR2;SOX9;MYT1L;NRIP1;NFIX;SAP30;DPF2;IGF2;PRDM5;KDM1B;CNOT1;ATN1;MED1;HDAC10;UBE2D1;PEG3;FOXM1;CUX2;BPTF;CHD8;ZBTB32;MED25;DMAP1;AR;MYC;ORC2;FGFR2;DCAF1;CRY2;AASS;ZBTB7A;KLF11;IMPACT;ZNF3;EFNA1;NR1D2;MBD2;CALR;DNMT3A;MAZ;SARS1;LDB2;LDB1;SKOR2;BMP2;SUV39H2;ZEB2;RIF1;CBFB;HEY1;THAP7;NR2C2;WWC1;EHMT2;MTA3;CDC73;FHL2;CNBP
prerank,negative regulation of autophagy (GO:0010507),0.27209040960259967,0.8317838364869782,0.727403156384505,0.9811379706205002,1.0,9/54,10.45%,EIF4G3;HTR2B;PTPN22;LRRK2;ZKSCAN3;GOLGA2;PINK1;MTOR;DAP
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.2952653074889258,0.8315169523457789,0.7103658536585366,0.9810281463803059,1.0,11/33,18.23%,HRG;RAC3;PTK2;JAM3;PLAU;TESC;LYN;FERMT3;EFNA1;PIK3CG;PDE3B
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2925075138220258,0.8313931956915209,0.685459940652819,0.9806310113626177,1.0,6/34,12.86%,EDN3;PHIP;CDC16;NUSAP1;ANAPC5;IGF2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2583680517738888,0.8312962686752354,0.7433155080213903,0.9802053799865835,1.0,17/70,18.61%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;CALR;PSMD14;PSMA7;PSMD11;PSMA2
prerank,positive regulation of cartilage development (GO:0061036),0.33722363683447776,0.8312154381010723,0.6826446280991736,0.9797444858970691,1.0,5/17,12.20%,LOXL2;SOX6;ZBTB16;TAPT1;SOX9
prerank,reverse cholesterol transport (GO:0043691),0.35504347901333366,0.8311633462165002,0.6866197183098591,0.9792103342604005,1.0,3/13,15.08%,LIPC;ABCA5;CLU
prerank,protein homooligomerization (GO:0051260),0.24068898112189777,0.8308311831651938,0.7669172932330827,0.9792088474757092,1.0,16/114,11.77%,SLC1A5;TRPA1;POLQ;MPP2;ADCY8;CLYBL;ASIC1;GOLGA2;APPL2;KCNC2;HCN1;GSDMD;GLRA3;VSTM5;PYCARD;TRPM2
prerank,response to leucine (GO:0043201),-0.35427598101881674,-0.8306505033726687,0.6912442396313364,0.882680647830246,1.0,3/10,11.74%,SESN1;UBR1;UBR2
prerank,cellular response to leucine (GO:0071233),-0.35427598101881674,-0.8306505033726687,0.6912442396313364,0.882680647830246,1.0,3/10,11.74%,SESN1;UBR1;UBR2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.31546390319007717,-0.8305040273582407,0.6650943396226415,0.8823093289378586,1.0,3/13,10.33%,ALG9;ALG12;MPDU1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3072906661037199,-0.8302964084418218,0.6871794871794872,0.8820634052243063,1.0,3/16,10.22%,IGF1R;INSR;CLEC16A
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.3377925989416058,0.8300686098664328,0.686084142394822,0.9801384242724205,1.0,5/18,20.96%,DDX19B;DDX19A;ENY2;IWS1;MCM3AP
prerank,somite development (GO:0061053),0.3678901281752626,0.8295799143433176,0.6732142857142858,0.9804708746125385,1.0,2/11,10.51%,LOXL3;PPP2R3A
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3754695497274769,0.829472079899766,0.6806569343065694,0.980044728718238,1.0,2/10,13.86%,KYNU;ATP7A
prerank,anterior/posterior pattern specification (GO:0009952),-0.22503968162535257,-0.8290151626976078,0.8135593220338984,0.8838739500905594,1.0,14/53,18.74%,BMPR2;SKI;WLS;TBX1;HOXC6;HEYL;HEY2;PCSK5;HHEX;ACVR2B;ATP6AP2;BHLHE40;HOXD3;HOXB6
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.3256381449424083,-0.8284865788000455,0.6741854636591479,0.884208662437031,1.0,8/13,34.95%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;GAL3ST3;B3GNT6;B4GAT1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.36065653547144194,0.8282847098023206,0.6721915285451197,0.9817930678641292,1.0,1/12,1.02%,PPARA
prerank,regulation of glycogen metabolic process (GO:0070873),-0.317647038353549,-0.8281693594530426,0.6658878504672897,0.8841119008007672,1.0,7/12,40.37%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3D;GCGR
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.29901236692862243,0.8276523237159347,0.728414442700157,0.9818540775806932,1.0,5/29,15.53%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.29901236692862243,0.8276523237159347,0.728414442700157,0.9818540775806932,1.0,5/29,15.53%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3133669867901737,0.8276467051165322,0.7013201320132013,0.9812297595644169,1.0,4/22,9.11%,PDE4B;FMR1;GNB5;CACNB4
prerank,positive regulation of neutrophil migration (GO:1902624),0.3326907820333192,0.827594665486565,0.6730434782608695,0.9806994401519523,1.0,1/18,0.63%,XCL1
prerank,actin filament network formation (GO:0051639),0.3642453465083545,0.8275268991208649,0.6609294320137694,0.9802110080807697,1.0,7/11,28.35%,CARMIL2;ACTN1;SPIRE1;PLS3;CARMIL1;LCP1;FHOD3
prerank,regulation of blood circulation (GO:1903522),0.29167919065869163,0.8274299370328532,0.7197640117994101,0.9797728439837288,1.0,3/34,8.16%,ECE1;KCNIP2;PER2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.33805674477611736,-0.8269939900634843,0.6812933025404158,0.8856879433591384,1.0,3/11,11.87%,NSUN2;NRDE2;NUP153
prerank,dendritic cell chemotaxis (GO:0002407),0.34949818757131,0.8269348742077228,0.691358024691358,0.980089514179962,1.0,5/14,25.86%,GPR183;TRPM2;PIK3CG;HMGB1;CCR5
prerank,global genome nucleotide-excision repair (GO:0070911),0.30702381048273736,0.8265660255654907,0.7006172839506173,0.980238457360716,1.0,9/26,20.71%,ERCC1;ERCC4;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1;USP45
prerank,sterol biosynthetic process (GO:0016126),0.2948076679154636,0.8264369340939812,0.7059748427672956,0.9798540415108428,1.0,7/33,12.24%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,centromere complex assembly (GO:0034508),0.2784525727264604,0.8262036035388011,0.7125193199381762,0.9796782976855158,1.0,7/36,15.90%,MIS18A;CENPU;CENPE;CENPC;CENPW;MIS18BP1;CENPF
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.1743025547037343,-0.8261085941449059,1.0,0.8866896816263904,1.0,105/336,25.79%,FOXO1;FOXP1;BCL2L1;XIAP;SAMHD1;VCPIP1;MCL1;ACER2;CBX3;PRKDC;UVRAG;KMT5B;APC;TRIP12;MAPK14;CASP2;FNIP2;VCP;INTS3;RNF8;NRDE2;TLK2;CRIP1;UBA6;BTG2;DYRK2;PAXX;UBE2A;BAX;RBBP8;INO80;RECQL5;CBX1;ZDHHC16;ATR;RTEL1;BID;OTUB1;HERC2;WDHD1;ETAA1;RNF169;BOK;ATM;POLE2;GNL1;NBN;CCND1;RAD51D;LIG1;NSMCE4A;PLK5;CDKN2AIP;RAD51C;GRB2;CDKN1A;DDX11;ENDOV;SIRT1;PARP4;NSMCE3;TRRAP;EPHA2;OARD1;HUS1;APTX;MUS81;OGG1;APBB1;XRCC2;NPM1;GTF2H4;CHD1L;CIB1;USP3;MACROD1;E2F1;MCM9;WDR48;RFWD3;FANCG;MGMT;TAOK2;BATF;ZRANB3;PHF1;IKBKG;MCM8;SUMO1;IKBKE;PARP2;BCL2L11;PARP1;RMI2;NCOA6;ATRIP;RAD51;DTX3L;TIGAR;CHEK2;BRCA1;HINFP;PCLAF;KMT5C;BRSK1
prerank,long-chain fatty acid import into cell (GO:0044539),0.3770587567817824,0.8255128397447663,0.6961805555555556,0.9804440457970043,1.0,2/10,7.69%,SPX;RPS6KB1
prerank,"phototransduction, visible light (GO:0007603)",0.347082114457179,0.8253955604061373,0.6916524701873935,0.9800445027144206,1.0,2/14,12.26%,GNA11;ABCA4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.26975776619903247,-0.8252191115148796,0.7361809045226131,0.8876826792078721,1.0,9/24,22.07%,BCL2L1;ACKR3;CD44;TPT1;SIRT1;CD74;SNAI1;MIF;CCAR2
prerank,regulation of chromatin organization (GO:1902275),-0.3106810288741815,-0.8246907626105305,0.712468193384224,0.8880178693301305,1.0,3/14,8.35%,MLLT3;TLK1;TLK2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.23549580319267055,0.8243796129576296,0.7835550181378477,0.9813874501877163,1.0,18/121,14.16%,IL34;GHR;UNC119;CD40;ERBB4;TSLP;DLG3;DGKQ;IL5;RELN;GRM5;TP53;DLG4;IL12A;IGF2;CASS4;CD81;LYN
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3139502483779611,0.8243148517978528,0.6848673946957878,0.9808766957551487,1.0,6/24,12.86%,ENPP1;IRS1;IRS2;GCK;GSK3A;IGF2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.35127209328789066,-0.8242058898929816,0.7023809523809523,0.8882628823601714,1.0,3/10,11.88%,VTN;GRB10;ITGB3
prerank,regulation of endocytic recycling (GO:2001135),-0.3349164070179728,-0.8241712845295289,0.7129411764705882,0.8876684076424036,1.0,2/11,4.89%,ACTN2;INPP5F
prerank,mitochondrial fission (GO:0000266),0.33781267165339635,0.8240989211001346,0.6790923824959482,0.9806722566671506,1.0,6/16,22.95%,MTFR2;OPA1;DNM1;MTFP1;GDAP1;FIS1
prerank,cellular copper ion homeostasis (GO:0006878),0.3515995746414806,0.8239409204093022,0.6797853309481217,0.9803666298580036,1.0,3/14,13.86%,CCDC22;ABCB6;ATP7A
prerank,striated muscle cell differentiation (GO:0051146),0.3446120147586492,0.8238960321711061,0.6621160409556314,0.9798339791195757,1.0,2/16,3.66%,NRG1;MYEF2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.24257716424014797,-0.8236597387871609,0.775,0.8879621619770443,1.0,14/39,25.67%,ARID2;PRKDC;KMT5B;SHLD2;PARP9;FUS;SMCHD1;DDX11;SETMAR;WDR48;MGMT;PARP1;DTX3L;KMT5C
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.3774831515617926,0.8233230101351047,0.6771799628942486,0.9803303159223374,1.0,6/11,28.15%,JAK1;IL12A;CANX;STAT1;JAK2;STAT3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.32911841253785146,-0.8232609483335023,0.7101769911504425,0.8880575353505359,1.0,5/11,42.88%,SIRT1;TAF7;CIITA;PF4;IL4
prerank,anterior/posterior axis specification (GO:0009948),-0.3129754882195538,-0.8226259028496915,0.7,0.8885745647417788,1.0,2/15,6.82%,SKI;WLS
prerank,regulation of protein catabolic process (GO:0042176),-0.19639350424056193,-0.8222038208889314,0.9159663865546218,0.8886693466944223,1.0,26/99,22.29%,FOXO1;WWP1;EGFR;WWP2;GPC3;APC;GSK3B;VCP;AZIN1;SMURF2;EEF1A1;ASB5;RNF41;APC2;FLNA;FURIN;OAZ1;CYP51A1;OAZ2;TMEM9;SNX3;WDR91;FZR1;VPS28;NDUFA13;TNFAIP3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3224434511521923,0.8217006378190859,0.7147487844408428,0.9829104153331456,1.0,2/21,1.54%,SPRY4;SPRY1
prerank,negative regulation of macroautophagy (GO:0016242),-0.26053281494774205,-0.8217003185279531,0.7361477572559367,0.8889416586238165,1.0,15/26,33.29%,MTM1;FEZ2;NRBP2;CLEC16A;TMEM39A;AKT1;CHMP4B;CHMP4A;NUPR1;SMG1;QSOX1;FEZ1;LZTS1;PIK3CA;PHF23
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.23878415211779094,-0.8216431006558808,0.7608695652173914,0.888415095987122,1.0,6/38,10.80%,CACNA1C;CAV1;CAMK2D;ANK2;KCNJ2;KCNQ1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.258667382458182,-0.8215919757806632,0.7457142857142857,0.8878523845824795,1.0,9/28,25.67%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;NUDT16L1;DTX3L;KMT5C
prerank,protein alkylation (GO:0008213),0.3059487173327621,0.8212144927310626,0.7053872053872053,0.9832867571777092,1.0,9/22,28.70%,PRMT3;VCPKMT;FAM98B;PRMT2;CAMKMT;ETF1;PCMT1;FAM98A;METTL22
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3158840597448226,-0.8206802391288287,0.6740088105726872,0.8888392083532971,1.0,6/13,25.29%,RPS15;NOP9;RAN;NPM1;LTV1;LSG1
prerank,iron-sulfur cluster assembly (GO:0016226),0.30557217840715994,0.8201321109890969,0.6786271450858035,0.9847593614437563,1.0,6/24,16.86%,NUBP2;FXN;ABCB7;CIAO1;MMS19;ISCA1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2342649703746521,-0.8199282869893123,0.8246753246753247,0.8895638077786111,1.0,11/42,20.29%,LBP;RPS19;DROSHA;SERPINE1;OPTN;RPL30;RNASE7;MPEG1;HMGB2;CHGA;ROMO1
prerank,maturation of 5.8S rRNA (GO:0000460),0.3250491432637935,0.8188745546758917,0.6715686274509803,0.9865332769947612,1.0,4/17,15.52%,C1D;NOL9;MTREX;EXOSC10
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.2817940285629172,0.8188250238259962,0.7047756874095513,0.9860020856511172,1.0,9/42,16.78%,CECR2;HDAC1;CHD4;MBD3;SPTY2D1;SMARCA1;CHD8;DMAP1;MBD2
prerank,positive regulation of JNK cascade (GO:0046330),0.25468441129632374,0.818341301538453,0.7648612945838837,0.9862862841731036,1.0,4/70,1.99%,SH3RF1;EDA2R;TRAF4;SH3RF3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.370907082269864,0.8183348358085923,0.6782449725776966,0.9856701018416316,1.0,2/10,8.09%,HRG;JAM3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.247799995569556,0.8183263329651493,0.7945736434108527,0.9850586000075039,1.0,20/84,18.61%,BUB1B;PSMD1;FBXO5;FBXO31;CDC16;PSMD10;CDC20B;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;ANAPC5;PSMB9;UBE2D1;PSMD14;PSMA7;CDC26;PSMD11;PSMA2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.32316839187483987,0.8181780907030393,0.7021996615905245,0.9847512104175449,1.0,5/19,16.66%,NR1H4;TLR4;IRAK1;TIRAP;LGALS9
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.24764916602745982,0.8181649578816137,0.7506666666666667,0.9841499655861397,1.0,21/78,19.82%,PRICKLE1;LRRK2;RNF180;SIRT6;PSMD10;HERPUD1;CBFA2T3;CDC20B;NKD2;ZYG11B;HECTD1;GSK3A;DDA1;CLU;DET1;CSNK1E;RNF19B;RNF217;DDRGK1;RNF144A;SUMO2
prerank,mesenchymal cell development (GO:0014031),-0.2904190047077496,-0.8176606971837294,0.751269035532995,0.8930396629957175,1.0,6/18,13.17%,FOXC1;NOTCH1;TCOF1;HEYL;HEY2;NOLC1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2746682077903697,0.8175317731646267,0.7280575539568346,0.984811877056305,1.0,8/43,15.46%,ZFYVE28;SPRY1;CBLB;EPS15;SH3KBP1;HGS;TSG101;AREG
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.3212999134722654,-0.8172821700859249,0.7051886792452831,0.8931315856639803,1.0,7/13,33.25%,RUNX1;ZBTB7B;TGFBR2;PNP;NCKAP1L;SOCS1;NKAP
prerank,ventricular septum development (GO:0003281),0.28381747101431637,0.817184541732255,0.7195845697329377,0.9848707622840585,1.0,8/37,15.41%,ROBO2;SALL1;MDM4;ZFPM2;TGFBR1;HECTD1;DAND5;GJA5
prerank,positive regulation of developmental growth (GO:0048639),0.27143919897045166,0.8170711873345698,0.7492753623188406,0.9844732208473205,1.0,8/49,13.35%,GHR;CDKL5;LIMK1;RIMS2;SYT3;PLAA;RIMS1;UNC13A
prerank,positive regulation of mitochondrial fission (GO:0090141),0.32889795361740914,0.8169662036617422,0.7033158813263525,0.9840462216018342,1.0,1/18,0.40%,DCN
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.28835078682844256,-0.816832051009463,0.7253886010362695,0.8933175853986014,1.0,1/18,0.43%,PLCB1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.28154332241869406,0.8167443195568148,0.7469512195121951,0.9838482041125031,1.0,10/36,18.13%,WNT5A;TCF7L2;AGO4;PPP3CB;AGO3;GNAO1;GNG2;TNRC6B;AGO1;CAMK2A
prerank,negative regulation of organelle assembly (GO:1902116),0.2818323483903499,0.8166953847253858,0.723338485316847,0.9833235049623963,1.0,6/35,11.01%,MDM1;LRRK2;TRIM37;PINK1;KAT2A;SCFD1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.24648996390115951,0.8163912325534408,0.7772020725388601,0.9832984163687409,1.0,23/88,19.51%,EIF4A3;NANOS3;EPRS1;DNAJC1;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;CNOT1;MALSU1;BAG6;EIF4ENIF1;PUS7;CNOT7;TSC1;CALR;IGF2BP3;CDK5;ILF3;EIF2AK3;PLAT;FXR1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.316802592716062,0.8156013100823062,0.7133220910623946,0.9841676905448147,1.0,7/20,17.43%,AGO4;AGO3;CNOT1;WTIP;TNRC6B;CNOT7;AGO1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3532816843948198,0.8153531183246999,0.6924398625429553,0.984038676791366,1.0,4/13,15.02%,GRIN2A;LGMN;ASPH;BAK1
prerank,maintenance of protein location in nucleus (GO:0051457),0.31363831085499666,0.8149190272125654,0.700626959247649,0.984262464535881,1.0,7/20,21.10%,SUN2;TAF3;SP100;SYNE1;TAF8;SUPT7L;BBS4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.22623725629718955,0.8148260810118533,0.8376168224299065,0.983821460020396,1.0,21/163,11.51%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;PDPK1;ICOSLG;PIK3R2;CD276;PTPN22;EIF2B1;PSMD10;PSMA5;PSMB5;PLEKHA1;TNFRSF21;PRKCB;PSMC4;PSMA4;FYN;PSMC5
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.33425013491515293,0.8147885070800044,0.7178130511463845,0.9832755724074482,1.0,4/16,10.93%,HNRNPA2B1;ERCC4;TERF1;DHX36
prerank,icosanoid metabolic process (GO:0006690),-0.23594516842843533,-0.8147028078557288,0.7836065573770492,0.896400219433265,1.0,5/40,5.06%,PTGS1;PLA2G4A;MGLL;CYP1B1;PON3
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3319980366086285,0.814486766878966,0.7075630252100841,0.9832500568720368,1.0,3/16,12.20%,ACADL;APPL2;SOX9
prerank,myofibril assembly (GO:0030239),0.2771769717827893,0.8142517808216712,0.7489114658925979,0.9830790204322317,1.0,1/42,0.15%,PDGFRA
prerank,negative regulation of telomere maintenance (GO:0032205),0.3339066077428483,0.8141967245352804,0.7049742710120068,0.982561625472447,1.0,3/15,7.85%,ERCC1;ERCC4;TERF1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3214339686204958,0.8137905837007184,0.7170418006430869,0.9827441990959351,1.0,2/18,4.99%,FBXO5;CDC7
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.22894843644780685,-0.8137844665160358,0.8184818481848185,0.897374674728234,1.0,11/46,20.56%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;DGKZ;DDHD1;DDHD2;PNPLA3;AGPAT2
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3064679600008972,0.8136949365918369,0.685099846390169,0.9823058054221637,1.0,4/24,9.24%,CXCL10;DUSP1;PLA2G7;LGMN
prerank,metal ion transport (GO:0030001),0.24167631214883273,0.8133934310239709,0.7791327913279132,0.9822903266839433,1.0,19/86,20.19%,CALCRL;CACNA1E;ITPR1;CACNG3;RYR2;SLC30A5;TRPC3;NDFIP2;FYN;TRPM2;TUSC3;RYR3;CACNA2D1;NDFIP1;GRIN3A;CAMK2A;ATP2C1;TRPC1;NIPA2
prerank,positive regulation of cell cycle (GO:0045787),-0.21696570963228073,-0.813305599979136,0.8040816326530612,0.8975840260874076,1.0,17/62,22.48%,EGFR;CCNYL1;APP;CCND2;TGFB2;LRP6;RPS15A;CITED2;CCND1;TAL1;ANKRD17;PKN2;EIF4EBP1;AKT1;RGCC;ASNS;NUPR1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.30904545538725214,-0.8132892089890651,0.7375,0.8969574835572462,1.0,11/14,50.98%,TYROBP;CSF1;POU4F1;CCR1;OCSTAMP;IL23A;TNF;TNFSF11;TRAF6;IL12B;IL23R
prerank,mitochondrial genome maintenance (GO:0000002),0.3558722262283465,0.8131072850332585,0.6795774647887324,0.9821885784346316,1.0,4/11,14.18%,OPA1;SLC25A33;TOP3A;LONP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3057542143588759,0.8130342918240651,0.7192691029900332,0.9817178501965407,1.0,8/22,20.66%,RPP40;NOL9;EXOSC9;RRS1;EXOSC10;EXOSC8;URB1;UTP20
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.33965531761072215,-0.812968360387473,0.6890951276102089,0.8962735096908339,1.0,4/11,19.75%,CCT3;CCT4;CCT7;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.33965531761072215,-0.812968360387473,0.6890951276102089,0.8962735096908339,1.0,4/11,19.75%,CCT3;CCT4;CCT7;MEPCE
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.280664020732386,0.8127374164135058,0.7421758569299552,0.981683555883387,1.0,5/39,7.45%,PIK3R1;PIP4K2A;PIK3R2;EFR3A;PI4KA
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.2940154261175091,0.812387734047043,0.7484375,0.9817480488887779,1.0,5/27,11.15%,UTRN;SCN2B;COMMD1;FXYD4;FGF12
prerank,regulation of sequestering of triglyceride (GO:0010889),0.33492774803936404,0.8123725398048587,0.7001675041876047,0.9811699268225237,1.0,3/15,13.27%,PPARA;CIDEA;PLIN2
prerank,neuron projection extension (GO:1990138),0.29095163204278685,0.8122282991863304,0.7405731523378583,0.9808648305264983,1.0,9/32,17.06%,AUTS2;SEMA5A;TMEM108;CDKL3;PPP3CB;IMPACT;ULK2;CYFIP1;CDK5
prerank,vesicle transport along actin filament (GO:0030050),0.31861649787779384,0.8119631862114715,0.7092436974789916,0.9807884447459729,1.0,4/19,11.79%,MYO7A;MYO1B;MYO6;MYO1G
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.2790479991492744,-0.811346974555949,0.7439353099730458,0.898481762211319,1.0,11/19,30.35%,AMPD3;TERT;DCK;GMPR2;APRT;TYMS;CDA;POLD2;PNP;POLD1;ADA
prerank,regulation of DNA recombination (GO:0000018),0.2876616252761862,0.8112918170811656,0.7328125,0.9814443242011054,1.0,10/32,22.11%,MSH3;SIRT6;ZCWPW1;SPIDR;KPNA1;FIGNL1;MSH6;TERF2IP;PPP4R2;KPNA2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23127291776139158,-0.810834590965816,0.8074712643678161,0.8987475279256574,1.0,18/40,28.69%,THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;DONSON;ALYREF;SETMAR;CDK9;MCM9;RFWD3;ZRANB3;RAD51;CENPX;GEN1;POLD1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2880002670246621,0.8107069833086972,0.7339593114241002,0.981934778097088,1.0,6/30,10.84%,NAT10;ERCC4;TERF1;PIF1;TENT4B;TP53
prerank,protein neddylation (GO:0045116),-0.31067800939454027,-0.8106684740823141,0.6976190476190476,0.8983559593456025,1.0,3/13,16.67%,UBE2F;DCUN1D3;NEDD8
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.32696755313384746,-0.8096376278778591,0.6910377358490566,0.8995673887490195,1.0,5/12,36.56%,FDX1;FDXR;STAR;TSPO;FDX2
prerank,regulation of primary metabolic process (GO:0080090),0.23138027695424063,0.8096239755837761,0.8059332509270705,0.9833897945929142,1.0,27/126,16.89%,PPARA;ODC1;NCOA2;PSMD1;PPARD;C1QTNF2;SC5D;IRS2;PSMD10;CHD9;PSMA5;PSMB5;NCOA1;EDF1;PSMC4;PSMA4;PSMC5;HMGCS1;CARM1;PSMB9;SREBF1;MED1;ELOVL6;NR1D2;IDI1;PSMD14;PSMA7
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.3210714218270615,-0.8095220721736008,0.696551724137931,0.8990858947901161,1.0,3/12,16.19%,ELAVL1;TERT;ESR1
prerank,acylglycerol biosynthetic process (GO:0046463),0.303373343926874,0.8087695275125323,0.7376,0.9843721838596757,1.0,5/23,15.36%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3048406597134472,0.8087407356896588,0.7077922077922078,0.9838080469938562,1.0,5/23,12.43%,SEC16A;SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,BMP signaling pathway (GO:0030509),0.2600101335446354,0.8087032341413095,0.741307371349096,0.983262067731604,1.0,4/62,2.75%,RUNX2;RGMB;RGMA;SMAD5
prerank,negative regulation of cell cycle process (GO:0010948),-0.21291399645239592,-0.808534268658295,0.8687258687258688,0.9001562835562974,1.0,24/61,29.56%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;GPER1;RBBP7;PPP1R10;E2F1;TOM1L2;PCGF2;CHMP4C;APAF1;RNF2;RAD51;BRCA1;CHMP2A;CHEK1;BMI1;E2F7;YAF2
prerank,secondary alcohol metabolic process (GO:1902652),-0.22980689918175343,-0.8082989482963062,0.821656050955414,0.8998821501848899,1.0,15/42,30.27%,FDX1;RXRA;APOE;PIP4P1;SOAT1;CLN8;OSBPL1A;IDH3B;IDH3A;EBP;TSKU;CLN6;CH25H;NSDHL;IDH2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.28461611121753994,0.8081674510690803,0.7446483180428135,0.9837062556095554,1.0,4/33,9.04%,PTEN;SUSD2;GLI1;APPL2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2536572677909259,0.8081312167069278,0.7677053824362606,0.983164831188433,1.0,13/62,13.09%,LRRK2;CDKN2D;NOL3;HERPUD1;NOC2L;PINK1;ARMC10;OPA1;RTKN2;BCL2L2;CREB3L1;HTRA2;PTTG1IP
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.36212158343470136,0.8079981563539986,0.6802973977695167,0.9827917834493948,1.0,2/11,12.28%,TIMM10;AGK
prerank,glial cell development (GO:0021782),0.2952847435350352,0.8078720148469684,0.7366771159874608,0.9824175657848309,1.0,5/25,13.25%,MXRA8;EIF2B1;NF1;SOX10;MYRF
prerank,regulation of DNA replication (GO:0006275),-0.2235038799432417,-0.8075684409607735,0.850609756097561,0.9005063350349324,1.0,10/49,12.44%,EGFR;S100A11;PPP2R1A;GLI2;ACVRL1;ESCO1;CCDC88A;ATR;STN1;PCNA
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3111701151756959,0.8074125770257066,0.7199341021416804,0.9826751889914375,1.0,6/22,17.80%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,response to alcohol (GO:0097305),0.2992106351753645,0.8069770918137078,0.7039370078740157,0.9829151016365447,1.0,6/27,18.07%,GRIN2B;GRIN2A;GLRA1;TGFBR1;ABCA2;GRIN3A
prerank,hexose biosynthetic process (GO:0019319),0.26927910600399313,0.806796655651728,0.735632183908046,0.9826479595357527,1.0,8/42,15.47%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3;SLC39A14;AKR1B1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.31670699627615273,0.8067027146516849,0.7040816326530612,0.9822242749254243,1.0,2/18,8.32%,XCL1;NAV3
prerank,Golgi to endosome transport (GO:0006895),-0.2964302841190345,-0.8064628433244782,0.72,0.9018777852871375,1.0,5/16,13.38%,DOP1B;AP2A1;KLHL20;MON2;VPS13A
prerank,copper ion homeostasis (GO:0055070),0.3242223277031095,0.8060273623535111,0.7171717171717171,0.9828638272763195,1.0,4/17,13.86%,CCDC22;COMMD1;ABCB6;ATP7A
prerank,histone H2A monoubiquitination (GO:0035518),0.32149151803781617,0.8058411775494052,0.7058823529411765,0.9826123918446256,1.0,3/17,9.16%,BCOR;TRIM37;RNF168
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.27994727054389534,0.805834943601035,0.7492447129909365,0.982016677139169,1.0,10/39,18.47%,ZFYVE28;SPRY1;EPS15;LGMN;SH3KBP1;HGS;TSG101;AREG;PTPN18;SPRY2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.35492921362702096,0.8055486856485665,0.6896551724137931,0.9819225603645525,1.0,2/11,7.85%,CCT5;TERF1
prerank,vesicle transport along microtubule (GO:0047496),-0.271829406602014,-0.8052536956194758,0.7533875338753387,0.9033182000826934,1.0,7/23,20.11%,NDEL1;DYNC1H1;TRAK2;DYNC1I1;RAB1A;KIF1C;BICDL1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.34135932833236265,-0.8052230196151501,0.6868008948545862,0.902718215067855,1.0,6/10,41.22%,TNFRSF1B;AGER;CCR2;TRPM4;ZBTB1;WAS
prerank,prostanoid metabolic process (GO:0006692),0.34568364642625904,0.8051711644131392,0.7111853088480802,0.9820271578777233,1.0,3/13,12.42%,PTGES;PLAA;PTGR2
prerank,ncRNA 3'-end processing (GO:0043628),0.34060034806081946,0.8046908663119782,0.7074829931972789,0.9823063068969967,1.0,3/14,16.04%,INTS8;INTS14;PTCD1
prerank,aminoglycan biosynthetic process (GO:0006023),0.26541840927448657,0.8045984020286678,0.7544581618655692,0.9818814160515755,1.0,12/49,15.44%,HSPG2;GPC4;GCNT2;GPC5;B3GNT8;HS6ST2;B4GALT7;B3GALT5;HS3ST6;HS3ST5;SDC2;HEXA
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3149808911344517,0.8045759589593461,0.7206132879045997,0.9807190337377488,1.0,8/20,25.19%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;HIBADH;BCKDK;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3149808911344517,0.8045759589593461,0.7206132879045997,0.9807190337377488,1.0,8/20,25.19%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;HIBADH;BCKDK;HIBCH
prerank,mRNA metabolic process (GO:0016071),0.2382293260660107,0.8045138282237368,0.8022959183673469,0.980219835722205,1.0,20/90,17.83%,AGO4;GEMIN2;ZC3H12D;ZFP36L2;LSM11;PCBP3;HNRNPA2B1;SRSF11;PRKACA;NUDT21;TP53;AGO3;PRPF18;DIS3L2;SLBP;SNRPF;NONO;SRSF9;SF3A3;DXO
prerank,skeletal muscle contraction (GO:0003009),-0.2858768653094517,-0.8040556191128762,0.726775956284153,0.904011590842869,1.0,14/19,53.91%,STAC;TNNT3;TNNI1;STAC2;TNNI3;TNNC1;CCDC78;TCAP;TNNI2;MYH14;TNNC2;JSRP1;TNNT1;CHRNA1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.24928692671954963,-0.8038094001503238,0.7961956521739131,0.9037721441800477,1.0,7/29,16.19%,KANK2;RUNX1;VPS18;WBP2;KCTD6;VPS11;ESR1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.19582400279538031,-0.8037582843809472,0.9400921658986175,0.9031996595066437,1.0,24/104,21.52%,SLC8A3;ACTB;TRIB2;CCND2;UVRAG;CALM1;CCNG1;LRP6;PPEF2;CAB39;RALB;MAP2K2;ETAA1;CCND1;CDKN1A;EZH2;SIRT1;SERTAD1;CCNE2;AKT1;ADRB2;CIB1;DUSP19;CSF1R
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.23856010205118394,-0.8028032655780148,0.8298507462686567,0.9041461434772813,1.0,12/37,25.57%,NFKB1;RIN3;APOE;OPTN;ITGB3;EDN1;SIRT5;SDCBP;MTMR2;ANKRD13D;MT3;BRCA1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.27271727916406485,0.8026706346623841,0.7477611940298508,0.9830817432511559,1.0,9/39,17.12%,UTRN;ANK3;SCN2B;NEDD4;FXYD4;FGF12;WNK2;FGF14;HECW1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2673256265976404,-0.8025314721410306,0.7835616438356164,0.9039371405065391,1.0,9/22,24.55%,GTF2H5;UBB;UBC;RAD23B;GTF2H4;CHD1L;UBA52;CETN2;PARP1
prerank,regulation of autophagosome assembly (GO:2000785),0.28244328809843516,0.8024234376301091,0.7527047913446677,0.9829405580252892,1.0,6/33,11.88%,PIP4K2A;NPRL2;LRRK2;PINK1;SCFD1;IFT88
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.30000455211418864,-0.8020522800945943,0.7418546365914787,0.9041043393862842,1.0,5/15,22.90%,SMO;SIX1;AGT;SIX4;SOX8
prerank,autophagosome assembly (GO:0000045),-0.21640066083181328,-0.80162876135101,0.8835820895522388,0.9041575504346864,1.0,23/52,30.86%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;ATG12;RAB1A;ATG2A;MAP1LC3A;AMBRA1;RAB1B;ATG101;MAP1LC3B;WDR45;SMURF1;EMC6;ATG16L1;RAB19;IRGM;UBXN2A;NSFL1C
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2954596833619641,0.8013752920335196,0.7445482866043613,0.9843186085838435,1.0,6/26,15.04%,POR;HTR2B;CDH3;S100A1;ATP7A;GDNF
prerank,regulation of presynapse organization (GO:0099174),0.32450328302473985,0.8011684223815484,0.706645056726094,0.9835054849808805,1.0,5/18,17.65%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of presynapse assembly (GO:1905606),0.32450328302473985,0.8011684223815484,0.706645056726094,0.9835054849808805,1.0,5/18,17.65%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2675406441788501,-0.8010400514223166,0.7626666666666667,0.9045305343597957,1.0,7/25,15.64%,SLIT2;KANK1;CAPZB;TBC1D7;EVI5L;ARHGAP44;PRKCD
prerank,regulation of sensory perception of pain (GO:0051930),-0.3342152635940761,-0.8008894804048234,0.7392290249433107,0.9041422348929987,1.0,2/11,4.82%,MGLL;CCN3
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.35356845630611256,0.8002278507346954,0.6985018726591761,0.9846780225545142,1.0,2/11,7.43%,NOVA1;PCBP3
prerank,Rac protein signal transduction (GO:0016601),0.3182059431292166,0.8001461357591937,0.7240204429301533,0.9842225877765546,1.0,7/18,25.15%,ELMO1;HACE1;CYFIP1;HACD3;RHOG;ABI2;FARP2
prerank,nuclear envelope organization (GO:0006998),-0.2733174175559344,-0.8001166072038409,0.7670886075949367,0.9047865718756689,1.0,7/20,26.85%,LEMD3;REEP3;TOR1A;TMEM170A;TOR1AIP1;EMD;REEP4
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3682525734371078,0.8000059981933247,0.7165775401069518,0.9838970878157606,1.0,10/10,63.20%,SAG;PDE6A;CNGA1;GRK1;GNB1;GNAT1;CNGB1;RHO;PDE6B;PDE6G
prerank,positive regulation of interleukin-12 production (GO:0032735),0.28941934100321515,0.7999262199088226,0.7358778625954199,0.9834201537770333,1.0,6/31,16.66%,CD40;IL16;TLR4;TIRAP;MAPK11;LGALS9
prerank,negative regulation of cellular component organization (GO:0051129),0.2469085076637524,0.7993993198045277,0.7952127659574468,0.9837845343858742,1.0,13/74,16.17%,NR1H4;FAP;TRAF3IP1;CARMIL2;SORL1;PRKD1;EPHA3;IAPP;HSPA5;CLU;PACSIN3;AR;IMPACT
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.33400173171022657,0.7991112643721887,0.7165492957746479,0.9837235380580449,1.0,4/15,12.43%,SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,organelle disassembly (GO:1903008),0.28167844545392473,0.7985347339014223,0.7312977099236642,0.9841456613487517,1.0,10/33,19.33%,GBF1;GOLGA2;RB1CC1;TEX264;KIF9;GFM2;VRK1;ULK2;MTIF2;DDRGK1
prerank,microtubule nucleation (GO:0007020),0.31234218794226765,0.7983462576364568,0.7325581395348837,0.9838784671016216,1.0,6/19,15.99%,CCDC57;GOLGA2;TUBGCP4;CLASP2;TUBGCP6;CLASP1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3350766788214225,0.798172002146649,0.7250859106529209,0.9835650644531035,1.0,6/15,21.20%,UNC119;SMAP1;NEU3;SCYL2;DGKD;SNAP91
prerank,positive regulation of ruffle assembly (GO:1900029),0.33211124154537,0.798078924241887,0.7172413793103448,0.9831301665053409,1.0,2/13,8.89%,CARMIL2;EPS8L1
prerank,double-strand break repair (GO:0006302),0.22300634358676844,0.7978714669085261,0.863582443653618,0.9829142951747708,1.0,34/158,18.51%,MORF4L1;ERCC1;LIG3;FAN1;FEN1;POLQ;ERCC5;POLA1;RPA1;ERCC4;POLL;MMS22L;RNF168;ZFYVE26;UBE2V2;BRCA2;REV3L;RECQL;SPIDR;POLN;XRCC1;RAD52;POLB;CYREN;EME2;PAXIP1;KDM2A;PSMD14;HELQ;NHEJ1;FBH1;SMARCAL1;WRN;RIF1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.27857297234945927,-0.7975865833402541,0.7818627450980392,0.908371893090097,1.0,7/18,23.27%,PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.33965812412577945,0.7974812405347205,0.725328947368421,0.9830414490313792,1.0,3/13,11.17%,GRIK2;SYP;SHISA6
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2466134375429825,0.7974586229093892,0.7924281984334204,0.982488142047999,1.0,17/72,18.61%,MAP3K14;PSMD1;TLR6;PSMD10;PSMA5;PSMB5;BIRC2;IRAK1;PSMC4;PSMA4;PSMC5;PSMB9;TIRAP;PSMD14;PSMA7;PSMD11;PSMA2
prerank,regulation of pH (GO:0006885),0.35357952627947864,0.79614607660055,0.7197986577181208,0.9842444771080863,1.0,3/11,11.83%,SLC9A1;CLCN3;PDK2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.34103231135120116,0.7957576345269338,0.7019400352733686,0.9843530051709113,1.0,3/14,9.67%,SCRIB;FSCN1;OPHN1
prerank,DNA duplex unwinding (GO:0032508),0.2607081131246952,0.7955266313181105,0.7868383404864091,0.984176991942135,1.0,16/50,20.10%,MCM7;RPA1;PIF1;XPC;MCM4;RECQL;GTF2H3;ERCC2;GTF2H1;DHX9;MCMDC2;WRN;CUL4A;SSBP1;DDB1;DDX1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.24232578244853498,-0.7948447222506159,0.8027397260273973,0.9121998396113419,1.0,8/32,13.67%,BCL2L1;VPS35;SOD2;HK2;BAD;BAX;BID;BOK
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.33590016239434833,0.794836700335592,0.7084078711985689,0.9848374028624186,1.0,4/14,12.06%,LRRK2;HERPUD1;OPA1;CREB3L1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.27681343375772854,-0.7946605548316374,0.7528868360277137,0.9118826645603666,1.0,5/17,18.05%,SOD2;HSPB1;PPIA;SIRT1;AKT1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.34353014806237836,-0.7939583219146176,0.738255033557047,0.9124327588779513,1.0,2/10,9.12%,NFKBIZ;RC3H1
prerank,regulation of cell cycle process (GO:0010564),0.23290357013037408,0.7939391165945272,0.8181818181818182,0.9858289542258023,1.0,18/104,15.14%,ATF5;L3MBTL1;TIPIN;PKMYT1;FBXO5;CDK13;ZFYVE26;RCC1;MKI67;USP19;SOX9;ENTR1;RAB11FIP3;DBF4;MAP9;BUB1;CEP250;CSNK2A2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.29941393722863413,-0.7938524817585771,0.7612612612612613,0.9119677059967335,1.0,2/13,4.63%,PLA2G4A;MGLL
prerank,mitochondrial membrane organization (GO:0007006),-0.239323591814662,-0.7937101437929694,0.8099415204678363,0.9115532550340971,1.0,10/32,24.71%,BCL2L1;APOOL;MICOS10;BAD;SLC25A5;GHITM;CHCHD3;PPIF;APOO;SLC25A4
prerank,cellular response to zinc ion (GO:0071294),-0.29558090495104555,-0.7933890156842804,0.7586206896551724,0.9114466837933246,1.0,11/15,32.14%,MT2A;MT3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;HVCN1
prerank,regulation of Golgi organization (GO:1903358),-0.2893014742422165,-0.7933107807431776,0.7649880095923262,0.9109168428530658,1.0,2/17,2.92%,ARMH3;STX18
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.24410071720512025,-0.7932466725772167,0.8200589970501475,0.9103877577486706,1.0,6/31,10.79%,KMT5B;RBP4;TFRC;DNAJB9;SHLD2;EPHB2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2133796773048167,0.7929782995945053,0.9069506726457399,0.9869686937126222,1.0,63/241,22.82%,TRA2B;EIF4A3;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;SNRPB2;WBP11;SMU1;SRRT;DDX41;SLU7;NUDT21;CWC22;DBR1;MTREX;SNW1;CASC3;SNRNP48;CWC25;SRSF10;SYF2;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SYMPK;SNRNP70;NONO;CWF19L2;SRSF9;SRRM2;CHERP;HNRNPL;SNRNP27;RBM5;SF3A3;DNAJC8;SRSF6;USP49;CTNNBL1;RBM6;ZCRB1;POLR2L;PRPF8;DHX15;TFIP11;RAVER2;DDX39B;SRSF12;RBM15;WBP4;CACTIN;HNRNPH3;LSM3
prerank,lipid phosphorylation (GO:0046834),-0.3346969166708398,-0.7929650082368195,0.7289719626168224,0.9101940123724713,1.0,3/10,12.34%,DGKH;DGKG;DGKZ
prerank,photoperiodism (GO:0009648),0.2882108278763732,0.792949339781162,0.7476780185758514,0.986428105486511,1.0,12/28,26.10%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,regulation of protein localization to nucleus (GO:1900180),-0.2273399161407035,-0.79282603571075,0.8522012578616353,0.9097665872439298,1.0,15/43,28.40%,TFRC;GSK3B;LAMTOR5;PARP9;SUMO3;CTNNA1;AKT1;MFHAS1;ILRUN;GLUL;WWTR1;CARD10;DTX3L;PARK7;SESN2
prerank,ceramide biosynthetic process (GO:0046513),0.26900304679755827,0.7927513190751628,0.7623318385650224,0.9862014561364429,1.0,10/40,14.28%,CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;ST6GALNAC6;CERS6
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.275821002855402,-0.7927145461911468,0.7974358974358975,0.9093240682882628,1.0,5/19,16.28%,CAT;MAOB;GPX1;PRDX1;PRDX3
prerank,sister chromatid segregation (GO:0000819),0.27964123772257726,0.7923292545890829,0.7511111111111111,0.9863295685176124,1.0,7/31,18.08%,TOP2B;SGO1;NSL1;NUSAP1;SMC1A;KLHL22;TOP2A
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.24697313895795964,0.791962391859662,0.7908847184986595,0.9863933537886656,1.0,9/65,8.26%,PPARA;SPRY1;PDPK1;HTRA3;SPRED1;MTMR4;IL17RD;SPRED2;CIDEA
prerank,regulation of ion transport (GO:0043269),0.2424858597045453,0.7913475471034728,0.8117489986648865,0.9868572341137023,1.0,19/76,20.49%,NKAIN1;ANK3;NKAIN2;VAMP2;NEDD4;SYT3;HTR1A;SYT7;P2RX4;SYT5;KCNJ8;GDNF;STC1;KCNJ10;SYT1;SYT6;KCNJ3;PXK;KCNJ16
prerank,regulation of protein modification process (GO:0031399),0.2513907831422183,0.7904089523072811,0.7819971870604782,0.9879170073019439,1.0,13/50,17.66%,PHIP;RABL3;SPRED1;PTK2;SPRED2;GRM5;FKTN;PLXNB2;IGF2;LYN;ATG14;NDUFS4;ABCA2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3108696007009029,-0.7903473962956454,0.7292161520190024,0.9119053133644249,1.0,3/12,11.86%,IGF1;LMCD1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3108696007009029,-0.7903473962956454,0.7292161520190024,0.9119053133644249,1.0,3/12,11.86%,IGF1;LMCD1;CAMTA1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2635538540629814,-0.790240802843345,0.7923627684964201,0.9114308806843329,1.0,11/23,32.42%,VCPIP1;MINDY1;OTUB1;USP25;TNFAIP3;BAP1;USP37;USP20;OTUB2;OTUD4;OTUD5
prerank,cellular response to acid chemical (GO:0071229),0.2922856305140949,0.7901413793084916,0.7644376899696048,0.9878097855602542,1.0,7/27,18.65%,CPEB1;MTOR;GLRA1;GLRA2;RRAGA;CAPN2;RRAGD
prerank,regulation of leukocyte migration (GO:0002685),-0.28829751742304655,-0.7901361454375775,0.7543859649122807,0.9109623406641533,1.0,2/16,5.43%,ANXA1;RAC1
prerank,artery morphogenesis (GO:0048844),-0.24719892888412492,-0.7900808928472958,0.803076923076923,0.9104005857615836,1.0,8/30,15.08%,BMPR2;NRP1;NOTCH1;TGFB2;TBX1;TBX2;HEY2;STRA6
prerank,long-chain fatty acid transport (GO:0015909),0.28258110668146447,0.7897218222497122,0.7432432432432432,0.9879688156895464,1.0,7/30,12.34%,ABCD2;FABP5;FABP4;SPX;RPS6KB1;SLC25A20;FABP3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.29349735391479703,0.7896615325646323,0.7542503863987635,0.9874815191763906,1.0,5/29,11.17%,NCDN;GRIK2;SYP;DLG4;SHISA6
prerank,pre-replicative complex assembly (GO:0036388),0.24768306878625795,0.789384466692014,0.7965194109772423,0.9873858503852163,1.0,17/64,18.61%,MCM7;PSMD1;PSMD10;GMNN;PSMA5;PSMB5;PSMC4;PSMA4;MCM4;PSMC5;CDT1;PSMB9;ORC2;PSMD14;PSMA7;PSMD11;PSMA2
prerank,regulation of DNA metabolic process (GO:0051052),0.26546963832438186,0.7890910938553052,0.780559646539028,0.9872902967189411,1.0,15/44,22.11%,USP1;PIF1;UBE2V2;POLH;MPHOSPH8;KPNA1;CDT1;KDM1B;HNRNPD;UBE2V1;MYC;KAT7;TERF2IP;WDR18;KPNA2
prerank,rRNA transcription (GO:0009303),-0.2897136860134885,-0.7884636480639214,0.7596899224806202,0.9123213269381537,1.0,6/17,22.70%,CAVIN1;TCOF1;NIFK;GTF3C6;POLR1G;GTF3A
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.24247220249471865,-0.7881247708075021,0.8354430379746836,0.9122264017431604,1.0,10/33,25.48%,AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;EGF;AGT;DOK1;CNOT9
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.33137212637223046,0.7880199440699477,0.7374784110535406,0.9886009124446067,1.0,5/13,22.32%,CISD3;CIAO1;MMS19;ISCA1;YAE1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2611661258006365,-0.7876548020558982,0.7786885245901639,0.9123554023981341,1.0,9/23,22.74%,PRCC;INTS3;ZW10;WEE1;PLK5;PABIR1;SETMAR;CHFR;CHMP4C
prerank,histone ubiquitination (GO:0016574),-0.2642785996586551,-0.7876067708574755,0.7876344086021505,0.9117864502672701,1.0,7/21,25.32%,RNF8;UBE2A;UBR2;UBE2N;LEO1;RNF20;DTX3L
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24435158041549518,0.7873880107909343,0.7882037533512064,0.9891271710479034,1.0,7/66,8.25%,PIK3R1;NGFR;JUP;PIK3R2;ZIC1;CCT5;NMD3
prerank,intracellular sterol transport (GO:0032366),0.3321369080362958,0.7870618113068445,0.7328881469115192,0.9891182529750681,1.0,5/13,19.96%,RELCH;SERAC1;ARV1;NPC2;OSBP
prerank,positive regulation of intracellular transport (GO:0032388),-0.22850269066860426,-0.7867822633448757,0.8404558404558404,0.9124742674517139,1.0,11/38,19.93%,ACTN2;STX18;RUFY3;PRR5L;CEP290;DYNC1H1;OAZ1;BCAS3;OAZ2;PLA2G4E;NUMA1
prerank,axonal transport of mitochondrion (GO:0019896),0.3482543814583329,0.7865116906081258,0.7280701754385965,0.9895218674428639,1.0,4/11,20.56%,OPA1;SYBU;HIF1A;ACTR10
prerank,macrophage chemotaxis (GO:0048246),0.361787597288476,0.7857125202635106,0.7225130890052356,0.9903077862624267,1.0,10/10,63.84%,CCL2;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF
prerank,positive regulation of DNA recombination (GO:0045911),0.28824167764744396,0.7854194665399659,0.7635239567233385,0.9902529218420388,1.0,8/27,18.51%,ZCWPW1;HMCES;MRNIP;ACTR2;ERCC2;PAXIP1;MMS19;RIF1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.2790900282045254,-0.7852885016708631,0.7941888619854721,0.9142067230872868,1.0,4/18,12.82%,ANXA1;KLF9;FAM107A;NR3C1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3228511332744309,-0.7851498867049546,0.7327188940092166,0.913814985866765,1.0,2/10,8.05%,LBP;IFI35
prerank,actin filament-based transport (GO:0099515),0.3060818580561948,0.7845889646315528,0.7596638655462185,0.9911242344915915,1.0,5/21,11.79%,MYO7A;MYO1B;SUN2;MYO6;MYO1G
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.31562002528846367,-0.7842950706323987,0.7426636568848759,0.9144878164013142,1.0,7/11,47.06%,ADRB2;ARRB2;ADM;DRD3;ADRB3;ARR3;ARRB1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.255581723528611,-0.784270004634711,0.8138297872340425,0.9138925902997863,1.0,12/25,29.34%,PRKDC;MAPK14;ETS1;TAL1;ABCB10;HMGB2;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,cardiocyte differentiation (GO:0035051),0.3637583773346303,0.7839590586563651,0.75,0.9916176585638219,1.0,1/10,0.90%,NRG1
prerank,membrane fusion (GO:0061025),0.27752527966684826,0.7839217273183126,0.7745839636913767,0.9910820107307661,1.0,10/33,17.32%,VAMP2;SNAP23;OPA1;SNAP29;RIMS1;DNM1;RABIF;VPS33B;HACE1;UBXN2B
prerank,regulation of lipid storage (GO:0010883),-0.25880628715328236,-0.7826837130184099,0.7979274611398963,0.9157244691756533,1.0,5/22,15.75%,NFKB1;NFKBIA;PTPN2;ITGB3;SIRT1
prerank,rRNA 3'-end processing (GO:0031125),-0.3411260142028336,-0.7824773547711319,0.7639198218262806,0.9153931433659562,1.0,4/10,15.91%,ERI1;RPS21;EXOSC2;EXOSC3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2338894102993343,0.7823895388018581,0.8350649350649351,0.9931985624777803,1.0,25/96,21.21%,EIF4A3;NUP214;AAAS;THOC7;POM121;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;FYTTD1;SYMPK;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;DDX39B;MCM3AP;RANBP2
prerank,regulation of interleukin-12 production (GO:0032655),-0.2186821052044913,-0.7822118611702235,0.8491803278688524,0.9151536469643775,1.0,3/47,2.21%,PLCB1;FOXP1;THBS1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.2670839456996162,-0.782201613112828,0.7698019801980198,0.9145268962118452,1.0,6/20,15.85%,ERLIN1;WNT4;SIK1;CEACAM1;ASXL3;GPER1
prerank,thyroid hormone generation (GO:0006590),0.3604391552656204,0.782161750015935,0.7302158273381295,0.9930293357914529,1.0,1/10,4.68%,CPQ
prerank,regulation of viral genome replication (GO:0045069),0.25112614364654784,0.7817247822975316,0.8187134502923976,0.9931801525985692,1.0,10/56,17.42%,PPARA;PPID;PPIH;PDE12;STAU1;EIF2AK2;CNOT7;ADAR;ILF3;HACD3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.3112857056007677,-0.7815146045992631,0.7610837438423645,0.9149726076686898,1.0,7/12,34.95%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1
prerank,respiratory tube development (GO:0030323),0.28427277414266433,0.781177936518737,0.7822706065318819,0.9935697410711779,1.0,6/28,15.73%,ITGA3;NPHP3;LOXL3;BAG6;FGFR2;CCDC39
prerank,androgen receptor signaling pathway (GO:0030521),-0.3250426832041966,-0.7811692357878522,0.7472283813747228,0.914862926239957,1.0,2/11,7.73%,DDX5;TMF1
prerank,mRNA catabolic process (GO:0006402),0.25986938585414165,0.7810992654608144,0.782608695652174,0.9931177954936399,1.0,11/44,17.83%,AGO4;ZC3H12D;PDE12;ZFP36L2;AGO3;EXOSC9;DIS3L2;MRTO4;EXOSC10;AGO1;DXO
prerank,mismatch repair (GO:0006298),0.2839849392356506,0.7810446402114389,0.7668711656441718,0.992623470761799,1.0,9/27,23.25%,ERCC1;MSH3;RPA1;XPC;MUTYH;MSH6;MLH1;ABL1;TDG
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.34526025513598124,0.7808580675863437,0.7379679144385026,0.9923740136317045,1.0,1/11,1.72%,TAF9B
prerank,retrograde axonal transport (GO:0008090),0.3215654055264356,0.7807957611678006,0.7530224525043178,0.9918896077890715,1.0,2/16,6.28%,DLG2;TMEM108
prerank,tRNA processing (GO:0008033),0.25029628030458895,0.7806895120846482,0.796875,0.9914527997870385,1.0,19/61,24.04%,RPP40;CTU1;POP5;QTRT2;POP7;TSEN15;FAM98B;TRMT61A;METTL1;WDR4;PTCD1;SARS1;RPP21;DDX1;TRMT10A;LCMT2;AARS1;TRMT10C;SSB
prerank,negative regulation of DNA replication (GO:0008156),0.32902378532224774,0.780593765687189,0.7579298831385642,0.9910118121657024,1.0,5/13,24.65%,GMNN;TERF1;TSPYL2;GMNC;GTPBP4
prerank,mitochondrial gene expression (GO:0140053),-0.222038944685927,-0.7805048850130225,0.8558282208588958,0.9151702567348295,1.0,18/42,29.96%,IARS2;MRPS7;NOA1;MRPS17;MRPL16;MRPL2;MRPS18A;MRPS18B;GATC;POLRMT;PTCD3;TWNK;MRPL57;LARS2;MRPS34;MRPS12;FASTKD2;MRPS2
prerank,actin polymerization or depolymerization (GO:0008154),0.25422995747975285,0.7802602502311331,0.8047091412742382,0.9909752501066351,1.0,4/50,6.96%,SVIL;MICALL2;ARHGAP6;WASF3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.23504462334120507,0.7801708213144148,0.8402597402597403,0.9905340272315988,1.0,23/85,19.82%,PRICKLE1;FMR1;LRRK2;RNF180;PSMD10;CBFA2T3;NKD2;PSMC5;ZYG11B;HECTD1;GSK3A;DDA1;BAG6;ATXN3;CLU;DET1;CSNK1E;USP13;RNF19B;RNF217;DDRGK1;RNF144A;SUMO2
prerank,cellular protein-containing complex assembly (GO:0034622),0.21899539004430355,0.7801465331592694,0.8688915375446961,0.9899864790082543,1.0,28/159,15.90%,NRG1;STXBP6;TCF4;VAMP2;DNAJC28;CENPE;EPS15;OMA1;DNAAF3;IMMP2L;TTC12;DNAI4;CCDC65;CYBA;DNAJB12;TBCE;VAMP4;CENPC;CENPW;NUP107;AXIN1;LONP1;HSPA4;COX7A2L;CLU;DHX9;CCDC39;CENPF
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2739911622226489,0.7800211471361445,0.770392749244713,0.9895968946356056,1.0,8/32,18.96%,CDK14;FBXO5;POLA1;CDT1;KLF11;CDK5;CCNE1;TFDP1
prerank,tRNA export from nucleus (GO:0006409),0.2784188390140886,0.7798462368429148,0.7981366459627329,0.9887025666332716,1.0,10/32,24.04%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2784188390140886,0.7798462368429148,0.7981366459627329,0.9887025666332716,1.0,10/32,24.04%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.31426250632516306,0.779753598845442,0.7406807131280388,0.9882790765324685,1.0,5/18,17.95%,TLR4;LRRC17;FBN1;MAFB;GPR137B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3073427150383933,0.7797180017117147,0.7303921568627451,0.9877552712515905,1.0,2/18,5.95%,TMEM102;NAIF1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.26161736379911427,-0.779438016700015,0.8184281842818428,0.916176300204866,1.0,3/21,10.49%,CCN3;DAB2;SH2B1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.20985825582495637,-0.7792431692521851,0.8551236749116607,0.9158248246970395,1.0,24/54,32.66%,OTULIN;HIPK1;MADD;CASP8;PTPN2;CYLD;LAPTM5;TNFRSF1A;CCDC3;TRADD;TRAF1;RFFL;TNFAIP3;CFLAR;IKBKB;IKBKG;BIRC3;HSPA1A;PELI3;HSPA1B;CASP1;TRAF2;GPS2;PYDC1
prerank,regulation of heart contraction (GO:0008016),0.23319189075365818,0.779168451753929,0.8283870967741935,0.9881285114829568,1.0,16/90,15.41%,ATP1A2;ITPR1;RYR2;ATP1A3;TMEM65;ATP2A2;KCNIP2;PRKACA;FXYD4;P2RX4;S100A1;GSK3A;ASPH;RYR3;STIM1;GJA5
prerank,negative regulation of protein depolymerization (GO:1901880),0.289322042811102,0.7790356264793702,0.7640449438202247,0.9877683992292754,1.0,6/24,18.76%,PLEKHH2;NAV3;STMN2;CLASP2;CLASP1;SPEF1
prerank,regulation of viral life cycle (GO:1903900),-0.27061365086302275,-0.7789074651594061,0.7763819095477387,0.9156736844642741,1.0,5/21,16.44%,TRIM25;TRIM5;TRIM14;PPIA;TRIM27
prerank,positive regulation of dephosphorylation (GO:0035306),0.28183008075251154,0.778632401706112,0.7800632911392406,0.9878704019550442,1.0,1/27,0.28%,DLC1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.32981025337549186,-0.77850108252917,0.750599520383693,0.915629892744307,1.0,5/10,30.91%,NUFIP1;RUVBL2;TAF9;PIH1D2;RUVBL1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.28464388161106163,-0.7771027204941546,0.7658536585365854,0.9170627649068245,1.0,8/15,26.75%,RPL5;RPS7;RPL11;RPL23;SMAD7;BAG2;DTX3L;PARK7
prerank,organonitrogen compound catabolic process (GO:1901565),0.25309349500025063,0.7762273641072153,0.8088235294117647,0.9914199476156675,1.0,9/57,11.81%,CPQ;LIPC;UCHL3;CAPN3;PLA2G7;ADO;MTOR;TXN2;SGPL1
prerank,negative regulation of ion transport (GO:0043271),0.28957080272939456,0.7757106893056149,0.7640449438202247,0.9916973962119191,1.0,7/24,19.83%,GPM6B;NEDD4;WNK2;PACSIN3;STC1;ADRA2A;PXK
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2651479671753837,-0.775193901411135,0.7989821882951654,0.9192502514158581,1.0,9/22,29.92%,ROCK2;GSK3B;PPP4R4;PPP1R11;MGAT5;IKBKB;NCKAP1L;FKBP1A;PPP1R15A
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3174367787630752,0.7751350809240026,0.7385964912280701,0.9921070829120477,1.0,2/16,12.27%,PTPN22;IL12A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.21894929177199232,0.7750661311904177,0.8820697954271961,0.9916442508550587,1.0,20/148,11.17%,HDAC1;L3MBTL1;TAF9B;PIP4K2A;TAF12;PDPK1;PRR5;CHD4;MBD3;TAF15;RPA1;TAF3;MDM4;NOC2L;MTOR;DAXX;RFC3;TP53;TOP3A;RPL37
prerank,snRNA metabolic process (GO:0016073),-0.2743789708275554,-0.7749268070827957,0.7881136950904393,0.9190150336219722,1.0,6/17,19.75%,INTS3;RBM7;INTS9;INTS10;INTS1;MEPCE
prerank,negative regulation of translational initiation (GO:0045947),-0.30085290366166384,-0.774565522818691,0.7878787878787878,0.918881853928482,1.0,5/13,17.74%,PAIP2;RBM4;EIF3E;EIF4EBP1;AGO2
prerank,regulation of centrosome duplication (GO:0010824),0.2790519540521394,0.7742424961400984,0.7546296296296297,0.9924776093885174,1.0,7/29,19.01%,NAT10;CEP295;TMEM67;FBXW5;ALMS1;VPS4B;CENATAC
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3128622089171732,0.7741935450390481,0.7574750830564784,0.9919665138823612,1.0,4/17,13.09%,PSMD10;TWIST1;ARMC10;PTTG1IP
prerank,phosphatidylcholine catabolic process (GO:0034638),0.36039774274354563,0.7736938310738121,0.7607913669064749,0.9922144104633028,1.0,2/10,7.89%,LIPC;PLA2G7
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24638769098854107,0.7735496925564841,0.8309859154929577,0.9918858124891616,1.0,9/63,10.45%,EIF4G3;GPLD1;HTR2B;PTPN22;SORL1;ZKSCAN3;GOLGA2;MTOR;DAP
prerank,regulation of chromatin binding (GO:0035561),0.3488503358077025,0.7733819601365086,0.7215411558669002,0.9915746291151419,1.0,4/10,14.80%,GMNN;CDT1;BTAF1;MED25
prerank,positive regulation of cholesterol transport (GO:0032376),0.28397086804030786,0.7729204812586034,0.7598116169544741,0.9917929238590447,1.0,2/27,4.17%,LRP1;NR1H2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2877832732574594,0.7729110482379671,0.7758887171561051,0.9912280676308882,1.0,8/26,20.42%,C1QC;TLR4;LRRC17;FBN1;MAFB;MYC;GPR137B;INHBA
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2597847133910261,0.772855294398507,0.7922848664688428,0.9907339278239116,1.0,11/42,20.27%,POLQ;SIRT6;MRNIP;SPIDR;ACTR2;FIGNL1;MMS19;FBH1;RIF1;TERF2IP;PPP4R2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.31353253839387796,0.7726799664040646,0.7457912457912458,0.9904504047250378,1.0,2/16,9.40%,NAA10;NAA50
prerank,cell junction maintenance (GO:0034331),0.3257620332149073,0.7726593852542419,0.7446102819237148,0.989905850555514,1.0,5/14,27.66%,CBLN1;F2R;PRTN3;MYADM;DCTN1
prerank,TOR signaling (GO:0031929),-0.2506477616677222,-0.7726344813866628,0.8346883468834688,0.9211429319249872,1.0,15/26,34.69%,FNIP1;RICTOR;PRR5L;CCDC88A;MAPKAP1;EIF4EBP1;AKT1;NPRL3;RHEBL1;MLST8;EIF4EBP2;SMG1;SYAP1;RPS6KB2;CARD11
prerank,cardiac muscle contraction (GO:0060048),0.2695218476070557,0.7725512570899155,0.7871720116618076,0.9895141357120669,1.0,3/34,4.15%,ATP1A2;RYR2;SCN2B
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.28191652025571906,0.772442038491482,0.7899543378995434,0.9891233934436415,1.0,8/27,21.13%,MORF4L1;BRD8;NAA50;KAT2A;BAG6;KAT7;PHF20L1;CREBBP
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3249913535815048,-0.7723427822076612,0.7476635514018691,0.9209017664155137,1.0,5/10,35.05%,CX3CR1;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2588088291056492,0.772118412744722,0.785031847133758,0.9890859460434775,1.0,7/38,14.63%,MIS18A;CENPU;ASF1A;UBN1;CENPC;CENPW;MIS18BP1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.24013357183325912,-0.7715623222853244,0.8263305322128851,0.9214115078125014,1.0,11/30,22.07%,BCL2L1;ACKR3;THOC1;CD44;RTEL1;TPT1;SIRT1;CD74;SNAI1;MIF;CCAR2
prerank,spinal cord development (GO:0021510),0.33553211773465924,0.7715000779192062,0.7290209790209791,0.9895479750625493,1.0,3/12,8.69%,LOXL3;NF1;RELN
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2941860097429815,-0.771279710236256,0.7821100917431193,0.9211679339642959,1.0,5/13,19.16%,RNF8;RECQL5;NELFCD;HEXIM1;EAPP
prerank,establishment of spindle orientation (GO:0051294),0.2787919046766774,0.7711305500080076,0.7771173848439822,0.9895847070536578,1.0,7/28,17.32%,GJA1;LLGL1;GPSM2;SPDL1;INSC;CLASP1;UBXN2B
prerank,histone acetylation (GO:0016573),0.23805381279297777,0.7706423611940926,0.8346055979643766,0.9898177571127941,1.0,19/69,21.13%,TAF12;MORF4L1;BRD8;WDR5;NAA50;BRCA2;KAT2A;POLE3;JADE1;EPC1;ATF2;DMAP1;KAT7;PHF20L1;TAF10;MBIP;SUPT7L;ING3;CREBBP
prerank,heart contraction (GO:0060047),0.26055431135357665,0.7706197732174712,0.8149717514124294,0.9892814338479706,1.0,3/41,4.15%,ATP1A2;RYR2;SCN2B
prerank,mitochondrial transcription (GO:0006390),0.35418545180204214,0.7704858361188943,0.7378815080789947,0.9889208724130861,1.0,5/10,28.12%,SLC25A33;TEFM;TFAM;FOXO3;MRPL12
prerank,lung development (GO:0030324),0.26919849302738424,0.7702935365909612,0.7845220030349014,0.9886513191756147,1.0,7/33,15.73%,ITGA3;NPHP3;LOXL3;RCN3;BAG6;FGFR2;CCDC39
prerank,macromolecule catabolic process (GO:0009057),0.28482771730393125,0.7696982015318847,0.8018720748829953,0.9890920376137969,1.0,5/26,9.24%,NEDD4;UCHL3;CAPN3;MTOR;LGMN
prerank,histone exchange (GO:0043486),0.26305525657689155,0.7693458682741828,0.7917329093799682,0.9891258395960533,1.0,7/37,15.42%,MIS18A;CENPU;SPTY2D1;CENPC;CENPW;MIS18BP1;DMAP1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3074336174030057,0.7682989431753855,0.758957654723127,0.9902953358396254,1.0,4/19,15.16%,TLR8;TLR4;DHX36;DHX9
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.26136982357554583,-0.7681926350080959,0.8034398034398035,0.9250181439972982,1.0,4/20,19.06%,PLCB1;RGS10;AGRN;LYPD1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.32824997270323675,-0.7681210796804403,0.7832167832167832,0.9244710985217315,1.0,2/10,3.93%,OSR1;CAMK2D
prerank,lipid modification (GO:0030258),0.26316860805050546,0.7677642802289011,0.7880184331797235,0.9906010610855484,1.0,8/37,14.83%,PLPPR3;DGKQ;PLA2G7;PLPPR2;PLPP6;DGKI;MBOAT7;PLPP5
prerank,calcium ion import (GO:0070509),0.2804685389577699,0.7676753994189554,0.7757774140752864,0.9901817945583048,1.0,4/28,8.86%,CACNA1E;ATP2A2;CACNA1G;MICU3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3140402232514748,-0.7672411400289044,0.7911832946635731,0.9250994277891238,1.0,7/11,26.94%,SERTAD1;ARID1B;SMARCD1;ELOF1;CDCA4;PADI2;CHEK1
prerank,calcium ion homeostasis (GO:0055074),0.22718618276338606,0.7672071322631631,0.8802083333333334,0.9903704380353041,1.0,9/95,9.26%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ATP13A3;HTR2C
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2530528642522173,0.7669513455573531,0.8056338028169014,0.9902316256748966,1.0,6/45,11.00%,WNT5A;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.29924949017707597,-0.7664341841114383,0.7827102803738317,0.9256597383954849,1.0,4/13,17.21%,EPN2;NIBAN2;PTPN1;HHEX
prerank,regulation of chromosome segregation (GO:0051983),0.31319615226370556,0.7661611186923611,0.7746243739565943,0.9909381000955021,1.0,3/16,15.14%,MKI67;BUB1;CSNK2A2
prerank,regulation of interleukin-8 production (GO:0032677),-0.19616672205300806,-0.7657848776259545,0.9233870967741935,0.9259432253964499,1.0,12/69,17.09%,AFAP1L2;KLF4;LBP;ANXA1;MAVS;LAMTOR5;SERPINE1;TMSB4X;MAP2K5;ANXA4;RAB1A;CD74
prerank,regulation of RNA splicing (GO:0043484),0.2350530584181305,0.7655230644248523,0.8577291381668947,0.9913815564762468,1.0,15/69,18.40%,PIK3R1;TRA2B;AFF2;PRX;KHDRBS3;CWC22;SRSF10;RBM20;ZNF326;SNRNP70;HNRNPLL;HNRNPL;HABP4;KHDRBS1;RRP1B
prerank,DNA modification (GO:0006304),0.2916544665567814,0.765346714195158,0.7520938023450586,0.9910968745401111,1.0,6/22,18.91%,NEIL3;TERF1;MUTYH;MBD4;EXOSC5;TERF2IP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.2989247187323121,-0.7652618652293425,0.7638190954773869,0.925377523727271,1.0,2/12,9.00%,GSK3B;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.2989247187323121,-0.7652618652293425,0.7638190954773869,0.925377523727271,1.0,2/12,9.00%,GSK3B;DYRK2
prerank,protein methylation (GO:0006479),0.2566415533098297,0.7647312170942795,0.8088467614533965,0.9915117557459022,1.0,16/40,27.41%,PRMT3;VCPKMT;NSD1;FAM98B;CARM1;PRMT2;N6AMT1;EHMT2;ATPSCKMT;CAMKMT;EHMT1;PRMT6;ETF1;PCMT1;FAM98A;NSD3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.35248113330489095,0.7646500260766705,0.7643979057591623,0.9910682493509795,1.0,2/10,4.84%,PRKD3;HTR2B
prerank,negative regulation of cell communication (GO:0010648),-0.2622711502064293,-0.7646421099023567,0.7924050632911392,0.9256504463912738,1.0,7/21,28.82%,IGFBP3;ACVR1;PTPN1;ERBB3;SOCS5;KIF26A;BRAP
prerank,embryonic hemopoiesis (GO:0035162),0.32686340292690563,0.7646403521162618,0.7615780445969125,0.9905079210467871,1.0,2/12,4.57%,FLT3LG;KMT2A
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.30060677423687154,-0.7645381105301556,0.7706422018348624,0.9251632081931348,1.0,5/12,19.16%,RNF8;RECQL5;NELFCD;HEXIM1;EAPP
prerank,mRNA processing (GO:0006397),0.20312488786912383,0.7644854432875742,0.9492833517089305,0.9901914056889671,1.0,74/287,22.82%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;THOC7;LSM4;BCAS2;HNRNPA2B1;SRSF11;SNRPB2;WBP11;PRKACA;SMU1;SRRT;DDX41;SLU7;NUDT21;CWC22;DBR1;MTREX;SNW1;CASC3;SNRNP48;CWC25;GTF2H3;PRPF18;SRSF10;SYF2;RBM4B;ERCC2;HNRNPUL1;RBM17;GTF2H1;HNRNPD;DHX9;SNRPF;SYMPK;SNRNP70;NONO;CWF19L2;SRSF9;SRRM2;CHERP;THOC5;HNRNPL;SNRNP27;RBM5;SF3A3;DNAJC8;SRSF6;USP49;CTNNBL1;RBM6;ZCRB1;CHTOP;POLR2L;PRPF8;DHX15;TFIP11;RAVER2;DDX39B;CDK7;SRSF12;RBM15;WBP4;CACTIN;RNGTT;HNRNPH3;LSM3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19991231455309186,0.7642889868026218,0.9387096774193548,0.9899473010078241,1.0,86/314,23.30%,BUB1B;FBXO9;FBXO45;PSMD1;FBXO5;FBXO31;BFAR;SEL1L;ZSWIM8;NEDD4;CDC16;DMAC2;PSMD10;CRBN;HERPUD1;CDC20B;PSMA5;PSMB5;AMN1;ECPAS;UBE2G2;UBXN4;BIRC2;DNAJB12;PLAA;FBXO17;PSMC4;MAN1B1;SEC61B;PSMA4;TMEM67;PSMC5;FBXW5;DNAJC10;USP19;FBXL13;CUL5;HSP90B1;GSK3A;AREL1;ANAPC5;PSMB9;TRIM2;UBE2D1;BAG6;HSPA5;ATXN3;RNF122;TRIM3;YOD1;HACE1;DNAJB14;PSMD14;PSMA7;HECW1;UBXN2B;KLHL22;CDC26;FEM1B;DCAF11;PSMD11;ZFAND2A;RNF187;PSMA2;CUL4A;FBXO4;FBXW4;UBE2J1;SPSB2;DDB1;MTA1;UBE2K;FBXL22;BTRC;DDIT3;RNF216;SPSB3;RMND5B;SPSB1;UBR3;FBXL12;MAD2L1;ANAPC4;FBXL5;FAF1;NHLRC3
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.28366358594451035,-0.764262743563613,0.8052884615384616,0.9249119539914485,1.0,4/16,13.29%,BMPR2;ACE;KLK2;DDAH1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.2549930262875675,-0.764179802715952,0.8254364089775561,0.924393755349261,1.0,7/24,24.27%,LEPR;COQ10A;COX15;SDHAF4;PID1;MRAP2;MT3
prerank,alcohol catabolic process (GO:0046164),0.3491811698537844,0.7641772203846726,0.7429577464788732,0.9895650497885204,1.0,1/10,2.00%,CEL
prerank,axonal fasciculation (GO:0007413),0.340632212442758,0.7638011845994669,0.7591240875912408,0.9896145026186403,1.0,5/12,16.06%,SEMA5A;CNTN4;EPHA3;ARHGAP35;NRCAM
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.31606236607214316,0.763658169754505,0.7465277777777778,0.9892779612279,1.0,4/15,18.78%,TLR6;TLR4;MYD88;HIF1A
prerank,heterocycle biosynthetic process (GO:0018130),-0.2914390313103873,-0.7632600518097981,0.7911547911547911,0.9250334529319185,1.0,7/14,27.68%,NFS1;GCH1;MOCS1;NOXRED1;PYCR2;MOCS3;PYCR3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.25233071881468455,0.7632274264505697,0.8288543140028288,0.9894282538184002,1.0,15/50,24.65%,CCNJ;PKMYT1;CDKN2D;CCNB2;CDKN2C;CCNA2;GTF2H1;CCNK;CCNE1;CCND3;CDK5R1;CDK7;CCNT2;CDC37;GTPBP4
prerank,membrane lipid metabolic process (GO:0006643),0.29405813677600245,0.7631649208093535,0.7648026315789473,0.9889530864955349,1.0,5/22,12.28%,SERINC1;SPTLC1;AGMO;B4GALT4;AGK
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2496420246748625,0.7630127279651604,0.8295774647887324,0.9886887978419953,1.0,6/50,8.16%,OGT;PRMT3;FBXO5;ADGRB1;LIMK1;PER2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.22993007370653357,-0.7623883259291202,0.863905325443787,0.9255675269175678,1.0,9/32,21.57%,CAVIN1;GTF2H5;UBTF;POLR2H;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,regulation of activated T cell proliferation (GO:0046006),0.2757593817774909,0.7623709590765827,0.7678018575851393,0.989152464021885,1.0,7/30,16.66%,SCRIB;ICOSLG;PDCD1LG2;PYCARD;IGF2;PRKAR1A;LGALS9
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.32145786668249016,-0.7621487560554796,0.7417840375586855,0.9252685721096482,1.0,4/10,24.26%,DCLRE1A;RTEL1;DCLRE1B;ACD
prerank,cellular component maintenance (GO:0043954),0.3326719311068159,0.761608193604347,0.7414383561643836,0.98977265851919,1.0,3/12,12.83%,ITGA3;FYN;LNPK
prerank,positive regulation of protein processing (GO:0010954),0.30248702727299537,0.7614637170487141,0.7895622895622896,0.9894301210928776,1.0,3/19,8.69%,KLKB1;CLEC3B;NKD2
prerank,cardiac muscle cell contraction (GO:0086003),-0.27220632336016515,-0.761453755620952,0.8227848101265823,0.9256423220213008,1.0,3/19,3.93%,CACNA1C;GSN;CAMK2D
prerank,neuron apoptotic process (GO:0051402),0.2994853255791563,0.7611010155616332,0.7640449438202247,0.9894390687678448,1.0,6/19,17.06%,NGFR;TNFRSF21;FAM162A;ATN1;SCN2A;CDK5
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.308725819397003,0.7605081567248403,0.7829059829059829,0.9898775435790917,1.0,8/17,25.59%,SEL1L;HERPUD1;SEC61B;HSP90B1;RHBDD1;UFD1;OS9;AUP1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.276966132157123,0.760489416586799,0.7789799072642968,0.9893370140275332,1.0,4/27,5.69%,PDE4B;RYR2;JUP;ATP2A2
prerank,protein localization to mitochondrion (GO:0070585),-0.3127452919259075,-0.7603249613231476,0.7841409691629956,0.9265719045810631,1.0,5/11,21.52%,HK1;HK2;ISG15;AKT1;COX18
prerank,L-serine metabolic process (GO:0006563),-0.3233843252597404,-0.7601414869292735,0.7788018433179723,0.9261953778160525,1.0,3/10,17.06%,SERINC3;PSAT1;CBS
prerank,lipid oxidation (GO:0034440),-0.3074605689890317,-0.7599650680401342,0.762589928057554,0.9257856965893817,1.0,1/12,2.47%,ADIPOR2
prerank,acyl-CoA metabolic process (GO:0006637),0.2653122007659634,0.7599166750195486,0.8179012345679012,0.9897277083630451,1.0,7/35,16.91%,ACSF2;DLST;ACOT7;HMGCS1;ACSL6;ACOT2;MCEE
prerank,NAD biosynthetic process (GO:0009435),0.2914808816701815,0.7598439357022099,0.7767145135566188,0.9892759594153355,1.0,3/20,11.72%,NMNAT3;KYNU;PTGIS
prerank,regulation of chromosome organization (GO:0033044),-0.2542729233698836,-0.759764837319072,0.8314285714285714,0.9254480809121837,1.0,9/22,25.45%,SMG6;MAPT;HDAC8;SMG5;SETMAR;SHCBP1L;RMI2;RB1;LIG4
prerank,cellular response to arsenic-containing substance (GO:0071243),0.31653196278696777,0.7591496426036101,0.7473867595818815,0.9898070799009973,1.0,3/15,10.93%,GSTO2;DAXX;DHX36
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2512746030041044,-0.7584922510889811,0.8310991957104558,0.9265458957117509,1.0,9/21,26.75%,BCL2L1;TMBIM6;NCK1;BOK;CREB3;SELENOS;BCL2L11;HSPA1A;PARK7
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.33928905600956655,0.7583570127403485,0.7865961199294532,0.9904919234068509,1.0,1/11,1.30%,PTPRT
prerank,rRNA methylation (GO:0031167),0.29151300855274276,0.7581722990334147,0.8028391167192429,0.9902073163465382,1.0,12/22,31.56%,MRM3;DIMT1;NSUN3;MTERF4;METTL15;METTL5;NSUN5;ZCCHC4;NSUN4;FTSJ3;METTL16;EMG1
prerank,regulation of defense response (GO:0031347),0.2315360242725646,0.7580122218803558,0.8603723404255319,0.989901945338405,1.0,13/76,12.71%,XCL1;WNT5A;CASP4;PTPN22;DHX58;ADAMTS12;BCL6;PTGES;APPL2;BIRC2;FGR;CASP12;AREL1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3091078594193138,0.7579970851309368,0.7668393782383419,0.989356539347051,1.0,5/17,17.29%,NTRK2;SORL1;RTN2;CLU;RTN3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2877081917877662,0.7579467138831002,0.7922297297297297,0.9888794671572778,1.0,6/22,18.61%,PSMA5;PSMB5;PSMA4;PSMB9;PSMA7;PSMA2
prerank,protein depolymerization (GO:0051261),-0.2411987857990825,-0.7579333215385763,0.8774373259052924,0.9266971371973198,1.0,8/27,21.40%,MICAL2;GSN;KIF24;CFL1;DSTN;MICAL3;TWF2;KATNB1
prerank,post-translational protein modification (GO:0043687),0.19799788779216088,0.7578019966700283,0.9665226781857451,0.9885282580497102,1.0,87/332,23.42%,LAMC1;LAMB1;CCDC22;FBXO9;PRKCSH;MXRA8;COPS3;VCAN;PSMD1;SPP1;FBXO31;RAB8A;ZBTB16;EPAS1;PSMD10;UCHL3;AMELX;PSMA5;PSMB5;WDR5;APLP2;COMMD1;KCTD7;FBXO17;PSMC4;PSMA4;RAB2A;PSMC5;FBXW5;ASB1;FBXL13;CUL5;HSP90B1;CAND1;COPS4;LGALS1;PSMB9;SPARCL1;ASB10;CHML;DDA1;FBN1;IGFBP7;SDC2;SERPINC1;WSB2;DCAF4;PSMD14;PSMA7;KLHL22;CUL7;CALU;FEM1B;DCAF11;SOCS6;MIA3;PSMD11;PSMA2;DCAF10;RCN1;HIF1A;CUL4A;FBXO4;ANO8;RHBDD1;FBXW4;SPSB2;DDB1;WSB1;MBTPS1;FBXL22;RBBP5;MEN1;SCG2;CHGB;WDTC1;BTRC;UBXN7;SENP8;SPSB3;ASB13;KTN1;SPSB1;FBXL12;FBXL5;FBXO21;KLHL5
prerank,mesonephros development (GO:0001823),-0.30976618282939206,-0.7573040859341296,0.7951219512195122,0.9269640204935186,1.0,2/11,7.72%,OSR1;FGF1
prerank,action potential (GO:0001508),0.25470593809748454,0.7570383146830921,0.810966810966811,0.9891463578696529,1.0,8/44,14.26%,ANK3;CACNA1G;GNA11;KCND2;KCNE4;SCN1A;AKAP6;SCN2A
prerank,synaptic vesicle localization (GO:0097479),0.3259726476272643,0.7569445510783546,0.7735191637630662,0.9887257998019701,1.0,4/13,17.06%,SYNDIG1;KIF5C;TMEM230;CDK5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.27380383345934745,-0.7566586699238653,0.7893462469733656,0.927184398349991,1.0,5/16,22.07%,BCL2L1;ACKR3;TPT1;SNAI1;CCAR2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3283116599846231,0.7564379106329372,0.7504393673110721,0.9889882877561093,1.0,2/13,8.54%,PPARA;PINK1
prerank,neural crest cell development (GO:0014032),0.24882693415999876,0.7562066134133844,0.8328445747800587,0.9888013596850449,1.0,6/44,10.40%,NRG1;SEMA5A;ERBB4;HTR2B;TAPT1;SOX10
prerank,histone deubiquitination (GO:0016578),0.29921676623041527,0.7560719625411727,0.7697594501718213,0.9884591926094897,1.0,8/18,25.13%,KAT2A;ENY2;USP21;USP16;USP49;TAF10;USP22;USP36
prerank,negative regulation of cell cycle (GO:0045786),0.23496825919620856,0.7553422090968883,0.8567708333333334,0.9890396043918244,1.0,14/73,16.42%,NR2F2;PTEN;CDKN2A;SIPA1;SCRIB;DUSP1;GMNN;BMP7;HTRA2;PDCD4;TSPYL2;TFAP4;RNF167;BRINP1
prerank,mitotic cytokinesis (GO:0000281),0.24942590604594075,0.7548362254302751,0.829232995658466,0.9892768520442181,1.0,12/47,17.54%,UNC119;SPTBN1;ANK3;EFHC1;JTB;INCENP;NUSAP1;RTKN;STMN1;CEP55;STAMBP;CUL7
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.32226462031235775,0.7546187225902722,0.76592082616179,0.9885127419515998,1.0,1/12,1.17%,SPRY4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.32226462031235775,0.7546187225902722,0.76592082616179,0.9885127419515998,1.0,1/12,1.17%,SPRY4
prerank,macroautophagy (GO:0016236),0.2163298551899277,0.754233166366861,0.9088575096277278,0.988543536191773,1.0,25/118,17.66%,DYNLL1;PIP4K2A;VPS39;VIPAS39;PINK1;RB1CC1;SNAP29;PLAA;ARL8B;TMEM74;LIX1L;VAMP7;HGS;MFN1;TSG101;HDAC10;ATG14;DYNLL2;SNF8;CSNK2A2;VPS33B;YOD1;UBXN6;VPS4B;WIPI2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2857484015683087,-0.7538165627585955,0.814385150812065,0.9304300330851574,1.0,5/14,24.26%,TNKS2;ATR;TERT;TPP1;ACD
prerank,proton transmembrane transport (GO:1902600),0.2626979009162043,0.7537147638210323,0.8110599078341014,0.9887596047764483,1.0,3/36,5.55%,ATP1A2;ATP1A3;SLC9A1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.28900483663378596,0.7533321739225625,0.792778649921507,0.9888141213730065,1.0,2/20,5.02%,PPID;PPIH
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2187409433763833,0.752991276754009,0.8856416772554002,0.9887954321218437,1.0,20/110,16.17%,HRG;NRG1;TRAF3IP1;SORL1;NAPB;MPP7;PINK1;SAR1A;IAPP;EIF2AK2;SLF1;SPIDR;CDT1;KIF9;HSPA5;TIRAP;BAK1;CLU;SLF2;IMPACT
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.20490019116556002,-0.7528761782220765,0.9003322259136213,0.9310825400798053,1.0,12/52,15.91%,TUT7;SAMD4A;CNOT10;PARN;PAN3;LSM6;CNOT8;RC3H1;EXOSC2;LSM2;NT5C3B;EXOSC3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.26858150588540725,-0.7527076401596479,0.8131067961165048,0.930676782473357,1.0,4/18,12.06%,PARN;CCT3;CCT4;CCT7
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.27408266305157314,0.7524273328450712,0.8092307692307692,0.989104979786073,1.0,9/29,21.06%,ERCC5;RPA1;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1;CDK7
prerank,negative regulation of signaling (GO:0023057),-0.24472542658221874,-0.7523424252324272,0.8467741935483871,0.9305049958665148,1.0,4/25,10.83%,IGFBP3;ACVR1;OPTN;PTPN1
prerank,histone H2A acetylation (GO:0043968),0.31645724518968477,0.7522961083488351,0.7902439024390244,0.9887561290564979,1.0,8/16,26.45%,MORF4L1;BRD8;EPC1;DMAP1;ING3;ACTL6A;MORF4L2;YEATS4
prerank,mitochondrial translational termination (GO:0070126),0.22481775444086718,0.7521002469239181,0.8829516539440203,0.9884747322274562,1.0,30/88,28.12%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL30;MRPL28;MRPS30;DAP3;MRPL10;GFM2;ERAL1;MRPL3;MRPS23;MRPL49;MTRF1L;MRPL51;MRPS5;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;MRPL14;MRPL32;CHCHD1;MRPL1;MRPL47;MRPL12
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2308072001240134,0.7516485654764271,0.8456284153005464,0.9885952839899925,1.0,17/69,16.79%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;SEC61B;TMEM67;DNAJC10;USP19;HSP90B1;BAG6;HSPA5;YOD1;DNAJB14
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.2993481719942442,-0.7514939060325669,0.8290398126463701,0.9310056275150174,1.0,6/12,24.24%,CLN5;ATP6AP2;TMEM9;CCDC115;TMEM199;CLN6
prerank,pseudouridine synthesis (GO:0001522),-0.28871943675527223,-0.7514449474700315,0.7926267281105991,0.9304311497249412,1.0,6/13,33.41%,PUS10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,positive regulation of protein kinase activity (GO:0045860),0.20997668740986386,0.75106506675632,0.9148681055155875,0.9889513812077824,1.0,27/148,18.34%,IL34;UNC119;TRAF4;MAP4K4;DLG3;CENPE;MTCP1;CALCA;MRNIP;PTK2;JTB;RELN;CACUL1;MAP2K1;DAXX;GRM5;DLG4;INCENP;CASS4;AXIN1;STRADB;CLU;TNIK;EFNA1;PAK5;ADRA2A;RHOA
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2428471847159725,-0.7505131709360621,0.8412698412698413,0.9310071264813655,1.0,7/25,21.40%,ATXN7;APC;APC2;TRPV4;CAMSAP2;CIB1;KATNB1
prerank,respiratory electron transport chain (GO:0022904),0.3199832399716719,0.7504379246296312,0.7634228187919463,0.9893591446927139,1.0,2/14,8.53%,SDHB;SLC25A22
prerank,positive regulation of DNA replication (GO:0045740),-0.27317455050965106,-0.7502274278682084,0.8058035714285714,0.9307496455123194,1.0,4/16,12.44%,EGFR;GLI2;STN1;PCNA
prerank,neuron projection fasciculation (GO:0106030),0.34389092772783003,0.7500235828439779,0.7677902621722846,0.9894398395296025,1.0,4/10,16.06%,SEMA5A;CNTN4;ARHGAP35;NRCAM
prerank,cellular response to BMP stimulus (GO:0071773),0.23789845929980574,0.7499204514853215,0.8492392807745505,0.9890320458554187,1.0,4/66,2.75%,RUNX2;RGMB;RGMA;SMAD5
prerank,regulation of cell cycle (GO:0051726),0.1984489671057294,0.7498805769506289,0.9413680781758957,0.9885331274345074,1.0,49/271,17.06%,CDC14B;L3MBTL1;TCF7L2;FAP;NANOS3;CDKN2A;SIPA1;DUSP1;FBXO5;GBF1;TBX3;RNF40;RRP8;DHCR24;CDKN2D;GMNN;PER2;CCNB2;SOX2;PRKACA;BMP7;MAP2K1;BIRC2;TP53;TTC28;TGFBR1;SOX9;IL12A;HTRA2;PDCD4;FIGNL1;CDKN2C;FOXM1;TSPYL2;MED25;CSNK2A2;TFAP4;CDK10;MLF1;MYC;FGFR2;RNF167;CENPF;BRINP1;TSC1;SRA1;CCPG1;CALR;CDK5
prerank,regulation of necroptotic process (GO:0060544),-0.2504897654661846,-0.7498485319730973,0.8026315789473685,0.9306025731119624,1.0,11/23,26.10%,YBX3;PELI1;CASP8;CYLD;SDCBP;PDCD6IP;MLKL;CFLAR;BIRC3;SLC25A4;FLOT1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.30774323729356545,0.7494229911983383,0.7811447811447811,0.9886705556288231,1.0,2/15,6.74%,REST;ZFP36L2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.29054648268337785,-0.7492410914241342,0.8151447661469933,0.930724826808607,1.0,6/13,22.48%,MTM1;FEZ2;TMEM39A;CHMP4B;CHMP4A;NUPR1
prerank,microtubule anchoring at centrosome (GO:0034454),0.33590539495372324,0.749010040359357,0.7481617647058824,0.9887247538310089,1.0,5/10,21.10%,PCM1;CEP19;NIN;KIF3A;BBS4
prerank,2-oxoglutarate metabolic process (GO:0006103),0.31838448426373467,0.7488542589516988,0.7705779334500875,0.9884008153998358,1.0,2/13,9.65%,L2HGDH;DLST
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.23761540758551078,0.7487662017063852,0.8400556328233658,0.9879710448133778,1.0,8/57,15.05%,CDC14B;TIPIN;FBXO31;MRNIP;TP53;RINT1;EME2;ATF2
prerank,ureteric bud morphogenesis (GO:0060675),0.31638021028070645,0.7487557627465216,0.7996389891696751,0.9874321650172558,1.0,6/16,25.12%,SALL1;GDNF;MYC;BMP2;PAX2;BMP4
prerank,transferrin transport (GO:0033572),0.255265236178689,0.7486809890144809,0.8320726172465961,0.9869836867599407,1.0,7/33,19.32%,STEAP3;ARHGAP1;ATP6V0E1;MCOLN1;ATP6V1G2;ATP6V0D1;ATP6AP1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.34697288478319444,0.7486031869999739,0.7526501766784452,0.9865450814223277,1.0,2/10,8.59%,GFPT2;PFKM
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.27715927605526536,0.7481922005618945,0.7931034482758621,0.9866002904526963,1.0,4/26,14.53%,TREML4;PTPN22;CYBA;TIRAP
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3329907319625133,0.7479525758180068,0.7632933104631218,0.986409161299459,1.0,3/11,14.41%,SIRT6;MPHOSPH8;RESF1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.2863731189990538,0.7477555453508182,0.7980456026058632,0.9861749262318551,1.0,4/20,14.72%,OGT;FLOT2;BIRC2;RIPK1
prerank,positive regulation of secretion by cell (GO:1903532),0.2304135122887236,0.7476579363982635,0.8715846994535519,0.9857918776831467,1.0,14/70,19.32%,EDN3;CADPS2;PPID;CADPS;IER3IP1;EXOC1;P2RX4;CLASP2;CLASP1;RAB2B;ADAM8;STXBP5;BMP2;ATP6AP1
prerank,glycerol metabolic process (GO:0006071),0.3395414916953758,0.7471671201860166,0.7760942760942761,0.985982609229726,1.0,2/10,10.07%,COQ3;GK
prerank,cellular response to misfolded protein (GO:0071218),-0.2537654649208826,-0.747098015262953,0.8383838383838383,0.9329085355185012,1.0,6/20,21.90%,RNF185;VCP;TOR1A;CUL3;RNF5;UGGT1
prerank,DNA recombination (GO:0006310),0.253787656228356,0.7462881949566688,0.8379629629629629,0.9867201102623271,1.0,10/37,22.27%,ERCC1;MSH3;RPA1;RECQL;RAD52;HDAC10;FBH1;WRN;HMGB1;RAD54L
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.30919644637014426,-0.7462692135565839,0.7991452991452992,0.9333984997188483,1.0,4/10,12.60%,NCK1;CITED2;VHL;BAG3
prerank,RNA biosynthetic process (GO:0032774),0.26104503458726386,0.7460942276658579,0.8215962441314554,0.9864577373890115,1.0,3/31,10.19%,TAF12;POLA1;TBPL1
prerank,snRNA transcription (GO:0009301),0.23030301289231936,0.7456217542633644,0.878213802435724,0.986609977243748,1.0,24/70,27.09%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;USPL1;SP1;POLR2L;TAF11;GTF2B;CDK7;GTF2A2;CCNT2;POU2F1;POLR2D;TAF5;GTF2E1;RPRD2;ELL;INTS6
prerank,regulation of neuron apoptotic process (GO:0043523),0.22224110093509689,0.7451228304990627,0.8824289405684754,0.986812581296733,1.0,9/96,9.24%,EPHA7;SLC30A10;NTRK2;GRID2;NF1;PRKCI;EGLN2;PINK1;LGMN
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.2551013217381757,-0.745121810043813,0.8186157517899761,0.934248675334342,1.0,7/19,30.41%,PRKDC;MDK;PPP2R3C;RHOH;CD27;NCKAP1L;IL7
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.28539149949903586,0.7449718222463109,0.8032786885245902,0.9864780245334446,1.0,7/22,22.09%,CDK13;THOC5;CCNK;KAT7;CDC73;DDX39B;CCNT2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.22550770601153808,-0.7447942100753285,0.8625730994152047,0.9340689841737817,1.0,10/35,19.98%,EZR;MINK1;XDH;GADD45B;CYLD;MAP3K4;PER1;DLG1;MFHAS1;GADD45G
prerank,negative regulation of phosphatase activity (GO:0010923),0.27924911770977817,0.7446627134162415,0.7951612903225806,0.9863957411017892,1.0,6/25,15.84%,BOD1;GPATCH2;PTPA;PPP1R26;ZCCHC9;CRY2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.26016169488286167,0.7436140396671309,0.8258164852255054,0.9874454861385437,1.0,1/32,0.36%,CDC14B
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.21008773514366832,0.7431631208011971,0.91320293398533,0.9875570985797312,1.0,20/136,15.26%,XCL1;TCF7L2;CDKN2A;FOXS1;PSMD10;BRMS1;TRIM37;TAF3;LRRC14;SP100;COMMD1;BMP7;IRAK1;DAP;PYCARD;PTGIS;PIM1;CTNNBIP1;PRMT2;PAXIP1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.26847863349643125,0.7430664389028602,0.8272583201267829,0.9871421452252938,1.0,7/32,16.64%,NR1H4;NANOS3;MTPN;GRM5;RBM4B;TSC1;CYFIP1
prerank,negative regulation of secretion by cell (GO:1903531),0.2551906777298127,0.7423943189340254,0.8189910979228486,0.9875662638479524,1.0,6/38,17.19%,STXBP6;PNKD;TRH;IL12A;IL1RAPL1;GRM7
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24597266986070115,0.7417020904534919,0.8394160583941606,0.9880182555290012,1.0,11/48,18.78%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.31008133330640764,-0.741458853789876,0.8,0.937503373440391,1.0,6/10,29.12%,RAPGEF3;SPHK2;BRCA1;SMAD4;CHEK1;HDAC5
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.26382731303733653,0.7406270062123421,0.832807570977918,0.9890876220048215,1.0,10/31,19.86%,PTEN;CDKN2A;SUSD2;CDKN2D;JADE1;CDKN2C;PRMT2;BRD7;CDC73;CCL2
prerank,regulation of cellular catabolic process (GO:0031329),0.23182075323728374,0.740567482283039,0.856353591160221,0.9886302698265914,1.0,7/62,7.80%,PIP4K2A;ITPR1;PIK3R2;MTMR4;LRRK2;RAB8A;WDR24
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2584958444858604,-0.7405288778671741,0.837037037037037,0.9380519663541579,1.0,4/18,12.75%,ADAM10;APOE;APH1A;APH1B
prerank,fatty acid oxidation (GO:0019395),0.23733828550863303,0.7398701209538251,0.8387096774193549,0.9890906742858412,1.0,5/57,6.52%,ABCD2;PEX2;PPARD;ACADL;ACADS
prerank,protein monoubiquitination (GO:0006513),-0.21660833939461016,-0.7397002651136195,0.8856304985337243,0.9384464035147279,1.0,8/36,25.32%,MGRN1;UBE2D3;TRIM25;UBE3D;CUL3;LEO1;RNF20;DTX3L
prerank,pentose-phosphate shunt (GO:0006098),-0.304621669244308,-0.7395962104385723,0.7968397291196389,0.9379221066109165,1.0,5/11,24.18%,DERA;TALDO1;PGM2;SHPK;PGLS
prerank,negative regulation of histone methylation (GO:0031061),0.33515514871445207,0.7392981166419161,0.7736549165120594,0.9893750214945307,1.0,3/10,15.93%,BCOR;WDR5;AASS
prerank,serine family amino acid metabolic process (GO:0009069),0.30415609716633696,0.7390489928942124,0.7760683760683761,0.989177545047882,1.0,1/16,1.44%,THNSL2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.306528529082983,0.7390112274132496,0.8020833333333334,0.98868413966402,1.0,4/15,19.23%,RYR2;SRPRA;ZFAND2A;RAB3GAP2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.30995895264774487,0.7381685723572067,0.7903780068728522,0.9893450344675453,1.0,4/15,19.21%,KCNIP2;KCNN2;KCNJ8;KCNJ3
prerank,telomere maintenance via telomerase (GO:0007004),0.2708132103355129,0.7380145397521667,0.8247261345852895,0.9890223742493903,1.0,7/28,18.91%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3110469691105932,0.7377620975487792,0.7872696817420436,0.9888527622604956,1.0,3/14,12.66%,CD40;PRKCI;PDCD4
prerank,protein polyglutamylation (GO:0018095),0.32563468403655643,0.7375042578712179,0.7843137254901961,0.9886668138688706,1.0,2/11,13.54%,TTLL6;TPGS1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.2950148765768943,0.7372128002175199,0.7917355371900826,0.9885461601696178,1.0,3/17,7.82%,SPRED1;DGKQ;SPRED2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.28787132260923054,-0.7368032856235218,0.7841726618705036,0.9406920351418891,1.0,5/13,22.21%,PRPF3;LSM2;CD2BP2;PRPF19;DDX20
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.22668293223198696,0.7367026744230268,0.8896457765667575,0.9887373112117692,1.0,7/73,9.47%,NTRK3;SH2D3C;MTCP1;DOCK7;PRKD1;PINK1;TENM1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.33596648118789707,0.7363375893357502,0.7761467889908257,0.9887205849301004,1.0,6/10,26.78%,EMC2;EMC9;EMC8;EMC10;EMC4;EMC1
prerank,RNA export from nucleus (GO:0006405),0.2186888057672459,0.7360903817779604,0.8997429305912596,0.9885433643586694,1.0,25/100,21.21%,EIF4A3;NUP214;AAAS;THOC7;POM121;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;FYTTD1;SYMPK;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;DDX39B;MCM3AP;RANBP2
prerank,transition metal ion transport (GO:0000041),0.2574290365935102,0.7357945257906179,0.8181818181818182,0.9884026893835453,1.0,6/35,13.86%,SLC30A10;SLC30A5;TRPC3;TRPC7;HEPH;ATP7A
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.25258790409161214,-0.7355606011830905,0.8453865336658354,0.9416135430756201,1.0,6/18,25.18%,ASH1L;SMYD2;EEF1AKMT2;SETMAR;SETD1A;KMT2B
prerank,body fluid secretion (GO:0007589),0.3127023614443717,0.7355266063215281,0.800978792822186,0.9882219646780565,1.0,1/15,2.23%,ERBB4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.27830968964666325,0.7354993204769675,0.8243451463790447,0.9877049686964989,1.0,4/23,11.83%,SLC12A6;SLC9A1;CLCN3;PDK2
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.29203717542655067,-0.7354096388284483,0.787746170678337,0.9411493701651347,1.0,6/11,34.63%,ZC3H3;LEO1;NCBP2;AHCYL1;BARD1;PAPOLA
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.22711933557756697,-0.7349399668850107,0.8746438746438746,0.9410337653372477,1.0,8/31,14.71%,TMBIM6;HSPA8;HSPB8;BAX;OPTN;PTPN1;BAG3;ERN1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.312589788789017,-0.7346967608443282,0.8132118451025057,0.9407242277297944,1.0,5/10,24.01%,THOC1;ETAA1;CCAR2;RFWD3;RPA2
prerank,spliceosomal snRNP assembly (GO:0000387),0.25238704766571496,0.7339776755435522,0.8515742128935532,0.9892730268249961,1.0,14/38,26.47%,GEMIN2;LSM4;SNUPN;SRSF10;CLNS1A;SNRPF;USP4;GEMIN8;PRPF8;SRSF12;GEMIN5;GEMIN7;SNRPG;COIL
prerank,myoblast fusion (GO:0007520),0.3290361020346846,0.7332462827906848,0.7912280701754386,0.9897174121596439,1.0,4/12,18.88%,ADGRB3;ADAM12;CD81;KCNH1
prerank,postreplication repair (GO:0006301),0.24395765226571164,0.7331897558564712,0.8581979320531757,0.9892560297861492,1.0,11/45,14.95%,POLK;RPA1;UBE2V2;RFC3;POLH;FAAP20;POLN;SPRTN;REV1;POLI;UBE2V1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.25790569172452243,0.733014164179101,0.8349056603773585,0.9889589141762106,1.0,10/33,19.33%,DNAAF4;NCOA2;CARM1;AXIN1;SAFB2;PRMT2;AR;CALR;CBFB;DDRGK1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.27190570842743833,0.7326095332884583,0.8137404580152672,0.9890000846754001,1.0,6/26,13.83%,PDPK1;ZFP36L2;DUSP22;SOX9;GAREM1;MED1
prerank,response to interleukin-1 (GO:0070555),0.22526559856280978,0.7324982865198493,0.8990944372574385,0.9886001742815019,1.0,10/73,12.20%,XCL1;CD40;CCL15;ADAMTS12;PRKCA;IRAK1;CCL25;PYCARD;PTGIS;SOX9
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.28078552591740974,0.7324635777018419,0.8061889250814332,0.9875635614058085,1.0,7/22,20.29%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.28078552591740974,0.7324635777018419,0.8061889250814332,0.9875635614058085,1.0,7/22,20.29%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.27912160705433,-0.7321044435506407,0.7995226730310262,0.9431940695107908,1.0,3/14,12.75%,ADAM10;APH1A;APH1B
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2664504652682973,-0.7314347212671304,0.8382352941176471,0.9433528043835739,1.0,9/17,32.01%,MTBP;ZW10;BUB3;CTCF;RB1;IK;TTK;ZWILCH;CENPA
prerank,positive regulation of transporter activity (GO:0032411),0.31151285245955185,0.7310377859403429,0.7956081081081081,0.9890116034840608,1.0,3/13,15.68%,KMT2A;KCTD7;SGK1
prerank,positive regulation of calcium ion import (GO:0090280),0.3150922191362599,0.7307752957638611,0.7728055077452668,0.9888412647504123,1.0,3/12,19.86%,STC1;PDGFRB;CCL2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2503313306099946,-0.73050271235002,0.8650793650793651,0.9438369015856216,1.0,11/21,35.72%,NES;CX3CR1;MDK;FZD3;CX3CL1;SMARCD3;KDM1A;DLL4;DISP3;LRP2;FZD9
prerank,positive regulation of interleukin-17 production (GO:0032740),0.2795284981387289,0.7303469786827288,0.8250825082508251,0.9889049812274486,1.0,1/22,1.54%,NR1H4
prerank,epithelial cell development (GO:0002064),-0.2534924966904347,-0.7301162258608899,0.8419689119170984,0.9436959921066463,1.0,13/20,44.61%,WNT5B;ACTA2;DACT2;SLC4A7;EXPH5;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3043654749571267,0.7301029407777956,0.8040540540540541,0.9886920832979929,1.0,5/15,21.31%,REEP2;LNPK;RTN3;ZFYVE27;ATL1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.2492045928966079,0.7289591970594946,0.857566765578635,0.9897546724300768,1.0,12/42,23.47%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS2;SARS1;AIMP1;PPA2;MARS2;AARS1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2797451682216493,0.727903845474546,0.7929373996789727,0.9906738938557905,1.0,2/20,3.93%,MBTPS2;NGFR
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.286330700412723,0.7269894801556197,0.800658978583196,0.9913443481462856,1.0,7/20,18.77%,SPRY1;TBX3;TGFBR1;OLFM1;PDCD4;BMP2;HEY1
prerank,ncRNA export from nucleus (GO:0097064),0.2532649656423517,0.7266523160116644,0.8612804878048781,0.991270711524797,1.0,11/36,24.04%,NUP214;AAAS;POM121;NUP42;NUP107;TSC1;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.23758973736373754,0.7259659614997958,0.8662790697674418,0.991674390248249,1.0,15/49,24.66%,TRAF3IP1;THRA;SORL1;JAM3;IAPP;HSPA5;CLU;IMPACT;PTGER4;TFIP11;ANKRD27;HMGB1;NLRP2B;KIF14;PMEPA1
prerank,piRNA metabolic process (GO:0034587),0.28185192256766545,0.7259129006521596,0.8100840336134454,0.9912171569424029,1.0,1/19,2.52%,TDRKH
prerank,protein ubiquitination (GO:0016567),0.18751790318358763,0.7253442888779351,0.9885057471264368,0.9914584852187758,1.0,96/471,20.05%,PDZRN3;SH3RF1;CCDC22;MYCBP2;FBXO9;SH3RF3;RNF220;PEX2;FBXO45;PSMD1;DTX4;FBXO31;BFAR;RNF40;FBXO28;ZSWIM8;NEDD4;RTF1;CDC16;EPAS1;PSMD10;BLMH;UCHL3;CRBN;UBE2QL1;PSMA5;TRIM37;PSMB5;UBE2G2;TRIM23;PINK1;UVSSA;RNF168;COMMD1;BIRC2;UBE2V2;FBXO17;PSMC4;PSMA4;RNF181;PSMC5;FBXW5;ASB1;FBXL13;CUL5;RNF182;CAND1;AREL1;TRIM44;PSMB9;PHC1;TRIM2;UBE2D1;RNF31;DDA1;UBE2Q2;RNF122;RC3H2;UBE2V1;TRIM3;RNF167;DET1;HACE1;RNF208;PSMD14;PSMA7;TRIM26;RRAGA;HECW1;KLHL22;FBH1;CUL7;PEX12;PSMD11;RNF187;PSMA2;CBFB;RNF19B;TRAIP;HIF1A;UBE2E3;RNF217;CUL4A;UBE2E2;FBXO4;PEX14;RNF144A;KLHL8;RNF13;FBXW4;UBE2J1;CDC73;BIRC6;SPSB2;DDB1;WSB1
prerank,phagosome maturation (GO:0090382),0.24955413605896726,0.7251389427437983,0.8702290076335878,0.9911847885412094,1.0,2/35,2.38%,RAB34;RAB20
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.32768334026445095,0.725138833181521,0.7931034482758621,0.9901044781449791,1.0,3/11,17.43%,AGO4;AGO3;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.32768334026445095,0.725138833181521,0.7931034482758621,0.9901044781449791,1.0,3/11,17.43%,AGO4;AGO3;AGO1
prerank,error-free translesion synthesis (GO:0070987),-0.24204691206089682,-0.7246518754834722,0.8654353562005277,0.9493509688709411,1.0,5/22,12.44%,NPLOC4;UBB;VCP;RCHY1;PCNA
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3014352845069844,0.7245734238155604,0.8252911813643927,0.9903368034394007,1.0,6/15,25.02%,GRM5;GRM7;GRM1;HOMER3;HOMER2;GRM8
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.2595467423459363,-0.7241673318458574,0.8481675392670157,0.9492748222089563,1.0,5/17,23.13%,CD55;TRIM5;CX3CL1;LY96;SIGIRR
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.25509233439765777,-0.7240222444439325,0.8548812664907651,0.9488042026407565,1.0,2/18,2.09%,NPLOC4;DDX60
prerank,nucleotide biosynthetic process (GO:0009165),0.2895098569320782,0.7239966324114824,0.832258064516129,0.9905564528545107,1.0,3/18,10.86%,NMNAT3;PRPS1L1;PRPS1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3002552964392633,0.7237675183412726,0.7959527824620574,0.9903236277640622,1.0,5/14,22.80%,NOL9;DDX18;URB1;RPL35;ZNHIT6
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2783229706627198,0.7236183275920139,0.8183306055646481,0.9899688707361024,1.0,3/21,8.95%,PTEN;CNKSR3;INPP5J
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3353158025526464,0.7235905601561734,0.7566607460035524,0.9894628049401408,1.0,5/10,24.85%,DSE;CSGALNACT2;B3GAT3;DSEL;B3GAT2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3038524260033865,0.7235210174013688,0.80623973727422,0.9890168848192867,1.0,5/14,22.09%,TLR6;IRAK1;TIRAP;TNFRSF10B;MALT1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2079120718962634,-0.7226923588486632,0.9,0.9497093721036541,1.0,15/45,23.73%,THAP4;GOT2;GPT2;RIMKLB;OAT;MTHFR;NOX4;ASS1;DDAH1;CBS;KYAT3;ASNS;DDAH2;GLUL;PYCR2
prerank,negative regulation of phagocytosis (GO:0050765),-0.262594702683027,-0.7221252234762324,0.8247422680412371,0.9497480686169739,1.0,3/17,18.88%,SIRPA;DYSF;SNX3
prerank,CENP-A containing chromatin organization (GO:0061641),0.2558882932842499,0.721642129257969,0.8156146179401993,0.9904644067495816,1.0,5/29,14.63%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.2558882932842499,0.721642129257969,0.8156146179401993,0.9904644067495816,1.0,5/29,14.63%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.27217193847294574,-0.7211441663867021,0.8450704225352113,0.9502133112836882,1.0,3/14,17.99%,MOXD1;NOS1;SLC22A2
prerank,protein localization to vacuole (GO:0072665),0.3107578331003896,0.720965423035573,0.7955326460481099,0.9908368984316193,1.0,3/13,13.40%,SZT2;RNF128;CD81
prerank,positive regulation of cellular senescence (GO:2000774),0.32661200545886043,0.7205137553509575,0.8035714285714286,0.9908911962989518,1.0,1/10,2.73%,CDKN2A
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.22229330073536369,0.72002121746449,0.9140083217753121,0.9909858507873769,1.0,3/72,4.07%,FLRT2;FGFR1;SPRED1
prerank,regulation of protein acetylation (GO:1901983),0.3086878648187149,0.7198796829527213,0.8115942028985508,0.9906436770382512,1.0,2/12,7.71%,CEP295;FAM161A
prerank,positive regulation of viral life cycle (GO:1903902),0.2743534560349957,0.7198208609938809,0.8316831683168316,0.9902016567764066,1.0,7/22,22.11%,FMR1;AXL;LGALS1;TSG101;LGALS9;DDB1;KPNA2
prerank,zymogen activation (GO:0031638),0.24787210307064886,0.719424049968419,0.8447024673439768,0.9901716833544161,1.0,7/39,15.02%,KLKB1;GRIN2A;OMA1;PLAU;LGMN;ASPH;BAK1
prerank,tRNA transport (GO:0051031),0.2491028730446672,0.7187677424621355,0.8505917159763313,0.9904686368778666,1.0,10/35,24.04%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,cellular response to radiation (GO:0071478),0.2424943346589263,0.7186330471204262,0.8569321533923304,0.9901047207966468,1.0,5/40,12.82%,GPR88;GPR52;TP53;SPIDR;FIGNL1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.21233796223348805,-0.7183333740213831,0.9123867069486404,0.9527160337423695,1.0,6/40,10.42%,SLC13A3;SLC38A11;SLC16A1;SLC38A5;SLC38A10;SLC7A5
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.30551295330314565,0.7182349250615625,0.7934027777777778,0.9900795876234405,1.0,2/13,10.29%,UNC93B1;IRAK1
prerank,translesion synthesis (GO:0019985),0.24059965111968418,0.7179694149649173,0.8727544910179641,0.9898905884073631,1.0,10/42,13.66%,POLK;RPA1;RFC3;POLH;REV3L;FAAP20;POLN;SPRTN;REV1;POLI
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2631155351109594,-0.7176846108233411,0.849624060150376,0.952795245618952,1.0,3/16,12.08%,ST3GAL4;ETS1;MDK
prerank,positive regulation of viral transcription (GO:0050434),-0.23497608915228552,-0.717555572879612,0.8769633507853403,0.9522897737106095,1.0,10/25,28.30%,POLR2B;POLR2H;POLR2G;POLR2C;CDK9;NELFCD;CTDP1;GTF2F2;POLR2I;POLR2K
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.26402967735226235,0.717505737710765,0.8596214511041009,0.989927616413077,1.0,4/26,9.74%,FLOT2;LRRC14;APPL2;BIRC2
prerank,negative regulation of calcium ion transport (GO:0051926),0.2967343718232341,0.7170590022076152,0.8169491525423729,0.9899835312554479,1.0,4/15,17.80%,ATP1A2;PACSIN3;STC1;ADRA2A
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.2536317890045853,-0.7168426485477214,0.8778054862842892,0.9524231649285112,1.0,3/17,16.47%,SLC7A5;PRKCZ;HAVCR2
prerank,peptidyl-methionine modification (GO:0018206),0.31476464470219423,0.7167282676621519,0.7969639468690702,0.9898677180497987,1.0,1/12,6.01%,METAP1D
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2210724547946244,0.7164864828062623,0.9149797570850202,0.9896409546236878,1.0,23/69,27.09%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;SP1;POLR2L;TAF11;GTF2B;CDK7;GTF2A2;CCNT2;POU2F1;POLR2D;TAF5;GTF2E1;RPRD2;ELL;INTS6
prerank,response to interferon-alpha (GO:0035455),-0.268121351129865,-0.7163608211251681,0.829683698296837,0.9522963672987741,1.0,4/16,10.14%,IFITM3;IFNAR1;IFITM1;KLHL20
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2824318168885787,0.7160686026454225,0.8201680672268907,0.9896421344913727,1.0,7/18,22.71%,NOL3;PINK1;HTRA2;NONO;HIF1A;BAG5;MAPK7
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.2825593873758224,-0.7154776170630848,0.805045871559633,0.9526828770061486,1.0,3/12,13.78%,DIAPH1;ANK2;PTK2B
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2598518685991134,0.7154332653741245,0.8683001531393568,0.9899355744725429,1.0,10/30,22.39%,ENTPD5;SELENOF;DNAJB12;HSPA13;HSPA5;DNAJB14;HSPE1;ST13;HSPA9;CHCHD4
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.2508384228135695,0.714755143708255,0.8942457231726283,0.9902598441299248,1.0,6/32,18.27%,DLC1;MTOR;PTPA;ANKLE2;SYMPK;PDGFRB
prerank,regulation of cell division (GO:0051302),0.22205400215040172,0.7142062438626458,0.9270687237026648,0.9904333110388145,1.0,12/72,15.69%,KDF1;SUSD2;EFHC1;NCOA3;HTR2B;ZFYVE26;INSC;ENTR1;RAB11FIP3;SMYD5;MYC;FGFR2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.268576804673749,-0.7139146751531888,0.8461538461538461,0.9536216793047195,1.0,6/14,32.66%,PTPN2;CCDC3;RFFL;PELI3;GPS2;PYDC1
prerank,melanosome localization (GO:0032400),-0.24211173931943553,-0.7134632236057524,0.8899755501222494,0.9535286094550794,1.0,8/21,31.20%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A;VPS33A
prerank,mitochondrial translation (GO:0032543),0.20859994639928886,0.7133021162502828,0.9486215538847118,0.9910643114554242,1.0,27/104,23.97%,MRPL44;EARS2;MRPS31;MRPS24;MTRF1;MRPS26;MRPL30;MRPL28;MRPS30;DAP3;MRPL10;GFM2;ERAL1;HARS1;MRPL3;MTIF2;MRPS23;MRPL49;MTRF1L;MRPL51;MRPS5;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21
prerank,histone mRNA metabolic process (GO:0008334),0.2638221815333218,0.7131921828186866,0.8617511520737328,0.9906736803355206,1.0,6/27,15.52%,LSM11;TENT4B;TENT2;SLBP;SNRPF;EXOSC10
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23700108696990413,0.7129230218024779,0.8887303851640513,0.9904831233170899,1.0,6/45,9.99%,BUB1B;SCRIB;ZFP36L2;BCL6;BMP7;NME6
prerank,negative regulation by host of viral process (GO:0044793),-0.3007402642518897,-0.7128764376239345,0.8329297820823245,0.9535408588519504,1.0,7/10,45.67%,VAPA;PSMC3;PRKN;CRP;ZC3H12A;CCL8;PTX3
prerank,regulation of programmed cell death (GO:0043067),0.1979647034940491,0.7124215197708361,0.9658421672555948,0.9905963282098913,1.0,32/161,17.06%,CXCL10;STEAP3;HS1BP3;CASP6;LRRK2;TM7SF3;ACTN1;OMA1;BCL6;USP42;BRMS1;CIDEA;PINK1;DAXX;BIRC2;TMEM219;TP53;SLK;PSMC5;SOX9;RTKN;LGALS1;AIFM2;NME1;RIPK1;CLU;SGK1;ZBTB7A;SRA1;HAX1;CALR;CDK5
prerank,regulation of tumor necrosis factor production (GO:0032680),0.20760948397498277,0.7123834427860645,0.9462759462759462,0.9901148518749858,1.0,13/112,15.16%,IL33;NR1H4;WNT5A;PTPN22;TWIST1;CIDEA;TLR4;CYBA;PYCARD;TIRAP;RIPK1;CLU;DHX9
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2663672823329763,-0.7123582635212409,0.8840579710144928,0.953484638173569,1.0,5/15,20.05%,SMPD3;SDC4;SDC1;SDCBP;PDCD6IP
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.27755480616328876,-0.712281277064559,0.861904761904762,0.952929274479964,1.0,5/12,25.07%,CRYAB;APOE;PFDN4;PFDN2;PFDN6
prerank,RNA methylation (GO:0001510),-0.1863242067518066,-0.711815861058858,0.9424460431654677,0.9527734317766012,1.0,17/60,26.45%,VIRMA;NSUN2;TRMT61B;CMTR1;FTSJ1;TRDMT1;TRMT5;METTL6;THUMPD2;GTPBP3;RBM15B;MEPCE;TRMT6;MRM2;TRMT12;TRMT112;NOP2
prerank,establishment of vesicle localization (GO:0051650),-0.2507249082016664,-0.7117454414087333,0.850632911392405,0.9522355431384958,1.0,9/18,33.71%,CCDC186;TOR1A;SYNJ1;SPG11;IKBKG;KIF5B;RAB11A;F8A1;DNM2
prerank,necroptotic process (GO:0070266),-0.26374764773872744,-0.7116564745790714,0.8595641646489104,0.951704869995893,1.0,6/16,21.15%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96
prerank,negative regulation of cilium assembly (GO:1902018),-0.2833212686474443,-0.7112110242460404,0.8299319727891157,0.9515371529073157,1.0,5/12,32.84%,TBC1D7;EVI5L;ODF2L;MAP4;TBC1D30
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2780157375795543,0.7110993182550097,0.8461538461538461,0.9912285645362864,1.0,3/19,9.65%,SLC25A21;ASPA;DLST
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.20648297625517606,-0.7107628417188865,0.9260355029585798,0.9513972553494855,1.0,9/36,20.57%,ITGB1;SHANK3;NRP1;EPHB2;EDN1;HFE;EGF;ADRB2;HDAC6
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.21505586000437227,-0.7107559644907457,0.9125364431486881,0.9507700413791869,1.0,14/33,29.34%,PRKDC;MAPK14;ETS1;TAL1;ABCB10;HMGB2;PITHD1;FES;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,regulation of defense response to virus (GO:0050688),0.3016681124214915,0.7106995386047517,0.8433734939759037,0.9912157316602901,1.0,3/14,15.16%,TRAF3IP1;IFNLR1;DHX9
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.2692234019074836,-0.7101405625943672,0.852803738317757,0.9507702618705539,1.0,6/14,19.98%,WNT9A;PTHLH;RFLNA;EFEMP1;CHADL;RFLNB
prerank,programmed necrotic cell death (GO:0097300),-0.2568845063110155,-0.7100995355690183,0.8835443037974684,0.9501783147003957,1.0,7/18,22.92%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96;PPIF
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.27125450509574806,0.709716198612429,0.8498402555910544,0.9919073494751052,1.0,2/21,4.99%,FBXO5;CDC7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.23963000196009565,-0.7096984598187063,0.8894736842105263,0.9499538726654938,1.0,7/23,20.09%,HOOK1;CCDC88A;CCDC88C;CCDC186;DYNC1I1;KIF1C;TUBA1C
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.31036033371137794,0.7093958966833271,0.8300884955752212,0.9917632121302283,1.0,1/12,1.72%,TAF9B
prerank,iron ion transport (GO:0006826),0.2335746814877921,0.7085971176360741,0.8820960698689956,0.9922145454844733,1.0,10/47,19.32%,STEAP3;ARHGAP1;HEPH;ATP6V0E1;SLC39A14;ABCB7;MCOLN1;ATP6V1G2;ATP6V0D1;ATP6AP1
prerank,pigment granule transport (GO:0051904),-0.250936825540725,-0.7085371915061537,0.848780487804878,0.9498624145506604,1.0,6/18,28.50%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,melanosome transport (GO:0032402),-0.250936825540725,-0.7085371915061537,0.848780487804878,0.9498624145506604,1.0,6/18,28.50%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,negative regulation of locomotion (GO:0040013),0.30906256886499983,0.7083318887276837,0.7975567190226877,0.992001942714887,1.0,3/12,16.16%,SPOCK3;CRK;FBLN1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2263303781982292,0.7080261743541781,0.8932038834951457,0.991843458459619,1.0,18/62,24.50%,NUP214;AAAS;FMR1;DND1;POM121;NUP42;NUP107;DHX9;WTIP;AGO1;NUP54;NUP155;FXR1;POLR2L;RANBP2;NUP35;IPO8;POLR2D
prerank,sulfur amino acid metabolic process (GO:0000096),0.2663242401847343,0.7079314553287057,0.8502415458937198,0.9914322226597273,1.0,7/24,22.78%,MTRR;ADO;TXN2;DPEP1;MMUT;MSRA;MTHFD1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3153382783496143,0.7077034162673373,0.8107142857142857,0.9911801188151608,1.0,3/10,19.87%,PDE4B;CACNA2D1;NIPSNAP2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.27035791500783873,0.7076832985315906,0.8267716535433071,0.9906714218407981,1.0,5/23,20.03%,COPS3;XPC;COPS4;CUL4A;DDB1
prerank,DNA dealkylation (GO:0035510),-0.2972270414892678,-0.7073337431136798,0.8220338983050848,0.9498672792506092,1.0,5/10,27.10%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.2972270414892678,-0.7073337431136798,0.8220338983050848,0.9498672792506092,1.0,5/10,27.10%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2
prerank,translational termination (GO:0006415),0.21034035745565544,0.7071736776062113,0.9323116219667944,0.9907683711150085,1.0,28/95,25.67%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL30;MRPL28;MRPS30;DAP3;MRPL10;GFM2;N6AMT1;ERAL1;MRPL3;MRPS23;MRPL49;MTRF1L;MRPL51;MRPS5;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;ETF1;MRPL14;MRPL32
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.1962757204512815,-0.7068178269077128,0.9707792207792207,0.9497204342375504,1.0,13/49,26.75%,AFAP1L2;LBP;MAVS;LAMTOR5;SERPINE1;RAB1A;CD74;TLR7;BCL10;HYAL2;NOD2;HSPA1A;PARK7
prerank,snRNA processing (GO:0016180),0.2899355045356413,0.7060887906098706,0.8208955223880597,0.9915737561890218,1.0,2/16,11.42%,INTS8;INTS14
prerank,chromatin remodeling at centromere (GO:0031055),0.24769516686467583,0.7060446908290227,0.8464,0.9911072360563946,1.0,5/31,14.63%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,tRNA modification (GO:0006400),0.22513420919143665,0.7055054468655743,0.9152777777777777,0.9912028650545737,1.0,18/62,24.04%,CTU1;DUS2;QTRT2;TRMT13;OSGEP;TYW3;TRMT44;TRMT61A;PUS7;METTL1;WDR4;THUMPD3;TRMT10A;METTL2B;METTL2A;LCMT2;AARS1;SSB
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2584736170961121,0.7051850298720345,0.8714499252615845,0.991080476804341,1.0,6/29,14.72%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,positive regulation of interferon-beta production (GO:0032728),0.24807469965632375,0.704815788294503,0.8728682170542635,0.9909810712696036,1.0,6/33,15.83%,DHX58;TRIM56;TLR8;TLR4;DHX9;POLR3A
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.26592654182045833,-0.7048052222852617,0.8615751789976134,0.9510985862392618,1.0,1/14,2.21%,THBS1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.23522027360724831,0.7033172424821011,0.8896848137535817,0.9922508039554997,1.0,11/45,21.23%,PIK3R1;SLC30A10;PDPK1;PTK2;SOX9;GAREM1;AREG;NCK2;PTPN11;DGKD;CBL
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2523420676965621,-0.7031064372138695,0.8594847775175644,0.9522170644068745,1.0,4/16,16.05%,AMPD3;ADSS2;LHPP;PFAS
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2669203495312876,0.702221907280786,0.8610687022900764,0.9930290770898913,1.0,5/24,15.88%,NCKAP5L;STMN2;STMN4;STMN1;KIF2A
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2543601040635213,0.7015830806185798,0.8641063515509602,0.993294787830069,1.0,6/30,14.72%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2489078759221092,0.7013708433562742,0.8629283489096573,0.9930068662537955,1.0,6/30,19.33%,OGT;EIF3H;FHIT;BAG6;USP14;DDRGK1
prerank,protein complex oligomerization (GO:0051259),0.20904067188732464,0.700128132188488,0.9445178335535006,0.9939746759601803,1.0,14/85,13.26%,POLQ;MPP2;SLC9A1;NOL3;ADCY8;KCNC2;OPA1;NUDT21;GSDMD;GLRA3;VSTM5;PYCARD;WDCP;LRRC8A
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2382690845853142,0.6994508660862563,0.8898678414096917,0.9942259815858728,1.0,6/39,11.79%,MYO7A;MYO1B;MYO6;PPFIA2;TANC2;MYO1G
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2727436369209829,-0.6990595684149691,0.8771498771498771,0.9554930506709478,1.0,3/13,15.37%,TRIM5;TRIM11;TRIM35
prerank,regulation of biosynthetic process (GO:0009889),0.31473313033812256,0.6989744895193607,0.8298245614035088,0.9942539879699713,1.0,2/11,18.86%,SLC25A33;ALOX5
prerank,peptide hormone secretion (GO:0030072),0.25814308068214503,0.6988806762546621,0.8613251155624037,0.9938398496464477,1.0,2/26,6.77%,EDN3;RIMS2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.27992768010869407,0.6965146956096276,0.8691275167785235,0.9961076074274928,1.0,8/18,23.80%,LYAR;UTP15;EIF2AK3;POLR2L;HEATR1;DHX33;MAF1;ATF4
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.18388756290982322,-0.6962209245842954,0.9656488549618321,0.9575318433392713,1.0,14/63,15.18%,PRKDC;CNOT10;CRADD;SOX4;CASP2;PLAGL1;CNOT8;BTG2;BAX;PCNA;RPL26;ATM;CCND1;CDKN1A
prerank,response to histamine (GO:0034776),-0.2948756396734808,-0.6962074765175861,0.8543046357615894,0.9569228431597997,1.0,1/10,2.25%,DIAPH1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2143349729390231,0.6959608375730532,0.924901185770751,0.9962366363348792,1.0,16/76,19.28%,C5AR1;P2RY1;HTR2B;CALCA;TRHR;CCKBR;HTR2C;LPAR1;GNA11;GRM5;F2R;LHCGR;ADRA2A;GPR35;GRM1;CMKLR1
prerank,protein sumoylation (GO:0016925),0.229695763625446,0.6950807038753465,0.8952654232424677,0.9967030811186349,1.0,18/49,27.04%,NUP214;AAAS;POM121;PIAS2;SAE1;NUP42;NUP107;NUP54;NUP155;SUMO2;RANBP2;NUP35;UBA2;TRIM28;NSMCE2;IFIH1;NUP210;NUP88
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2520836952575428,0.6937567069559346,0.875993640699523,0.9976500693246672,1.0,12/29,26.19%,HSD17B8;ELOVL2;ACSL6;ACLY;ELOVL6;ELOVL1;ACSBG1;ACACA;SCD5;ELOVL5;TECR;PPT1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21364407090769583,0.6922465479007485,0.9179415855354659,0.9988433968531383,1.0,14/72,15.38%,ARID3A;CNOT11;E2F4;RPS6KA6;MYO6;MDM4;SP100;TP53;CARM1;CNOT1;FOXM1;PAXIP1;TFAP4;CNOT7
prerank,regulation of striated muscle contraction (GO:0006942),0.2563955135028604,0.6916652817894096,0.8819018404907976,0.998947563773411,1.0,4/27,11.26%,ATP1A2;RYR2;PRKACA;P2RX4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.2460179479354181,-0.6914462232611673,0.8716577540106952,0.9607165289895508,1.0,5/17,20.79%,ALG9;ALG12;MPDU1;NUS1;DOLPP1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.18200040869207196,-0.6912991346251521,0.9635627530364372,0.9602227007513626,1.0,22/68,28.45%,CAVIN1;GTF2H5;WDR33;UBTF;SNRPE;POLR2H;TTF1;POLR1H;CLP1;TAF1C;GTF2H4;POLR1G;POLR1C;NCBP2;POLR3K;LSM10;SSU72;SMN1;CPSF7;MED18;POLR2K;MTERF2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.23416588270198396,-0.6905636436021576,0.9063291139240506,0.9602520453933099,1.0,3/22,9.97%,PPM1E;PPM1F;PPM1D
prerank,Golgi ribbon formation (GO:0090161),-0.26559369661582294,-0.6904010072818757,0.8752941176470588,0.959788846175771,1.0,4/13,21.59%,VTI1A;OPTN;FHDC1;MYO18A
prerank,cellular response to chemical stress (GO:0062197),0.20272750172244053,0.690272376639908,0.9552429667519181,1.0,1.0,19/96,17.48%,ETV5;PRDX6;ALDH3B1;LRRK2;PRDX5;CCS;PYCR1;PRKD1;PINK1;CYBA;ERMP1;HTRA2;RAD52;EIF2S1;LONP1;VKORC1L1;TXNRD2;NOX1;NUDT2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2138308306751318,-0.6901831073589044,0.9313432835820895,0.9593639281154207,1.0,14/29,39.69%,PLA2G4A;PLA2G6;PLAAT3;DBI;PLA2G4E;PLA2G4C;LPCAT2;PLA2G4F;LPCAT3;PLA2G4B;LPCAT4;PLA2G5;PLBD1;PLB1
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2353876052671009,-0.6898771996987384,0.8766066838046273,0.959000447401845,1.0,6/21,21.40%,ATXN7;APC;APC2;CAMSAP2;CIB1;KATNB1
prerank,positive regulation of T cell activation (GO:0050870),-0.1823634669070234,-0.6896449087895586,0.9732824427480916,0.9586046187868825,1.0,6/62,6.46%,SIRPA;ANXA1;SLC7A1;TFRC;IL6ST;NCK1
prerank,regulation of JUN kinase activity (GO:0043506),-0.20862790974860584,-0.689323977388681,0.9188405797101449,0.9582541087011763,1.0,8/33,20.81%,MAP3K5;HIPK3;PPEF2;MAP3K4;EDN1;MAPK8IP1;MAP3K10;DUSP19
prerank,cellular response to inorganic substance (GO:0071241),0.2724361738846629,0.6891002275512952,0.8547008547008547,1.0,1.0,4/21,11.73%,ADCY10;FMR1;KCNC2;SPIDR
prerank,protein insertion into membrane (GO:0051205),0.24882705857536608,0.6888675133808864,0.8900763358778626,1.0,1.0,4/32,10.76%,RTP4;VAMP2;SEC61B;TRAM2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.23984062715267662,0.6885411118071127,0.9046875,1.0,1.0,6/37,15.14%,OGT;EIF3H;PDCL3;FHIT;BAG6;CSNK2A2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.1940913910028737,-0.6864432531330426,0.95,0.960183458749571,1.0,18/48,32.66%,SLIT2;ROBO1;SAMHD1;PTPN2;NLRC5;ISG15;CCDC3;USP18;RFFL;SIGIRR;YTHDF2;PADI2;TTLL12;PELI3;PPARG;OTUD4;GPS2;PYDC1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.24818639174570828,0.6863146335534112,0.8697674418604651,1.0,1.0,8/25,24.10%,CDK13;RNF168;NELFA;EAF2;LDB1;CDC73;NELFB;EAF1
prerank,maintenance of protein localization in organelle (GO:0072595),0.2716716851298802,0.6861328586379989,0.8601973684210527,1.0,1.0,7/19,21.10%,TAF3;PINK1;TAPT1;HSPA5;TAF8;SUPT7L;BBS4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.22458585591937405,0.68601497874577,0.9126637554585153,1.0,1.0,8/52,12.24%,MDH1;L2HGDH;MTRR;MTHFD1L;DLST;HOGA1;ALDH5A1;ACLY
prerank,synaptic vesicle membrane organization (GO:0048499),0.28010332544663635,0.6859963707924318,0.8616666666666667,1.0,1.0,4/17,13.22%,SNAP23;SYP;SNAP29;AP3D1
prerank,epidermal cell differentiation (GO:0009913),0.22955231042374113,0.6858718649226573,0.9138686131386862,1.0,1.0,7/41,15.78%,HDAC1;WNT5A;GLI1;EVPL;MED1;ERCC2;JAG1
prerank,protein targeting to membrane (GO:0006612),0.20623798914262645,0.6856151597807914,0.9484808454425363,1.0,1.0,21/83,20.67%,RTP4;ABCD2;PEX2;PRKCI;SEC63;ZDHHC24;SRPRA;SLC25A17;PEX19;GET3;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;ALDH3A2;ZDHHC9;PEX3;PEX14;RABGEF1;SSR1;MICALL1
prerank,macrophage migration (GO:1905517),0.2987632619750143,0.6852041684119231,0.8291457286432161,1.0,1.0,13/13,70.15%,P2RX4;CCL2;P2RY12;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF;CCR2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.24563200952712338,0.6848267249322417,0.889894419306184,1.0,1.0,4/31,11.27%,NRG1;RYR2;ZFPM2;TGFBR1
prerank,axonal transport (GO:0098930),0.2346991569219879,0.6843699604251301,0.9097744360902256,1.0,1.0,11/36,23.97%,TMEM108;AP3M1;OPA1;SYBU;AP3D1;HIF1A;KIF3A;AP3B2;KIF1B;BLOC1S6;AP3S1
prerank,proteasomal protein catabolic process (GO:0010498),0.1860463549968217,0.6837881715116175,0.9788235294117648,1.0,1.0,57/201,23.59%,FBXO45;PSMD1;BFAR;SEL1L;ZSWIM8;NEDD4;PSMD10;CRBN;PSMA5;PSMB5;BIRC2;DNAJB12;PLAA;PSMC4;RCN3;PSMA4;PSMC5;FBXW5;GSK3A;AREL1;PSMB9;TRIM2;BAG6;ATXN3;RNF122;BRSK2;TRIM3;HACE1;PSMD14;UBXN6;PSMA7;HECW1;UBXN2B;KLHL22;FEM1B;DCAF11;SOCS6;PSMD11;ZFAND2A;RNF187;PSMA2;CUL4A;RHBDD1;SPSB2;DDB1;MTA1;UBE2K;FBXL22;BTRC;DDIT3;RNF216;SPSB3;RMND5B;SPSB1;FAF1;NHLRC3;KIF14
prerank,negative regulation of bone remodeling (GO:0046851),-0.2830285932794523,-0.6836097552706651,0.8793859649122807,0.9621358609881021,1.0,6/11,25.39%,SFRP1;TMEM119;P2RX7;GPR137;TNFAIP3;GREM1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.25574792531033297,-0.6834589870964108,0.8759124087591241,0.9616352203629274,1.0,10/15,42.88%,MAPK14;RAPGEF3;ADAM9;TYROBP;FLOT1;TREM2;EHD2;SCGB3A1;EHD1;IL4
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.24860774796559526,0.6833221613060044,0.8849144634525661,1.0,1.0,7/29,18.91%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,regulation of interleukin-17 production (GO:0032660),0.24425412628089047,0.683093451197214,0.9032761310452418,1.0,1.0,3/31,12.27%,NR1H4;TLR4;IL12A
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.24186316700296626,-0.6823292997432902,0.9014423076923077,0.9620026015245707,1.0,4/17,15.34%,STX1A;KCNB1;SLC4A8;RAB3D
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2323691429499865,0.6812373111052317,0.9019316493313522,1.0,1.0,13/38,25.16%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8
prerank,negative regulation of innate immune response (GO:0045824),0.23357490698134914,0.6799721774214016,0.8908507223113965,1.0,1.0,6/34,17.61%,SUSD4;DHX58;LYAR;FAM3A;CNOT7;A2M
prerank,B cell activation involved in immune response (GO:0002312),0.2892069812910608,0.6782272557915894,0.8603066439522998,1.0,1.0,4/13,19.77%,GPR183;RNF168;MSH6;CD180
prerank,response to UV-A (GO:0070141),0.28545114834427104,0.6782256476411925,0.8706739526411658,1.0,1.0,1/14,1.66%,PPID
prerank,calcium ion import across plasma membrane (GO:0098703),0.2846056341030607,0.6781662510345942,0.8767857142857143,1.0,1.0,3/14,14.98%,TRPV3;TRPM2;CACNA2D1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.2318986656242918,0.6780229943520862,0.8997093023255814,1.0,1.0,9/38,19.77%,DHX58;TLR8;AKIRIN2;PRKCA;CYBA;DHX9;ZCCHC3;ADAM8;CD180
prerank,natural killer cell mediated immunity (GO:0002228),0.28366012205975694,0.677912288707696,0.8647686832740213,1.0,1.0,3/15,20.71%,ARL8B;PLEKHM2;ULBP1
prerank,regulation of trophoblast cell migration (GO:1901163),0.2923121071046217,0.6772962171145189,0.8731218697829716,1.0,1.0,3/14,16.94%,GJA1;CALR;SYDE1
prerank,positive regulation of myelination (GO:0031643),-0.27110889994082604,-0.676848762612492,0.8498896247240618,0.966043261147661,1.0,2/11,7.09%,PARD3;DICER1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.24480975333471516,-0.6767939469457378,0.9075829383886256,0.9654597715952831,1.0,9/16,35.05%,TRIB2;TYROBP;JAK3;VSIR;DLL1;FCGR2B;AGER;CD274;LILRB1
prerank,modulation by host of symbiont process (GO:0051851),0.2350718363634425,0.6758002158115325,0.9233176838810642,1.0,1.0,8/31,20.32%,HDAC1;REST;SNW1;SAP30;TFAP4;RRP1B;SP1;TAF11
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.198113714529723,0.6755258835738438,0.9763975155279503,1.0,1.0,14/104,14.16%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,cellular response to lectin (GO:1990858),0.198113714529723,0.6755258835738438,0.9763975155279503,1.0,1.0,14/104,14.16%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,protein targeting (GO:0006605),0.1949524773354311,0.6753180090022135,0.9660804020100503,1.0,1.0,28/118,21.80%,RTP4;TIMM10;DNAJC19;CACNG3;SORL1;PRKCI;SEC63;ZDHHC24;SRPRA;PITRM1;LTBP2;TIMM44;AKAP6;PEX19;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;ZDHHC9;ZFAND2A;KIF13B;PEX6;HOMER3;RABGEF1;MICALL1;MFN2;GDAP1;FUT10
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.28887902707697555,0.6752956349823452,0.853195164075993,1.0,1.0,5/13,25.12%,CAMK4;ZC3H8;ADAM8;TOX;BMP4
prerank,smoothened signaling pathway (GO:0007224),0.23609110329035615,0.6748870451514337,0.8878787878787879,1.0,1.0,5/32,10.88%,PTCH2;PTCHD1;GLI1;GLI3;TCTN2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.19736764453813768,0.6745379982093888,0.9752781211372065,1.0,1.0,14/105,14.16%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,actin filament polymerization (GO:0030041),0.243894863286029,0.6743888941579472,0.9129082426127527,1.0,1.0,5/29,12.87%,MICALL2;ARHGAP6;WASF3;WASHC5;PREX1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.2973738923989492,0.6741553248420987,0.8628158844765343,1.0,1.0,2/11,13.71%,KCNIP2;AKAP6
prerank,lysosome localization (GO:0032418),0.23269323334387715,0.674092125682416,0.9039039039039038,0.999978741669412,1.0,7/37,19.41%,RAB34;KXD1;ARL8B;TFEB;VPS33B;PIK3CG;PLEKHM2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.23490075354510448,0.673896502564337,0.9047619047619048,0.9996622501944203,1.0,9/35,18.27%,BOD1;PPP6R2;MTOR;PTPA;HSP90B1;CRY2;TSC1;PPP6R3;PDGFRB
prerank,non-motile cilium assembly (GO:1905515),0.24476003118190995,0.6737461890193513,0.9052132701421801,0.9993047440682783,1.0,11/30,25.21%,DISC1;RPGRIP1;IFT88;CEP250;PCM1;BBS1;BBS4;RPGRIP1L;IFT122;TOGARAM1;TMEM216
prerank,regulation of vasculature development (GO:1901342),0.24850593656865105,0.6736924980381658,0.8855799373040752,0.9988381755809059,1.0,3/26,9.17%,ADGRA2;NF1;SP100
prerank,positive regulation of isotype switching (GO:0045830),0.2817726057661607,0.6720959369247662,0.8601036269430051,0.9999042567238429,1.0,4/15,18.51%,CD40;HMCES;PAXIP1;RIF1
prerank,membrane repolarization during action potential (GO:0086011),0.29251580139175676,0.6720705992051744,0.8554006968641115,0.9994151803304275,1.0,2/13,11.23%,KCNIP2;KCNE4
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2355749219104103,0.6720593222659959,0.8910256410256411,0.9989107411565515,1.0,7/32,18.76%,CLIP3;NAV3;STMN2;STMN1;CLASP2;CLASP1;SPEF1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2320200092306421,0.6717474685502943,0.9121725731895224,0.998709519062239,1.0,5/39,11.15%,UTRN;SCN2B;NEDD4;FXYD4;FGF12
prerank,secretory granule organization (GO:0033363),-0.28077147461345353,-0.671334384829282,0.8716814159292036,0.9694172764946096,1.0,1/10,3.34%,SRGN
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2396401493046581,0.6710019445135803,0.8932926829268293,0.9988998139055966,1.0,8/31,15.78%,LSM4;EDC3;EXOSC9;DIS3L2;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,response to acidic pH (GO:0010447),0.2872037934291144,0.6708602304754322,0.8667820069204152,0.9985335802007108,1.0,3/13,16.17%,SLC9A1;LGMN;IMPACT
prerank,intracellular pH reduction (GO:0051452),0.23355988991868365,0.6708562356266956,0.9156441717791411,0.9980229441057888,1.0,10/33,24.99%,RAB20;CLCN3;ATP6V0E1;ATP6V1G2;ATP6V0D1;GPR89A;GPR89B;ATP6V0B;DMXL1;RAB7A
prerank,lymphocyte proliferation (GO:0046651),0.25647907485116916,0.670742645615312,0.8694267515923567,0.9976195543717371,1.0,4/22,11.94%,CD40;CR2;PPP3CB;LMBR1L
prerank,histone H2A ubiquitination (GO:0033522),0.2686282263951444,0.6704364195657259,0.8830508474576271,0.9974000804617168,1.0,3/17,9.16%,BCOR;TRIM37;RNF168
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.20703060233120785,0.6703804998810649,0.9504021447721179,0.9969427661268581,1.0,15/76,18.82%,NTRK3;SEMA5A;FCHSD2;LIMK1;GPSM2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;HAX1;CDK5;CDC42EP3;VASP
prerank,RNA 3'-end processing (GO:0031123),0.2073482080243841,0.670062691029429,0.9643347050754458,0.9967328962832318,1.0,13/69,17.55%,EIF4A3;LIN28B;THOC7;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SYMPK;SRSF9;THOC5;SRSF6
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2128516236088484,-0.6696670693589069,0.9444444444444444,0.9700810829429046,1.0,9/27,29.86%,SIRPA;CD44;ETS1;MDK;SKAP1;HSPD1;ITGB2;HAS2;CCR2
prerank,mitotic metaphase plate congression (GO:0007080),0.21808806014454837,0.6693295235746443,0.9233926128590971,0.9969244250678623,1.0,11/51,18.45%,BOD1;DCTN2;CENPE;SPDL1;RMDN1;CENPC;CDT1;RRS1;CEP55;VPS4B;KPNB1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.22457546677779933,0.6684600640606759,0.9188445667125172,0.9972497165925518,1.0,12/44,20.08%,CARMIL2;FCHSD2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;SPIRE1;CDC42EP3;VASP;NCK2
prerank,regulation of interferon-alpha production (GO:0032647),0.2578422798660075,0.6683818962017614,0.8851132686084142,0.9968060417121437,1.0,4/23,15.16%,TLR8;TLR4;DHX36;DHX9
prerank,DNA replication checkpoint signaling (GO:0000076),0.2683582350136055,0.6678509788241642,0.8682042833607908,0.9967863668794746,1.0,2/16,12.47%,TIPIN;CDT1
prerank,potassium ion import across plasma membrane (GO:1990573),0.22758870939953874,0.6678498141632797,0.9203675344563553,0.9962767335018048,1.0,10/41,21.79%,ATP1A2;SLC12A6;ATP1A3;HCN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;SLC12A9;ABCC9
prerank,regulation of oxidoreductase activity (GO:0051341),-0.25922120793967457,-0.6676950381894466,0.8587962962962963,0.9709937706970451,1.0,5/13,24.27%,ECSIT;HDAC6;OXA1L;NOD2;MT3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.26396264550999005,-0.6671180133611725,0.8978102189781022,0.9707773916928305,1.0,6/12,32.94%,ERLIN1;CEACAM1;SIRT1;BRCA1;TRIB3;APOC1
prerank,RNA destabilization (GO:0050779),0.26242532335514457,0.6665305667659384,0.878682842287695,0.9969824890236115,1.0,5/18,18.90%,RBM24;LIN28B;FTO;DXO;YTHDF1
prerank,mitochondrial translational elongation (GO:0070125),0.1994080511819303,0.6660324375183814,0.9741602067183462,0.9969632038914225,1.0,29/88,28.12%,MRPL44;MRPS31;MRPS24;MRPS26;MRPL30;MRPL28;MRPS30;DAP3;MRPL10;GFM2;ERAL1;MRPL3;MRPS23;MRPL49;MRPL51;MRPS5;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;MRPL14;MRPL32;CHCHD1;GFM1;MRPL1;MRPL47;MRPL12
prerank,tRNA methylation (GO:0030488),0.2340749852383492,0.665754718531014,0.9210526315789473,0.9967146139747237,1.0,13/34,25.30%,PRORP;TRMT13;TYW3;TRMT44;TRMT61A;METTL1;THUMPD3;TRMT10A;METTL2B;METTL2A;LCMT2;TRMT10C;NSUN6
prerank,positive regulation of rRNA processing (GO:2000234),0.30534389151198826,0.6654292313502354,0.85451197053407,0.9965215579951547,1.0,4/10,23.05%,UTP15;DIMT1;HEATR1;RIOK2
prerank,glycine transport (GO:0015816),0.3033774736396509,0.664620830140619,0.8672727272727273,0.9967927188022115,1.0,4/10,25.94%,SLC7A8;SLC25A38;SLC6A5;SLC36A1
prerank,cellular macromolecule catabolic process (GO:0044265),0.2212322301949449,0.6642042055304832,0.93,0.9966595328436219,1.0,10/49,17.22%,RNASEH2C;UBE2G2;FBXO17;MTREX;RNASEH2B;HTRA2;RIPK1;HNRNPD;RNASEH1;PPP1R8
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.22158150091974485,-0.6637878069890819,0.9328165374677002,0.9727425189785909,1.0,5/23,15.32%,HACD1;FAR2;ACSL4;ELOVL7;ACSL5
prerank,negative regulation of dephosphorylation (GO:0035305),0.2636678464247872,0.6637507607964357,0.8776508972267537,0.9965825751203075,1.0,5/18,17.22%,GPATCH2;PTPA;PPP1R26;ZCCHC9;PPP1R8
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3015285025895977,0.662677238694717,0.8591549295774648,0.9971089381333408,1.0,2/10,12.66%,PTPN22;PDCD4
prerank,mRNA 3'-end processing (GO:0031124),0.20083387510155468,0.6619074977447404,0.9561752988047809,0.9972837617681457,1.0,17/78,19.66%,EIF4A3;THOC7;LSM11;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SLBP;SYMPK;SRSF9;THOC5;SRSF6;PAPOLB;CHTOP;CDC73
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.2509822059079909,0.6614868738467188,0.9236883942766295,0.9971868890843587,1.0,4/22,14.53%,PTPN22;APPL2;LYN;TIRAP
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2868412102800768,0.66083750413316,0.8848920863309353,0.9972517785005247,1.0,4/11,22.62%,ASF1A;UBN1;ATRX;IPO4
prerank,methylguanosine-cap decapping (GO:0110156),0.30612887954835444,0.6602460622001793,0.8756567425569177,0.9973009360071595,1.0,2/10,12.96%,EDC3;EDC4
prerank,positive regulation of protein acetylation (GO:1901985),0.2895996479623033,0.6601246557185722,0.8612099644128114,0.9968999950754841,1.0,2/12,7.71%,CEP295;FAM161A
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2330326053990762,0.659895121175862,0.8955223880597015,0.9966040925234427,1.0,6/33,17.09%,LSM11;NUDT21;SLBP;SNRPF;SYMPK;MAZ
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.26740277724122385,-0.6595686895060312,0.8791946308724832,0.9753409457386533,1.0,2/11,6.79%,ITPKB;IP6K2
prerank,acute-phase response (GO:0006953),-0.2579745799993196,-0.6585171732472367,0.884090909090909,0.9754498061471903,1.0,5/12,35.04%,LBP;IL22;SIGIRR;AHSG;CEBPB
prerank,peptidyl-lysine acetylation (GO:0018394),0.2961514172225798,0.6582188073284165,0.8772893772893773,0.9976402788649086,1.0,4/10,21.13%,KAT2A;BAG6;KAT7;CREBBP
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.20225411396129236,-0.6569062724694742,0.9425287356321839,0.9760365763041261,1.0,8/28,29.86%,SIRPA;PRKDC;TICAM1;TYROBP;NOD2;HSPD1;NCKAP1L;CCR2
prerank,myeloid dendritic cell activation (GO:0001773),0.28924982591226933,0.6568950653469848,0.8673835125448028,0.998311365430478,1.0,2/12,11.00%,CAMK4;PYCARD
prerank,positive regulation of protein export from nucleus (GO:0046827),0.27643303098093386,0.6568346591304701,0.8890756302521008,0.997852687284037,1.0,2/15,10.84%,TCF7L2;TP53
prerank,peptidyl-lysine methylation (GO:0018022),-0.20550315568124314,-0.6567029030920164,0.918918918918919,0.9755546017645794,1.0,3/26,11.47%,SMYD3;SMYD2;EEF2KMT
prerank,ubiquinone metabolic process (GO:0006743),0.274612721182915,0.6563299972372538,0.8747795414462081,0.9977925099682599,1.0,5/15,19.40%,COQ3;AIFM2;COQ8B;PDSS2;COQ7
prerank,regulation of protein neddylation (GO:2000434),-0.27772124349850685,-0.6561088301194663,0.8922018348623854,0.9753559092342181,1.0,4/10,19.86%,RPL5;RPL11;DCUN1D3;COPS9
prerank,negative regulation of cation channel activity (GO:2001258),0.2426135460932085,0.6559007479279316,0.9033280507131537,0.9976619257721432,1.0,3/26,8.50%,FMR1;KCNAB1;GNB5
prerank,cellular response to leucine starvation (GO:1990253),0.3017873224319024,0.6552756914655493,0.8837606837606837,0.9977013140026072,1.0,3/10,18.65%,MTOR;IMPACT;RRAGD
prerank,melanosome organization (GO:0032438),0.24122081483308874,0.6551060453741266,0.8870229007633588,0.9973499171430561,1.0,4/26,13.22%,HPS1;RAB29;ABCB6;AP3D1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2751980199591737,-0.6550651524908301,0.8703703703703703,0.9754905901743106,1.0,2/10,17.51%,SMYD2;EEF1AKMT2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.28539469490834635,0.6549277612029473,0.8780918727915195,0.9970086739210617,1.0,3/13,13.09%,PSMD10;TWIST1;PTTG1IP
prerank,regulation of gene silencing by RNA (GO:0060966),0.21686387195291182,0.6548228020368562,0.9365781710914455,0.9961070145812084,1.0,14/50,24.50%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;AGO1;NUP54;NUP155;POLR2L;RANBP2;NUP35;IPO8;POLR2D
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21686387195291182,0.6548228020368562,0.9365781710914455,0.9961070145812084,1.0,14/50,24.50%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;AGO1;NUP54;NUP155;POLR2L;RANBP2;NUP35;IPO8;POLR2D
prerank,insulin secretion (GO:0030073),0.2585169301537078,0.6546782250055295,0.8905228758169934,0.9957286801664614,1.0,2/19,6.77%,PTPRN2;RIMS2
prerank,lipoprotein biosynthetic process (GO:0042158),0.2891559250655278,0.6546096742350187,0.8740740740740741,0.9952831771159635,1.0,6/11,28.74%,WDR45B;WIPI2;ATG10;WIPI1;PIK3C3;ATG7
prerank,cellular response to hydroxyurea (GO:0072711),-0.27026285151468316,-0.6544448830684128,0.8972162740899358,0.9752977305070781,1.0,3/10,16.08%,DDI2;DDX11;NSMCE3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.22840744384439723,-0.6535146227816471,0.9285714285714286,0.9753176917496573,1.0,5/19,16.06%,HIPK1;DYRK2;HIPK2;SIRT1;TMEM109
prerank,negative regulation of T cell differentiation (GO:0045581),0.29206602161753314,0.6526538355577324,0.8765880217785844,0.9964985242441773,1.0,2/10,10.98%,GLI3;ZC3H8
prerank,intracellular cholesterol transport (GO:0032367),0.26606599019654903,0.6522821945389197,0.8846153846153846,0.9963159126476859,1.0,5/15,19.96%,RELCH;SERAC1;LDLRAP1;NPC2;OSBP
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.22707803181700986,0.6521787962384696,0.9254185692541856,0.9958894257102217,1.0,5/36,14.10%,OGT;EIF3H;OPHN1;FHIT;BAG6
prerank,phosphatidylserine metabolic process (GO:0006658),0.23529621023364178,0.6521672467462961,0.9144144144144144,0.9953946239996833,1.0,6/32,14.40%,SERINC1;ABHD16A;ABHD12;PTDSS2;SERINC5;PLA2G12A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.27093476398144956,-0.6520660899400939,0.8981042654028436,0.9756969508372354,1.0,3/11,17.93%,RENBP;UAP1;UAP1L1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.23832647505991272,-0.651269210240546,0.9207161125319693,0.975598247267053,1.0,9/15,48.17%,SYN3;ZDHHC3;ADRA1A;ZDHHC12;HAP1;STXBP1;NPS;DRD2;NPAS4
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.2934491612663854,0.6511982001658686,0.8819320214669052,0.9957417001689404,1.0,2/11,9.21%,PWP1;MTOR
prerank,calcium ion import into cytosol (GO:1902656),0.2700563223648293,0.6507214794972164,0.9188712522045855,0.9956577585663745,1.0,3/15,14.98%,TRPV3;TRPM2;CACNA2D1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.280307555925984,-0.6503554796885821,0.8735083532219571,0.9755951041248023,1.0,2/10,6.99%,PDGFA;TBX1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.2736863587549737,0.6498765668669069,0.8858603066439523,0.9958365116430231,1.0,2/14,9.42%,DUSP1;PPP2R2A
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.28068749550484284,0.6494804530321743,0.8723776223776224,0.9956503601563037,1.0,3/12,22.46%,ELOVL2;ELOVL1;ELOVL5
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.21318044226180058,-0.6482025858182952,0.9476439790575916,0.9764621362225597,1.0,11/23,38.98%,MAP3K5;MAP3K4;EDN1;MAP3K10;DUSP19;FZD10;TRAF2;SASH1;RPS3;MAP3K7;DAB2IP
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2175376426263651,-0.6474020708389078,0.9522613065326633,0.9763820357983607,1.0,9/21,29.92%,YWHAB;PPP1R16B;GSK3B;PPP4R4;PPP1R11;MFHAS1;ENSA;FKBP1A;PPP1R15A
prerank,regulation of B cell proliferation (GO:0030888),0.2163577846417004,0.6473060350643893,0.9468390804597702,0.9969623744132932,1.0,7/44,14.53%,CD40;IRS2;GPR183;TNFRSF21;CD81;LYN;TIRAP
prerank,detection of mechanical stimulus (GO:0050982),0.2500847710020496,0.6471866240595061,0.9096989966555183,0.9965605013572698,1.0,2/19,7.60%,JUP;PTK2
prerank,striated muscle contraction (GO:0006941),0.20950914201254522,0.6464168321230925,0.9616438356164384,0.9966977797246936,1.0,3/53,4.15%,ATP1A2;RYR2;SCN2B
prerank,monosaccharide transmembrane transport (GO:0015749),0.26233831470551294,0.6463362515106651,0.8851351351351351,0.9962602220224096,1.0,16/16,73.79%,SLC2A9;SLC45A3;SLC2A7;SLC2A8;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC2A6;SLC5A3;SLC50A1;SLC23A2;SLC23A1;SLC2A2;SLC2A12
prerank,nuclear transport (GO:0051169),0.2624780799978544,0.6454358648133123,0.8885191347753744,0.9964893480961976,1.0,3/16,13.41%,AAAS;NUTF2;NXT2
prerank,relaxation of muscle (GO:0090075),0.27598257656374336,0.6453078474662078,0.8879310344827587,0.996094257839769,1.0,2/13,11.26%,ATP1A2;P2RX4
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.24963125123491992,0.6450912934994503,0.9067796610169492,0.9957802803908322,1.0,9/20,28.38%,ATP2A2;HERPUD1;BAK1;PACS2;FIS1;CCDC47;SELENOK;BCAP31;BCL2
prerank,histone H3 acetylation (GO:0043966),0.22119996067628728,0.6447615409221975,0.9418777943368107,0.9955565513390573,1.0,11/40,20.65%,TAF12;WDR5;BRCA2;KAT2A;POLE3;JADE1;LDB1;KAT7;TAF10;MBIP;SUPT7L
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.28918352933304947,0.6444771061437005,0.8747884940778342,0.9952942717624234,1.0,4/10,24.52%,UBE2G2;YOD1;UBE2J1;OS9
prerank,cellular response to interferon-beta (GO:0035458),-0.2471600338154267,-0.6443370591707963,0.8968609865470852,0.9777575453459532,1.0,7/14,29.17%,IRF1;CDC34;IFITM2;NDUFA13;PNPT1;TRIM6;IRGM
prerank,establishment of mitotic spindle orientation (GO:0000132),0.24251529272896477,0.6440784818288741,0.9208074534161491,0.9951168132703864,1.0,4/23,11.49%,GJA1;GPSM2;SPDL1;INSC
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.24859081777408001,0.6437602658667049,0.9227129337539433,0.9948739452386786,1.0,8/22,23.80%,PWP1;LYAR;MTOR;UTP15;EIF2AK3;HEATR1;DHX33;ATF4
prerank,cholesterol efflux (GO:0033344),-0.21994669491770918,-0.6435456237645982,0.9367088607594937,0.9776641293966204,1.0,3/20,13.19%,SCARB1;APOE;SOAT1
prerank,positive regulation of cellular protein localization (GO:1903829),0.20120857691918534,0.6432313615454491,0.97165991902834,0.9947993869834415,1.0,16/69,19.38%,GNL3;NGFR;NECAB2;FYN;GAS8;ENTR1;CDT1;MEAK7;CEP250;FERMT2;GPR137B;ORMDL3;KAT7;EIF2AK3;DDRGK1;TRAPPC12
prerank,protein tetramerization (GO:0051262),0.197665667745955,0.6431745902189394,0.9710743801652892,0.994344964868232,1.0,13/67,19.00%,TRPA1;GRIN2B;GOLGA2;APPL2;HSD17B8;NUDT21;HCN1;TRPM2;RYR3;USP16;MCOLN1;ALDH9A1;SSBP1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.269543339560031,0.6421798151101478,0.8922558922558923,0.9946324740198232,1.0,3/14,15.57%,MRNIP;ACTR2;MMS19
prerank,erythrocyte development (GO:0048821),0.28930048812529124,0.6417378964529196,0.8825757575757576,0.9944913744340289,1.0,3/10,16.08%,LYAR;MED1;ZBTB7A
prerank,negative regulation of protein metabolic process (GO:0051248),0.21342503182355194,0.6414795069447977,0.9523121387283237,0.9942006884538557,1.0,8/48,15.08%,ITGAV;ADGRB1;FLOT2;MDM4;IAPP;EIF2AK1;SNX12;CLU
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.2668128955036146,0.6400555832475627,0.898989898989899,0.9948560455648066,1.0,3/15,14.97%,ADGRV1;SCN1A;PDZD7
prerank,aspartate family amino acid metabolic process (GO:0009066),0.2569168060087231,0.6398031419840736,0.8912280701754386,0.9945580109175545,1.0,8/18,25.82%,ASPA;NAT8L;FOLH1;ASPG;MSRA;MTHFD1;NAALAD2;SMS
prerank,response to UV-B (GO:0010224),-0.25246141783866666,-0.6395370786967233,0.9095238095238095,0.9795559282690885,1.0,6/12,27.20%,CRIP1;HYAL1;CDKN1A;MME;HYAL2;MSH2
prerank,positive regulation of cell aging (GO:0090343),0.28370722853326297,0.6393822090174648,0.9098939929328622,0.9943966244308029,1.0,1/11,2.73%,CDKN2A
prerank,protein localization to centrosome (GO:0071539),0.25948076194835157,0.6390849240006082,0.9176276771004942,0.9941372407399164,1.0,7/17,25.97%,DCTN2;CEP192;PCM1;NUDCD3;BBS4;GOLGB1;CCDC14
prerank,nucleosome organization (GO:0034728),0.20580220313394948,0.6383178121975539,0.9562146892655368,0.9942359523141175,1.0,15/55,22.26%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;NAP1L1;POLE3;SOX9;BPTF;DMAP1;SMARCD2;MCM3AP;LIN54;ZNHIT1;ATRX
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.24072170982717106,-0.6381916944105279,0.9452380952380952,0.9798158174684278,1.0,6/15,30.91%,CCT3;CCT4;CCT7;RUVBL2;NHP2;RUVBL1
prerank,protein destabilization (GO:0031648),-0.19607439897099033,-0.6380863476765649,0.9672131147540983,0.9792564424672398,1.0,6/32,16.69%,GSN;SOX17;CTSH;CCDC88C;SIRT1;CUL3
prerank,regulation of microglial cell activation (GO:1903978),-0.2355120236077102,-0.6374154214601478,0.8888888888888888,0.9790642228519915,1.0,15/15,76.48%,CX3CL1;TTBK1;TREM2;STAP1;CST7;TAFA3;IL6;CCL3;GRN;SYT11;LDLR;MMP8;SPHK1;NR1D1;PTPRC
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.23024845620280832,0.6372655614860744,0.9056,0.9945477593158117,1.0,5/28,16.71%,ABITRAM;FCHSD2;ARHGAP35;CTTN;HAX1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.20747838377573083,-0.6368519237599947,0.9518413597733711,0.9787954011013927,1.0,12/25,35.29%,TNFSF10;BAD;BAX;BID;GPER1;PPIF;BCL2L11;BIK;DNM1L;BMF;HRK;PMAIP1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.24156861355212902,0.6365743581653092,0.9088050314465409,0.9945849106084779,1.0,5/23,21.07%,ACOT7;ELOVL6;ALOX5;ACSBG1;GSTM1
prerank,cellular respiration (GO:0045333),0.22132898369520185,0.6363679457903437,0.9420505200594353,0.9942258006761756,1.0,7/41,16.23%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14;NDUFS4
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.23932579850844438,-0.6363474343433683,0.9148936170212766,0.9784665810709436,1.0,2/14,15.46%,IL6ST;PTGS2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.2921954254028727,0.6357046243007364,0.8927335640138409,0.9942298545056123,1.0,3/10,17.02%,IGF2;KDM1B;DNMT3A
prerank,histone H2B ubiquitination (GO:0033523),0.28277327968510235,0.6356136649269342,0.8881118881118881,0.9937974430142633,1.0,1/10,4.54%,RNF40
prerank,nucleocytoplasmic transport (GO:0006913),0.2165271192043628,0.6355046393550517,0.9401709401709402,0.9933811822926617,1.0,13/40,26.57%,GEMIN2;AAAS;NUTF2;SNUPN;NXT2;SNRPF;GEMIN8;XPO1;MALT1;GEMIN5;GEMIN7;SNRPG;ANP32A
prerank,glycoprotein catabolic process (GO:0006516),-0.2326642049477075,-0.6350862611503257,0.9196891191709845,0.9786119943500073,1.0,5/17,19.03%,OGA;MANBA;NGLY1;STT3B;EDEM1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.24903993379484796,0.6347253900462254,0.9117174959871589,0.9929652090845312,1.0,2/20,7.70%,GSTO2;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.24903993379484796,0.6347253900462254,0.9117174959871589,0.9929652090845312,1.0,2/20,7.70%,GSTO2;GSTA3
prerank,regulation of actin filament-based movement (GO:1903115),0.2859059453776888,0.6319348535871845,0.9026086956521739,0.9945225820067567,1.0,1/10,2.87%,PDE4B
prerank,early endosome to Golgi transport (GO:0034498),-0.2578460823366506,-0.6318464047453771,0.8842592592592593,0.9799359109368175,1.0,5/11,28.76%,SURF4;LMAN1;RAB6A;STX5;SNX2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.23906521592553534,0.6316760128277512,0.9205834683954619,0.9942039743875877,1.0,1/22,1.65%,WNT5A
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2372331679233189,0.6311839990909023,0.9197530864197531,0.9940586151108443,1.0,6/27,18.87%,CALCA;HTR2C;LPAR1;F2R;GPR35;GRM1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2593916089638762,0.6308264466435759,0.9037162162162162,0.9938132623693171,1.0,2/14,5.89%,ADK;GMPS
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.21151247984821714,-0.6304546788054245,0.9566395663956639,0.9801466847689791,1.0,4/22,12.08%,SLC16A2;NES;GATA2;MDK
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2390424451025841,0.6299239874329848,0.9251247920133111,0.9939528390554071,1.0,5/22,17.28%,NEDD4;PLAA;TSG101;SNF8;VPS4B
prerank,positive regulation of interleukin-13 production (GO:0032736),0.28739336882222843,0.6295527148597476,0.9147826086956522,0.9937282245292912,1.0,1/10,2.91%,TSLP
prerank,anterograde synaptic vesicle transport (GO:0048490),0.26340497944389685,0.6291789038899115,0.8948247078464107,0.9930180821899838,1.0,5/15,23.97%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.26340497944389685,0.6291789038899115,0.8948247078464107,0.9930180821899838,1.0,5/15,23.97%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1
prerank,regulation of interferon-beta production (GO:0032648),0.20801698074553704,0.6288018758849364,0.9580318379160637,0.9928012124712147,1.0,18/46,28.94%,DHX58;TRIM56;TLR8;TLR4;PYCARD;TIRAP;DHX9;POLR3A;PTPN11;RNF216;CACTIN;PPM1B;POLR3F;IFIH1;RELB;POLR3B;PTPRS;POLR3C
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2260006144181566,0.6286058038755196,0.9197530864197531,0.9924486873293544,1.0,7/29,15.78%,LSM4;EDC3;EXOSC9;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,negative regulation of transmembrane transport (GO:0034763),0.2821118098521501,0.6285680103786311,0.8673647469458988,0.9919910791607383,1.0,2/10,9.37%,IRS2;PRKCB
prerank,B cell mediated immunity (GO:0019724),0.2892954946295084,0.6282620336709446,0.8881118881118881,0.9916995814092827,1.0,1/10,6.54%,TLR8
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.2555586210745953,-0.6281282233904795,0.913953488372093,0.9808754328158974,1.0,5/12,24.69%,NINL;BICD2;CCDC68;CCDC120;BICD1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2549508063111394,0.6276209470427799,0.9073756432246999,0.9916489341691312,1.0,7/16,28.18%,HSD17B8;ACLY;ACACA;SCD5;DIP2A;PPT1;SLC25A1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.23879634378980735,0.6275381072442741,0.9211356466876972,0.991215792887968,1.0,1/23,0.63%,XCL1
prerank,positive regulation of protein maturation (GO:1903319),-0.2580138677901748,-0.6270654850559645,0.9387308533916849,0.980836928528417,1.0,2/11,9.31%,SOX4;CCBE1
prerank,tRNA wobble base modification (GO:0002097),-0.2376202640358125,-0.6264673469267339,0.9228855721393034,0.9805767635821159,1.0,9/14,34.61%,TRMT9B;GTPBP3;ELP3;MOCS3;KTI12;URM1;ALKBH1;ADAT2;CTU2
prerank,regulation of catecholamine secretion (GO:0050433),-0.19291897447022854,-0.6256709425210599,0.9698630136986301,0.9803824642146043,1.0,3/29,7.67%,SYT9;STX1A;KCNB1
prerank,regulation of defense response to virus by host (GO:0050691),0.22590914626719535,0.6254957106089096,0.9224924012158054,0.9921752333779519,1.0,8/30,25.81%,PTPN22;IFNLR1;TRIM44;DHX9;RNF216;STAT1;TRAF3IP2;AIM2
prerank,regulation of histone methylation (GO:0031060),0.2670406570192729,0.6250057982338092,0.9128205128205128,0.9920240157676299,1.0,3/13,19.42%,NSD1;AASS;CHTOP
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.2296724190504797,0.6238753538172543,0.9421875,0.9922999151684548,1.0,5/28,15.99%,STMN2;STMN4;STMN1;CLASP2;CLASP1
prerank,negative regulation of DNA recombination (GO:0045910),0.20637661002305838,0.6233239552467897,0.9515151515151515,0.9921721335629328,1.0,9/43,19.95%,POLQ;MSH3;TERF1;DAXX;FBH1;MSH6;RIF1;TERF2IP;POLR2L
prerank,DNA geometric change (GO:0032392),0.23694640179743362,0.6226597904880921,0.9388429752066115,0.9921274535948597,1.0,8/24,22.26%,HNRNPA2B1;PIF1;DHX36;RECQL;DHX9;WRN;DDX1;HMGB1
prerank,vitamin D metabolic process (GO:0042359),0.269435553475844,0.6225598968137261,0.9118705035971223,0.991705290700811,1.0,2/13,16.18%,LGMN;CYP2R1
prerank,peptidyl-proline modification (GO:0018208),0.2294697436532808,0.6215685220068026,0.95,0.9918832306809312,1.0,2/25,5.02%,PPID;PPIH
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.2737718882668363,0.6214316302816854,0.9026086956521739,0.9914883577144232,1.0,1/12,5.94%,LIN28B
prerank,anterograde axonal transport (GO:0008089),-0.18421610164320412,-0.621100941349152,0.9886039886039886,0.982354348565874,1.0,6/37,13.10%,MAPK8IP3;RAB21;HSPB1;AP3B1;AP3S2;TRAK2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.23921651704725969,-0.6209187395203339,0.9180327868852459,0.9818217816256778,1.0,3/13,10.83%,NCK1;DNAJB9;PTPN1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.25097492138797883,0.6201126391325086,0.9084745762711864,0.9918607530184199,1.0,3/17,12.93%,RYR2;KCNE4;KCNJ8
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.24531115594378222,-0.6194612741604555,0.9401913875598086,0.9820047233765036,1.0,3/13,17.93%,RENBP;UAP1;UAP1L1
prerank,relaxation of cardiac muscle (GO:0055119),0.26356997992399345,0.6183345460966231,0.8989547038327527,0.992531106719747,1.0,1/13,1.53%,ATP1A2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.26040335451609586,0.6180016801431362,0.9090909090909091,0.9922584398869068,1.0,3/14,9.38%,ERH;DHODH;DPYS
prerank,RNA modification (GO:0009451),0.20245969995970195,0.617390497762957,0.9660537482319661,0.992160035874266,1.0,14/54,24.04%,NAT10;CTU1;QTRT2;TRMT61A;PUS7;METTL1;WDR4;ADAR;NSUN3;RBM15;LCMT2;AARS1;NSUN5;SSB
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.26751537960062116,0.6171243940381992,0.9176672384219554,0.9918383144228543,1.0,2/12,12.20%,TLR4;SOX9
prerank,regulation of histone acetylation (GO:0035065),0.21653319263605916,0.6170474504349716,0.9541420118343196,0.9914037502559951,1.0,7/33,18.80%,KMT2A;SETD5;NOC2L;PAXIP1;IWS1;BRD7;THAP7
prerank,amino sugar biosynthetic process (GO:0046349),-0.2463637065832844,-0.6168119587037771,0.9212410501193318,0.9827290528361609,1.0,3/12,17.93%,RENBP;UAP1;UAP1L1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.20835691218816313,-0.6165833004245783,0.9630681818181818,0.9822439236631675,1.0,15/23,48.31%,PVR;PIK3R6;RAET1E;ARRB2;LAMP1;AP1G1;RASGRP1;LILRB1;SLAMF6;CD226;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2780127941818177,0.6162640286568896,0.9163763066202091,0.9914426649836033,1.0,3/10,23.67%,AREG;ADRA2A;ADAM17
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.23507166301216764,-0.6147343825286687,0.9536585365853658,0.9825995659227629,1.0,2/13,10.49%,DAB2;SH2B1
prerank,positive regulation of immune response (GO:0050778),0.19231149054307142,0.6145604761459624,0.9879194630872483,0.9920136805887602,1.0,9/64,17.69%,HRG;TLR8;AKIRIN2;CYBA;PYCARD;CD81;DHX9;LGALS9;ADAM8
prerank,mitochondrial fusion (GO:0008053),-0.22043481009969046,-0.6143753070657816,0.9513888888888888,0.9821788239121014,1.0,5/18,20.14%,MIEF1;USP30;BAX;CHCHD3;MIGA1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.21275805189997182,-0.6142565840116075,0.9513381995133819,0.9816227766158485,1.0,2/20,4.46%,GCLC;GATM
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.2424878853078817,-0.613605624925446,0.9333333333333333,0.9813249745583075,1.0,2/13,7.67%,STX1A;KCNB1
prerank,polarized epithelial cell differentiation (GO:0030859),0.26793866438495806,0.6133521267094874,0.9199288256227758,0.9923160497993178,1.0,4/13,20.94%,SCRIB;OPHN1;RHOA;RAP2A
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.239525887070618,0.6131424214268919,0.9414556962025317,0.9919658386506042,1.0,4/20,14.16%,PTPN22;TLR4;IRAK1;LYN
prerank,regulation of spindle organization (GO:0090224),0.23886888120356586,0.6130424196320404,0.9199288256227758,0.9915464384619673,1.0,3/18,14.06%,GPSM2;MAP9;SENP6
prerank,regulation of actin nucleation (GO:0051125),-0.24045159385419107,-0.6125605380801225,0.9305555555555556,0.9812593449094819,1.0,7/12,38.51%,GSN;ARPIN;CORO1B;ARF1;WHAMM;CORO1A;SCIN
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2677434074287864,0.6123127160973642,0.9152249134948097,0.9915131168056627,1.0,1/13,3.13%,JAK1
prerank,transcription by RNA polymerase III (GO:0006383),-0.19532572415534344,-0.6121973765376547,0.987146529562982,0.9807986775871586,1.0,10/27,32.29%,SNAPC3;CRCP;POLR3G;GTF3C6;POLR3K;GTF3A;ICE1;POLR2K;SNAPC2;GTF3C5
prerank,positive regulation of B cell proliferation (GO:0030890),0.22239900912707386,0.6112493323823993,0.9464831804281345,0.9916582033948961,1.0,5/29,14.53%,CD40;IRS2;GPR183;CD81;TIRAP
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.1999528706607218,-0.6106730569136883,0.9712041884816754,0.9809270275605319,1.0,12/25,34.61%,PTGES3;HSPA8;GAK;DNAJB5;DNAJB1;HSPA14;HSPA1A;HSPA1B;DNAJB4;HSPA2;SDF2L1;DNAJC18
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.22623726974488037,0.609751475045414,0.9375,0.9920710097635377,1.0,6/25,18.77%,TWIST1;PER2;NSD1;DOT1L;ZBTB7A;HEY1
prerank,purine-containing compound salvage (GO:0043101),0.2629480779907508,0.609578670940048,0.9116666666666666,0.9916926436910378,1.0,3/12,13.13%,ADK;AMPD2;DGUOK
prerank,mitotic sister chromatid segregation (GO:0000070),0.17950794203122586,0.6090314469721755,0.9912826899128269,0.9915527038382864,1.0,18/98,18.45%,BOD1;DCTN2;SGO1;CENPE;TEX14;NAA50;NSL1;SPDL1;NUSAP1;DIS3L2;NCAPH;RRS1;CSNK2A2;CEP55;SMC1A;VPS4B;KLHL22;KPNB1
prerank,Golgi to lysosome transport (GO:0090160),-0.24466820928385907,-0.6085251233201353,0.9147465437788018,0.9813500211393458,1.0,5/11,32.74%,GAK;LAPTM5;AP4M1;LAMP1;AP1G1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2763455922321851,0.6084765073278319,0.9045138888888888,0.9914270228439277,1.0,4/10,21.30%,MAP2K1;LYN;RNF13;MAPK1
prerank,response to iron ion (GO:0010039),-0.2473993522056806,-0.6073851591605195,0.9170403587443946,0.9812976870745201,1.0,3/12,16.82%,B2M;ACO1;HFE
prerank,steroid hormone biosynthetic process (GO:0120178),0.21978368483432492,0.6071925455802363,0.9533437013996889,0.9917146639962211,1.0,5/29,18.11%,HSD17B8;MED1;AKR1B1;HSD17B11;HSD17B2
prerank,response to hydroxyurea (GO:0072710),0.27182957081782083,0.6068983994818862,0.9099099099099099,0.9914197228633004,1.0,4/11,22.26%,FMR1;SPIDR;KAT7;ATRX
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.25625662573694463,0.6064293218238326,0.9198606271777003,0.9912263452771055,1.0,1/13,4.00%,DUSP1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.2372205592954934,-0.6059076587257728,0.9292682926829269,0.981413887747422,1.0,3/13,18.46%,HEY2;TMSB4X;SOX11
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.21943190854692143,0.6057044587476222,0.9410801963993454,0.9911459151683015,1.0,5/29,13.45%,FBXO5;LIMK1;PINK1;DCUN1D5;AXIN1
prerank,nuclear body organization (GO:0030575),0.2662273399782493,0.6054121312814975,0.9215328467153284,0.9908354584182198,1.0,3/12,18.55%,AFF2;HABP4;USPL1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2080589428422526,-0.6021759700296687,0.9634146341463414,0.9825424344192648,1.0,2/18,5.63%,FER;IL6ST
prerank,negative regulation of cell division (GO:0051782),0.26690902229529173,0.6020839603973301,0.9240282685512368,0.9922141947257892,1.0,1/11,3.19%,SUSD2
prerank,protein acylation (GO:0043543),0.20368918876209516,0.6005238361199203,0.9669172932330827,0.9925923113873188,1.0,10/38,21.13%,NAA10;NAT10;KAT2A;HHAT;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8;GTF2B;CREBBP
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.22612289214047626,-0.6005035245715721,0.9514563106796117,0.9826692821843893,1.0,8/14,41.63%,DDX60;ANKRD17;ZDHHC5;PUM1;OASL;TLR5;TLR3;TLR2
prerank,mesenchyme development (GO:0060485),0.2510741781603913,0.5996420066334883,0.9471890971039182,0.9925834169086349,1.0,4/15,18.20%,BMP7;TGFBR1;FGFR2;BMP2
prerank,regulation of rRNA processing (GO:2000232),0.243997221363772,0.5996205012953262,0.9417808219178082,0.9921096758521525,1.0,6/16,25.13%,UTP15;DIMT1;SHQ1;HEATR1;RIOK2;USP36
prerank,reticulophagy (GO:0061709),-0.2393755552297635,-0.5966259155009359,0.945823927765237,0.9837300550167676,1.0,4/12,22.31%,RETREG1;ATG2B;ATG2A;UFM1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2494955234394429,0.5964954143766525,0.9338842975206612,0.9933271184102281,1.0,3/15,15.05%,TIPIN;EME2;ATF2
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.21482197831100236,-0.5957624073841346,0.9652605459057072,0.9834967810018792,1.0,5/16,20.71%,SIX1;PTGS2;SIRT1;ZBTB7B;SOX13
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.21155522796510035,-0.5952987378267381,0.9587628865979382,0.983095090565483,1.0,7/18,38.41%,PRKDC;PRELID1;PRDM1;NCKAP1L;CCR2;IL4I1;IKZF3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.25679825031943054,0.5945330197963,0.9224137931034483,0.9938801886062255,1.0,4/14,19.33%,BFAR;HSPA5;BAK1;DDRGK1
prerank,positive regulation of chromatin organization (GO:1905269),0.25294939453007365,0.5938466533140168,0.9294755877034359,0.9937447502978868,1.0,4/12,22.26%,TERF1;DAXX;TERF2IP;ATRX
prerank,regulation of calcium ion transport (GO:0051924),0.19135073049692278,0.5931510911599385,0.9832167832167832,0.9936464405030113,1.0,12/54,19.60%,IL16;GRAMD2A;P2RX4;STIM1;CACNA2D1;F2R;PACSIN3;STC1;ADRA2A;CAMK2A;CRACR2A;HOMER3
prerank,protein localization to chromosome (GO:0034502),0.20524949795941944,0.5923566595281832,0.9658246656760773,0.9935614024764398,1.0,4/34,10.67%,BOD1;RPA1;MRNIP;SLF1
prerank,translational elongation (GO:0006414),-0.14255085378395682,-0.5916440364814541,1.0,0.9840057800527138,1.0,34/101,30.92%,EEF1G;MRPL39;EEF1A1;EEF2K;EEF1D;EEFSEC;MRPS7;GTPBP1;MRPS17;MRPL20;MRPL15;MRPL16;MRPL2;MRPS18A;GADD45GIP1;MRPS18B;MRPL58;MRPL24;PTCD3;OXA1L;MRPL57;MRPL55;MRPS34;MRPL36;MRPL35;MRPS12;MRPS9;MRPL34;MRPL38;MRPL18;GTPBP2;MRPS2;TUFM;MRPL11
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.22811274031550066,0.5910824687804767,0.9516908212560387,0.9937500465399038,1.0,6/20,19.29%,GMPS;AMPD2;AK4;AK3;ADSS1;IMPDH2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.20125715806769282,-0.5904173866325952,0.9512195121951219,0.9839074166636758,1.0,8/20,32.69%,MGRN1;YWHAB;MET;MRAP2;BICD1;ADA;PLEK;RGS2
prerank,spliceosomal complex assembly (GO:0000245),0.19646758494191469,0.5902050762883568,0.9812409812409812,0.9937172712464708,1.0,12/46,20.93%,ZRSR2;NOL3;CELF4;LUC7L2;SRSF10;SRSF9;RBM5;SF3A3;SRSF6;DDX1;LUC7L3;DDX39B
prerank,positive regulation of B cell activation (GO:0050871),0.193188988024715,0.5890607115399356,0.9830508474576272,0.993790211588772,1.0,8/50,15.26%,CD40;IRS2;HMCES;GPR183;SH3KBP1;CD81;TIRAP;PAXIP1
prerank,membrane raft organization (GO:0031579),0.24110056199318827,0.5888865922204379,0.9385665529010239,0.9933943090996521,1.0,2/15,9.77%,FLOT2;FA2H
prerank,lung epithelium development (GO:0060428),-0.253258180244129,-0.5885941696260043,0.9323770491803278,0.9840060186478535,1.0,2/10,15.08%,ERRFI1;STRA6
prerank,glucose transmembrane transport (GO:1904659),0.23355650722588778,0.5866177351376811,0.9477234401349073,0.9940134771353756,1.0,1/18,4.08%,PPARD
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.2258909108599298,-0.5851598393615632,0.9602803738317757,0.9847983909208586,1.0,1/13,1.79%,IL18
prerank,histone mRNA catabolic process (GO:0071044),-0.22243130589417603,-0.5848990967227874,0.966903073286052,0.984276575164701,1.0,3/15,13.91%,TUT7;ERI1;ATM
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2051725393726721,0.5839903493678448,0.9638009049773756,0.9948181036228557,1.0,7/33,18.91%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,regulation of exosomal secretion (GO:1903541),0.22591607703893823,0.583636417711248,0.9482758620689655,0.9944976815775475,1.0,5/19,17.28%,HGS;ATP9A;TSG101;SNF8;VPS4B
prerank,regulation of erythrocyte differentiation (GO:0045646),0.20214406536476914,0.582952699133076,0.9815100154083205,0.9943456623488528,1.0,12/35,22.56%,ANKRD54;MED1;LYN;MAFB;MAPK11;LDB1;ARNT;HIF1A;INHBA;HSPA9;HOXA5;STAT1
prerank,microglial cell activation (GO:0001774),0.2287801818583224,0.5826551796906762,0.9626016260162602,0.994008425654993,1.0,2/21,7.29%,C5AR1;C1QA
prerank,regulation of response to interferon-gamma (GO:0060330),0.24086300279254494,0.5814760556437975,0.9491525423728814,0.9940949386729827,1.0,1/14,3.13%,JAK1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.24023363817763393,-0.5812939753782347,0.9241379310344827,0.9850186676502328,1.0,1/10,3.48%,SIRPA
prerank,folic acid metabolic process (GO:0046655),0.2341551286762053,0.5809225740710204,0.9559322033898305,0.9938794906411103,1.0,6/18,25.23%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2523951507529805,0.5808693959123313,0.9349736379613357,0.9934284424266786,1.0,2/12,9.52%,SNAP23;SNAP29
prerank,folic acid-containing compound metabolic process (GO:0006760),0.23012490585835513,0.5808093797442291,0.9526226734348562,0.9929710700742412,1.0,6/19,25.23%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.23317982019421662,0.5799064248696578,0.9574105621805792,0.9928915736136887,1.0,7/18,24.51%,ELOVL2;ACSL6;ELOVL6;ELOVL1;ACSBG1;ELOVL5;TECR
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.21551286814421322,-0.579554099238048,0.9592875318066157,0.9850894827977915,1.0,11/16,48.31%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1
prerank,response to peptide (GO:1901652),0.20507757239764882,0.578751486562724,0.9615384615384616,0.992960692252852,1.0,7/33,23.33%,IRS1;EIF2B1;FYN;KAT7;CACNA1A;STAT1;EIF2B5
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.25835359067170544,0.5778938484551998,0.9351351351351351,0.992866936591643,1.0,2/10,18.80%,NOC2L;THAP7
prerank,mitochondrial transport (GO:0006839),0.18824679018622392,0.5767521362729583,0.9772079772079773,0.9928887837674615,1.0,13/53,24.24%,TIMM10;DNAJC19;BCS1L;PITRM1;TIMM44;BAK1;MFN2;SLC25A16;GDAP1;SLC25A24;FIS1;BNIP3;TOMM34
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21913840169916277,-0.5766088619986933,0.955503512880562,0.9855687589519531,1.0,6/15,26.84%,ERN1;CLP1;TSEN34;ZBTB8OS;TSEN54;TRPT1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.23448377217782138,-0.5758745535128504,0.9578713968957872,0.985202504408931,1.0,5/11,32.06%,EGLN3;CRTAP;P4HA3;P4HB;P3H2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.22724649155091545,-0.574809393018174,0.9574468085106383,0.9849706789971121,1.0,6/12,30.72%,ADSS2;LHPP;PFAS;ATIC;PAICS;PPAT
prerank,microtubule anchoring (GO:0034453),0.24889561308267316,0.571535558363561,0.9441441441441442,0.99469387775418,1.0,4/12,19.21%,CLASP2;CLASP1;PCM1;PEX14
prerank,purine nucleotide metabolic process (GO:0006163),0.21502042453114686,0.5711481487393781,0.969558599695586,0.994382099156864,1.0,4/24,10.86%,ITPA;FHIT;PRPS1L1;PRPS1
prerank,protein palmitoylation (GO:0018345),0.20666588364371127,0.569164621284463,0.9655712050078247,0.9947677507134131,1.0,8/30,20.29%,CLIP3;ZDHHC24;ZDHHC19;HHAT;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,positive regulation of type I interferon production (GO:0032481),0.17481730259067912,0.5682150901384072,0.9866310160427807,0.9946762988964022,1.0,17/73,22.56%,PTPN22;DHX58;TRIM56;TLR8;TLR4;DDX41;IRAK1;DHX36;DHX9;POLR3A;MYD88;POLR2L;LRRFIP1;PTPN11;CREBBP;DHX33;STAT1
prerank,C4-dicarboxylate transport (GO:0015740),0.23783856536538558,0.5679731660622053,0.9522998296422487,0.9943086205876903,1.0,3/14,15.37%,SLC25A22;SLC25A30;SLC25A14
prerank,negative regulation of gluconeogenesis (GO:0045721),0.25492365314504345,0.5675984997887742,0.9301075268817204,0.9939883756808201,1.0,2/11,11.41%,GCK;ERFE
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.24470257830592854,0.5659024967323458,0.9540034071550255,0.9941974273793487,1.0,4/13,24.37%,SAE1;SENP6;ATG10;UBA2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.18184029236903196,0.5657986993052063,0.9914651493598862,0.9937578518862109,1.0,11/54,20.48%,ARID3A;CNOT11;E2F4;MDM4;TP53;CARM1;CNOT1;CNOT7;CNOT3;TFDP1;CNOT2
prerank,V(D)J recombination (GO:0033151),0.2552274621859809,0.5654095941168785,0.935251798561151,0.9934467251392771,1.0,1/11,3.37%,LIG3
prerank,positive regulation of catalytic activity (GO:0043085),0.1946395233426794,0.565178633174148,0.9760479041916168,0.9930586960111999,1.0,11/37,22.42%,MSH3;FXN;IGF2;ATP7A;NHEJ1;MSH6;WRN;SSBP1;CHTOP;B3GAT3;ABL1
prerank,regulation of T cell proliferation (GO:0042129),0.17613738413954488,0.5646840266818793,0.9903448275862069,0.9927813303521488,1.0,4/61,9.03%,GLMN;CD276;PDCD1LG2;TNFRSF21
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.2193691797139754,0.5638963748325413,0.9632,0.9926182420903212,1.0,2/22,5.55%,RYR2;SLC9A1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.18490071168149433,0.5583857418715229,0.9843304843304843,0.994238836973714,1.0,10/47,20.81%,PPARD;ZBTB16;BMP7;WDFY2;CARM1;PIM1;FRZB;BMP2;CMKLR1;RARRES2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.24936911334666745,0.5582473391788987,0.9450757575757576,0.9938101316130765,1.0,3/11,15.78%,TENT4B;EXOSC10;EXOSC5
prerank,negative regulation of histone acetylation (GO:0035067),-0.22151333309416416,-0.5524475515047003,0.9585152838427947,0.9914756206453414,1.0,5/11,31.58%,SIRT1;BRCA1;SPI1;TAF7;SET
prerank,negative regulation of cartilage development (GO:0061037),0.2418762139382184,0.5505994017231107,0.9581151832460733,0.9960439013856336,1.0,3/13,12.20%,ADAMTS12;TGFBR1;SOX9
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.20231283409145004,-0.5459371183913667,0.9738903394255874,0.9926386187425463,1.0,12/17,50.41%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.23242089402310379,0.5450838198198399,0.9663716814159292,0.9974091091181466,1.0,14/14,76.78%,RAB29;CD81;NECTIN2;PRKD2;LCK;TESPA1;CD226;TRAT1;RELA;RPS3;CARD11;KCNN4;IKBKG;BCL10
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.24105123219951785,0.5445568031135466,0.9547826086956521,0.9971020284739741,1.0,2/12,10.84%,FBXO31;TP53
prerank,negative regulation of inclusion body assembly (GO:0090084),0.24472771074312213,0.5441986828697365,0.9637681159420289,0.9967471742057588,1.0,1/10,5.39%,SORL1
prerank,lipid biosynthetic process (GO:0008610),0.16631369888044592,0.5438427736661536,0.9960106382978723,0.9963968354030547,1.0,8/77,14.76%,PAM;LIPC;LIPH;HSD17B8;ACSL6;ACLY;SREBF1;NDUFAB1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.24124987196896275,0.5436782077146671,0.9265905383360522,0.995987117679903,1.0,2/12,13.93%,FEN1;BUB1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.2203345048502028,-0.5415077829346743,0.9659863945578231,0.9931659469815054,1.0,5/12,32.94%,SOAT1;MFSD2A;P4HB;LPCAT3;APOC1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.2126934414329419,-0.5414186726891399,0.9720101781170484,0.9925692976771794,1.0,4/13,20.71%,SIX1;PTGS2;ZBTB7B;SOX13
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.21926663682012318,0.5396056144216516,0.9604130808950087,0.9967639542558746,1.0,3/16,18.51%,POLQ;FBH1;RIF1
prerank,hexose transmembrane transport (GO:0008645),0.20775613547472888,0.5377578438222025,0.9728813559322034,0.9968467136657496,1.0,1/21,4.08%,PPARD
prerank,eosinophil migration (GO:0072677),-0.19870668006027123,-0.5376435368927428,0.9738095238095238,0.9922591379569097,1.0,14/14,80.15%,CX3CL1;CCL5;CCL4;CCL8;CCL13;CCL7;CCL1;CCL3;CCL11;LGALS3;CCL24;CCL26;SCG2;CCL2
prerank,eosinophil chemotaxis (GO:0048245),-0.19870668006027123,-0.5376435368927428,0.9738095238095238,0.9922591379569097,1.0,14/14,80.15%,CX3CL1;CCL5;CCL4;CCL8;CCL13;CCL7;CCL1;CCL3;CCL11;LGALS3;CCL24;CCL26;SCG2;CCL2
prerank,regulation of myoblast fusion (GO:1901739),0.24118674594832737,0.5375385161768648,0.9512635379061372,0.9964377831175895,1.0,1/11,5.54%,ADGRB1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.2142555799840278,-0.5347270104465218,0.955456570155902,0.992366169777555,1.0,3/11,20.10%,TFRC;ADCK1;PID1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.20388773054015785,-0.5344254518931028,0.9739336492890995,0.9918179673021443,1.0,8/14,44.75%,ERN1;NCBP2;CPSF6;CPSF7;CPSF4L;FIP1L1;CSTF2;CPSF4
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.2090695431241065,0.5335855156658509,0.9755700325732899,0.9971157737142049,1.0,6/20,24.70%,GCK;ERFE;GSK3A;BCKDK;CRY1;CLK2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.16442115921755612,-0.5332690529226604,0.9943342776203966,0.9914737055840311,1.0,12/30,32.92%,TRIP12;SHLD2;OTUB1;RNF169;SMCHD1;OGG1;RMI2;NUDT16L1;PARPBP;OTUB2;HSF1;SHLD3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.21215677842237785,-0.5322127677826425,0.9699769053117783,0.9910887880566882,1.0,7/11,41.79%,PLCG2;TREM2;P2RX3;P2RX5;TRAT1;CCL4;NEUROD2
prerank,negative regulation of B cell proliferation (GO:0030889),0.23518572724154613,0.5318324019328781,0.9623287671232876,0.9971257638559113,1.0,2/11,14.16%,TNFRSF21;LYN
prerank,protein localization to microtubule organizing center (GO:1905508),0.22508763257857395,0.5312985481396456,0.9679595278246206,0.9967868183137503,1.0,4/15,21.10%,DCTN2;CEP192;PCM1;BBS4
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.20134354595680565,-0.5306189270067994,0.9829268292682927,0.9908541327113333,1.0,14/14,79.89%,NGRN;MPV17L2;FASTKD2;RPUSD3;COA3;C1QBP;RMND1;FASTKD3;TRUB2;RPUSD4;TRMT10C;RCC1L;MRPS27;UQCC2
prerank,aminoglycan metabolic process (GO:0006022),0.24246798895305036,0.5266412186160332,0.9482142857142857,0.9975635627373329,1.0,10/10,75.77%,B4GALT7;B3GAT3;B3GAT2;CHST9;B3GAT1;XYLT1;GAL3ST3;B3GALT6;XYLT2;CLN6
prerank,quinone biosynthetic process (GO:1901663),0.22282302312128335,0.5265164297096196,0.9825174825174825,0.9971182388107829,1.0,4/14,19.40%,COQ3;COQ8B;PDSS2;COQ7
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.2247473162157072,0.5250635729187058,0.9602076124567474,0.9970313302530237,1.0,13/13,77.54%,NUDT21;TUT1;CPSF2;CSTF2T;NCBP1;CPSF1;CPSF4;CSTF2;FIP1L1;CPSF4L;CPSF7;CPSF6;NCBP2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2120726797702881,0.5236757380886774,0.9743150684931506,0.996929127123511,1.0,5/15,23.86%,GLI1;ATAD5;DDRGK1;CDC73;STXBP4
prerank,negative regulation of receptor internalization (GO:0002091),0.22880563192486517,0.521920835259208,0.9486725663716814,0.9969042840971718,1.0,2/12,11.08%,NECAB2;DLG4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.18256300659748914,-0.5201717552395448,0.9880668257756563,0.9924115102524943,1.0,5/20,23.18%,FAR2;CBR4;ACSL4;FITM2;GCDH
prerank,superoxide anion generation (GO:0042554),-0.20017556190907698,-0.5183898100780451,0.9801980198019802,0.9921489882613883,1.0,4/13,26.20%,NOX4;ALOX12;CYBB;NCF2
prerank,regulation of calcium ion import (GO:0090279),-0.17383743203673546,-0.5172945612628636,0.9973958333333334,0.9917539811396395,1.0,6/21,25.92%,TRIM27;EGF;SPHK2;PLN;PLPP4;PSEN2
prerank,regulation of integrin activation (GO:0033623),-0.19449778315077282,-0.5168602227913611,0.9923857868020305,0.99122370105335,1.0,7/15,32.79%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC;PLEK;SELP
prerank,tetrahydrofolate metabolic process (GO:0046653),0.22869549663254604,0.5152571178316938,0.9563636363636364,0.9980411884170253,1.0,4/10,25.23%,MTHFD1L;MTHFD2L;MTHFD1;MTHFS
prerank,T cell proliferation (GO:0042098),0.21819625058212622,0.5130336853075627,0.9723661485319517,0.9980527782307955,1.0,3/13,17.33%,PPP3CB;LMBR1L;PIK3CG
prerank,regulation of mitochondrial translation (GO:0070129),0.20139495602336266,0.5125821571497045,0.9803921568627451,0.9976848100523132,1.0,7/21,23.88%,MALSU1;UQCC2;MRPS27;NSUN3;MTG1;RCC1L;TRMT10C
prerank,synaptic vesicle transport (GO:0048489),0.22923677217990251,0.5108462405435261,0.9735915492957746,0.9975841980657619,1.0,3/11,17.06%,KIF5C;TMEM230;CDK5
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.18001879238362126,0.5098602629370691,0.9905956112852664,0.9973262038378877,1.0,10/34,26.24%,TLR6;LRRC14;TLR4;LYN;NFKBIL1;NLRP2B;CACTIN;RAB7B;NR1D1;GRAMD4
prerank,estrogen metabolic process (GO:0008210),0.20937479105786336,0.5094838815084382,0.9862778730703259,0.9969363174971424,1.0,3/15,18.11%,HSD17B8;HSD17B11;HSD17B2
prerank,ubiquinone biosynthetic process (GO:0006744),0.21200426279362666,0.5067353147682152,0.9863013698630136,0.9970440404212234,1.0,4/15,19.40%,COQ3;COQ8B;PDSS2;COQ7
prerank,regulation of DNA recombination at telomere (GO:0072695),0.19874723368753708,0.5027960830712962,0.986013986013986,0.9969088348391748,1.0,6/19,24.50%,TERF1;DAXX;TERF2IP;POLR2L;ATRX;POLR2D
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.19874723368753708,0.5027960830712962,0.986013986013986,0.9969088348391748,1.0,6/19,24.50%,TERF1;DAXX;TERF2IP;POLR2L;ATRX;POLR2D
prerank,regulation of cilium movement (GO:0003352),-0.20884440552043704,-0.5013559304319993,0.9753363228699552,0.9932628607624499,1.0,7/10,39.62%,DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CFAP206;CCDC40
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.2258347978910369,0.4912612566311783,0.9709618874773139,0.998085930882301,1.0,10/10,77.43%,CEP250;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.2258347978910369,0.4912612566311783,0.9709618874773139,0.998085930882301,1.0,10/10,77.43%,CEP250;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4;TULP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.20498805558631122,0.49031748886726656,0.9771528998242531,0.9977756801768489,1.0,3/14,20.10%,TSEN15;FAM98B;DDX1
prerank,regulation of B cell activation (GO:0050864),0.17754692928588456,0.48593386998521343,0.9951768488745981,0.9980230747720777,1.0,2/25,11.81%,ZFP36L2;SH3KBP1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.2168470708809832,0.4826447698231874,0.9840142095914742,0.9980469875239708,1.0,1/11,5.82%,KCNIP2
prerank,ether lipid biosynthetic process (GO:0008611),0.22092473889303715,0.4822049733130617,0.9844020797227037,0.9976464498995428,1.0,1/10,5.70%,PEX7
prerank,phagosome acidification (GO:0090383),0.17530944380317562,0.4819617471293671,0.9968652037617555,0.997214543550164,1.0,4/26,18.49%,RAB20;ATP6V0E1;ATP6V1G2;ATP6V0D1
prerank,sulfation (GO:0051923),0.2069237904100845,0.47591056282082234,0.980327868852459,0.9976368706099948,1.0,2/11,15.35%,HS3ST5;SULT6B1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.21254032475658208,0.4753882131084601,0.9813874788494078,0.9963053254334892,1.0,2/12,12.72%,CDC16;ANAPC5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.21254032475658208,0.4753882131084601,0.9813874788494078,0.9963053254334892,1.0,2/12,12.72%,CDC16;ANAPC5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.21254032475658208,0.4753882131084601,0.9813874788494078,0.9963053254334892,1.0,2/12,12.72%,CDC16;ANAPC5
prerank,ovarian follicle development (GO:0001541),-0.1805417811134704,-0.47236050224388526,0.9931192660550459,0.9963728894140536,1.0,5/13,37.02%,EIF2B4;INHBB;FOXL2;CEBPB;EIF2B2
prerank,negative regulation of mRNA processing (GO:0050686),-0.16985235129985193,-0.4604716555846209,0.9974160206718347,0.9968990817639983,1.0,3/15,15.70%,RBMX;SRSF4;SRSF7
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.18913147761781238,0.45731745177047806,0.989983305509182,0.9980619771095044,1.0,5/14,25.35%,SRSF10;SRSF9;SRSF6;SRSF12;RNPS1
prerank,organophosphate catabolic process (GO:0046434),-0.1800400167604991,-0.44710819893204046,0.9950980392156863,0.9973444277241745,1.0,1/11,9.63%,ENPP2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.20009306493461493,0.4426179989678207,0.9874551971326165,0.9989914662415132,1.0,2/10,20.16%,DLGAP3;NPTX2
prerank,regulation of neutrophil migration (GO:1902622),0.19175297052649448,0.42541674784683847,0.9946524064171123,0.9998231075773971,1.0,2/10,17.92%,JAM3;RHOG
prerank,regulation of B cell differentiation (GO:0045577),0.1685168053416109,0.4127517810091345,1.0,1.0,1.0,1/17,6.74%,ZFP36L2
prerank,exit from mitosis (GO:0010458),0.177024482109228,0.4078757436740397,0.9982876712328768,0.9998460130908339,1.0,12/12,82.31%,CLASP2;CLASP1;PPP2R2D;SIRT7;SPAST;EPS8;UBE2C;UBE2S;CHMP2A;CTDP1;CHMP4B;CHMP7
prerank,DNA catabolic process (GO:0006308),0.17853361968056544,0.40131390774325176,0.9946714031971581,0.9996494047523926,1.0,4/11,27.75%,FBH1;REXO4;DNASE1L2;ISG20
prerank,positive regulation of defense response to virus by host (GO:0002230),0.13733440890460133,0.36291798162822053,1.0,1.0,1.0,2/24,13.10%,PTPN22;TRIM44
prerank,megakaryocyte differentiation (GO:0030219),0.14456091896302808,0.3317960727674122,1.0,0.9999180076179123,1.0,11/11,85.55%,MED1;UBA5;SH2B3;MPIG6B;KIT;GATA1;ZFPM1;THPO;IL11;CDKN2B;TAL1
